{"text": "AND USAGE: IROSPAN 24/6 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs.", "_input_hash": 340180046, "_task_hash": -514526101, "_is_binary": false, "tokens": [{"text": "AND", "start": 0, "end": 3, "id": 0, "ws": true}, {"text": "USAGE", "start": 4, "end": 9, "id": 1, "ws": false}, {"text": ":", "start": 9, "end": 10, "id": 2, "ws": true}, {"text": "IROSPAN", "start": 11, "end": 18, "id": 3, "ws": true}, {"text": "24/6", "start": 19, "end": 23, "id": 4, "ws": true}, {"text": "is", "start": 24, "end": 26, "id": 5, "ws": true}, {"text": "indicated", "start": 27, "end": 36, "id": 6, "ws": true}, {"text": "for", "start": 37, "end": 40, "id": 7, "ws": true}, {"text": "the", "start": 41, "end": 44, "id": 8, "ws": true}, {"text": "treatment", "start": 45, "end": 54, "id": 9, "ws": true}, {"text": "of", "start": 55, "end": 57, "id": 10, "ws": true}, {"text": "all", "start": 58, "end": 61, "id": 11, "ws": true}, {"text": "anemias", "start": 62, "end": 69, "id": 12, "ws": true}, {"text": "that", "start": 70, "end": 74, "id": 13, "ws": true}, {"text": "are", "start": 75, "end": 78, "id": 14, "ws": true}, {"text": "responsive", "start": 79, "end": 89, "id": 15, "ws": true}, {"text": "to", "start": 90, "end": 92, "id": 16, "ws": true}, {"text": "oral", "start": 93, "end": 97, "id": 17, "ws": true}, {"text": "iron", "start": 98, "end": 102, "id": 18, "ws": true}, {"text": "therapy", "start": 103, "end": 110, "id": 19, "ws": false}, {"text": ".", "start": 110, "end": 111, "id": 20, "ws": true}, {"text": "These", "start": 112, "end": 117, "id": 21, "ws": true}, {"text": "include", "start": 118, "end": 125, "id": 22, "ws": false}, {"text": ":", "start": 125, "end": 126, "id": 23, "ws": true}, {"text": "hypochromic", "start": 127, "end": 138, "id": 24, "ws": true}, {"text": "anemia", "start": 139, "end": 145, "id": 25, "ws": true}, {"text": "associated", "start": 146, "end": 156, "id": 26, "ws": true}, {"text": "with", "start": 157, "end": 161, "id": 27, "ws": true}, {"text": "pregnancy", "start": 162, "end": 171, "id": 28, "ws": false}, {"text": ",", "start": 171, "end": 172, "id": 29, "ws": true}, {"text": "chronic", "start": 173, "end": 180, "id": 30, "ws": true}, {"text": "and/or", "start": 181, "end": 187, "id": 31, "ws": true}, {"text": "acute", "start": 188, "end": 193, "id": 32, "ws": true}, {"text": "blood", "start": 194, "end": 199, "id": 33, "ws": true}, {"text": "loss", "start": 200, "end": 204, "id": 34, "ws": false}, {"text": ",", "start": 204, "end": 205, "id": 35, "ws": true}, {"text": "metabolic", "start": 206, "end": 215, "id": 36, "ws": true}, {"text": "disease", "start": 216, "end": 223, "id": 37, "ws": false}, {"text": ",", "start": 223, "end": 224, "id": 38, "ws": true}, {"text": "post", "start": 225, "end": 229, "id": 39, "ws": false}, {"text": "-", "start": 229, "end": 230, "id": 40, "ws": false}, {"text": "surgical", "start": 230, "end": 238, "id": 41, "ws": true}, {"text": "convalescence", "start": 239, "end": 252, "id": 42, "ws": false}, {"text": ",", "start": 252, "end": 253, "id": 43, "ws": true}, {"text": "and", "start": 254, "end": 257, "id": 44, "ws": true}, {"text": "dietary", "start": 258, "end": 265, "id": 45, "ws": true}, {"text": "needs", "start": 266, "end": 271, "id": 46, "ws": false}, {"text": ".", "start": 271, "end": 272, "id": 47, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 11, "end": 18, "token_start": 3, "token_end": 3, "label": "DRUG"}, {"start": 45, "end": 54, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 62, "end": 69, "token_start": 12, "token_end": 12, "label": "INDICATION"}, {"start": 79, "end": 110, "token_start": 15, "token_end": 19, "label": "MEDICAL_CTX"}, {"start": 127, "end": 145, "token_start": 24, "token_end": 25, "label": "INDICATION"}, {"start": 162, "end": 171, "token_start": 28, "token_end": 28, "label": "BASECONDITION"}, {"start": 173, "end": 204, "token_start": 30, "token_end": 34, "label": "BASECONDITION"}, {"start": 206, "end": 223, "token_start": 36, "token_end": 37, "label": "BASECONDITION"}, {"start": 225, "end": 252, "token_start": 39, "token_end": 42, "label": "BASECONDITION"}, {"start": 258, "end": 271, "token_start": 45, "token_end": 46, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176045, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "XEPI is indicated for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older [see Clinical Studies (14)]. XEPI is a quinolone antimicrobial indicated for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older (1).", "_input_hash": 1668417608, "_task_hash": 775736862, "_is_binary": false, "tokens": [{"text": "XEPI", "start": 0, "end": 4, "id": 0, "ws": true}, {"text": "is", "start": 5, "end": 7, "id": 1, "ws": true}, {"text": "indicated", "start": 8, "end": 17, "id": 2, "ws": true}, {"text": "for", "start": 18, "end": 21, "id": 3, "ws": true}, {"text": "the", "start": 22, "end": 25, "id": 4, "ws": true}, {"text": "topical", "start": 26, "end": 33, "id": 5, "ws": true}, {"text": "treatment", "start": 34, "end": 43, "id": 6, "ws": true}, {"text": "of", "start": 44, "end": 46, "id": 7, "ws": true}, {"text": "impetigo", "start": 47, "end": 55, "id": 8, "ws": true}, {"text": "due", "start": 56, "end": 59, "id": 9, "ws": true}, {"text": "to", "start": 60, "end": 62, "id": 10, "ws": true}, {"text": "Staphylococcus", "start": 63, "end": 77, "id": 11, "ws": true}, {"text": "aureus", "start": 78, "end": 84, "id": 12, "ws": true}, {"text": "or", "start": 85, "end": 87, "id": 13, "ws": true}, {"text": "Streptococcus", "start": 88, "end": 101, "id": 14, "ws": true}, {"text": "pyogenes", "start": 102, "end": 110, "id": 15, "ws": true}, {"text": "in", "start": 111, "end": 113, "id": 16, "ws": true}, {"text": "adult", "start": 114, "end": 119, "id": 17, "ws": true}, {"text": "and", "start": 120, "end": 123, "id": 18, "ws": true}, {"text": "pediatric", "start": 124, "end": 133, "id": 19, "ws": true}, {"text": "patients", "start": 134, "end": 142, "id": 20, "ws": true}, {"text": "2", "start": 143, "end": 144, "id": 21, "ws": true}, {"text": "months", "start": 145, "end": 151, "id": 22, "ws": true}, {"text": "of", "start": 152, "end": 154, "id": 23, "ws": true}, {"text": "age", "start": 155, "end": 158, "id": 24, "ws": true}, {"text": "and", "start": 159, "end": 162, "id": 25, "ws": true}, {"text": "older", "start": 163, "end": 168, "id": 26, "ws": true}, {"text": "[", "start": 169, "end": 170, "id": 27, "ws": false}, {"text": "see", "start": 170, "end": 173, "id": 28, "ws": true}, {"text": "Clinical", "start": 174, "end": 182, "id": 29, "ws": true}, {"text": "Studies", "start": 183, "end": 190, "id": 30, "ws": true}, {"text": "(", "start": 191, "end": 192, "id": 31, "ws": false}, {"text": "14", "start": 192, "end": 194, "id": 32, "ws": false}, {"text": ")", "start": 194, "end": 195, "id": 33, "ws": false}, {"text": "]", "start": 195, "end": 196, "id": 34, "ws": false}, {"text": ".", "start": 196, "end": 197, "id": 35, "ws": true}, {"text": "XEPI", "start": 198, "end": 202, "id": 36, "ws": true}, {"text": "is", "start": 203, "end": 205, "id": 37, "ws": true}, {"text": "a", "start": 206, "end": 207, "id": 38, "ws": true}, {"text": "quinolone", "start": 208, "end": 217, "id": 39, "ws": true}, {"text": "antimicrobial", "start": 218, "end": 231, "id": 40, "ws": true}, {"text": "indicated", "start": 232, "end": 241, "id": 41, "ws": true}, {"text": "for", "start": 242, "end": 245, "id": 42, "ws": true}, {"text": "the", "start": 246, "end": 249, "id": 43, "ws": true}, {"text": "topical", "start": 250, "end": 257, "id": 44, "ws": true}, {"text": "treatment", "start": 258, "end": 267, "id": 45, "ws": true}, {"text": "of", "start": 268, "end": 270, "id": 46, "ws": true}, {"text": "impetigo", "start": 271, "end": 279, "id": 47, "ws": true}, {"text": "due", "start": 280, "end": 283, "id": 48, "ws": true}, {"text": "to", "start": 284, "end": 286, "id": 49, "ws": true}, {"text": "Staphylococcus", "start": 287, "end": 301, "id": 50, "ws": true}, {"text": "aureus", "start": 302, "end": 308, "id": 51, "ws": true}, {"text": "or", "start": 309, "end": 311, "id": 52, "ws": true}, {"text": "Streptococcus", "start": 312, "end": 325, "id": 53, "ws": true}, {"text": "pyogenes", "start": 326, "end": 334, "id": 54, "ws": true}, {"text": "in", "start": 335, "end": 337, "id": 55, "ws": true}, {"text": "adult", "start": 338, "end": 343, "id": 56, "ws": true}, {"text": "and", "start": 344, "end": 347, "id": 57, "ws": true}, {"text": "pediatric", "start": 348, "end": 357, "id": 58, "ws": true}, {"text": "patients", "start": 358, "end": 366, "id": 59, "ws": true}, {"text": "2", "start": 367, "end": 368, "id": 60, "ws": true}, {"text": "months", "start": 369, "end": 375, "id": 61, "ws": true}, {"text": "of", "start": 376, "end": 378, "id": 62, "ws": true}, {"text": "age", "start": 379, "end": 382, "id": 63, "ws": true}, {"text": "and", "start": 383, "end": 386, "id": 64, "ws": true}, {"text": "older", "start": 387, "end": 392, "id": 65, "ws": true}, {"text": "(", "start": 393, "end": 394, "id": 66, "ws": false}, {"text": "1", "start": 394, "end": 395, "id": 67, "ws": false}, {"text": ")", "start": 395, "end": 396, "id": 68, "ws": false}, {"text": ".", "start": 396, "end": 397, "id": 69, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 4, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 26, "end": 33, "token_start": 5, "token_end": 5, "label": "ROUTE"}, {"start": 34, "end": 43, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 56, "end": 110, "token_start": 9, "token_end": 15, "label": "CAUSED_BY"}, {"start": 114, "end": 119, "token_start": 17, "token_end": 17, "label": "ACTION"}, {"start": 124, "end": 168, "token_start": 19, "token_end": 26, "label": "ACTION"}, {"start": 198, "end": 202, "token_start": 36, "token_end": 36, "label": "DRUG"}, {"start": 208, "end": 231, "token_start": 39, "token_end": 40, "label": "MECHANISM"}, {"start": 250, "end": 257, "token_start": 44, "token_end": 44, "label": "ROUTE"}, {"start": 258, "end": 267, "token_start": 45, "token_end": 45, "label": "ACTION"}, {"start": 280, "end": 334, "token_start": 48, "token_end": 54, "label": "CAUSED_BY"}, {"start": 338, "end": 343, "token_start": 56, "token_end": 56, "label": "ACTION"}, {"start": 348, "end": 392, "token_start": 58, "token_end": 65, "label": "ACTION"}], "answer": "accept", "_timestamp": 1694527915, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.", "_input_hash": 1521193346, "_task_hash": 228730223, "_is_binary": false, "tokens": [{"text": "Theophylline", "start": 0, "end": 12, "id": 0, "ws": true}, {"text": "is", "start": 13, "end": 15, "id": 1, "ws": true}, {"text": "indicated", "start": 16, "end": 25, "id": 2, "ws": true}, {"text": "for", "start": 26, "end": 29, "id": 3, "ws": true}, {"text": "the", "start": 30, "end": 33, "id": 4, "ws": true}, {"text": "treatment", "start": 34, "end": 43, "id": 5, "ws": true}, {"text": "of", "start": 44, "end": 46, "id": 6, "ws": true}, {"text": "the", "start": 47, "end": 50, "id": 7, "ws": true}, {"text": "symptoms", "start": 51, "end": 59, "id": 8, "ws": true}, {"text": "and", "start": 60, "end": 63, "id": 9, "ws": true}, {"text": "reversible", "start": 64, "end": 74, "id": 10, "ws": true}, {"text": "airflow", "start": 75, "end": 82, "id": 11, "ws": true}, {"text": "obstruction", "start": 83, "end": 94, "id": 12, "ws": true}, {"text": "associated", "start": 95, "end": 105, "id": 13, "ws": true}, {"text": "with", "start": 106, "end": 110, "id": 14, "ws": true}, {"text": "chronic", "start": 111, "end": 118, "id": 15, "ws": true}, {"text": "asthma", "start": 119, "end": 125, "id": 16, "ws": true}, {"text": "and", "start": 126, "end": 129, "id": 17, "ws": true}, {"text": "other", "start": 130, "end": 135, "id": 18, "ws": true}, {"text": "chronic", "start": 136, "end": 143, "id": 19, "ws": true}, {"text": "lung", "start": 144, "end": 148, "id": 20, "ws": true}, {"text": "diseases", "start": 149, "end": 157, "id": 21, "ws": false}, {"text": ",", "start": 157, "end": 158, "id": 22, "ws": true}, {"text": "e.g.", "start": 159, "end": 163, "id": 23, "ws": false}, {"text": ",", "start": 163, "end": 164, "id": 24, "ws": true}, {"text": "emphysema", "start": 165, "end": 174, "id": 25, "ws": true}, {"text": "and", "start": 175, "end": 178, "id": 26, "ws": true}, {"text": "chronic", "start": 179, "end": 186, "id": 27, "ws": true}, {"text": "bronchitis", "start": 187, "end": 197, "id": 28, "ws": false}, {"text": ".", "start": 197, "end": 198, "id": 29, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 12, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 34, "end": 43, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 51, "end": 59, "token_start": 8, "token_end": 8, "label": "INDICATION"}, {"start": 64, "end": 94, "token_start": 10, "token_end": 12, "label": "INDICATION"}, {"start": 111, "end": 125, "token_start": 15, "token_end": 16, "label": "BASECONDITION"}, {"start": 136, "end": 157, "token_start": 19, "token_end": 21, "label": "BASECONDITION"}, {"start": 165, "end": 174, "token_start": 25, "token_end": 25, "label": "BASECONDITION"}, {"start": 179, "end": 197, "token_start": 27, "token_end": 28, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694177063, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "LEVEMIR is indicated for once- or twice-daily subcutaneous administration for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long acting) insulin for the control of hyperglycemia.", "_input_hash": -671193212, "_task_hash": -1645118430, "_is_binary": false, "tokens": [{"text": "LEVEMIR", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "once-", "start": 25, "end": 30, "id": 4, "ws": true}, {"text": "or", "start": 31, "end": 33, "id": 5, "ws": true}, {"text": "twice", "start": 34, "end": 39, "id": 6, "ws": false}, {"text": "-", "start": 39, "end": 40, "id": 7, "ws": false}, {"text": "daily", "start": 40, "end": 45, "id": 8, "ws": true}, {"text": "subcutaneous", "start": 46, "end": 58, "id": 9, "ws": true}, {"text": "administration", "start": 59, "end": 73, "id": 10, "ws": true}, {"text": "for", "start": 74, "end": 77, "id": 11, "ws": true}, {"text": "the", "start": 78, "end": 81, "id": 12, "ws": true}, {"text": "treatment", "start": 82, "end": 91, "id": 13, "ws": true}, {"text": "of", "start": 92, "end": 94, "id": 14, "ws": true}, {"text": "adult", "start": 95, "end": 100, "id": 15, "ws": true}, {"text": "and", "start": 101, "end": 104, "id": 16, "ws": true}, {"text": "pediatric", "start": 105, "end": 114, "id": 17, "ws": true}, {"text": "patients", "start": 115, "end": 123, "id": 18, "ws": true}, {"text": "with", "start": 124, "end": 128, "id": 19, "ws": true}, {"text": "type", "start": 129, "end": 133, "id": 20, "ws": true}, {"text": "1", "start": 134, "end": 135, "id": 21, "ws": true}, {"text": "diabetes", "start": 136, "end": 144, "id": 22, "ws": true}, {"text": "mellitus", "start": 145, "end": 153, "id": 23, "ws": true}, {"text": "or", "start": 154, "end": 156, "id": 24, "ws": true}, {"text": "adult", "start": 157, "end": 162, "id": 25, "ws": true}, {"text": "patients", "start": 163, "end": 171, "id": 26, "ws": true}, {"text": "with", "start": 172, "end": 176, "id": 27, "ws": true}, {"text": "type", "start": 177, "end": 181, "id": 28, "ws": true}, {"text": "2", "start": 182, "end": 183, "id": 29, "ws": true}, {"text": "diabetes", "start": 184, "end": 192, "id": 30, "ws": true}, {"text": "mellitus", "start": 193, "end": 201, "id": 31, "ws": true}, {"text": "who", "start": 202, "end": 205, "id": 32, "ws": true}, {"text": "require", "start": 206, "end": 213, "id": 33, "ws": true}, {"text": "basal", "start": 214, "end": 219, "id": 34, "ws": true}, {"text": "(", "start": 220, "end": 221, "id": 35, "ws": false}, {"text": "long", "start": 221, "end": 225, "id": 36, "ws": true}, {"text": "acting", "start": 226, "end": 232, "id": 37, "ws": false}, {"text": ")", "start": 232, "end": 233, "id": 38, "ws": true}, {"text": "insulin", "start": 234, "end": 241, "id": 39, "ws": true}, {"text": "for", "start": 242, "end": 245, "id": 40, "ws": true}, {"text": "the", "start": 246, "end": 249, "id": 41, "ws": true}, {"text": "control", "start": 250, "end": 257, "id": 42, "ws": true}, {"text": "of", "start": 258, "end": 260, "id": 43, "ws": true}, {"text": "hyperglycemia", "start": 261, "end": 274, "id": 44, "ws": false}, {"text": ".", "start": 274, "end": 275, "id": 45, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 46, "end": 58, "token_start": 9, "token_end": 9, "label": "ROUTE"}, {"start": 82, "end": 91, "token_start": 13, "token_end": 13, "label": "ACTION"}, {"start": 95, "end": 100, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 105, "end": 123, "token_start": 17, "token_end": 18, "label": "TARGET_GROUP"}, {"start": 129, "end": 153, "token_start": 20, "token_end": 23, "label": "BASECONDITION"}, {"start": 157, "end": 162, "token_start": 25, "token_end": 25, "label": "TARGET_GROUP"}, {"start": 177, "end": 201, "token_start": 28, "token_end": 31, "label": "BASECONDITION"}, {"start": 214, "end": 241, "token_start": 34, "token_end": 39, "label": "CO_PRESCRIPTION"}], "answer": "accept", "_timestamp": 1694176382, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Flomax (tamsulosin hydrochloride) capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [ see Clinical Studies (14) ]. FLOMAX capsules are not indicated for the treatment of hypertension. FLOMAX is an alpha1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia (1) FLOMAX capsules are not indicated for the treatment of hypertension (1)", "_input_hash": 908900298, "_task_hash": 1473051048, "_is_binary": false, "tokens": [{"text": "Flomax", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "(", "start": 7, "end": 8, "id": 1, "ws": false}, {"text": "tamsulosin", "start": 8, "end": 18, "id": 2, "ws": true}, {"text": "hydrochloride", "start": 19, "end": 32, "id": 3, "ws": false}, {"text": ")", "start": 32, "end": 33, "id": 4, "ws": true}, {"text": "capsules", "start": 34, "end": 42, "id": 5, "ws": true}, {"text": "are", "start": 43, "end": 46, "id": 6, "ws": true}, {"text": "indicated", "start": 47, "end": 56, "id": 7, "ws": true}, {"text": "for", "start": 57, "end": 60, "id": 8, "ws": true}, {"text": "the", "start": 61, "end": 64, "id": 9, "ws": true}, {"text": "treatment", "start": 65, "end": 74, "id": 10, "ws": true}, {"text": "of", "start": 75, "end": 77, "id": 11, "ws": true}, {"text": "the", "start": 78, "end": 81, "id": 12, "ws": true}, {"text": "signs", "start": 82, "end": 87, "id": 13, "ws": true}, {"text": "and", "start": 88, "end": 91, "id": 14, "ws": true}, {"text": "symptoms", "start": 92, "end": 100, "id": 15, "ws": true}, {"text": "of", "start": 101, "end": 103, "id": 16, "ws": true}, {"text": "benign", "start": 104, "end": 110, "id": 17, "ws": true}, {"text": "prostatic", "start": 111, "end": 120, "id": 18, "ws": true}, {"text": "hyperplasia", "start": 121, "end": 132, "id": 19, "ws": true}, {"text": "(", "start": 133, "end": 134, "id": 20, "ws": false}, {"text": "BPH", "start": 134, "end": 137, "id": 21, "ws": false}, {"text": ")", "start": 137, "end": 138, "id": 22, "ws": true}, {"text": "[", "start": 139, "end": 140, "id": 23, "ws": true}, {"text": "see", "start": 141, "end": 144, "id": 24, "ws": true}, {"text": "Clinical", "start": 145, "end": 153, "id": 25, "ws": true}, {"text": "Studies", "start": 154, "end": 161, "id": 26, "ws": true}, {"text": "(", "start": 162, "end": 163, "id": 27, "ws": false}, {"text": "14", "start": 163, "end": 165, "id": 28, "ws": false}, {"text": ")", "start": 165, "end": 166, "id": 29, "ws": true}, {"text": "]", "start": 167, "end": 168, "id": 30, "ws": false}, {"text": ".", "start": 168, "end": 169, "id": 31, "ws": true}, {"text": "FLOMAX", "start": 170, "end": 176, "id": 32, "ws": true}, {"text": "capsules", "start": 177, "end": 185, "id": 33, "ws": true}, {"text": "are", "start": 186, "end": 189, "id": 34, "ws": true}, {"text": "not", "start": 190, "end": 193, "id": 35, "ws": true}, {"text": "indicated", "start": 194, "end": 203, "id": 36, "ws": true}, {"text": "for", "start": 204, "end": 207, "id": 37, "ws": true}, {"text": "the", "start": 208, "end": 211, "id": 38, "ws": true}, {"text": "treatment", "start": 212, "end": 221, "id": 39, "ws": true}, {"text": "of", "start": 222, "end": 224, "id": 40, "ws": true}, {"text": "hypertension", "start": 225, "end": 237, "id": 41, "ws": false}, {"text": ".", "start": 237, "end": 238, "id": 42, "ws": true}, {"text": "FLOMAX", "start": 239, "end": 245, "id": 43, "ws": true}, {"text": "is", "start": 246, "end": 248, "id": 44, "ws": true}, {"text": "an", "start": 249, "end": 251, "id": 45, "ws": true}, {"text": "alpha1", "start": 252, "end": 258, "id": 46, "ws": true}, {"text": "adrenoceptor", "start": 259, "end": 271, "id": 47, "ws": true}, {"text": "antagonist", "start": 272, "end": 282, "id": 48, "ws": true}, {"text": "indicated", "start": 283, "end": 292, "id": 49, "ws": true}, {"text": "for", "start": 293, "end": 296, "id": 50, "ws": true}, {"text": "treatment", "start": 297, "end": 306, "id": 51, "ws": true}, {"text": "of", "start": 307, "end": 309, "id": 52, "ws": true}, {"text": "the", "start": 310, "end": 313, "id": 53, "ws": true}, {"text": "signs", "start": 314, "end": 319, "id": 54, "ws": true}, {"text": "and", "start": 320, "end": 323, "id": 55, "ws": true}, {"text": "symptoms", "start": 324, "end": 332, "id": 56, "ws": true}, {"text": "of", "start": 333, "end": 335, "id": 57, "ws": true}, {"text": "benign", "start": 336, "end": 342, "id": 58, "ws": true}, {"text": "prostatic", "start": 343, "end": 352, "id": 59, "ws": true}, {"text": "hyperplasia", "start": 353, "end": 364, "id": 60, "ws": true}, {"text": "(", "start": 365, "end": 366, "id": 61, "ws": false}, {"text": "1", "start": 366, "end": 367, "id": 62, "ws": false}, {"text": ")", "start": 367, "end": 368, "id": 63, "ws": true}, {"text": "FLOMAX", "start": 369, "end": 375, "id": 64, "ws": true}, {"text": "capsules", "start": 376, "end": 384, "id": 65, "ws": true}, {"text": "are", "start": 385, "end": 388, "id": 66, "ws": true}, {"text": "not", "start": 389, "end": 392, "id": 67, "ws": true}, {"text": "indicated", "start": 393, "end": 402, "id": 68, "ws": true}, {"text": "for", "start": 403, "end": 406, "id": 69, "ws": true}, {"text": "the", "start": 407, "end": 410, "id": 70, "ws": true}, {"text": "treatment", "start": 411, "end": 420, "id": 71, "ws": true}, {"text": "of", "start": 421, "end": 423, "id": 72, "ws": true}, {"text": "hypertension", "start": 424, "end": 436, "id": 73, "ws": true}, {"text": "(", "start": 437, "end": 438, "id": 74, "ws": false}, {"text": "1", "start": 438, "end": 439, "id": 75, "ws": false}, {"text": ")", "start": 439, "end": 440, "id": 76, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 18, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 19, "end": 32, "token_start": 3, "token_end": 3, "label": "SALT"}, {"start": 34, "end": 42, "token_start": 5, "token_end": 5, "label": "FORMULATION"}, {"start": 65, "end": 74, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 82, "end": 100, "token_start": 13, "token_end": 15, "label": "INDICATION"}, {"start": 104, "end": 132, "token_start": 17, "token_end": 19, "label": "BASECONDITION"}, {"start": 170, "end": 237, "token_start": 32, "token_end": 41, "label": "CONTRAINDICATION"}, {"start": 239, "end": 245, "token_start": 43, "token_end": 43, "label": "DRUG"}, {"start": 252, "end": 282, "token_start": 46, "token_end": 48, "label": "MECHANISM"}, {"start": 297, "end": 306, "token_start": 51, "token_end": 51, "label": "ACTION"}, {"start": 314, "end": 332, "token_start": 54, "token_end": 56, "label": "INDICATION"}, {"start": 336, "end": 364, "token_start": 58, "token_end": 60, "label": "BASECONDITION"}, {"start": 369, "end": 436, "token_start": 64, "token_end": 73, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694527002, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Silver sulfadiazine cream, USP 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.", "_input_hash": -468201472, "_task_hash": -1722163621, "_is_binary": false, "tokens": [{"text": "Silver", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "sulfadiazine", "start": 7, "end": 19, "id": 1, "ws": true}, {"text": "cream", "start": 20, "end": 25, "id": 2, "ws": false}, {"text": ",", "start": 25, "end": 26, "id": 3, "ws": true}, {"text": "USP", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "1", "start": 31, "end": 32, "id": 5, "ws": false}, {"text": "%", "start": 32, "end": 33, "id": 6, "ws": true}, {"text": "is", "start": 34, "end": 36, "id": 7, "ws": true}, {"text": "a", "start": 37, "end": 38, "id": 8, "ws": true}, {"text": "topical", "start": 39, "end": 46, "id": 9, "ws": true}, {"text": "antimicrobial", "start": 47, "end": 60, "id": 10, "ws": true}, {"text": "drug", "start": 61, "end": 65, "id": 11, "ws": true}, {"text": "indicated", "start": 66, "end": 75, "id": 12, "ws": true}, {"text": "as", "start": 76, "end": 78, "id": 13, "ws": true}, {"text": "an", "start": 79, "end": 81, "id": 14, "ws": true}, {"text": "adjunct", "start": 82, "end": 89, "id": 15, "ws": true}, {"text": "for", "start": 90, "end": 93, "id": 16, "ws": true}, {"text": "the", "start": 94, "end": 97, "id": 17, "ws": true}, {"text": "prevention", "start": 98, "end": 108, "id": 18, "ws": true}, {"text": "and", "start": 109, "end": 112, "id": 19, "ws": true}, {"text": "treatment", "start": 113, "end": 122, "id": 20, "ws": true}, {"text": "of", "start": 123, "end": 125, "id": 21, "ws": true}, {"text": "wound", "start": 126, "end": 131, "id": 22, "ws": true}, {"text": "sepsis", "start": 132, "end": 138, "id": 23, "ws": true}, {"text": "in", "start": 139, "end": 141, "id": 24, "ws": true}, {"text": "patients", "start": 142, "end": 150, "id": 25, "ws": true}, {"text": "with", "start": 151, "end": 155, "id": 26, "ws": true}, {"text": "second", "start": 156, "end": 162, "id": 27, "ws": true}, {"text": "and", "start": 163, "end": 166, "id": 28, "ws": true}, {"text": "third", "start": 167, "end": 172, "id": 29, "ws": true}, {"text": "degree", "start": 173, "end": 179, "id": 30, "ws": true}, {"text": "burns", "start": 180, "end": 185, "id": 31, "ws": false}, {"text": ".", "start": 185, "end": 186, "id": 32, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 7, "end": 19, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 20, "end": 25, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 82, "end": 89, "token_start": 15, "token_end": 15, "label": "ACTION"}, {"start": 98, "end": 108, "token_start": 18, "token_end": 18, "label": "ACTION"}, {"start": 113, "end": 122, "token_start": 20, "token_end": 20, "label": "ACTION"}, {"start": 126, "end": 138, "token_start": 22, "token_end": 23, "label": "INDICATION"}, {"start": 142, "end": 185, "token_start": 25, "token_end": 31, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694176061, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Meclizine hydrochloride is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. Meclizine hydrochloride is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults.", "_input_hash": 2135815053, "_task_hash": 1794181172, "_is_binary": false, "tokens": [{"text": "Meclizine", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 10, "end": 23, "id": 1, "ws": true}, {"text": "is", "start": 24, "end": 26, "id": 2, "ws": true}, {"text": "indicated", "start": 27, "end": 36, "id": 3, "ws": true}, {"text": "for", "start": 37, "end": 40, "id": 4, "ws": true}, {"text": "the", "start": 41, "end": 44, "id": 5, "ws": true}, {"text": "treatment", "start": 45, "end": 54, "id": 6, "ws": true}, {"text": "of", "start": 55, "end": 57, "id": 7, "ws": true}, {"text": "vertigo", "start": 58, "end": 65, "id": 8, "ws": true}, {"text": "associated", "start": 66, "end": 76, "id": 9, "ws": true}, {"text": "with", "start": 77, "end": 81, "id": 10, "ws": true}, {"text": "diseases", "start": 82, "end": 90, "id": 11, "ws": true}, {"text": "affecting", "start": 91, "end": 100, "id": 12, "ws": true}, {"text": "the", "start": 101, "end": 104, "id": 13, "ws": true}, {"text": "vestibular", "start": 105, "end": 115, "id": 14, "ws": true}, {"text": "system", "start": 116, "end": 122, "id": 15, "ws": true}, {"text": "in", "start": 123, "end": 125, "id": 16, "ws": true}, {"text": "adults", "start": 126, "end": 132, "id": 17, "ws": false}, {"text": ".", "start": 132, "end": 133, "id": 18, "ws": true}, {"text": "Meclizine", "start": 134, "end": 143, "id": 19, "ws": true}, {"text": "hydrochloride", "start": 144, "end": 157, "id": 20, "ws": true}, {"text": "is", "start": 158, "end": 160, "id": 21, "ws": true}, {"text": "indicated", "start": 161, "end": 170, "id": 22, "ws": true}, {"text": "for", "start": 171, "end": 174, "id": 23, "ws": true}, {"text": "the", "start": 175, "end": 178, "id": 24, "ws": true}, {"text": "treatment", "start": 179, "end": 188, "id": 25, "ws": true}, {"text": "of", "start": 189, "end": 191, "id": 26, "ws": true}, {"text": "vertigo", "start": 192, "end": 199, "id": 27, "ws": true}, {"text": "associated", "start": 200, "end": 210, "id": 28, "ws": true}, {"text": "with", "start": 211, "end": 215, "id": 29, "ws": true}, {"text": "diseases", "start": 216, "end": 224, "id": 30, "ws": true}, {"text": "affecting", "start": 225, "end": 234, "id": 31, "ws": true}, {"text": "the", "start": 235, "end": 238, "id": 32, "ws": true}, {"text": "vestibular", "start": 239, "end": 249, "id": 33, "ws": true}, {"text": "system", "start": 250, "end": 256, "id": 34, "ws": true}, {"text": "in", "start": 257, "end": 259, "id": 35, "ws": true}, {"text": "adults", "start": 260, "end": 266, "id": 36, "ws": false}, {"text": ".", "start": 266, "end": 267, "id": 37, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 45, "end": 54, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 58, "end": 65, "token_start": 8, "token_end": 8, "label": "INDICATION"}, {"start": 82, "end": 122, "token_start": 11, "token_end": 15, "label": "BASECONDITION"}, {"start": 126, "end": 132, "token_start": 17, "token_end": 17, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694176344, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Hydrocortisone Butyrate Ointment, 0.1% and Hydrocortisone Butyrate Cream USP, 0.1% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Hydrocortisone Butyrate Topical Solution, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of seborrheic dermatitis.", "_input_hash": -989152661, "_task_hash": 2037351181, "_is_binary": false, "tokens": [{"text": "Hydrocortisone", "start": 0, "end": 14, "id": 0, "ws": true}, {"text": "Butyrate", "start": 15, "end": 23, "id": 1, "ws": true}, {"text": "Ointment", "start": 24, "end": 32, "id": 2, "ws": false}, {"text": ",", "start": 32, "end": 33, "id": 3, "ws": true}, {"text": "0.1", "start": 34, "end": 37, "id": 4, "ws": false}, {"text": "%", "start": 37, "end": 38, "id": 5, "ws": true}, {"text": "and", "start": 39, "end": 42, "id": 6, "ws": true}, {"text": "Hydrocortisone", "start": 43, "end": 57, "id": 7, "ws": true}, {"text": "Butyrate", "start": 58, "end": 66, "id": 8, "ws": true}, {"text": "Cream", "start": 67, "end": 72, "id": 9, "ws": true}, {"text": "USP", "start": 73, "end": 76, "id": 10, "ws": false}, {"text": ",", "start": 76, "end": 77, "id": 11, "ws": true}, {"text": "0.1", "start": 78, "end": 81, "id": 12, "ws": false}, {"text": "%", "start": 81, "end": 82, "id": 13, "ws": true}, {"text": "are", "start": 83, "end": 86, "id": 14, "ws": true}, {"text": "indicated", "start": 87, "end": 96, "id": 15, "ws": true}, {"text": "for", "start": 97, "end": 100, "id": 16, "ws": true}, {"text": "the", "start": 101, "end": 104, "id": 17, "ws": true}, {"text": "relief", "start": 105, "end": 111, "id": 18, "ws": true}, {"text": "of", "start": 112, "end": 114, "id": 19, "ws": true}, {"text": "the", "start": 115, "end": 118, "id": 20, "ws": true}, {"text": "inflammatory", "start": 119, "end": 131, "id": 21, "ws": true}, {"text": "and", "start": 132, "end": 135, "id": 22, "ws": true}, {"text": "pruritic", "start": 136, "end": 144, "id": 23, "ws": true}, {"text": "manifestations", "start": 145, "end": 159, "id": 24, "ws": true}, {"text": "of", "start": 160, "end": 162, "id": 25, "ws": true}, {"text": "corticosteroid", "start": 163, "end": 177, "id": 26, "ws": false}, {"text": "-", "start": 177, "end": 178, "id": 27, "ws": false}, {"text": "responsive", "start": 178, "end": 188, "id": 28, "ws": true}, {"text": "dermatoses", "start": 189, "end": 199, "id": 29, "ws": false}, {"text": ".", "start": 199, "end": 200, "id": 30, "ws": true}, {"text": "Hydrocortisone", "start": 201, "end": 215, "id": 31, "ws": true}, {"text": "Butyrate", "start": 216, "end": 224, "id": 32, "ws": true}, {"text": "Topical", "start": 225, "end": 232, "id": 33, "ws": true}, {"text": "Solution", "start": 233, "end": 241, "id": 34, "ws": false}, {"text": ",", "start": 241, "end": 242, "id": 35, "ws": true}, {"text": "0.1", "start": 243, "end": 246, "id": 36, "ws": false}, {"text": "%", "start": 246, "end": 247, "id": 37, "ws": true}, {"text": "is", "start": 248, "end": 250, "id": 38, "ws": true}, {"text": "indicated", "start": 251, "end": 260, "id": 39, "ws": true}, {"text": "for", "start": 261, "end": 264, "id": 40, "ws": true}, {"text": "the", "start": 265, "end": 268, "id": 41, "ws": true}, {"text": "relief", "start": 269, "end": 275, "id": 42, "ws": true}, {"text": "of", "start": 276, "end": 278, "id": 43, "ws": true}, {"text": "the", "start": 279, "end": 282, "id": 44, "ws": true}, {"text": "inflammatory", "start": 283, "end": 295, "id": 45, "ws": true}, {"text": "and", "start": 296, "end": 299, "id": 46, "ws": true}, {"text": "pruritic", "start": 300, "end": 308, "id": 47, "ws": true}, {"text": "manifestations", "start": 309, "end": 323, "id": 48, "ws": true}, {"text": "of", "start": 324, "end": 326, "id": 49, "ws": true}, {"text": "seborrheic", "start": 327, "end": 337, "id": 50, "ws": true}, {"text": "dermatitis", "start": 338, "end": 348, "id": 51, "ws": false}, {"text": ".", "start": 348, "end": 349, "id": 52, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 14, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 15, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 32, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 43, "end": 57, "token_start": 7, "token_end": 7, "label": "DRUG"}, {"start": 58, "end": 66, "token_start": 8, "token_end": 8, "label": "SALT"}, {"start": 67, "end": 72, "token_start": 9, "token_end": 9, "label": "MECHANISM"}, {"start": 105, "end": 111, "token_start": 18, "token_end": 18, "label": "ACTION"}, {"start": 119, "end": 162, "token_start": 21, "token_end": 25, "label": "INDICATION"}, {"start": 163, "end": 199, "token_start": 26, "token_end": 29, "label": "BASECONDITION"}, {"start": 201, "end": 215, "token_start": 31, "token_end": 31, "label": "DRUG"}, {"start": 216, "end": 224, "token_start": 32, "token_end": 32, "label": "SALT"}, {"start": 225, "end": 232, "token_start": 33, "token_end": 33, "label": "ROUTE"}, {"start": 233, "end": 241, "token_start": 34, "token_end": 34, "label": "FORMULATION"}, {"start": 269, "end": 275, "token_start": 42, "token_end": 42, "label": "ACTION"}, {"start": 283, "end": 323, "token_start": 45, "token_end": 48, "label": "INDICATION"}, {"start": 327, "end": 349, "token_start": 50, "token_end": 52, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526074, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Ammonium Lactate Lotion, 12% is indicated for the treatment of dry, scaly skin (xerosis) and ichthyosis vulgaris, and for the temporary relief of itching associated with these conditions.", "_input_hash": -1854406958, "_task_hash": -602042072, "_is_binary": false, "tokens": [{"text": "Ammonium", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "Lactate", "start": 9, "end": 16, "id": 1, "ws": true}, {"text": "Lotion", "start": 17, "end": 23, "id": 2, "ws": false}, {"text": ",", "start": 23, "end": 24, "id": 3, "ws": true}, {"text": "12", "start": 25, "end": 27, "id": 4, "ws": false}, {"text": "%", "start": 27, "end": 28, "id": 5, "ws": true}, {"text": "is", "start": 29, "end": 31, "id": 6, "ws": true}, {"text": "indicated", "start": 32, "end": 41, "id": 7, "ws": true}, {"text": "for", "start": 42, "end": 45, "id": 8, "ws": true}, {"text": "the", "start": 46, "end": 49, "id": 9, "ws": true}, {"text": "treatment", "start": 50, "end": 59, "id": 10, "ws": true}, {"text": "of", "start": 60, "end": 62, "id": 11, "ws": true}, {"text": "dry", "start": 63, "end": 66, "id": 12, "ws": false}, {"text": ",", "start": 66, "end": 67, "id": 13, "ws": true}, {"text": "scaly", "start": 68, "end": 73, "id": 14, "ws": true}, {"text": "skin", "start": 74, "end": 78, "id": 15, "ws": true}, {"text": "(", "start": 79, "end": 80, "id": 16, "ws": false}, {"text": "xerosis", "start": 80, "end": 87, "id": 17, "ws": false}, {"text": ")", "start": 87, "end": 88, "id": 18, "ws": true}, {"text": "and", "start": 89, "end": 92, "id": 19, "ws": true}, {"text": "ichthyosis", "start": 93, "end": 103, "id": 20, "ws": true}, {"text": "vulgaris", "start": 104, "end": 112, "id": 21, "ws": false}, {"text": ",", "start": 112, "end": 113, "id": 22, "ws": true}, {"text": "and", "start": 114, "end": 117, "id": 23, "ws": true}, {"text": "for", "start": 118, "end": 121, "id": 24, "ws": true}, {"text": "the", "start": 122, "end": 125, "id": 25, "ws": true}, {"text": "temporary", "start": 126, "end": 135, "id": 26, "ws": true}, {"text": "relief", "start": 136, "end": 142, "id": 27, "ws": true}, {"text": "of", "start": 143, "end": 145, "id": 28, "ws": true}, {"text": "itching", "start": 146, "end": 153, "id": 29, "ws": true}, {"text": "associated", "start": 154, "end": 164, "id": 30, "ws": true}, {"text": "with", "start": 165, "end": 169, "id": 31, "ws": true}, {"text": "these", "start": 170, "end": 175, "id": 32, "ws": true}, {"text": "conditions", "start": 176, "end": 186, "id": 33, "ws": false}, {"text": ".", "start": 186, "end": 187, "id": 34, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 16, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 17, "end": 23, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 50, "end": 59, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 63, "end": 78, "token_start": 12, "token_end": 15, "label": "INDICATION"}, {"start": 80, "end": 87, "token_start": 17, "token_end": 17, "label": "INDICATION"}, {"start": 93, "end": 112, "token_start": 20, "token_end": 21, "label": "INDICATION"}, {"start": 146, "end": 153, "token_start": 29, "token_end": 29, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694175893, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Hemmorex-HC suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani.", "_input_hash": 992197285, "_task_hash": 1798554428, "_is_binary": false, "tokens": [{"text": "Hemmorex", "start": 0, "end": 8, "id": 0, "ws": false}, {"text": "-", "start": 8, "end": 9, "id": 1, "ws": false}, {"text": "HC", "start": 9, "end": 11, "id": 2, "ws": true}, {"text": "suppositories", "start": 12, "end": 25, "id": 3, "ws": true}, {"text": "are", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "indicated", "start": 30, "end": 39, "id": 5, "ws": true}, {"text": "for", "start": 40, "end": 43, "id": 6, "ws": true}, {"text": "use", "start": 44, "end": 47, "id": 7, "ws": true}, {"text": "in", "start": 48, "end": 50, "id": 8, "ws": true}, {"text": "inflamed", "start": 51, "end": 59, "id": 9, "ws": true}, {"text": "hemorrhoids", "start": 60, "end": 71, "id": 10, "ws": false}, {"text": ",", "start": 71, "end": 72, "id": 11, "ws": true}, {"text": "post", "start": 73, "end": 77, "id": 12, "ws": false}, {"text": "-", "start": 77, "end": 78, "id": 13, "ws": false}, {"text": "irradiation", "start": 78, "end": 89, "id": 14, "ws": true}, {"text": "(", "start": 90, "end": 91, "id": 15, "ws": false}, {"text": "factitial", "start": 91, "end": 100, "id": 16, "ws": false}, {"text": ")", "start": 100, "end": 101, "id": 17, "ws": true}, {"text": "proctitis", "start": 102, "end": 111, "id": 18, "ws": false}, {"text": ";", "start": 111, "end": 112, "id": 19, "ws": true}, {"text": "as", "start": 113, "end": 115, "id": 20, "ws": true}, {"text": "an", "start": 116, "end": 118, "id": 21, "ws": true}, {"text": "adjunct", "start": 119, "end": 126, "id": 22, "ws": true}, {"text": "in", "start": 127, "end": 129, "id": 23, "ws": true}, {"text": "the", "start": 130, "end": 133, "id": 24, "ws": true}, {"text": "treatment", "start": 134, "end": 143, "id": 25, "ws": true}, {"text": "of", "start": 144, "end": 146, "id": 26, "ws": true}, {"text": "chronic", "start": 147, "end": 154, "id": 27, "ws": true}, {"text": "ulcerative", "start": 155, "end": 165, "id": 28, "ws": true}, {"text": "colitis", "start": 166, "end": 173, "id": 29, "ws": false}, {"text": ";", "start": 173, "end": 174, "id": 30, "ws": true}, {"text": "cryptitis", "start": 175, "end": 184, "id": 31, "ws": false}, {"text": ";", "start": 184, "end": 185, "id": 32, "ws": true}, {"text": "and", "start": 186, "end": 189, "id": 33, "ws": true}, {"text": "other", "start": 190, "end": 195, "id": 34, "ws": true}, {"text": "inflammatory", "start": 196, "end": 208, "id": 35, "ws": true}, {"text": "conditions", "start": 209, "end": 219, "id": 36, "ws": true}, {"text": "of", "start": 220, "end": 222, "id": 37, "ws": true}, {"text": "anorectum", "start": 223, "end": 232, "id": 38, "ws": true}, {"text": "and", "start": 233, "end": 236, "id": 39, "ws": true}, {"text": "pruritus", "start": 237, "end": 245, "id": 40, "ws": true}, {"text": "ani", "start": 246, "end": 249, "id": 41, "ws": false}, {"text": ".", "start": 249, "end": 250, "id": 42, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 25, "token_start": 3, "token_end": 3, "label": "ROUTE"}, {"start": 44, "end": 47, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 51, "end": 71, "token_start": 9, "token_end": 10, "label": "INDICATION"}, {"start": 73, "end": 111, "token_start": 12, "token_end": 18, "label": "INDICATION"}, {"start": 119, "end": 146, "token_start": 22, "token_end": 26, "label": "ACTION"}, {"start": 147, "end": 173, "token_start": 27, "token_end": 29, "label": "INDICATION"}, {"start": 175, "end": 184, "token_start": 31, "token_end": 31, "label": "INDICATION"}, {"start": 196, "end": 219, "token_start": 35, "token_end": 36, "label": "INDICATION"}, {"start": 223, "end": 232, "token_start": 38, "token_end": 38, "label": "BASECONDITION"}, {"start": 237, "end": 249, "token_start": 40, "token_end": 41, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694174531, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "SAVELLA is indicated for the management of fibromyalgia. SAVELLA is not approved for use in pediatric patients [see Use in Specific Populations ( 8.4 )].  SAVELLA is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia (1).  SAVELLA is not approved for use in pediatric patients (1).", "_input_hash": 1411233715, "_task_hash": 1485202744, "_is_binary": false, "tokens": [{"text": "SAVELLA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "management", "start": 29, "end": 39, "id": 5, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "fibromyalgia", "start": 43, "end": 55, "id": 7, "ws": false}, {"text": ".", "start": 55, "end": 56, "id": 8, "ws": true}, {"text": "SAVELLA", "start": 57, "end": 64, "id": 9, "ws": true}, {"text": "is", "start": 65, "end": 67, "id": 10, "ws": true}, {"text": "not", "start": 68, "end": 71, "id": 11, "ws": true}, {"text": "approved", "start": 72, "end": 80, "id": 12, "ws": true}, {"text": "for", "start": 81, "end": 84, "id": 13, "ws": true}, {"text": "use", "start": 85, "end": 88, "id": 14, "ws": true}, {"text": "in", "start": 89, "end": 91, "id": 15, "ws": true}, {"text": "pediatric", "start": 92, "end": 101, "id": 16, "ws": true}, {"text": "patients", "start": 102, "end": 110, "id": 17, "ws": true}, {"text": "[", "start": 111, "end": 112, "id": 18, "ws": false}, {"text": "see", "start": 112, "end": 115, "id": 19, "ws": true}, {"text": "Use", "start": 116, "end": 119, "id": 20, "ws": true}, {"text": "in", "start": 120, "end": 122, "id": 21, "ws": true}, {"text": "Specific", "start": 123, "end": 131, "id": 22, "ws": true}, {"text": "Populations", "start": 132, "end": 143, "id": 23, "ws": true}, {"text": "(", "start": 144, "end": 145, "id": 24, "ws": true}, {"text": "8.4", "start": 146, "end": 149, "id": 25, "ws": true}, {"text": ")", "start": 150, "end": 151, "id": 26, "ws": false}, {"text": "]", "start": 151, "end": 152, "id": 27, "ws": false}, {"text": ".", "start": 152, "end": 153, "id": 28, "ws": true}, {"text": " ", "start": 154, "end": 155, "id": 29, "ws": false}, {"text": "SAVELLA", "start": 155, "end": 162, "id": 30, "ws": true}, {"text": "is", "start": 163, "end": 165, "id": 31, "ws": true}, {"text": "a", "start": 166, "end": 167, "id": 32, "ws": true}, {"text": "selective", "start": 168, "end": 177, "id": 33, "ws": true}, {"text": "serotonin", "start": 178, "end": 187, "id": 34, "ws": true}, {"text": "and", "start": 188, "end": 191, "id": 35, "ws": true}, {"text": "norepinephrine", "start": 192, "end": 206, "id": 36, "ws": true}, {"text": "reuptake", "start": 207, "end": 215, "id": 37, "ws": true}, {"text": "inhibitor", "start": 216, "end": 225, "id": 38, "ws": true}, {"text": "(", "start": 226, "end": 227, "id": 39, "ws": false}, {"text": "SNRI", "start": 227, "end": 231, "id": 40, "ws": false}, {"text": ")", "start": 231, "end": 232, "id": 41, "ws": true}, {"text": "indicated", "start": 233, "end": 242, "id": 42, "ws": true}, {"text": "for", "start": 243, "end": 246, "id": 43, "ws": true}, {"text": "the", "start": 247, "end": 250, "id": 44, "ws": true}, {"text": "management", "start": 251, "end": 261, "id": 45, "ws": true}, {"text": "of", "start": 262, "end": 264, "id": 46, "ws": true}, {"text": "fibromyalgia", "start": 265, "end": 277, "id": 47, "ws": true}, {"text": "(", "start": 278, "end": 279, "id": 48, "ws": false}, {"text": "1", "start": 279, "end": 280, "id": 49, "ws": false}, {"text": ")", "start": 280, "end": 281, "id": 50, "ws": false}, {"text": ".", "start": 281, "end": 282, "id": 51, "ws": true}, {"text": " ", "start": 283, "end": 284, "id": 52, "ws": false}, {"text": "SAVELLA", "start": 284, "end": 291, "id": 53, "ws": true}, {"text": "is", "start": 292, "end": 294, "id": 54, "ws": true}, {"text": "not", "start": 295, "end": 298, "id": 55, "ws": true}, {"text": "approved", "start": 299, "end": 307, "id": 56, "ws": true}, {"text": "for", "start": 308, "end": 311, "id": 57, "ws": true}, {"text": "use", "start": 312, "end": 315, "id": 58, "ws": true}, {"text": "in", "start": 316, "end": 318, "id": 59, "ws": true}, {"text": "pediatric", "start": 319, "end": 328, "id": 60, "ws": true}, {"text": "patients", "start": 329, "end": 337, "id": 61, "ws": true}, {"text": "(", "start": 338, "end": 339, "id": 62, "ws": false}, {"text": "1", "start": 339, "end": 340, "id": 63, "ws": false}, {"text": ")", "start": 340, "end": 341, "id": 64, "ws": false}, {"text": ".", "start": 341, "end": 342, "id": 65, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 39, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 43, "end": 55, "token_start": 7, "token_end": 7, "label": "INDICATION"}, {"start": 57, "end": 110, "token_start": 9, "token_end": 17, "label": "CONTRAINDICATION"}, {"start": 155, "end": 162, "token_start": 30, "token_end": 30, "label": "DRUG"}, {"start": 168, "end": 232, "token_start": 33, "token_end": 41, "label": "MECHANISM"}, {"start": 251, "end": 261, "token_start": 45, "token_end": 45, "label": "ACTION"}, {"start": 265, "end": 277, "token_start": 47, "token_end": 47, "label": "INDICATION"}, {"start": 284, "end": 337, "token_start": 53, "token_end": 61, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694525955, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. At the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. Minoxidil reduced supine diastolic blood pressure by 20 mm Hg or to 90 mm Hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs.", "_input_hash": 2044468935, "_task_hash": -1827987653, "_is_binary": false, "tokens": [{"text": "Because", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "of", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "the", "start": 11, "end": 14, "id": 2, "ws": true}, {"text": "potential", "start": 15, "end": 24, "id": 3, "ws": true}, {"text": "for", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "serious", "start": 29, "end": 36, "id": 5, "ws": true}, {"text": "adverse", "start": 37, "end": 44, "id": 6, "ws": true}, {"text": "effects", "start": 45, "end": 52, "id": 7, "ws": false}, {"text": ",", "start": 52, "end": 53, "id": 8, "ws": true}, {"text": "minoxidil", "start": 54, "end": 63, "id": 9, "ws": true}, {"text": "tablets", "start": 64, "end": 71, "id": 10, "ws": true}, {"text": "are", "start": 72, "end": 75, "id": 11, "ws": true}, {"text": "indicated", "start": 76, "end": 85, "id": 12, "ws": true}, {"text": "only", "start": 86, "end": 90, "id": 13, "ws": true}, {"text": "in", "start": 91, "end": 93, "id": 14, "ws": true}, {"text": "the", "start": 94, "end": 97, "id": 15, "ws": true}, {"text": "treatment", "start": 98, "end": 107, "id": 16, "ws": true}, {"text": "of", "start": 108, "end": 110, "id": 17, "ws": true}, {"text": "hypertension", "start": 111, "end": 123, "id": 18, "ws": true}, {"text": "that", "start": 124, "end": 128, "id": 19, "ws": true}, {"text": "is", "start": 129, "end": 131, "id": 20, "ws": true}, {"text": "symptomatic", "start": 132, "end": 143, "id": 21, "ws": true}, {"text": "or", "start": 144, "end": 146, "id": 22, "ws": true}, {"text": "associated", "start": 147, "end": 157, "id": 23, "ws": true}, {"text": "with", "start": 158, "end": 162, "id": 24, "ws": true}, {"text": "target", "start": 163, "end": 169, "id": 25, "ws": true}, {"text": "organ", "start": 170, "end": 175, "id": 26, "ws": true}, {"text": "damage", "start": 176, "end": 182, "id": 27, "ws": true}, {"text": "and", "start": 183, "end": 186, "id": 28, "ws": true}, {"text": "is", "start": 187, "end": 189, "id": 29, "ws": true}, {"text": "not", "start": 190, "end": 193, "id": 30, "ws": true}, {"text": "manageable", "start": 194, "end": 204, "id": 31, "ws": true}, {"text": "with", "start": 205, "end": 209, "id": 32, "ws": true}, {"text": "maximum", "start": 210, "end": 217, "id": 33, "ws": true}, {"text": "therapeutic", "start": 218, "end": 229, "id": 34, "ws": true}, {"text": "doses", "start": 230, "end": 235, "id": 35, "ws": true}, {"text": "of", "start": 236, "end": 238, "id": 36, "ws": true}, {"text": "a", "start": 239, "end": 240, "id": 37, "ws": true}, {"text": "diuretic", "start": 241, "end": 249, "id": 38, "ws": true}, {"text": "plus", "start": 250, "end": 254, "id": 39, "ws": true}, {"text": "two", "start": 255, "end": 258, "id": 40, "ws": true}, {"text": "other", "start": 259, "end": 264, "id": 41, "ws": true}, {"text": "antihypertensive", "start": 265, "end": 281, "id": 42, "ws": true}, {"text": "drugs", "start": 282, "end": 287, "id": 43, "ws": false}, {"text": ".", "start": 287, "end": 288, "id": 44, "ws": true}, {"text": "At", "start": 289, "end": 291, "id": 45, "ws": true}, {"text": "the", "start": 292, "end": 295, "id": 46, "ws": true}, {"text": "present", "start": 296, "end": 303, "id": 47, "ws": true}, {"text": "time", "start": 304, "end": 308, "id": 48, "ws": true}, {"text": "use", "start": 309, "end": 312, "id": 49, "ws": true}, {"text": "in", "start": 313, "end": 315, "id": 50, "ws": true}, {"text": "milder", "start": 316, "end": 322, "id": 51, "ws": true}, {"text": "degrees", "start": 323, "end": 330, "id": 52, "ws": true}, {"text": "of", "start": 331, "end": 333, "id": 53, "ws": true}, {"text": "hypertension", "start": 334, "end": 346, "id": 54, "ws": true}, {"text": "is", "start": 347, "end": 349, "id": 55, "ws": true}, {"text": "not", "start": 350, "end": 353, "id": 56, "ws": true}, {"text": "recommended", "start": 354, "end": 365, "id": 57, "ws": true}, {"text": "because", "start": 366, "end": 373, "id": 58, "ws": true}, {"text": "the", "start": 374, "end": 377, "id": 59, "ws": true}, {"text": "benefit", "start": 378, "end": 385, "id": 60, "ws": false}, {"text": "-", "start": 385, "end": 386, "id": 61, "ws": false}, {"text": "risk", "start": 386, "end": 390, "id": 62, "ws": true}, {"text": "relationship", "start": 391, "end": 403, "id": 63, "ws": true}, {"text": "in", "start": 404, "end": 406, "id": 64, "ws": true}, {"text": "such", "start": 407, "end": 411, "id": 65, "ws": true}, {"text": "patients", "start": 412, "end": 420, "id": 66, "ws": true}, {"text": "has", "start": 421, "end": 424, "id": 67, "ws": true}, {"text": "not", "start": 425, "end": 428, "id": 68, "ws": true}, {"text": "been", "start": 429, "end": 433, "id": 69, "ws": true}, {"text": "defined", "start": 434, "end": 441, "id": 70, "ws": false}, {"text": ".", "start": 441, "end": 442, "id": 71, "ws": true}, {"text": "Minoxidil", "start": 443, "end": 452, "id": 72, "ws": true}, {"text": "reduced", "start": 453, "end": 460, "id": 73, "ws": true}, {"text": "supine", "start": 461, "end": 467, "id": 74, "ws": true}, {"text": "diastolic", "start": 468, "end": 477, "id": 75, "ws": true}, {"text": "blood", "start": 478, "end": 483, "id": 76, "ws": true}, {"text": "pressure", "start": 484, "end": 492, "id": 77, "ws": true}, {"text": "by", "start": 493, "end": 495, "id": 78, "ws": true}, {"text": "20", "start": 496, "end": 498, "id": 79, "ws": true}, {"text": "mm", "start": 499, "end": 501, "id": 80, "ws": true}, {"text": "Hg", "start": 502, "end": 504, "id": 81, "ws": true}, {"text": "or", "start": 505, "end": 507, "id": 82, "ws": true}, {"text": "to", "start": 508, "end": 510, "id": 83, "ws": true}, {"text": "90", "start": 511, "end": 513, "id": 84, "ws": true}, {"text": "mm", "start": 514, "end": 516, "id": 85, "ws": true}, {"text": "Hg", "start": 517, "end": 519, "id": 86, "ws": true}, {"text": "or", "start": 520, "end": 522, "id": 87, "ws": true}, {"text": "less", "start": 523, "end": 527, "id": 88, "ws": true}, {"text": "in", "start": 528, "end": 530, "id": 89, "ws": true}, {"text": "approximately", "start": 531, "end": 544, "id": 90, "ws": true}, {"text": "75", "start": 545, "end": 547, "id": 91, "ws": false}, {"text": "%", "start": 547, "end": 548, "id": 92, "ws": true}, {"text": "of", "start": 549, "end": 551, "id": 93, "ws": true}, {"text": "patients", "start": 552, "end": 560, "id": 94, "ws": false}, {"text": ",", "start": 560, "end": 561, "id": 95, "ws": true}, {"text": "most", "start": 562, "end": 566, "id": 96, "ws": true}, {"text": "of", "start": 567, "end": 569, "id": 97, "ws": true}, {"text": "who", "start": 570, "end": 573, "id": 98, "ws": true}, {"text": "had", "start": 574, "end": 577, "id": 99, "ws": true}, {"text": "hypertension", "start": 578, "end": 590, "id": 100, "ws": true}, {"text": "that", "start": 591, "end": 595, "id": 101, "ws": true}, {"text": "could", "start": 596, "end": 601, "id": 102, "ws": true}, {"text": "not", "start": 602, "end": 605, "id": 103, "ws": true}, {"text": "be", "start": 606, "end": 608, "id": 104, "ws": true}, {"text": "controlled", "start": 609, "end": 619, "id": 105, "ws": true}, {"text": "by", "start": 620, "end": 622, "id": 106, "ws": true}, {"text": "other", "start": 623, "end": 628, "id": 107, "ws": true}, {"text": "drugs", "start": 629, "end": 634, "id": 108, "ws": false}, {"text": ".", "start": 634, "end": 635, "id": 109, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 54, "end": 63, "token_start": 9, "token_end": 9, "label": "DRUG"}, {"start": 64, "end": 71, "token_start": 10, "token_end": 10, "label": "FORMULATION"}, {"start": 98, "end": 110, "token_start": 16, "token_end": 17, "label": "ACTION"}, {"start": 111, "end": 123, "token_start": 18, "token_end": 18, "label": "INDICATION"}, {"start": 170, "end": 182, "token_start": 26, "token_end": 27, "label": "BASECONDITION"}, {"start": 190, "end": 287, "token_start": 30, "token_end": 43, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694174560, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Potassium chloride extended-release tablets are indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium chloride extended-release tablets are potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. (1)", "_input_hash": -2051451476, "_task_hash": 2145686598, "_is_binary": false, "tokens": [{"text": "Potassium", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "chloride", "start": 10, "end": 18, "id": 1, "ws": true}, {"text": "extended", "start": 19, "end": 27, "id": 2, "ws": false}, {"text": "-", "start": 27, "end": 28, "id": 3, "ws": false}, {"text": "release", "start": 28, "end": 35, "id": 4, "ws": true}, {"text": "tablets", "start": 36, "end": 43, "id": 5, "ws": true}, {"text": "are", "start": 44, "end": 47, "id": 6, "ws": true}, {"text": "indicated", "start": 48, "end": 57, "id": 7, "ws": true}, {"text": "for", "start": 58, "end": 61, "id": 8, "ws": true}, {"text": "the", "start": 62, "end": 65, "id": 9, "ws": true}, {"text": "treatment", "start": 66, "end": 75, "id": 10, "ws": true}, {"text": "and", "start": 76, "end": 79, "id": 11, "ws": true}, {"text": "prophylaxis", "start": 80, "end": 91, "id": 12, "ws": true}, {"text": "of", "start": 92, "end": 94, "id": 13, "ws": true}, {"text": "hypokalemia", "start": 95, "end": 106, "id": 14, "ws": true}, {"text": "with", "start": 107, "end": 111, "id": 15, "ws": true}, {"text": "or", "start": 112, "end": 114, "id": 16, "ws": true}, {"text": "without", "start": 115, "end": 122, "id": 17, "ws": true}, {"text": "metabolic", "start": 123, "end": 132, "id": 18, "ws": true}, {"text": "alkalosis", "start": 133, "end": 142, "id": 19, "ws": false}, {"text": ",", "start": 142, "end": 143, "id": 20, "ws": true}, {"text": "in", "start": 144, "end": 146, "id": 21, "ws": true}, {"text": "patients", "start": 147, "end": 155, "id": 22, "ws": true}, {"text": "for", "start": 156, "end": 159, "id": 23, "ws": true}, {"text": "whom", "start": 160, "end": 164, "id": 24, "ws": true}, {"text": "dietary", "start": 165, "end": 172, "id": 25, "ws": true}, {"text": "management", "start": 173, "end": 183, "id": 26, "ws": true}, {"text": "with", "start": 184, "end": 188, "id": 27, "ws": true}, {"text": "potassium", "start": 189, "end": 198, "id": 28, "ws": false}, {"text": "-", "start": 198, "end": 199, "id": 29, "ws": false}, {"text": "rich", "start": 199, "end": 203, "id": 30, "ws": true}, {"text": "foods", "start": 204, "end": 209, "id": 31, "ws": true}, {"text": "or", "start": 210, "end": 212, "id": 32, "ws": true}, {"text": "diuretic", "start": 213, "end": 221, "id": 33, "ws": true}, {"text": "dose", "start": 222, "end": 226, "id": 34, "ws": true}, {"text": "reduction", "start": 227, "end": 236, "id": 35, "ws": true}, {"text": "is", "start": 237, "end": 239, "id": 36, "ws": true}, {"text": "insufficient", "start": 240, "end": 252, "id": 37, "ws": false}, {"text": ".", "start": 252, "end": 253, "id": 38, "ws": true}, {"text": "Potassium", "start": 254, "end": 263, "id": 39, "ws": true}, {"text": "chloride", "start": 264, "end": 272, "id": 40, "ws": true}, {"text": "extended", "start": 273, "end": 281, "id": 41, "ws": false}, {"text": "-", "start": 281, "end": 282, "id": 42, "ws": false}, {"text": "release", "start": 282, "end": 289, "id": 43, "ws": true}, {"text": "tablets", "start": 290, "end": 297, "id": 44, "ws": true}, {"text": "are", "start": 298, "end": 301, "id": 45, "ws": true}, {"text": "potassium", "start": 302, "end": 311, "id": 46, "ws": true}, {"text": "salt", "start": 312, "end": 316, "id": 47, "ws": true}, {"text": "indicated", "start": 317, "end": 326, "id": 48, "ws": true}, {"text": "for", "start": 327, "end": 330, "id": 49, "ws": true}, {"text": "the", "start": 331, "end": 334, "id": 50, "ws": true}, {"text": "treatment", "start": 335, "end": 344, "id": 51, "ws": true}, {"text": "and", "start": 345, "end": 348, "id": 52, "ws": true}, {"text": "prophylaxis", "start": 349, "end": 360, "id": 53, "ws": true}, {"text": "of", "start": 361, "end": 363, "id": 54, "ws": true}, {"text": "hypokalemia", "start": 364, "end": 375, "id": 55, "ws": true}, {"text": "with", "start": 376, "end": 380, "id": 56, "ws": true}, {"text": "or", "start": 381, "end": 383, "id": 57, "ws": true}, {"text": "without", "start": 384, "end": 391, "id": 58, "ws": true}, {"text": "metabolic", "start": 392, "end": 401, "id": 59, "ws": true}, {"text": "alkalosis", "start": 402, "end": 411, "id": 60, "ws": true}, {"text": "in", "start": 412, "end": 414, "id": 61, "ws": true}, {"text": "patients", "start": 415, "end": 423, "id": 62, "ws": true}, {"text": "for", "start": 424, "end": 427, "id": 63, "ws": true}, {"text": "whom", "start": 428, "end": 432, "id": 64, "ws": true}, {"text": "dietary", "start": 433, "end": 440, "id": 65, "ws": true}, {"text": "management", "start": 441, "end": 451, "id": 66, "ws": true}, {"text": "with", "start": 452, "end": 456, "id": 67, "ws": true}, {"text": "potassium", "start": 457, "end": 466, "id": 68, "ws": false}, {"text": "-", "start": 466, "end": 467, "id": 69, "ws": false}, {"text": "rich", "start": 467, "end": 471, "id": 70, "ws": true}, {"text": "foods", "start": 472, "end": 477, "id": 71, "ws": true}, {"text": "or", "start": 478, "end": 480, "id": 72, "ws": true}, {"text": "diuretic", "start": 481, "end": 489, "id": 73, "ws": true}, {"text": "dose", "start": 490, "end": 494, "id": 74, "ws": true}, {"text": "reduction", "start": 495, "end": 504, "id": 75, "ws": true}, {"text": "is", "start": 505, "end": 507, "id": 76, "ws": true}, {"text": "insufficient", "start": 508, "end": 520, "id": 77, "ws": false}, {"text": ".", "start": 520, "end": 521, "id": 78, "ws": true}, {"text": "(", "start": 522, "end": 523, "id": 79, "ws": false}, {"text": "1", "start": 523, "end": 524, "id": 80, "ws": false}, {"text": ")", "start": 524, "end": 525, "id": 81, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 18, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 19, "end": 43, "token_start": 2, "token_end": 5, "label": "FORMULATION"}, {"start": 66, "end": 75, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 80, "end": 91, "token_start": 12, "token_end": 12, "label": "ACTION"}, {"start": 95, "end": 106, "token_start": 14, "token_end": 14, "label": "INDICATION"}, {"start": 165, "end": 252, "token_start": 25, "token_end": 37, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694175197, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Hydrocortisone butyrate cream USP, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "_input_hash": -280990102, "_task_hash": 466908477, "_is_binary": false, "tokens": [{"text": "Hydrocortisone", "start": 0, "end": 14, "id": 0, "ws": true}, {"text": "butyrate", "start": 15, "end": 23, "id": 1, "ws": true}, {"text": "cream", "start": 24, "end": 29, "id": 2, "ws": true}, {"text": "USP", "start": 30, "end": 33, "id": 3, "ws": false}, {"text": ",", "start": 33, "end": 34, "id": 4, "ws": true}, {"text": "0.1", "start": 35, "end": 38, "id": 5, "ws": false}, {"text": "%", "start": 38, "end": 39, "id": 6, "ws": true}, {"text": "is", "start": 40, "end": 42, "id": 7, "ws": true}, {"text": "indicated", "start": 43, "end": 52, "id": 8, "ws": true}, {"text": "for", "start": 53, "end": 56, "id": 9, "ws": true}, {"text": "the", "start": 57, "end": 60, "id": 10, "ws": true}, {"text": "relief", "start": 61, "end": 67, "id": 11, "ws": true}, {"text": "of", "start": 68, "end": 70, "id": 12, "ws": true}, {"text": "the", "start": 71, "end": 74, "id": 13, "ws": true}, {"text": "inflammatory", "start": 75, "end": 87, "id": 14, "ws": true}, {"text": "and", "start": 88, "end": 91, "id": 15, "ws": true}, {"text": "pruritic", "start": 92, "end": 100, "id": 16, "ws": true}, {"text": "manifestations", "start": 101, "end": 115, "id": 17, "ws": true}, {"text": "of", "start": 116, "end": 118, "id": 18, "ws": true}, {"text": "corticosteroid", "start": 119, "end": 133, "id": 19, "ws": false}, {"text": "-", "start": 133, "end": 134, "id": 20, "ws": false}, {"text": "responsive", "start": 134, "end": 144, "id": 21, "ws": true}, {"text": "dermatoses", "start": 145, "end": 155, "id": 22, "ws": false}, {"text": ".", "start": 155, "end": 156, "id": 23, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 14, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 15, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 29, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 61, "end": 67, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 75, "end": 115, "token_start": 14, "token_end": 17, "label": "INDICATION"}, {"start": 119, "end": 155, "token_start": 19, "token_end": 22, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527434, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Primidone, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy.", "_input_hash": 1242357698, "_task_hash": 13177126, "_is_binary": false, "tokens": [{"text": "Primidone", "start": 0, "end": 9, "id": 0, "ws": false}, {"text": ",", "start": 9, "end": 10, "id": 1, "ws": true}, {"text": "used", "start": 11, "end": 15, "id": 2, "ws": true}, {"text": "alone", "start": 16, "end": 21, "id": 3, "ws": true}, {"text": "or", "start": 22, "end": 24, "id": 4, "ws": true}, {"text": "concomitantly", "start": 25, "end": 38, "id": 5, "ws": true}, {"text": "with", "start": 39, "end": 43, "id": 6, "ws": true}, {"text": "other", "start": 44, "end": 49, "id": 7, "ws": true}, {"text": "anticonvulsants", "start": 50, "end": 65, "id": 8, "ws": false}, {"text": ",", "start": 65, "end": 66, "id": 9, "ws": true}, {"text": "is", "start": 67, "end": 69, "id": 10, "ws": true}, {"text": "indicated", "start": 70, "end": 79, "id": 11, "ws": true}, {"text": "in", "start": 80, "end": 82, "id": 12, "ws": true}, {"text": "the", "start": 83, "end": 86, "id": 13, "ws": true}, {"text": "control", "start": 87, "end": 94, "id": 14, "ws": true}, {"text": "of", "start": 95, "end": 97, "id": 15, "ws": true}, {"text": "grand", "start": 98, "end": 103, "id": 16, "ws": true}, {"text": "mal", "start": 104, "end": 107, "id": 17, "ws": false}, {"text": ",", "start": 107, "end": 108, "id": 18, "ws": true}, {"text": "psychomotor", "start": 109, "end": 120, "id": 19, "ws": false}, {"text": ",", "start": 120, "end": 121, "id": 20, "ws": true}, {"text": "and", "start": 122, "end": 125, "id": 21, "ws": true}, {"text": "focal", "start": 126, "end": 131, "id": 22, "ws": true}, {"text": "epileptic", "start": 132, "end": 141, "id": 23, "ws": true}, {"text": "seizures", "start": 142, "end": 150, "id": 24, "ws": false}, {"text": ".", "start": 150, "end": 151, "id": 25, "ws": true}, {"text": "It", "start": 152, "end": 154, "id": 26, "ws": true}, {"text": "may", "start": 155, "end": 158, "id": 27, "ws": true}, {"text": "control", "start": 159, "end": 166, "id": 28, "ws": true}, {"text": "grand", "start": 167, "end": 172, "id": 29, "ws": true}, {"text": "mal", "start": 173, "end": 176, "id": 30, "ws": true}, {"text": "seizures", "start": 177, "end": 185, "id": 31, "ws": true}, {"text": "refractory", "start": 186, "end": 196, "id": 32, "ws": true}, {"text": "to", "start": 197, "end": 199, "id": 33, "ws": true}, {"text": "other", "start": 200, "end": 205, "id": 34, "ws": true}, {"text": "anticonvulsant", "start": 206, "end": 220, "id": 35, "ws": true}, {"text": "therapy", "start": 221, "end": 228, "id": 36, "ws": false}, {"text": ".", "start": 228, "end": 229, "id": 37, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 87, "end": 94, "token_start": 14, "token_end": 14, "label": "ACTION"}, {"start": 98, "end": 107, "token_start": 16, "token_end": 17, "label": "INDICATION"}, {"start": 109, "end": 150, "token_start": 19, "token_end": 24, "label": "INDICATION"}, {"start": 159, "end": 166, "token_start": 28, "token_end": 28, "label": "ACTION"}, {"start": 167, "end": 185, "token_start": 29, "token_end": 31, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694525237, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "IDAMYCIN PFS Injection in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.", "_input_hash": 1201316842, "_task_hash": -1597303008, "_is_binary": false, "tokens": [{"text": "IDAMYCIN", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "PFS", "start": 9, "end": 12, "id": 1, "ws": true}, {"text": "Injection", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "in", "start": 23, "end": 25, "id": 3, "ws": true}, {"text": "combination", "start": 26, "end": 37, "id": 4, "ws": true}, {"text": "with", "start": 38, "end": 42, "id": 5, "ws": true}, {"text": "other", "start": 43, "end": 48, "id": 6, "ws": true}, {"text": "approved", "start": 49, "end": 57, "id": 7, "ws": true}, {"text": "antileukemic", "start": 58, "end": 70, "id": 8, "ws": true}, {"text": "drugs", "start": 71, "end": 76, "id": 9, "ws": true}, {"text": "is", "start": 77, "end": 79, "id": 10, "ws": true}, {"text": "indicated", "start": 80, "end": 89, "id": 11, "ws": true}, {"text": "for", "start": 90, "end": 93, "id": 12, "ws": true}, {"text": "the", "start": 94, "end": 97, "id": 13, "ws": true}, {"text": "treatment", "start": 98, "end": 107, "id": 14, "ws": true}, {"text": "of", "start": 108, "end": 110, "id": 15, "ws": true}, {"text": "acute", "start": 111, "end": 116, "id": 16, "ws": true}, {"text": "myeloid", "start": 117, "end": 124, "id": 17, "ws": true}, {"text": "leukemia", "start": 125, "end": 133, "id": 18, "ws": true}, {"text": "(", "start": 134, "end": 135, "id": 19, "ws": false}, {"text": "AML", "start": 135, "end": 138, "id": 20, "ws": false}, {"text": ")", "start": 138, "end": 139, "id": 21, "ws": true}, {"text": "in", "start": 140, "end": 142, "id": 22, "ws": true}, {"text": "adults", "start": 143, "end": 149, "id": 23, "ws": false}, {"text": ".", "start": 149, "end": 150, "id": 24, "ws": true}, {"text": "This", "start": 151, "end": 155, "id": 25, "ws": true}, {"text": "includes", "start": 156, "end": 164, "id": 26, "ws": true}, {"text": "French", "start": 165, "end": 171, "id": 27, "ws": false}, {"text": "-", "start": 171, "end": 172, "id": 28, "ws": false}, {"text": "American", "start": 172, "end": 180, "id": 29, "ws": false}, {"text": "-", "start": 180, "end": 181, "id": 30, "ws": false}, {"text": "British", "start": 181, "end": 188, "id": 31, "ws": true}, {"text": "(", "start": 189, "end": 190, "id": 32, "ws": false}, {"text": "FAB", "start": 190, "end": 193, "id": 33, "ws": false}, {"text": ")", "start": 193, "end": 194, "id": 34, "ws": true}, {"text": "classifications", "start": 195, "end": 210, "id": 35, "ws": true}, {"text": "M1", "start": 211, "end": 213, "id": 36, "ws": true}, {"text": "through", "start": 214, "end": 221, "id": 37, "ws": true}, {"text": "M7", "start": 222, "end": 224, "id": 38, "ws": false}, {"text": ".", "start": 224, "end": 225, "id": 39, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 13, "end": 22, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 58, "end": 76, "token_start": 8, "token_end": 9, "label": "CO_PRESCRIPTION"}, {"start": 98, "end": 110, "token_start": 14, "token_end": 15, "label": "ACTION"}, {"start": 111, "end": 133, "token_start": 16, "token_end": 18, "label": "INDICATION"}, {"start": 143, "end": 149, "token_start": 23, "token_end": 23, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694173927, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Collagenase Santyl Ointment is indicated for debriding chronic dermal ulcers 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 and severely burned areas. 3, 4, 5, 7, 16, 19, 20, 21", "_input_hash": -1135624153, "_task_hash": -1139710560, "_is_binary": false, "tokens": [{"text": "Collagenase", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "Santyl", "start": 12, "end": 18, "id": 1, "ws": true}, {"text": "Ointment", "start": 19, "end": 27, "id": 2, "ws": true}, {"text": "is", "start": 28, "end": 30, "id": 3, "ws": true}, {"text": "indicated", "start": 31, "end": 40, "id": 4, "ws": true}, {"text": "for", "start": 41, "end": 44, "id": 5, "ws": true}, {"text": "debriding", "start": 45, "end": 54, "id": 6, "ws": true}, {"text": "chronic", "start": 55, "end": 62, "id": 7, "ws": true}, {"text": "dermal", "start": 63, "end": 69, "id": 8, "ws": true}, {"text": "ulcers", "start": 70, "end": 76, "id": 9, "ws": true}, {"text": "2", "start": 77, "end": 78, "id": 10, "ws": false}, {"text": ",", "start": 78, "end": 79, "id": 11, "ws": true}, {"text": "3", "start": 80, "end": 81, "id": 12, "ws": false}, {"text": ",", "start": 81, "end": 82, "id": 13, "ws": true}, {"text": "4", "start": 83, "end": 84, "id": 14, "ws": false}, {"text": ",", "start": 84, "end": 85, "id": 15, "ws": true}, {"text": "5", "start": 86, "end": 87, "id": 16, "ws": false}, {"text": ",", "start": 87, "end": 88, "id": 17, "ws": true}, {"text": "6", "start": 89, "end": 90, "id": 18, "ws": false}, {"text": ",", "start": 90, "end": 91, "id": 19, "ws": true}, {"text": "8", "start": 92, "end": 93, "id": 20, "ws": false}, {"text": ",", "start": 93, "end": 94, "id": 21, "ws": true}, {"text": "9", "start": 95, "end": 96, "id": 22, "ws": false}, {"text": ",", "start": 96, "end": 97, "id": 23, "ws": true}, {"text": "10", "start": 98, "end": 100, "id": 24, "ws": false}, {"text": ",", "start": 100, "end": 101, "id": 25, "ws": true}, {"text": "11", "start": 102, "end": 104, "id": 26, "ws": false}, {"text": ",", "start": 104, "end": 105, "id": 27, "ws": true}, {"text": "12", "start": 106, "end": 108, "id": 28, "ws": false}, {"text": ",", "start": 108, "end": 109, "id": 29, "ws": true}, {"text": "13", "start": 110, "end": 112, "id": 30, "ws": false}, {"text": ",", "start": 112, "end": 113, "id": 31, "ws": true}, {"text": "14", "start": 114, "end": 116, "id": 32, "ws": false}, {"text": ",", "start": 116, "end": 117, "id": 33, "ws": true}, {"text": "15", "start": 118, "end": 120, "id": 34, "ws": false}, {"text": ",", "start": 120, "end": 121, "id": 35, "ws": true}, {"text": "16", "start": 122, "end": 124, "id": 36, "ws": false}, {"text": ",", "start": 124, "end": 125, "id": 37, "ws": true}, {"text": "17", "start": 126, "end": 128, "id": 38, "ws": false}, {"text": ",", "start": 128, "end": 129, "id": 39, "ws": true}, {"text": "18", "start": 130, "end": 132, "id": 40, "ws": true}, {"text": "and", "start": 133, "end": 136, "id": 41, "ws": true}, {"text": "severely", "start": 137, "end": 145, "id": 42, "ws": true}, {"text": "burned", "start": 146, "end": 152, "id": 43, "ws": true}, {"text": "areas", "start": 153, "end": 158, "id": 44, "ws": false}, {"text": ".", "start": 158, "end": 159, "id": 45, "ws": true}, {"text": "3", "start": 160, "end": 161, "id": 46, "ws": false}, {"text": ",", "start": 161, "end": 162, "id": 47, "ws": true}, {"text": "4", "start": 163, "end": 164, "id": 48, "ws": false}, {"text": ",", "start": 164, "end": 165, "id": 49, "ws": true}, {"text": "5", "start": 166, "end": 167, "id": 50, "ws": false}, {"text": ",", "start": 167, "end": 168, "id": 51, "ws": true}, {"text": "7", "start": 169, "end": 170, "id": 52, "ws": false}, {"text": ",", "start": 170, "end": 171, "id": 53, "ws": true}, {"text": "16", "start": 172, "end": 174, "id": 54, "ws": false}, {"text": ",", "start": 174, "end": 175, "id": 55, "ws": true}, {"text": "19", "start": 176, "end": 178, "id": 56, "ws": false}, {"text": ",", "start": 178, "end": 179, "id": 57, "ws": true}, {"text": "20", "start": 180, "end": 182, "id": 58, "ws": false}, {"text": ",", "start": 182, "end": 183, "id": 59, "ws": true}, {"text": "21", "start": 184, "end": 186, "id": 60, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 18, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 19, "end": 27, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 45, "end": 76, "token_start": 6, "token_end": 9, "label": "INDICATION"}, {"start": 137, "end": 158, "token_start": 42, "token_end": 44, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526345, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Hydrocortisone butyrate lotion, 0.1% is indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. Hydrocortisone butyrate lotion, 0.1% is a corticosteroid indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. (1)", "_input_hash": -1461589099, "_task_hash": -451995521, "_is_binary": false, "tokens": [{"text": "Hydrocortisone", "start": 0, "end": 14, "id": 0, "ws": true}, {"text": "butyrate", "start": 15, "end": 23, "id": 1, "ws": true}, {"text": "lotion", "start": 24, "end": 30, "id": 2, "ws": false}, {"text": ",", "start": 30, "end": 31, "id": 3, "ws": true}, {"text": "0.1", "start": 32, "end": 35, "id": 4, "ws": false}, {"text": "%", "start": 35, "end": 36, "id": 5, "ws": true}, {"text": "is", "start": 37, "end": 39, "id": 6, "ws": true}, {"text": "indicated", "start": 40, "end": 49, "id": 7, "ws": true}, {"text": "for", "start": 50, "end": 53, "id": 8, "ws": true}, {"text": "the", "start": 54, "end": 57, "id": 9, "ws": true}, {"text": "topical", "start": 58, "end": 65, "id": 10, "ws": true}, {"text": "treatment", "start": 66, "end": 75, "id": 11, "ws": true}, {"text": "of", "start": 76, "end": 78, "id": 12, "ws": true}, {"text": "mild", "start": 79, "end": 83, "id": 13, "ws": true}, {"text": "to", "start": 84, "end": 86, "id": 14, "ws": true}, {"text": "moderate", "start": 87, "end": 95, "id": 15, "ws": true}, {"text": "atopic", "start": 96, "end": 102, "id": 16, "ws": true}, {"text": "dermatitis", "start": 103, "end": 113, "id": 17, "ws": true}, {"text": "in", "start": 114, "end": 116, "id": 18, "ws": true}, {"text": "patients", "start": 117, "end": 125, "id": 19, "ws": true}, {"text": "3", "start": 126, "end": 127, "id": 20, "ws": true}, {"text": "months", "start": 128, "end": 134, "id": 21, "ws": true}, {"text": "of", "start": 135, "end": 137, "id": 22, "ws": true}, {"text": "age", "start": 138, "end": 141, "id": 23, "ws": true}, {"text": "and", "start": 142, "end": 145, "id": 24, "ws": true}, {"text": "older", "start": 146, "end": 151, "id": 25, "ws": false}, {"text": ".", "start": 151, "end": 152, "id": 26, "ws": true}, {"text": "Hydrocortisone", "start": 153, "end": 167, "id": 27, "ws": true}, {"text": "butyrate", "start": 168, "end": 176, "id": 28, "ws": true}, {"text": "lotion", "start": 177, "end": 183, "id": 29, "ws": false}, {"text": ",", "start": 183, "end": 184, "id": 30, "ws": true}, {"text": "0.1", "start": 185, "end": 188, "id": 31, "ws": false}, {"text": "%", "start": 188, "end": 189, "id": 32, "ws": true}, {"text": "is", "start": 190, "end": 192, "id": 33, "ws": true}, {"text": "a", "start": 193, "end": 194, "id": 34, "ws": true}, {"text": "corticosteroid", "start": 195, "end": 209, "id": 35, "ws": true}, {"text": "indicated", "start": 210, "end": 219, "id": 36, "ws": true}, {"text": "for", "start": 220, "end": 223, "id": 37, "ws": true}, {"text": "the", "start": 224, "end": 227, "id": 38, "ws": true}, {"text": "topical", "start": 228, "end": 235, "id": 39, "ws": true}, {"text": "treatment", "start": 236, "end": 245, "id": 40, "ws": true}, {"text": "of", "start": 246, "end": 248, "id": 41, "ws": true}, {"text": "mild", "start": 249, "end": 253, "id": 42, "ws": true}, {"text": "to", "start": 254, "end": 256, "id": 43, "ws": true}, {"text": "moderate", "start": 257, "end": 265, "id": 44, "ws": true}, {"text": "atopic", "start": 266, "end": 272, "id": 45, "ws": true}, {"text": "dermatitis", "start": 273, "end": 283, "id": 46, "ws": true}, {"text": "in", "start": 284, "end": 286, "id": 47, "ws": true}, {"text": "patients", "start": 287, "end": 295, "id": 48, "ws": true}, {"text": "3", "start": 296, "end": 297, "id": 49, "ws": true}, {"text": "months", "start": 298, "end": 304, "id": 50, "ws": true}, {"text": "of", "start": 305, "end": 307, "id": 51, "ws": true}, {"text": "age", "start": 308, "end": 311, "id": 52, "ws": true}, {"text": "and", "start": 312, "end": 315, "id": 53, "ws": true}, {"text": "older", "start": 316, "end": 321, "id": 54, "ws": false}, {"text": ".", "start": 321, "end": 322, "id": 55, "ws": true}, {"text": "(", "start": 323, "end": 324, "id": 56, "ws": false}, {"text": "1", "start": 324, "end": 325, "id": 57, "ws": false}, {"text": ")", "start": 325, "end": 326, "id": 58, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 14, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 15, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 30, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 58, "end": 75, "token_start": 10, "token_end": 11, "label": "ACTION"}, {"start": 79, "end": 95, "token_start": 13, "token_end": 15, "label": "SEVERITY"}, {"start": 96, "end": 113, "token_start": 16, "token_end": 17, "label": "INDICATION"}, {"start": 117, "end": 151, "token_start": 19, "token_end": 25, "label": "TARGET_GROUP"}, {"start": 195, "end": 209, "token_start": 35, "token_end": 35, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694525821, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction. STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction ( 1)", "_input_hash": 559289540, "_task_hash": -1145506024, "_is_binary": false, "tokens": [{"text": "STENDRA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "a", "start": 11, "end": 12, "id": 2, "ws": true}, {"text": "phosphodiesterase", "start": 13, "end": 30, "id": 3, "ws": true}, {"text": "5", "start": 31, "end": 32, "id": 4, "ws": true}, {"text": "(", "start": 33, "end": 34, "id": 5, "ws": false}, {"text": "PDE5", "start": 34, "end": 38, "id": 6, "ws": false}, {"text": ")", "start": 38, "end": 39, "id": 7, "ws": true}, {"text": "inhibitor", "start": 40, "end": 49, "id": 8, "ws": true}, {"text": "indicated", "start": 50, "end": 59, "id": 9, "ws": true}, {"text": "for", "start": 60, "end": 63, "id": 10, "ws": true}, {"text": "the", "start": 64, "end": 67, "id": 11, "ws": true}, {"text": "treatment", "start": 68, "end": 77, "id": 12, "ws": true}, {"text": "of", "start": 78, "end": 80, "id": 13, "ws": true}, {"text": "erectile", "start": 81, "end": 89, "id": 14, "ws": true}, {"text": "dysfunction", "start": 90, "end": 101, "id": 15, "ws": false}, {"text": ".", "start": 101, "end": 102, "id": 16, "ws": true}, {"text": "STENDRA", "start": 103, "end": 110, "id": 17, "ws": true}, {"text": "is", "start": 111, "end": 113, "id": 18, "ws": true}, {"text": "a", "start": 114, "end": 115, "id": 19, "ws": true}, {"text": "phosphodiesterase", "start": 116, "end": 133, "id": 20, "ws": true}, {"text": "5", "start": 134, "end": 135, "id": 21, "ws": true}, {"text": "(", "start": 136, "end": 137, "id": 22, "ws": false}, {"text": "PDE5", "start": 137, "end": 141, "id": 23, "ws": false}, {"text": ")", "start": 141, "end": 142, "id": 24, "ws": true}, {"text": "inhibitor", "start": 143, "end": 152, "id": 25, "ws": true}, {"text": "indicated", "start": 153, "end": 162, "id": 26, "ws": true}, {"text": "for", "start": 163, "end": 166, "id": 27, "ws": true}, {"text": "the", "start": 167, "end": 170, "id": 28, "ws": true}, {"text": "treatment", "start": 171, "end": 180, "id": 29, "ws": true}, {"text": "of", "start": 181, "end": 183, "id": 30, "ws": true}, {"text": "erectile", "start": 184, "end": 192, "id": 31, "ws": true}, {"text": "dysfunction", "start": 193, "end": 204, "id": 32, "ws": true}, {"text": "(", "start": 205, "end": 206, "id": 33, "ws": true}, {"text": "1", "start": 207, "end": 208, "id": 34, "ws": false}, {"text": ")", "start": 208, "end": 209, "id": 35, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 13, "end": 49, "token_start": 3, "token_end": 8, "label": "MECHANISM"}, {"start": 68, "end": 77, "token_start": 12, "token_end": 12, "label": "ACTION"}, {"start": 81, "end": 101, "token_start": 14, "token_end": 15, "label": "INDICATION"}, {"start": 103, "end": 110, "token_start": 17, "token_end": 17, "label": "DRUG"}, {"start": 116, "end": 152, "token_start": 20, "token_end": 25, "label": "MECHANISM"}, {"start": 171, "end": 180, "token_start": 29, "token_end": 29, "label": "ACTION"}, {"start": 184, "end": 204, "token_start": 31, "token_end": 32, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526569, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "JORNAY PM is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies (14)]. JORNAY PM is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. (1)", "_input_hash": -2021979707, "_task_hash": 356558321, "_is_binary": false, "tokens": [{"text": "JORNAY", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "PM", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 2, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 3, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 4, "ws": true}, {"text": "the", "start": 27, "end": 30, "id": 5, "ws": true}, {"text": "treatment", "start": 31, "end": 40, "id": 6, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 7, "ws": true}, {"text": "Attention", "start": 44, "end": 53, "id": 8, "ws": true}, {"text": "Deficit", "start": 54, "end": 61, "id": 9, "ws": true}, {"text": "Hyperactivity", "start": 62, "end": 75, "id": 10, "ws": true}, {"text": "Disorder", "start": 76, "end": 84, "id": 11, "ws": true}, {"text": "(", "start": 85, "end": 86, "id": 12, "ws": false}, {"text": "ADHD", "start": 86, "end": 90, "id": 13, "ws": false}, {"text": ")", "start": 90, "end": 91, "id": 14, "ws": true}, {"text": "in", "start": 92, "end": 94, "id": 15, "ws": true}, {"text": "patients", "start": 95, "end": 103, "id": 16, "ws": true}, {"text": "6", "start": 104, "end": 105, "id": 17, "ws": true}, {"text": "years", "start": 106, "end": 111, "id": 18, "ws": true}, {"text": "and", "start": 112, "end": 115, "id": 19, "ws": true}, {"text": "older", "start": 116, "end": 121, "id": 20, "ws": true}, {"text": "[", "start": 122, "end": 123, "id": 21, "ws": false}, {"text": "see", "start": 123, "end": 126, "id": 22, "ws": true}, {"text": "Clinical", "start": 127, "end": 135, "id": 23, "ws": true}, {"text": "Studies", "start": 136, "end": 143, "id": 24, "ws": true}, {"text": "(", "start": 144, "end": 145, "id": 25, "ws": false}, {"text": "14", "start": 145, "end": 147, "id": 26, "ws": false}, {"text": ")", "start": 147, "end": 148, "id": 27, "ws": false}, {"text": "]", "start": 148, "end": 149, "id": 28, "ws": false}, {"text": ".", "start": 149, "end": 150, "id": 29, "ws": true}, {"text": "JORNAY", "start": 151, "end": 157, "id": 30, "ws": true}, {"text": "PM", "start": 158, "end": 160, "id": 31, "ws": true}, {"text": "is", "start": 161, "end": 163, "id": 32, "ws": true}, {"text": "a", "start": 164, "end": 165, "id": 33, "ws": true}, {"text": "central", "start": 166, "end": 173, "id": 34, "ws": true}, {"text": "nervous", "start": 174, "end": 181, "id": 35, "ws": true}, {"text": "system", "start": 182, "end": 188, "id": 36, "ws": true}, {"text": "(", "start": 189, "end": 190, "id": 37, "ws": false}, {"text": "CNS", "start": 190, "end": 193, "id": 38, "ws": false}, {"text": ")", "start": 193, "end": 194, "id": 39, "ws": true}, {"text": "stimulant", "start": 195, "end": 204, "id": 40, "ws": true}, {"text": "indicated", "start": 205, "end": 214, "id": 41, "ws": true}, {"text": "for", "start": 215, "end": 218, "id": 42, "ws": true}, {"text": "the", "start": 219, "end": 222, "id": 43, "ws": true}, {"text": "treatment", "start": 223, "end": 232, "id": 44, "ws": true}, {"text": "of", "start": 233, "end": 235, "id": 45, "ws": true}, {"text": "Attention", "start": 236, "end": 245, "id": 46, "ws": true}, {"text": "Deficit", "start": 246, "end": 253, "id": 47, "ws": true}, {"text": "Hyperactivity", "start": 254, "end": 267, "id": 48, "ws": true}, {"text": "Disorder", "start": 268, "end": 276, "id": 49, "ws": true}, {"text": "(", "start": 277, "end": 278, "id": 50, "ws": false}, {"text": "ADHD", "start": 278, "end": 282, "id": 51, "ws": false}, {"text": ")", "start": 282, "end": 283, "id": 52, "ws": true}, {"text": "in", "start": 284, "end": 286, "id": 53, "ws": true}, {"text": "patients", "start": 287, "end": 295, "id": 54, "ws": true}, {"text": "6", "start": 296, "end": 297, "id": 55, "ws": true}, {"text": "years", "start": 298, "end": 303, "id": 56, "ws": true}, {"text": "and", "start": 304, "end": 307, "id": 57, "ws": true}, {"text": "older", "start": 308, "end": 313, "id": 58, "ws": false}, {"text": ".", "start": 313, "end": 314, "id": 59, "ws": true}, {"text": "(", "start": 315, "end": 316, "id": 60, "ws": false}, {"text": "1", "start": 316, "end": 317, "id": 61, "ws": false}, {"text": ")", "start": 317, "end": 318, "id": 62, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 40, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 44, "end": 91, "token_start": 8, "token_end": 14, "label": "INDICATION"}, {"start": 95, "end": 121, "token_start": 16, "token_end": 20, "label": "TARGET_GROUP"}, {"start": 166, "end": 204, "token_start": 34, "token_end": 40, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694525418, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "BenzePrO Foaming Cloths are indicated for use in the topical treatment of mild to moderate acne vulgaris.", "_input_hash": -1970713378, "_task_hash": -320028198, "_is_binary": false, "tokens": [{"text": "BenzePrO", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "Foaming", "start": 9, "end": 16, "id": 1, "ws": true}, {"text": "Cloths", "start": 17, "end": 23, "id": 2, "ws": true}, {"text": "are", "start": 24, "end": 27, "id": 3, "ws": true}, {"text": "indicated", "start": 28, "end": 37, "id": 4, "ws": true}, {"text": "for", "start": 38, "end": 41, "id": 5, "ws": true}, {"text": "use", "start": 42, "end": 45, "id": 6, "ws": true}, {"text": "in", "start": 46, "end": 48, "id": 7, "ws": true}, {"text": "the", "start": 49, "end": 52, "id": 8, "ws": true}, {"text": "topical", "start": 53, "end": 60, "id": 9, "ws": true}, {"text": "treatment", "start": 61, "end": 70, "id": 10, "ws": true}, {"text": "of", "start": 71, "end": 73, "id": 11, "ws": true}, {"text": "mild", "start": 74, "end": 78, "id": 12, "ws": true}, {"text": "to", "start": 79, "end": 81, "id": 13, "ws": true}, {"text": "moderate", "start": 82, "end": 90, "id": 14, "ws": true}, {"text": "acne", "start": 91, "end": 95, "id": 15, "ws": true}, {"text": "vulgaris", "start": 96, "end": 104, "id": 16, "ws": false}, {"text": ".", "start": 104, "end": 105, "id": 17, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 23, "token_start": 1, "token_end": 2, "label": "FORMULATION"}, {"start": 53, "end": 73, "token_start": 9, "token_end": 11, "label": "ACTION"}, {"start": 74, "end": 90, "token_start": 12, "token_end": 14, "label": "SEVERITY"}, {"start": 91, "end": 104, "token_start": 15, "token_end": 16, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694175012, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Pentazocine Hydrochloride and Acetaminophen Tablets are indicated for the relief of mild to moderate pain.", "_input_hash": 1398111112, "_task_hash": 652770137, "_is_binary": false, "tokens": [{"text": "Pentazocine", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "Hydrochloride", "start": 12, "end": 25, "id": 1, "ws": true}, {"text": "and", "start": 26, "end": 29, "id": 2, "ws": true}, {"text": "Acetaminophen", "start": 30, "end": 43, "id": 3, "ws": true}, {"text": "Tablets", "start": 44, "end": 51, "id": 4, "ws": true}, {"text": "are", "start": 52, "end": 55, "id": 5, "ws": true}, {"text": "indicated", "start": 56, "end": 65, "id": 6, "ws": true}, {"text": "for", "start": 66, "end": 69, "id": 7, "ws": true}, {"text": "the", "start": 70, "end": 73, "id": 8, "ws": true}, {"text": "relief", "start": 74, "end": 80, "id": 9, "ws": true}, {"text": "of", "start": 81, "end": 83, "id": 10, "ws": true}, {"text": "mild", "start": 84, "end": 88, "id": 11, "ws": true}, {"text": "to", "start": 89, "end": 91, "id": 12, "ws": true}, {"text": "moderate", "start": 92, "end": 100, "id": 13, "ws": true}, {"text": "pain", "start": 101, "end": 105, "id": 14, "ws": false}, {"text": ".", "start": 105, "end": 106, "id": 15, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 25, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 30, "end": 43, "token_start": 3, "token_end": 3, "label": "DRUG"}, {"start": 44, "end": 51, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 74, "end": 80, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 84, "end": 100, "token_start": 11, "token_end": 13, "label": "SEVERITY"}, {"start": 101, "end": 105, "token_start": 14, "token_end": 14, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694176297, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.", "_input_hash": -1397751422, "_task_hash": -1066626690, "_is_binary": false, "tokens": [{"text": "Zafirlukast", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "is", "start": 12, "end": 14, "id": 1, "ws": true}, {"text": "indicated", "start": 15, "end": 24, "id": 2, "ws": true}, {"text": "for", "start": 25, "end": 28, "id": 3, "ws": true}, {"text": "the", "start": 29, "end": 32, "id": 4, "ws": true}, {"text": "prophylaxis", "start": 33, "end": 44, "id": 5, "ws": true}, {"text": "and", "start": 45, "end": 48, "id": 6, "ws": true}, {"text": "chronic", "start": 49, "end": 56, "id": 7, "ws": true}, {"text": "treatment", "start": 57, "end": 66, "id": 8, "ws": true}, {"text": "of", "start": 67, "end": 69, "id": 9, "ws": true}, {"text": "asthma", "start": 70, "end": 76, "id": 10, "ws": true}, {"text": "in", "start": 77, "end": 79, "id": 11, "ws": true}, {"text": "adults", "start": 80, "end": 86, "id": 12, "ws": true}, {"text": "and", "start": 87, "end": 90, "id": 13, "ws": true}, {"text": "children", "start": 91, "end": 99, "id": 14, "ws": true}, {"text": "5", "start": 100, "end": 101, "id": 15, "ws": true}, {"text": "years", "start": 102, "end": 107, "id": 16, "ws": true}, {"text": "of", "start": 108, "end": 110, "id": 17, "ws": true}, {"text": "age", "start": 111, "end": 114, "id": 18, "ws": true}, {"text": "and", "start": 115, "end": 118, "id": 19, "ws": true}, {"text": "older", "start": 119, "end": 124, "id": 20, "ws": false}, {"text": ".", "start": 124, "end": 125, "id": 21, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 33, "end": 44, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 49, "end": 66, "token_start": 7, "token_end": 8, "label": "ACTION"}, {"start": 70, "end": 76, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 80, "end": 86, "token_start": 12, "token_end": 12, "label": "TARGET_GROUP"}, {"start": 91, "end": 124, "token_start": 14, "token_end": 20, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694528795, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Szary syndrome (SS) after at least one prior systemic therapy. POTELIGEO is a CC chemokine receptor type 4 (CCR4)-directed monoclonal antibody indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides or Szary syndrome after at least one prior systemic therapy (1).", "_input_hash": -1266950338, "_task_hash": 694824061, "_is_binary": false, "tokens": [{"text": "POTELIGEO", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 3, "ws": true}, {"text": "the", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "treatment", "start": 31, "end": 40, "id": 5, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 6, "ws": true}, {"text": "adult", "start": 44, "end": 49, "id": 7, "ws": true}, {"text": "patients", "start": 50, "end": 58, "id": 8, "ws": true}, {"text": "with", "start": 59, "end": 63, "id": 9, "ws": true}, {"text": "relapsed", "start": 64, "end": 72, "id": 10, "ws": true}, {"text": "or", "start": 73, "end": 75, "id": 11, "ws": true}, {"text": "refractory", "start": 76, "end": 86, "id": 12, "ws": true}, {"text": "mycosis", "start": 87, "end": 94, "id": 13, "ws": true}, {"text": "fungoides", "start": 95, "end": 104, "id": 14, "ws": true}, {"text": "(", "start": 105, "end": 106, "id": 15, "ws": false}, {"text": "MF", "start": 106, "end": 108, "id": 16, "ws": false}, {"text": ")", "start": 108, "end": 109, "id": 17, "ws": true}, {"text": "or", "start": 110, "end": 112, "id": 18, "ws": true}, {"text": "Szary", "start": 113, "end": 118, "id": 19, "ws": true}, {"text": "syndrome", "start": 119, "end": 127, "id": 20, "ws": true}, {"text": "(", "start": 128, "end": 129, "id": 21, "ws": false}, {"text": "SS", "start": 129, "end": 131, "id": 22, "ws": false}, {"text": ")", "start": 131, "end": 132, "id": 23, "ws": true}, {"text": "after", "start": 133, "end": 138, "id": 24, "ws": true}, {"text": "at", "start": 139, "end": 141, "id": 25, "ws": true}, {"text": "least", "start": 142, "end": 147, "id": 26, "ws": true}, {"text": "one", "start": 148, "end": 151, "id": 27, "ws": true}, {"text": "prior", "start": 152, "end": 157, "id": 28, "ws": true}, {"text": "systemic", "start": 158, "end": 166, "id": 29, "ws": true}, {"text": "therapy", "start": 167, "end": 174, "id": 30, "ws": false}, {"text": ".", "start": 174, "end": 175, "id": 31, "ws": true}, {"text": "POTELIGEO", "start": 176, "end": 185, "id": 32, "ws": true}, {"text": "is", "start": 186, "end": 188, "id": 33, "ws": true}, {"text": "a", "start": 189, "end": 190, "id": 34, "ws": true}, {"text": "CC", "start": 191, "end": 193, "id": 35, "ws": true}, {"text": "chemokine", "start": 194, "end": 203, "id": 36, "ws": true}, {"text": "receptor", "start": 204, "end": 212, "id": 37, "ws": true}, {"text": "type", "start": 213, "end": 217, "id": 38, "ws": true}, {"text": "4", "start": 218, "end": 219, "id": 39, "ws": true}, {"text": "(", "start": 220, "end": 221, "id": 40, "ws": false}, {"text": "CCR4)-directed", "start": 221, "end": 235, "id": 41, "ws": true}, {"text": "monoclonal", "start": 236, "end": 246, "id": 42, "ws": true}, {"text": "antibody", "start": 247, "end": 255, "id": 43, "ws": true}, {"text": "indicated", "start": 256, "end": 265, "id": 44, "ws": true}, {"text": "for", "start": 266, "end": 269, "id": 45, "ws": true}, {"text": "the", "start": 270, "end": 273, "id": 46, "ws": true}, {"text": "treatment", "start": 274, "end": 283, "id": 47, "ws": true}, {"text": "of", "start": 284, "end": 286, "id": 48, "ws": true}, {"text": "adult", "start": 287, "end": 292, "id": 49, "ws": true}, {"text": "patients", "start": 293, "end": 301, "id": 50, "ws": true}, {"text": "with", "start": 302, "end": 306, "id": 51, "ws": true}, {"text": "relapsed", "start": 307, "end": 315, "id": 52, "ws": true}, {"text": "or", "start": 316, "end": 318, "id": 53, "ws": true}, {"text": "refractory", "start": 319, "end": 329, "id": 54, "ws": true}, {"text": "mycosis", "start": 330, "end": 337, "id": 55, "ws": true}, {"text": "fungoides", "start": 338, "end": 347, "id": 56, "ws": true}, {"text": "or", "start": 348, "end": 350, "id": 57, "ws": true}, {"text": "Szary", "start": 351, "end": 356, "id": 58, "ws": true}, {"text": "syndrome", "start": 357, "end": 365, "id": 59, "ws": true}, {"text": "after", "start": 366, "end": 371, "id": 60, "ws": true}, {"text": "at", "start": 372, "end": 374, "id": 61, "ws": true}, {"text": "least", "start": 375, "end": 380, "id": 62, "ws": true}, {"text": "one", "start": 381, "end": 384, "id": 63, "ws": true}, {"text": "prior", "start": 385, "end": 390, "id": 64, "ws": true}, {"text": "systemic", "start": 391, "end": 399, "id": 65, "ws": true}, {"text": "therapy", "start": 400, "end": 407, "id": 66, "ws": true}, {"text": "(", "start": 408, "end": 409, "id": 67, "ws": false}, {"text": "1", "start": 409, "end": 410, "id": 68, "ws": false}, {"text": ")", "start": 410, "end": 411, "id": 69, "ws": false}, {"text": ".", "start": 411, "end": 412, "id": 70, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 40, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 44, "end": 49, "token_start": 7, "token_end": 7, "label": "TARGET_GROUP"}, {"start": 87, "end": 104, "token_start": 13, "token_end": 14, "label": "BASECONDITION"}, {"start": 113, "end": 127, "token_start": 19, "token_end": 20, "label": "BASECONDITION"}, {"start": 176, "end": 185, "token_start": 32, "token_end": 32, "label": "DRUG"}, {"start": 191, "end": 255, "token_start": 35, "token_end": 43, "label": "MECHANISM"}, {"start": 274, "end": 283, "token_start": 47, "token_end": 47, "label": "ACTION"}, {"start": 287, "end": 292, "token_start": 49, "token_end": 49, "label": "TARGET_GROUP"}, {"start": 330, "end": 347, "token_start": 55, "token_end": 56, "label": "BASECONDITION"}, {"start": 351, "end": 365, "token_start": 58, "token_end": 59, "label": "BASECONDITION"}, {"start": 366, "end": 407, "token_start": 60, "token_end": 66, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694528480, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). AGGRASTAT is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).", "_input_hash": -1717839452, "_task_hash": -154473468, "_is_binary": false, "tokens": [{"text": "AGGRASTAT", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "to", "start": 23, "end": 25, "id": 3, "ws": true}, {"text": "reduce", "start": 26, "end": 32, "id": 4, "ws": true}, {"text": "the", "start": 33, "end": 36, "id": 5, "ws": true}, {"text": "rate", "start": 37, "end": 41, "id": 6, "ws": true}, {"text": "of", "start": 42, "end": 44, "id": 7, "ws": true}, {"text": "thrombotic", "start": 45, "end": 55, "id": 8, "ws": true}, {"text": "cardiovascular", "start": 56, "end": 70, "id": 9, "ws": true}, {"text": "events", "start": 71, "end": 77, "id": 10, "ws": true}, {"text": "(", "start": 78, "end": 79, "id": 11, "ws": false}, {"text": "combined", "start": 79, "end": 87, "id": 12, "ws": true}, {"text": "endpoint", "start": 88, "end": 96, "id": 13, "ws": true}, {"text": "of", "start": 97, "end": 99, "id": 14, "ws": true}, {"text": "death", "start": 100, "end": 105, "id": 15, "ws": false}, {"text": ",", "start": 105, "end": 106, "id": 16, "ws": true}, {"text": "myocardial", "start": 107, "end": 117, "id": 17, "ws": true}, {"text": "infarction", "start": 118, "end": 128, "id": 18, "ws": false}, {"text": ",", "start": 128, "end": 129, "id": 19, "ws": true}, {"text": "or", "start": 130, "end": 132, "id": 20, "ws": true}, {"text": "refractory", "start": 133, "end": 143, "id": 21, "ws": true}, {"text": "ischemia", "start": 144, "end": 152, "id": 22, "ws": false}, {"text": "/", "start": 152, "end": 153, "id": 23, "ws": false}, {"text": "repeat", "start": 153, "end": 159, "id": 24, "ws": true}, {"text": "cardiac", "start": 160, "end": 167, "id": 25, "ws": true}, {"text": "procedure", "start": 168, "end": 177, "id": 26, "ws": false}, {"text": ")", "start": 177, "end": 178, "id": 27, "ws": true}, {"text": "in", "start": 179, "end": 181, "id": 28, "ws": true}, {"text": "patients", "start": 182, "end": 190, "id": 29, "ws": true}, {"text": "with", "start": 191, "end": 195, "id": 30, "ws": true}, {"text": "non", "start": 196, "end": 199, "id": 31, "ws": false}, {"text": "-", "start": 199, "end": 200, "id": 32, "ws": false}, {"text": "ST", "start": 200, "end": 202, "id": 33, "ws": true}, {"text": "elevation", "start": 203, "end": 212, "id": 34, "ws": true}, {"text": "acute", "start": 213, "end": 218, "id": 35, "ws": true}, {"text": "coronary", "start": 219, "end": 227, "id": 36, "ws": true}, {"text": "syndrome", "start": 228, "end": 236, "id": 37, "ws": true}, {"text": "(", "start": 237, "end": 238, "id": 38, "ws": false}, {"text": "NSTE", "start": 238, "end": 242, "id": 39, "ws": false}, {"text": "-", "start": 242, "end": 243, "id": 40, "ws": false}, {"text": "ACS", "start": 243, "end": 246, "id": 41, "ws": false}, {"text": ")", "start": 246, "end": 247, "id": 42, "ws": false}, {"text": ".", "start": 247, "end": 248, "id": 43, "ws": true}, {"text": "AGGRASTAT", "start": 249, "end": 258, "id": 44, "ws": true}, {"text": "is", "start": 259, "end": 261, "id": 45, "ws": true}, {"text": "a", "start": 262, "end": 263, "id": 46, "ws": true}, {"text": "platelet", "start": 264, "end": 272, "id": 47, "ws": true}, {"text": "aggregation", "start": 273, "end": 284, "id": 48, "ws": true}, {"text": "inhibitor", "start": 285, "end": 294, "id": 49, "ws": true}, {"text": "indicated", "start": 295, "end": 304, "id": 50, "ws": true}, {"text": "to", "start": 305, "end": 307, "id": 51, "ws": true}, {"text": "reduce", "start": 308, "end": 314, "id": 52, "ws": true}, {"text": "the", "start": 315, "end": 318, "id": 53, "ws": true}, {"text": "rate", "start": 319, "end": 323, "id": 54, "ws": true}, {"text": "of", "start": 324, "end": 326, "id": 55, "ws": true}, {"text": "thrombotic", "start": 327, "end": 337, "id": 56, "ws": true}, {"text": "cardiovascular", "start": 338, "end": 352, "id": 57, "ws": true}, {"text": "events", "start": 353, "end": 359, "id": 58, "ws": true}, {"text": "(", "start": 360, "end": 361, "id": 59, "ws": false}, {"text": "combined", "start": 361, "end": 369, "id": 60, "ws": true}, {"text": "endpoint", "start": 370, "end": 378, "id": 61, "ws": true}, {"text": "of", "start": 379, "end": 381, "id": 62, "ws": true}, {"text": "death", "start": 382, "end": 387, "id": 63, "ws": false}, {"text": ",", "start": 387, "end": 388, "id": 64, "ws": true}, {"text": "myocardial", "start": 389, "end": 399, "id": 65, "ws": true}, {"text": "infarction", "start": 400, "end": 410, "id": 66, "ws": false}, {"text": ",", "start": 410, "end": 411, "id": 67, "ws": true}, {"text": "or", "start": 412, "end": 414, "id": 68, "ws": true}, {"text": "refractory", "start": 415, "end": 425, "id": 69, "ws": true}, {"text": "ischemia", "start": 426, "end": 434, "id": 70, "ws": false}, {"text": "/", "start": 434, "end": 435, "id": 71, "ws": false}, {"text": "repeat", "start": 435, "end": 441, "id": 72, "ws": true}, {"text": "cardiac", "start": 442, "end": 449, "id": 73, "ws": true}, {"text": "procedure", "start": 450, "end": 459, "id": 74, "ws": false}, {"text": ")", "start": 459, "end": 460, "id": 75, "ws": true}, {"text": "in", "start": 461, "end": 463, "id": 76, "ws": true}, {"text": "patients", "start": 464, "end": 472, "id": 77, "ws": true}, {"text": "with", "start": 473, "end": 477, "id": 78, "ws": true}, {"text": "non", "start": 478, "end": 481, "id": 79, "ws": false}, {"text": "-", "start": 481, "end": 482, "id": 80, "ws": false}, {"text": "ST", "start": 482, "end": 484, "id": 81, "ws": true}, {"text": "elevation", "start": 485, "end": 494, "id": 82, "ws": true}, {"text": "acute", "start": 495, "end": 500, "id": 83, "ws": true}, {"text": "coronary", "start": 501, "end": 509, "id": 84, "ws": true}, {"text": "syndrome", "start": 510, "end": 518, "id": 85, "ws": true}, {"text": "(", "start": 519, "end": 520, "id": 86, "ws": false}, {"text": "NSTE", "start": 520, "end": 524, "id": 87, "ws": false}, {"text": "-", "start": 524, "end": 525, "id": 88, "ws": false}, {"text": "ACS", "start": 525, "end": 528, "id": 89, "ws": false}, {"text": ")", "start": 528, "end": 529, "id": 90, "ws": false}, {"text": ".", "start": 529, "end": 530, "id": 91, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 26, "end": 77, "token_start": 4, "token_end": 10, "label": "EFFECT"}, {"start": 196, "end": 236, "token_start": 31, "token_end": 37, "label": "BASECONDITION"}, {"start": 249, "end": 258, "token_start": 44, "token_end": 44, "label": "DRUG"}, {"start": 264, "end": 294, "token_start": 47, "token_end": 49, "label": "MECHANISM"}, {"start": 308, "end": 359, "token_start": 52, "token_end": 58, "label": "EFFECT"}, {"start": 478, "end": 518, "token_start": 79, "token_end": 85, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526697, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below:", "_input_hash": -954368024, "_task_hash": 1803963966, "_is_binary": false, "tokens": [{"text": "Ofloxacin", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "ophthalmic", "start": 10, "end": 20, "id": 1, "ws": true}, {"text": "solution", "start": 21, "end": 29, "id": 2, "ws": true}, {"text": "is", "start": 30, "end": 32, "id": 3, "ws": true}, {"text": "indicated", "start": 33, "end": 42, "id": 4, "ws": true}, {"text": "for", "start": 43, "end": 46, "id": 5, "ws": true}, {"text": "the", "start": 47, "end": 50, "id": 6, "ws": true}, {"text": "treatment", "start": 51, "end": 60, "id": 7, "ws": true}, {"text": "of", "start": 61, "end": 63, "id": 8, "ws": true}, {"text": "infections", "start": 64, "end": 74, "id": 9, "ws": true}, {"text": "caused", "start": 75, "end": 81, "id": 10, "ws": true}, {"text": "by", "start": 82, "end": 84, "id": 11, "ws": true}, {"text": "susceptible", "start": 85, "end": 96, "id": 12, "ws": true}, {"text": "strains", "start": 97, "end": 104, "id": 13, "ws": true}, {"text": "of", "start": 105, "end": 107, "id": 14, "ws": true}, {"text": "the", "start": 108, "end": 111, "id": 15, "ws": true}, {"text": "following", "start": 112, "end": 121, "id": 16, "ws": true}, {"text": "bacteria", "start": 122, "end": 130, "id": 17, "ws": true}, {"text": "in", "start": 131, "end": 133, "id": 18, "ws": true}, {"text": "the", "start": 134, "end": 137, "id": 19, "ws": true}, {"text": "conditions", "start": 138, "end": 148, "id": 20, "ws": true}, {"text": "listed", "start": 149, "end": 155, "id": 21, "ws": true}, {"text": "below", "start": 156, "end": 161, "id": 22, "ws": false}, {"text": ":", "start": 161, "end": 162, "id": 23, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 20, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 21, "end": 29, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 51, "end": 60, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 64, "end": 74, "token_start": 9, "token_end": 9, "label": "INDICATION"}, {"start": 122, "end": 130, "token_start": 17, "token_end": 17, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694526441, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "4% Lidocaine Hydrochloride Injection, USP is indicated for the production of topical anesthesia of the mucous membranes of the respiratory tract or the genito-urinary tract. It may be injected trans-tracheally to anesthetize the larynx and trachea, and it may be administered by retrobulbar injection to provide anesthesia for ophthalmic surgery.", "_input_hash": -1022350215, "_task_hash": 1303791710, "_is_binary": false, "tokens": [{"text": "4", "start": 0, "end": 1, "id": 0, "ws": false}, {"text": "%", "start": 1, "end": 2, "id": 1, "ws": true}, {"text": "Lidocaine", "start": 3, "end": 12, "id": 2, "ws": true}, {"text": "Hydrochloride", "start": 13, "end": 26, "id": 3, "ws": true}, {"text": "Injection", "start": 27, "end": 36, "id": 4, "ws": false}, {"text": ",", "start": 36, "end": 37, "id": 5, "ws": true}, {"text": "USP", "start": 38, "end": 41, "id": 6, "ws": true}, {"text": "is", "start": 42, "end": 44, "id": 7, "ws": true}, {"text": "indicated", "start": 45, "end": 54, "id": 8, "ws": true}, {"text": "for", "start": 55, "end": 58, "id": 9, "ws": true}, {"text": "the", "start": 59, "end": 62, "id": 10, "ws": true}, {"text": "production", "start": 63, "end": 73, "id": 11, "ws": true}, {"text": "of", "start": 74, "end": 76, "id": 12, "ws": true}, {"text": "topical", "start": 77, "end": 84, "id": 13, "ws": true}, {"text": "anesthesia", "start": 85, "end": 95, "id": 14, "ws": true}, {"text": "of", "start": 96, "end": 98, "id": 15, "ws": true}, {"text": "the", "start": 99, "end": 102, "id": 16, "ws": true}, {"text": "mucous", "start": 103, "end": 109, "id": 17, "ws": true}, {"text": "membranes", "start": 110, "end": 119, "id": 18, "ws": true}, {"text": "of", "start": 120, "end": 122, "id": 19, "ws": true}, {"text": "the", "start": 123, "end": 126, "id": 20, "ws": true}, {"text": "respiratory", "start": 127, "end": 138, "id": 21, "ws": true}, {"text": "tract", "start": 139, "end": 144, "id": 22, "ws": true}, {"text": "or", "start": 145, "end": 147, "id": 23, "ws": true}, {"text": "the", "start": 148, "end": 151, "id": 24, "ws": true}, {"text": "genito", "start": 152, "end": 158, "id": 25, "ws": false}, {"text": "-", "start": 158, "end": 159, "id": 26, "ws": false}, {"text": "urinary", "start": 159, "end": 166, "id": 27, "ws": true}, {"text": "tract", "start": 167, "end": 172, "id": 28, "ws": false}, {"text": ".", "start": 172, "end": 173, "id": 29, "ws": true}, {"text": "It", "start": 174, "end": 176, "id": 30, "ws": true}, {"text": "may", "start": 177, "end": 180, "id": 31, "ws": true}, {"text": "be", "start": 181, "end": 183, "id": 32, "ws": true}, {"text": "injected", "start": 184, "end": 192, "id": 33, "ws": true}, {"text": "trans", "start": 193, "end": 198, "id": 34, "ws": false}, {"text": "-", "start": 198, "end": 199, "id": 35, "ws": false}, {"text": "tracheally", "start": 199, "end": 209, "id": 36, "ws": true}, {"text": "to", "start": 210, "end": 212, "id": 37, "ws": true}, {"text": "anesthetize", "start": 213, "end": 224, "id": 38, "ws": true}, {"text": "the", "start": 225, "end": 228, "id": 39, "ws": true}, {"text": "larynx", "start": 229, "end": 235, "id": 40, "ws": true}, {"text": "and", "start": 236, "end": 239, "id": 41, "ws": true}, {"text": "trachea", "start": 240, "end": 247, "id": 42, "ws": false}, {"text": ",", "start": 247, "end": 248, "id": 43, "ws": true}, {"text": "and", "start": 249, "end": 252, "id": 44, "ws": true}, {"text": "it", "start": 253, "end": 255, "id": 45, "ws": true}, {"text": "may", "start": 256, "end": 259, "id": 46, "ws": true}, {"text": "be", "start": 260, "end": 262, "id": 47, "ws": true}, {"text": "administered", "start": 263, "end": 275, "id": 48, "ws": true}, {"text": "by", "start": 276, "end": 278, "id": 49, "ws": true}, {"text": "retrobulbar", "start": 279, "end": 290, "id": 50, "ws": true}, {"text": "injection", "start": 291, "end": 300, "id": 51, "ws": true}, {"text": "to", "start": 301, "end": 303, "id": 52, "ws": true}, {"text": "provide", "start": 304, "end": 311, "id": 53, "ws": true}, {"text": "anesthesia", "start": 312, "end": 322, "id": 54, "ws": true}, {"text": "for", "start": 323, "end": 326, "id": 55, "ws": true}, {"text": "ophthalmic", "start": 327, "end": 337, "id": 56, "ws": true}, {"text": "surgery", "start": 338, "end": 345, "id": 57, "ws": false}, {"text": ".", "start": 345, "end": 346, "id": 58, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 3, "end": 12, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 13, "end": 26, "token_start": 3, "token_end": 3, "label": "SALT"}, {"start": 27, "end": 36, "token_start": 4, "token_end": 4, "label": "ROUTE"}, {"start": 63, "end": 76, "token_start": 11, "token_end": 12, "label": "ACTION"}, {"start": 77, "end": 95, "token_start": 13, "token_end": 14, "label": "EFFECT"}, {"start": 103, "end": 144, "token_start": 17, "token_end": 22, "label": "ANATOMY"}, {"start": 152, "end": 172, "token_start": 25, "token_end": 28, "label": "ANATOMY"}], "answer": "accept", "_timestamp": 1694175265, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "ISOPTIN SR (verapamil HCI) is indicated for the management of essential hypertension.", "_input_hash": 2111432104, "_task_hash": -921346105, "_is_binary": false, "tokens": [{"text": "ISOPTIN", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "SR", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "(", "start": 11, "end": 12, "id": 2, "ws": false}, {"text": "verapamil", "start": 12, "end": 21, "id": 3, "ws": true}, {"text": "HCI", "start": 22, "end": 25, "id": 4, "ws": false}, {"text": ")", "start": 25, "end": 26, "id": 5, "ws": true}, {"text": "is", "start": 27, "end": 29, "id": 6, "ws": true}, {"text": "indicated", "start": 30, "end": 39, "id": 7, "ws": true}, {"text": "for", "start": 40, "end": 43, "id": 8, "ws": true}, {"text": "the", "start": 44, "end": 47, "id": 9, "ws": true}, {"text": "management", "start": 48, "end": 58, "id": 10, "ws": true}, {"text": "of", "start": 59, "end": 61, "id": 11, "ws": true}, {"text": "essential", "start": 62, "end": 71, "id": 12, "ws": true}, {"text": "hypertension", "start": 72, "end": 84, "id": 13, "ws": false}, {"text": ".", "start": 84, "end": 85, "id": 14, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 21, "token_start": 3, "token_end": 3, "label": "DRUG"}, {"start": 22, "end": 25, "token_start": 4, "token_end": 4, "label": "SALT"}, {"start": 48, "end": 61, "token_start": 10, "token_end": 11, "label": "ACTION"}, {"start": 62, "end": 84, "token_start": 12, "token_end": 13, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694174176, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "ULTRAVATE lotion is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. ULTRAVATE lotion is a corticosteroid indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older.", "_input_hash": 1401652809, "_task_hash": 109990598, "_is_binary": false, "tokens": [{"text": "ULTRAVATE", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "lotion", "start": 10, "end": 16, "id": 1, "ws": true}, {"text": "is", "start": 17, "end": 19, "id": 2, "ws": true}, {"text": "indicated", "start": 20, "end": 29, "id": 3, "ws": true}, {"text": "for", "start": 30, "end": 33, "id": 4, "ws": true}, {"text": "the", "start": 34, "end": 37, "id": 5, "ws": true}, {"text": "topical", "start": 38, "end": 45, "id": 6, "ws": true}, {"text": "treatment", "start": 46, "end": 55, "id": 7, "ws": true}, {"text": "of", "start": 56, "end": 58, "id": 8, "ws": true}, {"text": "plaque", "start": 59, "end": 65, "id": 9, "ws": true}, {"text": "psoriasis", "start": 66, "end": 75, "id": 10, "ws": true}, {"text": "in", "start": 76, "end": 78, "id": 11, "ws": true}, {"text": "patients", "start": 79, "end": 87, "id": 12, "ws": true}, {"text": "12", "start": 88, "end": 90, "id": 13, "ws": true}, {"text": "years", "start": 91, "end": 96, "id": 14, "ws": true}, {"text": "of", "start": 97, "end": 99, "id": 15, "ws": true}, {"text": "age", "start": 100, "end": 103, "id": 16, "ws": true}, {"text": "and", "start": 104, "end": 107, "id": 17, "ws": true}, {"text": "older", "start": 108, "end": 113, "id": 18, "ws": false}, {"text": ".", "start": 113, "end": 114, "id": 19, "ws": true}, {"text": "ULTRAVATE", "start": 115, "end": 124, "id": 20, "ws": true}, {"text": "lotion", "start": 125, "end": 131, "id": 21, "ws": true}, {"text": "is", "start": 132, "end": 134, "id": 22, "ws": true}, {"text": "a", "start": 135, "end": 136, "id": 23, "ws": true}, {"text": "corticosteroid", "start": 137, "end": 151, "id": 24, "ws": true}, {"text": "indicated", "start": 152, "end": 161, "id": 25, "ws": true}, {"text": "for", "start": 162, "end": 165, "id": 26, "ws": true}, {"text": "the", "start": 166, "end": 169, "id": 27, "ws": true}, {"text": "topical", "start": 170, "end": 177, "id": 28, "ws": true}, {"text": "treatment", "start": 178, "end": 187, "id": 29, "ws": true}, {"text": "of", "start": 188, "end": 190, "id": 30, "ws": true}, {"text": "plaque", "start": 191, "end": 197, "id": 31, "ws": true}, {"text": "psoriasis", "start": 198, "end": 207, "id": 32, "ws": true}, {"text": "in", "start": 208, "end": 210, "id": 33, "ws": true}, {"text": "patients", "start": 211, "end": 219, "id": 34, "ws": true}, {"text": "12", "start": 220, "end": 222, "id": 35, "ws": true}, {"text": "years", "start": 223, "end": 228, "id": 36, "ws": true}, {"text": "of", "start": 229, "end": 231, "id": 37, "ws": true}, {"text": "age", "start": 232, "end": 235, "id": 38, "ws": true}, {"text": "and", "start": 236, "end": 239, "id": 39, "ws": true}, {"text": "older", "start": 240, "end": 245, "id": 40, "ws": false}, {"text": ".", "start": 245, "end": 246, "id": 41, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 16, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 38, "end": 55, "token_start": 6, "token_end": 7, "label": "ACTION"}, {"start": 59, "end": 75, "token_start": 9, "token_end": 10, "label": "INDICATION"}, {"start": 79, "end": 113, "token_start": 12, "token_end": 18, "label": "TARGET_GROUP"}, {"start": 137, "end": 151, "token_start": 24, "token_end": 24, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694525508, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Nelarabine Injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. Nelarabine Injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. (1)", "_input_hash": -931900042, "_task_hash": 1163734810, "_is_binary": false, "tokens": [{"text": "Nelarabine", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "Injection", "start": 11, "end": 20, "id": 1, "ws": true}, {"text": "is", "start": 21, "end": 23, "id": 2, "ws": true}, {"text": "indicated", "start": 24, "end": 33, "id": 3, "ws": true}, {"text": "for", "start": 34, "end": 37, "id": 4, "ws": true}, {"text": "the", "start": 38, "end": 41, "id": 5, "ws": true}, {"text": "treatment", "start": 42, "end": 51, "id": 6, "ws": true}, {"text": "of", "start": 52, "end": 54, "id": 7, "ws": true}, {"text": "T", "start": 55, "end": 56, "id": 8, "ws": false}, {"text": "-", "start": 56, "end": 57, "id": 9, "ws": false}, {"text": "cell", "start": 57, "end": 61, "id": 10, "ws": true}, {"text": "acute", "start": 62, "end": 67, "id": 11, "ws": true}, {"text": "lymphoblastic", "start": 68, "end": 81, "id": 12, "ws": true}, {"text": "leukemia", "start": 82, "end": 90, "id": 13, "ws": true}, {"text": "(", "start": 91, "end": 92, "id": 14, "ws": false}, {"text": "T", "start": 92, "end": 93, "id": 15, "ws": false}, {"text": "-", "start": 93, "end": 94, "id": 16, "ws": false}, {"text": "ALL", "start": 94, "end": 97, "id": 17, "ws": false}, {"text": ")", "start": 97, "end": 98, "id": 18, "ws": true}, {"text": "and", "start": 99, "end": 102, "id": 19, "ws": true}, {"text": "T", "start": 103, "end": 104, "id": 20, "ws": false}, {"text": "-", "start": 104, "end": 105, "id": 21, "ws": false}, {"text": "cell", "start": 105, "end": 109, "id": 22, "ws": true}, {"text": "lymphoblastic", "start": 110, "end": 123, "id": 23, "ws": true}, {"text": "lymphoma", "start": 124, "end": 132, "id": 24, "ws": true}, {"text": "(", "start": 133, "end": 134, "id": 25, "ws": false}, {"text": "T", "start": 134, "end": 135, "id": 26, "ws": false}, {"text": "-", "start": 135, "end": 136, "id": 27, "ws": false}, {"text": "LBL", "start": 136, "end": 139, "id": 28, "ws": false}, {"text": ")", "start": 139, "end": 140, "id": 29, "ws": true}, {"text": "in", "start": 141, "end": 143, "id": 30, "ws": true}, {"text": "adult", "start": 144, "end": 149, "id": 31, "ws": true}, {"text": "and", "start": 150, "end": 153, "id": 32, "ws": true}, {"text": "pediatric", "start": 154, "end": 163, "id": 33, "ws": true}, {"text": "patients", "start": 164, "end": 172, "id": 34, "ws": true}, {"text": "age", "start": 173, "end": 176, "id": 35, "ws": true}, {"text": "1", "start": 177, "end": 178, "id": 36, "ws": true}, {"text": "year", "start": 179, "end": 183, "id": 37, "ws": true}, {"text": "and", "start": 184, "end": 187, "id": 38, "ws": true}, {"text": "older", "start": 188, "end": 193, "id": 39, "ws": true}, {"text": "whose", "start": 194, "end": 199, "id": 40, "ws": true}, {"text": "disease", "start": 200, "end": 207, "id": 41, "ws": true}, {"text": "has", "start": 208, "end": 211, "id": 42, "ws": true}, {"text": "not", "start": 212, "end": 215, "id": 43, "ws": true}, {"text": "responded", "start": 216, "end": 225, "id": 44, "ws": true}, {"text": "to", "start": 226, "end": 228, "id": 45, "ws": true}, {"text": "or", "start": 229, "end": 231, "id": 46, "ws": true}, {"text": "has", "start": 232, "end": 235, "id": 47, "ws": true}, {"text": "relapsed", "start": 236, "end": 244, "id": 48, "ws": true}, {"text": "following", "start": 245, "end": 254, "id": 49, "ws": true}, {"text": "treatment", "start": 255, "end": 264, "id": 50, "ws": true}, {"text": "with", "start": 265, "end": 269, "id": 51, "ws": true}, {"text": "at", "start": 270, "end": 272, "id": 52, "ws": true}, {"text": "least", "start": 273, "end": 278, "id": 53, "ws": true}, {"text": "two", "start": 279, "end": 282, "id": 54, "ws": true}, {"text": "chemotherapy", "start": 283, "end": 295, "id": 55, "ws": true}, {"text": "regimens", "start": 296, "end": 304, "id": 56, "ws": false}, {"text": ".", "start": 304, "end": 305, "id": 57, "ws": true}, {"text": "Nelarabine", "start": 306, "end": 316, "id": 58, "ws": true}, {"text": "Injection", "start": 317, "end": 326, "id": 59, "ws": true}, {"text": "is", "start": 327, "end": 329, "id": 60, "ws": true}, {"text": "a", "start": 330, "end": 331, "id": 61, "ws": true}, {"text": "nucleoside", "start": 332, "end": 342, "id": 62, "ws": true}, {"text": "metabolic", "start": 343, "end": 352, "id": 63, "ws": true}, {"text": "inhibitor", "start": 353, "end": 362, "id": 64, "ws": true}, {"text": "indicated", "start": 363, "end": 372, "id": 65, "ws": true}, {"text": "for", "start": 373, "end": 376, "id": 66, "ws": true}, {"text": "the", "start": 377, "end": 380, "id": 67, "ws": true}, {"text": "treatment", "start": 381, "end": 390, "id": 68, "ws": true}, {"text": "of", "start": 391, "end": 393, "id": 69, "ws": true}, {"text": "patients", "start": 394, "end": 402, "id": 70, "ws": true}, {"text": "with", "start": 403, "end": 407, "id": 71, "ws": true}, {"text": "T", "start": 408, "end": 409, "id": 72, "ws": false}, {"text": "-", "start": 409, "end": 410, "id": 73, "ws": false}, {"text": "cell", "start": 410, "end": 414, "id": 74, "ws": true}, {"text": "acute", "start": 415, "end": 420, "id": 75, "ws": true}, {"text": "lymphoblastic", "start": 421, "end": 434, "id": 76, "ws": true}, {"text": "leukemia", "start": 435, "end": 443, "id": 77, "ws": true}, {"text": "and", "start": 444, "end": 447, "id": 78, "ws": true}, {"text": "T", "start": 448, "end": 449, "id": 79, "ws": false}, {"text": "-", "start": 449, "end": 450, "id": 80, "ws": false}, {"text": "cell", "start": 450, "end": 454, "id": 81, "ws": true}, {"text": "lymphoblastic", "start": 455, "end": 468, "id": 82, "ws": true}, {"text": "lymphoma", "start": 469, "end": 477, "id": 83, "ws": true}, {"text": "in", "start": 478, "end": 480, "id": 84, "ws": true}, {"text": "adult", "start": 481, "end": 486, "id": 85, "ws": true}, {"text": "and", "start": 487, "end": 490, "id": 86, "ws": true}, {"text": "pediatric", "start": 491, "end": 500, "id": 87, "ws": true}, {"text": "patients", "start": 501, "end": 509, "id": 88, "ws": true}, {"text": "age", "start": 510, "end": 513, "id": 89, "ws": true}, {"text": "1", "start": 514, "end": 515, "id": 90, "ws": true}, {"text": "year", "start": 516, "end": 520, "id": 91, "ws": true}, {"text": "and", "start": 521, "end": 524, "id": 92, "ws": true}, {"text": "older", "start": 525, "end": 530, "id": 93, "ws": true}, {"text": "whose", "start": 531, "end": 536, "id": 94, "ws": true}, {"text": "disease", "start": 537, "end": 544, "id": 95, "ws": true}, {"text": "has", "start": 545, "end": 548, "id": 96, "ws": true}, {"text": "not", "start": 549, "end": 552, "id": 97, "ws": true}, {"text": "responded", "start": 553, "end": 562, "id": 98, "ws": true}, {"text": "to", "start": 563, "end": 565, "id": 99, "ws": true}, {"text": "or", "start": 566, "end": 568, "id": 100, "ws": true}, {"text": "has", "start": 569, "end": 572, "id": 101, "ws": true}, {"text": "relapsed", "start": 573, "end": 581, "id": 102, "ws": true}, {"text": "following", "start": 582, "end": 591, "id": 103, "ws": true}, {"text": "treatment", "start": 592, "end": 601, "id": 104, "ws": true}, {"text": "with", "start": 602, "end": 606, "id": 105, "ws": true}, {"text": "at", "start": 607, "end": 609, "id": 106, "ws": true}, {"text": "least", "start": 610, "end": 615, "id": 107, "ws": true}, {"text": "two", "start": 616, "end": 619, "id": 108, "ws": true}, {"text": "chemotherapy", "start": 620, "end": 632, "id": 109, "ws": true}, {"text": "regimens", "start": 633, "end": 641, "id": 110, "ws": false}, {"text": ".", "start": 641, "end": 642, "id": 111, "ws": true}, {"text": "(", "start": 643, "end": 644, "id": 112, "ws": false}, {"text": "1", "start": 644, "end": 645, "id": 113, "ws": false}, {"text": ")", "start": 645, "end": 646, "id": 114, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 20, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 42, "end": 51, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 52, "end": 90, "token_start": 7, "token_end": 13, "label": "INDICATION"}, {"start": 103, "end": 132, "token_start": 20, "token_end": 24, "label": "INDICATION"}, {"start": 144, "end": 149, "token_start": 31, "token_end": 31, "label": "TARGET_GROUP"}, {"start": 154, "end": 193, "token_start": 33, "token_end": 39, "label": "TARGET_GROUP"}, {"start": 194, "end": 304, "token_start": 40, "token_end": 56, "label": "MEDICAL_CTX"}, {"start": 306, "end": 316, "token_start": 58, "token_end": 58, "label": "DRUG"}, {"start": 317, "end": 326, "token_start": 59, "token_end": 59, "label": "FORMULATION"}, {"start": 332, "end": 362, "token_start": 62, "token_end": 64, "label": "MECHANISM"}, {"start": 381, "end": 390, "token_start": 68, "token_end": 68, "label": "ACTION"}, {"start": 408, "end": 443, "token_start": 72, "token_end": 77, "label": "INDICATION"}, {"start": 448, "end": 480, "token_start": 79, "token_end": 84, "label": "INDICATION"}, {"start": 481, "end": 486, "token_start": 85, "token_end": 85, "label": "TARGET_GROUP"}, {"start": 491, "end": 530, "token_start": 87, "token_end": 93, "label": "TARGET_GROUP"}, {"start": 531, "end": 641, "token_start": 94, "token_end": 110, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694526237, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma. Temsirolimus injection is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. (1)", "_input_hash": 94515917, "_task_hash": -1838837300, "_is_binary": false, "tokens": [{"text": "Temsirolimus", "start": 0, "end": 12, "id": 0, "ws": true}, {"text": "injection", "start": 13, "end": 22, "id": 1, "ws": true}, {"text": "is", "start": 23, "end": 25, "id": 2, "ws": true}, {"text": "indicated", "start": 26, "end": 35, "id": 3, "ws": true}, {"text": "for", "start": 36, "end": 39, "id": 4, "ws": true}, {"text": "the", "start": 40, "end": 43, "id": 5, "ws": true}, {"text": "treatment", "start": 44, "end": 53, "id": 6, "ws": true}, {"text": "of", "start": 54, "end": 56, "id": 7, "ws": true}, {"text": "advanced", "start": 57, "end": 65, "id": 8, "ws": true}, {"text": "renal", "start": 66, "end": 71, "id": 9, "ws": true}, {"text": "cell", "start": 72, "end": 76, "id": 10, "ws": true}, {"text": "carcinoma", "start": 77, "end": 86, "id": 11, "ws": false}, {"text": ".", "start": 86, "end": 87, "id": 12, "ws": true}, {"text": "Temsirolimus", "start": 88, "end": 100, "id": 13, "ws": true}, {"text": "injection", "start": 101, "end": 110, "id": 14, "ws": true}, {"text": "is", "start": 111, "end": 113, "id": 15, "ws": true}, {"text": "a", "start": 114, "end": 115, "id": 16, "ws": true}, {"text": "kinase", "start": 116, "end": 122, "id": 17, "ws": true}, {"text": "inhibitor", "start": 123, "end": 132, "id": 18, "ws": true}, {"text": "indicated", "start": 133, "end": 142, "id": 19, "ws": true}, {"text": "for", "start": 143, "end": 146, "id": 20, "ws": true}, {"text": "the", "start": 147, "end": 150, "id": 21, "ws": true}, {"text": "treatment", "start": 151, "end": 160, "id": 22, "ws": true}, {"text": "of", "start": 161, "end": 163, "id": 23, "ws": true}, {"text": "advanced", "start": 164, "end": 172, "id": 24, "ws": true}, {"text": "renal", "start": 173, "end": 178, "id": 25, "ws": true}, {"text": "cell", "start": 179, "end": 183, "id": 26, "ws": true}, {"text": "carcinoma", "start": 184, "end": 193, "id": 27, "ws": false}, {"text": ".", "start": 193, "end": 194, "id": 28, "ws": true}, {"text": "(", "start": 195, "end": 196, "id": 29, "ws": false}, {"text": "1", "start": 196, "end": 197, "id": 30, "ws": false}, {"text": ")", "start": 197, "end": 198, "id": 31, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 12, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 13, "end": 22, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 44, "end": 53, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 57, "end": 86, "token_start": 8, "token_end": 11, "label": "INDICATION"}, {"start": 88, "end": 100, "token_start": 13, "token_end": 13, "label": "DRUG"}, {"start": 101, "end": 110, "token_start": 14, "token_end": 14, "label": "FORMULATION"}, {"start": 116, "end": 132, "token_start": 17, "token_end": 18, "label": "MECHANISM"}, {"start": 151, "end": 160, "token_start": 22, "token_end": 22, "label": "ACTION"}, {"start": 164, "end": 193, "token_start": 24, "token_end": 27, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527290, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ISTODAX is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy. ISTODAX is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy (1).", "_input_hash": 332985713, "_task_hash": 1641723674, "_is_binary": false, "tokens": [{"text": "ISTODAX", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "cutaneous", "start": 42, "end": 51, "id": 7, "ws": true}, {"text": "T", "start": 52, "end": 53, "id": 8, "ws": false}, {"text": "-", "start": 53, "end": 54, "id": 9, "ws": false}, {"text": "cell", "start": 54, "end": 58, "id": 10, "ws": true}, {"text": "lymphoma", "start": 59, "end": 67, "id": 11, "ws": true}, {"text": "(", "start": 68, "end": 69, "id": 12, "ws": false}, {"text": "CTCL", "start": 69, "end": 73, "id": 13, "ws": false}, {"text": ")", "start": 73, "end": 74, "id": 14, "ws": true}, {"text": "in", "start": 75, "end": 77, "id": 15, "ws": true}, {"text": "adult", "start": 78, "end": 83, "id": 16, "ws": true}, {"text": "patients", "start": 84, "end": 92, "id": 17, "ws": true}, {"text": "who", "start": 93, "end": 96, "id": 18, "ws": true}, {"text": "have", "start": 97, "end": 101, "id": 19, "ws": true}, {"text": "received", "start": 102, "end": 110, "id": 20, "ws": true}, {"text": "at", "start": 111, "end": 113, "id": 21, "ws": true}, {"text": "least", "start": 114, "end": 119, "id": 22, "ws": true}, {"text": "one", "start": 120, "end": 123, "id": 23, "ws": true}, {"text": "prior", "start": 124, "end": 129, "id": 24, "ws": true}, {"text": "systemic", "start": 130, "end": 138, "id": 25, "ws": true}, {"text": "therapy", "start": 139, "end": 146, "id": 26, "ws": false}, {"text": ".", "start": 146, "end": 147, "id": 27, "ws": true}, {"text": "ISTODAX", "start": 148, "end": 155, "id": 28, "ws": true}, {"text": "is", "start": 156, "end": 158, "id": 29, "ws": true}, {"text": "a", "start": 159, "end": 160, "id": 30, "ws": true}, {"text": "histone", "start": 161, "end": 168, "id": 31, "ws": true}, {"text": "deacetylase", "start": 169, "end": 180, "id": 32, "ws": true}, {"text": "(", "start": 181, "end": 182, "id": 33, "ws": false}, {"text": "HDAC", "start": 182, "end": 186, "id": 34, "ws": false}, {"text": ")", "start": 186, "end": 187, "id": 35, "ws": true}, {"text": "inhibitor", "start": 188, "end": 197, "id": 36, "ws": true}, {"text": "indicated", "start": 198, "end": 207, "id": 37, "ws": true}, {"text": "for", "start": 208, "end": 211, "id": 38, "ws": true}, {"text": "the", "start": 212, "end": 215, "id": 39, "ws": true}, {"text": "treatment", "start": 216, "end": 225, "id": 40, "ws": true}, {"text": "of", "start": 226, "end": 228, "id": 41, "ws": true}, {"text": "cutaneous", "start": 229, "end": 238, "id": 42, "ws": true}, {"text": "T", "start": 239, "end": 240, "id": 43, "ws": false}, {"text": "-", "start": 240, "end": 241, "id": 44, "ws": false}, {"text": "cell", "start": 241, "end": 245, "id": 45, "ws": true}, {"text": "lymphoma", "start": 246, "end": 254, "id": 46, "ws": true}, {"text": "(", "start": 255, "end": 256, "id": 47, "ws": false}, {"text": "CTCL", "start": 256, "end": 260, "id": 48, "ws": false}, {"text": ")", "start": 260, "end": 261, "id": 49, "ws": true}, {"text": "in", "start": 262, "end": 264, "id": 50, "ws": true}, {"text": "adult", "start": 265, "end": 270, "id": 51, "ws": true}, {"text": "patients", "start": 271, "end": 279, "id": 52, "ws": true}, {"text": "who", "start": 280, "end": 283, "id": 53, "ws": true}, {"text": "have", "start": 284, "end": 288, "id": 54, "ws": true}, {"text": "received", "start": 289, "end": 297, "id": 55, "ws": true}, {"text": "at", "start": 298, "end": 300, "id": 56, "ws": true}, {"text": "least", "start": 301, "end": 306, "id": 57, "ws": true}, {"text": "one", "start": 307, "end": 310, "id": 58, "ws": true}, {"text": "prior", "start": 311, "end": 316, "id": 59, "ws": true}, {"text": "systemic", "start": 317, "end": 325, "id": 60, "ws": true}, {"text": "therapy", "start": 326, "end": 333, "id": 61, "ws": true}, {"text": "(", "start": 334, "end": 335, "id": 62, "ws": false}, {"text": "1", "start": 335, "end": 336, "id": 63, "ws": false}, {"text": ")", "start": 336, "end": 337, "id": 64, "ws": false}, {"text": ".", "start": 337, "end": 338, "id": 65, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 42, "end": 74, "token_start": 7, "token_end": 14, "label": "INDICATION"}, {"start": 78, "end": 83, "token_start": 16, "token_end": 16, "label": "TARGET_GROUP"}, {"start": 93, "end": 146, "token_start": 18, "token_end": 26, "label": "HISTORY"}], "answer": "accept", "_timestamp": 1694175993, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Alprazolam XR is indicated for the treatment of panic disorder with or without agoraphobia, in adults. Alprazolam XR is a benzodiazepine indicated for the treatment of panic disorder with or without agoraphobia, in adults. (1)", "_input_hash": 381270410, "_task_hash": 1365468297, "_is_binary": false, "tokens": [{"text": "Alprazolam", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "XR", "start": 11, "end": 13, "id": 1, "ws": true}, {"text": "is", "start": 14, "end": 16, "id": 2, "ws": true}, {"text": "indicated", "start": 17, "end": 26, "id": 3, "ws": true}, {"text": "for", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "the", "start": 31, "end": 34, "id": 5, "ws": true}, {"text": "treatment", "start": 35, "end": 44, "id": 6, "ws": true}, {"text": "of", "start": 45, "end": 47, "id": 7, "ws": true}, {"text": "panic", "start": 48, "end": 53, "id": 8, "ws": true}, {"text": "disorder", "start": 54, "end": 62, "id": 9, "ws": true}, {"text": "with", "start": 63, "end": 67, "id": 10, "ws": true}, {"text": "or", "start": 68, "end": 70, "id": 11, "ws": true}, {"text": "without", "start": 71, "end": 78, "id": 12, "ws": true}, {"text": "agoraphobia", "start": 79, "end": 90, "id": 13, "ws": false}, {"text": ",", "start": 90, "end": 91, "id": 14, "ws": true}, {"text": "in", "start": 92, "end": 94, "id": 15, "ws": true}, {"text": "adults", "start": 95, "end": 101, "id": 16, "ws": false}, {"text": ".", "start": 101, "end": 102, "id": 17, "ws": true}, {"text": "Alprazolam", "start": 103, "end": 113, "id": 18, "ws": true}, {"text": "XR", "start": 114, "end": 116, "id": 19, "ws": true}, {"text": "is", "start": 117, "end": 119, "id": 20, "ws": true}, {"text": "a", "start": 120, "end": 121, "id": 21, "ws": true}, {"text": "benzodiazepine", "start": 122, "end": 136, "id": 22, "ws": true}, {"text": "indicated", "start": 137, "end": 146, "id": 23, "ws": true}, {"text": "for", "start": 147, "end": 150, "id": 24, "ws": true}, {"text": "the", "start": 151, "end": 154, "id": 25, "ws": true}, {"text": "treatment", "start": 155, "end": 164, "id": 26, "ws": true}, {"text": "of", "start": 165, "end": 167, "id": 27, "ws": true}, {"text": "panic", "start": 168, "end": 173, "id": 28, "ws": true}, {"text": "disorder", "start": 174, "end": 182, "id": 29, "ws": true}, {"text": "with", "start": 183, "end": 187, "id": 30, "ws": true}, {"text": "or", "start": 188, "end": 190, "id": 31, "ws": true}, {"text": "without", "start": 191, "end": 198, "id": 32, "ws": true}, {"text": "agoraphobia", "start": 199, "end": 210, "id": 33, "ws": false}, {"text": ",", "start": 210, "end": 211, "id": 34, "ws": true}, {"text": "in", "start": 212, "end": 214, "id": 35, "ws": true}, {"text": "adults", "start": 215, "end": 221, "id": 36, "ws": false}, {"text": ".", "start": 221, "end": 222, "id": 37, "ws": true}, {"text": "(", "start": 223, "end": 224, "id": 38, "ws": false}, {"text": "1", "start": 224, "end": 225, "id": 39, "ws": false}, {"text": ")", "start": 225, "end": 226, "id": 40, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 35, "end": 44, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 48, "end": 62, "token_start": 8, "token_end": 9, "label": "INDICATION"}, {"start": 95, "end": 101, "token_start": 16, "token_end": 16, "label": "TARGET_GROUP"}, {"start": 103, "end": 113, "token_start": 18, "token_end": 18, "label": "DRUG"}, {"start": 122, "end": 136, "token_start": 22, "token_end": 22, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694177255, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "HALOG (Halcinonide Cream, USP) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "_input_hash": 1938221802, "_task_hash": -1908983648, "_is_binary": false, "tokens": [{"text": "HALOG", "start": 0, "end": 5, "id": 0, "ws": true}, {"text": "(", "start": 6, "end": 7, "id": 1, "ws": false}, {"text": "Halcinonide", "start": 7, "end": 18, "id": 2, "ws": true}, {"text": "Cream", "start": 19, "end": 24, "id": 3, "ws": false}, {"text": ",", "start": 24, "end": 25, "id": 4, "ws": true}, {"text": "USP", "start": 26, "end": 29, "id": 5, "ws": false}, {"text": ")", "start": 29, "end": 30, "id": 6, "ws": true}, {"text": "0.1", "start": 31, "end": 34, "id": 7, "ws": false}, {"text": "%", "start": 34, "end": 35, "id": 8, "ws": true}, {"text": "is", "start": 36, "end": 38, "id": 9, "ws": true}, {"text": "indicated", "start": 39, "end": 48, "id": 10, "ws": true}, {"text": "for", "start": 49, "end": 52, "id": 11, "ws": true}, {"text": "the", "start": 53, "end": 56, "id": 12, "ws": true}, {"text": "relief", "start": 57, "end": 63, "id": 13, "ws": true}, {"text": "of", "start": 64, "end": 66, "id": 14, "ws": true}, {"text": "the", "start": 67, "end": 70, "id": 15, "ws": true}, {"text": "inflammatory", "start": 71, "end": 83, "id": 16, "ws": true}, {"text": "and", "start": 84, "end": 87, "id": 17, "ws": true}, {"text": "pruritic", "start": 88, "end": 96, "id": 18, "ws": true}, {"text": "manifestations", "start": 97, "end": 111, "id": 19, "ws": true}, {"text": "of", "start": 112, "end": 114, "id": 20, "ws": true}, {"text": "corticosteroid", "start": 115, "end": 129, "id": 21, "ws": false}, {"text": "-", "start": 129, "end": 130, "id": 22, "ws": false}, {"text": "responsive", "start": 130, "end": 140, "id": 23, "ws": true}, {"text": "dermatoses", "start": 141, "end": 151, "id": 24, "ws": false}, {"text": ".", "start": 151, "end": 152, "id": 25, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 5, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 7, "end": 18, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 19, "end": 24, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 57, "end": 66, "token_start": 13, "token_end": 14, "label": "ACTION"}, {"start": 71, "end": 111, "token_start": 16, "token_end": 19, "label": "INDICATION"}, {"start": 115, "end": 151, "token_start": 21, "token_end": 24, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694175159, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Sodium Acetate Injection, USP (4 mEq per mL) is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.", "_input_hash": -808606508, "_task_hash": 667191086, "_is_binary": false, "tokens": [{"text": "Sodium", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "Acetate", "start": 7, "end": 14, "id": 1, "ws": true}, {"text": "Injection", "start": 15, "end": 24, "id": 2, "ws": false}, {"text": ",", "start": 24, "end": 25, "id": 3, "ws": true}, {"text": "USP", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "(", "start": 30, "end": 31, "id": 5, "ws": false}, {"text": "4", "start": 31, "end": 32, "id": 6, "ws": true}, {"text": "mEq", "start": 33, "end": 36, "id": 7, "ws": true}, {"text": "per", "start": 37, "end": 40, "id": 8, "ws": true}, {"text": "mL", "start": 41, "end": 43, "id": 9, "ws": false}, {"text": ")", "start": 43, "end": 44, "id": 10, "ws": true}, {"text": "is", "start": 45, "end": 47, "id": 11, "ws": true}, {"text": "indicated", "start": 48, "end": 57, "id": 12, "ws": true}, {"text": "as", "start": 58, "end": 60, "id": 13, "ws": true}, {"text": "a", "start": 61, "end": 62, "id": 14, "ws": true}, {"text": "source", "start": 63, "end": 69, "id": 15, "ws": true}, {"text": "of", "start": 70, "end": 72, "id": 16, "ws": true}, {"text": "sodium", "start": 73, "end": 79, "id": 17, "ws": true}, {"text": "for", "start": 80, "end": 83, "id": 18, "ws": true}, {"text": "addition", "start": 84, "end": 92, "id": 19, "ws": true}, {"text": "to", "start": 93, "end": 95, "id": 20, "ws": true}, {"text": "large", "start": 96, "end": 101, "id": 21, "ws": true}, {"text": "volume", "start": 102, "end": 108, "id": 22, "ws": true}, {"text": "intravenous", "start": 109, "end": 120, "id": 23, "ws": true}, {"text": "fluids", "start": 121, "end": 127, "id": 24, "ws": true}, {"text": "to", "start": 128, "end": 130, "id": 25, "ws": true}, {"text": "prevent", "start": 131, "end": 138, "id": 26, "ws": true}, {"text": "or", "start": 139, "end": 141, "id": 27, "ws": true}, {"text": "correct", "start": 142, "end": 149, "id": 28, "ws": true}, {"text": "hyponatremia", "start": 150, "end": 162, "id": 29, "ws": true}, {"text": "in", "start": 163, "end": 165, "id": 30, "ws": true}, {"text": "patients", "start": 166, "end": 174, "id": 31, "ws": true}, {"text": "with", "start": 175, "end": 179, "id": 32, "ws": true}, {"text": "restricted", "start": 180, "end": 190, "id": 33, "ws": true}, {"text": "or", "start": 191, "end": 193, "id": 34, "ws": true}, {"text": "no", "start": 194, "end": 196, "id": 35, "ws": true}, {"text": "oral", "start": 197, "end": 201, "id": 36, "ws": true}, {"text": "intake", "start": 202, "end": 208, "id": 37, "ws": false}, {"text": ".", "start": 208, "end": 209, "id": 38, "ws": true}, {"text": "It", "start": 210, "end": 212, "id": 39, "ws": true}, {"text": "is", "start": 213, "end": 215, "id": 40, "ws": true}, {"text": "also", "start": 216, "end": 220, "id": 41, "ws": true}, {"text": "useful", "start": 221, "end": 227, "id": 42, "ws": true}, {"text": "as", "start": 228, "end": 230, "id": 43, "ws": true}, {"text": "an", "start": 231, "end": 233, "id": 44, "ws": true}, {"text": "additive", "start": 234, "end": 242, "id": 45, "ws": true}, {"text": "for", "start": 243, "end": 246, "id": 46, "ws": true}, {"text": "preparing", "start": 247, "end": 256, "id": 47, "ws": true}, {"text": "specific", "start": 257, "end": 265, "id": 48, "ws": true}, {"text": "intravenous", "start": 266, "end": 277, "id": 49, "ws": true}, {"text": "fluid", "start": 278, "end": 283, "id": 50, "ws": true}, {"text": "formulas", "start": 284, "end": 292, "id": 51, "ws": true}, {"text": "when", "start": 293, "end": 297, "id": 52, "ws": true}, {"text": "the", "start": 298, "end": 301, "id": 53, "ws": true}, {"text": "needs", "start": 302, "end": 307, "id": 54, "ws": true}, {"text": "of", "start": 308, "end": 310, "id": 55, "ws": true}, {"text": "the", "start": 311, "end": 314, "id": 56, "ws": true}, {"text": "patient", "start": 315, "end": 322, "id": 57, "ws": true}, {"text": "can", "start": 323, "end": 326, "id": 58, "ws": false}, {"text": "not", "start": 326, "end": 329, "id": 59, "ws": true}, {"text": "be", "start": 330, "end": 332, "id": 60, "ws": true}, {"text": "met", "start": 333, "end": 336, "id": 61, "ws": true}, {"text": "by", "start": 337, "end": 339, "id": 62, "ws": true}, {"text": "standard", "start": 340, "end": 348, "id": 63, "ws": true}, {"text": "electrolyte", "start": 349, "end": 360, "id": 64, "ws": true}, {"text": "or", "start": 361, "end": 363, "id": 65, "ws": true}, {"text": "nutrient", "start": 364, "end": 372, "id": 66, "ws": true}, {"text": "solutions", "start": 373, "end": 382, "id": 67, "ws": false}, {"text": ".", "start": 382, "end": 383, "id": 68, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 7, "end": 14, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 15, "end": 24, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 63, "end": 79, "token_start": 15, "token_end": 17, "label": "EFFECT"}, {"start": 150, "end": 162, "token_start": 29, "token_end": 29, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527689, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Velphoro is indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Velphoro is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. ( 1)", "_input_hash": -2078296643, "_task_hash": -1290872322, "_is_binary": false, "tokens": [{"text": "Velphoro", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "control", "start": 30, "end": 37, "id": 5, "ws": true}, {"text": "of", "start": 38, "end": 40, "id": 6, "ws": true}, {"text": "serum", "start": 41, "end": 46, "id": 7, "ws": true}, {"text": "phosphorus", "start": 47, "end": 57, "id": 8, "ws": true}, {"text": "levels", "start": 58, "end": 64, "id": 9, "ws": true}, {"text": "in", "start": 65, "end": 67, "id": 10, "ws": true}, {"text": "patients", "start": 68, "end": 76, "id": 11, "ws": true}, {"text": "with", "start": 77, "end": 81, "id": 12, "ws": true}, {"text": "chronic", "start": 82, "end": 89, "id": 13, "ws": true}, {"text": "kidney", "start": 90, "end": 96, "id": 14, "ws": true}, {"text": "disease", "start": 97, "end": 104, "id": 15, "ws": true}, {"text": "on", "start": 105, "end": 107, "id": 16, "ws": true}, {"text": "dialysis", "start": 108, "end": 116, "id": 17, "ws": false}, {"text": ".", "start": 116, "end": 117, "id": 18, "ws": true}, {"text": "Velphoro", "start": 118, "end": 126, "id": 19, "ws": true}, {"text": "is", "start": 127, "end": 129, "id": 20, "ws": true}, {"text": "a", "start": 130, "end": 131, "id": 21, "ws": true}, {"text": "phosphate", "start": 132, "end": 141, "id": 22, "ws": true}, {"text": "binder", "start": 142, "end": 148, "id": 23, "ws": true}, {"text": "indicated", "start": 149, "end": 158, "id": 24, "ws": true}, {"text": "for", "start": 159, "end": 162, "id": 25, "ws": true}, {"text": "the", "start": 163, "end": 166, "id": 26, "ws": true}, {"text": "control", "start": 167, "end": 174, "id": 27, "ws": true}, {"text": "of", "start": 175, "end": 177, "id": 28, "ws": true}, {"text": "serum", "start": 178, "end": 183, "id": 29, "ws": true}, {"text": "phosphorus", "start": 184, "end": 194, "id": 30, "ws": true}, {"text": "levels", "start": 195, "end": 201, "id": 31, "ws": true}, {"text": "in", "start": 202, "end": 204, "id": 32, "ws": true}, {"text": "patients", "start": 205, "end": 213, "id": 33, "ws": true}, {"text": "with", "start": 214, "end": 218, "id": 34, "ws": true}, {"text": "chronic", "start": 219, "end": 226, "id": 35, "ws": true}, {"text": "kidney", "start": 227, "end": 233, "id": 36, "ws": true}, {"text": "disease", "start": 234, "end": 241, "id": 37, "ws": true}, {"text": "on", "start": 242, "end": 244, "id": 38, "ws": true}, {"text": "dialysis", "start": 245, "end": 253, "id": 39, "ws": false}, {"text": ".", "start": 253, "end": 254, "id": 40, "ws": true}, {"text": "(", "start": 255, "end": 256, "id": 41, "ws": true}, {"text": "1", "start": 257, "end": 258, "id": 42, "ws": false}, {"text": ")", "start": 258, "end": 259, "id": 43, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 37, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 41, "end": 64, "token_start": 7, "token_end": 9, "label": "MEDICAL_CTX"}, {"start": 82, "end": 104, "token_start": 13, "token_end": 15, "label": "BASECONDITION"}, {"start": 108, "end": 116, "token_start": 17, "token_end": 17, "label": "MEDICAL_CTX"}, {"start": 118, "end": 126, "token_start": 19, "token_end": 19, "label": "DRUG"}, {"start": 132, "end": 148, "token_start": 22, "token_end": 23, "label": "MECHANISM"}, {"start": 167, "end": 174, "token_start": 27, "token_end": 27, "label": "ACTION"}, {"start": 178, "end": 194, "token_start": 29, "token_end": 30, "label": "MEDICAL_CTX"}, {"start": 219, "end": 241, "token_start": 35, "token_end": 37, "label": "BASECONDITION"}, {"start": 245, "end": 253, "token_start": 39, "token_end": 39, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694528523, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "FABIOR (tazarotene) Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. FABIOR Foam is a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. (1)", "_input_hash": 994901058, "_task_hash": 584584838, "_is_binary": false, "tokens": [{"text": "FABIOR", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "(", "start": 7, "end": 8, "id": 1, "ws": false}, {"text": "tazarotene", "start": 8, "end": 18, "id": 2, "ws": false}, {"text": ")", "start": 18, "end": 19, "id": 3, "ws": true}, {"text": "Foam", "start": 20, "end": 24, "id": 4, "ws": false}, {"text": ",", "start": 24, "end": 25, "id": 5, "ws": true}, {"text": "0.1", "start": 26, "end": 29, "id": 6, "ws": false}, {"text": "%", "start": 29, "end": 30, "id": 7, "ws": true}, {"text": "is", "start": 31, "end": 33, "id": 8, "ws": true}, {"text": "indicated", "start": 34, "end": 43, "id": 9, "ws": true}, {"text": "for", "start": 44, "end": 47, "id": 10, "ws": true}, {"text": "the", "start": 48, "end": 51, "id": 11, "ws": true}, {"text": "topical", "start": 52, "end": 59, "id": 12, "ws": true}, {"text": "treatment", "start": 60, "end": 69, "id": 13, "ws": true}, {"text": "of", "start": 70, "end": 72, "id": 14, "ws": true}, {"text": "acne", "start": 73, "end": 77, "id": 15, "ws": true}, {"text": "vulgaris", "start": 78, "end": 86, "id": 16, "ws": true}, {"text": "in", "start": 87, "end": 89, "id": 17, "ws": true}, {"text": "patients", "start": 90, "end": 98, "id": 18, "ws": true}, {"text": "12", "start": 99, "end": 101, "id": 19, "ws": true}, {"text": "years", "start": 102, "end": 107, "id": 20, "ws": true}, {"text": "of", "start": 108, "end": 110, "id": 21, "ws": true}, {"text": "age", "start": 111, "end": 114, "id": 22, "ws": true}, {"text": "or", "start": 115, "end": 117, "id": 23, "ws": true}, {"text": "older", "start": 118, "end": 123, "id": 24, "ws": false}, {"text": ".", "start": 123, "end": 124, "id": 25, "ws": true}, {"text": "FABIOR", "start": 125, "end": 131, "id": 26, "ws": true}, {"text": "Foam", "start": 132, "end": 136, "id": 27, "ws": true}, {"text": "is", "start": 137, "end": 139, "id": 28, "ws": true}, {"text": "a", "start": 140, "end": 141, "id": 29, "ws": true}, {"text": "retinoid", "start": 142, "end": 150, "id": 30, "ws": true}, {"text": "indicated", "start": 151, "end": 160, "id": 31, "ws": true}, {"text": "for", "start": 161, "end": 164, "id": 32, "ws": true}, {"text": "the", "start": 165, "end": 168, "id": 33, "ws": true}, {"text": "topical", "start": 169, "end": 176, "id": 34, "ws": true}, {"text": "treatment", "start": 177, "end": 186, "id": 35, "ws": true}, {"text": "of", "start": 187, "end": 189, "id": 36, "ws": true}, {"text": "acne", "start": 190, "end": 194, "id": 37, "ws": true}, {"text": "vulgaris", "start": 195, "end": 203, "id": 38, "ws": true}, {"text": "in", "start": 204, "end": 206, "id": 39, "ws": true}, {"text": "patients", "start": 207, "end": 215, "id": 40, "ws": true}, {"text": "12", "start": 216, "end": 218, "id": 41, "ws": true}, {"text": "years", "start": 219, "end": 224, "id": 42, "ws": true}, {"text": "of", "start": 225, "end": 227, "id": 43, "ws": true}, {"text": "age", "start": 228, "end": 231, "id": 44, "ws": true}, {"text": "or", "start": 232, "end": 234, "id": 45, "ws": true}, {"text": "older", "start": 235, "end": 240, "id": 46, "ws": false}, {"text": ".", "start": 240, "end": 241, "id": 47, "ws": true}, {"text": "(", "start": 242, "end": 243, "id": 48, "ws": false}, {"text": "1", "start": 243, "end": 244, "id": 49, "ws": false}, {"text": ")", "start": 244, "end": 245, "id": 50, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 18, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 20, "end": 24, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 52, "end": 69, "token_start": 12, "token_end": 13, "label": "ACTION"}, {"start": 73, "end": 86, "token_start": 15, "token_end": 16, "label": "INDICATION"}, {"start": 90, "end": 123, "token_start": 18, "token_end": 24, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694525352, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Carefully consider the potential benefits and risks of CATAFLAM (diclofenac potassium tablets, USP) and other treatment options before deciding to use CATAFLAM. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation ). CATAFLAM is indicated: For treatment of primary dysmenorrhea For relief of mild to moderate pain For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis", "_input_hash": 1054213836, "_task_hash": -1023182693, "_is_binary": false, "tokens": [{"text": "Carefully", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "consider", "start": 10, "end": 18, "id": 1, "ws": true}, {"text": "the", "start": 19, "end": 22, "id": 2, "ws": true}, {"text": "potential", "start": 23, "end": 32, "id": 3, "ws": true}, {"text": "benefits", "start": 33, "end": 41, "id": 4, "ws": true}, {"text": "and", "start": 42, "end": 45, "id": 5, "ws": true}, {"text": "risks", "start": 46, "end": 51, "id": 6, "ws": true}, {"text": "of", "start": 52, "end": 54, "id": 7, "ws": true}, {"text": "CATAFLAM", "start": 55, "end": 63, "id": 8, "ws": true}, {"text": "(", "start": 64, "end": 65, "id": 9, "ws": false}, {"text": "diclofenac", "start": 65, "end": 75, "id": 10, "ws": true}, {"text": "potassium", "start": 76, "end": 85, "id": 11, "ws": true}, {"text": "tablets", "start": 86, "end": 93, "id": 12, "ws": false}, {"text": ",", "start": 93, "end": 94, "id": 13, "ws": true}, {"text": "USP", "start": 95, "end": 98, "id": 14, "ws": false}, {"text": ")", "start": 98, "end": 99, "id": 15, "ws": true}, {"text": "and", "start": 100, "end": 103, "id": 16, "ws": true}, {"text": "other", "start": 104, "end": 109, "id": 17, "ws": true}, {"text": "treatment", "start": 110, "end": 119, "id": 18, "ws": true}, {"text": "options", "start": 120, "end": 127, "id": 19, "ws": true}, {"text": "before", "start": 128, "end": 134, "id": 20, "ws": true}, {"text": "deciding", "start": 135, "end": 143, "id": 21, "ws": true}, {"text": "to", "start": 144, "end": 146, "id": 22, "ws": true}, {"text": "use", "start": 147, "end": 150, "id": 23, "ws": true}, {"text": "CATAFLAM", "start": 151, "end": 159, "id": 24, "ws": false}, {"text": ".", "start": 159, "end": 160, "id": 25, "ws": true}, {"text": "Use", "start": 161, "end": 164, "id": 26, "ws": true}, {"text": "the", "start": 165, "end": 168, "id": 27, "ws": true}, {"text": "lowest", "start": 169, "end": 175, "id": 28, "ws": true}, {"text": "effective", "start": 176, "end": 185, "id": 29, "ws": true}, {"text": "dose", "start": 186, "end": 190, "id": 30, "ws": true}, {"text": "for", "start": 191, "end": 194, "id": 31, "ws": true}, {"text": "the", "start": 195, "end": 198, "id": 32, "ws": true}, {"text": "shortest", "start": 199, "end": 207, "id": 33, "ws": true}, {"text": "duration", "start": 208, "end": 216, "id": 34, "ws": true}, {"text": "consistent", "start": 217, "end": 227, "id": 35, "ws": true}, {"text": "with", "start": 228, "end": 232, "id": 36, "ws": true}, {"text": "individual", "start": 233, "end": 243, "id": 37, "ws": true}, {"text": "patient", "start": 244, "end": 251, "id": 38, "ws": true}, {"text": "treatment", "start": 252, "end": 261, "id": 39, "ws": true}, {"text": "goals", "start": 262, "end": 267, "id": 40, "ws": true}, {"text": "(", "start": 268, "end": 269, "id": 41, "ws": false}, {"text": "see", "start": 269, "end": 272, "id": 42, "ws": true}, {"text": "WARNINGS", "start": 273, "end": 281, "id": 43, "ws": false}, {"text": ":", "start": 281, "end": 282, "id": 44, "ws": true}, {"text": "Gastrointestinal", "start": 283, "end": 299, "id": 45, "ws": true}, {"text": "Bleeding", "start": 300, "end": 308, "id": 46, "ws": false}, {"text": ",", "start": 308, "end": 309, "id": 47, "ws": true}, {"text": "Ulceration", "start": 310, "end": 320, "id": 48, "ws": false}, {"text": ",", "start": 320, "end": 321, "id": 49, "ws": true}, {"text": "and", "start": 322, "end": 325, "id": 50, "ws": true}, {"text": "Perforation", "start": 326, "end": 337, "id": 51, "ws": true}, {"text": ")", "start": 338, "end": 339, "id": 52, "ws": false}, {"text": ".", "start": 339, "end": 340, "id": 53, "ws": true}, {"text": "CATAFLAM", "start": 341, "end": 349, "id": 54, "ws": true}, {"text": "is", "start": 350, "end": 352, "id": 55, "ws": true}, {"text": "indicated", "start": 353, "end": 362, "id": 56, "ws": false}, {"text": ":", "start": 362, "end": 363, "id": 57, "ws": true}, {"text": "For", "start": 364, "end": 367, "id": 58, "ws": true}, {"text": "treatment", "start": 368, "end": 377, "id": 59, "ws": true}, {"text": "of", "start": 378, "end": 380, "id": 60, "ws": true}, {"text": "primary", "start": 381, "end": 388, "id": 61, "ws": true}, {"text": "dysmenorrhea", "start": 389, "end": 401, "id": 62, "ws": true}, {"text": "For", "start": 402, "end": 405, "id": 63, "ws": true}, {"text": "relief", "start": 406, "end": 412, "id": 64, "ws": true}, {"text": "of", "start": 413, "end": 415, "id": 65, "ws": true}, {"text": "mild", "start": 416, "end": 420, "id": 66, "ws": true}, {"text": "to", "start": 421, "end": 423, "id": 67, "ws": true}, {"text": "moderate", "start": 424, "end": 432, "id": 68, "ws": true}, {"text": "pain", "start": 433, "end": 437, "id": 69, "ws": true}, {"text": "For", "start": 438, "end": 441, "id": 70, "ws": true}, {"text": "relief", "start": 442, "end": 448, "id": 71, "ws": true}, {"text": "of", "start": 449, "end": 451, "id": 72, "ws": true}, {"text": "the", "start": 452, "end": 455, "id": 73, "ws": true}, {"text": "signs", "start": 456, "end": 461, "id": 74, "ws": true}, {"text": "and", "start": 462, "end": 465, "id": 75, "ws": true}, {"text": "symptoms", "start": 466, "end": 474, "id": 76, "ws": true}, {"text": "of", "start": 475, "end": 477, "id": 77, "ws": true}, {"text": "osteoarthritis", "start": 478, "end": 492, "id": 78, "ws": true}, {"text": "For", "start": 493, "end": 496, "id": 79, "ws": true}, {"text": "relief", "start": 497, "end": 503, "id": 80, "ws": true}, {"text": "of", "start": 504, "end": 506, "id": 81, "ws": true}, {"text": "the", "start": 507, "end": 510, "id": 82, "ws": true}, {"text": "signs", "start": 511, "end": 516, "id": 83, "ws": true}, {"text": "and", "start": 517, "end": 520, "id": 84, "ws": true}, {"text": "symptoms", "start": 521, "end": 529, "id": 85, "ws": true}, {"text": "of", "start": 530, "end": 532, "id": 86, "ws": true}, {"text": "rheumatoid", "start": 533, "end": 543, "id": 87, "ws": true}, {"text": "arthritis", "start": 544, "end": 553, "id": 88, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 341, "end": 349, "token_start": 54, "token_end": 54, "label": "DRUG"}, {"start": 368, "end": 377, "token_start": 59, "token_end": 59, "label": "ACTION"}, {"start": 381, "end": 401, "token_start": 61, "token_end": 62, "label": "INDICATION"}, {"start": 406, "end": 412, "token_start": 64, "token_end": 64, "label": "ACTION"}, {"start": 416, "end": 432, "token_start": 66, "token_end": 68, "label": "SEVERITY"}, {"start": 433, "end": 437, "token_start": 69, "token_end": 69, "label": "INDICATION"}, {"start": 442, "end": 448, "token_start": 71, "token_end": 71, "label": "ACTION"}, {"start": 456, "end": 474, "token_start": 74, "token_end": 76, "label": "INDICATION"}, {"start": 478, "end": 492, "token_start": 78, "token_end": 78, "label": "BASECONDITION"}, {"start": 497, "end": 503, "token_start": 80, "token_end": 80, "label": "ACTION"}, {"start": 511, "end": 529, "token_start": 83, "token_end": 85, "label": "INDICATION"}, {"start": 533, "end": 553, "token_start": 87, "token_end": 88, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527074, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ALPHAGAN  P (brimonidine tartrate ophthalmic solution) 0.1% or 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ALPHAGAN  P is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. (1)", "_input_hash": -702991308, "_task_hash": 1394966511, "_is_binary": false, "tokens": [{"text": "ALPHAGAN", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": " ", "start": 9, "end": 10, "id": 1, "ws": false}, {"text": "P", "start": 10, "end": 11, "id": 2, "ws": true}, {"text": "(", "start": 12, "end": 13, "id": 3, "ws": false}, {"text": "brimonidine", "start": 13, "end": 24, "id": 4, "ws": true}, {"text": "tartrate", "start": 25, "end": 33, "id": 5, "ws": true}, {"text": "ophthalmic", "start": 34, "end": 44, "id": 6, "ws": true}, {"text": "solution", "start": 45, "end": 53, "id": 7, "ws": false}, {"text": ")", "start": 53, "end": 54, "id": 8, "ws": true}, {"text": "0.1", "start": 55, "end": 58, "id": 9, "ws": false}, {"text": "%", "start": 58, "end": 59, "id": 10, "ws": true}, {"text": "or", "start": 60, "end": 62, "id": 11, "ws": true}, {"text": "0.15", "start": 63, "end": 67, "id": 12, "ws": false}, {"text": "%", "start": 67, "end": 68, "id": 13, "ws": true}, {"text": "is", "start": 69, "end": 71, "id": 14, "ws": true}, {"text": "an", "start": 72, "end": 74, "id": 15, "ws": true}, {"text": "alpha", "start": 75, "end": 80, "id": 16, "ws": true}, {"text": "adrenergic", "start": 81, "end": 91, "id": 17, "ws": true}, {"text": "receptor", "start": 92, "end": 100, "id": 18, "ws": true}, {"text": "agonist", "start": 101, "end": 108, "id": 19, "ws": true}, {"text": "indicated", "start": 109, "end": 118, "id": 20, "ws": true}, {"text": "for", "start": 119, "end": 122, "id": 21, "ws": true}, {"text": "the", "start": 123, "end": 126, "id": 22, "ws": true}, {"text": "reduction", "start": 127, "end": 136, "id": 23, "ws": true}, {"text": "of", "start": 137, "end": 139, "id": 24, "ws": true}, {"text": "elevated", "start": 140, "end": 148, "id": 25, "ws": true}, {"text": "intraocular", "start": 149, "end": 160, "id": 26, "ws": true}, {"text": "pressure", "start": 161, "end": 169, "id": 27, "ws": true}, {"text": "(", "start": 170, "end": 171, "id": 28, "ws": false}, {"text": "IOP", "start": 171, "end": 174, "id": 29, "ws": false}, {"text": ")", "start": 174, "end": 175, "id": 30, "ws": true}, {"text": "in", "start": 176, "end": 178, "id": 31, "ws": true}, {"text": "patients", "start": 179, "end": 187, "id": 32, "ws": true}, {"text": "with", "start": 188, "end": 192, "id": 33, "ws": true}, {"text": "open", "start": 193, "end": 197, "id": 34, "ws": false}, {"text": "-", "start": 197, "end": 198, "id": 35, "ws": false}, {"text": "angle", "start": 198, "end": 203, "id": 36, "ws": true}, {"text": "glaucoma", "start": 204, "end": 212, "id": 37, "ws": true}, {"text": "or", "start": 213, "end": 215, "id": 38, "ws": true}, {"text": "ocular", "start": 216, "end": 222, "id": 39, "ws": true}, {"text": "hypertension", "start": 223, "end": 235, "id": 40, "ws": false}, {"text": ".", "start": 235, "end": 236, "id": 41, "ws": true}, {"text": "ALPHAGAN", "start": 237, "end": 245, "id": 42, "ws": true}, {"text": " ", "start": 246, "end": 247, "id": 43, "ws": false}, {"text": "P", "start": 247, "end": 248, "id": 44, "ws": true}, {"text": "is", "start": 249, "end": 251, "id": 45, "ws": true}, {"text": "an", "start": 252, "end": 254, "id": 46, "ws": true}, {"text": "alpha", "start": 255, "end": 260, "id": 47, "ws": true}, {"text": "adrenergic", "start": 261, "end": 271, "id": 48, "ws": true}, {"text": "receptor", "start": 272, "end": 280, "id": 49, "ws": true}, {"text": "agonist", "start": 281, "end": 288, "id": 50, "ws": true}, {"text": "indicated", "start": 289, "end": 298, "id": 51, "ws": true}, {"text": "for", "start": 299, "end": 302, "id": 52, "ws": true}, {"text": "the", "start": 303, "end": 306, "id": 53, "ws": true}, {"text": "reduction", "start": 307, "end": 316, "id": 54, "ws": true}, {"text": "of", "start": 317, "end": 319, "id": 55, "ws": true}, {"text": "elevated", "start": 320, "end": 328, "id": 56, "ws": true}, {"text": "intraocular", "start": 329, "end": 340, "id": 57, "ws": true}, {"text": "pressure", "start": 341, "end": 349, "id": 58, "ws": true}, {"text": "(", "start": 350, "end": 351, "id": 59, "ws": false}, {"text": "IOP", "start": 351, "end": 354, "id": 60, "ws": false}, {"text": ")", "start": 354, "end": 355, "id": 61, "ws": true}, {"text": "in", "start": 356, "end": 358, "id": 62, "ws": true}, {"text": "patients", "start": 359, "end": 367, "id": 63, "ws": true}, {"text": "with", "start": 368, "end": 372, "id": 64, "ws": true}, {"text": "open", "start": 373, "end": 377, "id": 65, "ws": false}, {"text": "-", "start": 377, "end": 378, "id": 66, "ws": false}, {"text": "angle", "start": 378, "end": 383, "id": 67, "ws": true}, {"text": "glaucoma", "start": 384, "end": 392, "id": 68, "ws": true}, {"text": "or", "start": 393, "end": 395, "id": 69, "ws": true}, {"text": "ocular", "start": 396, "end": 402, "id": 70, "ws": true}, {"text": "hypertension", "start": 403, "end": 415, "id": 71, "ws": false}, {"text": ".", "start": 415, "end": 416, "id": 72, "ws": true}, {"text": "(", "start": 417, "end": 418, "id": 73, "ws": false}, {"text": "1", "start": 418, "end": 419, "id": 74, "ws": false}, {"text": ")", "start": 419, "end": 420, "id": 75, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 13, "end": 24, "token_start": 4, "token_end": 4, "label": "DRUG"}, {"start": 25, "end": 33, "token_start": 5, "token_end": 5, "label": "SALT"}, {"start": 34, "end": 44, "token_start": 6, "token_end": 6, "label": "ROUTE"}, {"start": 45, "end": 53, "token_start": 7, "token_end": 7, "label": "FORMULATION"}, {"start": 75, "end": 108, "token_start": 16, "token_end": 19, "label": "MECHANISM"}, {"start": 127, "end": 169, "token_start": 23, "token_end": 27, "label": "EFFECT"}, {"start": 193, "end": 212, "token_start": 34, "token_end": 37, "label": "BASECONDITION"}, {"start": 216, "end": 235, "token_start": 39, "token_end": 40, "label": "BASECONDITION"}, {"start": 237, "end": 245, "token_start": 42, "token_end": 42, "label": "DRUG"}, {"start": 255, "end": 288, "token_start": 47, "token_end": 50, "label": "MECHANISM"}, {"start": 307, "end": 354, "token_start": 54, "token_end": 60, "label": "EFFECT"}, {"start": 373, "end": 392, "token_start": 65, "token_end": 68, "label": "BASECONDITION"}, {"start": 396, "end": 415, "token_start": 70, "token_end": 71, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527416, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ESBRIET is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). ESBRIET is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF).", "_input_hash": -1227943924, "_task_hash": 1484764123, "_is_binary": false, "tokens": [{"text": "ESBRIET", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "idiopathic", "start": 42, "end": 52, "id": 7, "ws": true}, {"text": "pulmonary", "start": 53, "end": 62, "id": 8, "ws": true}, {"text": "fibrosis", "start": 63, "end": 71, "id": 9, "ws": true}, {"text": "(", "start": 72, "end": 73, "id": 10, "ws": false}, {"text": "IPF", "start": 73, "end": 76, "id": 11, "ws": false}, {"text": ")", "start": 76, "end": 77, "id": 12, "ws": false}, {"text": ".", "start": 77, "end": 78, "id": 13, "ws": true}, {"text": "ESBRIET", "start": 79, "end": 86, "id": 14, "ws": true}, {"text": "is", "start": 87, "end": 89, "id": 15, "ws": true}, {"text": "a", "start": 90, "end": 91, "id": 16, "ws": true}, {"text": "pyridone", "start": 92, "end": 100, "id": 17, "ws": true}, {"text": "indicated", "start": 101, "end": 110, "id": 18, "ws": true}, {"text": "for", "start": 111, "end": 114, "id": 19, "ws": true}, {"text": "the", "start": 115, "end": 118, "id": 20, "ws": true}, {"text": "treatment", "start": 119, "end": 128, "id": 21, "ws": true}, {"text": "of", "start": 129, "end": 131, "id": 22, "ws": true}, {"text": "idiopathic", "start": 132, "end": 142, "id": 23, "ws": true}, {"text": "pulmonary", "start": 143, "end": 152, "id": 24, "ws": true}, {"text": "fibrosis", "start": 153, "end": 161, "id": 25, "ws": true}, {"text": "(", "start": 162, "end": 163, "id": 26, "ws": false}, {"text": "IPF", "start": 163, "end": 166, "id": 27, "ws": false}, {"text": ")", "start": 166, "end": 167, "id": 28, "ws": false}, {"text": ".", "start": 167, "end": 168, "id": 29, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 42, "end": 71, "token_start": 7, "token_end": 9, "label": "INDICATION"}, {"start": 79, "end": 86, "token_start": 14, "token_end": 14, "label": "DRUG"}, {"start": 92, "end": 100, "token_start": 17, "token_end": 17, "label": "MECHANISM"}, {"start": 119, "end": 128, "token_start": 21, "token_end": 21, "label": "ACTION"}, {"start": 132, "end": 161, "token_start": 23, "token_end": 25, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526042, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Rasagiline tablets are indicated for the treatment of Parkinsons disease (PD). Rasagiline tablets, a monoamine oxidase (MAO)-B inhibitor (MAOI), are indicated for the treatment of Parkinsons disease (1)", "_input_hash": -458361001, "_task_hash": 476185950, "_is_binary": false, "tokens": [{"text": "Rasagiline", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "tablets", "start": 11, "end": 18, "id": 1, "ws": true}, {"text": "are", "start": 19, "end": 22, "id": 2, "ws": true}, {"text": "indicated", "start": 23, "end": 32, "id": 3, "ws": true}, {"text": "for", "start": 33, "end": 36, "id": 4, "ws": true}, {"text": "the", "start": 37, "end": 40, "id": 5, "ws": true}, {"text": "treatment", "start": 41, "end": 50, "id": 6, "ws": true}, {"text": "of", "start": 51, "end": 53, "id": 7, "ws": true}, {"text": "Parkinsons", "start": 54, "end": 64, "id": 8, "ws": true}, {"text": "disease", "start": 65, "end": 72, "id": 9, "ws": true}, {"text": "(", "start": 73, "end": 74, "id": 10, "ws": false}, {"text": "PD", "start": 74, "end": 76, "id": 11, "ws": false}, {"text": ")", "start": 76, "end": 77, "id": 12, "ws": false}, {"text": ".", "start": 77, "end": 78, "id": 13, "ws": true}, {"text": "Rasagiline", "start": 79, "end": 89, "id": 14, "ws": true}, {"text": "tablets", "start": 90, "end": 97, "id": 15, "ws": false}, {"text": ",", "start": 97, "end": 98, "id": 16, "ws": true}, {"text": "a", "start": 99, "end": 100, "id": 17, "ws": true}, {"text": "monoamine", "start": 101, "end": 110, "id": 18, "ws": true}, {"text": "oxidase", "start": 111, "end": 118, "id": 19, "ws": true}, {"text": "(", "start": 119, "end": 120, "id": 20, "ws": false}, {"text": "MAO)-B", "start": 120, "end": 126, "id": 21, "ws": true}, {"text": "inhibitor", "start": 127, "end": 136, "id": 22, "ws": true}, {"text": "(", "start": 137, "end": 138, "id": 23, "ws": false}, {"text": "MAOI", "start": 138, "end": 142, "id": 24, "ws": false}, {"text": ")", "start": 142, "end": 143, "id": 25, "ws": false}, {"text": ",", "start": 143, "end": 144, "id": 26, "ws": true}, {"text": "are", "start": 145, "end": 148, "id": 27, "ws": true}, {"text": "indicated", "start": 149, "end": 158, "id": 28, "ws": true}, {"text": "for", "start": 159, "end": 162, "id": 29, "ws": true}, {"text": "the", "start": 163, "end": 166, "id": 30, "ws": true}, {"text": "treatment", "start": 167, "end": 176, "id": 31, "ws": true}, {"text": "of", "start": 177, "end": 179, "id": 32, "ws": true}, {"text": "Parkinsons", "start": 180, "end": 190, "id": 33, "ws": true}, {"text": "disease", "start": 191, "end": 198, "id": 34, "ws": true}, {"text": "(", "start": 199, "end": 200, "id": 35, "ws": false}, {"text": "1", "start": 200, "end": 201, "id": 36, "ws": false}, {"text": ")", "start": 201, "end": 202, "id": 37, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 18, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 41, "end": 50, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 54, "end": 72, "token_start": 8, "token_end": 9, "label": "INDICATION"}, {"start": 79, "end": 89, "token_start": 14, "token_end": 14, "label": "DRUG"}, {"start": 90, "end": 97, "token_start": 15, "token_end": 15, "label": "FORMULATION"}, {"start": 101, "end": 136, "token_start": 18, "token_end": 22, "label": "MECHANISM"}, {"start": 167, "end": 176, "token_start": 31, "token_end": 31, "label": "ACTION"}, {"start": 180, "end": 198, "token_start": 33, "token_end": 34, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527830, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "WELIREG is indicated for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. WELIREG is a hypoxia-inducible factor inhibitor indicated for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. (1)", "_input_hash": 1811756907, "_task_hash": 415731351, "_is_binary": false, "tokens": [{"text": "WELIREG", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "treatment", "start": 25, "end": 34, "id": 4, "ws": true}, {"text": "of", "start": 35, "end": 37, "id": 5, "ws": true}, {"text": "adult", "start": 38, "end": 43, "id": 6, "ws": true}, {"text": "patients", "start": 44, "end": 52, "id": 7, "ws": true}, {"text": "with", "start": 53, "end": 57, "id": 8, "ws": true}, {"text": "von", "start": 58, "end": 61, "id": 9, "ws": true}, {"text": "Hippel", "start": 62, "end": 68, "id": 10, "ws": false}, {"text": "-", "start": 68, "end": 69, "id": 11, "ws": false}, {"text": "Lindau", "start": 69, "end": 75, "id": 12, "ws": true}, {"text": "(", "start": 76, "end": 77, "id": 13, "ws": false}, {"text": "VHL", "start": 77, "end": 80, "id": 14, "ws": false}, {"text": ")", "start": 80, "end": 81, "id": 15, "ws": true}, {"text": "disease", "start": 82, "end": 89, "id": 16, "ws": true}, {"text": "who", "start": 90, "end": 93, "id": 17, "ws": true}, {"text": "require", "start": 94, "end": 101, "id": 18, "ws": true}, {"text": "therapy", "start": 102, "end": 109, "id": 19, "ws": true}, {"text": "for", "start": 110, "end": 113, "id": 20, "ws": true}, {"text": "associated", "start": 114, "end": 124, "id": 21, "ws": true}, {"text": "renal", "start": 125, "end": 130, "id": 22, "ws": true}, {"text": "cell", "start": 131, "end": 135, "id": 23, "ws": true}, {"text": "carcinoma", "start": 136, "end": 145, "id": 24, "ws": true}, {"text": "(", "start": 146, "end": 147, "id": 25, "ws": false}, {"text": "RCC", "start": 147, "end": 150, "id": 26, "ws": false}, {"text": ")", "start": 150, "end": 151, "id": 27, "ws": false}, {"text": ",", "start": 151, "end": 152, "id": 28, "ws": true}, {"text": "central", "start": 153, "end": 160, "id": 29, "ws": true}, {"text": "nervous", "start": 161, "end": 168, "id": 30, "ws": true}, {"text": "system", "start": 169, "end": 175, "id": 31, "ws": true}, {"text": "(", "start": 176, "end": 177, "id": 32, "ws": false}, {"text": "CNS", "start": 177, "end": 180, "id": 33, "ws": false}, {"text": ")", "start": 180, "end": 181, "id": 34, "ws": true}, {"text": "hemangioblastomas", "start": 182, "end": 199, "id": 35, "ws": false}, {"text": ",", "start": 199, "end": 200, "id": 36, "ws": true}, {"text": "or", "start": 201, "end": 203, "id": 37, "ws": true}, {"text": "pancreatic", "start": 204, "end": 214, "id": 38, "ws": true}, {"text": "neuroendocrine", "start": 215, "end": 229, "id": 39, "ws": true}, {"text": "tumors", "start": 230, "end": 236, "id": 40, "ws": true}, {"text": "(", "start": 237, "end": 238, "id": 41, "ws": false}, {"text": "pNET", "start": 238, "end": 242, "id": 42, "ws": false}, {"text": ")", "start": 242, "end": 243, "id": 43, "ws": false}, {"text": ",", "start": 243, "end": 244, "id": 44, "ws": true}, {"text": "not", "start": 245, "end": 248, "id": 45, "ws": true}, {"text": "requiring", "start": 249, "end": 258, "id": 46, "ws": true}, {"text": "immediate", "start": 259, "end": 268, "id": 47, "ws": true}, {"text": "surgery", "start": 269, "end": 276, "id": 48, "ws": false}, {"text": ".", "start": 276, "end": 277, "id": 49, "ws": true}, {"text": "WELIREG", "start": 278, "end": 285, "id": 50, "ws": true}, {"text": "is", "start": 286, "end": 288, "id": 51, "ws": true}, {"text": "a", "start": 289, "end": 290, "id": 52, "ws": true}, {"text": "hypoxia", "start": 291, "end": 298, "id": 53, "ws": false}, {"text": "-", "start": 298, "end": 299, "id": 54, "ws": false}, {"text": "inducible", "start": 299, "end": 308, "id": 55, "ws": true}, {"text": "factor", "start": 309, "end": 315, "id": 56, "ws": true}, {"text": "inhibitor", "start": 316, "end": 325, "id": 57, "ws": true}, {"text": "indicated", "start": 326, "end": 335, "id": 58, "ws": true}, {"text": "for", "start": 336, "end": 339, "id": 59, "ws": true}, {"text": "treatment", "start": 340, "end": 349, "id": 60, "ws": true}, {"text": "of", "start": 350, "end": 352, "id": 61, "ws": true}, {"text": "adult", "start": 353, "end": 358, "id": 62, "ws": true}, {"text": "patients", "start": 359, "end": 367, "id": 63, "ws": true}, {"text": "with", "start": 368, "end": 372, "id": 64, "ws": true}, {"text": "von", "start": 373, "end": 376, "id": 65, "ws": true}, {"text": "Hippel", "start": 377, "end": 383, "id": 66, "ws": false}, {"text": "-", "start": 383, "end": 384, "id": 67, "ws": false}, {"text": "Lindau", "start": 384, "end": 390, "id": 68, "ws": true}, {"text": "(", "start": 391, "end": 392, "id": 69, "ws": false}, {"text": "VHL", "start": 392, "end": 395, "id": 70, "ws": false}, {"text": ")", "start": 395, "end": 396, "id": 71, "ws": true}, {"text": "disease", "start": 397, "end": 404, "id": 72, "ws": true}, {"text": "who", "start": 405, "end": 408, "id": 73, "ws": true}, {"text": "require", "start": 409, "end": 416, "id": 74, "ws": true}, {"text": "therapy", "start": 417, "end": 424, "id": 75, "ws": true}, {"text": "for", "start": 425, "end": 428, "id": 76, "ws": true}, {"text": "associated", "start": 429, "end": 439, "id": 77, "ws": true}, {"text": "renal", "start": 440, "end": 445, "id": 78, "ws": true}, {"text": "cell", "start": 446, "end": 450, "id": 79, "ws": true}, {"text": "carcinoma", "start": 451, "end": 460, "id": 80, "ws": true}, {"text": "(", "start": 461, "end": 462, "id": 81, "ws": false}, {"text": "RCC", "start": 462, "end": 465, "id": 82, "ws": false}, {"text": ")", "start": 465, "end": 466, "id": 83, "ws": false}, {"text": ",", "start": 466, "end": 467, "id": 84, "ws": true}, {"text": "central", "start": 468, "end": 475, "id": 85, "ws": true}, {"text": "nervous", "start": 476, "end": 483, "id": 86, "ws": true}, {"text": "system", "start": 484, "end": 490, "id": 87, "ws": true}, {"text": "(", "start": 491, "end": 492, "id": 88, "ws": false}, {"text": "CNS", "start": 492, "end": 495, "id": 89, "ws": false}, {"text": ")", "start": 495, "end": 496, "id": 90, "ws": true}, {"text": "hemangioblastomas", "start": 497, "end": 514, "id": 91, "ws": false}, {"text": ",", "start": 514, "end": 515, "id": 92, "ws": true}, {"text": "or", "start": 516, "end": 518, "id": 93, "ws": true}, {"text": "pancreatic", "start": 519, "end": 529, "id": 94, "ws": true}, {"text": "neuroendocrine", "start": 530, "end": 544, "id": 95, "ws": true}, {"text": "tumors", "start": 545, "end": 551, "id": 96, "ws": true}, {"text": "(", "start": 552, "end": 553, "id": 97, "ws": false}, {"text": "pNET", "start": 553, "end": 557, "id": 98, "ws": false}, {"text": ")", "start": 557, "end": 558, "id": 99, "ws": false}, {"text": ",", "start": 558, "end": 559, "id": 100, "ws": true}, {"text": "not", "start": 560, "end": 563, "id": 101, "ws": true}, {"text": "requiring", "start": 564, "end": 573, "id": 102, "ws": true}, {"text": "immediate", "start": 574, "end": 583, "id": 103, "ws": true}, {"text": "surgery", "start": 584, "end": 591, "id": 104, "ws": false}, {"text": ".", "start": 591, "end": 592, "id": 105, "ws": true}, {"text": "(", "start": 593, "end": 594, "id": 106, "ws": false}, {"text": "1", "start": 594, "end": 595, "id": 107, "ws": false}, {"text": ")", "start": 595, "end": 596, "id": 108, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 25, "end": 34, "token_start": 4, "token_end": 4, "label": "ACTION"}, {"start": 38, "end": 43, "token_start": 6, "token_end": 6, "label": "TARGET_GROUP"}, {"start": 58, "end": 89, "token_start": 9, "token_end": 16, "label": "INDICATION"}, {"start": 114, "end": 145, "token_start": 21, "token_end": 24, "label": "CO_MORBIDITY"}, {"start": 153, "end": 199, "token_start": 29, "token_end": 35, "label": "CO_MORBIDITY"}, {"start": 204, "end": 242, "token_start": 38, "token_end": 42, "label": "CO_MORBIDITY"}, {"start": 245, "end": 276, "token_start": 45, "token_end": 48, "label": "MEDICAL_CTX"}, {"start": 278, "end": 285, "token_start": 50, "token_end": 50, "label": "DRUG"}, {"start": 291, "end": 325, "token_start": 53, "token_end": 57, "label": "MECHANISM"}, {"start": 340, "end": 349, "token_start": 60, "token_end": 60, "label": "ACTION"}, {"start": 353, "end": 358, "token_start": 62, "token_end": 62, "label": "TARGET_GROUP"}, {"start": 373, "end": 404, "token_start": 65, "token_end": 72, "label": "INDICATION"}, {"start": 440, "end": 460, "token_start": 78, "token_end": 80, "label": "CO_MORBIDITY"}, {"start": 468, "end": 514, "token_start": 85, "token_end": 91, "label": "CO_MORBIDITY"}, {"start": 519, "end": 551, "token_start": 94, "token_end": 96, "label": "CO_MORBIDITY"}, {"start": 560, "end": 591, "token_start": 101, "token_end": 104, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694527352, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Potassium Acetate Injection, USP (2 mEq/mL) is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.", "_input_hash": -131278242, "_task_hash": -865288176, "_is_binary": false, "tokens": [{"text": "Potassium", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "Acetate", "start": 10, "end": 17, "id": 1, "ws": true}, {"text": "Injection", "start": 18, "end": 27, "id": 2, "ws": false}, {"text": ",", "start": 27, "end": 28, "id": 3, "ws": true}, {"text": "USP", "start": 29, "end": 32, "id": 4, "ws": true}, {"text": "(", "start": 33, "end": 34, "id": 5, "ws": false}, {"text": "2", "start": 34, "end": 35, "id": 6, "ws": true}, {"text": "mEq", "start": 36, "end": 39, "id": 7, "ws": false}, {"text": "/", "start": 39, "end": 40, "id": 8, "ws": false}, {"text": "mL", "start": 40, "end": 42, "id": 9, "ws": false}, {"text": ")", "start": 42, "end": 43, "id": 10, "ws": true}, {"text": "is", "start": 44, "end": 46, "id": 11, "ws": true}, {"text": "indicated", "start": 47, "end": 56, "id": 12, "ws": true}, {"text": "as", "start": 57, "end": 59, "id": 13, "ws": true}, {"text": "a", "start": 60, "end": 61, "id": 14, "ws": true}, {"text": "source", "start": 62, "end": 68, "id": 15, "ws": true}, {"text": "of", "start": 69, "end": 71, "id": 16, "ws": true}, {"text": "potassium", "start": 72, "end": 81, "id": 17, "ws": false}, {"text": ",", "start": 81, "end": 82, "id": 18, "ws": true}, {"text": "for", "start": 83, "end": 86, "id": 19, "ws": true}, {"text": "the", "start": 87, "end": 90, "id": 20, "ws": true}, {"text": "addition", "start": 91, "end": 99, "id": 21, "ws": true}, {"text": "to", "start": 100, "end": 102, "id": 22, "ws": true}, {"text": "large", "start": 103, "end": 108, "id": 23, "ws": true}, {"text": "volume", "start": 109, "end": 115, "id": 24, "ws": true}, {"text": "intravenous", "start": 116, "end": 127, "id": 25, "ws": true}, {"text": "fluids", "start": 128, "end": 134, "id": 26, "ws": false}, {"text": ",", "start": 134, "end": 135, "id": 27, "ws": true}, {"text": "to", "start": 136, "end": 138, "id": 28, "ws": true}, {"text": "prevent", "start": 139, "end": 146, "id": 29, "ws": true}, {"text": "or", "start": 147, "end": 149, "id": 30, "ws": true}, {"text": "correct", "start": 150, "end": 157, "id": 31, "ws": true}, {"text": "hypokalemia", "start": 158, "end": 169, "id": 32, "ws": true}, {"text": "in", "start": 170, "end": 172, "id": 33, "ws": true}, {"text": "patients", "start": 173, "end": 181, "id": 34, "ws": true}, {"text": "with", "start": 182, "end": 186, "id": 35, "ws": true}, {"text": "restricted", "start": 187, "end": 197, "id": 36, "ws": true}, {"text": "or", "start": 198, "end": 200, "id": 37, "ws": true}, {"text": "no", "start": 201, "end": 203, "id": 38, "ws": true}, {"text": "oral", "start": 204, "end": 208, "id": 39, "ws": true}, {"text": "intake", "start": 209, "end": 215, "id": 40, "ws": false}, {"text": ".", "start": 215, "end": 216, "id": 41, "ws": true}, {"text": "It", "start": 217, "end": 219, "id": 42, "ws": true}, {"text": "is", "start": 220, "end": 222, "id": 43, "ws": true}, {"text": "also", "start": 223, "end": 227, "id": 44, "ws": true}, {"text": "useful", "start": 228, "end": 234, "id": 45, "ws": true}, {"text": "as", "start": 235, "end": 237, "id": 46, "ws": true}, {"text": "an", "start": 238, "end": 240, "id": 47, "ws": true}, {"text": "additive", "start": 241, "end": 249, "id": 48, "ws": true}, {"text": "for", "start": 250, "end": 253, "id": 49, "ws": true}, {"text": "preparing", "start": 254, "end": 263, "id": 50, "ws": true}, {"text": "specific", "start": 264, "end": 272, "id": 51, "ws": true}, {"text": "intravenous", "start": 273, "end": 284, "id": 52, "ws": true}, {"text": "fluid", "start": 285, "end": 290, "id": 53, "ws": true}, {"text": "formulas", "start": 291, "end": 299, "id": 54, "ws": true}, {"text": "when", "start": 300, "end": 304, "id": 55, "ws": true}, {"text": "the", "start": 305, "end": 308, "id": 56, "ws": true}, {"text": "needs", "start": 309, "end": 314, "id": 57, "ws": true}, {"text": "of", "start": 315, "end": 317, "id": 58, "ws": true}, {"text": "the", "start": 318, "end": 321, "id": 59, "ws": true}, {"text": "patient", "start": 322, "end": 329, "id": 60, "ws": true}, {"text": "can", "start": 330, "end": 333, "id": 61, "ws": false}, {"text": "not", "start": 333, "end": 336, "id": 62, "ws": true}, {"text": "be", "start": 337, "end": 339, "id": 63, "ws": true}, {"text": "met", "start": 340, "end": 343, "id": 64, "ws": true}, {"text": "by", "start": 344, "end": 346, "id": 65, "ws": true}, {"text": "standard", "start": 347, "end": 355, "id": 66, "ws": true}, {"text": "electrolyte", "start": 356, "end": 367, "id": 67, "ws": true}, {"text": "or", "start": 368, "end": 370, "id": 68, "ws": true}, {"text": "nutrient", "start": 371, "end": 379, "id": 69, "ws": true}, {"text": "solutions", "start": 380, "end": 389, "id": 70, "ws": false}, {"text": ".", "start": 389, "end": 390, "id": 71, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 17, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 18, "end": 27, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 62, "end": 81, "token_start": 15, "token_end": 17, "label": "MECHANISM"}, {"start": 139, "end": 169, "token_start": 29, "token_end": 32, "label": "EFFECT"}, {"start": 173, "end": 215, "token_start": 34, "token_end": 40, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694526297, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Ursodiol capsules, USP are indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of ursodiol capsules beyond 24 months is not established. 2. Ursodiol capsules are indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss.", "_input_hash": 1528528923, "_task_hash": -710964920, "_is_binary": false, "tokens": [{"text": "Ursodiol", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "capsules", "start": 9, "end": 17, "id": 1, "ws": false}, {"text": ",", "start": 17, "end": 18, "id": 2, "ws": true}, {"text": "USP", "start": 19, "end": 22, "id": 3, "ws": true}, {"text": "are", "start": 23, "end": 26, "id": 4, "ws": true}, {"text": "indicated", "start": 27, "end": 36, "id": 5, "ws": true}, {"text": "for", "start": 37, "end": 40, "id": 6, "ws": true}, {"text": "patients", "start": 41, "end": 49, "id": 7, "ws": true}, {"text": "with", "start": 50, "end": 54, "id": 8, "ws": true}, {"text": "radiolucent", "start": 55, "end": 66, "id": 9, "ws": false}, {"text": ",", "start": 66, "end": 67, "id": 10, "ws": true}, {"text": "noncalcified", "start": 68, "end": 80, "id": 11, "ws": true}, {"text": "gallbladder", "start": 81, "end": 92, "id": 12, "ws": true}, {"text": "stones", "start": 93, "end": 99, "id": 13, "ws": true}, {"text": "<", "start": 100, "end": 101, "id": 14, "ws": true}, {"text": "20", "start": 102, "end": 104, "id": 15, "ws": true}, {"text": "mm", "start": 105, "end": 107, "id": 16, "ws": true}, {"text": "in", "start": 108, "end": 110, "id": 17, "ws": true}, {"text": "greatest", "start": 111, "end": 119, "id": 18, "ws": true}, {"text": "diameter", "start": 120, "end": 128, "id": 19, "ws": true}, {"text": "in", "start": 129, "end": 131, "id": 20, "ws": true}, {"text": "whom", "start": 132, "end": 136, "id": 21, "ws": true}, {"text": "elective", "start": 137, "end": 145, "id": 22, "ws": true}, {"text": "cholecystectomy", "start": 146, "end": 161, "id": 23, "ws": true}, {"text": "would", "start": 162, "end": 167, "id": 24, "ws": true}, {"text": "be", "start": 168, "end": 170, "id": 25, "ws": true}, {"text": "undertaken", "start": 171, "end": 181, "id": 26, "ws": true}, {"text": "except", "start": 182, "end": 188, "id": 27, "ws": true}, {"text": "for", "start": 189, "end": 192, "id": 28, "ws": true}, {"text": "the", "start": 193, "end": 196, "id": 29, "ws": true}, {"text": "presence", "start": 197, "end": 205, "id": 30, "ws": true}, {"text": "of", "start": 206, "end": 208, "id": 31, "ws": true}, {"text": "increased", "start": 209, "end": 218, "id": 32, "ws": true}, {"text": "surgical", "start": 219, "end": 227, "id": 33, "ws": true}, {"text": "risk", "start": 228, "end": 232, "id": 34, "ws": true}, {"text": "due", "start": 233, "end": 236, "id": 35, "ws": true}, {"text": "to", "start": 237, "end": 239, "id": 36, "ws": true}, {"text": "systemic", "start": 240, "end": 248, "id": 37, "ws": true}, {"text": "disease", "start": 249, "end": 256, "id": 38, "ws": false}, {"text": ",", "start": 256, "end": 257, "id": 39, "ws": true}, {"text": "advanced", "start": 258, "end": 266, "id": 40, "ws": true}, {"text": "age", "start": 267, "end": 270, "id": 41, "ws": false}, {"text": ",", "start": 270, "end": 271, "id": 42, "ws": true}, {"text": "idiosyncratic", "start": 272, "end": 285, "id": 43, "ws": true}, {"text": "reaction", "start": 286, "end": 294, "id": 44, "ws": true}, {"text": "to", "start": 295, "end": 297, "id": 45, "ws": true}, {"text": "general", "start": 298, "end": 305, "id": 46, "ws": true}, {"text": "anesthesia", "start": 306, "end": 316, "id": 47, "ws": false}, {"text": ",", "start": 316, "end": 317, "id": 48, "ws": true}, {"text": "or", "start": 318, "end": 320, "id": 49, "ws": true}, {"text": "for", "start": 321, "end": 324, "id": 50, "ws": true}, {"text": "those", "start": 325, "end": 330, "id": 51, "ws": true}, {"text": "patients", "start": 331, "end": 339, "id": 52, "ws": true}, {"text": "who", "start": 340, "end": 343, "id": 53, "ws": true}, {"text": "refuse", "start": 344, "end": 350, "id": 54, "ws": true}, {"text": "surgery", "start": 351, "end": 358, "id": 55, "ws": false}, {"text": ".", "start": 358, "end": 359, "id": 56, "ws": true}, {"text": "Safety", "start": 360, "end": 366, "id": 57, "ws": true}, {"text": "of", "start": 367, "end": 369, "id": 58, "ws": true}, {"text": "use", "start": 370, "end": 373, "id": 59, "ws": true}, {"text": "of", "start": 374, "end": 376, "id": 60, "ws": true}, {"text": "ursodiol", "start": 377, "end": 385, "id": 61, "ws": true}, {"text": "capsules", "start": 386, "end": 394, "id": 62, "ws": true}, {"text": "beyond", "start": 395, "end": 401, "id": 63, "ws": true}, {"text": "24", "start": 402, "end": 404, "id": 64, "ws": true}, {"text": "months", "start": 405, "end": 411, "id": 65, "ws": true}, {"text": "is", "start": 412, "end": 414, "id": 66, "ws": true}, {"text": "not", "start": 415, "end": 418, "id": 67, "ws": true}, {"text": "established", "start": 419, "end": 430, "id": 68, "ws": false}, {"text": ".", "start": 430, "end": 431, "id": 69, "ws": true}, {"text": "2", "start": 432, "end": 433, "id": 70, "ws": false}, {"text": ".", "start": 433, "end": 434, "id": 71, "ws": true}, {"text": "Ursodiol", "start": 435, "end": 443, "id": 72, "ws": true}, {"text": "capsules", "start": 444, "end": 452, "id": 73, "ws": true}, {"text": "are", "start": 453, "end": 456, "id": 74, "ws": true}, {"text": "indicated", "start": 457, "end": 466, "id": 75, "ws": true}, {"text": "for", "start": 467, "end": 470, "id": 76, "ws": true}, {"text": "the", "start": 471, "end": 474, "id": 77, "ws": true}, {"text": "prevention", "start": 475, "end": 485, "id": 78, "ws": true}, {"text": "of", "start": 486, "end": 488, "id": 79, "ws": true}, {"text": "gallstone", "start": 489, "end": 498, "id": 80, "ws": true}, {"text": "formation", "start": 499, "end": 508, "id": 81, "ws": true}, {"text": "in", "start": 509, "end": 511, "id": 82, "ws": true}, {"text": "obese", "start": 512, "end": 517, "id": 83, "ws": true}, {"text": "patients", "start": 518, "end": 526, "id": 84, "ws": true}, {"text": "experiencing", "start": 527, "end": 539, "id": 85, "ws": true}, {"text": "rapid", "start": 540, "end": 545, "id": 86, "ws": true}, {"text": "weight", "start": 546, "end": 552, "id": 87, "ws": true}, {"text": "loss", "start": 553, "end": 557, "id": 88, "ws": false}, {"text": ".", "start": 557, "end": 558, "id": 89, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 17, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 55, "end": 99, "token_start": 9, "token_end": 13, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526459, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Diclofenac sodium topical solution is indicated for the treatment of the pain of osteoarthritis of the knee(s).", "_input_hash": 205454193, "_task_hash": 246804536, "_is_binary": false, "tokens": [{"text": "Diclofenac", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "sodium", "start": 11, "end": 17, "id": 1, "ws": true}, {"text": "topical", "start": 18, "end": 25, "id": 2, "ws": true}, {"text": "solution", "start": 26, "end": 34, "id": 3, "ws": true}, {"text": "is", "start": 35, "end": 37, "id": 4, "ws": true}, {"text": "indicated", "start": 38, "end": 47, "id": 5, "ws": true}, {"text": "for", "start": 48, "end": 51, "id": 6, "ws": true}, {"text": "the", "start": 52, "end": 55, "id": 7, "ws": true}, {"text": "treatment", "start": 56, "end": 65, "id": 8, "ws": true}, {"text": "of", "start": 66, "end": 68, "id": 9, "ws": true}, {"text": "the", "start": 69, "end": 72, "id": 10, "ws": true}, {"text": "pain", "start": 73, "end": 77, "id": 11, "ws": true}, {"text": "of", "start": 78, "end": 80, "id": 12, "ws": true}, {"text": "osteoarthritis", "start": 81, "end": 95, "id": 13, "ws": true}, {"text": "of", "start": 96, "end": 98, "id": 14, "ws": true}, {"text": "the", "start": 99, "end": 102, "id": 15, "ws": true}, {"text": "knee(s", "start": 103, "end": 109, "id": 16, "ws": false}, {"text": ")", "start": 109, "end": 110, "id": 17, "ws": false}, {"text": ".", "start": 110, "end": 111, "id": 18, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 17, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 18, "end": 25, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 26, "end": 34, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 56, "end": 65, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 73, "end": 77, "token_start": 11, "token_end": 11, "label": "INDICATION"}, {"start": 81, "end": 95, "token_start": 13, "token_end": 13, "label": "BASECONDITION"}, {"start": 103, "end": 109, "token_start": 16, "token_end": 16, "label": "ANATOMY"}], "answer": "accept", "_timestamp": 1694526253, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Carefully consider the potential benefits and risks of LOFENA (diclofenac potassium tablets, USP) and other treatment options before deciding to use LOFENA. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation ). LOFENA is indicated: For treatment of primary dysmenorrhea For relief of mild to moderate pain For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis", "_input_hash": -1309123384, "_task_hash": -375680609, "_is_binary": false, "tokens": [{"text": "Carefully", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "consider", "start": 10, "end": 18, "id": 1, "ws": true}, {"text": "the", "start": 19, "end": 22, "id": 2, "ws": true}, {"text": "potential", "start": 23, "end": 32, "id": 3, "ws": true}, {"text": "benefits", "start": 33, "end": 41, "id": 4, "ws": true}, {"text": "and", "start": 42, "end": 45, "id": 5, "ws": true}, {"text": "risks", "start": 46, "end": 51, "id": 6, "ws": true}, {"text": "of", "start": 52, "end": 54, "id": 7, "ws": true}, {"text": "LOFENA", "start": 55, "end": 61, "id": 8, "ws": true}, {"text": "(", "start": 62, "end": 63, "id": 9, "ws": false}, {"text": "diclofenac", "start": 63, "end": 73, "id": 10, "ws": true}, {"text": "potassium", "start": 74, "end": 83, "id": 11, "ws": true}, {"text": "tablets", "start": 84, "end": 91, "id": 12, "ws": false}, {"text": ",", "start": 91, "end": 92, "id": 13, "ws": true}, {"text": "USP", "start": 93, "end": 96, "id": 14, "ws": false}, {"text": ")", "start": 96, "end": 97, "id": 15, "ws": true}, {"text": "and", "start": 98, "end": 101, "id": 16, "ws": true}, {"text": "other", "start": 102, "end": 107, "id": 17, "ws": true}, {"text": "treatment", "start": 108, "end": 117, "id": 18, "ws": true}, {"text": "options", "start": 118, "end": 125, "id": 19, "ws": true}, {"text": "before", "start": 126, "end": 132, "id": 20, "ws": true}, {"text": "deciding", "start": 133, "end": 141, "id": 21, "ws": true}, {"text": "to", "start": 142, "end": 144, "id": 22, "ws": true}, {"text": "use", "start": 145, "end": 148, "id": 23, "ws": true}, {"text": "LOFENA", "start": 149, "end": 155, "id": 24, "ws": false}, {"text": ".", "start": 155, "end": 156, "id": 25, "ws": true}, {"text": "Use", "start": 157, "end": 160, "id": 26, "ws": true}, {"text": "the", "start": 161, "end": 164, "id": 27, "ws": true}, {"text": "lowest", "start": 165, "end": 171, "id": 28, "ws": true}, {"text": "effective", "start": 172, "end": 181, "id": 29, "ws": true}, {"text": "dose", "start": 182, "end": 186, "id": 30, "ws": true}, {"text": "for", "start": 187, "end": 190, "id": 31, "ws": true}, {"text": "the", "start": 191, "end": 194, "id": 32, "ws": true}, {"text": "shortest", "start": 195, "end": 203, "id": 33, "ws": true}, {"text": "duration", "start": 204, "end": 212, "id": 34, "ws": true}, {"text": "consistent", "start": 213, "end": 223, "id": 35, "ws": true}, {"text": "with", "start": 224, "end": 228, "id": 36, "ws": true}, {"text": "individual", "start": 229, "end": 239, "id": 37, "ws": true}, {"text": "patient", "start": 240, "end": 247, "id": 38, "ws": true}, {"text": "treatment", "start": 248, "end": 257, "id": 39, "ws": true}, {"text": "goals", "start": 258, "end": 263, "id": 40, "ws": true}, {"text": "(", "start": 264, "end": 265, "id": 41, "ws": false}, {"text": "see", "start": 265, "end": 268, "id": 42, "ws": true}, {"text": "WARNINGS", "start": 269, "end": 277, "id": 43, "ws": false}, {"text": ":", "start": 277, "end": 278, "id": 44, "ws": true}, {"text": "Gastrointestinal", "start": 279, "end": 295, "id": 45, "ws": true}, {"text": "Bleeding", "start": 296, "end": 304, "id": 46, "ws": false}, {"text": ",", "start": 304, "end": 305, "id": 47, "ws": true}, {"text": "Ulceration", "start": 306, "end": 316, "id": 48, "ws": false}, {"text": ",", "start": 316, "end": 317, "id": 49, "ws": true}, {"text": "and", "start": 318, "end": 321, "id": 50, "ws": true}, {"text": "Perforation", "start": 322, "end": 333, "id": 51, "ws": true}, {"text": ")", "start": 334, "end": 335, "id": 52, "ws": false}, {"text": ".", "start": 335, "end": 336, "id": 53, "ws": true}, {"text": "LOFENA", "start": 337, "end": 343, "id": 54, "ws": true}, {"text": "is", "start": 344, "end": 346, "id": 55, "ws": true}, {"text": "indicated", "start": 347, "end": 356, "id": 56, "ws": false}, {"text": ":", "start": 356, "end": 357, "id": 57, "ws": true}, {"text": "For", "start": 358, "end": 361, "id": 58, "ws": true}, {"text": "treatment", "start": 362, "end": 371, "id": 59, "ws": true}, {"text": "of", "start": 372, "end": 374, "id": 60, "ws": true}, {"text": "primary", "start": 375, "end": 382, "id": 61, "ws": true}, {"text": "dysmenorrhea", "start": 383, "end": 395, "id": 62, "ws": true}, {"text": "For", "start": 396, "end": 399, "id": 63, "ws": true}, {"text": "relief", "start": 400, "end": 406, "id": 64, "ws": true}, {"text": "of", "start": 407, "end": 409, "id": 65, "ws": true}, {"text": "mild", "start": 410, "end": 414, "id": 66, "ws": true}, {"text": "to", "start": 415, "end": 417, "id": 67, "ws": true}, {"text": "moderate", "start": 418, "end": 426, "id": 68, "ws": true}, {"text": "pain", "start": 427, "end": 431, "id": 69, "ws": true}, {"text": "For", "start": 432, "end": 435, "id": 70, "ws": true}, {"text": "relief", "start": 436, "end": 442, "id": 71, "ws": true}, {"text": "of", "start": 443, "end": 445, "id": 72, "ws": true}, {"text": "the", "start": 446, "end": 449, "id": 73, "ws": true}, {"text": "signs", "start": 450, "end": 455, "id": 74, "ws": true}, {"text": "and", "start": 456, "end": 459, "id": 75, "ws": true}, {"text": "symptoms", "start": 460, "end": 468, "id": 76, "ws": true}, {"text": "of", "start": 469, "end": 471, "id": 77, "ws": true}, {"text": "osteoarthritis", "start": 472, "end": 486, "id": 78, "ws": true}, {"text": "For", "start": 487, "end": 490, "id": 79, "ws": true}, {"text": "relief", "start": 491, "end": 497, "id": 80, "ws": true}, {"text": "of", "start": 498, "end": 500, "id": 81, "ws": true}, {"text": "the", "start": 501, "end": 504, "id": 82, "ws": true}, {"text": "signs", "start": 505, "end": 510, "id": 83, "ws": true}, {"text": "and", "start": 511, "end": 514, "id": 84, "ws": true}, {"text": "symptoms", "start": 515, "end": 523, "id": 85, "ws": true}, {"text": "of", "start": 524, "end": 526, "id": 86, "ws": true}, {"text": "rheumatoid", "start": 527, "end": 537, "id": 87, "ws": true}, {"text": "arthritis", "start": 538, "end": 547, "id": 88, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 337, "end": 343, "token_start": 54, "token_end": 54, "label": "DRUG"}, {"start": 362, "end": 371, "token_start": 59, "token_end": 59, "label": "ACTION"}, {"start": 375, "end": 395, "token_start": 61, "token_end": 62, "label": "INDICATION"}, {"start": 400, "end": 406, "token_start": 64, "token_end": 64, "label": "ACTION"}, {"start": 410, "end": 426, "token_start": 66, "token_end": 68, "label": "SEVERITY"}, {"start": 427, "end": 431, "token_start": 69, "token_end": 69, "label": "INDICATION"}, {"start": 436, "end": 442, "token_start": 71, "token_end": 71, "label": "ACTION"}, {"start": 460, "end": 468, "token_start": 76, "token_end": 76, "label": "INDICATION"}, {"start": 472, "end": 486, "token_start": 78, "token_end": 78, "label": "BASECONDITION"}, {"start": 491, "end": 497, "token_start": 80, "token_end": 80, "label": "ACTION"}, {"start": 515, "end": 523, "token_start": 85, "token_end": 85, "label": "INDICATION"}, {"start": 527, "end": 547, "token_start": 87, "token_end": 88, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527955, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. Ferrlecit is an iron replacement product for treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. (1)", "_input_hash": -2056553953, "_task_hash": 682453813, "_is_binary": false, "tokens": [{"text": "Ferrlecit", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 3, "ws": true}, {"text": "the", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "treatment", "start": 31, "end": 40, "id": 5, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 6, "ws": true}, {"text": "iron", "start": 44, "end": 48, "id": 7, "ws": true}, {"text": "deficiency", "start": 49, "end": 59, "id": 8, "ws": true}, {"text": "anemia", "start": 60, "end": 66, "id": 9, "ws": true}, {"text": "in", "start": 67, "end": 69, "id": 10, "ws": true}, {"text": "adult", "start": 70, "end": 75, "id": 11, "ws": true}, {"text": "patients", "start": 76, "end": 84, "id": 12, "ws": true}, {"text": "and", "start": 85, "end": 88, "id": 13, "ws": true}, {"text": "in", "start": 89, "end": 91, "id": 14, "ws": true}, {"text": "pediatric", "start": 92, "end": 101, "id": 15, "ws": true}, {"text": "patients", "start": 102, "end": 110, "id": 16, "ws": true}, {"text": "age", "start": 111, "end": 114, "id": 17, "ws": true}, {"text": "6", "start": 115, "end": 116, "id": 18, "ws": true}, {"text": "years", "start": 117, "end": 122, "id": 19, "ws": true}, {"text": "and", "start": 123, "end": 126, "id": 20, "ws": true}, {"text": "older", "start": 127, "end": 132, "id": 21, "ws": true}, {"text": "with", "start": 133, "end": 137, "id": 22, "ws": true}, {"text": "chronic", "start": 138, "end": 145, "id": 23, "ws": true}, {"text": "kidney", "start": 146, "end": 152, "id": 24, "ws": true}, {"text": "disease", "start": 153, "end": 160, "id": 25, "ws": true}, {"text": "receiving", "start": 161, "end": 170, "id": 26, "ws": true}, {"text": "hemodialysis", "start": 171, "end": 183, "id": 27, "ws": true}, {"text": "who", "start": 184, "end": 187, "id": 28, "ws": true}, {"text": "are", "start": 188, "end": 191, "id": 29, "ws": true}, {"text": "receiving", "start": 192, "end": 201, "id": 30, "ws": true}, {"text": "supplemental", "start": 202, "end": 214, "id": 31, "ws": true}, {"text": "epoetin", "start": 215, "end": 222, "id": 32, "ws": true}, {"text": "therapy", "start": 223, "end": 230, "id": 33, "ws": false}, {"text": ".", "start": 230, "end": 231, "id": 34, "ws": true}, {"text": "Ferrlecit", "start": 232, "end": 241, "id": 35, "ws": true}, {"text": "is", "start": 242, "end": 244, "id": 36, "ws": true}, {"text": "an", "start": 245, "end": 247, "id": 37, "ws": true}, {"text": "iron", "start": 248, "end": 252, "id": 38, "ws": true}, {"text": "replacement", "start": 253, "end": 264, "id": 39, "ws": true}, {"text": "product", "start": 265, "end": 272, "id": 40, "ws": true}, {"text": "for", "start": 273, "end": 276, "id": 41, "ws": true}, {"text": "treatment", "start": 277, "end": 286, "id": 42, "ws": true}, {"text": "of", "start": 287, "end": 289, "id": 43, "ws": true}, {"text": "iron", "start": 290, "end": 294, "id": 44, "ws": true}, {"text": "deficiency", "start": 295, "end": 305, "id": 45, "ws": true}, {"text": "anemia", "start": 306, "end": 312, "id": 46, "ws": true}, {"text": "in", "start": 313, "end": 315, "id": 47, "ws": true}, {"text": "adult", "start": 316, "end": 321, "id": 48, "ws": true}, {"text": "patients", "start": 322, "end": 330, "id": 49, "ws": true}, {"text": "and", "start": 331, "end": 334, "id": 50, "ws": true}, {"text": "in", "start": 335, "end": 337, "id": 51, "ws": true}, {"text": "pediatric", "start": 338, "end": 347, "id": 52, "ws": true}, {"text": "patients", "start": 348, "end": 356, "id": 53, "ws": true}, {"text": "age", "start": 357, "end": 360, "id": 54, "ws": true}, {"text": "6", "start": 361, "end": 362, "id": 55, "ws": true}, {"text": "years", "start": 363, "end": 368, "id": 56, "ws": true}, {"text": "and", "start": 369, "end": 372, "id": 57, "ws": true}, {"text": "older", "start": 373, "end": 378, "id": 58, "ws": true}, {"text": "with", "start": 379, "end": 383, "id": 59, "ws": true}, {"text": "chronic", "start": 384, "end": 391, "id": 60, "ws": true}, {"text": "kidney", "start": 392, "end": 398, "id": 61, "ws": true}, {"text": "disease", "start": 399, "end": 406, "id": 62, "ws": true}, {"text": "receiving", "start": 407, "end": 416, "id": 63, "ws": true}, {"text": "hemodialysis", "start": 417, "end": 429, "id": 64, "ws": true}, {"text": "who", "start": 430, "end": 433, "id": 65, "ws": true}, {"text": "are", "start": 434, "end": 437, "id": 66, "ws": true}, {"text": "receiving", "start": 438, "end": 447, "id": 67, "ws": true}, {"text": "supplemental", "start": 448, "end": 460, "id": 68, "ws": true}, {"text": "epoetin", "start": 461, "end": 468, "id": 69, "ws": true}, {"text": "therapy", "start": 469, "end": 476, "id": 70, "ws": false}, {"text": ".", "start": 476, "end": 477, "id": 71, "ws": true}, {"text": "(", "start": 478, "end": 479, "id": 72, "ws": false}, {"text": "1", "start": 479, "end": 480, "id": 73, "ws": false}, {"text": ")", "start": 480, "end": 481, "id": 74, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 40, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 44, "end": 66, "token_start": 7, "token_end": 9, "label": "INDICATION"}, {"start": 70, "end": 75, "token_start": 11, "token_end": 11, "label": "TARGET_GROUP"}, {"start": 92, "end": 132, "token_start": 15, "token_end": 21, "label": "TARGET_GROUP"}, {"start": 138, "end": 160, "token_start": 23, "token_end": 25, "label": "BASECONDITION"}, {"start": 161, "end": 230, "token_start": 26, "token_end": 33, "label": "MEDICAL_CTX"}, {"start": 232, "end": 241, "token_start": 35, "token_end": 35, "label": "DRUG"}, {"start": 248, "end": 264, "token_start": 38, "token_end": 39, "label": "MECHANISM"}, {"start": 277, "end": 286, "token_start": 42, "token_end": 42, "label": "ACTION"}, {"start": 290, "end": 312, "token_start": 44, "token_end": 46, "label": "INDICATION"}, {"start": 316, "end": 321, "token_start": 48, "token_end": 48, "label": "TARGET_GROUP"}, {"start": 338, "end": 378, "token_start": 52, "token_end": 58, "label": "TARGET_GROUP"}, {"start": 384, "end": 406, "token_start": 60, "token_end": 62, "label": "BASECONDITION"}, {"start": 407, "end": 476, "token_start": 63, "token_end": 70, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694527131, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Erythromycin pledgets, USP are indicated for the topical treatment of acne vulgaris.", "_input_hash": 553588701, "_task_hash": 228569716, "_is_binary": false, "tokens": [{"text": "Erythromycin", "start": 0, "end": 12, "id": 0, "ws": true}, {"text": "pledgets", "start": 13, "end": 21, "id": 1, "ws": false}, {"text": ",", "start": 21, "end": 22, "id": 2, "ws": true}, {"text": "USP", "start": 23, "end": 26, "id": 3, "ws": true}, {"text": "are", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "indicated", "start": 31, "end": 40, "id": 5, "ws": true}, {"text": "for", "start": 41, "end": 44, "id": 6, "ws": true}, {"text": "the", "start": 45, "end": 48, "id": 7, "ws": true}, {"text": "topical", "start": 49, "end": 56, "id": 8, "ws": true}, {"text": "treatment", "start": 57, "end": 66, "id": 9, "ws": true}, {"text": "of", "start": 67, "end": 69, "id": 10, "ws": true}, {"text": "acne", "start": 70, "end": 74, "id": 11, "ws": true}, {"text": "vulgaris", "start": 75, "end": 83, "id": 12, "ws": false}, {"text": ".", "start": 83, "end": 84, "id": 13, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 12, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 13, "end": 21, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 49, "end": 56, "token_start": 8, "token_end": 8, "label": "ROUTE"}, {"start": 57, "end": 66, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 70, "end": 83, "token_start": 11, "token_end": 12, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526781, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Angiomax is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Angiomax is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS). (1)", "_input_hash": -274648844, "_task_hash": 1753219033, "_is_binary": false, "tokens": [{"text": "Angiomax", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "use", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "as", "start": 30, "end": 32, "id": 5, "ws": true}, {"text": "an", "start": 33, "end": 35, "id": 6, "ws": true}, {"text": "anticoagulant", "start": 36, "end": 49, "id": 7, "ws": true}, {"text": "for", "start": 50, "end": 53, "id": 8, "ws": true}, {"text": "use", "start": 54, "end": 57, "id": 9, "ws": true}, {"text": "in", "start": 58, "end": 60, "id": 10, "ws": true}, {"text": "patients", "start": 61, "end": 69, "id": 11, "ws": true}, {"text": "undergoing", "start": 70, "end": 80, "id": 12, "ws": true}, {"text": "percutaneous", "start": 81, "end": 93, "id": 13, "ws": true}, {"text": "coronary", "start": 94, "end": 102, "id": 14, "ws": true}, {"text": "intervention", "start": 103, "end": 115, "id": 15, "ws": true}, {"text": "(", "start": 116, "end": 117, "id": 16, "ws": false}, {"text": "PCI", "start": 117, "end": 120, "id": 17, "ws": false}, {"text": ")", "start": 120, "end": 121, "id": 18, "ws": true}, {"text": "including", "start": 122, "end": 131, "id": 19, "ws": true}, {"text": "patients", "start": 132, "end": 140, "id": 20, "ws": true}, {"text": "with", "start": 141, "end": 145, "id": 21, "ws": true}, {"text": "heparin", "start": 146, "end": 153, "id": 22, "ws": false}, {"text": "-", "start": 153, "end": 154, "id": 23, "ws": false}, {"text": "induced", "start": 154, "end": 161, "id": 24, "ws": true}, {"text": "thrombocytopenia", "start": 162, "end": 178, "id": 25, "ws": true}, {"text": "and", "start": 179, "end": 182, "id": 26, "ws": true}, {"text": "heparin", "start": 183, "end": 190, "id": 27, "ws": false}, {"text": "-", "start": 190, "end": 191, "id": 28, "ws": false}, {"text": "induced", "start": 191, "end": 198, "id": 29, "ws": true}, {"text": "thrombocytopenia", "start": 199, "end": 215, "id": 30, "ws": true}, {"text": "and", "start": 216, "end": 219, "id": 31, "ws": true}, {"text": "thrombosis", "start": 220, "end": 230, "id": 32, "ws": true}, {"text": "syndrome", "start": 231, "end": 239, "id": 33, "ws": false}, {"text": ".", "start": 239, "end": 240, "id": 34, "ws": true}, {"text": "Angiomax", "start": 241, "end": 249, "id": 35, "ws": true}, {"text": "is", "start": 250, "end": 252, "id": 36, "ws": true}, {"text": "a", "start": 253, "end": 254, "id": 37, "ws": true}, {"text": "direct", "start": 255, "end": 261, "id": 38, "ws": true}, {"text": "thrombin", "start": 262, "end": 270, "id": 39, "ws": true}, {"text": "inhibitor", "start": 271, "end": 280, "id": 40, "ws": true}, {"text": "indicated", "start": 281, "end": 290, "id": 41, "ws": true}, {"text": "for", "start": 291, "end": 294, "id": 42, "ws": true}, {"text": "use", "start": 295, "end": 298, "id": 43, "ws": true}, {"text": "as", "start": 299, "end": 301, "id": 44, "ws": true}, {"text": "an", "start": 302, "end": 304, "id": 45, "ws": true}, {"text": "anticoagulant", "start": 305, "end": 318, "id": 46, "ws": true}, {"text": "in", "start": 319, "end": 321, "id": 47, "ws": true}, {"text": "patients", "start": 322, "end": 330, "id": 48, "ws": true}, {"text": "undergoing", "start": 331, "end": 341, "id": 49, "ws": true}, {"text": "percutaneous", "start": 342, "end": 354, "id": 50, "ws": true}, {"text": "coronary", "start": 355, "end": 363, "id": 51, "ws": true}, {"text": "intervention", "start": 364, "end": 376, "id": 52, "ws": true}, {"text": "(", "start": 377, "end": 378, "id": 53, "ws": false}, {"text": "PCI", "start": 378, "end": 381, "id": 54, "ws": false}, {"text": ")", "start": 381, "end": 382, "id": 55, "ws": true}, {"text": "including", "start": 383, "end": 392, "id": 56, "ws": true}, {"text": "patients", "start": 393, "end": 401, "id": 57, "ws": true}, {"text": "with", "start": 402, "end": 406, "id": 58, "ws": true}, {"text": "heparin", "start": 407, "end": 414, "id": 59, "ws": false}, {"text": "-", "start": 414, "end": 415, "id": 60, "ws": false}, {"text": "induced", "start": 415, "end": 422, "id": 61, "ws": true}, {"text": "thrombocytopenia", "start": 423, "end": 439, "id": 62, "ws": true}, {"text": "(", "start": 440, "end": 441, "id": 63, "ws": false}, {"text": "HIT", "start": 441, "end": 444, "id": 64, "ws": false}, {"text": ")", "start": 444, "end": 445, "id": 65, "ws": true}, {"text": "or", "start": 446, "end": 448, "id": 66, "ws": true}, {"text": "heparin", "start": 449, "end": 456, "id": 67, "ws": false}, {"text": "-", "start": 456, "end": 457, "id": 68, "ws": false}, {"text": "induced", "start": 457, "end": 464, "id": 69, "ws": true}, {"text": "thrombocytopenia", "start": 465, "end": 481, "id": 70, "ws": true}, {"text": "and", "start": 482, "end": 485, "id": 71, "ws": true}, {"text": "thrombosis", "start": 486, "end": 496, "id": 72, "ws": true}, {"text": "syndrome", "start": 497, "end": 505, "id": 73, "ws": true}, {"text": "(", "start": 506, "end": 507, "id": 74, "ws": false}, {"text": "HITTS", "start": 507, "end": 512, "id": 75, "ws": false}, {"text": ")", "start": 512, "end": 513, "id": 76, "ws": false}, {"text": ".", "start": 513, "end": 514, "id": 77, "ws": true}, {"text": "(", "start": 515, "end": 516, "id": 78, "ws": false}, {"text": "1", "start": 516, "end": 517, "id": 79, "ws": false}, {"text": ")", "start": 517, "end": 518, "id": 80, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 36, "end": 49, "token_start": 7, "token_end": 7, "label": "EFFECT"}, {"start": 54, "end": 57, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 61, "end": 115, "token_start": 11, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 241, "end": 249, "token_start": 35, "token_end": 35, "label": "DRUG"}, {"start": 255, "end": 280, "token_start": 38, "token_end": 40, "label": "MECHANISM"}, {"start": 295, "end": 298, "token_start": 43, "token_end": 43, "label": "ACTION"}, {"start": 305, "end": 318, "token_start": 46, "token_end": 46, "label": "EFFECT"}, {"start": 322, "end": 376, "token_start": 48, "token_end": 52, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694527268, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Use This is a prescription fluoride treatment foam used to help prevent dental decay.", "_input_hash": 1679109672, "_task_hash": -1603288122, "_is_binary": false, "tokens": [{"text": "Use", "start": 0, "end": 3, "id": 0, "ws": true}, {"text": "This", "start": 4, "end": 8, "id": 1, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 2, "ws": true}, {"text": "a", "start": 12, "end": 13, "id": 3, "ws": true}, {"text": "prescription", "start": 14, "end": 26, "id": 4, "ws": true}, {"text": "fluoride", "start": 27, "end": 35, "id": 5, "ws": true}, {"text": "treatment", "start": 36, "end": 45, "id": 6, "ws": true}, {"text": "foam", "start": 46, "end": 50, "id": 7, "ws": true}, {"text": "used", "start": 51, "end": 55, "id": 8, "ws": true}, {"text": "to", "start": 56, "end": 58, "id": 9, "ws": true}, {"text": "help", "start": 59, "end": 63, "id": 10, "ws": true}, {"text": "prevent", "start": 64, "end": 71, "id": 11, "ws": true}, {"text": "dental", "start": 72, "end": 78, "id": 12, "ws": true}, {"text": "decay", "start": 79, "end": 84, "id": 13, "ws": false}, {"text": ".", "start": 84, "end": 85, "id": 14, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 27, "end": 35, "token_start": 5, "token_end": 5, "label": "DRUG"}, {"start": 46, "end": 50, "token_start": 7, "token_end": 7, "label": "FORMULATION"}, {"start": 64, "end": 71, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 72, "end": 84, "token_start": 12, "token_end": 13, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694176672, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Pentazocine and Naloxone Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses, reserve Pentazocine and Naloxone Tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia", "_input_hash": -1422808822, "_task_hash": -345570076, "_is_binary": false, "tokens": [{"text": "Pentazocine", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "and", "start": 12, "end": 15, "id": 1, "ws": true}, {"text": "Naloxone", "start": 16, "end": 24, "id": 2, "ws": true}, {"text": "Tablets", "start": 25, "end": 32, "id": 3, "ws": true}, {"text": "are", "start": 33, "end": 36, "id": 4, "ws": true}, {"text": "indicated", "start": 37, "end": 46, "id": 5, "ws": true}, {"text": "for", "start": 47, "end": 50, "id": 6, "ws": true}, {"text": "the", "start": 51, "end": 54, "id": 7, "ws": true}, {"text": "management", "start": 55, "end": 65, "id": 8, "ws": true}, {"text": "of", "start": 66, "end": 68, "id": 9, "ws": true}, {"text": "pain", "start": 69, "end": 73, "id": 10, "ws": true}, {"text": "severe", "start": 74, "end": 80, "id": 11, "ws": true}, {"text": "enough", "start": 81, "end": 87, "id": 12, "ws": true}, {"text": "to", "start": 88, "end": 90, "id": 13, "ws": true}, {"text": "require", "start": 91, "end": 98, "id": 14, "ws": true}, {"text": "an", "start": 99, "end": 101, "id": 15, "ws": true}, {"text": "opioid", "start": 102, "end": 108, "id": 16, "ws": true}, {"text": "analgesic", "start": 109, "end": 118, "id": 17, "ws": true}, {"text": "and", "start": 119, "end": 122, "id": 18, "ws": true}, {"text": "for", "start": 123, "end": 126, "id": 19, "ws": true}, {"text": "which", "start": 127, "end": 132, "id": 20, "ws": true}, {"text": "alternative", "start": 133, "end": 144, "id": 21, "ws": true}, {"text": "treatments", "start": 145, "end": 155, "id": 22, "ws": true}, {"text": "are", "start": 156, "end": 159, "id": 23, "ws": true}, {"text": "inadequate", "start": 160, "end": 170, "id": 24, "ws": false}, {"text": ".", "start": 170, "end": 171, "id": 25, "ws": true}, {"text": "Limitations", "start": 172, "end": 183, "id": 26, "ws": true}, {"text": "of", "start": 184, "end": 186, "id": 27, "ws": true}, {"text": "Use", "start": 187, "end": 190, "id": 28, "ws": true}, {"text": "Because", "start": 191, "end": 198, "id": 29, "ws": true}, {"text": "of", "start": 199, "end": 201, "id": 30, "ws": true}, {"text": "the", "start": 202, "end": 205, "id": 31, "ws": true}, {"text": "risks", "start": 206, "end": 211, "id": 32, "ws": true}, {"text": "of", "start": 212, "end": 214, "id": 33, "ws": true}, {"text": "addiction", "start": 215, "end": 224, "id": 34, "ws": false}, {"text": ",", "start": 224, "end": 225, "id": 35, "ws": true}, {"text": "abuse", "start": 226, "end": 231, "id": 36, "ws": false}, {"text": ",", "start": 231, "end": 232, "id": 37, "ws": true}, {"text": "and", "start": 233, "end": 236, "id": 38, "ws": true}, {"text": "misuse", "start": 237, "end": 243, "id": 39, "ws": false}, {"text": ",", "start": 243, "end": 244, "id": 40, "ws": true}, {"text": "with", "start": 245, "end": 249, "id": 41, "ws": true}, {"text": "opioids", "start": 250, "end": 257, "id": 42, "ws": false}, {"text": ",", "start": 257, "end": 258, "id": 43, "ws": true}, {"text": "even", "start": 259, "end": 263, "id": 44, "ws": true}, {"text": "at", "start": 264, "end": 266, "id": 45, "ws": true}, {"text": "recommended", "start": 267, "end": 278, "id": 46, "ws": true}, {"text": "doses", "start": 279, "end": 284, "id": 47, "ws": false}, {"text": ",", "start": 284, "end": 285, "id": 48, "ws": true}, {"text": "reserve", "start": 286, "end": 293, "id": 49, "ws": true}, {"text": "Pentazocine", "start": 294, "end": 305, "id": 50, "ws": true}, {"text": "and", "start": 306, "end": 309, "id": 51, "ws": true}, {"text": "Naloxone", "start": 310, "end": 318, "id": 52, "ws": true}, {"text": "Tablets", "start": 319, "end": 326, "id": 53, "ws": true}, {"text": "for", "start": 327, "end": 330, "id": 54, "ws": true}, {"text": "use", "start": 331, "end": 334, "id": 55, "ws": true}, {"text": "in", "start": 335, "end": 337, "id": 56, "ws": true}, {"text": "patients", "start": 338, "end": 346, "id": 57, "ws": true}, {"text": "for", "start": 347, "end": 350, "id": 58, "ws": true}, {"text": "whom", "start": 351, "end": 355, "id": 59, "ws": true}, {"text": "alternative", "start": 356, "end": 367, "id": 60, "ws": true}, {"text": "treatment", "start": 368, "end": 377, "id": 61, "ws": true}, {"text": "options", "start": 378, "end": 385, "id": 62, "ws": true}, {"text": "[", "start": 386, "end": 387, "id": 63, "ws": false}, {"text": "e.g.", "start": 387, "end": 391, "id": 64, "ws": false}, {"text": ",", "start": 391, "end": 392, "id": 65, "ws": true}, {"text": "non", "start": 393, "end": 396, "id": 66, "ws": false}, {"text": "-", "start": 396, "end": 397, "id": 67, "ws": false}, {"text": "opioid", "start": 397, "end": 403, "id": 68, "ws": true}, {"text": "analgesics", "start": 404, "end": 414, "id": 69, "ws": false}, {"text": "]", "start": 414, "end": 415, "id": 70, "ws": true}, {"text": "Have", "start": 416, "end": 420, "id": 71, "ws": true}, {"text": "not", "start": 421, "end": 424, "id": 72, "ws": true}, {"text": "been", "start": 425, "end": 429, "id": 73, "ws": true}, {"text": "tolerated", "start": 430, "end": 439, "id": 74, "ws": false}, {"text": ",", "start": 439, "end": 440, "id": 75, "ws": true}, {"text": "or", "start": 441, "end": 443, "id": 76, "ws": true}, {"text": "are", "start": 444, "end": 447, "id": 77, "ws": true}, {"text": "not", "start": 448, "end": 451, "id": 78, "ws": true}, {"text": "expected", "start": 452, "end": 460, "id": 79, "ws": true}, {"text": "to", "start": 461, "end": 463, "id": 80, "ws": true}, {"text": "be", "start": 464, "end": 466, "id": 81, "ws": true}, {"text": "tolerated", "start": 467, "end": 476, "id": 82, "ws": false}, {"text": ",", "start": 476, "end": 477, "id": 83, "ws": true}, {"text": "Have", "start": 478, "end": 482, "id": 84, "ws": true}, {"text": "not", "start": 483, "end": 486, "id": 85, "ws": true}, {"text": "provided", "start": 487, "end": 495, "id": 86, "ws": true}, {"text": "adequate", "start": 496, "end": 504, "id": 87, "ws": true}, {"text": "analgesia", "start": 505, "end": 514, "id": 88, "ws": false}, {"text": ",", "start": 514, "end": 515, "id": 89, "ws": true}, {"text": "or", "start": 516, "end": 518, "id": 90, "ws": true}, {"text": "are", "start": 519, "end": 522, "id": 91, "ws": true}, {"text": "not", "start": 523, "end": 526, "id": 92, "ws": true}, {"text": "expected", "start": 527, "end": 535, "id": 93, "ws": true}, {"text": "to", "start": 536, "end": 538, "id": 94, "ws": true}, {"text": "provide", "start": 539, "end": 546, "id": 95, "ws": true}, {"text": "adequate", "start": 547, "end": 555, "id": 96, "ws": true}, {"text": "analgesia", "start": 556, "end": 565, "id": 97, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 16, "end": 24, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 25, "end": 32, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 55, "end": 65, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 69, "end": 73, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 74, "end": 170, "token_start": 11, "token_end": 24, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694528342, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Jinteli is an estrogen plus progestin indicated in a woman with a uterus for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1) Prevention of Postmenopausal Osteoporosis (1.2) 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause . 1.2 Prevention of Postmenopausal Osteoporosis Limitation of Use When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medication should be carefully considered.", "_input_hash": -842419210, "_task_hash": -1444642584, "_is_binary": false, "tokens": [{"text": "Jinteli", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "an", "start": 11, "end": 13, "id": 2, "ws": true}, {"text": "estrogen", "start": 14, "end": 22, "id": 3, "ws": true}, {"text": "plus", "start": 23, "end": 27, "id": 4, "ws": true}, {"text": "progestin", "start": 28, "end": 37, "id": 5, "ws": true}, {"text": "indicated", "start": 38, "end": 47, "id": 6, "ws": true}, {"text": "in", "start": 48, "end": 50, "id": 7, "ws": true}, {"text": "a", "start": 51, "end": 52, "id": 8, "ws": true}, {"text": "woman", "start": 53, "end": 58, "id": 9, "ws": true}, {"text": "with", "start": 59, "end": 63, "id": 10, "ws": true}, {"text": "a", "start": 64, "end": 65, "id": 11, "ws": true}, {"text": "uterus", "start": 66, "end": 72, "id": 12, "ws": true}, {"text": "for", "start": 73, "end": 76, "id": 13, "ws": false}, {"text": ":", "start": 76, "end": 77, "id": 14, "ws": true}, {"text": "Treatment", "start": 78, "end": 87, "id": 15, "ws": true}, {"text": "of", "start": 88, "end": 90, "id": 16, "ws": true}, {"text": "Moderate", "start": 91, "end": 99, "id": 17, "ws": true}, {"text": "to", "start": 100, "end": 102, "id": 18, "ws": true}, {"text": "Severe", "start": 103, "end": 109, "id": 19, "ws": true}, {"text": "Vasomotor", "start": 110, "end": 119, "id": 20, "ws": true}, {"text": "Symptoms", "start": 120, "end": 128, "id": 21, "ws": true}, {"text": "due", "start": 129, "end": 132, "id": 22, "ws": true}, {"text": "to", "start": 133, "end": 135, "id": 23, "ws": true}, {"text": "Menopause", "start": 136, "end": 145, "id": 24, "ws": true}, {"text": "(", "start": 146, "end": 147, "id": 25, "ws": false}, {"text": "1.1", "start": 147, "end": 150, "id": 26, "ws": false}, {"text": ")", "start": 150, "end": 151, "id": 27, "ws": true}, {"text": "Prevention", "start": 152, "end": 162, "id": 28, "ws": true}, {"text": "of", "start": 163, "end": 165, "id": 29, "ws": true}, {"text": "Postmenopausal", "start": 166, "end": 180, "id": 30, "ws": true}, {"text": "Osteoporosis", "start": 181, "end": 193, "id": 31, "ws": true}, {"text": "(", "start": 194, "end": 195, "id": 32, "ws": false}, {"text": "1.2", "start": 195, "end": 198, "id": 33, "ws": false}, {"text": ")", "start": 198, "end": 199, "id": 34, "ws": true}, {"text": "1.1", "start": 200, "end": 203, "id": 35, "ws": true}, {"text": "Treatment", "start": 204, "end": 213, "id": 36, "ws": true}, {"text": "of", "start": 214, "end": 216, "id": 37, "ws": true}, {"text": "Moderate", "start": 217, "end": 225, "id": 38, "ws": true}, {"text": "to", "start": 226, "end": 228, "id": 39, "ws": true}, {"text": "Severe", "start": 229, "end": 235, "id": 40, "ws": true}, {"text": "Vasomotor", "start": 236, "end": 245, "id": 41, "ws": true}, {"text": "Symptoms", "start": 246, "end": 254, "id": 42, "ws": true}, {"text": "due", "start": 255, "end": 258, "id": 43, "ws": true}, {"text": "to", "start": 259, "end": 261, "id": 44, "ws": true}, {"text": "Menopause", "start": 262, "end": 271, "id": 45, "ws": true}, {"text": ".", "start": 272, "end": 273, "id": 46, "ws": true}, {"text": "1.2", "start": 274, "end": 277, "id": 47, "ws": true}, {"text": "Prevention", "start": 278, "end": 288, "id": 48, "ws": true}, {"text": "of", "start": 289, "end": 291, "id": 49, "ws": true}, {"text": "Postmenopausal", "start": 292, "end": 306, "id": 50, "ws": true}, {"text": "Osteoporosis", "start": 307, "end": 319, "id": 51, "ws": true}, {"text": "Limitation", "start": 320, "end": 330, "id": 52, "ws": true}, {"text": "of", "start": 331, "end": 333, "id": 53, "ws": true}, {"text": "Use", "start": 334, "end": 337, "id": 54, "ws": true}, {"text": "When", "start": 338, "end": 342, "id": 55, "ws": true}, {"text": "prescribing", "start": 343, "end": 354, "id": 56, "ws": true}, {"text": "solely", "start": 355, "end": 361, "id": 57, "ws": true}, {"text": "for", "start": 362, "end": 365, "id": 58, "ws": true}, {"text": "the", "start": 366, "end": 369, "id": 59, "ws": true}, {"text": "prevention", "start": 370, "end": 380, "id": 60, "ws": true}, {"text": "of", "start": 381, "end": 383, "id": 61, "ws": true}, {"text": "postmenopausal", "start": 384, "end": 398, "id": 62, "ws": true}, {"text": "osteoporosis", "start": 399, "end": 411, "id": 63, "ws": false}, {"text": ",", "start": 411, "end": 412, "id": 64, "ws": true}, {"text": "therapy", "start": 413, "end": 420, "id": 65, "ws": true}, {"text": "should", "start": 421, "end": 427, "id": 66, "ws": true}, {"text": "only", "start": 428, "end": 432, "id": 67, "ws": true}, {"text": "be", "start": 433, "end": 435, "id": 68, "ws": true}, {"text": "considered", "start": 436, "end": 446, "id": 69, "ws": true}, {"text": "for", "start": 447, "end": 450, "id": 70, "ws": true}, {"text": "women", "start": 451, "end": 456, "id": 71, "ws": true}, {"text": "at", "start": 457, "end": 459, "id": 72, "ws": true}, {"text": "significant", "start": 460, "end": 471, "id": 73, "ws": true}, {"text": "risk", "start": 472, "end": 476, "id": 74, "ws": true}, {"text": "of", "start": 477, "end": 479, "id": 75, "ws": true}, {"text": "osteoporosis", "start": 480, "end": 492, "id": 76, "ws": true}, {"text": "and", "start": 493, "end": 496, "id": 77, "ws": true}, {"text": "non", "start": 497, "end": 500, "id": 78, "ws": false}, {"text": "-", "start": 500, "end": 501, "id": 79, "ws": false}, {"text": "estrogen", "start": 501, "end": 509, "id": 80, "ws": true}, {"text": "medication", "start": 510, "end": 520, "id": 81, "ws": true}, {"text": "should", "start": 521, "end": 527, "id": 82, "ws": true}, {"text": "be", "start": 528, "end": 530, "id": 83, "ws": true}, {"text": "carefully", "start": 531, "end": 540, "id": 84, "ws": true}, {"text": "considered", "start": 541, "end": 551, "id": 85, "ws": false}, {"text": ".", "start": 551, "end": 552, "id": 86, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 37, "token_start": 3, "token_end": 5, "label": "MECHANISM"}, {"start": 53, "end": 72, "token_start": 9, "token_end": 12, "label": "TARGET_GROUP"}, {"start": 78, "end": 87, "token_start": 15, "token_end": 15, "label": "ACTION"}, {"start": 91, "end": 109, "token_start": 17, "token_end": 19, "label": "SEVERITY"}, {"start": 110, "end": 128, "token_start": 20, "token_end": 21, "label": "INDICATION"}, {"start": 136, "end": 145, "token_start": 24, "token_end": 24, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176654, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "MYDCOMBI (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1% / 2.5% is indicated to induce mydriasis for diagnostic procedures and in conditions where short term pupil dilation is desired. MYDCOMBI is a combination of tropicamide, an anticholinergic, and phenylephrine hydrochloride, an alpha-1 adrenergic receptor agonist indicated to induce mydriasis for diagnostic procedures and in conditions where short term pupil dilation is desired (1)", "_input_hash": 1236292224, "_task_hash": -1774866187, "_is_binary": false, "tokens": [{"text": "MYDCOMBI", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "(", "start": 9, "end": 10, "id": 1, "ws": false}, {"text": "tropicamide", "start": 10, "end": 21, "id": 2, "ws": true}, {"text": "and", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "phenylephrine", "start": 26, "end": 39, "id": 4, "ws": true}, {"text": "hydrochloride", "start": 40, "end": 53, "id": 5, "ws": true}, {"text": "ophthalmic", "start": 54, "end": 64, "id": 6, "ws": true}, {"text": "spray", "start": 65, "end": 70, "id": 7, "ws": false}, {"text": ")", "start": 70, "end": 71, "id": 8, "ws": true}, {"text": "1", "start": 72, "end": 73, "id": 9, "ws": false}, {"text": "%", "start": 73, "end": 74, "id": 10, "ws": true}, {"text": "/", "start": 75, "end": 76, "id": 11, "ws": true}, {"text": "2.5", "start": 77, "end": 80, "id": 12, "ws": false}, {"text": "%", "start": 80, "end": 81, "id": 13, "ws": true}, {"text": "is", "start": 82, "end": 84, "id": 14, "ws": true}, {"text": "indicated", "start": 85, "end": 94, "id": 15, "ws": true}, {"text": "to", "start": 95, "end": 97, "id": 16, "ws": true}, {"text": "induce", "start": 98, "end": 104, "id": 17, "ws": true}, {"text": "mydriasis", "start": 105, "end": 114, "id": 18, "ws": true}, {"text": "for", "start": 115, "end": 118, "id": 19, "ws": true}, {"text": "diagnostic", "start": 119, "end": 129, "id": 20, "ws": true}, {"text": "procedures", "start": 130, "end": 140, "id": 21, "ws": true}, {"text": "and", "start": 141, "end": 144, "id": 22, "ws": true}, {"text": "in", "start": 145, "end": 147, "id": 23, "ws": true}, {"text": "conditions", "start": 148, "end": 158, "id": 24, "ws": true}, {"text": "where", "start": 159, "end": 164, "id": 25, "ws": true}, {"text": "short", "start": 165, "end": 170, "id": 26, "ws": true}, {"text": "term", "start": 171, "end": 175, "id": 27, "ws": true}, {"text": "pupil", "start": 176, "end": 181, "id": 28, "ws": true}, {"text": "dilation", "start": 182, "end": 190, "id": 29, "ws": true}, {"text": "is", "start": 191, "end": 193, "id": 30, "ws": true}, {"text": "desired", "start": 194, "end": 201, "id": 31, "ws": false}, {"text": ".", "start": 201, "end": 202, "id": 32, "ws": true}, {"text": "MYDCOMBI", "start": 203, "end": 211, "id": 33, "ws": true}, {"text": "is", "start": 212, "end": 214, "id": 34, "ws": true}, {"text": "a", "start": 215, "end": 216, "id": 35, "ws": true}, {"text": "combination", "start": 217, "end": 228, "id": 36, "ws": true}, {"text": "of", "start": 229, "end": 231, "id": 37, "ws": true}, {"text": "tropicamide", "start": 232, "end": 243, "id": 38, "ws": false}, {"text": ",", "start": 243, "end": 244, "id": 39, "ws": true}, {"text": "an", "start": 245, "end": 247, "id": 40, "ws": true}, {"text": "anticholinergic", "start": 248, "end": 263, "id": 41, "ws": false}, {"text": ",", "start": 263, "end": 264, "id": 42, "ws": true}, {"text": "and", "start": 265, "end": 268, "id": 43, "ws": true}, {"text": "phenylephrine", "start": 269, "end": 282, "id": 44, "ws": true}, {"text": "hydrochloride", "start": 283, "end": 296, "id": 45, "ws": false}, {"text": ",", "start": 296, "end": 297, "id": 46, "ws": true}, {"text": "an", "start": 298, "end": 300, "id": 47, "ws": true}, {"text": "alpha-1", "start": 301, "end": 308, "id": 48, "ws": true}, {"text": "adrenergic", "start": 309, "end": 319, "id": 49, "ws": true}, {"text": "receptor", "start": 320, "end": 328, "id": 50, "ws": true}, {"text": "agonist", "start": 329, "end": 336, "id": 51, "ws": true}, {"text": "indicated", "start": 337, "end": 346, "id": 52, "ws": true}, {"text": "to", "start": 347, "end": 349, "id": 53, "ws": true}, {"text": "induce", "start": 350, "end": 356, "id": 54, "ws": true}, {"text": "mydriasis", "start": 357, "end": 366, "id": 55, "ws": true}, {"text": "for", "start": 367, "end": 370, "id": 56, "ws": true}, {"text": "diagnostic", "start": 371, "end": 381, "id": 57, "ws": true}, {"text": "procedures", "start": 382, "end": 392, "id": 58, "ws": true}, {"text": "and", "start": 393, "end": 396, "id": 59, "ws": true}, {"text": "in", "start": 397, "end": 399, "id": 60, "ws": true}, {"text": "conditions", "start": 400, "end": 410, "id": 61, "ws": true}, {"text": "where", "start": 411, "end": 416, "id": 62, "ws": true}, {"text": "short", "start": 417, "end": 422, "id": 63, "ws": true}, {"text": "term", "start": 423, "end": 427, "id": 64, "ws": true}, {"text": "pupil", "start": 428, "end": 433, "id": 65, "ws": true}, {"text": "dilation", "start": 434, "end": 442, "id": 66, "ws": true}, {"text": "is", "start": 443, "end": 445, "id": 67, "ws": true}, {"text": "desired", "start": 446, "end": 453, "id": 68, "ws": true}, {"text": "(", "start": 454, "end": 455, "id": 69, "ws": false}, {"text": "1", "start": 455, "end": 456, "id": 70, "ws": false}, {"text": ")", "start": 456, "end": 457, "id": 71, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 21, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 26, "end": 39, "token_start": 4, "token_end": 4, "label": "DRUG"}, {"start": 40, "end": 53, "token_start": 5, "token_end": 5, "label": "SALT"}, {"start": 54, "end": 64, "token_start": 6, "token_end": 6, "label": "ROUTE"}, {"start": 65, "end": 70, "token_start": 7, "token_end": 7, "label": "FORMULATION"}, {"start": 98, "end": 104, "token_start": 17, "token_end": 17, "label": "ACTION"}, {"start": 105, "end": 114, "token_start": 18, "token_end": 18, "label": "EFFECT"}, {"start": 119, "end": 140, "token_start": 20, "token_end": 21, "label": "MEDICAL_CTX"}, {"start": 165, "end": 190, "token_start": 26, "token_end": 29, "label": "EFFECT"}], "answer": "accept", "_timestamp": 1694175360, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Femynor Tablets are indicated for use by females of reproductive potential to prevent pregnancy [see Clinical Studies (14) ]. Femynor are estrogen/progestin COCs, indicated for use by women to prevent pregnancy. (1)", "_input_hash": 893035843, "_task_hash": -160428411, "_is_binary": false, "tokens": [{"text": "Femynor", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "Tablets", "start": 8, "end": 15, "id": 1, "ws": true}, {"text": "are", "start": 16, "end": 19, "id": 2, "ws": true}, {"text": "indicated", "start": 20, "end": 29, "id": 3, "ws": true}, {"text": "for", "start": 30, "end": 33, "id": 4, "ws": true}, {"text": "use", "start": 34, "end": 37, "id": 5, "ws": true}, {"text": "by", "start": 38, "end": 40, "id": 6, "ws": true}, {"text": "females", "start": 41, "end": 48, "id": 7, "ws": true}, {"text": "of", "start": 49, "end": 51, "id": 8, "ws": true}, {"text": "reproductive", "start": 52, "end": 64, "id": 9, "ws": true}, {"text": "potential", "start": 65, "end": 74, "id": 10, "ws": true}, {"text": "to", "start": 75, "end": 77, "id": 11, "ws": true}, {"text": "prevent", "start": 78, "end": 85, "id": 12, "ws": true}, {"text": "pregnancy", "start": 86, "end": 95, "id": 13, "ws": true}, {"text": "[", "start": 96, "end": 97, "id": 14, "ws": false}, {"text": "see", "start": 97, "end": 100, "id": 15, "ws": true}, {"text": "Clinical", "start": 101, "end": 109, "id": 16, "ws": true}, {"text": "Studies", "start": 110, "end": 117, "id": 17, "ws": true}, {"text": "(", "start": 118, "end": 119, "id": 18, "ws": false}, {"text": "14", "start": 119, "end": 121, "id": 19, "ws": false}, {"text": ")", "start": 121, "end": 122, "id": 20, "ws": true}, {"text": "]", "start": 123, "end": 124, "id": 21, "ws": false}, {"text": ".", "start": 124, "end": 125, "id": 22, "ws": true}, {"text": "Femynor", "start": 126, "end": 133, "id": 23, "ws": true}, {"text": "are", "start": 134, "end": 137, "id": 24, "ws": true}, {"text": "estrogen", "start": 138, "end": 146, "id": 25, "ws": false}, {"text": "/", "start": 146, "end": 147, "id": 26, "ws": false}, {"text": "progestin", "start": 147, "end": 156, "id": 27, "ws": true}, {"text": "COCs", "start": 157, "end": 161, "id": 28, "ws": false}, {"text": ",", "start": 161, "end": 162, "id": 29, "ws": true}, {"text": "indicated", "start": 163, "end": 172, "id": 30, "ws": true}, {"text": "for", "start": 173, "end": 176, "id": 31, "ws": true}, {"text": "use", "start": 177, "end": 180, "id": 32, "ws": true}, {"text": "by", "start": 181, "end": 183, "id": 33, "ws": true}, {"text": "women", "start": 184, "end": 189, "id": 34, "ws": true}, {"text": "to", "start": 190, "end": 192, "id": 35, "ws": true}, {"text": "prevent", "start": 193, "end": 200, "id": 36, "ws": true}, {"text": "pregnancy", "start": 201, "end": 210, "id": 37, "ws": false}, {"text": ".", "start": 210, "end": 211, "id": 38, "ws": true}, {"text": "(", "start": 212, "end": 213, "id": 39, "ws": false}, {"text": "1", "start": 213, "end": 214, "id": 40, "ws": false}, {"text": ")", "start": 214, "end": 215, "id": 41, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 15, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 41, "end": 74, "token_start": 7, "token_end": 10, "label": "TARGET_GROUP"}, {"start": 78, "end": 85, "token_start": 12, "token_end": 12, "label": "ACTION"}, {"start": 86, "end": 95, "token_start": 13, "token_end": 13, "label": "INDICATION"}, {"start": 126, "end": 133, "token_start": 23, "token_end": 23, "label": "DRUG"}, {"start": 184, "end": 189, "token_start": 34, "token_end": 34, "label": "TARGET_GROUP"}, {"start": 193, "end": 200, "token_start": 36, "token_end": 36, "label": "ACTION"}, {"start": 201, "end": 210, "token_start": 37, "token_end": 37, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694528584, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine. Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage. Naloxone may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see CLINICAL PHARMACOLOGY; ADJUNCTIVE USE IN SEPTIC SHOCK).", "_input_hash": 54405487, "_task_hash": -2040767019, "_is_binary": false, "tokens": [{"text": "Naloxone", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "Hydrochloride", "start": 9, "end": 22, "id": 1, "ws": true}, {"text": "Injection", "start": 23, "end": 32, "id": 2, "ws": true}, {"text": "is", "start": 33, "end": 35, "id": 3, "ws": true}, {"text": "indicated", "start": 36, "end": 45, "id": 4, "ws": true}, {"text": "for", "start": 46, "end": 49, "id": 5, "ws": true}, {"text": "the", "start": 50, "end": 53, "id": 6, "ws": true}, {"text": "complete", "start": 54, "end": 62, "id": 7, "ws": true}, {"text": "or", "start": 63, "end": 65, "id": 8, "ws": true}, {"text": "partial", "start": 66, "end": 73, "id": 9, "ws": true}, {"text": "reversal", "start": 74, "end": 82, "id": 10, "ws": true}, {"text": "of", "start": 83, "end": 85, "id": 11, "ws": true}, {"text": "opioid", "start": 86, "end": 92, "id": 12, "ws": true}, {"text": "depression", "start": 93, "end": 103, "id": 13, "ws": false}, {"text": ",", "start": 103, "end": 104, "id": 14, "ws": true}, {"text": "including", "start": 105, "end": 114, "id": 15, "ws": true}, {"text": "respiratory", "start": 115, "end": 126, "id": 16, "ws": true}, {"text": "depression", "start": 127, "end": 137, "id": 17, "ws": false}, {"text": ",", "start": 137, "end": 138, "id": 18, "ws": true}, {"text": "induced", "start": 139, "end": 146, "id": 19, "ws": true}, {"text": "by", "start": 147, "end": 149, "id": 20, "ws": true}, {"text": "natural", "start": 150, "end": 157, "id": 21, "ws": true}, {"text": "and", "start": 158, "end": 161, "id": 22, "ws": true}, {"text": "synthetic", "start": 162, "end": 171, "id": 23, "ws": true}, {"text": "opioids", "start": 172, "end": 179, "id": 24, "ws": true}, {"text": "including", "start": 180, "end": 189, "id": 25, "ws": true}, {"text": "propoxyphene", "start": 190, "end": 202, "id": 26, "ws": false}, {"text": ",", "start": 202, "end": 203, "id": 27, "ws": true}, {"text": "methadone", "start": 204, "end": 213, "id": 28, "ws": false}, {"text": ",", "start": 213, "end": 214, "id": 29, "ws": true}, {"text": "and", "start": 215, "end": 218, "id": 30, "ws": true}, {"text": "certain", "start": 219, "end": 226, "id": 31, "ws": true}, {"text": "mixed", "start": 227, "end": 232, "id": 32, "ws": true}, {"text": "agonist", "start": 233, "end": 240, "id": 33, "ws": false}, {"text": "-", "start": 240, "end": 241, "id": 34, "ws": false}, {"text": "antagonist", "start": 241, "end": 251, "id": 35, "ws": true}, {"text": "analgesics", "start": 252, "end": 262, "id": 36, "ws": false}, {"text": ":", "start": 262, "end": 263, "id": 37, "ws": true}, {"text": "nalbuphine", "start": 264, "end": 274, "id": 38, "ws": false}, {"text": ",", "start": 274, "end": 275, "id": 39, "ws": true}, {"text": "pentazocine", "start": 276, "end": 287, "id": 40, "ws": false}, {"text": ",", "start": 287, "end": 288, "id": 41, "ws": true}, {"text": "butorphanol", "start": 289, "end": 300, "id": 42, "ws": false}, {"text": ",", "start": 300, "end": 301, "id": 43, "ws": true}, {"text": "and", "start": 302, "end": 305, "id": 44, "ws": true}, {"text": "cyclazocine", "start": 306, "end": 317, "id": 45, "ws": false}, {"text": ".", "start": 317, "end": 318, "id": 46, "ws": true}, {"text": "Naloxone", "start": 319, "end": 327, "id": 47, "ws": true}, {"text": "hydrochloride", "start": 328, "end": 341, "id": 48, "ws": true}, {"text": "is", "start": 342, "end": 344, "id": 49, "ws": true}, {"text": "also", "start": 345, "end": 349, "id": 50, "ws": true}, {"text": "indicated", "start": 350, "end": 359, "id": 51, "ws": true}, {"text": "for", "start": 360, "end": 363, "id": 52, "ws": true}, {"text": "the", "start": 364, "end": 367, "id": 53, "ws": true}, {"text": "diagnosis", "start": 368, "end": 377, "id": 54, "ws": true}, {"text": "of", "start": 378, "end": 380, "id": 55, "ws": true}, {"text": "suspected", "start": 381, "end": 390, "id": 56, "ws": true}, {"text": "or", "start": 391, "end": 393, "id": 57, "ws": true}, {"text": "known", "start": 394, "end": 399, "id": 58, "ws": true}, {"text": "acute", "start": 400, "end": 405, "id": 59, "ws": true}, {"text": "opioid", "start": 406, "end": 412, "id": 60, "ws": true}, {"text": "overdosage", "start": 413, "end": 423, "id": 61, "ws": false}, {"text": ".", "start": 423, "end": 424, "id": 62, "ws": true}, {"text": "Naloxone", "start": 425, "end": 433, "id": 63, "ws": true}, {"text": "may", "start": 434, "end": 437, "id": 64, "ws": true}, {"text": "be", "start": 438, "end": 440, "id": 65, "ws": true}, {"text": "useful", "start": 441, "end": 447, "id": 66, "ws": true}, {"text": "as", "start": 448, "end": 450, "id": 67, "ws": true}, {"text": "an", "start": 451, "end": 453, "id": 68, "ws": true}, {"text": "adjunctive", "start": 454, "end": 464, "id": 69, "ws": true}, {"text": "agent", "start": 465, "end": 470, "id": 70, "ws": true}, {"text": "to", "start": 471, "end": 473, "id": 71, "ws": true}, {"text": "increase", "start": 474, "end": 482, "id": 72, "ws": true}, {"text": "blood", "start": 483, "end": 488, "id": 73, "ws": true}, {"text": "pressure", "start": 489, "end": 497, "id": 74, "ws": true}, {"text": "in", "start": 498, "end": 500, "id": 75, "ws": true}, {"text": "the", "start": 501, "end": 504, "id": 76, "ws": true}, {"text": "management", "start": 505, "end": 515, "id": 77, "ws": true}, {"text": "of", "start": 516, "end": 518, "id": 78, "ws": true}, {"text": "septic", "start": 519, "end": 525, "id": 79, "ws": true}, {"text": "shock", "start": 526, "end": 531, "id": 80, "ws": true}, {"text": "(", "start": 532, "end": 533, "id": 81, "ws": false}, {"text": "see", "start": 533, "end": 536, "id": 82, "ws": true}, {"text": "CLINICAL", "start": 537, "end": 545, "id": 83, "ws": true}, {"text": "PHARMACOLOGY", "start": 546, "end": 558, "id": 84, "ws": false}, {"text": ";", "start": 558, "end": 559, "id": 85, "ws": true}, {"text": "ADJUNCTIVE", "start": 560, "end": 570, "id": 86, "ws": true}, {"text": "USE", "start": 571, "end": 574, "id": 87, "ws": true}, {"text": "IN", "start": 575, "end": 577, "id": 88, "ws": true}, {"text": "SEPTIC", "start": 578, "end": 584, "id": 89, "ws": true}, {"text": "SHOCK", "start": 585, "end": 590, "id": 90, "ws": false}, {"text": ")", "start": 590, "end": 591, "id": 91, "ws": false}, {"text": ".", "start": 591, "end": 592, "id": 92, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 22, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 23, "end": 32, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 54, "end": 82, "token_start": 7, "token_end": 10, "label": "ACTION"}, {"start": 86, "end": 103, "token_start": 12, "token_end": 13, "label": "INDICATION"}, {"start": 115, "end": 137, "token_start": 16, "token_end": 17, "label": "INDICATION"}, {"start": 139, "end": 179, "token_start": 19, "token_end": 24, "label": "CAUSED_BY"}, {"start": 190, "end": 202, "token_start": 26, "token_end": 26, "label": "CAUSED_BY"}, {"start": 204, "end": 213, "token_start": 28, "token_end": 28, "label": "CAUSED_BY"}, {"start": 219, "end": 262, "token_start": 31, "token_end": 36, "label": "CAUSED_BY"}, {"start": 264, "end": 274, "token_start": 38, "token_end": 38, "label": "CAUSED_BY"}, {"start": 276, "end": 287, "token_start": 40, "token_end": 40, "label": "CAUSED_BY"}, {"start": 289, "end": 300, "token_start": 42, "token_end": 42, "label": "CAUSED_BY"}, {"start": 306, "end": 317, "token_start": 45, "token_end": 45, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694177337, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Neostigmine methylsulfate injection is a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Neostigmine Methylsulfate Injection, a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery.", "_input_hash": -1020321456, "_task_hash": 732478648, "_is_binary": false, "tokens": [{"text": "Neostigmine", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "methylsulfate", "start": 12, "end": 25, "id": 1, "ws": true}, {"text": "injection", "start": 26, "end": 35, "id": 2, "ws": true}, {"text": "is", "start": 36, "end": 38, "id": 3, "ws": true}, {"text": "a", "start": 39, "end": 40, "id": 4, "ws": true}, {"text": "cholinesterase", "start": 41, "end": 55, "id": 5, "ws": true}, {"text": "inhibitor", "start": 56, "end": 65, "id": 6, "ws": true}, {"text": "indicated", "start": 66, "end": 75, "id": 7, "ws": true}, {"text": "for", "start": 76, "end": 79, "id": 8, "ws": true}, {"text": "the", "start": 80, "end": 83, "id": 9, "ws": true}, {"text": "reversal", "start": 84, "end": 92, "id": 10, "ws": true}, {"text": "of", "start": 93, "end": 95, "id": 11, "ws": true}, {"text": "the", "start": 96, "end": 99, "id": 12, "ws": true}, {"text": "effects", "start": 100, "end": 107, "id": 13, "ws": true}, {"text": "of", "start": 108, "end": 110, "id": 14, "ws": true}, {"text": "non", "start": 111, "end": 114, "id": 15, "ws": false}, {"text": "-", "start": 114, "end": 115, "id": 16, "ws": false}, {"text": "depolarizing", "start": 115, "end": 127, "id": 17, "ws": true}, {"text": "neuromuscular", "start": 128, "end": 141, "id": 18, "ws": true}, {"text": "blocking", "start": 142, "end": 150, "id": 19, "ws": true}, {"text": "agents", "start": 151, "end": 157, "id": 20, "ws": true}, {"text": "after", "start": 158, "end": 163, "id": 21, "ws": true}, {"text": "surgery", "start": 164, "end": 171, "id": 22, "ws": false}, {"text": ".", "start": 171, "end": 172, "id": 23, "ws": true}, {"text": "Neostigmine", "start": 173, "end": 184, "id": 24, "ws": true}, {"text": "Methylsulfate", "start": 185, "end": 198, "id": 25, "ws": true}, {"text": "Injection", "start": 199, "end": 208, "id": 26, "ws": false}, {"text": ",", "start": 208, "end": 209, "id": 27, "ws": true}, {"text": "a", "start": 210, "end": 211, "id": 28, "ws": true}, {"text": "cholinesterase", "start": 212, "end": 226, "id": 29, "ws": true}, {"text": "inhibitor", "start": 227, "end": 236, "id": 30, "ws": false}, {"text": ",", "start": 236, "end": 237, "id": 31, "ws": true}, {"text": "is", "start": 238, "end": 240, "id": 32, "ws": true}, {"text": "indicated", "start": 241, "end": 250, "id": 33, "ws": true}, {"text": "for", "start": 251, "end": 254, "id": 34, "ws": true}, {"text": "the", "start": 255, "end": 258, "id": 35, "ws": true}, {"text": "reversal", "start": 259, "end": 267, "id": 36, "ws": true}, {"text": "of", "start": 268, "end": 270, "id": 37, "ws": true}, {"text": "the", "start": 271, "end": 274, "id": 38, "ws": true}, {"text": "effects", "start": 275, "end": 282, "id": 39, "ws": true}, {"text": "of", "start": 283, "end": 285, "id": 40, "ws": true}, {"text": "non", "start": 286, "end": 289, "id": 41, "ws": false}, {"text": "-", "start": 289, "end": 290, "id": 42, "ws": false}, {"text": "depolarizing", "start": 290, "end": 302, "id": 43, "ws": true}, {"text": "neuromuscular", "start": 303, "end": 316, "id": 44, "ws": true}, {"text": "blocking", "start": 317, "end": 325, "id": 45, "ws": true}, {"text": "agents", "start": 326, "end": 332, "id": 46, "ws": true}, {"text": "(", "start": 333, "end": 334, "id": 47, "ws": false}, {"text": "NMBAs", "start": 334, "end": 339, "id": 48, "ws": false}, {"text": ")", "start": 339, "end": 340, "id": 49, "ws": true}, {"text": "after", "start": 341, "end": 346, "id": 50, "ws": true}, {"text": "surgery", "start": 347, "end": 354, "id": 51, "ws": false}, {"text": ".", "start": 354, "end": 355, "id": 52, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 25, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 26, "end": 35, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 41, "end": 65, "token_start": 5, "token_end": 6, "label": "MECHANISM"}, {"start": 84, "end": 92, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 100, "end": 157, "token_start": 13, "token_end": 20, "label": "INDICATION"}, {"start": 158, "end": 171, "token_start": 21, "token_end": 22, "label": "TEMPORALITY"}, {"start": 212, "end": 236, "token_start": 29, "token_end": 30, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694525896, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "EGATEN is indicated for the treatment of fascioliasis in patients 6 years of age and older. EGATEN tablet is an anthelmintic indicated for the treatment of fascioliasis in patients 6 years of age and older.", "_input_hash": 1205428566, "_task_hash": 529512609, "_is_binary": false, "tokens": [{"text": "EGATEN", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "for", "start": 20, "end": 23, "id": 3, "ws": true}, {"text": "the", "start": 24, "end": 27, "id": 4, "ws": true}, {"text": "treatment", "start": 28, "end": 37, "id": 5, "ws": true}, {"text": "of", "start": 38, "end": 40, "id": 6, "ws": true}, {"text": "fascioliasis", "start": 41, "end": 53, "id": 7, "ws": true}, {"text": "in", "start": 54, "end": 56, "id": 8, "ws": true}, {"text": "patients", "start": 57, "end": 65, "id": 9, "ws": true}, {"text": "6", "start": 66, "end": 67, "id": 10, "ws": true}, {"text": "years", "start": 68, "end": 73, "id": 11, "ws": true}, {"text": "of", "start": 74, "end": 76, "id": 12, "ws": true}, {"text": "age", "start": 77, "end": 80, "id": 13, "ws": true}, {"text": "and", "start": 81, "end": 84, "id": 14, "ws": true}, {"text": "older", "start": 85, "end": 90, "id": 15, "ws": false}, {"text": ".", "start": 90, "end": 91, "id": 16, "ws": true}, {"text": "EGATEN", "start": 92, "end": 98, "id": 17, "ws": true}, {"text": "tablet", "start": 99, "end": 105, "id": 18, "ws": true}, {"text": "is", "start": 106, "end": 108, "id": 19, "ws": true}, {"text": "an", "start": 109, "end": 111, "id": 20, "ws": true}, {"text": "anthelmintic", "start": 112, "end": 124, "id": 21, "ws": true}, {"text": "indicated", "start": 125, "end": 134, "id": 22, "ws": true}, {"text": "for", "start": 135, "end": 138, "id": 23, "ws": true}, {"text": "the", "start": 139, "end": 142, "id": 24, "ws": true}, {"text": "treatment", "start": 143, "end": 152, "id": 25, "ws": true}, {"text": "of", "start": 153, "end": 155, "id": 26, "ws": true}, {"text": "fascioliasis", "start": 156, "end": 168, "id": 27, "ws": true}, {"text": "in", "start": 169, "end": 171, "id": 28, "ws": true}, {"text": "patients", "start": 172, "end": 180, "id": 29, "ws": true}, {"text": "6", "start": 181, "end": 182, "id": 30, "ws": true}, {"text": "years", "start": 183, "end": 188, "id": 31, "ws": true}, {"text": "of", "start": 189, "end": 191, "id": 32, "ws": true}, {"text": "age", "start": 192, "end": 195, "id": 33, "ws": true}, {"text": "and", "start": 196, "end": 199, "id": 34, "ws": true}, {"text": "older", "start": 200, "end": 205, "id": 35, "ws": false}, {"text": ".", "start": 205, "end": 206, "id": 36, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 28, "end": 37, "token_start": 5, "token_end": 5, "label": "DRUG"}, {"start": 41, "end": 53, "token_start": 7, "token_end": 7, "label": "INDICATION"}, {"start": 57, "end": 90, "token_start": 9, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 92, "end": 98, "token_start": 17, "token_end": 17, "label": "DRUG"}, {"start": 99, "end": 105, "token_start": 18, "token_end": 18, "label": "FORMULATION"}, {"start": 112, "end": 124, "token_start": 21, "token_end": 21, "label": "MECHANISM"}, {"start": 143, "end": 152, "token_start": 25, "token_end": 25, "label": "ACTION"}, {"start": 156, "end": 168, "token_start": 27, "token_end": 27, "label": "INDICATION"}, {"start": 172, "end": 205, "token_start": 29, "token_end": 35, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694176197, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE may be used when a patient is sensitive to the preservative in Timolol Maleate Ophthalmic Solution, benzalkonium chloride, or when use of a preservative-free topical medication is advisable.", "_input_hash": 498359169, "_task_hash": -654253319, "_is_binary": false, "tokens": [{"text": "Preservative", "start": 0, "end": 12, "id": 0, "ws": false}, {"text": "-", "start": 12, "end": 13, "id": 1, "ws": false}, {"text": "free", "start": 13, "end": 17, "id": 2, "ws": true}, {"text": "Timolol", "start": 18, "end": 25, "id": 3, "ws": true}, {"text": "Maleate", "start": 26, "end": 33, "id": 4, "ws": true}, {"text": "Ophthalmic", "start": 34, "end": 44, "id": 5, "ws": true}, {"text": "Solution", "start": 45, "end": 53, "id": 6, "ws": true}, {"text": "in", "start": 54, "end": 56, "id": 7, "ws": true}, {"text": "OCUDOSE", "start": 57, "end": 64, "id": 8, "ws": true}, {"text": "is", "start": 65, "end": 67, "id": 9, "ws": true}, {"text": "indicated", "start": 68, "end": 77, "id": 10, "ws": true}, {"text": "in", "start": 78, "end": 80, "id": 11, "ws": true}, {"text": "the", "start": 81, "end": 84, "id": 12, "ws": true}, {"text": "treatment", "start": 85, "end": 94, "id": 13, "ws": true}, {"text": "of", "start": 95, "end": 97, "id": 14, "ws": true}, {"text": "elevated", "start": 98, "end": 106, "id": 15, "ws": true}, {"text": "intraocular", "start": 107, "end": 118, "id": 16, "ws": true}, {"text": "pressure", "start": 119, "end": 127, "id": 17, "ws": true}, {"text": "in", "start": 128, "end": 130, "id": 18, "ws": true}, {"text": "patients", "start": 131, "end": 139, "id": 19, "ws": true}, {"text": "with", "start": 140, "end": 144, "id": 20, "ws": true}, {"text": "ocular", "start": 145, "end": 151, "id": 21, "ws": true}, {"text": "hypertension", "start": 152, "end": 164, "id": 22, "ws": true}, {"text": "or", "start": 165, "end": 167, "id": 23, "ws": true}, {"text": "open", "start": 168, "end": 172, "id": 24, "ws": false}, {"text": "-", "start": 172, "end": 173, "id": 25, "ws": false}, {"text": "angle", "start": 173, "end": 178, "id": 26, "ws": true}, {"text": "glaucoma", "start": 179, "end": 187, "id": 27, "ws": false}, {"text": ".", "start": 187, "end": 188, "id": 28, "ws": true}, {"text": "Preservative", "start": 189, "end": 201, "id": 29, "ws": false}, {"text": "-", "start": 201, "end": 202, "id": 30, "ws": false}, {"text": "free", "start": 202, "end": 206, "id": 31, "ws": true}, {"text": "Timolol", "start": 207, "end": 214, "id": 32, "ws": true}, {"text": "Maleate", "start": 215, "end": 222, "id": 33, "ws": true}, {"text": "Ophthalmic", "start": 223, "end": 233, "id": 34, "ws": true}, {"text": "Solution", "start": 234, "end": 242, "id": 35, "ws": true}, {"text": "in", "start": 243, "end": 245, "id": 36, "ws": true}, {"text": "OCUDOSE", "start": 246, "end": 253, "id": 37, "ws": true}, {"text": "may", "start": 254, "end": 257, "id": 38, "ws": true}, {"text": "be", "start": 258, "end": 260, "id": 39, "ws": true}, {"text": "used", "start": 261, "end": 265, "id": 40, "ws": true}, {"text": "when", "start": 266, "end": 270, "id": 41, "ws": true}, {"text": "a", "start": 271, "end": 272, "id": 42, "ws": true}, {"text": "patient", "start": 273, "end": 280, "id": 43, "ws": true}, {"text": "is", "start": 281, "end": 283, "id": 44, "ws": true}, {"text": "sensitive", "start": 284, "end": 293, "id": 45, "ws": true}, {"text": "to", "start": 294, "end": 296, "id": 46, "ws": true}, {"text": "the", "start": 297, "end": 300, "id": 47, "ws": true}, {"text": "preservative", "start": 301, "end": 313, "id": 48, "ws": true}, {"text": "in", "start": 314, "end": 316, "id": 49, "ws": true}, {"text": "Timolol", "start": 317, "end": 324, "id": 50, "ws": true}, {"text": "Maleate", "start": 325, "end": 332, "id": 51, "ws": true}, {"text": "Ophthalmic", "start": 333, "end": 343, "id": 52, "ws": true}, {"text": "Solution", "start": 344, "end": 352, "id": 53, "ws": false}, {"text": ",", "start": 352, "end": 353, "id": 54, "ws": true}, {"text": "benzalkonium", "start": 354, "end": 366, "id": 55, "ws": true}, {"text": "chloride", "start": 367, "end": 375, "id": 56, "ws": false}, {"text": ",", "start": 375, "end": 376, "id": 57, "ws": true}, {"text": "or", "start": 377, "end": 379, "id": 58, "ws": true}, {"text": "when", "start": 380, "end": 384, "id": 59, "ws": true}, {"text": "use", "start": 385, "end": 388, "id": 60, "ws": true}, {"text": "of", "start": 389, "end": 391, "id": 61, "ws": true}, {"text": "a", "start": 392, "end": 393, "id": 62, "ws": true}, {"text": "preservative", "start": 394, "end": 406, "id": 63, "ws": false}, {"text": "-", "start": 406, "end": 407, "id": 64, "ws": false}, {"text": "free", "start": 407, "end": 411, "id": 65, "ws": true}, {"text": "topical", "start": 412, "end": 419, "id": 66, "ws": true}, {"text": "medication", "start": 420, "end": 430, "id": 67, "ws": true}, {"text": "is", "start": 431, "end": 433, "id": 68, "ws": true}, {"text": "advisable", "start": 434, "end": 443, "id": 69, "ws": false}, {"text": ".", "start": 443, "end": 444, "id": 70, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 18, "end": 25, "token_start": 3, "token_end": 3, "label": "DRUG"}, {"start": 26, "end": 33, "token_start": 4, "token_end": 4, "label": "SALT"}, {"start": 34, "end": 44, "token_start": 5, "token_end": 5, "label": "ROUTE"}, {"start": 45, "end": 53, "token_start": 6, "token_end": 6, "label": "FORMULATION"}, {"start": 57, "end": 64, "token_start": 8, "token_end": 8, "label": "DRUG"}, {"start": 85, "end": 94, "token_start": 13, "token_end": 13, "label": "ACTION"}, {"start": 98, "end": 127, "token_start": 15, "token_end": 17, "label": "INDICATION"}, {"start": 145, "end": 164, "token_start": 21, "token_end": 22, "label": "BASECONDITION"}, {"start": 168, "end": 187, "token_start": 24, "token_end": 27, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694177390, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "TAVALISSE is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. TAVALISSE is a kinase inhibitor indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.", "_input_hash": 1064066134, "_task_hash": 1604379006, "_is_binary": false, "tokens": [{"text": "TAVALISSE", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 3, "ws": true}, {"text": "the", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "treatment", "start": 31, "end": 40, "id": 5, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 6, "ws": true}, {"text": "thrombocytopenia", "start": 44, "end": 60, "id": 7, "ws": true}, {"text": "in", "start": 61, "end": 63, "id": 8, "ws": true}, {"text": "adult", "start": 64, "end": 69, "id": 9, "ws": true}, {"text": "patients", "start": 70, "end": 78, "id": 10, "ws": true}, {"text": "with", "start": 79, "end": 83, "id": 11, "ws": true}, {"text": "chronic", "start": 84, "end": 91, "id": 12, "ws": true}, {"text": "immune", "start": 92, "end": 98, "id": 13, "ws": true}, {"text": "thrombocytopenia", "start": 99, "end": 115, "id": 14, "ws": true}, {"text": "(", "start": 116, "end": 117, "id": 15, "ws": false}, {"text": "ITP", "start": 117, "end": 120, "id": 16, "ws": false}, {"text": ")", "start": 120, "end": 121, "id": 17, "ws": true}, {"text": "who", "start": 122, "end": 125, "id": 18, "ws": true}, {"text": "have", "start": 126, "end": 130, "id": 19, "ws": true}, {"text": "had", "start": 131, "end": 134, "id": 20, "ws": true}, {"text": "an", "start": 135, "end": 137, "id": 21, "ws": true}, {"text": "insufficient", "start": 138, "end": 150, "id": 22, "ws": true}, {"text": "response", "start": 151, "end": 159, "id": 23, "ws": true}, {"text": "to", "start": 160, "end": 162, "id": 24, "ws": true}, {"text": "a", "start": 163, "end": 164, "id": 25, "ws": true}, {"text": "previous", "start": 165, "end": 173, "id": 26, "ws": true}, {"text": "treatment", "start": 174, "end": 183, "id": 27, "ws": false}, {"text": ".", "start": 183, "end": 184, "id": 28, "ws": true}, {"text": "TAVALISSE", "start": 185, "end": 194, "id": 29, "ws": true}, {"text": "is", "start": 195, "end": 197, "id": 30, "ws": true}, {"text": "a", "start": 198, "end": 199, "id": 31, "ws": true}, {"text": "kinase", "start": 200, "end": 206, "id": 32, "ws": true}, {"text": "inhibitor", "start": 207, "end": 216, "id": 33, "ws": true}, {"text": "indicated", "start": 217, "end": 226, "id": 34, "ws": true}, {"text": "for", "start": 227, "end": 230, "id": 35, "ws": true}, {"text": "the", "start": 231, "end": 234, "id": 36, "ws": true}, {"text": "treatment", "start": 235, "end": 244, "id": 37, "ws": true}, {"text": "of", "start": 245, "end": 247, "id": 38, "ws": true}, {"text": "thrombocytopenia", "start": 248, "end": 264, "id": 39, "ws": true}, {"text": "in", "start": 265, "end": 267, "id": 40, "ws": true}, {"text": "adult", "start": 268, "end": 273, "id": 41, "ws": true}, {"text": "patients", "start": 274, "end": 282, "id": 42, "ws": true}, {"text": "with", "start": 283, "end": 287, "id": 43, "ws": true}, {"text": "chronic", "start": 288, "end": 295, "id": 44, "ws": true}, {"text": "immune", "start": 296, "end": 302, "id": 45, "ws": true}, {"text": "thrombocytopenia", "start": 303, "end": 319, "id": 46, "ws": true}, {"text": "(", "start": 320, "end": 321, "id": 47, "ws": false}, {"text": "ITP", "start": 321, "end": 324, "id": 48, "ws": false}, {"text": ")", "start": 324, "end": 325, "id": 49, "ws": true}, {"text": "who", "start": 326, "end": 329, "id": 50, "ws": true}, {"text": "have", "start": 330, "end": 334, "id": 51, "ws": true}, {"text": "had", "start": 335, "end": 338, "id": 52, "ws": true}, {"text": "an", "start": 339, "end": 341, "id": 53, "ws": true}, {"text": "insufficient", "start": 342, "end": 354, "id": 54, "ws": true}, {"text": "response", "start": 355, "end": 363, "id": 55, "ws": true}, {"text": "to", "start": 364, "end": 366, "id": 56, "ws": true}, {"text": "a", "start": 367, "end": 368, "id": 57, "ws": true}, {"text": "previous", "start": 369, "end": 377, "id": 58, "ws": true}, {"text": "treatment", "start": 378, "end": 387, "id": 59, "ws": false}, {"text": ".", "start": 387, "end": 388, "id": 60, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 40, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 44, "end": 60, "token_start": 7, "token_end": 7, "label": "INDICATION"}, {"start": 64, "end": 69, "token_start": 9, "token_end": 9, "label": "TARGET_GROUP"}, {"start": 84, "end": 115, "token_start": 12, "token_end": 14, "label": "BASECONDITION"}, {"start": 122, "end": 183, "token_start": 18, "token_end": 27, "label": "MEDICAL_CTX"}, {"start": 185, "end": 194, "token_start": 29, "token_end": 29, "label": "DRUG"}, {"start": 200, "end": 216, "token_start": 32, "token_end": 33, "label": "MECHANISM"}, {"start": 235, "end": 244, "token_start": 37, "token_end": 37, "label": "ACTION"}, {"start": 248, "end": 264, "token_start": 39, "token_end": 39, "label": "INDICATION"}, {"start": 268, "end": 273, "token_start": 41, "token_end": 41, "label": "TARGET_GROUP"}, {"start": 288, "end": 319, "token_start": 44, "token_end": 46, "label": "BASECONDITION"}, {"start": 326, "end": 387, "token_start": 50, "token_end": 59, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694526739, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.", "_input_hash": -2013365196, "_task_hash": -358000981, "_is_binary": false, "tokens": [{"text": "Zonisamide", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "capsules", "start": 11, "end": 19, "id": 1, "ws": true}, {"text": "are", "start": 20, "end": 23, "id": 2, "ws": true}, {"text": "indicated", "start": 24, "end": 33, "id": 3, "ws": true}, {"text": "as", "start": 34, "end": 36, "id": 4, "ws": true}, {"text": "adjunctive", "start": 37, "end": 47, "id": 5, "ws": true}, {"text": "therapy", "start": 48, "end": 55, "id": 6, "ws": true}, {"text": "in", "start": 56, "end": 58, "id": 7, "ws": true}, {"text": "the", "start": 59, "end": 62, "id": 8, "ws": true}, {"text": "treatment", "start": 63, "end": 72, "id": 9, "ws": true}, {"text": "of", "start": 73, "end": 75, "id": 10, "ws": true}, {"text": "partial", "start": 76, "end": 83, "id": 11, "ws": true}, {"text": "seizures", "start": 84, "end": 92, "id": 12, "ws": true}, {"text": "in", "start": 93, "end": 95, "id": 13, "ws": true}, {"text": "adults", "start": 96, "end": 102, "id": 14, "ws": true}, {"text": "with", "start": 103, "end": 107, "id": 15, "ws": true}, {"text": "epilepsy", "start": 108, "end": 116, "id": 16, "ws": false}, {"text": ".", "start": 116, "end": 117, "id": 17, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 19, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 37, "end": 47, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 96, "end": 102, "token_start": 14, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 108, "end": 116, "token_start": 16, "token_end": 16, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527675, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ELFABRIO is indicated for the treatment of adults with confirmed Fabry disease. ELFABRIO is a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme indicated for the treatment of adults with confirmed Fabry disease. (1)", "_input_hash": 1351080667, "_task_hash": 1771673333, "_is_binary": false, "tokens": [{"text": "ELFABRIO", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "treatment", "start": 30, "end": 39, "id": 5, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "adults", "start": 43, "end": 49, "id": 7, "ws": true}, {"text": "with", "start": 50, "end": 54, "id": 8, "ws": true}, {"text": "confirmed", "start": 55, "end": 64, "id": 9, "ws": true}, {"text": "Fabry", "start": 65, "end": 70, "id": 10, "ws": true}, {"text": "disease", "start": 71, "end": 78, "id": 11, "ws": false}, {"text": ".", "start": 78, "end": 79, "id": 12, "ws": true}, {"text": "ELFABRIO", "start": 80, "end": 88, "id": 13, "ws": true}, {"text": "is", "start": 89, "end": 91, "id": 14, "ws": true}, {"text": "a", "start": 92, "end": 93, "id": 15, "ws": true}, {"text": "hydrolytic", "start": 94, "end": 104, "id": 16, "ws": true}, {"text": "lysosomal", "start": 105, "end": 114, "id": 17, "ws": true}, {"text": "neutral", "start": 115, "end": 122, "id": 18, "ws": true}, {"text": "glycosphingolipid", "start": 123, "end": 140, "id": 19, "ws": false}, {"text": "-", "start": 140, "end": 141, "id": 20, "ws": false}, {"text": "specific", "start": 141, "end": 149, "id": 21, "ws": true}, {"text": "enzyme", "start": 150, "end": 156, "id": 22, "ws": true}, {"text": "indicated", "start": 157, "end": 166, "id": 23, "ws": true}, {"text": "for", "start": 167, "end": 170, "id": 24, "ws": true}, {"text": "the", "start": 171, "end": 174, "id": 25, "ws": true}, {"text": "treatment", "start": 175, "end": 184, "id": 26, "ws": true}, {"text": "of", "start": 185, "end": 187, "id": 27, "ws": true}, {"text": "adults", "start": 188, "end": 194, "id": 28, "ws": true}, {"text": "with", "start": 195, "end": 199, "id": 29, "ws": true}, {"text": "confirmed", "start": 200, "end": 209, "id": 30, "ws": true}, {"text": "Fabry", "start": 210, "end": 215, "id": 31, "ws": true}, {"text": "disease", "start": 216, "end": 223, "id": 32, "ws": false}, {"text": ".", "start": 223, "end": 224, "id": 33, "ws": true}, {"text": "(", "start": 225, "end": 226, "id": 34, "ws": false}, {"text": "1", "start": 226, "end": 227, "id": 35, "ws": false}, {"text": ")", "start": 227, "end": 228, "id": 36, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 39, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 43, "end": 49, "token_start": 7, "token_end": 7, "label": "TARGET_GROUP"}, {"start": 65, "end": 78, "token_start": 10, "token_end": 11, "label": "BASECONDITION"}, {"start": 94, "end": 156, "token_start": 16, "token_end": 22, "label": "MECHANISM"}, {"start": 175, "end": 184, "token_start": 26, "token_end": 26, "label": "ACTION"}, {"start": 188, "end": 194, "token_start": 28, "token_end": 28, "label": "TARGET_GROUP"}, {"start": 210, "end": 223, "token_start": 31, "token_end": 32, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176329, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP). TRIPTODUR is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients 2 years and older with central precocious puberty. (1)", "_input_hash": -2007548832, "_task_hash": 854873404, "_is_binary": false, "tokens": [{"text": "TRIPTODUR", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 3, "ws": true}, {"text": "the", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "treatment", "start": 31, "end": 40, "id": 5, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 6, "ws": true}, {"text": "pediatric", "start": 44, "end": 53, "id": 7, "ws": true}, {"text": "patients", "start": 54, "end": 62, "id": 8, "ws": true}, {"text": "2", "start": 63, "end": 64, "id": 9, "ws": true}, {"text": "years", "start": 65, "end": 70, "id": 10, "ws": true}, {"text": "of", "start": 71, "end": 73, "id": 11, "ws": true}, {"text": "age", "start": 74, "end": 77, "id": 12, "ws": true}, {"text": "and", "start": 78, "end": 81, "id": 13, "ws": true}, {"text": "older", "start": 82, "end": 87, "id": 14, "ws": true}, {"text": "with", "start": 88, "end": 92, "id": 15, "ws": true}, {"text": "central", "start": 93, "end": 100, "id": 16, "ws": true}, {"text": "precocious", "start": 101, "end": 111, "id": 17, "ws": true}, {"text": "puberty", "start": 112, "end": 119, "id": 18, "ws": true}, {"text": "(", "start": 120, "end": 121, "id": 19, "ws": false}, {"text": "CPP", "start": 121, "end": 124, "id": 20, "ws": false}, {"text": ")", "start": 124, "end": 125, "id": 21, "ws": false}, {"text": ".", "start": 125, "end": 126, "id": 22, "ws": true}, {"text": "TRIPTODUR", "start": 127, "end": 136, "id": 23, "ws": true}, {"text": "is", "start": 137, "end": 139, "id": 24, "ws": true}, {"text": "a", "start": 140, "end": 141, "id": 25, "ws": true}, {"text": "gonadotropin", "start": 142, "end": 154, "id": 26, "ws": true}, {"text": "releasing", "start": 155, "end": 164, "id": 27, "ws": true}, {"text": "hormone", "start": 165, "end": 172, "id": 28, "ws": true}, {"text": "(", "start": 173, "end": 174, "id": 29, "ws": false}, {"text": "GnRH", "start": 174, "end": 178, "id": 30, "ws": false}, {"text": ")", "start": 178, "end": 179, "id": 31, "ws": true}, {"text": "agonist", "start": 180, "end": 187, "id": 32, "ws": true}, {"text": "indicated", "start": 188, "end": 197, "id": 33, "ws": true}, {"text": "for", "start": 198, "end": 201, "id": 34, "ws": true}, {"text": "the", "start": 202, "end": 205, "id": 35, "ws": true}, {"text": "treatment", "start": 206, "end": 215, "id": 36, "ws": true}, {"text": "of", "start": 216, "end": 218, "id": 37, "ws": true}, {"text": "pediatric", "start": 219, "end": 228, "id": 38, "ws": true}, {"text": "patients", "start": 229, "end": 237, "id": 39, "ws": true}, {"text": "2", "start": 238, "end": 239, "id": 40, "ws": true}, {"text": "years", "start": 240, "end": 245, "id": 41, "ws": true}, {"text": "and", "start": 246, "end": 249, "id": 42, "ws": true}, {"text": "older", "start": 250, "end": 255, "id": 43, "ws": true}, {"text": "with", "start": 256, "end": 260, "id": 44, "ws": true}, {"text": "central", "start": 261, "end": 268, "id": 45, "ws": true}, {"text": "precocious", "start": 269, "end": 279, "id": 46, "ws": true}, {"text": "puberty", "start": 280, "end": 287, "id": 47, "ws": false}, {"text": ".", "start": 287, "end": 288, "id": 48, "ws": true}, {"text": "(", "start": 289, "end": 290, "id": 49, "ws": false}, {"text": "1", "start": 290, "end": 291, "id": 50, "ws": false}, {"text": ")", "start": 291, "end": 292, "id": 51, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 40, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 44, "end": 87, "token_start": 7, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 93, "end": 119, "token_start": 16, "token_end": 18, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176007, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Carefully consider the potential benefits and risks of ketoprofen extended-release capsules before deciding to use ketoprofen extended-release capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Ketoprofen extended-release capsules are indicated for the management of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Ketoprofen extended-release capsules are not recommended for treatment of acute pain because of its extended-release characteristics (see CLINICAL PHARMACOLOGY: Pharmacokinetics).", "_input_hash": 807832018, "_task_hash": -1421304360, "_is_binary": false, "tokens": [{"text": "Carefully", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "consider", "start": 10, "end": 18, "id": 1, "ws": true}, {"text": "the", "start": 19, "end": 22, "id": 2, "ws": true}, {"text": "potential", "start": 23, "end": 32, "id": 3, "ws": true}, {"text": "benefits", "start": 33, "end": 41, "id": 4, "ws": true}, {"text": "and", "start": 42, "end": 45, "id": 5, "ws": true}, {"text": "risks", "start": 46, "end": 51, "id": 6, "ws": true}, {"text": "of", "start": 52, "end": 54, "id": 7, "ws": true}, {"text": "ketoprofen", "start": 55, "end": 65, "id": 8, "ws": true}, {"text": "extended", "start": 66, "end": 74, "id": 9, "ws": false}, {"text": "-", "start": 74, "end": 75, "id": 10, "ws": false}, {"text": "release", "start": 75, "end": 82, "id": 11, "ws": true}, {"text": "capsules", "start": 83, "end": 91, "id": 12, "ws": true}, {"text": "before", "start": 92, "end": 98, "id": 13, "ws": true}, {"text": "deciding", "start": 99, "end": 107, "id": 14, "ws": true}, {"text": "to", "start": 108, "end": 110, "id": 15, "ws": true}, {"text": "use", "start": 111, "end": 114, "id": 16, "ws": true}, {"text": "ketoprofen", "start": 115, "end": 125, "id": 17, "ws": true}, {"text": "extended", "start": 126, "end": 134, "id": 18, "ws": false}, {"text": "-", "start": 134, "end": 135, "id": 19, "ws": false}, {"text": "release", "start": 135, "end": 142, "id": 20, "ws": true}, {"text": "capsules", "start": 143, "end": 151, "id": 21, "ws": false}, {"text": ".", "start": 151, "end": 152, "id": 22, "ws": true}, {"text": "Use", "start": 153, "end": 156, "id": 23, "ws": true}, {"text": "the", "start": 157, "end": 160, "id": 24, "ws": true}, {"text": "lowest", "start": 161, "end": 167, "id": 25, "ws": true}, {"text": "effective", "start": 168, "end": 177, "id": 26, "ws": true}, {"text": "dose", "start": 178, "end": 182, "id": 27, "ws": true}, {"text": "for", "start": 183, "end": 186, "id": 28, "ws": true}, {"text": "the", "start": 187, "end": 190, "id": 29, "ws": true}, {"text": "shortest", "start": 191, "end": 199, "id": 30, "ws": true}, {"text": "duration", "start": 200, "end": 208, "id": 31, "ws": true}, {"text": "consistent", "start": 209, "end": 219, "id": 32, "ws": true}, {"text": "with", "start": 220, "end": 224, "id": 33, "ws": true}, {"text": "individual", "start": 225, "end": 235, "id": 34, "ws": true}, {"text": "patient", "start": 236, "end": 243, "id": 35, "ws": true}, {"text": "treatment", "start": 244, "end": 253, "id": 36, "ws": true}, {"text": "goals", "start": 254, "end": 259, "id": 37, "ws": true}, {"text": "(", "start": 260, "end": 261, "id": 38, "ws": false}, {"text": "see", "start": 261, "end": 264, "id": 39, "ws": true}, {"text": "WARNINGS", "start": 265, "end": 273, "id": 40, "ws": false}, {"text": ")", "start": 273, "end": 274, "id": 41, "ws": false}, {"text": ".", "start": 274, "end": 275, "id": 42, "ws": true}, {"text": "Ketoprofen", "start": 276, "end": 286, "id": 43, "ws": true}, {"text": "extended", "start": 287, "end": 295, "id": 44, "ws": false}, {"text": "-", "start": 295, "end": 296, "id": 45, "ws": false}, {"text": "release", "start": 296, "end": 303, "id": 46, "ws": true}, {"text": "capsules", "start": 304, "end": 312, "id": 47, "ws": true}, {"text": "are", "start": 313, "end": 316, "id": 48, "ws": true}, {"text": "indicated", "start": 317, "end": 326, "id": 49, "ws": true}, {"text": "for", "start": 327, "end": 330, "id": 50, "ws": true}, {"text": "the", "start": 331, "end": 334, "id": 51, "ws": true}, {"text": "management", "start": 335, "end": 345, "id": 52, "ws": true}, {"text": "of", "start": 346, "end": 348, "id": 53, "ws": true}, {"text": "the", "start": 349, "end": 352, "id": 54, "ws": true}, {"text": "signs", "start": 353, "end": 358, "id": 55, "ws": true}, {"text": "and", "start": 359, "end": 362, "id": 56, "ws": true}, {"text": "symptoms", "start": 363, "end": 371, "id": 57, "ws": true}, {"text": "of", "start": 372, "end": 374, "id": 58, "ws": true}, {"text": "rheumatoid", "start": 375, "end": 385, "id": 59, "ws": true}, {"text": "arthritis", "start": 386, "end": 395, "id": 60, "ws": true}, {"text": "and", "start": 396, "end": 399, "id": 61, "ws": true}, {"text": "osteoarthritis", "start": 400, "end": 414, "id": 62, "ws": false}, {"text": ".", "start": 414, "end": 415, "id": 63, "ws": true}, {"text": "Ketoprofen", "start": 416, "end": 426, "id": 64, "ws": true}, {"text": "extended", "start": 427, "end": 435, "id": 65, "ws": false}, {"text": "-", "start": 435, "end": 436, "id": 66, "ws": false}, {"text": "release", "start": 436, "end": 443, "id": 67, "ws": true}, {"text": "capsules", "start": 444, "end": 452, "id": 68, "ws": true}, {"text": "are", "start": 453, "end": 456, "id": 69, "ws": true}, {"text": "not", "start": 457, "end": 460, "id": 70, "ws": true}, {"text": "recommended", "start": 461, "end": 472, "id": 71, "ws": true}, {"text": "for", "start": 473, "end": 476, "id": 72, "ws": true}, {"text": "treatment", "start": 477, "end": 486, "id": 73, "ws": true}, {"text": "of", "start": 487, "end": 489, "id": 74, "ws": true}, {"text": "acute", "start": 490, "end": 495, "id": 75, "ws": true}, {"text": "pain", "start": 496, "end": 500, "id": 76, "ws": true}, {"text": "because", "start": 501, "end": 508, "id": 77, "ws": true}, {"text": "of", "start": 509, "end": 511, "id": 78, "ws": true}, {"text": "its", "start": 512, "end": 515, "id": 79, "ws": true}, {"text": "extended", "start": 516, "end": 524, "id": 80, "ws": false}, {"text": "-", "start": 524, "end": 525, "id": 81, "ws": false}, {"text": "release", "start": 525, "end": 532, "id": 82, "ws": true}, {"text": "characteristics", "start": 533, "end": 548, "id": 83, "ws": true}, {"text": "(", "start": 549, "end": 550, "id": 84, "ws": false}, {"text": "see", "start": 550, "end": 553, "id": 85, "ws": true}, {"text": "CLINICAL", "start": 554, "end": 562, "id": 86, "ws": true}, {"text": "PHARMACOLOGY", "start": 563, "end": 575, "id": 87, "ws": false}, {"text": ":", "start": 575, "end": 576, "id": 88, "ws": true}, {"text": "Pharmacokinetics", "start": 577, "end": 593, "id": 89, "ws": false}, {"text": ")", "start": 593, "end": 594, "id": 90, "ws": false}, {"text": ".", "start": 594, "end": 595, "id": 91, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 276, "end": 286, "token_start": 43, "token_end": 43, "label": "DRUG"}, {"start": 287, "end": 312, "token_start": 44, "token_end": 47, "label": "FORMULATION"}, {"start": 335, "end": 348, "token_start": 52, "token_end": 53, "label": "ACTION"}, {"start": 353, "end": 371, "token_start": 55, "token_end": 57, "label": "INDICATION"}, {"start": 375, "end": 395, "token_start": 59, "token_end": 60, "label": "BASECONDITION"}, {"start": 400, "end": 414, "token_start": 62, "token_end": 62, "label": "BASECONDITION"}, {"start": 416, "end": 548, "token_start": 64, "token_end": 83, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694174109, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "PROTOPIC Ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. PROTOPIC Ointment is not indicated for children younger than 2 years of age (see boxed WARNING, WARNINGS and PRECAUTIONS: Pediatric Use).", "_input_hash": 1661927618, "_task_hash": -549688127, "_is_binary": false, "tokens": [{"text": "PROTOPIC", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "Ointment", "start": 9, "end": 17, "id": 1, "ws": false}, {"text": ",", "start": 17, "end": 18, "id": 2, "ws": true}, {"text": "both", "start": 19, "end": 23, "id": 3, "ws": true}, {"text": "0.03", "start": 24, "end": 28, "id": 4, "ws": false}, {"text": "%", "start": 28, "end": 29, "id": 5, "ws": true}, {"text": "and", "start": 30, "end": 33, "id": 6, "ws": true}, {"text": "0.1", "start": 34, "end": 37, "id": 7, "ws": false}, {"text": "%", "start": 37, "end": 38, "id": 8, "ws": true}, {"text": "for", "start": 39, "end": 42, "id": 9, "ws": true}, {"text": "adults", "start": 43, "end": 49, "id": 10, "ws": false}, {"text": ",", "start": 49, "end": 50, "id": 11, "ws": true}, {"text": "and", "start": 51, "end": 54, "id": 12, "ws": true}, {"text": "only", "start": 55, "end": 59, "id": 13, "ws": true}, {"text": "0.03", "start": 60, "end": 64, "id": 14, "ws": false}, {"text": "%", "start": 64, "end": 65, "id": 15, "ws": true}, {"text": "for", "start": 66, "end": 69, "id": 16, "ws": true}, {"text": "children", "start": 70, "end": 78, "id": 17, "ws": true}, {"text": "aged", "start": 79, "end": 83, "id": 18, "ws": true}, {"text": "2", "start": 84, "end": 85, "id": 19, "ws": true}, {"text": "to", "start": 86, "end": 88, "id": 20, "ws": true}, {"text": "15", "start": 89, "end": 91, "id": 21, "ws": true}, {"text": "years", "start": 92, "end": 97, "id": 22, "ws": false}, {"text": ",", "start": 97, "end": 98, "id": 23, "ws": true}, {"text": "is", "start": 99, "end": 101, "id": 24, "ws": true}, {"text": "indicated", "start": 102, "end": 111, "id": 25, "ws": true}, {"text": "as", "start": 112, "end": 114, "id": 26, "ws": true}, {"text": "second", "start": 115, "end": 121, "id": 27, "ws": false}, {"text": "-", "start": 121, "end": 122, "id": 28, "ws": false}, {"text": "line", "start": 122, "end": 126, "id": 29, "ws": true}, {"text": "therapy", "start": 127, "end": 134, "id": 30, "ws": true}, {"text": "for", "start": 135, "end": 138, "id": 31, "ws": true}, {"text": "the", "start": 139, "end": 142, "id": 32, "ws": true}, {"text": "short", "start": 143, "end": 148, "id": 33, "ws": false}, {"text": "-", "start": 148, "end": 149, "id": 34, "ws": false}, {"text": "term", "start": 149, "end": 153, "id": 35, "ws": true}, {"text": "and", "start": 154, "end": 157, "id": 36, "ws": true}, {"text": "non", "start": 158, "end": 161, "id": 37, "ws": false}, {"text": "-", "start": 161, "end": 162, "id": 38, "ws": false}, {"text": "continuous", "start": 162, "end": 172, "id": 39, "ws": true}, {"text": "chronic", "start": 173, "end": 180, "id": 40, "ws": true}, {"text": "treatment", "start": 181, "end": 190, "id": 41, "ws": true}, {"text": "of", "start": 191, "end": 193, "id": 42, "ws": true}, {"text": "moderate", "start": 194, "end": 202, "id": 43, "ws": true}, {"text": "to", "start": 203, "end": 205, "id": 44, "ws": true}, {"text": "severe", "start": 206, "end": 212, "id": 45, "ws": true}, {"text": "atopic", "start": 213, "end": 219, "id": 46, "ws": true}, {"text": "dermatitis", "start": 220, "end": 230, "id": 47, "ws": true}, {"text": "in", "start": 231, "end": 233, "id": 48, "ws": true}, {"text": "non", "start": 234, "end": 237, "id": 49, "ws": false}, {"text": "-", "start": 237, "end": 238, "id": 50, "ws": false}, {"text": "immunocompromised", "start": 238, "end": 255, "id": 51, "ws": true}, {"text": "adults", "start": 256, "end": 262, "id": 52, "ws": true}, {"text": "and", "start": 263, "end": 266, "id": 53, "ws": true}, {"text": "children", "start": 267, "end": 275, "id": 54, "ws": true}, {"text": "who", "start": 276, "end": 279, "id": 55, "ws": true}, {"text": "have", "start": 280, "end": 284, "id": 56, "ws": true}, {"text": "failed", "start": 285, "end": 291, "id": 57, "ws": true}, {"text": "to", "start": 292, "end": 294, "id": 58, "ws": true}, {"text": "respond", "start": 295, "end": 302, "id": 59, "ws": true}, {"text": "adequately", "start": 303, "end": 313, "id": 60, "ws": true}, {"text": "to", "start": 314, "end": 316, "id": 61, "ws": true}, {"text": "other", "start": 317, "end": 322, "id": 62, "ws": true}, {"text": "topical", "start": 323, "end": 330, "id": 63, "ws": true}, {"text": "prescription", "start": 331, "end": 343, "id": 64, "ws": true}, {"text": "treatments", "start": 344, "end": 354, "id": 65, "ws": true}, {"text": "for", "start": 355, "end": 358, "id": 66, "ws": true}, {"text": "atopic", "start": 359, "end": 365, "id": 67, "ws": true}, {"text": "dermatitis", "start": 366, "end": 376, "id": 68, "ws": false}, {"text": ",", "start": 376, "end": 377, "id": 69, "ws": true}, {"text": "or", "start": 378, "end": 380, "id": 70, "ws": true}, {"text": "when", "start": 381, "end": 385, "id": 71, "ws": true}, {"text": "those", "start": 386, "end": 391, "id": 72, "ws": true}, {"text": "treatments", "start": 392, "end": 402, "id": 73, "ws": true}, {"text": "are", "start": 403, "end": 406, "id": 74, "ws": true}, {"text": "not", "start": 407, "end": 410, "id": 75, "ws": true}, {"text": "advisable", "start": 411, "end": 420, "id": 76, "ws": false}, {"text": ".", "start": 420, "end": 421, "id": 77, "ws": true}, {"text": "PROTOPIC", "start": 422, "end": 430, "id": 78, "ws": true}, {"text": "Ointment", "start": 431, "end": 439, "id": 79, "ws": true}, {"text": "is", "start": 440, "end": 442, "id": 80, "ws": true}, {"text": "not", "start": 443, "end": 446, "id": 81, "ws": true}, {"text": "indicated", "start": 447, "end": 456, "id": 82, "ws": true}, {"text": "for", "start": 457, "end": 460, "id": 83, "ws": true}, {"text": "children", "start": 461, "end": 469, "id": 84, "ws": true}, {"text": "younger", "start": 470, "end": 477, "id": 85, "ws": true}, {"text": "than", "start": 478, "end": 482, "id": 86, "ws": true}, {"text": "2", "start": 483, "end": 484, "id": 87, "ws": true}, {"text": "years", "start": 485, "end": 490, "id": 88, "ws": true}, {"text": "of", "start": 491, "end": 493, "id": 89, "ws": true}, {"text": "age", "start": 494, "end": 497, "id": 90, "ws": true}, {"text": "(", "start": 498, "end": 499, "id": 91, "ws": false}, {"text": "see", "start": 499, "end": 502, "id": 92, "ws": true}, {"text": "boxed", "start": 503, "end": 508, "id": 93, "ws": true}, {"text": "WARNING", "start": 509, "end": 516, "id": 94, "ws": false}, {"text": ",", "start": 516, "end": 517, "id": 95, "ws": true}, {"text": "WARNINGS", "start": 518, "end": 526, "id": 96, "ws": true}, {"text": "and", "start": 527, "end": 530, "id": 97, "ws": true}, {"text": "PRECAUTIONS", "start": 531, "end": 542, "id": 98, "ws": false}, {"text": ":", "start": 542, "end": 543, "id": 99, "ws": true}, {"text": "Pediatric", "start": 544, "end": 553, "id": 100, "ws": true}, {"text": "Use", "start": 554, "end": 557, "id": 101, "ws": false}, {"text": ")", "start": 557, "end": 558, "id": 102, "ws": false}, {"text": ".", "start": 558, "end": 559, "id": 103, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 17, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 181, "end": 190, "token_start": 41, "token_end": 41, "label": "ACTION"}, {"start": 194, "end": 212, "token_start": 43, "token_end": 45, "label": "SEVERITY"}, {"start": 213, "end": 230, "token_start": 46, "token_end": 47, "label": "INDICATION"}, {"start": 234, "end": 262, "token_start": 49, "token_end": 52, "label": "TARGET_GROUP"}, {"start": 267, "end": 376, "token_start": 54, "token_end": 68, "label": "TARGET_GROUP"}, {"start": 422, "end": 497, "token_start": 78, "token_end": 90, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694175741, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "SERNIVO Spray is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. SERNIVO Spray is a corticosteroid indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. (1)", "_input_hash": 1233888758, "_task_hash": 129227219, "_is_binary": false, "tokens": [{"text": "SERNIVO", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "Spray", "start": 8, "end": 13, "id": 1, "ws": true}, {"text": "is", "start": 14, "end": 16, "id": 2, "ws": true}, {"text": "indicated", "start": 17, "end": 26, "id": 3, "ws": true}, {"text": "for", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "the", "start": 31, "end": 34, "id": 5, "ws": true}, {"text": "treatment", "start": 35, "end": 44, "id": 6, "ws": true}, {"text": "of", "start": 45, "end": 47, "id": 7, "ws": true}, {"text": "mild", "start": 48, "end": 52, "id": 8, "ws": true}, {"text": "to", "start": 53, "end": 55, "id": 9, "ws": true}, {"text": "moderate", "start": 56, "end": 64, "id": 10, "ws": true}, {"text": "plaque", "start": 65, "end": 71, "id": 11, "ws": true}, {"text": "psoriasis", "start": 72, "end": 81, "id": 12, "ws": true}, {"text": "in", "start": 82, "end": 84, "id": 13, "ws": true}, {"text": "patients", "start": 85, "end": 93, "id": 14, "ws": true}, {"text": "18", "start": 94, "end": 96, "id": 15, "ws": true}, {"text": "years", "start": 97, "end": 102, "id": 16, "ws": true}, {"text": "of", "start": 103, "end": 105, "id": 17, "ws": true}, {"text": "age", "start": 106, "end": 109, "id": 18, "ws": true}, {"text": "or", "start": 110, "end": 112, "id": 19, "ws": true}, {"text": "older", "start": 113, "end": 118, "id": 20, "ws": false}, {"text": ".", "start": 118, "end": 119, "id": 21, "ws": true}, {"text": "SERNIVO", "start": 120, "end": 127, "id": 22, "ws": true}, {"text": "Spray", "start": 128, "end": 133, "id": 23, "ws": true}, {"text": "is", "start": 134, "end": 136, "id": 24, "ws": true}, {"text": "a", "start": 137, "end": 138, "id": 25, "ws": true}, {"text": "corticosteroid", "start": 139, "end": 153, "id": 26, "ws": true}, {"text": "indicated", "start": 154, "end": 163, "id": 27, "ws": true}, {"text": "for", "start": 164, "end": 167, "id": 28, "ws": true}, {"text": "the", "start": 168, "end": 171, "id": 29, "ws": true}, {"text": "treatment", "start": 172, "end": 181, "id": 30, "ws": true}, {"text": "of", "start": 182, "end": 184, "id": 31, "ws": true}, {"text": "mild", "start": 185, "end": 189, "id": 32, "ws": true}, {"text": "to", "start": 190, "end": 192, "id": 33, "ws": true}, {"text": "moderate", "start": 193, "end": 201, "id": 34, "ws": true}, {"text": "plaque", "start": 202, "end": 208, "id": 35, "ws": true}, {"text": "psoriasis", "start": 209, "end": 218, "id": 36, "ws": true}, {"text": "in", "start": 219, "end": 221, "id": 37, "ws": true}, {"text": "patients", "start": 222, "end": 230, "id": 38, "ws": true}, {"text": "18", "start": 231, "end": 233, "id": 39, "ws": true}, {"text": "years", "start": 234, "end": 239, "id": 40, "ws": true}, {"text": "of", "start": 240, "end": 242, "id": 41, "ws": true}, {"text": "age", "start": 243, "end": 246, "id": 42, "ws": true}, {"text": "or", "start": 247, "end": 249, "id": 43, "ws": true}, {"text": "older", "start": 250, "end": 255, "id": 44, "ws": false}, {"text": ".", "start": 255, "end": 256, "id": 45, "ws": true}, {"text": "(", "start": 257, "end": 258, "id": 46, "ws": false}, {"text": "1", "start": 258, "end": 259, "id": 47, "ws": false}, {"text": ")", "start": 259, "end": 260, "id": 48, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 13, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 35, "end": 44, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 48, "end": 64, "token_start": 8, "token_end": 10, "label": "SEVERITY"}, {"start": 65, "end": 81, "token_start": 11, "token_end": 12, "label": "INDICATION"}, {"start": 85, "end": 118, "token_start": 14, "token_end": 20, "label": "TARGET_GROUP"}, {"start": 120, "end": 127, "token_start": 22, "token_end": 22, "label": "DRUG"}, {"start": 128, "end": 133, "token_start": 23, "token_end": 23, "label": "FORMULATION"}, {"start": 139, "end": 153, "token_start": 26, "token_end": 26, "label": "MECHANISM"}, {"start": 172, "end": 181, "token_start": 30, "token_end": 30, "label": "ACTION"}, {"start": 185, "end": 201, "token_start": 32, "token_end": 34, "label": "SEVERITY"}, {"start": 202, "end": 218, "token_start": 35, "token_end": 36, "label": "INDICATION"}, {"start": 222, "end": 255, "token_start": 38, "token_end": 44, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694528759, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "AND USAGE Diflorasone diacetate cream USP, 0.05% is a high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "_input_hash": -1400205276, "_task_hash": -828826028, "_is_binary": false, "tokens": [{"text": "AND", "start": 0, "end": 3, "id": 0, "ws": true}, {"text": "USAGE", "start": 4, "end": 9, "id": 1, "ws": true}, {"text": "Diflorasone", "start": 10, "end": 21, "id": 2, "ws": true}, {"text": "diacetate", "start": 22, "end": 31, "id": 3, "ws": true}, {"text": "cream", "start": 32, "end": 37, "id": 4, "ws": true}, {"text": "USP", "start": 38, "end": 41, "id": 5, "ws": false}, {"text": ",", "start": 41, "end": 42, "id": 6, "ws": true}, {"text": "0.05", "start": 43, "end": 47, "id": 7, "ws": false}, {"text": "%", "start": 47, "end": 48, "id": 8, "ws": true}, {"text": "is", "start": 49, "end": 51, "id": 9, "ws": true}, {"text": "a", "start": 52, "end": 53, "id": 10, "ws": true}, {"text": "high", "start": 54, "end": 58, "id": 11, "ws": true}, {"text": "potency", "start": 59, "end": 66, "id": 12, "ws": true}, {"text": "corticosteroid", "start": 67, "end": 81, "id": 13, "ws": true}, {"text": "indicated", "start": 82, "end": 91, "id": 14, "ws": true}, {"text": "for", "start": 92, "end": 95, "id": 15, "ws": true}, {"text": "the", "start": 96, "end": 99, "id": 16, "ws": true}, {"text": "relief", "start": 100, "end": 106, "id": 17, "ws": true}, {"text": "of", "start": 107, "end": 109, "id": 18, "ws": true}, {"text": "the", "start": 110, "end": 113, "id": 19, "ws": true}, {"text": "inflammatory", "start": 114, "end": 126, "id": 20, "ws": true}, {"text": "and", "start": 127, "end": 130, "id": 21, "ws": true}, {"text": "pruritic", "start": 131, "end": 139, "id": 22, "ws": true}, {"text": "manifestations", "start": 140, "end": 154, "id": 23, "ws": true}, {"text": "of", "start": 155, "end": 157, "id": 24, "ws": true}, {"text": "corticosteroid", "start": 158, "end": 172, "id": 25, "ws": false}, {"text": "-", "start": 172, "end": 173, "id": 26, "ws": false}, {"text": "responsive", "start": 173, "end": 183, "id": 27, "ws": true}, {"text": "dermatoses", "start": 184, "end": 194, "id": 28, "ws": false}, {"text": ".", "start": 194, "end": 195, "id": 29, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 10, "end": 21, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 22, "end": 31, "token_start": 3, "token_end": 3, "label": "SALT"}, {"start": 32, "end": 37, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 54, "end": 81, "token_start": 11, "token_end": 13, "label": "MECHANISM"}, {"start": 100, "end": 106, "token_start": 17, "token_end": 17, "label": "ACTION"}, {"start": 114, "end": 154, "token_start": 20, "token_end": 23, "label": "INDICATION"}, {"start": 158, "end": 194, "token_start": 25, "token_end": 28, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527366, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels.", "_input_hash": 2010171267, "_task_hash": -668870539, "_is_binary": false, "tokens": [{"text": "Calcium", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "Chloride", "start": 8, "end": 16, "id": 1, "ws": true}, {"text": "Injection", "start": 17, "end": 26, "id": 2, "ws": false}, {"text": ",", "start": 26, "end": 27, "id": 3, "ws": true}, {"text": "USP", "start": 28, "end": 31, "id": 4, "ws": true}, {"text": "is", "start": 32, "end": 34, "id": 5, "ws": true}, {"text": "indicated", "start": 35, "end": 44, "id": 6, "ws": true}, {"text": "for", "start": 45, "end": 48, "id": 7, "ws": true}, {"text": "the", "start": 49, "end": 52, "id": 8, "ws": true}, {"text": "treatment", "start": 53, "end": 62, "id": 9, "ws": true}, {"text": "of", "start": 63, "end": 65, "id": 10, "ws": true}, {"text": "hypocalcemia", "start": 66, "end": 78, "id": 11, "ws": true}, {"text": "in", "start": 79, "end": 81, "id": 12, "ws": true}, {"text": "those", "start": 82, "end": 87, "id": 13, "ws": true}, {"text": "conditions", "start": 88, "end": 98, "id": 14, "ws": true}, {"text": "requiring", "start": 99, "end": 108, "id": 15, "ws": true}, {"text": "a", "start": 109, "end": 110, "id": 16, "ws": true}, {"text": "prompt", "start": 111, "end": 117, "id": 17, "ws": true}, {"text": "increase", "start": 118, "end": 126, "id": 18, "ws": true}, {"text": "in", "start": 127, "end": 129, "id": 19, "ws": true}, {"text": "plasma", "start": 130, "end": 136, "id": 20, "ws": true}, {"text": "calcium", "start": 137, "end": 144, "id": 21, "ws": true}, {"text": "levels", "start": 145, "end": 151, "id": 22, "ws": false}, {"text": ".", "start": 151, "end": 152, "id": 23, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 16, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 17, "end": 26, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 53, "end": 62, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 66, "end": 78, "token_start": 11, "token_end": 11, "label": "INDICATION"}, {"start": 88, "end": 151, "token_start": 14, "token_end": 22, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694528442, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "RELEXXII is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults (up to the age of 65 years) and pediatric patients 6 years of age and older [see Clinical Studies (14)]. RELEXXII is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults (up to the age of 65 years) and pediatric patients 6 years of age and older (1)", "_input_hash": 162157769, "_task_hash": 69543267, "_is_binary": false, "tokens": [{"text": "RELEXXII", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "treatment", "start": 30, "end": 39, "id": 5, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "Attention", "start": 43, "end": 52, "id": 7, "ws": true}, {"text": "Deficit", "start": 53, "end": 60, "id": 8, "ws": true}, {"text": "Hyperactivity", "start": 61, "end": 74, "id": 9, "ws": true}, {"text": "Disorder", "start": 75, "end": 83, "id": 10, "ws": true}, {"text": "(", "start": 84, "end": 85, "id": 11, "ws": false}, {"text": "ADHD", "start": 85, "end": 89, "id": 12, "ws": false}, {"text": ")", "start": 89, "end": 90, "id": 13, "ws": true}, {"text": "in", "start": 91, "end": 93, "id": 14, "ws": true}, {"text": "adults", "start": 94, "end": 100, "id": 15, "ws": true}, {"text": "(", "start": 101, "end": 102, "id": 16, "ws": false}, {"text": "up", "start": 102, "end": 104, "id": 17, "ws": true}, {"text": "to", "start": 105, "end": 107, "id": 18, "ws": true}, {"text": "the", "start": 108, "end": 111, "id": 19, "ws": true}, {"text": "age", "start": 112, "end": 115, "id": 20, "ws": true}, {"text": "of", "start": 116, "end": 118, "id": 21, "ws": true}, {"text": "65", "start": 119, "end": 121, "id": 22, "ws": true}, {"text": "years", "start": 122, "end": 127, "id": 23, "ws": false}, {"text": ")", "start": 127, "end": 128, "id": 24, "ws": true}, {"text": "and", "start": 129, "end": 132, "id": 25, "ws": true}, {"text": "pediatric", "start": 133, "end": 142, "id": 26, "ws": true}, {"text": "patients", "start": 143, "end": 151, "id": 27, "ws": true}, {"text": "6", "start": 152, "end": 153, "id": 28, "ws": true}, {"text": "years", "start": 154, "end": 159, "id": 29, "ws": true}, {"text": "of", "start": 160, "end": 162, "id": 30, "ws": true}, {"text": "age", "start": 163, "end": 166, "id": 31, "ws": true}, {"text": "and", "start": 167, "end": 170, "id": 32, "ws": true}, {"text": "older", "start": 171, "end": 176, "id": 33, "ws": true}, {"text": "[", "start": 177, "end": 178, "id": 34, "ws": false}, {"text": "see", "start": 178, "end": 181, "id": 35, "ws": true}, {"text": "Clinical", "start": 182, "end": 190, "id": 36, "ws": true}, {"text": "Studies", "start": 191, "end": 198, "id": 37, "ws": true}, {"text": "(", "start": 199, "end": 200, "id": 38, "ws": false}, {"text": "14", "start": 200, "end": 202, "id": 39, "ws": false}, {"text": ")", "start": 202, "end": 203, "id": 40, "ws": false}, {"text": "]", "start": 203, "end": 204, "id": 41, "ws": false}, {"text": ".", "start": 204, "end": 205, "id": 42, "ws": true}, {"text": "RELEXXII", "start": 206, "end": 214, "id": 43, "ws": true}, {"text": "is", "start": 215, "end": 217, "id": 44, "ws": true}, {"text": "a", "start": 218, "end": 219, "id": 45, "ws": true}, {"text": "central", "start": 220, "end": 227, "id": 46, "ws": true}, {"text": "nervous", "start": 228, "end": 235, "id": 47, "ws": true}, {"text": "system", "start": 236, "end": 242, "id": 48, "ws": true}, {"text": "(", "start": 243, "end": 244, "id": 49, "ws": false}, {"text": "CNS", "start": 244, "end": 247, "id": 50, "ws": false}, {"text": ")", "start": 247, "end": 248, "id": 51, "ws": true}, {"text": "stimulant", "start": 249, "end": 258, "id": 52, "ws": true}, {"text": "indicated", "start": 259, "end": 268, "id": 53, "ws": true}, {"text": "for", "start": 269, "end": 272, "id": 54, "ws": true}, {"text": "the", "start": 273, "end": 276, "id": 55, "ws": true}, {"text": "treatment", "start": 277, "end": 286, "id": 56, "ws": true}, {"text": "of", "start": 287, "end": 289, "id": 57, "ws": true}, {"text": "Attention", "start": 290, "end": 299, "id": 58, "ws": true}, {"text": "Deficit", "start": 300, "end": 307, "id": 59, "ws": true}, {"text": "Hyperactivity", "start": 308, "end": 321, "id": 60, "ws": true}, {"text": "Disorder", "start": 322, "end": 330, "id": 61, "ws": true}, {"text": "(", "start": 331, "end": 332, "id": 62, "ws": false}, {"text": "ADHD", "start": 332, "end": 336, "id": 63, "ws": false}, {"text": ")", "start": 336, "end": 337, "id": 64, "ws": true}, {"text": "in", "start": 338, "end": 340, "id": 65, "ws": true}, {"text": "adults", "start": 341, "end": 347, "id": 66, "ws": true}, {"text": "(", "start": 348, "end": 349, "id": 67, "ws": false}, {"text": "up", "start": 349, "end": 351, "id": 68, "ws": true}, {"text": "to", "start": 352, "end": 354, "id": 69, "ws": true}, {"text": "the", "start": 355, "end": 358, "id": 70, "ws": true}, {"text": "age", "start": 359, "end": 362, "id": 71, "ws": true}, {"text": "of", "start": 363, "end": 365, "id": 72, "ws": true}, {"text": "65", "start": 366, "end": 368, "id": 73, "ws": true}, {"text": "years", "start": 369, "end": 374, "id": 74, "ws": false}, {"text": ")", "start": 374, "end": 375, "id": 75, "ws": true}, {"text": "and", "start": 376, "end": 379, "id": 76, "ws": true}, {"text": "pediatric", "start": 380, "end": 389, "id": 77, "ws": true}, {"text": "patients", "start": 390, "end": 398, "id": 78, "ws": true}, {"text": "6", "start": 399, "end": 400, "id": 79, "ws": true}, {"text": "years", "start": 401, "end": 406, "id": 80, "ws": true}, {"text": "of", "start": 407, "end": 409, "id": 81, "ws": true}, {"text": "age", "start": 410, "end": 413, "id": 82, "ws": true}, {"text": "and", "start": 414, "end": 417, "id": 83, "ws": true}, {"text": "older", "start": 418, "end": 423, "id": 84, "ws": true}, {"text": "(", "start": 424, "end": 425, "id": 85, "ws": false}, {"text": "1", "start": 425, "end": 426, "id": 86, "ws": false}, {"text": ")", "start": 426, "end": 427, "id": 87, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 39, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 43, "end": 83, "token_start": 7, "token_end": 10, "label": "INDICATION"}, {"start": 94, "end": 128, "token_start": 15, "token_end": 24, "label": "TARGET_GROUP"}, {"start": 133, "end": 176, "token_start": 26, "token_end": 33, "label": "TARGET_GROUP"}, {"start": 206, "end": 214, "token_start": 43, "token_end": 43, "label": "DRUG"}, {"start": 218, "end": 258, "token_start": 45, "token_end": 52, "label": "MECHANISM"}, {"start": 277, "end": 289, "token_start": 56, "token_end": 57, "label": "ACTION"}, {"start": 290, "end": 337, "token_start": 58, "token_end": 64, "label": "INDICATION"}, {"start": 341, "end": 375, "token_start": 66, "token_end": 75, "label": "TARGET_GROUP"}, {"start": 380, "end": 423, "token_start": 77, "token_end": 84, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694175454, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Bivalirudin for injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Bivalirudin for injection is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS).(1)", "_input_hash": 418632809, "_task_hash": 257657828, "_is_binary": false, "tokens": [{"text": "Bivalirudin", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "for", "start": 12, "end": 15, "id": 1, "ws": true}, {"text": "injection", "start": 16, "end": 25, "id": 2, "ws": true}, {"text": "is", "start": 26, "end": 28, "id": 3, "ws": true}, {"text": "indicated", "start": 29, "end": 38, "id": 4, "ws": true}, {"text": "for", "start": 39, "end": 42, "id": 5, "ws": true}, {"text": "use", "start": 43, "end": 46, "id": 6, "ws": true}, {"text": "as", "start": 47, "end": 49, "id": 7, "ws": true}, {"text": "an", "start": 50, "end": 52, "id": 8, "ws": true}, {"text": "anticoagulant", "start": 53, "end": 66, "id": 9, "ws": true}, {"text": "for", "start": 67, "end": 70, "id": 10, "ws": true}, {"text": "use", "start": 71, "end": 74, "id": 11, "ws": true}, {"text": "in", "start": 75, "end": 77, "id": 12, "ws": true}, {"text": "patients", "start": 78, "end": 86, "id": 13, "ws": true}, {"text": "undergoing", "start": 87, "end": 97, "id": 14, "ws": true}, {"text": "percutaneous", "start": 98, "end": 110, "id": 15, "ws": true}, {"text": "coronary", "start": 111, "end": 119, "id": 16, "ws": true}, {"text": "intervention", "start": 120, "end": 132, "id": 17, "ws": true}, {"text": "(", "start": 133, "end": 134, "id": 18, "ws": false}, {"text": "PCI", "start": 134, "end": 137, "id": 19, "ws": false}, {"text": ")", "start": 137, "end": 138, "id": 20, "ws": true}, {"text": "including", "start": 139, "end": 148, "id": 21, "ws": true}, {"text": "patients", "start": 149, "end": 157, "id": 22, "ws": true}, {"text": "with", "start": 158, "end": 162, "id": 23, "ws": true}, {"text": "heparin", "start": 163, "end": 170, "id": 24, "ws": false}, {"text": "-", "start": 170, "end": 171, "id": 25, "ws": false}, {"text": "induced", "start": 171, "end": 178, "id": 26, "ws": true}, {"text": "thrombocytopenia", "start": 179, "end": 195, "id": 27, "ws": true}, {"text": "and", "start": 196, "end": 199, "id": 28, "ws": true}, {"text": "heparin", "start": 200, "end": 207, "id": 29, "ws": false}, {"text": "-", "start": 207, "end": 208, "id": 30, "ws": false}, {"text": "induced", "start": 208, "end": 215, "id": 31, "ws": true}, {"text": "thrombocytopenia", "start": 216, "end": 232, "id": 32, "ws": true}, {"text": "and", "start": 233, "end": 236, "id": 33, "ws": true}, {"text": "thrombosis", "start": 237, "end": 247, "id": 34, "ws": true}, {"text": "syndrome", "start": 248, "end": 256, "id": 35, "ws": false}, {"text": ".", "start": 256, "end": 257, "id": 36, "ws": true}, {"text": "Bivalirudin", "start": 258, "end": 269, "id": 37, "ws": true}, {"text": "for", "start": 270, "end": 273, "id": 38, "ws": true}, {"text": "injection", "start": 274, "end": 283, "id": 39, "ws": true}, {"text": "is", "start": 284, "end": 286, "id": 40, "ws": true}, {"text": "a", "start": 287, "end": 288, "id": 41, "ws": true}, {"text": "direct", "start": 289, "end": 295, "id": 42, "ws": true}, {"text": "thrombin", "start": 296, "end": 304, "id": 43, "ws": true}, {"text": "inhibitor", "start": 305, "end": 314, "id": 44, "ws": true}, {"text": "indicated", "start": 315, "end": 324, "id": 45, "ws": true}, {"text": "for", "start": 325, "end": 328, "id": 46, "ws": true}, {"text": "use", "start": 329, "end": 332, "id": 47, "ws": true}, {"text": "as", "start": 333, "end": 335, "id": 48, "ws": true}, {"text": "an", "start": 336, "end": 338, "id": 49, "ws": true}, {"text": "anticoagulant", "start": 339, "end": 352, "id": 50, "ws": true}, {"text": "in", "start": 353, "end": 355, "id": 51, "ws": true}, {"text": "patients", "start": 356, "end": 364, "id": 52, "ws": true}, {"text": "undergoing", "start": 365, "end": 375, "id": 53, "ws": true}, {"text": "percutaneous", "start": 376, "end": 388, "id": 54, "ws": true}, {"text": "coronary", "start": 389, "end": 397, "id": 55, "ws": true}, {"text": "intervention", "start": 398, "end": 410, "id": 56, "ws": true}, {"text": "(", "start": 411, "end": 412, "id": 57, "ws": false}, {"text": "PCI", "start": 412, "end": 415, "id": 58, "ws": false}, {"text": ")", "start": 415, "end": 416, "id": 59, "ws": true}, {"text": "including", "start": 417, "end": 426, "id": 60, "ws": true}, {"text": "patients", "start": 427, "end": 435, "id": 61, "ws": true}, {"text": "with", "start": 436, "end": 440, "id": 62, "ws": true}, {"text": "heparin", "start": 441, "end": 448, "id": 63, "ws": false}, {"text": "-", "start": 448, "end": 449, "id": 64, "ws": false}, {"text": "induced", "start": 449, "end": 456, "id": 65, "ws": true}, {"text": "thrombocytopenia", "start": 457, "end": 473, "id": 66, "ws": true}, {"text": "(", "start": 474, "end": 475, "id": 67, "ws": false}, {"text": "HIT", "start": 475, "end": 478, "id": 68, "ws": false}, {"text": ")", "start": 478, "end": 479, "id": 69, "ws": true}, {"text": "or", "start": 480, "end": 482, "id": 70, "ws": true}, {"text": "heparin", "start": 483, "end": 490, "id": 71, "ws": false}, {"text": "-", "start": 490, "end": 491, "id": 72, "ws": false}, {"text": "induced", "start": 491, "end": 498, "id": 73, "ws": true}, {"text": "thrombocytopenia", "start": 499, "end": 515, "id": 74, "ws": true}, {"text": "and", "start": 516, "end": 519, "id": 75, "ws": true}, {"text": "thrombosis", "start": 520, "end": 530, "id": 76, "ws": true}, {"text": "syndrome", "start": 531, "end": 539, "id": 77, "ws": true}, {"text": "(", "start": 540, "end": 541, "id": 78, "ws": false}, {"text": "HITTS).(1", "start": 541, "end": 550, "id": 79, "ws": false}, {"text": ")", "start": 550, "end": 551, "id": 80, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 16, "end": 25, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 43, "end": 46, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 53, "end": 66, "token_start": 9, "token_end": 9, "label": "EFFECT"}, {"start": 98, "end": 132, "token_start": 15, "token_end": 17, "label": "MEDICAL_CTX"}, {"start": 163, "end": 195, "token_start": 24, "token_end": 27, "label": "BASECONDITION"}, {"start": 200, "end": 232, "token_start": 29, "token_end": 32, "label": "BASECONDITION"}, {"start": 258, "end": 269, "token_start": 37, "token_end": 37, "label": "DRUG"}, {"start": 274, "end": 283, "token_start": 39, "token_end": 39, "label": "ROUTE"}, {"start": 296, "end": 314, "token_start": 43, "token_end": 44, "label": "MECHANISM"}, {"start": 339, "end": 352, "token_start": 50, "token_end": 50, "label": "EFFECT"}, {"start": 365, "end": 410, "token_start": 53, "token_end": 56, "label": "MEDICAL_CTX"}, {"start": 441, "end": 473, "token_start": 63, "token_end": 66, "label": "BASECONDITION"}, {"start": 483, "end": 515, "token_start": 71, "token_end": 74, "label": "BASECONDITION"}, {"start": 520, "end": 539, "token_start": 76, "token_end": 77, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694174740, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Metronidazole Topical Cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.", "_input_hash": 1760120455, "_task_hash": -1624619453, "_is_binary": false, "tokens": [{"text": "Metronidazole", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "Topical", "start": 14, "end": 21, "id": 1, "ws": true}, {"text": "Cream", "start": 22, "end": 27, "id": 2, "ws": true}, {"text": "is", "start": 28, "end": 30, "id": 3, "ws": true}, {"text": "indicated", "start": 31, "end": 40, "id": 4, "ws": true}, {"text": "for", "start": 41, "end": 44, "id": 5, "ws": true}, {"text": "topical", "start": 45, "end": 52, "id": 6, "ws": true}, {"text": "application", "start": 53, "end": 64, "id": 7, "ws": true}, {"text": "in", "start": 65, "end": 67, "id": 8, "ws": true}, {"text": "the", "start": 68, "end": 71, "id": 9, "ws": true}, {"text": "treatment", "start": 72, "end": 81, "id": 10, "ws": true}, {"text": "of", "start": 82, "end": 84, "id": 11, "ws": true}, {"text": "inflammatory", "start": 85, "end": 97, "id": 12, "ws": true}, {"text": "papules", "start": 98, "end": 105, "id": 13, "ws": true}, {"text": "and", "start": 106, "end": 109, "id": 14, "ws": true}, {"text": "pustules", "start": 110, "end": 118, "id": 15, "ws": true}, {"text": "of", "start": 119, "end": 121, "id": 16, "ws": true}, {"text": "rosacea", "start": 122, "end": 129, "id": 17, "ws": false}, {"text": ".", "start": 129, "end": 130, "id": 18, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 21, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 22, "end": 27, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 72, "end": 81, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 85, "end": 105, "token_start": 12, "token_end": 13, "label": "INDICATION"}, {"start": 110, "end": 129, "token_start": 15, "token_end": 17, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694176746, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "MARCAINE SPINAL is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia). MARCAINE SPINAL is an amide-local anesthetic indicated in adults for subarachnoid injection for the production of subarachnoid block (spinal anesthesia). (1)", "_input_hash": 243119007, "_task_hash": 1764959242, "_is_binary": false, "tokens": [{"text": "MARCAINE", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "SPINAL", "start": 9, "end": 15, "id": 1, "ws": true}, {"text": "is", "start": 16, "end": 18, "id": 2, "ws": true}, {"text": "indicated", "start": 19, "end": 28, "id": 3, "ws": true}, {"text": "for", "start": 29, "end": 32, "id": 4, "ws": true}, {"text": "subarachnoid", "start": 33, "end": 45, "id": 5, "ws": true}, {"text": "injection", "start": 46, "end": 55, "id": 6, "ws": true}, {"text": "in", "start": 56, "end": 58, "id": 7, "ws": true}, {"text": "adults", "start": 59, "end": 65, "id": 8, "ws": true}, {"text": "for", "start": 66, "end": 69, "id": 9, "ws": true}, {"text": "the", "start": 70, "end": 73, "id": 10, "ws": true}, {"text": "production", "start": 74, "end": 84, "id": 11, "ws": true}, {"text": "of", "start": 85, "end": 87, "id": 12, "ws": true}, {"text": "subarachnoid", "start": 88, "end": 100, "id": 13, "ws": true}, {"text": "block", "start": 101, "end": 106, "id": 14, "ws": true}, {"text": "(", "start": 107, "end": 108, "id": 15, "ws": false}, {"text": "spinal", "start": 108, "end": 114, "id": 16, "ws": true}, {"text": "anesthesia", "start": 115, "end": 125, "id": 17, "ws": false}, {"text": ")", "start": 125, "end": 126, "id": 18, "ws": false}, {"text": ".", "start": 126, "end": 127, "id": 19, "ws": true}, {"text": "MARCAINE", "start": 128, "end": 136, "id": 20, "ws": true}, {"text": "SPINAL", "start": 137, "end": 143, "id": 21, "ws": true}, {"text": "is", "start": 144, "end": 146, "id": 22, "ws": true}, {"text": "an", "start": 147, "end": 149, "id": 23, "ws": true}, {"text": "amide", "start": 150, "end": 155, "id": 24, "ws": false}, {"text": "-", "start": 155, "end": 156, "id": 25, "ws": false}, {"text": "local", "start": 156, "end": 161, "id": 26, "ws": true}, {"text": "anesthetic", "start": 162, "end": 172, "id": 27, "ws": true}, {"text": "indicated", "start": 173, "end": 182, "id": 28, "ws": true}, {"text": "in", "start": 183, "end": 185, "id": 29, "ws": true}, {"text": "adults", "start": 186, "end": 192, "id": 30, "ws": true}, {"text": "for", "start": 193, "end": 196, "id": 31, "ws": true}, {"text": "subarachnoid", "start": 197, "end": 209, "id": 32, "ws": true}, {"text": "injection", "start": 210, "end": 219, "id": 33, "ws": true}, {"text": "for", "start": 220, "end": 223, "id": 34, "ws": true}, {"text": "the", "start": 224, "end": 227, "id": 35, "ws": true}, {"text": "production", "start": 228, "end": 238, "id": 36, "ws": true}, {"text": "of", "start": 239, "end": 241, "id": 37, "ws": true}, {"text": "subarachnoid", "start": 242, "end": 254, "id": 38, "ws": true}, {"text": "block", "start": 255, "end": 260, "id": 39, "ws": true}, {"text": "(", "start": 261, "end": 262, "id": 40, "ws": false}, {"text": "spinal", "start": 262, "end": 268, "id": 41, "ws": true}, {"text": "anesthesia", "start": 269, "end": 279, "id": 42, "ws": false}, {"text": ")", "start": 279, "end": 280, "id": 43, "ws": false}, {"text": ".", "start": 280, "end": 281, "id": 44, "ws": true}, {"text": "(", "start": 282, "end": 283, "id": 45, "ws": false}, {"text": "1", "start": 283, "end": 284, "id": 46, "ws": false}, {"text": ")", "start": 284, "end": 285, "id": 47, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 33, "end": 45, "token_start": 5, "token_end": 5, "label": "ANATOMY"}, {"start": 46, "end": 55, "token_start": 6, "token_end": 6, "label": "ROUTE"}, {"start": 59, "end": 65, "token_start": 8, "token_end": 8, "label": "TARGET_GROUP"}, {"start": 74, "end": 106, "token_start": 11, "token_end": 14, "label": "EFFECT"}, {"start": 128, "end": 136, "token_start": 20, "token_end": 20, "label": "DRUG"}, {"start": 150, "end": 172, "token_start": 24, "token_end": 27, "label": "MECHANISM"}, {"start": 186, "end": 192, "token_start": 30, "token_end": 30, "label": "TARGET_GROUP"}, {"start": 197, "end": 209, "token_start": 32, "token_end": 32, "label": "ANATOMY"}, {"start": 210, "end": 219, "token_start": 33, "token_end": 33, "label": "ROUTE"}, {"start": 228, "end": 260, "token_start": 36, "token_end": 39, "label": "EFFECT"}], "answer": "accept", "_timestamp": 1694526910, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "CHANTIX is indicated for use as an aid to smoking cessation treatment. CHANTIX is a nicotinic receptor partial agonist indicated for use as an aid to smoking cessation treatment. (1 and 2.1)", "_input_hash": 311159244, "_task_hash": -1746611256, "_is_binary": false, "tokens": [{"text": "CHANTIX", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "use", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "as", "start": 29, "end": 31, "id": 5, "ws": true}, {"text": "an", "start": 32, "end": 34, "id": 6, "ws": true}, {"text": "aid", "start": 35, "end": 38, "id": 7, "ws": true}, {"text": "to", "start": 39, "end": 41, "id": 8, "ws": true}, {"text": "smoking", "start": 42, "end": 49, "id": 9, "ws": true}, {"text": "cessation", "start": 50, "end": 59, "id": 10, "ws": true}, {"text": "treatment", "start": 60, "end": 69, "id": 11, "ws": false}, {"text": ".", "start": 69, "end": 70, "id": 12, "ws": true}, {"text": "CHANTIX", "start": 71, "end": 78, "id": 13, "ws": true}, {"text": "is", "start": 79, "end": 81, "id": 14, "ws": true}, {"text": "a", "start": 82, "end": 83, "id": 15, "ws": true}, {"text": "nicotinic", "start": 84, "end": 93, "id": 16, "ws": true}, {"text": "receptor", "start": 94, "end": 102, "id": 17, "ws": true}, {"text": "partial", "start": 103, "end": 110, "id": 18, "ws": true}, {"text": "agonist", "start": 111, "end": 118, "id": 19, "ws": true}, {"text": "indicated", "start": 119, "end": 128, "id": 20, "ws": true}, {"text": "for", "start": 129, "end": 132, "id": 21, "ws": true}, {"text": "use", "start": 133, "end": 136, "id": 22, "ws": true}, {"text": "as", "start": 137, "end": 139, "id": 23, "ws": true}, {"text": "an", "start": 140, "end": 142, "id": 24, "ws": true}, {"text": "aid", "start": 143, "end": 146, "id": 25, "ws": true}, {"text": "to", "start": 147, "end": 149, "id": 26, "ws": true}, {"text": "smoking", "start": 150, "end": 157, "id": 27, "ws": true}, {"text": "cessation", "start": 158, "end": 167, "id": 28, "ws": true}, {"text": "treatment", "start": 168, "end": 177, "id": 29, "ws": false}, {"text": ".", "start": 177, "end": 178, "id": 30, "ws": true}, {"text": "(", "start": 179, "end": 180, "id": 31, "ws": false}, {"text": "1", "start": 180, "end": 181, "id": 32, "ws": true}, {"text": "and", "start": 182, "end": 185, "id": 33, "ws": true}, {"text": "2.1", "start": 186, "end": 189, "id": 34, "ws": false}, {"text": ")", "start": 189, "end": 190, "id": 35, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 25, "end": 28, "token_start": 4, "token_end": 4, "label": "ACTION"}, {"start": 42, "end": 59, "token_start": 9, "token_end": 10, "label": "EFFECT"}, {"start": 71, "end": 78, "token_start": 13, "token_end": 13, "label": "DRUG"}, {"start": 84, "end": 118, "token_start": 16, "token_end": 19, "label": "MECHANISM"}, {"start": 133, "end": 136, "token_start": 22, "token_end": 22, "label": "ACTION"}, {"start": 150, "end": 167, "token_start": 27, "token_end": 28, "label": "EFFECT"}], "answer": "accept", "_timestamp": 1694527788, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack.", "_input_hash": 1141533874, "_task_hash": 658398274, "_is_binary": false, "tokens": [{"text": "Transdermal", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "nitroglycerin", "start": 12, "end": 25, "id": 1, "ws": true}, {"text": "is", "start": 26, "end": 28, "id": 2, "ws": true}, {"text": "indicated", "start": 29, "end": 38, "id": 3, "ws": true}, {"text": "for", "start": 39, "end": 42, "id": 4, "ws": true}, {"text": "the", "start": 43, "end": 46, "id": 5, "ws": true}, {"text": "prevention", "start": 47, "end": 57, "id": 6, "ws": true}, {"text": "of", "start": 58, "end": 60, "id": 7, "ws": true}, {"text": "angina", "start": 61, "end": 67, "id": 8, "ws": true}, {"text": "pectoris", "start": 68, "end": 76, "id": 9, "ws": true}, {"text": "due", "start": 77, "end": 80, "id": 10, "ws": true}, {"text": "to", "start": 81, "end": 83, "id": 11, "ws": true}, {"text": "coronary", "start": 84, "end": 92, "id": 12, "ws": true}, {"text": "artery", "start": 93, "end": 99, "id": 13, "ws": true}, {"text": "disease", "start": 100, "end": 107, "id": 14, "ws": false}, {"text": ".", "start": 107, "end": 108, "id": 15, "ws": true}, {"text": "The", "start": 109, "end": 112, "id": 16, "ws": true}, {"text": "onset", "start": 113, "end": 118, "id": 17, "ws": true}, {"text": "of", "start": 119, "end": 121, "id": 18, "ws": true}, {"text": "action", "start": 122, "end": 128, "id": 19, "ws": true}, {"text": "of", "start": 129, "end": 131, "id": 20, "ws": true}, {"text": "transdermal", "start": 132, "end": 143, "id": 21, "ws": true}, {"text": "nitroglycerin", "start": 144, "end": 157, "id": 22, "ws": true}, {"text": "is", "start": 158, "end": 160, "id": 23, "ws": true}, {"text": "not", "start": 161, "end": 164, "id": 24, "ws": true}, {"text": "sufficiently", "start": 165, "end": 177, "id": 25, "ws": true}, {"text": "rapid", "start": 178, "end": 183, "id": 26, "ws": true}, {"text": "for", "start": 184, "end": 187, "id": 27, "ws": true}, {"text": "this", "start": 188, "end": 192, "id": 28, "ws": true}, {"text": "product", "start": 193, "end": 200, "id": 29, "ws": true}, {"text": "to", "start": 201, "end": 203, "id": 30, "ws": true}, {"text": "be", "start": 204, "end": 206, "id": 31, "ws": true}, {"text": "useful", "start": 207, "end": 213, "id": 32, "ws": true}, {"text": "in", "start": 214, "end": 216, "id": 33, "ws": true}, {"text": "aborting", "start": 217, "end": 225, "id": 34, "ws": true}, {"text": "an", "start": 226, "end": 228, "id": 35, "ws": true}, {"text": "acute", "start": 229, "end": 234, "id": 36, "ws": true}, {"text": "attack", "start": 235, "end": 241, "id": 37, "ws": false}, {"text": ".", "start": 241, "end": 242, "id": 38, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "ROUTE"}, {"start": 12, "end": 25, "token_start": 1, "token_end": 1, "label": "DRUG"}, {"start": 47, "end": 57, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 61, "end": 76, "token_start": 8, "token_end": 9, "label": "INDICATION"}, {"start": 84, "end": 107, "token_start": 12, "token_end": 14, "label": "BASECONDITION"}, {"start": 132, "end": 143, "token_start": 21, "token_end": 21, "label": "ROUTE"}, {"start": 144, "end": 157, "token_start": 22, "token_end": 22, "label": "DRUG"}], "answer": "accept", "_timestamp": 1694528322, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Didanosine delayed-release capsules, also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infection [see Clinical Studies (14)]. Didanosine delayed-release capsules are a nucleoside reverse transcriptase inhibitor for use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV)-1 infection. (1)", "_input_hash": 125311645, "_task_hash": 825258231, "_is_binary": false, "tokens": [{"text": "Didanosine", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "delayed", "start": 11, "end": 18, "id": 1, "ws": false}, {"text": "-", "start": 18, "end": 19, "id": 2, "ws": false}, {"text": "release", "start": 19, "end": 26, "id": 3, "ws": true}, {"text": "capsules", "start": 27, "end": 35, "id": 4, "ws": false}, {"text": ",", "start": 35, "end": 36, "id": 5, "ws": true}, {"text": "also", "start": 37, "end": 41, "id": 6, "ws": true}, {"text": "known", "start": 42, "end": 47, "id": 7, "ws": true}, {"text": "as", "start": 48, "end": 50, "id": 8, "ws": true}, {"text": "ddI", "start": 51, "end": 54, "id": 9, "ws": false}, {"text": ",", "start": 54, "end": 55, "id": 10, "ws": true}, {"text": "in", "start": 56, "end": 58, "id": 11, "ws": true}, {"text": "combination", "start": 59, "end": 70, "id": 12, "ws": true}, {"text": "with", "start": 71, "end": 75, "id": 13, "ws": true}, {"text": "other", "start": 76, "end": 81, "id": 14, "ws": true}, {"text": "antiretroviral", "start": 82, "end": 96, "id": 15, "ws": true}, {"text": "agents", "start": 97, "end": 103, "id": 16, "ws": true}, {"text": "is", "start": 104, "end": 106, "id": 17, "ws": true}, {"text": "indicated", "start": 107, "end": 116, "id": 18, "ws": true}, {"text": "for", "start": 117, "end": 120, "id": 19, "ws": true}, {"text": "the", "start": 121, "end": 124, "id": 20, "ws": true}, {"text": "treatment", "start": 125, "end": 134, "id": 21, "ws": true}, {"text": "of", "start": 135, "end": 137, "id": 22, "ws": true}, {"text": "human", "start": 138, "end": 143, "id": 23, "ws": true}, {"text": "immunodeficiency", "start": 144, "end": 160, "id": 24, "ws": true}, {"text": "virus", "start": 161, "end": 166, "id": 25, "ws": true}, {"text": "(", "start": 167, "end": 168, "id": 26, "ws": false}, {"text": "HIV)-1", "start": 168, "end": 174, "id": 27, "ws": true}, {"text": "infection", "start": 175, "end": 184, "id": 28, "ws": true}, {"text": "[", "start": 185, "end": 186, "id": 29, "ws": false}, {"text": "see", "start": 186, "end": 189, "id": 30, "ws": true}, {"text": "Clinical", "start": 190, "end": 198, "id": 31, "ws": true}, {"text": "Studies", "start": 199, "end": 206, "id": 32, "ws": true}, {"text": "(", "start": 207, "end": 208, "id": 33, "ws": false}, {"text": "14", "start": 208, "end": 210, "id": 34, "ws": false}, {"text": ")", "start": 210, "end": 211, "id": 35, "ws": false}, {"text": "]", "start": 211, "end": 212, "id": 36, "ws": false}, {"text": ".", "start": 212, "end": 213, "id": 37, "ws": true}, {"text": "Didanosine", "start": 214, "end": 224, "id": 38, "ws": true}, {"text": "delayed", "start": 225, "end": 232, "id": 39, "ws": false}, {"text": "-", "start": 232, "end": 233, "id": 40, "ws": false}, {"text": "release", "start": 233, "end": 240, "id": 41, "ws": true}, {"text": "capsules", "start": 241, "end": 249, "id": 42, "ws": true}, {"text": "are", "start": 250, "end": 253, "id": 43, "ws": true}, {"text": "a", "start": 254, "end": 255, "id": 44, "ws": true}, {"text": "nucleoside", "start": 256, "end": 266, "id": 45, "ws": true}, {"text": "reverse", "start": 267, "end": 274, "id": 46, "ws": true}, {"text": "transcriptase", "start": 275, "end": 288, "id": 47, "ws": true}, {"text": "inhibitor", "start": 289, "end": 298, "id": 48, "ws": true}, {"text": "for", "start": 299, "end": 302, "id": 49, "ws": true}, {"text": "use", "start": 303, "end": 306, "id": 50, "ws": true}, {"text": "in", "start": 307, "end": 309, "id": 51, "ws": true}, {"text": "combination", "start": 310, "end": 321, "id": 52, "ws": true}, {"text": "with", "start": 322, "end": 326, "id": 53, "ws": true}, {"text": "other", "start": 327, "end": 332, "id": 54, "ws": true}, {"text": "antiretroviral", "start": 333, "end": 347, "id": 55, "ws": true}, {"text": "agents", "start": 348, "end": 354, "id": 56, "ws": true}, {"text": "for", "start": 355, "end": 358, "id": 57, "ws": true}, {"text": "the", "start": 359, "end": 362, "id": 58, "ws": true}, {"text": "treatment", "start": 363, "end": 372, "id": 59, "ws": true}, {"text": "of", "start": 373, "end": 375, "id": 60, "ws": true}, {"text": "human", "start": 376, "end": 381, "id": 61, "ws": true}, {"text": "immunodeficiency", "start": 382, "end": 398, "id": 62, "ws": true}, {"text": "virus", "start": 399, "end": 404, "id": 63, "ws": true}, {"text": "(", "start": 405, "end": 406, "id": 64, "ws": false}, {"text": "HIV)-1", "start": 406, "end": 412, "id": 65, "ws": true}, {"text": "infection", "start": 413, "end": 422, "id": 66, "ws": false}, {"text": ".", "start": 422, "end": 423, "id": 67, "ws": true}, {"text": "(", "start": 424, "end": 425, "id": 68, "ws": false}, {"text": "1", "start": 425, "end": 426, "id": 69, "ws": false}, {"text": ")", "start": 426, "end": 427, "id": 70, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 35, "token_start": 1, "token_end": 4, "label": "FORMULATION"}, {"start": 56, "end": 103, "token_start": 11, "token_end": 16, "label": "CO_PRESCRIPTION"}, {"start": 125, "end": 134, "token_start": 21, "token_end": 21, "label": "ACTION"}, {"start": 138, "end": 184, "token_start": 23, "token_end": 28, "label": "INDICATION"}, {"start": 214, "end": 224, "token_start": 38, "token_end": 38, "label": "DRUG"}, {"start": 225, "end": 249, "token_start": 39, "token_end": 42, "label": "FORMULATION"}, {"start": 256, "end": 298, "token_start": 45, "token_end": 48, "label": "MECHANISM"}, {"start": 310, "end": 354, "token_start": 52, "token_end": 56, "label": "CO_PRESCRIPTION"}, {"start": 363, "end": 372, "token_start": 59, "token_end": 59, "label": "ACTION"}, {"start": 376, "end": 422, "token_start": 61, "token_end": 66, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694528094, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "VERMOX CHEWABLE is indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm). VERMOX CHEWABLE is an anthelmintic indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by: Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm) (1).", "_input_hash": -1796816550, "_task_hash": -1605072743, "_is_binary": false, "tokens": [{"text": "VERMOX", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "CHEWABLE", "start": 7, "end": 15, "id": 1, "ws": true}, {"text": "is", "start": 16, "end": 18, "id": 2, "ws": true}, {"text": "indicated", "start": 19, "end": 28, "id": 3, "ws": true}, {"text": "for", "start": 29, "end": 32, "id": 4, "ws": true}, {"text": "the", "start": 33, "end": 36, "id": 5, "ws": true}, {"text": "treatment", "start": 37, "end": 46, "id": 6, "ws": true}, {"text": "of", "start": 47, "end": 49, "id": 7, "ws": true}, {"text": "patients", "start": 50, "end": 58, "id": 8, "ws": true}, {"text": "one", "start": 59, "end": 62, "id": 9, "ws": true}, {"text": "year", "start": 63, "end": 67, "id": 10, "ws": true}, {"text": "of", "start": 68, "end": 70, "id": 11, "ws": true}, {"text": "age", "start": 71, "end": 74, "id": 12, "ws": true}, {"text": "and", "start": 75, "end": 78, "id": 13, "ws": true}, {"text": "older", "start": 79, "end": 84, "id": 14, "ws": true}, {"text": "with", "start": 85, "end": 89, "id": 15, "ws": true}, {"text": "gastrointestinal", "start": 90, "end": 106, "id": 16, "ws": true}, {"text": "infections", "start": 107, "end": 117, "id": 17, "ws": true}, {"text": "caused", "start": 118, "end": 124, "id": 18, "ws": true}, {"text": "by", "start": 125, "end": 127, "id": 19, "ws": true}, {"text": "Ascaris", "start": 128, "end": 135, "id": 20, "ws": true}, {"text": "lumbricoides", "start": 136, "end": 148, "id": 21, "ws": true}, {"text": "(", "start": 149, "end": 150, "id": 22, "ws": false}, {"text": "roundworm", "start": 150, "end": 159, "id": 23, "ws": false}, {"text": ")", "start": 159, "end": 160, "id": 24, "ws": true}, {"text": "and", "start": 161, "end": 164, "id": 25, "ws": true}, {"text": "Trichuris", "start": 165, "end": 174, "id": 26, "ws": true}, {"text": "trichiura", "start": 175, "end": 184, "id": 27, "ws": true}, {"text": "(", "start": 185, "end": 186, "id": 28, "ws": false}, {"text": "whipworm", "start": 186, "end": 194, "id": 29, "ws": false}, {"text": ")", "start": 194, "end": 195, "id": 30, "ws": false}, {"text": ".", "start": 195, "end": 196, "id": 31, "ws": true}, {"text": "VERMOX", "start": 197, "end": 203, "id": 32, "ws": true}, {"text": "CHEWABLE", "start": 204, "end": 212, "id": 33, "ws": true}, {"text": "is", "start": 213, "end": 215, "id": 34, "ws": true}, {"text": "an", "start": 216, "end": 218, "id": 35, "ws": true}, {"text": "anthelmintic", "start": 219, "end": 231, "id": 36, "ws": true}, {"text": "indicated", "start": 232, "end": 241, "id": 37, "ws": true}, {"text": "for", "start": 242, "end": 245, "id": 38, "ws": true}, {"text": "the", "start": 246, "end": 249, "id": 39, "ws": true}, {"text": "treatment", "start": 250, "end": 259, "id": 40, "ws": true}, {"text": "of", "start": 260, "end": 262, "id": 41, "ws": true}, {"text": "patients", "start": 263, "end": 271, "id": 42, "ws": true}, {"text": "one", "start": 272, "end": 275, "id": 43, "ws": true}, {"text": "year", "start": 276, "end": 280, "id": 44, "ws": true}, {"text": "of", "start": 281, "end": 283, "id": 45, "ws": true}, {"text": "age", "start": 284, "end": 287, "id": 46, "ws": true}, {"text": "and", "start": 288, "end": 291, "id": 47, "ws": true}, {"text": "older", "start": 292, "end": 297, "id": 48, "ws": true}, {"text": "with", "start": 298, "end": 302, "id": 49, "ws": true}, {"text": "gastrointestinal", "start": 303, "end": 319, "id": 50, "ws": true}, {"text": "infections", "start": 320, "end": 330, "id": 51, "ws": true}, {"text": "caused", "start": 331, "end": 337, "id": 52, "ws": true}, {"text": "by", "start": 338, "end": 340, "id": 53, "ws": false}, {"text": ":", "start": 340, "end": 341, "id": 54, "ws": true}, {"text": "Ascaris", "start": 342, "end": 349, "id": 55, "ws": true}, {"text": "lumbricoides", "start": 350, "end": 362, "id": 56, "ws": true}, {"text": "(", "start": 363, "end": 364, "id": 57, "ws": false}, {"text": "roundworm", "start": 364, "end": 373, "id": 58, "ws": false}, {"text": ")", "start": 373, "end": 374, "id": 59, "ws": true}, {"text": "and", "start": 375, "end": 378, "id": 60, "ws": true}, {"text": "Trichuris", "start": 379, "end": 388, "id": 61, "ws": true}, {"text": "trichiura", "start": 389, "end": 398, "id": 62, "ws": true}, {"text": "(", "start": 399, "end": 400, "id": 63, "ws": false}, {"text": "whipworm", "start": 400, "end": 408, "id": 64, "ws": false}, {"text": ")", "start": 408, "end": 409, "id": 65, "ws": true}, {"text": "(", "start": 410, "end": 411, "id": 66, "ws": false}, {"text": "1", "start": 411, "end": 412, "id": 67, "ws": false}, {"text": ")", "start": 412, "end": 413, "id": 68, "ws": false}, {"text": ".", "start": 413, "end": 414, "id": 69, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 7, "end": 15, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 37, "end": 46, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 50, "end": 84, "token_start": 8, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 90, "end": 117, "token_start": 16, "token_end": 17, "label": "CO_MORBIDITY"}, {"start": 128, "end": 160, "token_start": 20, "token_end": 24, "label": "CAUSED_BY"}, {"start": 165, "end": 195, "token_start": 26, "token_end": 30, "label": "CAUSED_BY"}, {"start": 219, "end": 231, "token_start": 36, "token_end": 36, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694525770, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Citalopram Capsules are indicated for the treatment of Major Depressive Disorder (MDD) in adults [see Clinical Studies (14)]. Citalopram Capsules is a selective serotonin reuptake inhibitor (SSRI) indicated for treatment of Major Depressive Disorder (MDD) in adults. (1)", "_input_hash": -1755746218, "_task_hash": 1019898186, "_is_binary": false, "tokens": [{"text": "Citalopram", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "Capsules", "start": 11, "end": 19, "id": 1, "ws": true}, {"text": "are", "start": 20, "end": 23, "id": 2, "ws": true}, {"text": "indicated", "start": 24, "end": 33, "id": 3, "ws": true}, {"text": "for", "start": 34, "end": 37, "id": 4, "ws": true}, {"text": "the", "start": 38, "end": 41, "id": 5, "ws": true}, {"text": "treatment", "start": 42, "end": 51, "id": 6, "ws": true}, {"text": "of", "start": 52, "end": 54, "id": 7, "ws": true}, {"text": "Major", "start": 55, "end": 60, "id": 8, "ws": true}, {"text": "Depressive", "start": 61, "end": 71, "id": 9, "ws": true}, {"text": "Disorder", "start": 72, "end": 80, "id": 10, "ws": true}, {"text": "(", "start": 81, "end": 82, "id": 11, "ws": false}, {"text": "MDD", "start": 82, "end": 85, "id": 12, "ws": false}, {"text": ")", "start": 85, "end": 86, "id": 13, "ws": true}, {"text": "in", "start": 87, "end": 89, "id": 14, "ws": true}, {"text": "adults", "start": 90, "end": 96, "id": 15, "ws": true}, {"text": "[", "start": 97, "end": 98, "id": 16, "ws": false}, {"text": "see", "start": 98, "end": 101, "id": 17, "ws": true}, {"text": "Clinical", "start": 102, "end": 110, "id": 18, "ws": true}, {"text": "Studies", "start": 111, "end": 118, "id": 19, "ws": true}, {"text": "(", "start": 119, "end": 120, "id": 20, "ws": false}, {"text": "14", "start": 120, "end": 122, "id": 21, "ws": false}, {"text": ")", "start": 122, "end": 123, "id": 22, "ws": false}, {"text": "]", "start": 123, "end": 124, "id": 23, "ws": false}, {"text": ".", "start": 124, "end": 125, "id": 24, "ws": true}, {"text": "Citalopram", "start": 126, "end": 136, "id": 25, "ws": true}, {"text": "Capsules", "start": 137, "end": 145, "id": 26, "ws": true}, {"text": "is", "start": 146, "end": 148, "id": 27, "ws": true}, {"text": "a", "start": 149, "end": 150, "id": 28, "ws": true}, {"text": "selective", "start": 151, "end": 160, "id": 29, "ws": true}, {"text": "serotonin", "start": 161, "end": 170, "id": 30, "ws": true}, {"text": "reuptake", "start": 171, "end": 179, "id": 31, "ws": true}, {"text": "inhibitor", "start": 180, "end": 189, "id": 32, "ws": true}, {"text": "(", "start": 190, "end": 191, "id": 33, "ws": false}, {"text": "SSRI", "start": 191, "end": 195, "id": 34, "ws": false}, {"text": ")", "start": 195, "end": 196, "id": 35, "ws": true}, {"text": "indicated", "start": 197, "end": 206, "id": 36, "ws": true}, {"text": "for", "start": 207, "end": 210, "id": 37, "ws": true}, {"text": "treatment", "start": 211, "end": 220, "id": 38, "ws": true}, {"text": "of", "start": 221, "end": 223, "id": 39, "ws": true}, {"text": "Major", "start": 224, "end": 229, "id": 40, "ws": true}, {"text": "Depressive", "start": 230, "end": 240, "id": 41, "ws": true}, {"text": "Disorder", "start": 241, "end": 249, "id": 42, "ws": true}, {"text": "(", "start": 250, "end": 251, "id": 43, "ws": false}, {"text": "MDD", "start": 251, "end": 254, "id": 44, "ws": false}, {"text": ")", "start": 254, "end": 255, "id": 45, "ws": true}, {"text": "in", "start": 256, "end": 258, "id": 46, "ws": true}, {"text": "adults", "start": 259, "end": 265, "id": 47, "ws": false}, {"text": ".", "start": 265, "end": 266, "id": 48, "ws": true}, {"text": "(", "start": 267, "end": 268, "id": 49, "ws": false}, {"text": "1", "start": 268, "end": 269, "id": 50, "ws": false}, {"text": ")", "start": 269, "end": 270, "id": 51, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 19, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 42, "end": 54, "token_start": 6, "token_end": 7, "label": "ACTION"}, {"start": 55, "end": 80, "token_start": 8, "token_end": 10, "label": "INDICATION"}, {"start": 90, "end": 96, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 126, "end": 136, "token_start": 25, "token_end": 25, "label": "DRUG"}, {"start": 137, "end": 145, "token_start": 26, "token_end": 26, "label": "FORMULATION"}, {"start": 211, "end": 223, "token_start": 38, "token_end": 39, "label": "ACTION"}, {"start": 224, "end": 249, "token_start": 40, "token_end": 42, "label": "INDICATION"}, {"start": 259, "end": 265, "token_start": 47, "token_end": 47, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694174767, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "BASAGLAR is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. BASAGLAR is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. (1) Limitations of Use:Not recommended for treating diabetic ketoacidosis. (1) Limitations of Use BASAGLAR is not recommended for the treatment of diabetic ketoacidosis.", "_input_hash": -1743983958, "_task_hash": -765029966, "_is_binary": false, "tokens": [{"text": "BASAGLAR", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "to", "start": 22, "end": 24, "id": 3, "ws": true}, {"text": "improve", "start": 25, "end": 32, "id": 4, "ws": true}, {"text": "glycemic", "start": 33, "end": 41, "id": 5, "ws": true}, {"text": "control", "start": 42, "end": 49, "id": 6, "ws": true}, {"text": "in", "start": 50, "end": 52, "id": 7, "ws": true}, {"text": "adults", "start": 53, "end": 59, "id": 8, "ws": true}, {"text": "and", "start": 60, "end": 63, "id": 9, "ws": true}, {"text": "pediatric", "start": 64, "end": 73, "id": 10, "ws": true}, {"text": "patients", "start": 74, "end": 82, "id": 11, "ws": true}, {"text": "with", "start": 83, "end": 87, "id": 12, "ws": true}, {"text": "type", "start": 88, "end": 92, "id": 13, "ws": true}, {"text": "1", "start": 93, "end": 94, "id": 14, "ws": true}, {"text": "diabetes", "start": 95, "end": 103, "id": 15, "ws": true}, {"text": "mellitus", "start": 104, "end": 112, "id": 16, "ws": true}, {"text": "and", "start": 113, "end": 116, "id": 17, "ws": true}, {"text": "in", "start": 117, "end": 119, "id": 18, "ws": true}, {"text": "adults", "start": 120, "end": 126, "id": 19, "ws": true}, {"text": "with", "start": 127, "end": 131, "id": 20, "ws": true}, {"text": "type", "start": 132, "end": 136, "id": 21, "ws": true}, {"text": "2", "start": 137, "end": 138, "id": 22, "ws": true}, {"text": "diabetes", "start": 139, "end": 147, "id": 23, "ws": true}, {"text": "mellitus", "start": 148, "end": 156, "id": 24, "ws": false}, {"text": ".", "start": 156, "end": 157, "id": 25, "ws": true}, {"text": "BASAGLAR", "start": 158, "end": 166, "id": 26, "ws": true}, {"text": "is", "start": 167, "end": 169, "id": 27, "ws": true}, {"text": "a", "start": 170, "end": 171, "id": 28, "ws": true}, {"text": "long", "start": 172, "end": 176, "id": 29, "ws": false}, {"text": "-", "start": 176, "end": 177, "id": 30, "ws": false}, {"text": "acting", "start": 177, "end": 183, "id": 31, "ws": true}, {"text": "human", "start": 184, "end": 189, "id": 32, "ws": true}, {"text": "insulin", "start": 190, "end": 197, "id": 33, "ws": true}, {"text": "analog", "start": 198, "end": 204, "id": 34, "ws": true}, {"text": "indicated", "start": 205, "end": 214, "id": 35, "ws": true}, {"text": "to", "start": 215, "end": 217, "id": 36, "ws": true}, {"text": "improve", "start": 218, "end": 225, "id": 37, "ws": true}, {"text": "glycemic", "start": 226, "end": 234, "id": 38, "ws": true}, {"text": "control", "start": 235, "end": 242, "id": 39, "ws": true}, {"text": "in", "start": 243, "end": 245, "id": 40, "ws": true}, {"text": "adults", "start": 246, "end": 252, "id": 41, "ws": true}, {"text": "and", "start": 253, "end": 256, "id": 42, "ws": true}, {"text": "pediatric", "start": 257, "end": 266, "id": 43, "ws": true}, {"text": "patients", "start": 267, "end": 275, "id": 44, "ws": true}, {"text": "with", "start": 276, "end": 280, "id": 45, "ws": true}, {"text": "type", "start": 281, "end": 285, "id": 46, "ws": true}, {"text": "1", "start": 286, "end": 287, "id": 47, "ws": true}, {"text": "diabetes", "start": 288, "end": 296, "id": 48, "ws": true}, {"text": "mellitus", "start": 297, "end": 305, "id": 49, "ws": true}, {"text": "and", "start": 306, "end": 309, "id": 50, "ws": true}, {"text": "in", "start": 310, "end": 312, "id": 51, "ws": true}, {"text": "adults", "start": 313, "end": 319, "id": 52, "ws": true}, {"text": "with", "start": 320, "end": 324, "id": 53, "ws": true}, {"text": "type", "start": 325, "end": 329, "id": 54, "ws": true}, {"text": "2", "start": 330, "end": 331, "id": 55, "ws": true}, {"text": "diabetes", "start": 332, "end": 340, "id": 56, "ws": true}, {"text": "mellitus", "start": 341, "end": 349, "id": 57, "ws": false}, {"text": ".", "start": 349, "end": 350, "id": 58, "ws": true}, {"text": "(", "start": 351, "end": 352, "id": 59, "ws": false}, {"text": "1", "start": 352, "end": 353, "id": 60, "ws": false}, {"text": ")", "start": 353, "end": 354, "id": 61, "ws": true}, {"text": "Limitations", "start": 355, "end": 366, "id": 62, "ws": true}, {"text": "of", "start": 367, "end": 369, "id": 63, "ws": true}, {"text": "Use", "start": 370, "end": 373, "id": 64, "ws": false}, {"text": ":", "start": 373, "end": 374, "id": 65, "ws": false}, {"text": "Not", "start": 374, "end": 377, "id": 66, "ws": true}, {"text": "recommended", "start": 378, "end": 389, "id": 67, "ws": true}, {"text": "for", "start": 390, "end": 393, "id": 68, "ws": true}, {"text": "treating", "start": 394, "end": 402, "id": 69, "ws": true}, {"text": "diabetic", "start": 403, "end": 411, "id": 70, "ws": true}, {"text": "ketoacidosis", "start": 412, "end": 424, "id": 71, "ws": false}, {"text": ".", "start": 424, "end": 425, "id": 72, "ws": true}, {"text": "(", "start": 426, "end": 427, "id": 73, "ws": false}, {"text": "1", "start": 427, "end": 428, "id": 74, "ws": false}, {"text": ")", "start": 428, "end": 429, "id": 75, "ws": true}, {"text": "Limitations", "start": 430, "end": 441, "id": 76, "ws": true}, {"text": "of", "start": 442, "end": 444, "id": 77, "ws": true}, {"text": "Use", "start": 445, "end": 448, "id": 78, "ws": true}, {"text": "BASAGLAR", "start": 449, "end": 457, "id": 79, "ws": true}, {"text": "is", "start": 458, "end": 460, "id": 80, "ws": true}, {"text": "not", "start": 461, "end": 464, "id": 81, "ws": true}, {"text": "recommended", "start": 465, "end": 476, "id": 82, "ws": true}, {"text": "for", "start": 477, "end": 480, "id": 83, "ws": true}, {"text": "the", "start": 481, "end": 484, "id": 84, "ws": true}, {"text": "treatment", "start": 485, "end": 494, "id": 85, "ws": true}, {"text": "of", "start": 495, "end": 497, "id": 86, "ws": true}, {"text": "diabetic", "start": 498, "end": 506, "id": 87, "ws": true}, {"text": "ketoacidosis", "start": 507, "end": 519, "id": 88, "ws": false}, {"text": ".", "start": 519, "end": 520, "id": 89, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 25, "end": 49, "token_start": 4, "token_end": 6, "label": "EFFECT"}, {"start": 53, "end": 59, "token_start": 8, "token_end": 8, "label": "TARGET_GROUP"}, {"start": 64, "end": 82, "token_start": 10, "token_end": 11, "label": "TARGET_GROUP"}, {"start": 88, "end": 112, "token_start": 13, "token_end": 16, "label": "BASECONDITION"}, {"start": 120, "end": 126, "token_start": 19, "token_end": 19, "label": "TARGET_GROUP"}, {"start": 132, "end": 156, "token_start": 21, "token_end": 24, "label": "BASECONDITION"}, {"start": 158, "end": 166, "token_start": 26, "token_end": 26, "label": "DRUG"}, {"start": 184, "end": 204, "token_start": 32, "token_end": 34, "label": "MECHANISM"}, {"start": 218, "end": 242, "token_start": 37, "token_end": 39, "label": "EFFECT"}, {"start": 246, "end": 252, "token_start": 41, "token_end": 41, "label": "TARGET_GROUP"}, {"start": 257, "end": 275, "token_start": 43, "token_end": 44, "label": "TARGET_GROUP"}, {"start": 281, "end": 305, "token_start": 46, "token_end": 49, "label": "BASECONDITION"}, {"start": 313, "end": 319, "token_start": 52, "token_end": 52, "label": "TARGET_GROUP"}, {"start": 325, "end": 349, "token_start": 54, "token_end": 57, "label": "BASECONDITION"}, {"start": 374, "end": 424, "token_start": 66, "token_end": 71, "label": "CONTRAINDICATION"}, {"start": 449, "end": 519, "token_start": 79, "token_end": 88, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694527768, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Sotradecol (sodium tetradecyl sulfate injection) is indicated in the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves. The benefit-to-risk ratio should be considered in selected patients who are great surgical risks.", "_input_hash": 415689388, "_task_hash": 2955866, "_is_binary": false, "tokens": [{"text": "Sotradecol", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "(", "start": 11, "end": 12, "id": 1, "ws": false}, {"text": "sodium", "start": 12, "end": 18, "id": 2, "ws": true}, {"text": "tetradecyl", "start": 19, "end": 29, "id": 3, "ws": true}, {"text": "sulfate", "start": 30, "end": 37, "id": 4, "ws": true}, {"text": "injection", "start": 38, "end": 47, "id": 5, "ws": false}, {"text": ")", "start": 47, "end": 48, "id": 6, "ws": true}, {"text": "is", "start": 49, "end": 51, "id": 7, "ws": true}, {"text": "indicated", "start": 52, "end": 61, "id": 8, "ws": true}, {"text": "in", "start": 62, "end": 64, "id": 9, "ws": true}, {"text": "the", "start": 65, "end": 68, "id": 10, "ws": true}, {"text": "treatment", "start": 69, "end": 78, "id": 11, "ws": true}, {"text": "of", "start": 79, "end": 81, "id": 12, "ws": true}, {"text": "small", "start": 82, "end": 87, "id": 13, "ws": true}, {"text": "uncomplicated", "start": 88, "end": 101, "id": 14, "ws": true}, {"text": "varicose", "start": 102, "end": 110, "id": 15, "ws": true}, {"text": "veins", "start": 111, "end": 116, "id": 16, "ws": true}, {"text": "of", "start": 117, "end": 119, "id": 17, "ws": true}, {"text": "the", "start": 120, "end": 123, "id": 18, "ws": true}, {"text": "lower", "start": 124, "end": 129, "id": 19, "ws": true}, {"text": "extremities", "start": 130, "end": 141, "id": 20, "ws": true}, {"text": "that", "start": 142, "end": 146, "id": 21, "ws": true}, {"text": "show", "start": 147, "end": 151, "id": 22, "ws": true}, {"text": "simple", "start": 152, "end": 158, "id": 23, "ws": true}, {"text": "dilation", "start": 159, "end": 167, "id": 24, "ws": true}, {"text": "with", "start": 168, "end": 172, "id": 25, "ws": true}, {"text": "competent", "start": 173, "end": 182, "id": 26, "ws": true}, {"text": "valves", "start": 183, "end": 189, "id": 27, "ws": false}, {"text": ".", "start": 189, "end": 190, "id": 28, "ws": true}, {"text": "The", "start": 191, "end": 194, "id": 29, "ws": true}, {"text": "benefit", "start": 195, "end": 202, "id": 30, "ws": false}, {"text": "-", "start": 202, "end": 203, "id": 31, "ws": false}, {"text": "to", "start": 203, "end": 205, "id": 32, "ws": false}, {"text": "-", "start": 205, "end": 206, "id": 33, "ws": false}, {"text": "risk", "start": 206, "end": 210, "id": 34, "ws": true}, {"text": "ratio", "start": 211, "end": 216, "id": 35, "ws": true}, {"text": "should", "start": 217, "end": 223, "id": 36, "ws": true}, {"text": "be", "start": 224, "end": 226, "id": 37, "ws": true}, {"text": "considered", "start": 227, "end": 237, "id": 38, "ws": true}, {"text": "in", "start": 238, "end": 240, "id": 39, "ws": true}, {"text": "selected", "start": 241, "end": 249, "id": 40, "ws": true}, {"text": "patients", "start": 250, "end": 258, "id": 41, "ws": true}, {"text": "who", "start": 259, "end": 262, "id": 42, "ws": true}, {"text": "are", "start": 263, "end": 266, "id": 43, "ws": true}, {"text": "great", "start": 267, "end": 272, "id": 44, "ws": true}, {"text": "surgical", "start": 273, "end": 281, "id": 45, "ws": true}, {"text": "risks", "start": 282, "end": 287, "id": 46, "ws": false}, {"text": ".", "start": 287, "end": 288, "id": 47, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 29, "token_start": 2, "token_end": 3, "label": "DRUG"}, {"start": 30, "end": 37, "token_start": 4, "token_end": 4, "label": "SALT"}, {"start": 38, "end": 47, "token_start": 5, "token_end": 5, "label": "ROUTE"}, {"start": 69, "end": 78, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 82, "end": 101, "token_start": 13, "token_end": 14, "label": "SEVERITY"}, {"start": 102, "end": 116, "token_start": 15, "token_end": 16, "label": "INDICATION"}, {"start": 124, "end": 141, "token_start": 19, "token_end": 20, "label": "ANATOMY"}, {"start": 142, "end": 189, "token_start": 21, "token_end": 27, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694527562, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ACCOLATE is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.", "_input_hash": 1882680634, "_task_hash": -541380409, "_is_binary": false, "tokens": [{"text": "ACCOLATE", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "prophylaxis", "start": 30, "end": 41, "id": 5, "ws": true}, {"text": "and", "start": 42, "end": 45, "id": 6, "ws": true}, {"text": "chronic", "start": 46, "end": 53, "id": 7, "ws": true}, {"text": "treatment", "start": 54, "end": 63, "id": 8, "ws": true}, {"text": "of", "start": 64, "end": 66, "id": 9, "ws": true}, {"text": "asthma", "start": 67, "end": 73, "id": 10, "ws": true}, {"text": "in", "start": 74, "end": 76, "id": 11, "ws": true}, {"text": "adults", "start": 77, "end": 83, "id": 12, "ws": true}, {"text": "and", "start": 84, "end": 87, "id": 13, "ws": true}, {"text": "children", "start": 88, "end": 96, "id": 14, "ws": true}, {"text": "5", "start": 97, "end": 98, "id": 15, "ws": true}, {"text": "years", "start": 99, "end": 104, "id": 16, "ws": true}, {"text": "of", "start": 105, "end": 107, "id": 17, "ws": true}, {"text": "age", "start": 108, "end": 111, "id": 18, "ws": true}, {"text": "and", "start": 112, "end": 115, "id": 19, "ws": true}, {"text": "older", "start": 116, "end": 121, "id": 20, "ws": false}, {"text": ".", "start": 121, "end": 122, "id": 21, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 41, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 46, "end": 63, "token_start": 7, "token_end": 8, "label": "ACTION"}, {"start": 67, "end": 73, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 77, "end": 83, "token_start": 12, "token_end": 12, "label": "TARGET_GROUP"}, {"start": 88, "end": 121, "token_start": 14, "token_end": 20, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694177270, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus (1).", "_input_hash": -775498203, "_task_hash": -1822640172, "_is_binary": false, "tokens": [{"text": "NOVOLOG", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "to", "start": 21, "end": 23, "id": 3, "ws": true}, {"text": "improve", "start": 24, "end": 31, "id": 4, "ws": true}, {"text": "glycemic", "start": 32, "end": 40, "id": 5, "ws": true}, {"text": "control", "start": 41, "end": 48, "id": 6, "ws": true}, {"text": "in", "start": 49, "end": 51, "id": 7, "ws": true}, {"text": "adults", "start": 52, "end": 58, "id": 8, "ws": true}, {"text": "and", "start": 59, "end": 62, "id": 9, "ws": true}, {"text": "pediatric", "start": 63, "end": 72, "id": 10, "ws": true}, {"text": "patients", "start": 73, "end": 81, "id": 11, "ws": true}, {"text": "with", "start": 82, "end": 86, "id": 12, "ws": true}, {"text": "diabetes", "start": 87, "end": 95, "id": 13, "ws": true}, {"text": "mellitus", "start": 96, "end": 104, "id": 14, "ws": false}, {"text": ".", "start": 104, "end": 105, "id": 15, "ws": true}, {"text": "NOVOLOG", "start": 106, "end": 113, "id": 16, "ws": true}, {"text": "is", "start": 114, "end": 116, "id": 17, "ws": true}, {"text": "rapid", "start": 117, "end": 122, "id": 18, "ws": true}, {"text": "acting", "start": 123, "end": 129, "id": 19, "ws": true}, {"text": "human", "start": 130, "end": 135, "id": 20, "ws": true}, {"text": "insulin", "start": 136, "end": 143, "id": 21, "ws": true}, {"text": "analog", "start": 144, "end": 150, "id": 22, "ws": true}, {"text": "indicated", "start": 151, "end": 160, "id": 23, "ws": true}, {"text": "to", "start": 161, "end": 163, "id": 24, "ws": true}, {"text": "improve", "start": 164, "end": 171, "id": 25, "ws": true}, {"text": "glycemic", "start": 172, "end": 180, "id": 26, "ws": true}, {"text": "control", "start": 181, "end": 188, "id": 27, "ws": true}, {"text": "in", "start": 189, "end": 191, "id": 28, "ws": true}, {"text": "adults", "start": 192, "end": 198, "id": 29, "ws": true}, {"text": "and", "start": 199, "end": 202, "id": 30, "ws": true}, {"text": "pediatric", "start": 203, "end": 212, "id": 31, "ws": true}, {"text": "patients", "start": 213, "end": 221, "id": 32, "ws": true}, {"text": "with", "start": 222, "end": 226, "id": 33, "ws": true}, {"text": "diabetes", "start": 227, "end": 235, "id": 34, "ws": true}, {"text": "mellitus", "start": 236, "end": 244, "id": 35, "ws": true}, {"text": "(", "start": 245, "end": 246, "id": 36, "ws": false}, {"text": "1", "start": 246, "end": 247, "id": 37, "ws": false}, {"text": ")", "start": 247, "end": 248, "id": 38, "ws": false}, {"text": ".", "start": 248, "end": 249, "id": 39, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 24, "end": 31, "token_start": 4, "token_end": 4, "label": "ACTION"}, {"start": 32, "end": 48, "token_start": 5, "token_end": 6, "label": "INDICATION"}, {"start": 52, "end": 58, "token_start": 8, "token_end": 8, "label": "TARGET_GROUP"}, {"start": 63, "end": 81, "token_start": 10, "token_end": 11, "label": "TARGET_GROUP"}, {"start": 87, "end": 104, "token_start": 13, "token_end": 14, "label": "BASECONDITION"}, {"start": 106, "end": 113, "token_start": 16, "token_end": 16, "label": "DRUG"}, {"start": 117, "end": 150, "token_start": 18, "token_end": 22, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694177216, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Thermazene (Silver Sulfadiazine) Cream, 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.", "_input_hash": -1691772165, "_task_hash": -130812388, "_is_binary": false, "tokens": [{"text": "Thermazene", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "(", "start": 11, "end": 12, "id": 1, "ws": false}, {"text": "Silver", "start": 12, "end": 18, "id": 2, "ws": true}, {"text": "Sulfadiazine", "start": 19, "end": 31, "id": 3, "ws": false}, {"text": ")", "start": 31, "end": 32, "id": 4, "ws": true}, {"text": "Cream", "start": 33, "end": 38, "id": 5, "ws": false}, {"text": ",", "start": 38, "end": 39, "id": 6, "ws": true}, {"text": "1", "start": 40, "end": 41, "id": 7, "ws": false}, {"text": "%", "start": 41, "end": 42, "id": 8, "ws": true}, {"text": "is", "start": 43, "end": 45, "id": 9, "ws": true}, {"text": "a", "start": 46, "end": 47, "id": 10, "ws": true}, {"text": "topical", "start": 48, "end": 55, "id": 11, "ws": true}, {"text": "antimicrobial", "start": 56, "end": 69, "id": 12, "ws": true}, {"text": "drug", "start": 70, "end": 74, "id": 13, "ws": true}, {"text": "indicated", "start": 75, "end": 84, "id": 14, "ws": true}, {"text": "as", "start": 85, "end": 87, "id": 15, "ws": true}, {"text": "an", "start": 88, "end": 90, "id": 16, "ws": true}, {"text": "adjunct", "start": 91, "end": 98, "id": 17, "ws": true}, {"text": "for", "start": 99, "end": 102, "id": 18, "ws": true}, {"text": "the", "start": 103, "end": 106, "id": 19, "ws": true}, {"text": "prevention", "start": 107, "end": 117, "id": 20, "ws": true}, {"text": "and", "start": 118, "end": 121, "id": 21, "ws": true}, {"text": "treatment", "start": 122, "end": 131, "id": 22, "ws": true}, {"text": "of", "start": 132, "end": 134, "id": 23, "ws": true}, {"text": "wound", "start": 135, "end": 140, "id": 24, "ws": true}, {"text": "sepsis", "start": 141, "end": 147, "id": 25, "ws": true}, {"text": "in", "start": 148, "end": 150, "id": 26, "ws": true}, {"text": "patients", "start": 151, "end": 159, "id": 27, "ws": true}, {"text": "with", "start": 160, "end": 164, "id": 28, "ws": true}, {"text": "second", "start": 165, "end": 171, "id": 29, "ws": true}, {"text": "and", "start": 172, "end": 175, "id": 30, "ws": true}, {"text": "third", "start": 176, "end": 181, "id": 31, "ws": true}, {"text": "degree", "start": 182, "end": 188, "id": 32, "ws": true}, {"text": "burns", "start": 189, "end": 194, "id": 33, "ws": false}, {"text": ".", "start": 194, "end": 195, "id": 34, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 33, "end": 38, "token_start": 5, "token_end": 5, "label": "FORMULATION"}, {"start": 48, "end": 74, "token_start": 11, "token_end": 13, "label": "MECHANISM"}, {"start": 107, "end": 117, "token_start": 20, "token_end": 20, "label": "ACTION"}, {"start": 122, "end": 131, "token_start": 22, "token_end": 22, "label": "ACTION"}, {"start": 135, "end": 147, "token_start": 24, "token_end": 25, "label": "INDICATION"}, {"start": 151, "end": 194, "token_start": 27, "token_end": 33, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694175853, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "VIMPAT is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. As the safety of VIMPAT injection in pediatric patients has not been established, VIMPAT injection is indicated for the treatment of partial-onset seizures only in adult patients (17 years of age and older). VIMPAT is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. As the safety of VIMPAT injection has not been established in pediatric patients, VIMPAT injection is indicated for the treatment of partial-onset seizures only in adult patients (17 years of age and older) ( 1)", "_input_hash": -1152719254, "_task_hash": 1589668053, "_is_binary": false, "tokens": [{"text": "VIMPAT", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "for", "start": 20, "end": 23, "id": 3, "ws": true}, {"text": "the", "start": 24, "end": 27, "id": 4, "ws": true}, {"text": "treatment", "start": 28, "end": 37, "id": 5, "ws": true}, {"text": "of", "start": 38, "end": 40, "id": 6, "ws": true}, {"text": "partial", "start": 41, "end": 48, "id": 7, "ws": false}, {"text": "-", "start": 48, "end": 49, "id": 8, "ws": false}, {"text": "onset", "start": 49, "end": 54, "id": 9, "ws": true}, {"text": "seizures", "start": 55, "end": 63, "id": 10, "ws": true}, {"text": "in", "start": 64, "end": 66, "id": 11, "ws": true}, {"text": "patients", "start": 67, "end": 75, "id": 12, "ws": true}, {"text": "4", "start": 76, "end": 77, "id": 13, "ws": true}, {"text": "years", "start": 78, "end": 83, "id": 14, "ws": true}, {"text": "of", "start": 84, "end": 86, "id": 15, "ws": true}, {"text": "age", "start": 87, "end": 90, "id": 16, "ws": true}, {"text": "and", "start": 91, "end": 94, "id": 17, "ws": true}, {"text": "older", "start": 95, "end": 100, "id": 18, "ws": false}, {"text": ".", "start": 100, "end": 101, "id": 19, "ws": true}, {"text": "As", "start": 102, "end": 104, "id": 20, "ws": true}, {"text": "the", "start": 105, "end": 108, "id": 21, "ws": true}, {"text": "safety", "start": 109, "end": 115, "id": 22, "ws": true}, {"text": "of", "start": 116, "end": 118, "id": 23, "ws": true}, {"text": "VIMPAT", "start": 119, "end": 125, "id": 24, "ws": true}, {"text": "injection", "start": 126, "end": 135, "id": 25, "ws": true}, {"text": "in", "start": 136, "end": 138, "id": 26, "ws": true}, {"text": "pediatric", "start": 139, "end": 148, "id": 27, "ws": true}, {"text": "patients", "start": 149, "end": 157, "id": 28, "ws": true}, {"text": "has", "start": 158, "end": 161, "id": 29, "ws": true}, {"text": "not", "start": 162, "end": 165, "id": 30, "ws": true}, {"text": "been", "start": 166, "end": 170, "id": 31, "ws": true}, {"text": "established", "start": 171, "end": 182, "id": 32, "ws": false}, {"text": ",", "start": 182, "end": 183, "id": 33, "ws": true}, {"text": "VIMPAT", "start": 184, "end": 190, "id": 34, "ws": true}, {"text": "injection", "start": 191, "end": 200, "id": 35, "ws": true}, {"text": "is", "start": 201, "end": 203, "id": 36, "ws": true}, {"text": "indicated", "start": 204, "end": 213, "id": 37, "ws": true}, {"text": "for", "start": 214, "end": 217, "id": 38, "ws": true}, {"text": "the", "start": 218, "end": 221, "id": 39, "ws": true}, {"text": "treatment", "start": 222, "end": 231, "id": 40, "ws": true}, {"text": "of", "start": 232, "end": 234, "id": 41, "ws": true}, {"text": "partial", "start": 235, "end": 242, "id": 42, "ws": false}, {"text": "-", "start": 242, "end": 243, "id": 43, "ws": false}, {"text": "onset", "start": 243, "end": 248, "id": 44, "ws": true}, {"text": "seizures", "start": 249, "end": 257, "id": 45, "ws": true}, {"text": "only", "start": 258, "end": 262, "id": 46, "ws": true}, {"text": "in", "start": 263, "end": 265, "id": 47, "ws": true}, {"text": "adult", "start": 266, "end": 271, "id": 48, "ws": true}, {"text": "patients", "start": 272, "end": 280, "id": 49, "ws": true}, {"text": "(", "start": 281, "end": 282, "id": 50, "ws": false}, {"text": "17", "start": 282, "end": 284, "id": 51, "ws": true}, {"text": "years", "start": 285, "end": 290, "id": 52, "ws": true}, {"text": "of", "start": 291, "end": 293, "id": 53, "ws": true}, {"text": "age", "start": 294, "end": 297, "id": 54, "ws": true}, {"text": "and", "start": 298, "end": 301, "id": 55, "ws": true}, {"text": "older", "start": 302, "end": 307, "id": 56, "ws": false}, {"text": ")", "start": 307, "end": 308, "id": 57, "ws": false}, {"text": ".", "start": 308, "end": 309, "id": 58, "ws": true}, {"text": "VIMPAT", "start": 310, "end": 316, "id": 59, "ws": true}, {"text": "is", "start": 317, "end": 319, "id": 60, "ws": true}, {"text": "indicated", "start": 320, "end": 329, "id": 61, "ws": true}, {"text": "for", "start": 330, "end": 333, "id": 62, "ws": true}, {"text": "the", "start": 334, "end": 337, "id": 63, "ws": true}, {"text": "treatment", "start": 338, "end": 347, "id": 64, "ws": true}, {"text": "of", "start": 348, "end": 350, "id": 65, "ws": true}, {"text": "partial", "start": 351, "end": 358, "id": 66, "ws": false}, {"text": "-", "start": 358, "end": 359, "id": 67, "ws": false}, {"text": "onset", "start": 359, "end": 364, "id": 68, "ws": true}, {"text": "seizures", "start": 365, "end": 373, "id": 69, "ws": true}, {"text": "in", "start": 374, "end": 376, "id": 70, "ws": true}, {"text": "patients", "start": 377, "end": 385, "id": 71, "ws": true}, {"text": "4", "start": 386, "end": 387, "id": 72, "ws": true}, {"text": "years", "start": 388, "end": 393, "id": 73, "ws": true}, {"text": "of", "start": 394, "end": 396, "id": 74, "ws": true}, {"text": "age", "start": 397, "end": 400, "id": 75, "ws": true}, {"text": "and", "start": 401, "end": 404, "id": 76, "ws": true}, {"text": "older", "start": 405, "end": 410, "id": 77, "ws": false}, {"text": ".", "start": 410, "end": 411, "id": 78, "ws": true}, {"text": "As", "start": 412, "end": 414, "id": 79, "ws": true}, {"text": "the", "start": 415, "end": 418, "id": 80, "ws": true}, {"text": "safety", "start": 419, "end": 425, "id": 81, "ws": true}, {"text": "of", "start": 426, "end": 428, "id": 82, "ws": true}, {"text": "VIMPAT", "start": 429, "end": 435, "id": 83, "ws": true}, {"text": "injection", "start": 436, "end": 445, "id": 84, "ws": true}, {"text": "has", "start": 446, "end": 449, "id": 85, "ws": true}, {"text": "not", "start": 450, "end": 453, "id": 86, "ws": true}, {"text": "been", "start": 454, "end": 458, "id": 87, "ws": true}, {"text": "established", "start": 459, "end": 470, "id": 88, "ws": true}, {"text": "in", "start": 471, "end": 473, "id": 89, "ws": true}, {"text": "pediatric", "start": 474, "end": 483, "id": 90, "ws": true}, {"text": "patients", "start": 484, "end": 492, "id": 91, "ws": false}, {"text": ",", "start": 492, "end": 493, "id": 92, "ws": true}, {"text": "VIMPAT", "start": 494, "end": 500, "id": 93, "ws": true}, {"text": "injection", "start": 501, "end": 510, "id": 94, "ws": true}, {"text": "is", "start": 511, "end": 513, "id": 95, "ws": true}, {"text": "indicated", "start": 514, "end": 523, "id": 96, "ws": true}, {"text": "for", "start": 524, "end": 527, "id": 97, "ws": true}, {"text": "the", "start": 528, "end": 531, "id": 98, "ws": true}, {"text": "treatment", "start": 532, "end": 541, "id": 99, "ws": true}, {"text": "of", "start": 542, "end": 544, "id": 100, "ws": true}, {"text": "partial", "start": 545, "end": 552, "id": 101, "ws": false}, {"text": "-", "start": 552, "end": 553, "id": 102, "ws": false}, {"text": "onset", "start": 553, "end": 558, "id": 103, "ws": true}, {"text": "seizures", "start": 559, "end": 567, "id": 104, "ws": true}, {"text": "only", "start": 568, "end": 572, "id": 105, "ws": true}, {"text": "in", "start": 573, "end": 575, "id": 106, "ws": true}, {"text": "adult", "start": 576, "end": 581, "id": 107, "ws": true}, {"text": "patients", "start": 582, "end": 590, "id": 108, "ws": true}, {"text": "(", "start": 591, "end": 592, "id": 109, "ws": false}, {"text": "17", "start": 592, "end": 594, "id": 110, "ws": true}, {"text": "years", "start": 595, "end": 600, "id": 111, "ws": true}, {"text": "of", "start": 601, "end": 603, "id": 112, "ws": true}, {"text": "age", "start": 604, "end": 607, "id": 113, "ws": true}, {"text": "and", "start": 608, "end": 611, "id": 114, "ws": true}, {"text": "older", "start": 612, "end": 617, "id": 115, "ws": false}, {"text": ")", "start": 617, "end": 618, "id": 116, "ws": true}, {"text": "(", "start": 619, "end": 620, "id": 117, "ws": true}, {"text": "1", "start": 621, "end": 622, "id": 118, "ws": false}, {"text": ")", "start": 622, "end": 623, "id": 119, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 28, "end": 37, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 41, "end": 63, "token_start": 7, "token_end": 10, "label": "INDICATION"}, {"start": 67, "end": 100, "token_start": 12, "token_end": 18, "label": "TARGET_GROUP"}, {"start": 184, "end": 190, "token_start": 34, "token_end": 34, "label": "DRUG"}, {"start": 191, "end": 200, "token_start": 35, "token_end": 35, "label": "ROUTE"}, {"start": 222, "end": 231, "token_start": 40, "token_end": 40, "label": "ACTION"}, {"start": 235, "end": 257, "token_start": 42, "token_end": 45, "label": "INDICATION"}, {"start": 266, "end": 308, "token_start": 48, "token_end": 57, "label": "TARGET_GROUP"}, {"start": 310, "end": 316, "token_start": 59, "token_end": 59, "label": "DRUG"}, {"start": 338, "end": 347, "token_start": 64, "token_end": 64, "label": "ACTION"}, {"start": 351, "end": 373, "token_start": 66, "token_end": 69, "label": "INDICATION"}, {"start": 377, "end": 410, "token_start": 71, "token_end": 77, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694525669, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults. Trazodone hydrochloride is a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) ( 1).", "_input_hash": 1219437854, "_task_hash": -1373951468, "_is_binary": false, "tokens": [{"text": "Trazodone", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 10, "end": 23, "id": 1, "ws": true}, {"text": "tablets", "start": 24, "end": 31, "id": 2, "ws": true}, {"text": "are", "start": 32, "end": 35, "id": 3, "ws": true}, {"text": "indicated", "start": 36, "end": 45, "id": 4, "ws": true}, {"text": "for", "start": 46, "end": 49, "id": 5, "ws": true}, {"text": "the", "start": 50, "end": 53, "id": 6, "ws": true}, {"text": "treatment", "start": 54, "end": 63, "id": 7, "ws": true}, {"text": "of", "start": 64, "end": 66, "id": 8, "ws": true}, {"text": "major", "start": 67, "end": 72, "id": 9, "ws": true}, {"text": "depressive", "start": 73, "end": 83, "id": 10, "ws": true}, {"text": "disorder", "start": 84, "end": 92, "id": 11, "ws": true}, {"text": "(", "start": 93, "end": 94, "id": 12, "ws": false}, {"text": "MDD", "start": 94, "end": 97, "id": 13, "ws": false}, {"text": ")", "start": 97, "end": 98, "id": 14, "ws": true}, {"text": "in", "start": 99, "end": 101, "id": 15, "ws": true}, {"text": "adults", "start": 102, "end": 108, "id": 16, "ws": false}, {"text": ".", "start": 108, "end": 109, "id": 17, "ws": true}, {"text": "Trazodone", "start": 110, "end": 119, "id": 18, "ws": true}, {"text": "hydrochloride", "start": 120, "end": 133, "id": 19, "ws": true}, {"text": "is", "start": 134, "end": 136, "id": 20, "ws": true}, {"text": "a", "start": 137, "end": 138, "id": 21, "ws": true}, {"text": "selective", "start": 139, "end": 148, "id": 22, "ws": true}, {"text": "serotonin", "start": 149, "end": 158, "id": 23, "ws": true}, {"text": "reuptake", "start": 159, "end": 167, "id": 24, "ws": true}, {"text": "inhibitor", "start": 168, "end": 177, "id": 25, "ws": true}, {"text": "indicated", "start": 178, "end": 187, "id": 26, "ws": true}, {"text": "for", "start": 188, "end": 191, "id": 27, "ws": true}, {"text": "the", "start": 192, "end": 195, "id": 28, "ws": true}, {"text": "treatment", "start": 196, "end": 205, "id": 29, "ws": true}, {"text": "of", "start": 206, "end": 208, "id": 30, "ws": true}, {"text": "major", "start": 209, "end": 214, "id": 31, "ws": true}, {"text": "depressive", "start": 215, "end": 225, "id": 32, "ws": true}, {"text": "disorder", "start": 226, "end": 234, "id": 33, "ws": true}, {"text": "(", "start": 235, "end": 236, "id": 34, "ws": false}, {"text": "MDD", "start": 236, "end": 239, "id": 35, "ws": false}, {"text": ")", "start": 239, "end": 240, "id": 36, "ws": true}, {"text": "(", "start": 241, "end": 242, "id": 37, "ws": true}, {"text": "1", "start": 243, "end": 244, "id": 38, "ws": false}, {"text": ")", "start": 244, "end": 245, "id": 39, "ws": false}, {"text": ".", "start": 245, "end": 246, "id": 40, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 31, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 54, "end": 63, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 67, "end": 92, "token_start": 9, "token_end": 11, "label": "INDICATION"}, {"start": 110, "end": 119, "token_start": 18, "token_end": 18, "label": "DRUG"}, {"start": 120, "end": 133, "token_start": 19, "token_end": 19, "label": "SALT"}, {"start": 139, "end": 177, "token_start": 22, "token_end": 25, "label": "MECHANISM"}, {"start": 196, "end": 205, "token_start": 29, "token_end": 29, "label": "ACTION"}, {"start": 209, "end": 234, "token_start": 31, "token_end": 33, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527810, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ESTRING is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.", "_input_hash": 1643634903, "_task_hash": 379955685, "_is_binary": false, "tokens": [{"text": "ESTRING", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "moderate", "start": 42, "end": 50, "id": 7, "ws": true}, {"text": "to", "start": 51, "end": 53, "id": 8, "ws": true}, {"text": "severe", "start": 54, "end": 60, "id": 9, "ws": true}, {"text": "symptoms", "start": 61, "end": 69, "id": 10, "ws": true}, {"text": "of", "start": 70, "end": 72, "id": 11, "ws": true}, {"text": "vulvar", "start": 73, "end": 79, "id": 12, "ws": true}, {"text": "and", "start": 80, "end": 83, "id": 13, "ws": true}, {"text": "vaginal", "start": 84, "end": 91, "id": 14, "ws": true}, {"text": "atrophy", "start": 92, "end": 99, "id": 15, "ws": true}, {"text": "due", "start": 100, "end": 103, "id": 16, "ws": true}, {"text": "to", "start": 104, "end": 106, "id": 17, "ws": true}, {"text": "menopause", "start": 107, "end": 116, "id": 18, "ws": false}, {"text": ".", "start": 116, "end": 117, "id": 19, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 42, "end": 60, "token_start": 7, "token_end": 9, "label": "SEVERITY"}, {"start": 61, "end": 69, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 73, "end": 99, "token_start": 12, "token_end": 15, "label": "BASECONDITION"}, {"start": 107, "end": 116, "token_start": 18, "token_end": 18, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694525744, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Droperidol Injection, USP is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.", "_input_hash": 525967668, "_task_hash": 432909983, "_is_binary": false, "tokens": [{"text": "Droperidol", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "Injection", "start": 11, "end": 20, "id": 1, "ws": false}, {"text": ",", "start": 20, "end": 21, "id": 2, "ws": true}, {"text": "USP", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "is", "start": 26, "end": 28, "id": 4, "ws": true}, {"text": "indicated", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "to", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "reduce", "start": 42, "end": 48, "id": 7, "ws": true}, {"text": "the", "start": 49, "end": 52, "id": 8, "ws": true}, {"text": "incidence", "start": 53, "end": 62, "id": 9, "ws": true}, {"text": "of", "start": 63, "end": 65, "id": 10, "ws": true}, {"text": "nausea", "start": 66, "end": 72, "id": 11, "ws": true}, {"text": "and", "start": 73, "end": 76, "id": 12, "ws": true}, {"text": "vomiting", "start": 77, "end": 85, "id": 13, "ws": true}, {"text": "associated", "start": 86, "end": 96, "id": 14, "ws": true}, {"text": "with", "start": 97, "end": 101, "id": 15, "ws": true}, {"text": "surgical", "start": 102, "end": 110, "id": 16, "ws": true}, {"text": "and", "start": 111, "end": 114, "id": 17, "ws": true}, {"text": "diagnostic", "start": 115, "end": 125, "id": 18, "ws": true}, {"text": "procedures", "start": 126, "end": 136, "id": 19, "ws": false}, {"text": ".", "start": 136, "end": 137, "id": 20, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 20, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 42, "end": 62, "token_start": 7, "token_end": 9, "label": "ACTION"}, {"start": 66, "end": 72, "token_start": 11, "token_end": 11, "label": "INDICATION"}, {"start": 77, "end": 85, "token_start": 13, "token_end": 13, "label": "INDICATION"}, {"start": 102, "end": 136, "token_start": 16, "token_end": 19, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694175379, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "ERLEADA is indicated for the treatment of patients with Metastatic castration-sensitive prostate cancer (mCSPC) Non-metastatic castration-resistant prostate cancer (nmCRPC) ERLEADA is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer. ( 1) non-metastatic castration-resistant prostate cancer. ( 1)", "_input_hash": 1674463167, "_task_hash": 1773361942, "_is_binary": false, "tokens": [{"text": "ERLEADA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "patients", "start": 42, "end": 50, "id": 7, "ws": true}, {"text": "with", "start": 51, "end": 55, "id": 8, "ws": true}, {"text": "Metastatic", "start": 56, "end": 66, "id": 9, "ws": true}, {"text": "castration", "start": 67, "end": 77, "id": 10, "ws": false}, {"text": "-", "start": 77, "end": 78, "id": 11, "ws": false}, {"text": "sensitive", "start": 78, "end": 87, "id": 12, "ws": true}, {"text": "prostate", "start": 88, "end": 96, "id": 13, "ws": true}, {"text": "cancer", "start": 97, "end": 103, "id": 14, "ws": true}, {"text": "(", "start": 104, "end": 105, "id": 15, "ws": false}, {"text": "mCSPC", "start": 105, "end": 110, "id": 16, "ws": false}, {"text": ")", "start": 110, "end": 111, "id": 17, "ws": true}, {"text": "Non", "start": 112, "end": 115, "id": 18, "ws": false}, {"text": "-", "start": 115, "end": 116, "id": 19, "ws": false}, {"text": "metastatic", "start": 116, "end": 126, "id": 20, "ws": true}, {"text": "castration", "start": 127, "end": 137, "id": 21, "ws": false}, {"text": "-", "start": 137, "end": 138, "id": 22, "ws": false}, {"text": "resistant", "start": 138, "end": 147, "id": 23, "ws": true}, {"text": "prostate", "start": 148, "end": 156, "id": 24, "ws": true}, {"text": "cancer", "start": 157, "end": 163, "id": 25, "ws": true}, {"text": "(", "start": 164, "end": 165, "id": 26, "ws": false}, {"text": "nmCRPC", "start": 165, "end": 171, "id": 27, "ws": false}, {"text": ")", "start": 171, "end": 172, "id": 28, "ws": true}, {"text": "ERLEADA", "start": 173, "end": 180, "id": 29, "ws": true}, {"text": "is", "start": 181, "end": 183, "id": 30, "ws": true}, {"text": "an", "start": 184, "end": 186, "id": 31, "ws": true}, {"text": "androgen", "start": 187, "end": 195, "id": 32, "ws": true}, {"text": "receptor", "start": 196, "end": 204, "id": 33, "ws": true}, {"text": "inhibitor", "start": 205, "end": 214, "id": 34, "ws": true}, {"text": "indicated", "start": 215, "end": 224, "id": 35, "ws": true}, {"text": "for", "start": 225, "end": 228, "id": 36, "ws": true}, {"text": "the", "start": 229, "end": 232, "id": 37, "ws": true}, {"text": "treatment", "start": 233, "end": 242, "id": 38, "ws": true}, {"text": "of", "start": 243, "end": 245, "id": 39, "ws": true}, {"text": "patients", "start": 246, "end": 254, "id": 40, "ws": true}, {"text": "with", "start": 255, "end": 259, "id": 41, "ws": true}, {"text": "metastatic", "start": 260, "end": 270, "id": 42, "ws": true}, {"text": "castration", "start": 271, "end": 281, "id": 43, "ws": false}, {"text": "-", "start": 281, "end": 282, "id": 44, "ws": false}, {"text": "sensitive", "start": 282, "end": 291, "id": 45, "ws": true}, {"text": "prostate", "start": 292, "end": 300, "id": 46, "ws": true}, {"text": "cancer", "start": 301, "end": 307, "id": 47, "ws": false}, {"text": ".", "start": 307, "end": 308, "id": 48, "ws": true}, {"text": "(", "start": 309, "end": 310, "id": 49, "ws": true}, {"text": "1", "start": 311, "end": 312, "id": 50, "ws": false}, {"text": ")", "start": 312, "end": 313, "id": 51, "ws": true}, {"text": "non", "start": 314, "end": 317, "id": 52, "ws": false}, {"text": "-", "start": 317, "end": 318, "id": 53, "ws": false}, {"text": "metastatic", "start": 318, "end": 328, "id": 54, "ws": true}, {"text": "castration", "start": 329, "end": 339, "id": 55, "ws": false}, {"text": "-", "start": 339, "end": 340, "id": 56, "ws": false}, {"text": "resistant", "start": 340, "end": 349, "id": 57, "ws": true}, {"text": "prostate", "start": 350, "end": 358, "id": 58, "ws": true}, {"text": "cancer", "start": 359, "end": 365, "id": 59, "ws": false}, {"text": ".", "start": 365, "end": 366, "id": 60, "ws": true}, {"text": "(", "start": 367, "end": 368, "id": 61, "ws": true}, {"text": "1", "start": 369, "end": 370, "id": 62, "ws": false}, {"text": ")", "start": 370, "end": 371, "id": 63, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 56, "end": 103, "token_start": 9, "token_end": 14, "label": "INDICATION"}, {"start": 112, "end": 163, "token_start": 18, "token_end": 25, "label": "INDICATION"}, {"start": 173, "end": 180, "token_start": 29, "token_end": 29, "label": "DRUG"}, {"start": 187, "end": 214, "token_start": 32, "token_end": 34, "label": "MECHANISM"}, {"start": 233, "end": 242, "token_start": 38, "token_end": 38, "label": "ACTION"}, {"start": 260, "end": 307, "token_start": 42, "token_end": 47, "label": "INDICATION"}, {"start": 314, "end": 365, "token_start": 52, "token_end": 59, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526642, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. The physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition (1)", "_input_hash": -374919931, "_task_hash": -1936409444, "_is_binary": false, "tokens": [{"text": "INFUVITE", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "PEDIATRIC", "start": 9, "end": 18, "id": 1, "ws": true}, {"text": "is", "start": 19, "end": 21, "id": 2, "ws": true}, {"text": "a", "start": 22, "end": 23, "id": 3, "ws": true}, {"text": "combination", "start": 24, "end": 35, "id": 4, "ws": true}, {"text": "of", "start": 36, "end": 38, "id": 5, "ws": true}, {"text": "vitamins", "start": 39, "end": 47, "id": 6, "ws": true}, {"text": "indicated", "start": 48, "end": 57, "id": 7, "ws": true}, {"text": "for", "start": 58, "end": 61, "id": 8, "ws": true}, {"text": "the", "start": 62, "end": 65, "id": 9, "ws": true}, {"text": "prevention", "start": 66, "end": 76, "id": 10, "ws": true}, {"text": "of", "start": 77, "end": 79, "id": 11, "ws": true}, {"text": "vitamin", "start": 80, "end": 87, "id": 12, "ws": true}, {"text": "deficiency", "start": 88, "end": 98, "id": 13, "ws": true}, {"text": "in", "start": 99, "end": 101, "id": 14, "ws": true}, {"text": "pediatric", "start": 102, "end": 111, "id": 15, "ws": true}, {"text": "patients", "start": 112, "end": 120, "id": 16, "ws": true}, {"text": "up", "start": 121, "end": 123, "id": 17, "ws": true}, {"text": "to", "start": 124, "end": 126, "id": 18, "ws": true}, {"text": "11", "start": 127, "end": 129, "id": 19, "ws": true}, {"text": "years", "start": 130, "end": 135, "id": 20, "ws": true}, {"text": "of", "start": 136, "end": 138, "id": 21, "ws": true}, {"text": "age", "start": 139, "end": 142, "id": 22, "ws": true}, {"text": "receiving", "start": 143, "end": 152, "id": 23, "ws": true}, {"text": "parenteral", "start": 153, "end": 163, "id": 24, "ws": true}, {"text": "nutrition", "start": 164, "end": 173, "id": 25, "ws": false}, {"text": ".", "start": 173, "end": 174, "id": 26, "ws": true}, {"text": "The", "start": 175, "end": 178, "id": 27, "ws": true}, {"text": "physician", "start": 179, "end": 188, "id": 28, "ws": true}, {"text": "should", "start": 189, "end": 195, "id": 29, "ws": true}, {"text": "not", "start": 196, "end": 199, "id": 30, "ws": true}, {"text": "await", "start": 200, "end": 205, "id": 31, "ws": true}, {"text": "the", "start": 206, "end": 209, "id": 32, "ws": true}, {"text": "development", "start": 210, "end": 221, "id": 33, "ws": true}, {"text": "of", "start": 222, "end": 224, "id": 34, "ws": true}, {"text": "clinical", "start": 225, "end": 233, "id": 35, "ws": true}, {"text": "signs", "start": 234, "end": 239, "id": 36, "ws": true}, {"text": "of", "start": 240, "end": 242, "id": 37, "ws": true}, {"text": "vitamin", "start": 243, "end": 250, "id": 38, "ws": true}, {"text": "deficiency", "start": 251, "end": 261, "id": 39, "ws": true}, {"text": "before", "start": 262, "end": 268, "id": 40, "ws": true}, {"text": "initiating", "start": 269, "end": 279, "id": 41, "ws": true}, {"text": "vitamin", "start": 280, "end": 287, "id": 42, "ws": true}, {"text": "therapy", "start": 288, "end": 295, "id": 43, "ws": false}, {"text": ".", "start": 295, "end": 296, "id": 44, "ws": true}, {"text": "INFUVITE", "start": 297, "end": 305, "id": 45, "ws": true}, {"text": "PEDIATRIC", "start": 306, "end": 315, "id": 46, "ws": true}, {"text": "is", "start": 316, "end": 318, "id": 47, "ws": true}, {"text": "a", "start": 319, "end": 320, "id": 48, "ws": true}, {"text": "combination", "start": 321, "end": 332, "id": 49, "ws": true}, {"text": "of", "start": 333, "end": 335, "id": 50, "ws": true}, {"text": "vitamins", "start": 336, "end": 344, "id": 51, "ws": true}, {"text": "indicated", "start": 345, "end": 354, "id": 52, "ws": true}, {"text": "for", "start": 355, "end": 358, "id": 53, "ws": true}, {"text": "the", "start": 359, "end": 362, "id": 54, "ws": true}, {"text": "prevention", "start": 363, "end": 373, "id": 55, "ws": true}, {"text": "of", "start": 374, "end": 376, "id": 56, "ws": true}, {"text": "vitamin", "start": 377, "end": 384, "id": 57, "ws": true}, {"text": "deficiency", "start": 385, "end": 395, "id": 58, "ws": true}, {"text": "in", "start": 396, "end": 398, "id": 59, "ws": true}, {"text": "pediatric", "start": 399, "end": 408, "id": 60, "ws": true}, {"text": "patients", "start": 409, "end": 417, "id": 61, "ws": true}, {"text": "up", "start": 418, "end": 420, "id": 62, "ws": true}, {"text": "to", "start": 421, "end": 423, "id": 63, "ws": true}, {"text": "11", "start": 424, "end": 426, "id": 64, "ws": true}, {"text": "years", "start": 427, "end": 432, "id": 65, "ws": true}, {"text": "of", "start": 433, "end": 435, "id": 66, "ws": true}, {"text": "age", "start": 436, "end": 439, "id": 67, "ws": true}, {"text": "receiving", "start": 440, "end": 449, "id": 68, "ws": true}, {"text": "parenteral", "start": 450, "end": 460, "id": 69, "ws": true}, {"text": "nutrition", "start": 461, "end": 470, "id": 70, "ws": true}, {"text": "(", "start": 471, "end": 472, "id": 71, "ws": false}, {"text": "1", "start": 472, "end": 473, "id": 72, "ws": false}, {"text": ")", "start": 473, "end": 474, "id": 73, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 66, "end": 79, "token_start": 10, "token_end": 11, "label": "ACTION"}, {"start": 80, "end": 98, "token_start": 12, "token_end": 13, "label": "INDICATION"}, {"start": 102, "end": 173, "token_start": 15, "token_end": 25, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694175036, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "ENJUVIA tablets are indicated in the: Treatment of moderate to severe vasomotor symptoms associated with menopause. Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause. When prescribing solely for the treatment of moderate to severe vaginal dryness and pain with intercourse, topical vaginal products should be considered.", "_input_hash": 1065193714, "_task_hash": -301515914, "_is_binary": false, "tokens": [{"text": "ENJUVIA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "tablets", "start": 8, "end": 15, "id": 1, "ws": true}, {"text": "are", "start": 16, "end": 19, "id": 2, "ws": true}, {"text": "indicated", "start": 20, "end": 29, "id": 3, "ws": true}, {"text": "in", "start": 30, "end": 32, "id": 4, "ws": true}, {"text": "the", "start": 33, "end": 36, "id": 5, "ws": false}, {"text": ":", "start": 36, "end": 37, "id": 6, "ws": true}, {"text": "Treatment", "start": 38, "end": 47, "id": 7, "ws": true}, {"text": "of", "start": 48, "end": 50, "id": 8, "ws": true}, {"text": "moderate", "start": 51, "end": 59, "id": 9, "ws": true}, {"text": "to", "start": 60, "end": 62, "id": 10, "ws": true}, {"text": "severe", "start": 63, "end": 69, "id": 11, "ws": true}, {"text": "vasomotor", "start": 70, "end": 79, "id": 12, "ws": true}, {"text": "symptoms", "start": 80, "end": 88, "id": 13, "ws": true}, {"text": "associated", "start": 89, "end": 99, "id": 14, "ws": true}, {"text": "with", "start": 100, "end": 104, "id": 15, "ws": true}, {"text": "menopause", "start": 105, "end": 114, "id": 16, "ws": false}, {"text": ".", "start": 114, "end": 115, "id": 17, "ws": true}, {"text": "Treatment", "start": 116, "end": 125, "id": 18, "ws": true}, {"text": "of", "start": 126, "end": 128, "id": 19, "ws": true}, {"text": "moderate", "start": 129, "end": 137, "id": 20, "ws": true}, {"text": "to", "start": 138, "end": 140, "id": 21, "ws": true}, {"text": "severe", "start": 141, "end": 147, "id": 22, "ws": true}, {"text": "vaginal", "start": 148, "end": 155, "id": 23, "ws": true}, {"text": "dryness", "start": 156, "end": 163, "id": 24, "ws": true}, {"text": "and", "start": 164, "end": 167, "id": 25, "ws": true}, {"text": "pain", "start": 168, "end": 172, "id": 26, "ws": true}, {"text": "with", "start": 173, "end": 177, "id": 27, "ws": true}, {"text": "intercourse", "start": 178, "end": 189, "id": 28, "ws": false}, {"text": ",", "start": 189, "end": 190, "id": 29, "ws": true}, {"text": "symptoms", "start": 191, "end": 199, "id": 30, "ws": true}, {"text": "of", "start": 200, "end": 202, "id": 31, "ws": true}, {"text": "vulvar", "start": 203, "end": 209, "id": 32, "ws": true}, {"text": "and", "start": 210, "end": 213, "id": 33, "ws": true}, {"text": "vaginal", "start": 214, "end": 221, "id": 34, "ws": true}, {"text": "atrophy", "start": 222, "end": 229, "id": 35, "ws": false}, {"text": ",", "start": 229, "end": 230, "id": 36, "ws": true}, {"text": "associated", "start": 231, "end": 241, "id": 37, "ws": true}, {"text": "with", "start": 242, "end": 246, "id": 38, "ws": true}, {"text": "menopause", "start": 247, "end": 256, "id": 39, "ws": false}, {"text": ".", "start": 256, "end": 257, "id": 40, "ws": true}, {"text": "When", "start": 258, "end": 262, "id": 41, "ws": true}, {"text": "prescribing", "start": 263, "end": 274, "id": 42, "ws": true}, {"text": "solely", "start": 275, "end": 281, "id": 43, "ws": true}, {"text": "for", "start": 282, "end": 285, "id": 44, "ws": true}, {"text": "the", "start": 286, "end": 289, "id": 45, "ws": true}, {"text": "treatment", "start": 290, "end": 299, "id": 46, "ws": true}, {"text": "of", "start": 300, "end": 302, "id": 47, "ws": true}, {"text": "moderate", "start": 303, "end": 311, "id": 48, "ws": true}, {"text": "to", "start": 312, "end": 314, "id": 49, "ws": true}, {"text": "severe", "start": 315, "end": 321, "id": 50, "ws": true}, {"text": "vaginal", "start": 322, "end": 329, "id": 51, "ws": true}, {"text": "dryness", "start": 330, "end": 337, "id": 52, "ws": true}, {"text": "and", "start": 338, "end": 341, "id": 53, "ws": true}, {"text": "pain", "start": 342, "end": 346, "id": 54, "ws": true}, {"text": "with", "start": 347, "end": 351, "id": 55, "ws": true}, {"text": "intercourse", "start": 352, "end": 363, "id": 56, "ws": false}, {"text": ",", "start": 363, "end": 364, "id": 57, "ws": true}, {"text": "topical", "start": 365, "end": 372, "id": 58, "ws": true}, {"text": "vaginal", "start": 373, "end": 380, "id": 59, "ws": true}, {"text": "products", "start": 381, "end": 389, "id": 60, "ws": true}, {"text": "should", "start": 390, "end": 396, "id": 61, "ws": true}, {"text": "be", "start": 397, "end": 399, "id": 62, "ws": true}, {"text": "considered", "start": 400, "end": 410, "id": 63, "ws": false}, {"text": ".", "start": 410, "end": 411, "id": 64, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 15, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 38, "end": 47, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 51, "end": 69, "token_start": 9, "token_end": 11, "label": "SEVERITY"}, {"start": 70, "end": 88, "token_start": 12, "token_end": 13, "label": "INDICATION"}, {"start": 105, "end": 114, "token_start": 16, "token_end": 16, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694175556, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in patients 4 weeks of age and older. The use of other active agents with ISENTRESS is associated with a greater likelihood of treatment response [see CLINICAL STUDIES (14)].", "_input_hash": -1285960788, "_task_hash": 1167934861, "_is_binary": false, "tokens": [{"text": "ISENTRESS", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "in", "start": 23, "end": 25, "id": 3, "ws": true}, {"text": "combination", "start": 26, "end": 37, "id": 4, "ws": true}, {"text": "with", "start": 38, "end": 42, "id": 5, "ws": true}, {"text": "other", "start": 43, "end": 48, "id": 6, "ws": true}, {"text": "antiretroviral", "start": 49, "end": 63, "id": 7, "ws": true}, {"text": "agents", "start": 64, "end": 70, "id": 8, "ws": true}, {"text": "for", "start": 71, "end": 74, "id": 9, "ws": true}, {"text": "the", "start": 75, "end": 78, "id": 10, "ws": true}, {"text": "treatment", "start": 79, "end": 88, "id": 11, "ws": true}, {"text": "of", "start": 89, "end": 91, "id": 12, "ws": true}, {"text": "human", "start": 92, "end": 97, "id": 13, "ws": true}, {"text": "immunodeficiency", "start": 98, "end": 114, "id": 14, "ws": true}, {"text": "virus", "start": 115, "end": 120, "id": 15, "ws": true}, {"text": "(", "start": 121, "end": 122, "id": 16, "ws": false}, {"text": "HIV-1", "start": 122, "end": 127, "id": 17, "ws": false}, {"text": ")", "start": 127, "end": 128, "id": 18, "ws": true}, {"text": "infection", "start": 129, "end": 138, "id": 19, "ws": true}, {"text": "in", "start": 139, "end": 141, "id": 20, "ws": true}, {"text": "patients", "start": 142, "end": 150, "id": 21, "ws": true}, {"text": "4", "start": 151, "end": 152, "id": 22, "ws": true}, {"text": "weeks", "start": 153, "end": 158, "id": 23, "ws": true}, {"text": "of", "start": 159, "end": 161, "id": 24, "ws": true}, {"text": "age", "start": 162, "end": 165, "id": 25, "ws": true}, {"text": "and", "start": 166, "end": 169, "id": 26, "ws": true}, {"text": "older", "start": 170, "end": 175, "id": 27, "ws": false}, {"text": ".", "start": 175, "end": 176, "id": 28, "ws": true}, {"text": "The", "start": 177, "end": 180, "id": 29, "ws": true}, {"text": "use", "start": 181, "end": 184, "id": 30, "ws": true}, {"text": "of", "start": 185, "end": 187, "id": 31, "ws": true}, {"text": "other", "start": 188, "end": 193, "id": 32, "ws": true}, {"text": "active", "start": 194, "end": 200, "id": 33, "ws": true}, {"text": "agents", "start": 201, "end": 207, "id": 34, "ws": true}, {"text": "with", "start": 208, "end": 212, "id": 35, "ws": true}, {"text": "ISENTRESS", "start": 213, "end": 222, "id": 36, "ws": true}, {"text": "is", "start": 223, "end": 225, "id": 37, "ws": true}, {"text": "associated", "start": 226, "end": 236, "id": 38, "ws": true}, {"text": "with", "start": 237, "end": 241, "id": 39, "ws": true}, {"text": "a", "start": 242, "end": 243, "id": 40, "ws": true}, {"text": "greater", "start": 244, "end": 251, "id": 41, "ws": true}, {"text": "likelihood", "start": 252, "end": 262, "id": 42, "ws": true}, {"text": "of", "start": 263, "end": 265, "id": 43, "ws": true}, {"text": "treatment", "start": 266, "end": 275, "id": 44, "ws": true}, {"text": "response", "start": 276, "end": 284, "id": 45, "ws": true}, {"text": "[", "start": 285, "end": 286, "id": 46, "ws": false}, {"text": "see", "start": 286, "end": 289, "id": 47, "ws": true}, {"text": "CLINICAL", "start": 290, "end": 298, "id": 48, "ws": true}, {"text": "STUDIES", "start": 299, "end": 306, "id": 49, "ws": true}, {"text": "(", "start": 307, "end": 308, "id": 50, "ws": false}, {"text": "14", "start": 308, "end": 310, "id": 51, "ws": false}, {"text": ")", "start": 310, "end": 311, "id": 52, "ws": false}, {"text": "]", "start": 311, "end": 312, "id": 53, "ws": false}, {"text": ".", "start": 312, "end": 313, "id": 54, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 26, "end": 70, "token_start": 4, "token_end": 8, "label": "CO_PRESCRIPTION"}, {"start": 79, "end": 88, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 92, "end": 138, "token_start": 13, "token_end": 19, "label": "INDICATION"}, {"start": 142, "end": 175, "token_start": 21, "token_end": 27, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694528779, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium Chloride is a potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. ( 1)", "_input_hash": -1154965140, "_task_hash": -830569240, "_is_binary": false, "tokens": [{"text": "Potassium", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "Chloride", "start": 10, "end": 18, "id": 1, "ws": true}, {"text": "is", "start": 19, "end": 21, "id": 2, "ws": true}, {"text": "indicated", "start": 22, "end": 31, "id": 3, "ws": true}, {"text": "for", "start": 32, "end": 35, "id": 4, "ws": true}, {"text": "the", "start": 36, "end": 39, "id": 5, "ws": true}, {"text": "treatment", "start": 40, "end": 49, "id": 6, "ws": true}, {"text": "and", "start": 50, "end": 53, "id": 7, "ws": true}, {"text": "prophylaxis", "start": 54, "end": 65, "id": 8, "ws": true}, {"text": "of", "start": 66, "end": 68, "id": 9, "ws": true}, {"text": "hypokalemia", "start": 69, "end": 80, "id": 10, "ws": true}, {"text": "with", "start": 81, "end": 85, "id": 11, "ws": true}, {"text": "or", "start": 86, "end": 88, "id": 12, "ws": true}, {"text": "without", "start": 89, "end": 96, "id": 13, "ws": true}, {"text": "metabolic", "start": 97, "end": 106, "id": 14, "ws": true}, {"text": "alkalosis", "start": 107, "end": 116, "id": 15, "ws": false}, {"text": ",", "start": 116, "end": 117, "id": 16, "ws": true}, {"text": "in", "start": 118, "end": 120, "id": 17, "ws": true}, {"text": "patients", "start": 121, "end": 129, "id": 18, "ws": true}, {"text": "for", "start": 130, "end": 133, "id": 19, "ws": true}, {"text": "whom", "start": 134, "end": 138, "id": 20, "ws": true}, {"text": "dietary", "start": 139, "end": 146, "id": 21, "ws": true}, {"text": "management", "start": 147, "end": 157, "id": 22, "ws": true}, {"text": "with", "start": 158, "end": 162, "id": 23, "ws": true}, {"text": "potassium", "start": 163, "end": 172, "id": 24, "ws": false}, {"text": "-", "start": 172, "end": 173, "id": 25, "ws": false}, {"text": "rich", "start": 173, "end": 177, "id": 26, "ws": true}, {"text": "foods", "start": 178, "end": 183, "id": 27, "ws": true}, {"text": "or", "start": 184, "end": 186, "id": 28, "ws": true}, {"text": "diuretic", "start": 187, "end": 195, "id": 29, "ws": true}, {"text": "dose", "start": 196, "end": 200, "id": 30, "ws": true}, {"text": "reduction", "start": 201, "end": 210, "id": 31, "ws": true}, {"text": "is", "start": 211, "end": 213, "id": 32, "ws": true}, {"text": "insufficient", "start": 214, "end": 226, "id": 33, "ws": false}, {"text": ".", "start": 226, "end": 227, "id": 34, "ws": true}, {"text": "Potassium", "start": 228, "end": 237, "id": 35, "ws": true}, {"text": "Chloride", "start": 238, "end": 246, "id": 36, "ws": true}, {"text": "is", "start": 247, "end": 249, "id": 37, "ws": true}, {"text": "a", "start": 250, "end": 251, "id": 38, "ws": true}, {"text": "potassium", "start": 252, "end": 261, "id": 39, "ws": true}, {"text": "salt", "start": 262, "end": 266, "id": 40, "ws": true}, {"text": "indicated", "start": 267, "end": 276, "id": 41, "ws": true}, {"text": "for", "start": 277, "end": 280, "id": 42, "ws": true}, {"text": "the", "start": 281, "end": 284, "id": 43, "ws": true}, {"text": "treatment", "start": 285, "end": 294, "id": 44, "ws": true}, {"text": "and", "start": 295, "end": 298, "id": 45, "ws": true}, {"text": "prophylaxis", "start": 299, "end": 310, "id": 46, "ws": true}, {"text": "of", "start": 311, "end": 313, "id": 47, "ws": true}, {"text": "hypokalemia", "start": 314, "end": 325, "id": 48, "ws": true}, {"text": "with", "start": 326, "end": 330, "id": 49, "ws": true}, {"text": "or", "start": 331, "end": 333, "id": 50, "ws": true}, {"text": "without", "start": 334, "end": 341, "id": 51, "ws": true}, {"text": "metabolic", "start": 342, "end": 351, "id": 52, "ws": true}, {"text": "alkalosis", "start": 352, "end": 361, "id": 53, "ws": false}, {"text": ",", "start": 361, "end": 362, "id": 54, "ws": true}, {"text": "in", "start": 363, "end": 365, "id": 55, "ws": true}, {"text": "patients", "start": 366, "end": 374, "id": 56, "ws": true}, {"text": "for", "start": 375, "end": 378, "id": 57, "ws": true}, {"text": "whom", "start": 379, "end": 383, "id": 58, "ws": true}, {"text": "dietary", "start": 384, "end": 391, "id": 59, "ws": true}, {"text": "management", "start": 392, "end": 402, "id": 60, "ws": true}, {"text": "with", "start": 403, "end": 407, "id": 61, "ws": true}, {"text": "potassium", "start": 408, "end": 417, "id": 62, "ws": false}, {"text": "-", "start": 417, "end": 418, "id": 63, "ws": false}, {"text": "rich", "start": 418, "end": 422, "id": 64, "ws": true}, {"text": "foods", "start": 423, "end": 428, "id": 65, "ws": true}, {"text": "or", "start": 429, "end": 431, "id": 66, "ws": true}, {"text": "diuretic", "start": 432, "end": 440, "id": 67, "ws": true}, {"text": "dose", "start": 441, "end": 445, "id": 68, "ws": true}, {"text": "reduction", "start": 446, "end": 455, "id": 69, "ws": true}, {"text": "is", "start": 456, "end": 458, "id": 70, "ws": true}, {"text": "insufficient", "start": 459, "end": 471, "id": 71, "ws": false}, {"text": ".", "start": 471, "end": 472, "id": 72, "ws": true}, {"text": "(", "start": 473, "end": 474, "id": 73, "ws": true}, {"text": "1", "start": 475, "end": 476, "id": 74, "ws": false}, {"text": ")", "start": 476, "end": 477, "id": 75, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 18, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 40, "end": 49, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 54, "end": 65, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 69, "end": 80, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 139, "end": 226, "token_start": 21, "token_end": 33, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694175234, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Cabergoline Tablets, USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.", "_input_hash": -656167126, "_task_hash": 1761245644, "_is_binary": false, "tokens": [{"text": "Cabergoline", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "Tablets", "start": 12, "end": 19, "id": 1, "ws": false}, {"text": ",", "start": 19, "end": 20, "id": 2, "ws": true}, {"text": "USP", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "are", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "indicated", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "for", "start": 39, "end": 42, "id": 6, "ws": true}, {"text": "the", "start": 43, "end": 46, "id": 7, "ws": true}, {"text": "treatment", "start": 47, "end": 56, "id": 8, "ws": true}, {"text": "of", "start": 57, "end": 59, "id": 9, "ws": true}, {"text": "hyperprolactinemic", "start": 60, "end": 78, "id": 10, "ws": true}, {"text": "disorders", "start": 79, "end": 88, "id": 11, "ws": false}, {"text": ",", "start": 88, "end": 89, "id": 12, "ws": true}, {"text": "either", "start": 90, "end": 96, "id": 13, "ws": true}, {"text": "idiopathic", "start": 97, "end": 107, "id": 14, "ws": true}, {"text": "or", "start": 108, "end": 110, "id": 15, "ws": true}, {"text": "due", "start": 111, "end": 114, "id": 16, "ws": true}, {"text": "to", "start": 115, "end": 117, "id": 17, "ws": true}, {"text": "pituitary", "start": 118, "end": 127, "id": 18, "ws": true}, {"text": "adenomas", "start": 128, "end": 136, "id": 19, "ws": false}, {"text": ".", "start": 136, "end": 137, "id": 20, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 19, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 47, "end": 56, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 60, "end": 88, "token_start": 10, "token_end": 11, "label": "INDICATION"}, {"start": 111, "end": 136, "token_start": 16, "token_end": 19, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694527845, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Budesonide inhalation suspension is an inhaled corticosteroid indicated for: Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. (Error! Hyperlink reference not valid.) Limitations of Use: Not indicated for the relief of acute bronchospasm. (Error! Hyperlink reference not valid.) 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.", "_input_hash": 90403200, "_task_hash": -564735474, "_is_binary": false, "tokens": [{"text": "Budesonide", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "inhalation", "start": 11, "end": 21, "id": 1, "ws": true}, {"text": "suspension", "start": 22, "end": 32, "id": 2, "ws": true}, {"text": "is", "start": 33, "end": 35, "id": 3, "ws": true}, {"text": "an", "start": 36, "end": 38, "id": 4, "ws": true}, {"text": "inhaled", "start": 39, "end": 46, "id": 5, "ws": true}, {"text": "corticosteroid", "start": 47, "end": 61, "id": 6, "ws": true}, {"text": "indicated", "start": 62, "end": 71, "id": 7, "ws": true}, {"text": "for", "start": 72, "end": 75, "id": 8, "ws": false}, {"text": ":", "start": 75, "end": 76, "id": 9, "ws": true}, {"text": "Maintenance", "start": 77, "end": 88, "id": 10, "ws": true}, {"text": "treatment", "start": 89, "end": 98, "id": 11, "ws": true}, {"text": "of", "start": 99, "end": 101, "id": 12, "ws": true}, {"text": "asthma", "start": 102, "end": 108, "id": 13, "ws": true}, {"text": "and", "start": 109, "end": 112, "id": 14, "ws": true}, {"text": "as", "start": 113, "end": 115, "id": 15, "ws": true}, {"text": "prophylactic", "start": 116, "end": 128, "id": 16, "ws": true}, {"text": "therapy", "start": 129, "end": 136, "id": 17, "ws": true}, {"text": "in", "start": 137, "end": 139, "id": 18, "ws": true}, {"text": "children", "start": 140, "end": 148, "id": 19, "ws": true}, {"text": "12", "start": 149, "end": 151, "id": 20, "ws": true}, {"text": "months", "start": 152, "end": 158, "id": 21, "ws": true}, {"text": "to", "start": 159, "end": 161, "id": 22, "ws": true}, {"text": "8", "start": 162, "end": 163, "id": 23, "ws": true}, {"text": "years", "start": 164, "end": 169, "id": 24, "ws": true}, {"text": "of", "start": 170, "end": 172, "id": 25, "ws": true}, {"text": "age", "start": 173, "end": 176, "id": 26, "ws": false}, {"text": ".", "start": 176, "end": 177, "id": 27, "ws": true}, {"text": "(", "start": 178, "end": 179, "id": 28, "ws": false}, {"text": "Error", "start": 179, "end": 184, "id": 29, "ws": false}, {"text": "!", "start": 184, "end": 185, "id": 30, "ws": true}, {"text": "Hyperlink", "start": 186, "end": 195, "id": 31, "ws": true}, {"text": "reference", "start": 196, "end": 205, "id": 32, "ws": true}, {"text": "not", "start": 206, "end": 209, "id": 33, "ws": true}, {"text": "valid", "start": 210, "end": 215, "id": 34, "ws": false}, {"text": ".", "start": 215, "end": 216, "id": 35, "ws": false}, {"text": ")", "start": 216, "end": 217, "id": 36, "ws": true}, {"text": "Limitations", "start": 218, "end": 229, "id": 37, "ws": true}, {"text": "of", "start": 230, "end": 232, "id": 38, "ws": true}, {"text": "Use", "start": 233, "end": 236, "id": 39, "ws": false}, {"text": ":", "start": 236, "end": 237, "id": 40, "ws": true}, {"text": "Not", "start": 238, "end": 241, "id": 41, "ws": true}, {"text": "indicated", "start": 242, "end": 251, "id": 42, "ws": true}, {"text": "for", "start": 252, "end": 255, "id": 43, "ws": true}, {"text": "the", "start": 256, "end": 259, "id": 44, "ws": true}, {"text": "relief", "start": 260, "end": 266, "id": 45, "ws": true}, {"text": "of", "start": 267, "end": 269, "id": 46, "ws": true}, {"text": "acute", "start": 270, "end": 275, "id": 47, "ws": true}, {"text": "bronchospasm", "start": 276, "end": 288, "id": 48, "ws": false}, {"text": ".", "start": 288, "end": 289, "id": 49, "ws": true}, {"text": "(", "start": 290, "end": 291, "id": 50, "ws": false}, {"text": "Error", "start": 291, "end": 296, "id": 51, "ws": false}, {"text": "!", "start": 296, "end": 297, "id": 52, "ws": true}, {"text": "Hyperlink", "start": 298, "end": 307, "id": 53, "ws": true}, {"text": "reference", "start": 308, "end": 317, "id": 54, "ws": true}, {"text": "not", "start": 318, "end": 321, "id": 55, "ws": true}, {"text": "valid", "start": 322, "end": 327, "id": 56, "ws": false}, {"text": ".", "start": 327, "end": 328, "id": 57, "ws": false}, {"text": ")", "start": 328, "end": 329, "id": 58, "ws": true}, {"text": "1.1", "start": 330, "end": 333, "id": 59, "ws": true}, {"text": "Maintenance", "start": 334, "end": 345, "id": 60, "ws": true}, {"text": "Treatment", "start": 346, "end": 355, "id": 61, "ws": true}, {"text": "of", "start": 356, "end": 358, "id": 62, "ws": true}, {"text": "Asthma", "start": 359, "end": 365, "id": 63, "ws": true}, {"text": "Budesonide", "start": 366, "end": 376, "id": 64, "ws": true}, {"text": "inhalation", "start": 377, "end": 387, "id": 65, "ws": true}, {"text": "suspension", "start": 388, "end": 398, "id": 66, "ws": true}, {"text": "is", "start": 399, "end": 401, "id": 67, "ws": true}, {"text": "indicated", "start": 402, "end": 411, "id": 68, "ws": true}, {"text": "for", "start": 412, "end": 415, "id": 69, "ws": true}, {"text": "the", "start": 416, "end": 419, "id": 70, "ws": true}, {"text": "maintenance", "start": 420, "end": 431, "id": 71, "ws": true}, {"text": "treatment", "start": 432, "end": 441, "id": 72, "ws": true}, {"text": "of", "start": 442, "end": 444, "id": 73, "ws": true}, {"text": "asthma", "start": 445, "end": 451, "id": 74, "ws": true}, {"text": "and", "start": 452, "end": 455, "id": 75, "ws": true}, {"text": "as", "start": 456, "end": 458, "id": 76, "ws": true}, {"text": "prophylactic", "start": 459, "end": 471, "id": 77, "ws": true}, {"text": "therapy", "start": 472, "end": 479, "id": 78, "ws": true}, {"text": "in", "start": 480, "end": 482, "id": 79, "ws": true}, {"text": "children", "start": 483, "end": 491, "id": 80, "ws": true}, {"text": "12", "start": 492, "end": 494, "id": 81, "ws": true}, {"text": "months", "start": 495, "end": 501, "id": 82, "ws": true}, {"text": "to", "start": 502, "end": 504, "id": 83, "ws": true}, {"text": "8", "start": 505, "end": 506, "id": 84, "ws": true}, {"text": "years", "start": 507, "end": 512, "id": 85, "ws": true}, {"text": "of", "start": 513, "end": 515, "id": 86, "ws": true}, {"text": "age", "start": 516, "end": 519, "id": 87, "ws": false}, {"text": ".", "start": 519, "end": 520, "id": 88, "ws": true}, {"text": "Limitations", "start": 521, "end": 532, "id": 89, "ws": true}, {"text": "of", "start": 533, "end": 535, "id": 90, "ws": true}, {"text": "Use", "start": 536, "end": 539, "id": 91, "ws": false}, {"text": ":", "start": 539, "end": 540, "id": 92, "ws": true}, {"text": "Budesonide", "start": 541, "end": 551, "id": 93, "ws": true}, {"text": "inhalation", "start": 552, "end": 562, "id": 94, "ws": true}, {"text": "suspension", "start": 563, "end": 573, "id": 95, "ws": true}, {"text": "is", "start": 574, "end": 576, "id": 96, "ws": true}, {"text": "NOT", "start": 577, "end": 580, "id": 97, "ws": true}, {"text": "indicated", "start": 581, "end": 590, "id": 98, "ws": true}, {"text": "for", "start": 591, "end": 594, "id": 99, "ws": true}, {"text": "the", "start": 595, "end": 598, "id": 100, "ws": true}, {"text": "relief", "start": 599, "end": 605, "id": 101, "ws": true}, {"text": "of", "start": 606, "end": 608, "id": 102, "ws": true}, {"text": "acute", "start": 609, "end": 614, "id": 103, "ws": true}, {"text": "bronchospasm", "start": 615, "end": 627, "id": 104, "ws": false}, {"text": ".", "start": 627, "end": 628, "id": 105, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 21, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 22, "end": 32, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 47, "end": 61, "token_start": 6, "token_end": 6, "label": "MECHANISM"}, {"start": 77, "end": 98, "token_start": 10, "token_end": 11, "label": "ACTION"}, {"start": 102, "end": 108, "token_start": 13, "token_end": 13, "label": "INDICATION"}, {"start": 116, "end": 136, "token_start": 16, "token_end": 17, "label": "ACTION"}, {"start": 140, "end": 176, "token_start": 19, "token_end": 26, "label": "TARGET_GROUP"}, {"start": 238, "end": 288, "token_start": 41, "token_end": 48, "label": "CONTRAINDICATION"}, {"start": 541, "end": 627, "token_start": 93, "token_end": 104, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694177047, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Gabapentin oral solution is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin oral solution is indicated for: Postherpetic neuralgia in adults (1) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy (1)", "_input_hash": 100614927, "_task_hash": 1395287295, "_is_binary": false, "tokens": [{"text": "Gabapentin", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "oral", "start": 11, "end": 15, "id": 1, "ws": true}, {"text": "solution", "start": 16, "end": 24, "id": 2, "ws": true}, {"text": "is", "start": 25, "end": 27, "id": 3, "ws": true}, {"text": "indicated", "start": 28, "end": 37, "id": 4, "ws": true}, {"text": "for", "start": 38, "end": 41, "id": 5, "ws": false}, {"text": ":", "start": 41, "end": 42, "id": 6, "ws": true}, {"text": "Management", "start": 43, "end": 53, "id": 7, "ws": true}, {"text": "of", "start": 54, "end": 56, "id": 8, "ws": true}, {"text": "postherpetic", "start": 57, "end": 69, "id": 9, "ws": true}, {"text": "neuralgia", "start": 70, "end": 79, "id": 10, "ws": true}, {"text": "in", "start": 80, "end": 82, "id": 11, "ws": true}, {"text": "adults", "start": 83, "end": 89, "id": 12, "ws": true}, {"text": "Adjunctive", "start": 90, "end": 100, "id": 13, "ws": true}, {"text": "therapy", "start": 101, "end": 108, "id": 14, "ws": true}, {"text": "in", "start": 109, "end": 111, "id": 15, "ws": true}, {"text": "the", "start": 112, "end": 115, "id": 16, "ws": true}, {"text": "treatment", "start": 116, "end": 125, "id": 17, "ws": true}, {"text": "of", "start": 126, "end": 128, "id": 18, "ws": true}, {"text": "partial", "start": 129, "end": 136, "id": 19, "ws": true}, {"text": "onset", "start": 137, "end": 142, "id": 20, "ws": true}, {"text": "seizures", "start": 143, "end": 151, "id": 21, "ws": false}, {"text": ",", "start": 151, "end": 152, "id": 22, "ws": true}, {"text": "with", "start": 153, "end": 157, "id": 23, "ws": true}, {"text": "and", "start": 158, "end": 161, "id": 24, "ws": true}, {"text": "without", "start": 162, "end": 169, "id": 25, "ws": true}, {"text": "secondary", "start": 170, "end": 179, "id": 26, "ws": true}, {"text": "generalization", "start": 180, "end": 194, "id": 27, "ws": false}, {"text": ",", "start": 194, "end": 195, "id": 28, "ws": true}, {"text": "in", "start": 196, "end": 198, "id": 29, "ws": true}, {"text": "adults", "start": 199, "end": 205, "id": 30, "ws": true}, {"text": "and", "start": 206, "end": 209, "id": 31, "ws": true}, {"text": "pediatric", "start": 210, "end": 219, "id": 32, "ws": true}, {"text": "patients", "start": 220, "end": 228, "id": 33, "ws": true}, {"text": "3", "start": 229, "end": 230, "id": 34, "ws": true}, {"text": "years", "start": 231, "end": 236, "id": 35, "ws": true}, {"text": "and", "start": 237, "end": 240, "id": 36, "ws": true}, {"text": "older", "start": 241, "end": 246, "id": 37, "ws": true}, {"text": "with", "start": 247, "end": 251, "id": 38, "ws": true}, {"text": "epilepsy", "start": 252, "end": 260, "id": 39, "ws": true}, {"text": "Gabapentin", "start": 261, "end": 271, "id": 40, "ws": true}, {"text": "oral", "start": 272, "end": 276, "id": 41, "ws": true}, {"text": "solution", "start": 277, "end": 285, "id": 42, "ws": true}, {"text": "is", "start": 286, "end": 288, "id": 43, "ws": true}, {"text": "indicated", "start": 289, "end": 298, "id": 44, "ws": true}, {"text": "for", "start": 299, "end": 302, "id": 45, "ws": false}, {"text": ":", "start": 302, "end": 303, "id": 46, "ws": true}, {"text": "Postherpetic", "start": 304, "end": 316, "id": 47, "ws": true}, {"text": "neuralgia", "start": 317, "end": 326, "id": 48, "ws": true}, {"text": "in", "start": 327, "end": 329, "id": 49, "ws": true}, {"text": "adults", "start": 330, "end": 336, "id": 50, "ws": true}, {"text": "(", "start": 337, "end": 338, "id": 51, "ws": false}, {"text": "1", "start": 338, "end": 339, "id": 52, "ws": false}, {"text": ")", "start": 339, "end": 340, "id": 53, "ws": true}, {"text": "Adjunctive", "start": 341, "end": 351, "id": 54, "ws": true}, {"text": "therapy", "start": 352, "end": 359, "id": 55, "ws": true}, {"text": "in", "start": 360, "end": 362, "id": 56, "ws": true}, {"text": "the", "start": 363, "end": 366, "id": 57, "ws": true}, {"text": "treatment", "start": 367, "end": 376, "id": 58, "ws": true}, {"text": "of", "start": 377, "end": 379, "id": 59, "ws": true}, {"text": "partial", "start": 380, "end": 387, "id": 60, "ws": true}, {"text": "onset", "start": 388, "end": 393, "id": 61, "ws": true}, {"text": "seizures", "start": 394, "end": 402, "id": 62, "ws": false}, {"text": ",", "start": 402, "end": 403, "id": 63, "ws": true}, {"text": "with", "start": 404, "end": 408, "id": 64, "ws": true}, {"text": "and", "start": 409, "end": 412, "id": 65, "ws": true}, {"text": "without", "start": 413, "end": 420, "id": 66, "ws": true}, {"text": "secondary", "start": 421, "end": 430, "id": 67, "ws": true}, {"text": "generalization", "start": 431, "end": 445, "id": 68, "ws": false}, {"text": ",", "start": 445, "end": 446, "id": 69, "ws": true}, {"text": "in", "start": 447, "end": 449, "id": 70, "ws": true}, {"text": "adults", "start": 450, "end": 456, "id": 71, "ws": true}, {"text": "and", "start": 457, "end": 460, "id": 72, "ws": true}, {"text": "pediatric", "start": 461, "end": 470, "id": 73, "ws": true}, {"text": "patients", "start": 471, "end": 479, "id": 74, "ws": true}, {"text": "3", "start": 480, "end": 481, "id": 75, "ws": true}, {"text": "years", "start": 482, "end": 487, "id": 76, "ws": true}, {"text": "and", "start": 488, "end": 491, "id": 77, "ws": true}, {"text": "older", "start": 492, "end": 497, "id": 78, "ws": true}, {"text": "with", "start": 498, "end": 502, "id": 79, "ws": true}, {"text": "epilepsy", "start": 503, "end": 511, "id": 80, "ws": true}, {"text": "(", "start": 512, "end": 513, "id": 81, "ws": false}, {"text": "1", "start": 513, "end": 514, "id": 82, "ws": false}, {"text": ")", "start": 514, "end": 515, "id": 83, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 15, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 16, "end": 24, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 43, "end": 53, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 57, "end": 79, "token_start": 9, "token_end": 10, "label": "INDICATION"}, {"start": 83, "end": 89, "token_start": 12, "token_end": 12, "label": "TARGET_GROUP"}, {"start": 90, "end": 108, "token_start": 13, "token_end": 14, "label": "ACTION"}, {"start": 129, "end": 151, "token_start": 19, "token_end": 21, "label": "INDICATION"}, {"start": 199, "end": 205, "token_start": 30, "token_end": 30, "label": "TARGET_GROUP"}, {"start": 210, "end": 251, "token_start": 32, "token_end": 38, "label": "TARGET_GROUP"}, {"start": 252, "end": 260, "token_start": 39, "token_end": 39, "label": "BASECONDITION"}, {"start": 261, "end": 271, "token_start": 40, "token_end": 40, "label": "DRUG"}, {"start": 272, "end": 276, "token_start": 41, "token_end": 41, "label": "ROUTE"}, {"start": 277, "end": 285, "token_start": 42, "token_end": 42, "label": "FORMULATION"}, {"start": 304, "end": 326, "token_start": 47, "token_end": 48, "label": "INDICATION"}, {"start": 330, "end": 336, "token_start": 50, "token_end": 50, "label": "TARGET_GROUP"}, {"start": 341, "end": 359, "token_start": 54, "token_end": 55, "label": "ACTION"}, {"start": 380, "end": 402, "token_start": 60, "token_end": 62, "label": "INDICATION"}, {"start": 450, "end": 456, "token_start": 71, "token_end": 71, "label": "TARGET_GROUP"}, {"start": 461, "end": 497, "token_start": 73, "token_end": 78, "label": "TARGET_GROUP"}, {"start": 503, "end": 511, "token_start": 80, "token_end": 80, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527500, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Dilantin is indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. Phenytoin serum level determinations may be necessary for optimal dosage adjustments (see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY sections).", "_input_hash": 380434237, "_task_hash": 508462630, "_is_binary": false, "tokens": [{"text": "Dilantin", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "control", "start": 30, "end": 37, "id": 5, "ws": true}, {"text": "of", "start": 38, "end": 40, "id": 6, "ws": true}, {"text": "generalized", "start": 41, "end": 52, "id": 7, "ws": true}, {"text": "tonic", "start": 53, "end": 58, "id": 8, "ws": false}, {"text": "-", "start": 58, "end": 59, "id": 9, "ws": false}, {"text": "clonic", "start": 59, "end": 65, "id": 10, "ws": true}, {"text": "(", "start": 66, "end": 67, "id": 11, "ws": false}, {"text": "grand", "start": 67, "end": 72, "id": 12, "ws": true}, {"text": "mal", "start": 73, "end": 76, "id": 13, "ws": false}, {"text": ")", "start": 76, "end": 77, "id": 14, "ws": true}, {"text": "and", "start": 78, "end": 81, "id": 15, "ws": true}, {"text": "complex", "start": 82, "end": 89, "id": 16, "ws": true}, {"text": "partial", "start": 90, "end": 97, "id": 17, "ws": true}, {"text": "(", "start": 98, "end": 99, "id": 18, "ws": false}, {"text": "psychomotor", "start": 99, "end": 110, "id": 19, "ws": false}, {"text": ",", "start": 110, "end": 111, "id": 20, "ws": true}, {"text": "temporal", "start": 112, "end": 120, "id": 21, "ws": true}, {"text": "lobe", "start": 121, "end": 125, "id": 22, "ws": false}, {"text": ")", "start": 125, "end": 126, "id": 23, "ws": true}, {"text": "seizures", "start": 127, "end": 135, "id": 24, "ws": true}, {"text": "and", "start": 136, "end": 139, "id": 25, "ws": true}, {"text": "prevention", "start": 140, "end": 150, "id": 26, "ws": true}, {"text": "and", "start": 151, "end": 154, "id": 27, "ws": true}, {"text": "treatment", "start": 155, "end": 164, "id": 28, "ws": true}, {"text": "of", "start": 165, "end": 167, "id": 29, "ws": true}, {"text": "seizures", "start": 168, "end": 176, "id": 30, "ws": true}, {"text": "occurring", "start": 177, "end": 186, "id": 31, "ws": true}, {"text": "during", "start": 187, "end": 193, "id": 32, "ws": true}, {"text": "or", "start": 194, "end": 196, "id": 33, "ws": true}, {"text": "following", "start": 197, "end": 206, "id": 34, "ws": true}, {"text": "neurosurgery", "start": 207, "end": 219, "id": 35, "ws": false}, {"text": ".", "start": 219, "end": 220, "id": 36, "ws": true}, {"text": "Phenytoin", "start": 221, "end": 230, "id": 37, "ws": true}, {"text": "serum", "start": 231, "end": 236, "id": 38, "ws": true}, {"text": "level", "start": 237, "end": 242, "id": 39, "ws": true}, {"text": "determinations", "start": 243, "end": 257, "id": 40, "ws": true}, {"text": "may", "start": 258, "end": 261, "id": 41, "ws": true}, {"text": "be", "start": 262, "end": 264, "id": 42, "ws": true}, {"text": "necessary", "start": 265, "end": 274, "id": 43, "ws": true}, {"text": "for", "start": 275, "end": 278, "id": 44, "ws": true}, {"text": "optimal", "start": 279, "end": 286, "id": 45, "ws": true}, {"text": "dosage", "start": 287, "end": 293, "id": 46, "ws": true}, {"text": "adjustments", "start": 294, "end": 305, "id": 47, "ws": true}, {"text": "(", "start": 306, "end": 307, "id": 48, "ws": false}, {"text": "see", "start": 307, "end": 310, "id": 49, "ws": true}, {"text": "DOSAGE", "start": 311, "end": 317, "id": 50, "ws": true}, {"text": "AND", "start": 318, "end": 321, "id": 51, "ws": true}, {"text": "ADMINISTRATION", "start": 322, "end": 336, "id": 52, "ws": true}, {"text": "and", "start": 337, "end": 340, "id": 53, "ws": true}, {"text": "CLINICAL", "start": 341, "end": 349, "id": 54, "ws": true}, {"text": "PHARMACOLOGY", "start": 350, "end": 362, "id": 55, "ws": true}, {"text": "sections", "start": 363, "end": 371, "id": 56, "ws": false}, {"text": ")", "start": 371, "end": 372, "id": 57, "ws": false}, {"text": ".", "start": 372, "end": 373, "id": 58, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 37, "token_start": 5, "token_end": 5, "label": "DRUG"}, {"start": 41, "end": 65, "token_start": 7, "token_end": 10, "label": "INDICATION"}, {"start": 67, "end": 76, "token_start": 12, "token_end": 13, "label": "INDICATION"}, {"start": 82, "end": 135, "token_start": 16, "token_end": 24, "label": "INDICATION"}, {"start": 140, "end": 150, "token_start": 26, "token_end": 26, "label": "ACTION"}, {"start": 155, "end": 164, "token_start": 28, "token_end": 28, "label": "ACTION"}, {"start": 168, "end": 176, "token_start": 30, "token_end": 30, "label": "INDICATION"}, {"start": 207, "end": 219, "token_start": 35, "token_end": 35, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694176149, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset. The clinical trials performed in support of efficacy were up to six months in duration. The final formal assessments of sleep latency were performed after two days of treatment during the crossover study (elderly only), at five weeks in the six week studies (adults and elderly), and at the end of the six month study (adults and elderly) [see Clinical Studies (14)]. Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset. (1)", "_input_hash": -964288889, "_task_hash": 556053687, "_is_binary": false, "tokens": [{"text": "Ramelteon", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "tablets", "start": 10, "end": 17, "id": 1, "ws": true}, {"text": "are", "start": 18, "end": 21, "id": 2, "ws": true}, {"text": "indicated", "start": 22, "end": 31, "id": 3, "ws": true}, {"text": "for", "start": 32, "end": 35, "id": 4, "ws": true}, {"text": "the", "start": 36, "end": 39, "id": 5, "ws": true}, {"text": "treatment", "start": 40, "end": 49, "id": 6, "ws": true}, {"text": "of", "start": 50, "end": 52, "id": 7, "ws": true}, {"text": "insomnia", "start": 53, "end": 61, "id": 8, "ws": true}, {"text": "characterized", "start": 62, "end": 75, "id": 9, "ws": true}, {"text": "by", "start": 76, "end": 78, "id": 10, "ws": true}, {"text": "difficulty", "start": 79, "end": 89, "id": 11, "ws": true}, {"text": "with", "start": 90, "end": 94, "id": 12, "ws": true}, {"text": "sleep", "start": 95, "end": 100, "id": 13, "ws": true}, {"text": "onset", "start": 101, "end": 106, "id": 14, "ws": false}, {"text": ".", "start": 106, "end": 107, "id": 15, "ws": true}, {"text": "The", "start": 108, "end": 111, "id": 16, "ws": true}, {"text": "clinical", "start": 112, "end": 120, "id": 17, "ws": true}, {"text": "trials", "start": 121, "end": 127, "id": 18, "ws": true}, {"text": "performed", "start": 128, "end": 137, "id": 19, "ws": true}, {"text": "in", "start": 138, "end": 140, "id": 20, "ws": true}, {"text": "support", "start": 141, "end": 148, "id": 21, "ws": true}, {"text": "of", "start": 149, "end": 151, "id": 22, "ws": true}, {"text": "efficacy", "start": 152, "end": 160, "id": 23, "ws": true}, {"text": "were", "start": 161, "end": 165, "id": 24, "ws": true}, {"text": "up", "start": 166, "end": 168, "id": 25, "ws": true}, {"text": "to", "start": 169, "end": 171, "id": 26, "ws": true}, {"text": "six", "start": 172, "end": 175, "id": 27, "ws": true}, {"text": "months", "start": 176, "end": 182, "id": 28, "ws": true}, {"text": "in", "start": 183, "end": 185, "id": 29, "ws": true}, {"text": "duration", "start": 186, "end": 194, "id": 30, "ws": false}, {"text": ".", "start": 194, "end": 195, "id": 31, "ws": true}, {"text": "The", "start": 196, "end": 199, "id": 32, "ws": true}, {"text": "final", "start": 200, "end": 205, "id": 33, "ws": true}, {"text": "formal", "start": 206, "end": 212, "id": 34, "ws": true}, {"text": "assessments", "start": 213, "end": 224, "id": 35, "ws": true}, {"text": "of", "start": 225, "end": 227, "id": 36, "ws": true}, {"text": "sleep", "start": 228, "end": 233, "id": 37, "ws": true}, {"text": "latency", "start": 234, "end": 241, "id": 38, "ws": true}, {"text": "were", "start": 242, "end": 246, "id": 39, "ws": true}, {"text": "performed", "start": 247, "end": 256, "id": 40, "ws": true}, {"text": "after", "start": 257, "end": 262, "id": 41, "ws": true}, {"text": "two", "start": 263, "end": 266, "id": 42, "ws": true}, {"text": "days", "start": 267, "end": 271, "id": 43, "ws": true}, {"text": "of", "start": 272, "end": 274, "id": 44, "ws": true}, {"text": "treatment", "start": 275, "end": 284, "id": 45, "ws": true}, {"text": "during", "start": 285, "end": 291, "id": 46, "ws": true}, {"text": "the", "start": 292, "end": 295, "id": 47, "ws": true}, {"text": "crossover", "start": 296, "end": 305, "id": 48, "ws": true}, {"text": "study", "start": 306, "end": 311, "id": 49, "ws": true}, {"text": "(", "start": 312, "end": 313, "id": 50, "ws": false}, {"text": "elderly", "start": 313, "end": 320, "id": 51, "ws": true}, {"text": "only", "start": 321, "end": 325, "id": 52, "ws": false}, {"text": ")", "start": 325, "end": 326, "id": 53, "ws": false}, {"text": ",", "start": 326, "end": 327, "id": 54, "ws": true}, {"text": "at", "start": 328, "end": 330, "id": 55, "ws": true}, {"text": "five", "start": 331, "end": 335, "id": 56, "ws": true}, {"text": "weeks", "start": 336, "end": 341, "id": 57, "ws": true}, {"text": "in", "start": 342, "end": 344, "id": 58, "ws": true}, {"text": "the", "start": 345, "end": 348, "id": 59, "ws": true}, {"text": "six", "start": 349, "end": 352, "id": 60, "ws": true}, {"text": "week", "start": 353, "end": 357, "id": 61, "ws": true}, {"text": "studies", "start": 358, "end": 365, "id": 62, "ws": true}, {"text": "(", "start": 366, "end": 367, "id": 63, "ws": false}, {"text": "adults", "start": 367, "end": 373, "id": 64, "ws": true}, {"text": "and", "start": 374, "end": 377, "id": 65, "ws": true}, {"text": "elderly", "start": 378, "end": 385, "id": 66, "ws": false}, {"text": ")", "start": 385, "end": 386, "id": 67, "ws": false}, {"text": ",", "start": 386, "end": 387, "id": 68, "ws": true}, {"text": "and", "start": 388, "end": 391, "id": 69, "ws": true}, {"text": "at", "start": 392, "end": 394, "id": 70, "ws": true}, {"text": "the", "start": 395, "end": 398, "id": 71, "ws": true}, {"text": "end", "start": 399, "end": 402, "id": 72, "ws": true}, {"text": "of", "start": 403, "end": 405, "id": 73, "ws": true}, {"text": "the", "start": 406, "end": 409, "id": 74, "ws": true}, {"text": "six", "start": 410, "end": 413, "id": 75, "ws": true}, {"text": "month", "start": 414, "end": 419, "id": 76, "ws": true}, {"text": "study", "start": 420, "end": 425, "id": 77, "ws": true}, {"text": "(", "start": 426, "end": 427, "id": 78, "ws": false}, {"text": "adults", "start": 427, "end": 433, "id": 79, "ws": true}, {"text": "and", "start": 434, "end": 437, "id": 80, "ws": true}, {"text": "elderly", "start": 438, "end": 445, "id": 81, "ws": false}, {"text": ")", "start": 445, "end": 446, "id": 82, "ws": true}, {"text": "[", "start": 447, "end": 448, "id": 83, "ws": false}, {"text": "see", "start": 448, "end": 451, "id": 84, "ws": true}, {"text": "Clinical", "start": 452, "end": 460, "id": 85, "ws": true}, {"text": "Studies", "start": 461, "end": 468, "id": 86, "ws": true}, {"text": "(", "start": 469, "end": 470, "id": 87, "ws": false}, {"text": "14", "start": 470, "end": 472, "id": 88, "ws": false}, {"text": ")", "start": 472, "end": 473, "id": 89, "ws": false}, {"text": "]", "start": 473, "end": 474, "id": 90, "ws": false}, {"text": ".", "start": 474, "end": 475, "id": 91, "ws": true}, {"text": "Ramelteon", "start": 476, "end": 485, "id": 92, "ws": true}, {"text": "tablets", "start": 486, "end": 493, "id": 93, "ws": true}, {"text": "are", "start": 494, "end": 497, "id": 94, "ws": true}, {"text": "indicated", "start": 498, "end": 507, "id": 95, "ws": true}, {"text": "for", "start": 508, "end": 511, "id": 96, "ws": true}, {"text": "the", "start": 512, "end": 515, "id": 97, "ws": true}, {"text": "treatment", "start": 516, "end": 525, "id": 98, "ws": true}, {"text": "of", "start": 526, "end": 528, "id": 99, "ws": true}, {"text": "insomnia", "start": 529, "end": 537, "id": 100, "ws": true}, {"text": "characterized", "start": 538, "end": 551, "id": 101, "ws": true}, {"text": "by", "start": 552, "end": 554, "id": 102, "ws": true}, {"text": "difficulty", "start": 555, "end": 565, "id": 103, "ws": true}, {"text": "with", "start": 566, "end": 570, "id": 104, "ws": true}, {"text": "sleep", "start": 571, "end": 576, "id": 105, "ws": true}, {"text": "onset", "start": 577, "end": 582, "id": 106, "ws": false}, {"text": ".", "start": 582, "end": 583, "id": 107, "ws": true}, {"text": "(", "start": 584, "end": 585, "id": 108, "ws": false}, {"text": "1", "start": 585, "end": 586, "id": 109, "ws": false}, {"text": ")", "start": 586, "end": 587, "id": 110, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 17, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 40, "end": 49, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 53, "end": 61, "token_start": 8, "token_end": 8, "label": "INDICATION"}, {"start": 79, "end": 106, "token_start": 11, "token_end": 14, "label": "SYMPTOM"}], "answer": "accept", "_timestamp": 1694527629, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Loxapine Capsules USP are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.", "_input_hash": -1343974639, "_task_hash": -493693854, "_is_binary": false, "tokens": [{"text": "Loxapine", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "Capsules", "start": 9, "end": 17, "id": 1, "ws": true}, {"text": "USP", "start": 18, "end": 21, "id": 2, "ws": true}, {"text": "are", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "indicated", "start": 26, "end": 35, "id": 4, "ws": true}, {"text": "for", "start": 36, "end": 39, "id": 5, "ws": true}, {"text": "the", "start": 40, "end": 43, "id": 6, "ws": true}, {"text": "treatment", "start": 44, "end": 53, "id": 7, "ws": true}, {"text": "of", "start": 54, "end": 56, "id": 8, "ws": true}, {"text": "schizophrenia", "start": 57, "end": 70, "id": 9, "ws": false}, {"text": ".", "start": 70, "end": 71, "id": 10, "ws": true}, {"text": "The", "start": 72, "end": 75, "id": 11, "ws": true}, {"text": "efficacy", "start": 76, "end": 84, "id": 12, "ws": true}, {"text": "of", "start": 85, "end": 87, "id": 13, "ws": true}, {"text": "loxapine", "start": 88, "end": 96, "id": 14, "ws": true}, {"text": "in", "start": 97, "end": 99, "id": 15, "ws": true}, {"text": "schizophrenia", "start": 100, "end": 113, "id": 16, "ws": true}, {"text": "was", "start": 114, "end": 117, "id": 17, "ws": true}, {"text": "established", "start": 118, "end": 129, "id": 18, "ws": true}, {"text": "in", "start": 130, "end": 132, "id": 19, "ws": true}, {"text": "clinical", "start": 133, "end": 141, "id": 20, "ws": true}, {"text": "studies", "start": 142, "end": 149, "id": 21, "ws": true}, {"text": "which", "start": 150, "end": 155, "id": 22, "ws": true}, {"text": "enrolled", "start": 156, "end": 164, "id": 23, "ws": true}, {"text": "newly", "start": 165, "end": 170, "id": 24, "ws": true}, {"text": "hospitalized", "start": 171, "end": 183, "id": 25, "ws": true}, {"text": "and", "start": 184, "end": 187, "id": 26, "ws": true}, {"text": "chronically", "start": 188, "end": 199, "id": 27, "ws": true}, {"text": "hospitalized", "start": 200, "end": 212, "id": 28, "ws": true}, {"text": "acutely", "start": 213, "end": 220, "id": 29, "ws": true}, {"text": "ill", "start": 221, "end": 224, "id": 30, "ws": true}, {"text": "schizophrenic", "start": 225, "end": 238, "id": 31, "ws": true}, {"text": "patients", "start": 239, "end": 247, "id": 32, "ws": true}, {"text": "as", "start": 248, "end": 250, "id": 33, "ws": true}, {"text": "subjects", "start": 251, "end": 259, "id": 34, "ws": false}, {"text": ".", "start": 259, "end": 260, "id": 35, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 17, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 44, "end": 53, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 57, "end": 70, "token_start": 9, "token_end": 9, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694177365, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "DYMISTA is indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older. DYMISTA contains an H1-receptor antagonist and a corticosteroid, and is indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older. (1)", "_input_hash": 2020882577, "_task_hash": -1147506491, "_is_binary": false, "tokens": [{"text": "DYMISTA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "relief", "start": 29, "end": 35, "id": 5, "ws": true}, {"text": "of", "start": 36, "end": 38, "id": 6, "ws": true}, {"text": "symptoms", "start": 39, "end": 47, "id": 7, "ws": true}, {"text": "of", "start": 48, "end": 50, "id": 8, "ws": true}, {"text": "seasonal", "start": 51, "end": 59, "id": 9, "ws": true}, {"text": "allergic", "start": 60, "end": 68, "id": 10, "ws": true}, {"text": "rhinitis", "start": 69, "end": 77, "id": 11, "ws": true}, {"text": "in", "start": 78, "end": 80, "id": 12, "ws": true}, {"text": "adult", "start": 81, "end": 86, "id": 13, "ws": true}, {"text": "and", "start": 87, "end": 90, "id": 14, "ws": true}, {"text": "pediatric", "start": 91, "end": 100, "id": 15, "ws": true}, {"text": "patients", "start": 101, "end": 109, "id": 16, "ws": true}, {"text": "6", "start": 110, "end": 111, "id": 17, "ws": true}, {"text": "years", "start": 112, "end": 117, "id": 18, "ws": true}, {"text": "of", "start": 118, "end": 120, "id": 19, "ws": true}, {"text": "age", "start": 121, "end": 124, "id": 20, "ws": true}, {"text": "and", "start": 125, "end": 128, "id": 21, "ws": true}, {"text": "older", "start": 129, "end": 134, "id": 22, "ws": false}, {"text": ".", "start": 134, "end": 135, "id": 23, "ws": true}, {"text": "DYMISTA", "start": 136, "end": 143, "id": 24, "ws": true}, {"text": "contains", "start": 144, "end": 152, "id": 25, "ws": true}, {"text": "an", "start": 153, "end": 155, "id": 26, "ws": true}, {"text": "H1", "start": 156, "end": 158, "id": 27, "ws": false}, {"text": "-", "start": 158, "end": 159, "id": 28, "ws": false}, {"text": "receptor", "start": 159, "end": 167, "id": 29, "ws": true}, {"text": "antagonist", "start": 168, "end": 178, "id": 30, "ws": true}, {"text": "and", "start": 179, "end": 182, "id": 31, "ws": true}, {"text": "a", "start": 183, "end": 184, "id": 32, "ws": true}, {"text": "corticosteroid", "start": 185, "end": 199, "id": 33, "ws": false}, {"text": ",", "start": 199, "end": 200, "id": 34, "ws": true}, {"text": "and", "start": 201, "end": 204, "id": 35, "ws": true}, {"text": "is", "start": 205, "end": 207, "id": 36, "ws": true}, {"text": "indicated", "start": 208, "end": 217, "id": 37, "ws": true}, {"text": "for", "start": 218, "end": 221, "id": 38, "ws": true}, {"text": "the", "start": 222, "end": 225, "id": 39, "ws": true}, {"text": "relief", "start": 226, "end": 232, "id": 40, "ws": true}, {"text": "of", "start": 233, "end": 235, "id": 41, "ws": true}, {"text": "symptoms", "start": 236, "end": 244, "id": 42, "ws": true}, {"text": "of", "start": 245, "end": 247, "id": 43, "ws": true}, {"text": "seasonal", "start": 248, "end": 256, "id": 44, "ws": true}, {"text": "allergic", "start": 257, "end": 265, "id": 45, "ws": true}, {"text": "rhinitis", "start": 266, "end": 274, "id": 46, "ws": true}, {"text": "in", "start": 275, "end": 277, "id": 47, "ws": true}, {"text": "adult", "start": 278, "end": 283, "id": 48, "ws": true}, {"text": "and", "start": 284, "end": 287, "id": 49, "ws": true}, {"text": "pediatric", "start": 288, "end": 297, "id": 50, "ws": true}, {"text": "patients", "start": 298, "end": 306, "id": 51, "ws": true}, {"text": "6", "start": 307, "end": 308, "id": 52, "ws": true}, {"text": "years", "start": 309, "end": 314, "id": 53, "ws": true}, {"text": "of", "start": 315, "end": 317, "id": 54, "ws": true}, {"text": "age", "start": 318, "end": 321, "id": 55, "ws": true}, {"text": "and", "start": 322, "end": 325, "id": 56, "ws": true}, {"text": "older", "start": 326, "end": 331, "id": 57, "ws": false}, {"text": ".", "start": 331, "end": 332, "id": 58, "ws": true}, {"text": "(", "start": 333, "end": 334, "id": 59, "ws": false}, {"text": "1", "start": 334, "end": 335, "id": 60, "ws": false}, {"text": ")", "start": 335, "end": 336, "id": 61, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 35, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 39, "end": 47, "token_start": 7, "token_end": 7, "label": "INDICATION"}, {"start": 51, "end": 77, "token_start": 9, "token_end": 11, "label": "BASECONDITION"}, {"start": 81, "end": 86, "token_start": 13, "token_end": 13, "label": "TARGET_GROUP"}, {"start": 91, "end": 134, "token_start": 15, "token_end": 22, "label": "TARGET_GROUP"}, {"start": 136, "end": 143, "token_start": 24, "token_end": 24, "label": "DRUG"}, {"start": 156, "end": 178, "token_start": 27, "token_end": 30, "label": "MECHANISM"}, {"start": 185, "end": 199, "token_start": 33, "token_end": 33, "label": "MECHANISM"}, {"start": 226, "end": 232, "token_start": 40, "token_end": 40, "label": "ACTION"}, {"start": 236, "end": 244, "token_start": 42, "token_end": 42, "label": "INDICATION"}, {"start": 248, "end": 274, "token_start": 44, "token_end": 46, "label": "BASECONDITION"}, {"start": 278, "end": 283, "token_start": 48, "token_end": 48, "label": "TARGET_GROUP"}, {"start": 288, "end": 331, "token_start": 50, "token_end": 57, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694176708, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone.", "_input_hash": 562808813, "_task_hash": 1852094135, "_is_binary": false, "tokens": [{"text": "Edema", "start": 0, "end": 5, "id": 0, "ws": true}, {"text": "Furosemide", "start": 6, "end": 16, "id": 1, "ws": true}, {"text": "is", "start": 17, "end": 19, "id": 2, "ws": true}, {"text": "indicated", "start": 20, "end": 29, "id": 3, "ws": true}, {"text": "in", "start": 30, "end": 32, "id": 4, "ws": true}, {"text": "adults", "start": 33, "end": 39, "id": 5, "ws": true}, {"text": "and", "start": 40, "end": 43, "id": 6, "ws": true}, {"text": "pediatric", "start": 44, "end": 53, "id": 7, "ws": true}, {"text": "patients", "start": 54, "end": 62, "id": 8, "ws": true}, {"text": "for", "start": 63, "end": 66, "id": 9, "ws": true}, {"text": "the", "start": 67, "end": 70, "id": 10, "ws": true}, {"text": "treatment", "start": 71, "end": 80, "id": 11, "ws": true}, {"text": "of", "start": 81, "end": 83, "id": 12, "ws": true}, {"text": "edema", "start": 84, "end": 89, "id": 13, "ws": true}, {"text": "associated", "start": 90, "end": 100, "id": 14, "ws": true}, {"text": "with", "start": 101, "end": 105, "id": 15, "ws": true}, {"text": "congestive", "start": 106, "end": 116, "id": 16, "ws": true}, {"text": "heart", "start": 117, "end": 122, "id": 17, "ws": true}, {"text": "failure", "start": 123, "end": 130, "id": 18, "ws": false}, {"text": ",", "start": 130, "end": 131, "id": 19, "ws": true}, {"text": "cirrhosis", "start": 132, "end": 141, "id": 20, "ws": true}, {"text": "of", "start": 142, "end": 144, "id": 21, "ws": true}, {"text": "the", "start": 145, "end": 148, "id": 22, "ws": true}, {"text": "liver", "start": 149, "end": 154, "id": 23, "ws": true}, {"text": "and", "start": 155, "end": 158, "id": 24, "ws": true}, {"text": "renal", "start": 159, "end": 164, "id": 25, "ws": true}, {"text": "disease", "start": 165, "end": 172, "id": 26, "ws": false}, {"text": ",", "start": 172, "end": 173, "id": 27, "ws": true}, {"text": "including", "start": 174, "end": 183, "id": 28, "ws": true}, {"text": "the", "start": 184, "end": 187, "id": 29, "ws": true}, {"text": "nephrotic", "start": 188, "end": 197, "id": 30, "ws": true}, {"text": "syndrome", "start": 198, "end": 206, "id": 31, "ws": false}, {"text": ".", "start": 206, "end": 207, "id": 32, "ws": true}, {"text": "Furosemide", "start": 208, "end": 218, "id": 33, "ws": true}, {"text": "is", "start": 219, "end": 221, "id": 34, "ws": true}, {"text": "particularly", "start": 222, "end": 234, "id": 35, "ws": true}, {"text": "useful", "start": 235, "end": 241, "id": 36, "ws": true}, {"text": "when", "start": 242, "end": 246, "id": 37, "ws": true}, {"text": "an", "start": 247, "end": 249, "id": 38, "ws": true}, {"text": "agent", "start": 250, "end": 255, "id": 39, "ws": true}, {"text": "with", "start": 256, "end": 260, "id": 40, "ws": true}, {"text": "greater", "start": 261, "end": 268, "id": 41, "ws": true}, {"text": "diuretic", "start": 269, "end": 277, "id": 42, "ws": true}, {"text": "potential", "start": 278, "end": 287, "id": 43, "ws": true}, {"text": "is", "start": 288, "end": 290, "id": 44, "ws": true}, {"text": "desired", "start": 291, "end": 298, "id": 45, "ws": false}, {"text": ".", "start": 298, "end": 299, "id": 46, "ws": true}, {"text": "Hypertension", "start": 300, "end": 312, "id": 47, "ws": true}, {"text": "Oral", "start": 313, "end": 317, "id": 48, "ws": true}, {"text": "furosemide", "start": 318, "end": 328, "id": 49, "ws": true}, {"text": "may", "start": 329, "end": 332, "id": 50, "ws": true}, {"text": "be", "start": 333, "end": 335, "id": 51, "ws": true}, {"text": "used", "start": 336, "end": 340, "id": 52, "ws": true}, {"text": "in", "start": 341, "end": 343, "id": 53, "ws": true}, {"text": "adults", "start": 344, "end": 350, "id": 54, "ws": true}, {"text": "for", "start": 351, "end": 354, "id": 55, "ws": true}, {"text": "the", "start": 355, "end": 358, "id": 56, "ws": true}, {"text": "treatment", "start": 359, "end": 368, "id": 57, "ws": true}, {"text": "of", "start": 369, "end": 371, "id": 58, "ws": true}, {"text": "hypertension", "start": 372, "end": 384, "id": 59, "ws": true}, {"text": "alone", "start": 385, "end": 390, "id": 60, "ws": true}, {"text": "or", "start": 391, "end": 393, "id": 61, "ws": true}, {"text": "in", "start": 394, "end": 396, "id": 62, "ws": true}, {"text": "combination", "start": 397, "end": 408, "id": 63, "ws": true}, {"text": "with", "start": 409, "end": 413, "id": 64, "ws": true}, {"text": "other", "start": 414, "end": 419, "id": 65, "ws": true}, {"text": "antihypertensive", "start": 420, "end": 436, "id": 66, "ws": true}, {"text": "agents", "start": 437, "end": 443, "id": 67, "ws": false}, {"text": ".", "start": 443, "end": 444, "id": 68, "ws": true}, {"text": "Hypertensive", "start": 445, "end": 457, "id": 69, "ws": true}, {"text": "patients", "start": 458, "end": 466, "id": 70, "ws": true}, {"text": "who", "start": 467, "end": 470, "id": 71, "ws": true}, {"text": "can", "start": 471, "end": 474, "id": 72, "ws": false}, {"text": "not", "start": 474, "end": 477, "id": 73, "ws": true}, {"text": "be", "start": 478, "end": 480, "id": 74, "ws": true}, {"text": "adequately", "start": 481, "end": 491, "id": 75, "ws": true}, {"text": "controlled", "start": 492, "end": 502, "id": 76, "ws": true}, {"text": "with", "start": 503, "end": 507, "id": 77, "ws": true}, {"text": "thiazides", "start": 508, "end": 517, "id": 78, "ws": true}, {"text": "will", "start": 518, "end": 522, "id": 79, "ws": true}, {"text": "probably", "start": 523, "end": 531, "id": 80, "ws": true}, {"text": "also", "start": 532, "end": 536, "id": 81, "ws": true}, {"text": "not", "start": 537, "end": 540, "id": 82, "ws": true}, {"text": "be", "start": 541, "end": 543, "id": 83, "ws": true}, {"text": "adequately", "start": 544, "end": 554, "id": 84, "ws": true}, {"text": "controlled", "start": 555, "end": 565, "id": 85, "ws": true}, {"text": "with", "start": 566, "end": 570, "id": 86, "ws": true}, {"text": "furosemide", "start": 571, "end": 581, "id": 87, "ws": true}, {"text": "alone", "start": 582, "end": 587, "id": 88, "ws": false}, {"text": ".", "start": 587, "end": 588, "id": 89, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 16, "token_start": 0, "token_end": 1, "label": "DRUG"}, {"start": 33, "end": 39, "token_start": 5, "token_end": 5, "label": "TARGET_GROUP"}, {"start": 44, "end": 53, "token_start": 7, "token_end": 7, "label": "TARGET_GROUP"}, {"start": 71, "end": 80, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 84, "end": 89, "token_start": 13, "token_end": 13, "label": "INDICATION"}, {"start": 106, "end": 130, "token_start": 16, "token_end": 18, "label": "BASECONDITION"}, {"start": 132, "end": 141, "token_start": 20, "token_end": 20, "label": "BASECONDITION"}, {"start": 149, "end": 154, "token_start": 23, "token_end": 23, "label": "ANATOMY"}, {"start": 159, "end": 172, "token_start": 25, "token_end": 26, "label": "BASECONDITION"}, {"start": 188, "end": 206, "token_start": 30, "token_end": 31, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176962, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Silver Sulfadiazine Cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.", "_input_hash": 969885022, "_task_hash": 163332372, "_is_binary": false, "tokens": [{"text": "Silver", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "Sulfadiazine", "start": 7, "end": 19, "id": 1, "ws": true}, {"text": "Cream", "start": 20, "end": 25, "id": 2, "ws": true}, {"text": "is", "start": 26, "end": 28, "id": 3, "ws": true}, {"text": "a", "start": 29, "end": 30, "id": 4, "ws": true}, {"text": "topical", "start": 31, "end": 38, "id": 5, "ws": true}, {"text": "antimicrobial", "start": 39, "end": 52, "id": 6, "ws": true}, {"text": "drug", "start": 53, "end": 57, "id": 7, "ws": true}, {"text": "indicated", "start": 58, "end": 67, "id": 8, "ws": true}, {"text": "as", "start": 68, "end": 70, "id": 9, "ws": true}, {"text": "an", "start": 71, "end": 73, "id": 10, "ws": true}, {"text": "adjunct", "start": 74, "end": 81, "id": 11, "ws": true}, {"text": "for", "start": 82, "end": 85, "id": 12, "ws": true}, {"text": "the", "start": 86, "end": 89, "id": 13, "ws": true}, {"text": "prevention", "start": 90, "end": 100, "id": 14, "ws": true}, {"text": "and", "start": 101, "end": 104, "id": 15, "ws": true}, {"text": "treatment", "start": 105, "end": 114, "id": 16, "ws": true}, {"text": "of", "start": 115, "end": 117, "id": 17, "ws": true}, {"text": "wound", "start": 118, "end": 123, "id": 18, "ws": true}, {"text": "sepsis", "start": 124, "end": 130, "id": 19, "ws": true}, {"text": "in", "start": 131, "end": 133, "id": 20, "ws": true}, {"text": "patients", "start": 134, "end": 142, "id": 21, "ws": true}, {"text": "with", "start": 143, "end": 147, "id": 22, "ws": true}, {"text": "second", "start": 148, "end": 154, "id": 23, "ws": true}, {"text": "and", "start": 155, "end": 158, "id": 24, "ws": true}, {"text": "third", "start": 159, "end": 164, "id": 25, "ws": true}, {"text": "degree", "start": 165, "end": 171, "id": 26, "ws": true}, {"text": "burns", "start": 172, "end": 177, "id": 27, "ws": false}, {"text": ".", "start": 177, "end": 178, "id": 28, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 7, "end": 19, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 20, "end": 25, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 31, "end": 38, "token_start": 5, "token_end": 5, "label": "ROUTE"}, {"start": 39, "end": 52, "token_start": 6, "token_end": 6, "label": "ROUTE"}, {"start": 74, "end": 81, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 90, "end": 100, "token_start": 14, "token_end": 14, "label": "ACTION"}, {"start": 105, "end": 114, "token_start": 16, "token_end": 16, "label": "ACTION"}, {"start": 118, "end": 130, "token_start": 18, "token_end": 19, "label": "INDICATION"}, {"start": 148, "end": 177, "token_start": 23, "token_end": 27, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527606, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimers type. NAMENDA is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimers type. (1)", "_input_hash": -555894035, "_task_hash": -803006678, "_is_binary": false, "tokens": [{"text": "NAMENDA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "(", "start": 8, "end": 9, "id": 1, "ws": false}, {"text": "memantine", "start": 9, "end": 18, "id": 2, "ws": true}, {"text": "hydrochloride", "start": 19, "end": 32, "id": 3, "ws": false}, {"text": ")", "start": 32, "end": 33, "id": 4, "ws": true}, {"text": "is", "start": 34, "end": 36, "id": 5, "ws": true}, {"text": "indicated", "start": 37, "end": 46, "id": 6, "ws": true}, {"text": "for", "start": 47, "end": 50, "id": 7, "ws": true}, {"text": "the", "start": 51, "end": 54, "id": 8, "ws": true}, {"text": "treatment", "start": 55, "end": 64, "id": 9, "ws": true}, {"text": "of", "start": 65, "end": 67, "id": 10, "ws": true}, {"text": "moderate", "start": 68, "end": 76, "id": 11, "ws": true}, {"text": "to", "start": 77, "end": 79, "id": 12, "ws": true}, {"text": "severe", "start": 80, "end": 86, "id": 13, "ws": true}, {"text": "dementia", "start": 87, "end": 95, "id": 14, "ws": true}, {"text": "of", "start": 96, "end": 98, "id": 15, "ws": true}, {"text": "the", "start": 99, "end": 102, "id": 16, "ws": true}, {"text": "Alzheimers", "start": 103, "end": 113, "id": 17, "ws": true}, {"text": "type", "start": 114, "end": 118, "id": 18, "ws": false}, {"text": ".", "start": 118, "end": 119, "id": 19, "ws": true}, {"text": "NAMENDA", "start": 120, "end": 127, "id": 20, "ws": true}, {"text": "is", "start": 128, "end": 130, "id": 21, "ws": true}, {"text": "a", "start": 131, "end": 132, "id": 22, "ws": true}, {"text": "N", "start": 133, "end": 134, "id": 23, "ws": false}, {"text": "-", "start": 134, "end": 135, "id": 24, "ws": false}, {"text": "methyl", "start": 135, "end": 141, "id": 25, "ws": false}, {"text": "-", "start": 141, "end": 142, "id": 26, "ws": false}, {"text": "D", "start": 142, "end": 143, "id": 27, "ws": false}, {"text": "-", "start": 143, "end": 144, "id": 28, "ws": false}, {"text": "aspartate", "start": 144, "end": 153, "id": 29, "ws": true}, {"text": "(", "start": 154, "end": 155, "id": 30, "ws": false}, {"text": "NMDA", "start": 155, "end": 159, "id": 31, "ws": false}, {"text": ")", "start": 159, "end": 160, "id": 32, "ws": true}, {"text": "receptor", "start": 161, "end": 169, "id": 33, "ws": true}, {"text": "antagonist", "start": 170, "end": 180, "id": 34, "ws": true}, {"text": "indicated", "start": 181, "end": 190, "id": 35, "ws": true}, {"text": "for", "start": 191, "end": 194, "id": 36, "ws": true}, {"text": "the", "start": 195, "end": 198, "id": 37, "ws": true}, {"text": "treatment", "start": 199, "end": 208, "id": 38, "ws": true}, {"text": "of", "start": 209, "end": 211, "id": 39, "ws": true}, {"text": "moderate", "start": 212, "end": 220, "id": 40, "ws": true}, {"text": "to", "start": 221, "end": 223, "id": 41, "ws": true}, {"text": "severe", "start": 224, "end": 230, "id": 42, "ws": true}, {"text": "dementia", "start": 231, "end": 239, "id": 43, "ws": true}, {"text": "of", "start": 240, "end": 242, "id": 44, "ws": true}, {"text": "the", "start": 243, "end": 246, "id": 45, "ws": true}, {"text": "Alzheimers", "start": 247, "end": 257, "id": 46, "ws": true}, {"text": "type", "start": 258, "end": 262, "id": 47, "ws": false}, {"text": ".", "start": 262, "end": 263, "id": 48, "ws": true}, {"text": "(", "start": 264, "end": 265, "id": 49, "ws": false}, {"text": "1", "start": 265, "end": 266, "id": 50, "ws": false}, {"text": ")", "start": 266, "end": 267, "id": 51, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 18, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 19, "end": 32, "token_start": 3, "token_end": 3, "label": "SALT"}, {"start": 55, "end": 64, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 68, "end": 86, "token_start": 11, "token_end": 13, "label": "SEVERITY"}, {"start": 87, "end": 95, "token_start": 14, "token_end": 14, "label": "INDICATION"}, {"start": 103, "end": 113, "token_start": 17, "token_end": 17, "label": "BASECONDITION"}, {"start": 133, "end": 180, "token_start": 23, "token_end": 34, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694525918, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "NORITATE is indicated for the topical treatment of inflammatory lesions and erythema of rosacea.", "_input_hash": 1499447825, "_task_hash": -1211208757, "_is_binary": false, "tokens": [{"text": "NORITATE", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "topical", "start": 30, "end": 37, "id": 5, "ws": true}, {"text": "treatment", "start": 38, "end": 47, "id": 6, "ws": true}, {"text": "of", "start": 48, "end": 50, "id": 7, "ws": true}, {"text": "inflammatory", "start": 51, "end": 63, "id": 8, "ws": true}, {"text": "lesions", "start": 64, "end": 71, "id": 9, "ws": true}, {"text": "and", "start": 72, "end": 75, "id": 10, "ws": true}, {"text": "erythema", "start": 76, "end": 84, "id": 11, "ws": true}, {"text": "of", "start": 85, "end": 87, "id": 12, "ws": true}, {"text": "rosacea", "start": 88, "end": 95, "id": 13, "ws": false}, {"text": ".", "start": 95, "end": 96, "id": 14, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 38, "end": 47, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 51, "end": 71, "token_start": 8, "token_end": 9, "label": "INDICATION"}, {"start": 76, "end": 95, "token_start": 11, "token_end": 13, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694176451, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Simpesse (levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy. Simpesse is a combination of levonorgestrel, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. (1)", "_input_hash": -479754088, "_task_hash": 1346677251, "_is_binary": false, "tokens": [{"text": "Simpesse", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "(", "start": 9, "end": 10, "id": 1, "ws": false}, {"text": "levonorgestrel", "start": 10, "end": 24, "id": 2, "ws": true}, {"text": "and", "start": 25, "end": 28, "id": 3, "ws": true}, {"text": "ethinyl", "start": 29, "end": 36, "id": 4, "ws": true}, {"text": "estradiol", "start": 37, "end": 46, "id": 5, "ws": true}, {"text": "tablets", "start": 47, "end": 54, "id": 6, "ws": true}, {"text": "and", "start": 55, "end": 58, "id": 7, "ws": true}, {"text": "ethinyl", "start": 59, "end": 66, "id": 8, "ws": true}, {"text": "estradiol", "start": 67, "end": 76, "id": 9, "ws": true}, {"text": "tablets", "start": 77, "end": 84, "id": 10, "ws": false}, {"text": ")", "start": 84, "end": 85, "id": 11, "ws": true}, {"text": "is", "start": 86, "end": 88, "id": 12, "ws": true}, {"text": "indicated", "start": 89, "end": 98, "id": 13, "ws": true}, {"text": "for", "start": 99, "end": 102, "id": 14, "ws": true}, {"text": "use", "start": 103, "end": 106, "id": 15, "ws": true}, {"text": "by", "start": 107, "end": 109, "id": 16, "ws": true}, {"text": "females", "start": 110, "end": 117, "id": 17, "ws": true}, {"text": "of", "start": 118, "end": 120, "id": 18, "ws": true}, {"text": "reproductive", "start": 121, "end": 133, "id": 19, "ws": true}, {"text": "potential", "start": 134, "end": 143, "id": 20, "ws": true}, {"text": "to", "start": 144, "end": 146, "id": 21, "ws": true}, {"text": "prevent", "start": 147, "end": 154, "id": 22, "ws": true}, {"text": "pregnancy", "start": 155, "end": 164, "id": 23, "ws": false}, {"text": ".", "start": 164, "end": 165, "id": 24, "ws": true}, {"text": "Simpesse", "start": 166, "end": 174, "id": 25, "ws": true}, {"text": "is", "start": 175, "end": 177, "id": 26, "ws": true}, {"text": "a", "start": 178, "end": 179, "id": 27, "ws": true}, {"text": "combination", "start": 180, "end": 191, "id": 28, "ws": true}, {"text": "of", "start": 192, "end": 194, "id": 29, "ws": true}, {"text": "levonorgestrel", "start": 195, "end": 209, "id": 30, "ws": false}, {"text": ",", "start": 209, "end": 210, "id": 31, "ws": true}, {"text": "a", "start": 211, "end": 212, "id": 32, "ws": true}, {"text": "progestin", "start": 213, "end": 222, "id": 33, "ws": false}, {"text": ",", "start": 222, "end": 223, "id": 34, "ws": true}, {"text": "and", "start": 224, "end": 227, "id": 35, "ws": true}, {"text": "ethinyl", "start": 228, "end": 235, "id": 36, "ws": true}, {"text": "estradiol", "start": 236, "end": 245, "id": 37, "ws": false}, {"text": ",", "start": 245, "end": 246, "id": 38, "ws": true}, {"text": "an", "start": 247, "end": 249, "id": 39, "ws": true}, {"text": "estrogen", "start": 250, "end": 258, "id": 40, "ws": false}, {"text": ",", "start": 258, "end": 259, "id": 41, "ws": true}, {"text": "indicated", "start": 260, "end": 269, "id": 42, "ws": true}, {"text": "for", "start": 270, "end": 273, "id": 43, "ws": true}, {"text": "use", "start": 274, "end": 277, "id": 44, "ws": true}, {"text": "by", "start": 278, "end": 280, "id": 45, "ws": true}, {"text": "females", "start": 281, "end": 288, "id": 46, "ws": true}, {"text": "of", "start": 289, "end": 291, "id": 47, "ws": true}, {"text": "reproductive", "start": 292, "end": 304, "id": 48, "ws": true}, {"text": "potential", "start": 305, "end": 314, "id": 49, "ws": true}, {"text": "to", "start": 315, "end": 317, "id": 50, "ws": true}, {"text": "prevent", "start": 318, "end": 325, "id": 51, "ws": true}, {"text": "pregnancy", "start": 326, "end": 335, "id": 52, "ws": false}, {"text": ".", "start": 335, "end": 336, "id": 53, "ws": true}, {"text": "(", "start": 337, "end": 338, "id": 54, "ws": false}, {"text": "1", "start": 338, "end": 339, "id": 55, "ws": false}, {"text": ")", "start": 339, "end": 340, "id": 56, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 24, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 29, "end": 46, "token_start": 4, "token_end": 5, "label": "DRUG"}, {"start": 47, "end": 54, "token_start": 6, "token_end": 6, "label": "FORMULATION"}, {"start": 59, "end": 76, "token_start": 8, "token_end": 9, "label": "DRUG"}, {"start": 77, "end": 84, "token_start": 10, "token_end": 10, "label": "FORMULATION"}, {"start": 110, "end": 143, "token_start": 17, "token_end": 20, "label": "TARGET_GROUP"}, {"start": 147, "end": 154, "token_start": 22, "token_end": 22, "label": "ACTION"}, {"start": 155, "end": 164, "token_start": 23, "token_end": 23, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694177438, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Complex HQ Plus is indicated for the gradual lightening of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigenes, and other unwanted areas of melanin hyperpigmention.", "_input_hash": 1720079419, "_task_hash": 268423163, "_is_binary": false, "tokens": [{"text": "Complex", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "HQ", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "Plus", "start": 11, "end": 15, "id": 2, "ws": true}, {"text": "is", "start": 16, "end": 18, "id": 3, "ws": true}, {"text": "indicated", "start": 19, "end": 28, "id": 4, "ws": true}, {"text": "for", "start": 29, "end": 32, "id": 5, "ws": true}, {"text": "the", "start": 33, "end": 36, "id": 6, "ws": true}, {"text": "gradual", "start": 37, "end": 44, "id": 7, "ws": true}, {"text": "lightening", "start": 45, "end": 55, "id": 8, "ws": true}, {"text": "of", "start": 56, "end": 58, "id": 9, "ws": true}, {"text": "hyperpigmented", "start": 59, "end": 73, "id": 10, "ws": true}, {"text": "skin", "start": 74, "end": 78, "id": 11, "ws": true}, {"text": "conditions", "start": 79, "end": 89, "id": 12, "ws": true}, {"text": "such", "start": 90, "end": 94, "id": 13, "ws": true}, {"text": "as", "start": 95, "end": 97, "id": 14, "ws": true}, {"text": "chloasma", "start": 98, "end": 106, "id": 15, "ws": false}, {"text": ",", "start": 106, "end": 107, "id": 16, "ws": true}, {"text": "melasma", "start": 108, "end": 115, "id": 17, "ws": false}, {"text": ",", "start": 115, "end": 116, "id": 18, "ws": true}, {"text": "freckles", "start": 117, "end": 125, "id": 19, "ws": false}, {"text": ",", "start": 125, "end": 126, "id": 20, "ws": true}, {"text": "senile", "start": 127, "end": 133, "id": 21, "ws": true}, {"text": "lentigenes", "start": 134, "end": 144, "id": 22, "ws": false}, {"text": ",", "start": 144, "end": 145, "id": 23, "ws": true}, {"text": "and", "start": 146, "end": 149, "id": 24, "ws": true}, {"text": "other", "start": 150, "end": 155, "id": 25, "ws": true}, {"text": "unwanted", "start": 156, "end": 164, "id": 26, "ws": true}, {"text": "areas", "start": 165, "end": 170, "id": 27, "ws": true}, {"text": "of", "start": 171, "end": 173, "id": 28, "ws": true}, {"text": "melanin", "start": 174, "end": 181, "id": 29, "ws": true}, {"text": "hyperpigmention", "start": 182, "end": 197, "id": 30, "ws": false}, {"text": ".", "start": 197, "end": 198, "id": 31, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 15, "token_start": 0, "token_end": 2, "label": "DRUG"}, {"start": 37, "end": 55, "token_start": 7, "token_end": 8, "label": "ACTION"}, {"start": 59, "end": 89, "token_start": 10, "token_end": 12, "label": "INDICATION"}, {"start": 98, "end": 106, "token_start": 15, "token_end": 15, "label": "INDICATION"}, {"start": 108, "end": 115, "token_start": 17, "token_end": 17, "label": "INDICATION"}, {"start": 117, "end": 125, "token_start": 19, "token_end": 19, "label": "INDICATION"}, {"start": 127, "end": 144, "token_start": 21, "token_end": 22, "label": "INDICATION"}, {"start": 156, "end": 164, "token_start": 26, "token_end": 26, "label": "SEVERITY"}, {"start": 174, "end": 197, "token_start": 29, "token_end": 30, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694525861, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Sucralfate OralSuspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.", "_input_hash": -478689226, "_task_hash": 1455483142, "_is_binary": false, "tokens": [{"text": "Sucralfate", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "OralSuspension", "start": 11, "end": 25, "id": 1, "ws": true}, {"text": "is", "start": 26, "end": 28, "id": 2, "ws": true}, {"text": "indicated", "start": 29, "end": 38, "id": 3, "ws": true}, {"text": "in", "start": 39, "end": 41, "id": 4, "ws": true}, {"text": "the", "start": 42, "end": 45, "id": 5, "ws": true}, {"text": "short", "start": 46, "end": 51, "id": 6, "ws": false}, {"text": "-", "start": 51, "end": 52, "id": 7, "ws": false}, {"text": "term", "start": 52, "end": 56, "id": 8, "ws": true}, {"text": "(", "start": 57, "end": 58, "id": 9, "ws": false}, {"text": "up", "start": 58, "end": 60, "id": 10, "ws": true}, {"text": "to", "start": 61, "end": 63, "id": 11, "ws": true}, {"text": "8", "start": 64, "end": 65, "id": 12, "ws": true}, {"text": "weeks", "start": 66, "end": 71, "id": 13, "ws": false}, {"text": ")", "start": 71, "end": 72, "id": 14, "ws": true}, {"text": "treatment", "start": 73, "end": 82, "id": 15, "ws": true}, {"text": "of", "start": 83, "end": 85, "id": 16, "ws": true}, {"text": "active", "start": 86, "end": 92, "id": 17, "ws": true}, {"text": "duodenal", "start": 93, "end": 101, "id": 18, "ws": true}, {"text": "ulcer", "start": 102, "end": 107, "id": 19, "ws": false}, {"text": ".", "start": 107, "end": 108, "id": 20, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 73, "end": 85, "token_start": 15, "token_end": 16, "label": "ACTION"}, {"start": 86, "end": 107, "token_start": 17, "token_end": 19, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694174575, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Budesonide extended-release tablets are indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. Budesonide extended-release tablets are a glucocorticosteroid indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. (1)", "_input_hash": -738035612, "_task_hash": 1303505978, "_is_binary": false, "tokens": [{"text": "Budesonide", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "extended", "start": 11, "end": 19, "id": 1, "ws": false}, {"text": "-", "start": 19, "end": 20, "id": 2, "ws": false}, {"text": "release", "start": 20, "end": 27, "id": 3, "ws": true}, {"text": "tablets", "start": 28, "end": 35, "id": 4, "ws": true}, {"text": "are", "start": 36, "end": 39, "id": 5, "ws": true}, {"text": "indicated", "start": 40, "end": 49, "id": 6, "ws": true}, {"text": "for", "start": 50, "end": 53, "id": 7, "ws": true}, {"text": "the", "start": 54, "end": 57, "id": 8, "ws": true}, {"text": "induction", "start": 58, "end": 67, "id": 9, "ws": true}, {"text": "of", "start": 68, "end": 70, "id": 10, "ws": true}, {"text": "remission", "start": 71, "end": 80, "id": 11, "ws": true}, {"text": "in", "start": 81, "end": 83, "id": 12, "ws": true}, {"text": "patients", "start": 84, "end": 92, "id": 13, "ws": true}, {"text": "with", "start": 93, "end": 97, "id": 14, "ws": true}, {"text": "active", "start": 98, "end": 104, "id": 15, "ws": false}, {"text": ",", "start": 104, "end": 105, "id": 16, "ws": true}, {"text": "mild", "start": 106, "end": 110, "id": 17, "ws": true}, {"text": "to", "start": 111, "end": 113, "id": 18, "ws": true}, {"text": "moderate", "start": 114, "end": 122, "id": 19, "ws": true}, {"text": "ulcerative", "start": 123, "end": 133, "id": 20, "ws": true}, {"text": "colitis", "start": 134, "end": 141, "id": 21, "ws": false}, {"text": ".", "start": 141, "end": 142, "id": 22, "ws": true}, {"text": "Budesonide", "start": 143, "end": 153, "id": 23, "ws": true}, {"text": "extended", "start": 154, "end": 162, "id": 24, "ws": false}, {"text": "-", "start": 162, "end": 163, "id": 25, "ws": false}, {"text": "release", "start": 163, "end": 170, "id": 26, "ws": true}, {"text": "tablets", "start": 171, "end": 178, "id": 27, "ws": true}, {"text": "are", "start": 179, "end": 182, "id": 28, "ws": true}, {"text": "a", "start": 183, "end": 184, "id": 29, "ws": true}, {"text": "glucocorticosteroid", "start": 185, "end": 204, "id": 30, "ws": true}, {"text": "indicated", "start": 205, "end": 214, "id": 31, "ws": true}, {"text": "for", "start": 215, "end": 218, "id": 32, "ws": true}, {"text": "the", "start": 219, "end": 222, "id": 33, "ws": true}, {"text": "induction", "start": 223, "end": 232, "id": 34, "ws": true}, {"text": "of", "start": 233, "end": 235, "id": 35, "ws": true}, {"text": "remission", "start": 236, "end": 245, "id": 36, "ws": true}, {"text": "in", "start": 246, "end": 248, "id": 37, "ws": true}, {"text": "patients", "start": 249, "end": 257, "id": 38, "ws": true}, {"text": "with", "start": 258, "end": 262, "id": 39, "ws": true}, {"text": "active", "start": 263, "end": 269, "id": 40, "ws": false}, {"text": ",", "start": 269, "end": 270, "id": 41, "ws": true}, {"text": "mild", "start": 271, "end": 275, "id": 42, "ws": true}, {"text": "to", "start": 276, "end": 278, "id": 43, "ws": true}, {"text": "moderate", "start": 279, "end": 287, "id": 44, "ws": true}, {"text": "ulcerative", "start": 288, "end": 298, "id": 45, "ws": true}, {"text": "colitis", "start": 299, "end": 306, "id": 46, "ws": false}, {"text": ".", "start": 306, "end": 307, "id": 47, "ws": true}, {"text": "(", "start": 308, "end": 309, "id": 48, "ws": false}, {"text": "1", "start": 309, "end": 310, "id": 49, "ws": false}, {"text": ")", "start": 310, "end": 311, "id": 50, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 35, "token_start": 1, "token_end": 4, "label": "FORMULATION"}, {"start": 58, "end": 80, "token_start": 9, "token_end": 11, "label": "EFFECT"}, {"start": 98, "end": 122, "token_start": 15, "token_end": 19, "label": "SEVERITY"}, {"start": 123, "end": 141, "token_start": 20, "token_end": 21, "label": "INDICATION"}, {"start": 143, "end": 153, "token_start": 23, "token_end": 23, "label": "DRUG"}, {"start": 154, "end": 178, "token_start": 24, "token_end": 27, "label": "FORMULATION"}, {"start": 185, "end": 204, "token_start": 30, "token_end": 30, "label": "MECHANISM"}, {"start": 223, "end": 245, "token_start": 34, "token_end": 36, "label": "ACTION"}, {"start": 263, "end": 287, "token_start": 40, "token_end": 44, "label": "SEVERITY"}, {"start": 288, "end": 306, "token_start": 45, "token_end": 46, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526520, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "SAJAZIR (icatibant) injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. SAJAZIR (icatibant) injection is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. (1)", "_input_hash": 1190904131, "_task_hash": 1672995852, "_is_binary": false, "tokens": [{"text": "SAJAZIR", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "(", "start": 8, "end": 9, "id": 1, "ws": false}, {"text": "icatibant", "start": 9, "end": 18, "id": 2, "ws": false}, {"text": ")", "start": 18, "end": 19, "id": 3, "ws": true}, {"text": "injection", "start": 20, "end": 29, "id": 4, "ws": true}, {"text": "is", "start": 30, "end": 32, "id": 5, "ws": true}, {"text": "indicated", "start": 33, "end": 42, "id": 6, "ws": true}, {"text": "for", "start": 43, "end": 46, "id": 7, "ws": true}, {"text": "the", "start": 47, "end": 50, "id": 8, "ws": true}, {"text": "treatment", "start": 51, "end": 60, "id": 9, "ws": true}, {"text": "of", "start": 61, "end": 63, "id": 10, "ws": true}, {"text": "acute", "start": 64, "end": 69, "id": 11, "ws": true}, {"text": "attacks", "start": 70, "end": 77, "id": 12, "ws": true}, {"text": "of", "start": 78, "end": 80, "id": 13, "ws": true}, {"text": "hereditary", "start": 81, "end": 91, "id": 14, "ws": true}, {"text": "angioedema", "start": 92, "end": 102, "id": 15, "ws": true}, {"text": "(", "start": 103, "end": 104, "id": 16, "ws": false}, {"text": "HAE", "start": 104, "end": 107, "id": 17, "ws": false}, {"text": ")", "start": 107, "end": 108, "id": 18, "ws": true}, {"text": "in", "start": 109, "end": 111, "id": 19, "ws": true}, {"text": "adults", "start": 112, "end": 118, "id": 20, "ws": true}, {"text": "18", "start": 119, "end": 121, "id": 21, "ws": true}, {"text": "years", "start": 122, "end": 127, "id": 22, "ws": true}, {"text": "of", "start": 128, "end": 130, "id": 23, "ws": true}, {"text": "age", "start": 131, "end": 134, "id": 24, "ws": true}, {"text": "and", "start": 135, "end": 138, "id": 25, "ws": true}, {"text": "older", "start": 139, "end": 144, "id": 26, "ws": false}, {"text": ".", "start": 144, "end": 145, "id": 27, "ws": true}, {"text": "SAJAZIR", "start": 146, "end": 153, "id": 28, "ws": true}, {"text": "(", "start": 154, "end": 155, "id": 29, "ws": false}, {"text": "icatibant", "start": 155, "end": 164, "id": 30, "ws": false}, {"text": ")", "start": 164, "end": 165, "id": 31, "ws": true}, {"text": "injection", "start": 166, "end": 175, "id": 32, "ws": true}, {"text": "is", "start": 176, "end": 178, "id": 33, "ws": true}, {"text": "a", "start": 179, "end": 180, "id": 34, "ws": true}, {"text": "bradykinin", "start": 181, "end": 191, "id": 35, "ws": true}, {"text": "B2", "start": 192, "end": 194, "id": 36, "ws": true}, {"text": "receptor", "start": 195, "end": 203, "id": 37, "ws": true}, {"text": "antagonist", "start": 204, "end": 214, "id": 38, "ws": true}, {"text": "indicated", "start": 215, "end": 224, "id": 39, "ws": true}, {"text": "for", "start": 225, "end": 228, "id": 40, "ws": true}, {"text": "treatment", "start": 229, "end": 238, "id": 41, "ws": true}, {"text": "of", "start": 239, "end": 241, "id": 42, "ws": true}, {"text": "acute", "start": 242, "end": 247, "id": 43, "ws": true}, {"text": "attacks", "start": 248, "end": 255, "id": 44, "ws": true}, {"text": "of", "start": 256, "end": 258, "id": 45, "ws": true}, {"text": "hereditary", "start": 259, "end": 269, "id": 46, "ws": true}, {"text": "angioedema", "start": 270, "end": 280, "id": 47, "ws": true}, {"text": "(", "start": 281, "end": 282, "id": 48, "ws": false}, {"text": "HAE", "start": 282, "end": 285, "id": 49, "ws": false}, {"text": ")", "start": 285, "end": 286, "id": 50, "ws": true}, {"text": "in", "start": 287, "end": 289, "id": 51, "ws": true}, {"text": "adults", "start": 290, "end": 296, "id": 52, "ws": true}, {"text": "18", "start": 297, "end": 299, "id": 53, "ws": true}, {"text": "years", "start": 300, "end": 305, "id": 54, "ws": true}, {"text": "of", "start": 306, "end": 308, "id": 55, "ws": true}, {"text": "age", "start": 309, "end": 312, "id": 56, "ws": true}, {"text": "and", "start": 313, "end": 316, "id": 57, "ws": true}, {"text": "older", "start": 317, "end": 322, "id": 58, "ws": false}, {"text": ".", "start": 322, "end": 323, "id": 59, "ws": true}, {"text": "(", "start": 324, "end": 325, "id": 60, "ws": false}, {"text": "1", "start": 325, "end": 326, "id": 61, "ws": false}, {"text": ")", "start": 326, "end": 327, "id": 62, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 18, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 20, "end": 29, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 51, "end": 60, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 81, "end": 102, "token_start": 14, "token_end": 15, "label": "BASECONDITION"}, {"start": 112, "end": 144, "token_start": 20, "token_end": 26, "label": "BASECONDITION"}, {"start": 146, "end": 153, "token_start": 28, "token_end": 28, "label": "DRUG"}, {"start": 155, "end": 164, "token_start": 30, "token_end": 30, "label": "DRUG"}, {"start": 166, "end": 175, "token_start": 32, "token_end": 32, "label": "FORMULATION"}, {"start": 181, "end": 214, "token_start": 35, "token_end": 38, "label": "MECHANISM"}, {"start": 229, "end": 238, "token_start": 41, "token_end": 41, "label": "ACTION"}, {"start": 259, "end": 280, "token_start": 46, "token_end": 47, "label": "BASECONDITION"}, {"start": 290, "end": 322, "token_start": 52, "token_end": 58, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694175823, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Lidocaine hydrochloride jelly USP, 2% (Anestacon) is indicated for prevention and control of pain in procedures involving the male and female urethra, for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal).", "_input_hash": 627044384, "_task_hash": 1081252722, "_is_binary": false, "tokens": [{"text": "Lidocaine", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 10, "end": 23, "id": 1, "ws": true}, {"text": "jelly", "start": 24, "end": 29, "id": 2, "ws": true}, {"text": "USP", "start": 30, "end": 33, "id": 3, "ws": false}, {"text": ",", "start": 33, "end": 34, "id": 4, "ws": true}, {"text": "2", "start": 35, "end": 36, "id": 5, "ws": false}, {"text": "%", "start": 36, "end": 37, "id": 6, "ws": true}, {"text": "(", "start": 38, "end": 39, "id": 7, "ws": false}, {"text": "Anestacon", "start": 39, "end": 48, "id": 8, "ws": false}, {"text": ")", "start": 48, "end": 49, "id": 9, "ws": true}, {"text": "is", "start": 50, "end": 52, "id": 10, "ws": true}, {"text": "indicated", "start": 53, "end": 62, "id": 11, "ws": true}, {"text": "for", "start": 63, "end": 66, "id": 12, "ws": true}, {"text": "prevention", "start": 67, "end": 77, "id": 13, "ws": true}, {"text": "and", "start": 78, "end": 81, "id": 14, "ws": true}, {"text": "control", "start": 82, "end": 89, "id": 15, "ws": true}, {"text": "of", "start": 90, "end": 92, "id": 16, "ws": true}, {"text": "pain", "start": 93, "end": 97, "id": 17, "ws": true}, {"text": "in", "start": 98, "end": 100, "id": 18, "ws": true}, {"text": "procedures", "start": 101, "end": 111, "id": 19, "ws": true}, {"text": "involving", "start": 112, "end": 121, "id": 20, "ws": true}, {"text": "the", "start": 122, "end": 125, "id": 21, "ws": true}, {"text": "male", "start": 126, "end": 130, "id": 22, "ws": true}, {"text": "and", "start": 131, "end": 134, "id": 23, "ws": true}, {"text": "female", "start": 135, "end": 141, "id": 24, "ws": true}, {"text": "urethra", "start": 142, "end": 149, "id": 25, "ws": false}, {"text": ",", "start": 149, "end": 150, "id": 26, "ws": true}, {"text": "for", "start": 151, "end": 154, "id": 27, "ws": true}, {"text": "topical", "start": 155, "end": 162, "id": 28, "ws": true}, {"text": "treatment", "start": 163, "end": 172, "id": 29, "ws": true}, {"text": "of", "start": 173, "end": 175, "id": 30, "ws": true}, {"text": "painful", "start": 176, "end": 183, "id": 31, "ws": true}, {"text": "urethritis", "start": 184, "end": 194, "id": 32, "ws": false}, {"text": ",", "start": 194, "end": 195, "id": 33, "ws": true}, {"text": "and", "start": 196, "end": 199, "id": 34, "ws": true}, {"text": "as", "start": 200, "end": 202, "id": 35, "ws": true}, {"text": "an", "start": 203, "end": 205, "id": 36, "ws": true}, {"text": "anesthetic", "start": 206, "end": 216, "id": 37, "ws": true}, {"text": "lubricant", "start": 217, "end": 226, "id": 38, "ws": true}, {"text": "for", "start": 227, "end": 230, "id": 39, "ws": true}, {"text": "endotracheal", "start": 231, "end": 243, "id": 40, "ws": true}, {"text": "intubation", "start": 244, "end": 254, "id": 41, "ws": true}, {"text": "(", "start": 255, "end": 256, "id": 42, "ws": false}, {"text": "oral", "start": 256, "end": 260, "id": 43, "ws": true}, {"text": "and", "start": 261, "end": 264, "id": 44, "ws": true}, {"text": "nasal", "start": 265, "end": 270, "id": 45, "ws": false}, {"text": ")", "start": 270, "end": 271, "id": 46, "ws": false}, {"text": ".", "start": 271, "end": 272, "id": 47, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 29, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 67, "end": 77, "token_start": 13, "token_end": 13, "label": "ACTION"}, {"start": 82, "end": 89, "token_start": 15, "token_end": 15, "label": "ACTION"}, {"start": 93, "end": 97, "token_start": 17, "token_end": 17, "label": "INDICATION"}, {"start": 101, "end": 149, "token_start": 19, "token_end": 25, "label": "MEDICAL_CTX"}, {"start": 155, "end": 175, "token_start": 28, "token_end": 30, "label": "ACTION"}, {"start": 176, "end": 183, "token_start": 31, "token_end": 31, "label": "SEVERITY"}, {"start": 184, "end": 194, "token_start": 32, "token_end": 32, "label": "INDICATION"}, {"start": 206, "end": 226, "token_start": 37, "token_end": 38, "label": "MECHANISM"}, {"start": 231, "end": 254, "token_start": 40, "token_end": 41, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694175312, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "BAQSIMI is indicated for the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 4 years and above. BAQSIMI is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 4 years and above. (1)", "_input_hash": 2085140106, "_task_hash": -1897931212, "_is_binary": false, "tokens": [{"text": "BAQSIMI", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "severe", "start": 42, "end": 48, "id": 7, "ws": true}, {"text": "hypoglycemia", "start": 49, "end": 61, "id": 8, "ws": true}, {"text": "in", "start": 62, "end": 64, "id": 9, "ws": true}, {"text": "adult", "start": 65, "end": 70, "id": 10, "ws": true}, {"text": "and", "start": 71, "end": 74, "id": 11, "ws": true}, {"text": "pediatric", "start": 75, "end": 84, "id": 12, "ws": true}, {"text": "patients", "start": 85, "end": 93, "id": 13, "ws": true}, {"text": "with", "start": 94, "end": 98, "id": 14, "ws": true}, {"text": "diabetes", "start": 99, "end": 107, "id": 15, "ws": true}, {"text": "ages", "start": 108, "end": 112, "id": 16, "ws": true}, {"text": "4", "start": 113, "end": 114, "id": 17, "ws": true}, {"text": "years", "start": 115, "end": 120, "id": 18, "ws": true}, {"text": "and", "start": 121, "end": 124, "id": 19, "ws": true}, {"text": "above", "start": 125, "end": 130, "id": 20, "ws": false}, {"text": ".", "start": 130, "end": 131, "id": 21, "ws": true}, {"text": "BAQSIMI", "start": 132, "end": 139, "id": 22, "ws": true}, {"text": "is", "start": 140, "end": 142, "id": 23, "ws": true}, {"text": "an", "start": 143, "end": 145, "id": 24, "ws": true}, {"text": "antihypoglycemic", "start": 146, "end": 162, "id": 25, "ws": true}, {"text": "agent", "start": 163, "end": 168, "id": 26, "ws": true}, {"text": "indicated", "start": 169, "end": 178, "id": 27, "ws": true}, {"text": "for", "start": 179, "end": 182, "id": 28, "ws": true}, {"text": "the", "start": 183, "end": 186, "id": 29, "ws": true}, {"text": "treatment", "start": 187, "end": 196, "id": 30, "ws": true}, {"text": "of", "start": 197, "end": 199, "id": 31, "ws": true}, {"text": "severe", "start": 200, "end": 206, "id": 32, "ws": true}, {"text": "hypoglycemia", "start": 207, "end": 219, "id": 33, "ws": true}, {"text": "in", "start": 220, "end": 222, "id": 34, "ws": true}, {"text": "adult", "start": 223, "end": 228, "id": 35, "ws": true}, {"text": "and", "start": 229, "end": 232, "id": 36, "ws": true}, {"text": "pediatric", "start": 233, "end": 242, "id": 37, "ws": true}, {"text": "patients", "start": 243, "end": 251, "id": 38, "ws": true}, {"text": "with", "start": 252, "end": 256, "id": 39, "ws": true}, {"text": "diabetes", "start": 257, "end": 265, "id": 40, "ws": true}, {"text": "ages", "start": 266, "end": 270, "id": 41, "ws": true}, {"text": "4", "start": 271, "end": 272, "id": 42, "ws": true}, {"text": "years", "start": 273, "end": 278, "id": 43, "ws": true}, {"text": "and", "start": 279, "end": 282, "id": 44, "ws": true}, {"text": "above", "start": 283, "end": 288, "id": 45, "ws": false}, {"text": ".", "start": 288, "end": 289, "id": 46, "ws": true}, {"text": "(", "start": 290, "end": 291, "id": 47, "ws": false}, {"text": "1", "start": 291, "end": 292, "id": 48, "ws": false}, {"text": ")", "start": 292, "end": 293, "id": 49, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 42, "end": 48, "token_start": 7, "token_end": 7, "label": "SEVERITY"}, {"start": 49, "end": 61, "token_start": 8, "token_end": 8, "label": "INDICATION"}, {"start": 65, "end": 70, "token_start": 10, "token_end": 10, "label": "TARGET_GROUP"}, {"start": 75, "end": 130, "token_start": 12, "token_end": 20, "label": "TARGET_GROUP"}, {"start": 132, "end": 139, "token_start": 22, "token_end": 22, "label": "DRUG"}, {"start": 146, "end": 168, "token_start": 25, "token_end": 26, "label": "MECHANISM"}, {"start": 187, "end": 196, "token_start": 30, "token_end": 30, "label": "ACTION"}, {"start": 200, "end": 206, "token_start": 32, "token_end": 32, "label": "SEVERITY"}, {"start": 207, "end": 219, "token_start": 33, "token_end": 33, "label": "INDICATION"}, {"start": 223, "end": 228, "token_start": 35, "token_end": 35, "label": "TARGET_GROUP"}, {"start": 233, "end": 288, "token_start": 37, "token_end": 45, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694528725, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "AVINZA capsules are a modified-release formulation of morphine sulfate intended for once daily administration indicated for the relief of moderate to severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time. AVINZA is NOT intended for use as a prn analgesic. The safety and efficacy of using AVINZA in the postoperative setting has not been evaluated. AVINZA is not indicated for postoperative use. If the patient has been receiving the drug prior to surgery, resumption of the pre-surgical dose may be appropriate once the patient is able to take the drug by mouth. Physicians should individualize treatment, moving from parenteral to oral analgesics as appropriate. (see American Pain Society guidelines)", "_input_hash": 109598702, "_task_hash": -1964729935, "_is_binary": false, "tokens": [{"text": "AVINZA", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "capsules", "start": 7, "end": 15, "id": 1, "ws": true}, {"text": "are", "start": 16, "end": 19, "id": 2, "ws": true}, {"text": "a", "start": 20, "end": 21, "id": 3, "ws": true}, {"text": "modified", "start": 22, "end": 30, "id": 4, "ws": false}, {"text": "-", "start": 30, "end": 31, "id": 5, "ws": false}, {"text": "release", "start": 31, "end": 38, "id": 6, "ws": true}, {"text": "formulation", "start": 39, "end": 50, "id": 7, "ws": true}, {"text": "of", "start": 51, "end": 53, "id": 8, "ws": true}, {"text": "morphine", "start": 54, "end": 62, "id": 9, "ws": true}, {"text": "sulfate", "start": 63, "end": 70, "id": 10, "ws": true}, {"text": "intended", "start": 71, "end": 79, "id": 11, "ws": true}, {"text": "for", "start": 80, "end": 83, "id": 12, "ws": true}, {"text": "once", "start": 84, "end": 88, "id": 13, "ws": true}, {"text": "daily", "start": 89, "end": 94, "id": 14, "ws": true}, {"text": "administration", "start": 95, "end": 109, "id": 15, "ws": true}, {"text": "indicated", "start": 110, "end": 119, "id": 16, "ws": true}, {"text": "for", "start": 120, "end": 123, "id": 17, "ws": true}, {"text": "the", "start": 124, "end": 127, "id": 18, "ws": true}, {"text": "relief", "start": 128, "end": 134, "id": 19, "ws": true}, {"text": "of", "start": 135, "end": 137, "id": 20, "ws": true}, {"text": "moderate", "start": 138, "end": 146, "id": 21, "ws": true}, {"text": "to", "start": 147, "end": 149, "id": 22, "ws": true}, {"text": "severe", "start": 150, "end": 156, "id": 23, "ws": true}, {"text": "pain", "start": 157, "end": 161, "id": 24, "ws": true}, {"text": "requiring", "start": 162, "end": 171, "id": 25, "ws": true}, {"text": "continuous", "start": 172, "end": 182, "id": 26, "ws": false}, {"text": ",", "start": 182, "end": 183, "id": 27, "ws": true}, {"text": "around", "start": 184, "end": 190, "id": 28, "ws": false}, {"text": "-", "start": 190, "end": 191, "id": 29, "ws": false}, {"text": "the", "start": 191, "end": 194, "id": 30, "ws": false}, {"text": "-", "start": 194, "end": 195, "id": 31, "ws": false}, {"text": "clock", "start": 195, "end": 200, "id": 32, "ws": true}, {"text": "opioid", "start": 201, "end": 207, "id": 33, "ws": true}, {"text": "therapy", "start": 208, "end": 215, "id": 34, "ws": true}, {"text": "for", "start": 216, "end": 219, "id": 35, "ws": true}, {"text": "an", "start": 220, "end": 222, "id": 36, "ws": true}, {"text": "extended", "start": 223, "end": 231, "id": 37, "ws": true}, {"text": "period", "start": 232, "end": 238, "id": 38, "ws": true}, {"text": "of", "start": 239, "end": 241, "id": 39, "ws": true}, {"text": "time", "start": 242, "end": 246, "id": 40, "ws": false}, {"text": ".", "start": 246, "end": 247, "id": 41, "ws": true}, {"text": "AVINZA", "start": 248, "end": 254, "id": 42, "ws": true}, {"text": "is", "start": 255, "end": 257, "id": 43, "ws": true}, {"text": "NOT", "start": 258, "end": 261, "id": 44, "ws": true}, {"text": "intended", "start": 262, "end": 270, "id": 45, "ws": true}, {"text": "for", "start": 271, "end": 274, "id": 46, "ws": true}, {"text": "use", "start": 275, "end": 278, "id": 47, "ws": true}, {"text": "as", "start": 279, "end": 281, "id": 48, "ws": true}, {"text": "a", "start": 282, "end": 283, "id": 49, "ws": true}, {"text": "prn", "start": 284, "end": 287, "id": 50, "ws": true}, {"text": "analgesic", "start": 288, "end": 297, "id": 51, "ws": false}, {"text": ".", "start": 297, "end": 298, "id": 52, "ws": true}, {"text": "The", "start": 299, "end": 302, "id": 53, "ws": true}, {"text": "safety", "start": 303, "end": 309, "id": 54, "ws": true}, {"text": "and", "start": 310, "end": 313, "id": 55, "ws": true}, {"text": "efficacy", "start": 314, "end": 322, "id": 56, "ws": true}, {"text": "of", "start": 323, "end": 325, "id": 57, "ws": true}, {"text": "using", "start": 326, "end": 331, "id": 58, "ws": true}, {"text": "AVINZA", "start": 332, "end": 338, "id": 59, "ws": true}, {"text": "in", "start": 339, "end": 341, "id": 60, "ws": true}, {"text": "the", "start": 342, "end": 345, "id": 61, "ws": true}, {"text": "postoperative", "start": 346, "end": 359, "id": 62, "ws": true}, {"text": "setting", "start": 360, "end": 367, "id": 63, "ws": true}, {"text": "has", "start": 368, "end": 371, "id": 64, "ws": true}, {"text": "not", "start": 372, "end": 375, "id": 65, "ws": true}, {"text": "been", "start": 376, "end": 380, "id": 66, "ws": true}, {"text": "evaluated", "start": 381, "end": 390, "id": 67, "ws": false}, {"text": ".", "start": 390, "end": 391, "id": 68, "ws": true}, {"text": "AVINZA", "start": 392, "end": 398, "id": 69, "ws": true}, {"text": "is", "start": 399, "end": 401, "id": 70, "ws": true}, {"text": "not", "start": 402, "end": 405, "id": 71, "ws": true}, {"text": "indicated", "start": 406, "end": 415, "id": 72, "ws": true}, {"text": "for", "start": 416, "end": 419, "id": 73, "ws": true}, {"text": "postoperative", "start": 420, "end": 433, "id": 74, "ws": true}, {"text": "use", "start": 434, "end": 437, "id": 75, "ws": false}, {"text": ".", "start": 437, "end": 438, "id": 76, "ws": true}, {"text": "If", "start": 439, "end": 441, "id": 77, "ws": true}, {"text": "the", "start": 442, "end": 445, "id": 78, "ws": true}, {"text": "patient", "start": 446, "end": 453, "id": 79, "ws": true}, {"text": "has", "start": 454, "end": 457, "id": 80, "ws": true}, {"text": "been", "start": 458, "end": 462, "id": 81, "ws": true}, {"text": "receiving", "start": 463, "end": 472, "id": 82, "ws": true}, {"text": "the", "start": 473, "end": 476, "id": 83, "ws": true}, {"text": "drug", "start": 477, "end": 481, "id": 84, "ws": true}, {"text": "prior", "start": 482, "end": 487, "id": 85, "ws": true}, {"text": "to", "start": 488, "end": 490, "id": 86, "ws": true}, {"text": "surgery", "start": 491, "end": 498, "id": 87, "ws": false}, {"text": ",", "start": 498, "end": 499, "id": 88, "ws": true}, {"text": "resumption", "start": 500, "end": 510, "id": 89, "ws": true}, {"text": "of", "start": 511, "end": 513, "id": 90, "ws": true}, {"text": "the", "start": 514, "end": 517, "id": 91, "ws": true}, {"text": "pre", "start": 518, "end": 521, "id": 92, "ws": false}, {"text": "-", "start": 521, "end": 522, "id": 93, "ws": false}, {"text": "surgical", "start": 522, "end": 530, "id": 94, "ws": true}, {"text": "dose", "start": 531, "end": 535, "id": 95, "ws": true}, {"text": "may", "start": 536, "end": 539, "id": 96, "ws": true}, {"text": "be", "start": 540, "end": 542, "id": 97, "ws": true}, {"text": "appropriate", "start": 543, "end": 554, "id": 98, "ws": true}, {"text": "once", "start": 555, "end": 559, "id": 99, "ws": true}, {"text": "the", "start": 560, "end": 563, "id": 100, "ws": true}, {"text": "patient", "start": 564, "end": 571, "id": 101, "ws": true}, {"text": "is", "start": 572, "end": 574, "id": 102, "ws": true}, {"text": "able", "start": 575, "end": 579, "id": 103, "ws": true}, {"text": "to", "start": 580, "end": 582, "id": 104, "ws": true}, {"text": "take", "start": 583, "end": 587, "id": 105, "ws": true}, {"text": "the", "start": 588, "end": 591, "id": 106, "ws": true}, {"text": "drug", "start": 592, "end": 596, "id": 107, "ws": true}, {"text": "by", "start": 597, "end": 599, "id": 108, "ws": true}, {"text": "mouth", "start": 600, "end": 605, "id": 109, "ws": false}, {"text": ".", "start": 605, "end": 606, "id": 110, "ws": true}, {"text": "Physicians", "start": 607, "end": 617, "id": 111, "ws": true}, {"text": "should", "start": 618, "end": 624, "id": 112, "ws": true}, {"text": "individualize", "start": 625, "end": 638, "id": 113, "ws": true}, {"text": "treatment", "start": 639, "end": 648, "id": 114, "ws": false}, {"text": ",", "start": 648, "end": 649, "id": 115, "ws": true}, {"text": "moving", "start": 650, "end": 656, "id": 116, "ws": true}, {"text": "from", "start": 657, "end": 661, "id": 117, "ws": true}, {"text": "parenteral", "start": 662, "end": 672, "id": 118, "ws": true}, {"text": "to", "start": 673, "end": 675, "id": 119, "ws": true}, {"text": "oral", "start": 676, "end": 680, "id": 120, "ws": true}, {"text": "analgesics", "start": 681, "end": 691, "id": 121, "ws": true}, {"text": "as", "start": 692, "end": 694, "id": 122, "ws": true}, {"text": "appropriate", "start": 695, "end": 706, "id": 123, "ws": false}, {"text": ".", "start": 706, "end": 707, "id": 124, "ws": true}, {"text": "(", "start": 708, "end": 709, "id": 125, "ws": false}, {"text": "see", "start": 709, "end": 712, "id": 126, "ws": true}, {"text": "American", "start": 713, "end": 721, "id": 127, "ws": true}, {"text": "Pain", "start": 722, "end": 726, "id": 128, "ws": true}, {"text": "Society", "start": 727, "end": 734, "id": 129, "ws": true}, {"text": "guidelines", "start": 735, "end": 745, "id": 130, "ws": false}, {"text": ")", "start": 745, "end": 746, "id": 131, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 7, "end": 15, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 128, "end": 134, "token_start": 19, "token_end": 19, "label": "ACTION"}, {"start": 138, "end": 156, "token_start": 21, "token_end": 23, "label": "SEVERITY"}, {"start": 157, "end": 161, "token_start": 24, "token_end": 24, "label": "INDICATION"}, {"start": 162, "end": 246, "token_start": 25, "token_end": 40, "label": "MEDICAL_CTX"}, {"start": 248, "end": 297, "token_start": 42, "token_end": 51, "label": "CONTRAINDICATION"}, {"start": 392, "end": 437, "token_start": 69, "token_end": 75, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694526020, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Tazarotene Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. Tazarotene Foam is a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. (1)", "_input_hash": 1155904069, "_task_hash": 843426525, "_is_binary": false, "tokens": [{"text": "Tazarotene", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "Foam", "start": 11, "end": 15, "id": 1, "ws": false}, {"text": ",", "start": 15, "end": 16, "id": 2, "ws": true}, {"text": "0.1", "start": 17, "end": 20, "id": 3, "ws": false}, {"text": "%", "start": 20, "end": 21, "id": 4, "ws": true}, {"text": "is", "start": 22, "end": 24, "id": 5, "ws": true}, {"text": "indicated", "start": 25, "end": 34, "id": 6, "ws": true}, {"text": "for", "start": 35, "end": 38, "id": 7, "ws": true}, {"text": "the", "start": 39, "end": 42, "id": 8, "ws": true}, {"text": "topical", "start": 43, "end": 50, "id": 9, "ws": true}, {"text": "treatment", "start": 51, "end": 60, "id": 10, "ws": true}, {"text": "of", "start": 61, "end": 63, "id": 11, "ws": true}, {"text": "acne", "start": 64, "end": 68, "id": 12, "ws": true}, {"text": "vulgaris", "start": 69, "end": 77, "id": 13, "ws": true}, {"text": "in", "start": 78, "end": 80, "id": 14, "ws": true}, {"text": "patients", "start": 81, "end": 89, "id": 15, "ws": true}, {"text": "12", "start": 90, "end": 92, "id": 16, "ws": true}, {"text": "years", "start": 93, "end": 98, "id": 17, "ws": true}, {"text": "of", "start": 99, "end": 101, "id": 18, "ws": true}, {"text": "age", "start": 102, "end": 105, "id": 19, "ws": true}, {"text": "or", "start": 106, "end": 108, "id": 20, "ws": true}, {"text": "older", "start": 109, "end": 114, "id": 21, "ws": false}, {"text": ".", "start": 114, "end": 115, "id": 22, "ws": true}, {"text": "Tazarotene", "start": 116, "end": 126, "id": 23, "ws": true}, {"text": "Foam", "start": 127, "end": 131, "id": 24, "ws": true}, {"text": "is", "start": 132, "end": 134, "id": 25, "ws": true}, {"text": "a", "start": 135, "end": 136, "id": 26, "ws": true}, {"text": "retinoid", "start": 137, "end": 145, "id": 27, "ws": true}, {"text": "indicated", "start": 146, "end": 155, "id": 28, "ws": true}, {"text": "for", "start": 156, "end": 159, "id": 29, "ws": true}, {"text": "the", "start": 160, "end": 163, "id": 30, "ws": true}, {"text": "topical", "start": 164, "end": 171, "id": 31, "ws": true}, {"text": "treatment", "start": 172, "end": 181, "id": 32, "ws": true}, {"text": "of", "start": 182, "end": 184, "id": 33, "ws": true}, {"text": "acne", "start": 185, "end": 189, "id": 34, "ws": true}, {"text": "vulgaris", "start": 190, "end": 198, "id": 35, "ws": true}, {"text": "in", "start": 199, "end": 201, "id": 36, "ws": true}, {"text": "patients", "start": 202, "end": 210, "id": 37, "ws": true}, {"text": "12", "start": 211, "end": 213, "id": 38, "ws": true}, {"text": "years", "start": 214, "end": 219, "id": 39, "ws": true}, {"text": "of", "start": 220, "end": 222, "id": 40, "ws": true}, {"text": "age", "start": 223, "end": 226, "id": 41, "ws": true}, {"text": "or", "start": 227, "end": 229, "id": 42, "ws": true}, {"text": "older", "start": 230, "end": 235, "id": 43, "ws": false}, {"text": ".", "start": 235, "end": 236, "id": 44, "ws": true}, {"text": "(", "start": 237, "end": 238, "id": 45, "ws": false}, {"text": "1", "start": 238, "end": 239, "id": 46, "ws": false}, {"text": ")", "start": 239, "end": 240, "id": 47, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 15, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 43, "end": 50, "token_start": 9, "token_end": 9, "label": "ROUTE"}, {"start": 51, "end": 60, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 64, "end": 77, "token_start": 12, "token_end": 13, "label": "INDICATION"}, {"start": 81, "end": 114, "token_start": 15, "token_end": 21, "label": "TARGET_GROUP"}, {"start": 116, "end": 126, "token_start": 23, "token_end": 23, "label": "DRUG"}, {"start": 127, "end": 131, "token_start": 24, "token_end": 24, "label": "FORMULATION"}, {"start": 164, "end": 171, "token_start": 31, "token_end": 31, "label": "ROUTE"}, {"start": 172, "end": 181, "token_start": 32, "token_end": 32, "label": "ACTION"}, {"start": 185, "end": 198, "token_start": 34, "token_end": 35, "label": "INDICATION"}, {"start": 202, "end": 235, "token_start": 37, "token_end": 43, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694528249, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "XIPERE (triamcinolone acetonide injectable suspension) 40 mg/mL is indicated for the treatment of macular edema associated with uveitis. XIPERE is a corticosteroid indicated for the treatment of macular edema associated with uveitis. (1)", "_input_hash": 83879705, "_task_hash": 78315636, "_is_binary": false, "tokens": [{"text": "XIPERE", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "(", "start": 7, "end": 8, "id": 1, "ws": false}, {"text": "triamcinolone", "start": 8, "end": 21, "id": 2, "ws": true}, {"text": "acetonide", "start": 22, "end": 31, "id": 3, "ws": true}, {"text": "injectable", "start": 32, "end": 42, "id": 4, "ws": true}, {"text": "suspension", "start": 43, "end": 53, "id": 5, "ws": false}, {"text": ")", "start": 53, "end": 54, "id": 6, "ws": true}, {"text": "40", "start": 55, "end": 57, "id": 7, "ws": true}, {"text": "mg", "start": 58, "end": 60, "id": 8, "ws": false}, {"text": "/", "start": 60, "end": 61, "id": 9, "ws": false}, {"text": "mL", "start": 61, "end": 63, "id": 10, "ws": true}, {"text": "is", "start": 64, "end": 66, "id": 11, "ws": true}, {"text": "indicated", "start": 67, "end": 76, "id": 12, "ws": true}, {"text": "for", "start": 77, "end": 80, "id": 13, "ws": true}, {"text": "the", "start": 81, "end": 84, "id": 14, "ws": true}, {"text": "treatment", "start": 85, "end": 94, "id": 15, "ws": true}, {"text": "of", "start": 95, "end": 97, "id": 16, "ws": true}, {"text": "macular", "start": 98, "end": 105, "id": 17, "ws": true}, {"text": "edema", "start": 106, "end": 111, "id": 18, "ws": true}, {"text": "associated", "start": 112, "end": 122, "id": 19, "ws": true}, {"text": "with", "start": 123, "end": 127, "id": 20, "ws": true}, {"text": "uveitis", "start": 128, "end": 135, "id": 21, "ws": false}, {"text": ".", "start": 135, "end": 136, "id": 22, "ws": true}, {"text": "XIPERE", "start": 137, "end": 143, "id": 23, "ws": true}, {"text": "is", "start": 144, "end": 146, "id": 24, "ws": true}, {"text": "a", "start": 147, "end": 148, "id": 25, "ws": true}, {"text": "corticosteroid", "start": 149, "end": 163, "id": 26, "ws": true}, {"text": "indicated", "start": 164, "end": 173, "id": 27, "ws": true}, {"text": "for", "start": 174, "end": 177, "id": 28, "ws": true}, {"text": "the", "start": 178, "end": 181, "id": 29, "ws": true}, {"text": "treatment", "start": 182, "end": 191, "id": 30, "ws": true}, {"text": "of", "start": 192, "end": 194, "id": 31, "ws": true}, {"text": "macular", "start": 195, "end": 202, "id": 32, "ws": true}, {"text": "edema", "start": 203, "end": 208, "id": 33, "ws": true}, {"text": "associated", "start": 209, "end": 219, "id": 34, "ws": true}, {"text": "with", "start": 220, "end": 224, "id": 35, "ws": true}, {"text": "uveitis", "start": 225, "end": 232, "id": 36, "ws": false}, {"text": ".", "start": 232, "end": 233, "id": 37, "ws": true}, {"text": "(", "start": 234, "end": 235, "id": 38, "ws": false}, {"text": "1", "start": 235, "end": 236, "id": 39, "ws": false}, {"text": ")", "start": 236, "end": 237, "id": 40, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 21, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 22, "end": 31, "token_start": 3, "token_end": 3, "label": "SALT"}, {"start": 32, "end": 42, "token_start": 4, "token_end": 4, "label": "ROUTE"}, {"start": 43, "end": 53, "token_start": 5, "token_end": 5, "label": "FORMULATION"}, {"start": 85, "end": 94, "token_start": 15, "token_end": 15, "label": "ACTION"}, {"start": 98, "end": 111, "token_start": 17, "token_end": 18, "label": "INDICATION"}, {"start": 128, "end": 135, "token_start": 21, "token_end": 21, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176432, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of anorectum, and pruritus ani.", "_input_hash": 1427612923, "_task_hash": 327103781, "_is_binary": false, "tokens": [{"text": "Hydrocortisone", "start": 0, "end": 14, "id": 0, "ws": true}, {"text": "acetate", "start": 15, "end": 22, "id": 1, "ws": true}, {"text": "suppositories", "start": 23, "end": 36, "id": 2, "ws": true}, {"text": "are", "start": 37, "end": 40, "id": 3, "ws": true}, {"text": "indicated", "start": 41, "end": 50, "id": 4, "ws": true}, {"text": "for", "start": 51, "end": 54, "id": 5, "ws": true}, {"text": "use", "start": 55, "end": 58, "id": 6, "ws": true}, {"text": "in", "start": 59, "end": 61, "id": 7, "ws": true}, {"text": "inflamed", "start": 62, "end": 70, "id": 8, "ws": true}, {"text": "hemorrhoids", "start": 71, "end": 82, "id": 9, "ws": false}, {"text": ",", "start": 82, "end": 83, "id": 10, "ws": true}, {"text": "post", "start": 84, "end": 88, "id": 11, "ws": false}, {"text": "-", "start": 88, "end": 89, "id": 12, "ws": false}, {"text": "irradiation", "start": 89, "end": 100, "id": 13, "ws": true}, {"text": "(", "start": 101, "end": 102, "id": 14, "ws": false}, {"text": "factitial", "start": 102, "end": 111, "id": 15, "ws": false}, {"text": ")", "start": 111, "end": 112, "id": 16, "ws": true}, {"text": "proctitis", "start": 113, "end": 122, "id": 17, "ws": false}, {"text": ",", "start": 122, "end": 123, "id": 18, "ws": true}, {"text": "as", "start": 124, "end": 126, "id": 19, "ws": true}, {"text": "an", "start": 127, "end": 129, "id": 20, "ws": true}, {"text": "adjunct", "start": 130, "end": 137, "id": 21, "ws": true}, {"text": "in", "start": 138, "end": 140, "id": 22, "ws": true}, {"text": "the", "start": 141, "end": 144, "id": 23, "ws": true}, {"text": "treatment", "start": 145, "end": 154, "id": 24, "ws": true}, {"text": "of", "start": 155, "end": 157, "id": 25, "ws": true}, {"text": "chronic", "start": 158, "end": 165, "id": 26, "ws": true}, {"text": "ulcerative", "start": 166, "end": 176, "id": 27, "ws": true}, {"text": "colitis", "start": 177, "end": 184, "id": 28, "ws": false}, {"text": ",", "start": 184, "end": 185, "id": 29, "ws": true}, {"text": "cryptitis", "start": 186, "end": 195, "id": 30, "ws": false}, {"text": ",", "start": 195, "end": 196, "id": 31, "ws": true}, {"text": "other", "start": 197, "end": 202, "id": 32, "ws": true}, {"text": "inflammatory", "start": 203, "end": 215, "id": 33, "ws": true}, {"text": "conditions", "start": 216, "end": 226, "id": 34, "ws": true}, {"text": "of", "start": 227, "end": 229, "id": 35, "ws": true}, {"text": "anorectum", "start": 230, "end": 239, "id": 36, "ws": false}, {"text": ",", "start": 239, "end": 240, "id": 37, "ws": true}, {"text": "and", "start": 241, "end": 244, "id": 38, "ws": true}, {"text": "pruritus", "start": 245, "end": 253, "id": 39, "ws": true}, {"text": "ani", "start": 254, "end": 257, "id": 40, "ws": false}, {"text": ".", "start": 257, "end": 258, "id": 41, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 14, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 15, "end": 22, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 23, "end": 36, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 55, "end": 58, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 62, "end": 82, "token_start": 8, "token_end": 9, "label": "INDICATION"}, {"start": 84, "end": 122, "token_start": 11, "token_end": 17, "label": "INDICATION"}, {"start": 130, "end": 154, "token_start": 21, "token_end": 24, "label": "ACTION"}, {"start": 158, "end": 184, "token_start": 26, "token_end": 28, "label": "INDICATION"}, {"start": 186, "end": 195, "token_start": 30, "token_end": 30, "label": "INDICATION"}, {"start": 203, "end": 239, "token_start": 33, "token_end": 36, "label": "INDICATION"}, {"start": 245, "end": 257, "token_start": 39, "token_end": 40, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526109, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets are a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1)", "_input_hash": 1466968527, "_task_hash": 2057501190, "_is_binary": false, "tokens": [{"text": "Metformin", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 10, "end": 23, "id": 1, "ws": true}, {"text": "extended", "start": 24, "end": 32, "id": 2, "ws": false}, {"text": "-", "start": 32, "end": 33, "id": 3, "ws": false}, {"text": "release", "start": 33, "end": 40, "id": 4, "ws": true}, {"text": "tablets", "start": 41, "end": 48, "id": 5, "ws": true}, {"text": "are", "start": 49, "end": 52, "id": 6, "ws": true}, {"text": "indicated", "start": 53, "end": 62, "id": 7, "ws": true}, {"text": "as", "start": 63, "end": 65, "id": 8, "ws": true}, {"text": "an", "start": 66, "end": 68, "id": 9, "ws": true}, {"text": "adjunct", "start": 69, "end": 76, "id": 10, "ws": true}, {"text": "to", "start": 77, "end": 79, "id": 11, "ws": true}, {"text": "diet", "start": 80, "end": 84, "id": 12, "ws": true}, {"text": "and", "start": 85, "end": 88, "id": 13, "ws": true}, {"text": "exercise", "start": 89, "end": 97, "id": 14, "ws": true}, {"text": "to", "start": 98, "end": 100, "id": 15, "ws": true}, {"text": "improve", "start": 101, "end": 108, "id": 16, "ws": true}, {"text": "glycemic", "start": 109, "end": 117, "id": 17, "ws": true}, {"text": "control", "start": 118, "end": 125, "id": 18, "ws": true}, {"text": "in", "start": 126, "end": 128, "id": 19, "ws": true}, {"text": "adults", "start": 129, "end": 135, "id": 20, "ws": true}, {"text": "with", "start": 136, "end": 140, "id": 21, "ws": true}, {"text": "type", "start": 141, "end": 145, "id": 22, "ws": true}, {"text": "2", "start": 146, "end": 147, "id": 23, "ws": true}, {"text": "diabetes", "start": 148, "end": 156, "id": 24, "ws": true}, {"text": "mellitus", "start": 157, "end": 165, "id": 25, "ws": false}, {"text": ".", "start": 165, "end": 166, "id": 26, "ws": true}, {"text": "Metformin", "start": 167, "end": 176, "id": 27, "ws": true}, {"text": "hydrochloride", "start": 177, "end": 190, "id": 28, "ws": true}, {"text": "extended", "start": 191, "end": 199, "id": 29, "ws": false}, {"text": "-", "start": 199, "end": 200, "id": 30, "ws": false}, {"text": "release", "start": 200, "end": 207, "id": 31, "ws": true}, {"text": "tablets", "start": 208, "end": 215, "id": 32, "ws": true}, {"text": "are", "start": 216, "end": 219, "id": 33, "ws": true}, {"text": "a", "start": 220, "end": 221, "id": 34, "ws": true}, {"text": "biguanide", "start": 222, "end": 231, "id": 35, "ws": true}, {"text": "indicated", "start": 232, "end": 241, "id": 36, "ws": true}, {"text": "as", "start": 242, "end": 244, "id": 37, "ws": true}, {"text": "an", "start": 245, "end": 247, "id": 38, "ws": true}, {"text": "adjunct", "start": 248, "end": 255, "id": 39, "ws": true}, {"text": "to", "start": 256, "end": 258, "id": 40, "ws": true}, {"text": "diet", "start": 259, "end": 263, "id": 41, "ws": true}, {"text": "and", "start": 264, "end": 267, "id": 42, "ws": true}, {"text": "exercise", "start": 268, "end": 276, "id": 43, "ws": true}, {"text": "to", "start": 277, "end": 279, "id": 44, "ws": true}, {"text": "improve", "start": 280, "end": 287, "id": 45, "ws": true}, {"text": "glycemic", "start": 288, "end": 296, "id": 46, "ws": true}, {"text": "control", "start": 297, "end": 304, "id": 47, "ws": true}, {"text": "in", "start": 305, "end": 307, "id": 48, "ws": true}, {"text": "adults", "start": 308, "end": 314, "id": 49, "ws": true}, {"text": "with", "start": 315, "end": 319, "id": 50, "ws": true}, {"text": "type", "start": 320, "end": 324, "id": 51, "ws": true}, {"text": "2", "start": 325, "end": 326, "id": 52, "ws": true}, {"text": "diabetes", "start": 327, "end": 335, "id": 53, "ws": true}, {"text": "mellitus", "start": 336, "end": 344, "id": 54, "ws": false}, {"text": ".", "start": 344, "end": 345, "id": 55, "ws": true}, {"text": "(", "start": 346, "end": 347, "id": 56, "ws": false}, {"text": "1", "start": 347, "end": 348, "id": 57, "ws": false}, {"text": ")", "start": 348, "end": 349, "id": 58, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 48, "token_start": 2, "token_end": 5, "label": "FORMULATION"}, {"start": 69, "end": 76, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 101, "end": 125, "token_start": 16, "token_end": 18, "label": "EFFECT"}, {"start": 129, "end": 135, "token_start": 20, "token_end": 20, "label": "TARGET_GROUP"}, {"start": 141, "end": 165, "token_start": 22, "token_end": 25, "label": "BASECONDITION"}, {"start": 167, "end": 176, "token_start": 27, "token_end": 27, "label": "DRUG"}, {"start": 177, "end": 190, "token_start": 28, "token_end": 28, "label": "SALT"}, {"start": 191, "end": 215, "token_start": 29, "token_end": 32, "label": "FORMULATION"}, {"start": 222, "end": 231, "token_start": 35, "token_end": 35, "label": "MECHANISM"}, {"start": 248, "end": 255, "token_start": 39, "token_end": 39, "label": "ACTION"}, {"start": 280, "end": 304, "token_start": 45, "token_end": 47, "label": "EFFECT"}, {"start": 308, "end": 314, "token_start": 49, "token_end": 49, "label": "TARGET_GROUP"}, {"start": 320, "end": 344, "token_start": 51, "token_end": 54, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527171, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "AUBAGIO is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. AUBAGIO is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. (1)", "_input_hash": -1683160291, "_task_hash": 1337676175, "_is_binary": false, "tokens": [{"text": "AUBAGIO", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "relapsing", "start": 42, "end": 51, "id": 7, "ws": true}, {"text": "forms", "start": 52, "end": 57, "id": 8, "ws": true}, {"text": "of", "start": 58, "end": 60, "id": 9, "ws": true}, {"text": "multiple", "start": 61, "end": 69, "id": 10, "ws": true}, {"text": "sclerosis", "start": 70, "end": 79, "id": 11, "ws": true}, {"text": "(", "start": 80, "end": 81, "id": 12, "ws": false}, {"text": "MS", "start": 81, "end": 83, "id": 13, "ws": false}, {"text": ")", "start": 83, "end": 84, "id": 14, "ws": false}, {"text": ",", "start": 84, "end": 85, "id": 15, "ws": true}, {"text": "to", "start": 86, "end": 88, "id": 16, "ws": true}, {"text": "include", "start": 89, "end": 96, "id": 17, "ws": true}, {"text": "clinically", "start": 97, "end": 107, "id": 18, "ws": true}, {"text": "isolated", "start": 108, "end": 116, "id": 19, "ws": true}, {"text": "syndrome", "start": 117, "end": 125, "id": 20, "ws": false}, {"text": ",", "start": 125, "end": 126, "id": 21, "ws": true}, {"text": "relapsing", "start": 127, "end": 136, "id": 22, "ws": false}, {"text": "-", "start": 136, "end": 137, "id": 23, "ws": false}, {"text": "remitting", "start": 137, "end": 146, "id": 24, "ws": true}, {"text": "disease", "start": 147, "end": 154, "id": 25, "ws": false}, {"text": ",", "start": 154, "end": 155, "id": 26, "ws": true}, {"text": "and", "start": 156, "end": 159, "id": 27, "ws": true}, {"text": "active", "start": 160, "end": 166, "id": 28, "ws": true}, {"text": "secondary", "start": 167, "end": 176, "id": 29, "ws": true}, {"text": "progressive", "start": 177, "end": 188, "id": 30, "ws": true}, {"text": "disease", "start": 189, "end": 196, "id": 31, "ws": false}, {"text": ",", "start": 196, "end": 197, "id": 32, "ws": true}, {"text": "in", "start": 198, "end": 200, "id": 33, "ws": true}, {"text": "adults", "start": 201, "end": 207, "id": 34, "ws": false}, {"text": ".", "start": 207, "end": 208, "id": 35, "ws": true}, {"text": "AUBAGIO", "start": 209, "end": 216, "id": 36, "ws": true}, {"text": "is", "start": 217, "end": 219, "id": 37, "ws": true}, {"text": "a", "start": 220, "end": 221, "id": 38, "ws": true}, {"text": "pyrimidine", "start": 222, "end": 232, "id": 39, "ws": true}, {"text": "synthesis", "start": 233, "end": 242, "id": 40, "ws": true}, {"text": "inhibitor", "start": 243, "end": 252, "id": 41, "ws": true}, {"text": "indicated", "start": 253, "end": 262, "id": 42, "ws": true}, {"text": "for", "start": 263, "end": 266, "id": 43, "ws": true}, {"text": "the", "start": 267, "end": 270, "id": 44, "ws": true}, {"text": "treatment", "start": 271, "end": 280, "id": 45, "ws": true}, {"text": "of", "start": 281, "end": 283, "id": 46, "ws": true}, {"text": "relapsing", "start": 284, "end": 293, "id": 47, "ws": true}, {"text": "forms", "start": 294, "end": 299, "id": 48, "ws": true}, {"text": "of", "start": 300, "end": 302, "id": 49, "ws": true}, {"text": "multiple", "start": 303, "end": 311, "id": 50, "ws": true}, {"text": "sclerosis", "start": 312, "end": 321, "id": 51, "ws": true}, {"text": "(", "start": 322, "end": 323, "id": 52, "ws": false}, {"text": "MS", "start": 323, "end": 325, "id": 53, "ws": false}, {"text": ")", "start": 325, "end": 326, "id": 54, "ws": false}, {"text": ",", "start": 326, "end": 327, "id": 55, "ws": true}, {"text": "to", "start": 328, "end": 330, "id": 56, "ws": true}, {"text": "include", "start": 331, "end": 338, "id": 57, "ws": true}, {"text": "clinically", "start": 339, "end": 349, "id": 58, "ws": true}, {"text": "isolated", "start": 350, "end": 358, "id": 59, "ws": true}, {"text": "syndrome", "start": 359, "end": 367, "id": 60, "ws": false}, {"text": ",", "start": 367, "end": 368, "id": 61, "ws": true}, {"text": "relapsing", "start": 369, "end": 378, "id": 62, "ws": false}, {"text": "-", "start": 378, "end": 379, "id": 63, "ws": false}, {"text": "remitting", "start": 379, "end": 388, "id": 64, "ws": true}, {"text": "disease", "start": 389, "end": 396, "id": 65, "ws": false}, {"text": ",", "start": 396, "end": 397, "id": 66, "ws": true}, {"text": "and", "start": 398, "end": 401, "id": 67, "ws": true}, {"text": "active", "start": 402, "end": 408, "id": 68, "ws": true}, {"text": "secondary", "start": 409, "end": 418, "id": 69, "ws": true}, {"text": "progressive", "start": 419, "end": 430, "id": 70, "ws": true}, {"text": "disease", "start": 431, "end": 438, "id": 71, "ws": false}, {"text": ",", "start": 438, "end": 439, "id": 72, "ws": true}, {"text": "in", "start": 440, "end": 442, "id": 73, "ws": true}, {"text": "adults", "start": 443, "end": 449, "id": 74, "ws": false}, {"text": ".", "start": 449, "end": 450, "id": 75, "ws": true}, {"text": "(", "start": 451, "end": 452, "id": 76, "ws": false}, {"text": "1", "start": 452, "end": 453, "id": 77, "ws": false}, {"text": ")", "start": 453, "end": 454, "id": 78, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 42, "end": 57, "token_start": 7, "token_end": 8, "label": "SEVERITY"}, {"start": 61, "end": 79, "token_start": 10, "token_end": 11, "label": "INDICATION"}, {"start": 201, "end": 207, "token_start": 34, "token_end": 34, "label": "TARGET_GROUP"}, {"start": 209, "end": 216, "token_start": 36, "token_end": 36, "label": "DRUG"}, {"start": 222, "end": 252, "token_start": 39, "token_end": 41, "label": "MECHANISM"}, {"start": 284, "end": 299, "token_start": 47, "token_end": 48, "label": "SEVERITY"}, {"start": 303, "end": 321, "token_start": 50, "token_end": 51, "label": "INDICATION"}, {"start": 443, "end": 449, "token_start": 74, "token_end": 74, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694176417, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "MOTEGRITY is indicated for the treatment of chronic idiopathic constipation (CIC) in adults. MOTEGRITY is a serotonin-4 (5-HT4) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. (1)", "_input_hash": -130133081, "_task_hash": 34559905, "_is_binary": false, "tokens": [{"text": "MOTEGRITY", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 3, "ws": true}, {"text": "the", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "treatment", "start": 31, "end": 40, "id": 5, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 6, "ws": true}, {"text": "chronic", "start": 44, "end": 51, "id": 7, "ws": true}, {"text": "idiopathic", "start": 52, "end": 62, "id": 8, "ws": true}, {"text": "constipation", "start": 63, "end": 75, "id": 9, "ws": true}, {"text": "(", "start": 76, "end": 77, "id": 10, "ws": false}, {"text": "CIC", "start": 77, "end": 80, "id": 11, "ws": false}, {"text": ")", "start": 80, "end": 81, "id": 12, "ws": true}, {"text": "in", "start": 82, "end": 84, "id": 13, "ws": true}, {"text": "adults", "start": 85, "end": 91, "id": 14, "ws": false}, {"text": ".", "start": 91, "end": 92, "id": 15, "ws": true}, {"text": "MOTEGRITY", "start": 93, "end": 102, "id": 16, "ws": true}, {"text": "is", "start": 103, "end": 105, "id": 17, "ws": true}, {"text": "a", "start": 106, "end": 107, "id": 18, "ws": true}, {"text": "serotonin-4", "start": 108, "end": 119, "id": 19, "ws": true}, {"text": "(", "start": 120, "end": 121, "id": 20, "ws": false}, {"text": "5", "start": 121, "end": 122, "id": 21, "ws": false}, {"text": "-", "start": 122, "end": 123, "id": 22, "ws": false}, {"text": "HT4", "start": 123, "end": 126, "id": 23, "ws": false}, {"text": ")", "start": 126, "end": 127, "id": 24, "ws": true}, {"text": "receptor", "start": 128, "end": 136, "id": 25, "ws": true}, {"text": "agonist", "start": 137, "end": 144, "id": 26, "ws": true}, {"text": "indicated", "start": 145, "end": 154, "id": 27, "ws": true}, {"text": "for", "start": 155, "end": 158, "id": 28, "ws": true}, {"text": "the", "start": 159, "end": 162, "id": 29, "ws": true}, {"text": "treatment", "start": 163, "end": 172, "id": 30, "ws": true}, {"text": "of", "start": 173, "end": 175, "id": 31, "ws": true}, {"text": "chronic", "start": 176, "end": 183, "id": 32, "ws": true}, {"text": "idiopathic", "start": 184, "end": 194, "id": 33, "ws": true}, {"text": "constipation", "start": 195, "end": 207, "id": 34, "ws": true}, {"text": "(", "start": 208, "end": 209, "id": 35, "ws": false}, {"text": "CIC", "start": 209, "end": 212, "id": 36, "ws": false}, {"text": ")", "start": 212, "end": 213, "id": 37, "ws": true}, {"text": "in", "start": 214, "end": 216, "id": 38, "ws": true}, {"text": "adults", "start": 217, "end": 223, "id": 39, "ws": false}, {"text": ".", "start": 223, "end": 224, "id": 40, "ws": true}, {"text": "(", "start": 225, "end": 226, "id": 41, "ws": false}, {"text": "1", "start": 226, "end": 227, "id": 42, "ws": false}, {"text": ")", "start": 227, "end": 228, "id": 43, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 43, "token_start": 5, "token_end": 6, "label": "ACTION"}, {"start": 52, "end": 75, "token_start": 8, "token_end": 9, "label": "INDICATION"}, {"start": 85, "end": 91, "token_start": 14, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 93, "end": 102, "token_start": 16, "token_end": 16, "label": "DRUG"}, {"start": 108, "end": 144, "token_start": 19, "token_end": 26, "label": "MECHANISM"}, {"start": 163, "end": 175, "token_start": 30, "token_end": 31, "label": "ACTION"}, {"start": 176, "end": 207, "token_start": 32, "token_end": 34, "label": "INDICATION"}, {"start": 217, "end": 223, "token_start": 39, "token_end": 39, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694174075, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "NAMZARIC is indicated for the treatment of moderate to severe dementia of the Alzheimers type in patients stabilized on 10 mg of donepezil hydrochloride once daily. NAMZARIC is a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimers type in patients stabilized on 10 mg of donepezil hydrochloride once daily. (1)", "_input_hash": 1327150170, "_task_hash": 296576080, "_is_binary": false, "tokens": [{"text": "NAMZARIC", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "treatment", "start": 30, "end": 39, "id": 5, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "moderate", "start": 43, "end": 51, "id": 7, "ws": true}, {"text": "to", "start": 52, "end": 54, "id": 8, "ws": true}, {"text": "severe", "start": 55, "end": 61, "id": 9, "ws": true}, {"text": "dementia", "start": 62, "end": 70, "id": 10, "ws": true}, {"text": "of", "start": 71, "end": 73, "id": 11, "ws": true}, {"text": "the", "start": 74, "end": 77, "id": 12, "ws": true}, {"text": "Alzheimers", "start": 78, "end": 88, "id": 13, "ws": true}, {"text": "type", "start": 89, "end": 93, "id": 14, "ws": true}, {"text": "in", "start": 94, "end": 96, "id": 15, "ws": true}, {"text": "patients", "start": 97, "end": 105, "id": 16, "ws": true}, {"text": "stabilized", "start": 106, "end": 116, "id": 17, "ws": true}, {"text": "on", "start": 117, "end": 119, "id": 18, "ws": true}, {"text": "10", "start": 120, "end": 122, "id": 19, "ws": true}, {"text": "mg", "start": 123, "end": 125, "id": 20, "ws": true}, {"text": "of", "start": 126, "end": 128, "id": 21, "ws": true}, {"text": "donepezil", "start": 129, "end": 138, "id": 22, "ws": true}, {"text": "hydrochloride", "start": 139, "end": 152, "id": 23, "ws": true}, {"text": "once", "start": 153, "end": 157, "id": 24, "ws": true}, {"text": "daily", "start": 158, "end": 163, "id": 25, "ws": false}, {"text": ".", "start": 163, "end": 164, "id": 26, "ws": true}, {"text": "NAMZARIC", "start": 165, "end": 173, "id": 27, "ws": true}, {"text": "is", "start": 174, "end": 176, "id": 28, "ws": true}, {"text": "a", "start": 177, "end": 178, "id": 29, "ws": true}, {"text": "combination", "start": 179, "end": 190, "id": 30, "ws": true}, {"text": "of", "start": 191, "end": 193, "id": 31, "ws": true}, {"text": "memantine", "start": 194, "end": 203, "id": 32, "ws": true}, {"text": "hydrochloride", "start": 204, "end": 217, "id": 33, "ws": false}, {"text": ",", "start": 217, "end": 218, "id": 34, "ws": true}, {"text": "an", "start": 219, "end": 221, "id": 35, "ws": true}, {"text": "NMDA", "start": 222, "end": 226, "id": 36, "ws": true}, {"text": "receptor", "start": 227, "end": 235, "id": 37, "ws": true}, {"text": "antagonist", "start": 236, "end": 246, "id": 38, "ws": false}, {"text": ",", "start": 246, "end": 247, "id": 39, "ws": true}, {"text": "and", "start": 248, "end": 251, "id": 40, "ws": true}, {"text": "donepezil", "start": 252, "end": 261, "id": 41, "ws": true}, {"text": "hydrochloride", "start": 262, "end": 275, "id": 42, "ws": false}, {"text": ",", "start": 275, "end": 276, "id": 43, "ws": true}, {"text": "an", "start": 277, "end": 279, "id": 44, "ws": true}, {"text": "acetylcholinesterase", "start": 280, "end": 300, "id": 45, "ws": true}, {"text": "inhibitor", "start": 301, "end": 310, "id": 46, "ws": false}, {"text": ",", "start": 310, "end": 311, "id": 47, "ws": true}, {"text": "indicated", "start": 312, "end": 321, "id": 48, "ws": true}, {"text": "for", "start": 322, "end": 325, "id": 49, "ws": true}, {"text": "the", "start": 326, "end": 329, "id": 50, "ws": true}, {"text": "treatment", "start": 330, "end": 339, "id": 51, "ws": true}, {"text": "of", "start": 340, "end": 342, "id": 52, "ws": true}, {"text": "moderate", "start": 343, "end": 351, "id": 53, "ws": true}, {"text": "to", "start": 352, "end": 354, "id": 54, "ws": true}, {"text": "severe", "start": 355, "end": 361, "id": 55, "ws": true}, {"text": "dementia", "start": 362, "end": 370, "id": 56, "ws": true}, {"text": "of", "start": 371, "end": 373, "id": 57, "ws": true}, {"text": "the", "start": 374, "end": 377, "id": 58, "ws": true}, {"text": "Alzheimers", "start": 378, "end": 388, "id": 59, "ws": true}, {"text": "type", "start": 389, "end": 393, "id": 60, "ws": true}, {"text": "in", "start": 394, "end": 396, "id": 61, "ws": true}, {"text": "patients", "start": 397, "end": 405, "id": 62, "ws": true}, {"text": "stabilized", "start": 406, "end": 416, "id": 63, "ws": true}, {"text": "on", "start": 417, "end": 419, "id": 64, "ws": true}, {"text": "10", "start": 420, "end": 422, "id": 65, "ws": true}, {"text": "mg", "start": 423, "end": 425, "id": 66, "ws": true}, {"text": "of", "start": 426, "end": 428, "id": 67, "ws": true}, {"text": "donepezil", "start": 429, "end": 438, "id": 68, "ws": true}, {"text": "hydrochloride", "start": 439, "end": 452, "id": 69, "ws": true}, {"text": "once", "start": 453, "end": 457, "id": 70, "ws": true}, {"text": "daily", "start": 458, "end": 463, "id": 71, "ws": false}, {"text": ".", "start": 463, "end": 464, "id": 72, "ws": true}, {"text": "(", "start": 465, "end": 466, "id": 73, "ws": false}, {"text": "1", "start": 466, "end": 467, "id": 74, "ws": false}, {"text": ")", "start": 467, "end": 468, "id": 75, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 39, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 43, "end": 61, "token_start": 7, "token_end": 9, "label": "SEVERITY"}, {"start": 62, "end": 70, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 78, "end": 88, "token_start": 13, "token_end": 13, "label": "BASECONDITION"}, {"start": 120, "end": 163, "token_start": 19, "token_end": 25, "label": "CO_PRESCRIPTION"}, {"start": 165, "end": 173, "token_start": 27, "token_end": 27, "label": "DRUG"}, {"start": 280, "end": 310, "token_start": 45, "token_end": 46, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694528657, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Levocetirizine dihydrochloride tablets are a histamine H1-receptor antagonist indicated for:  The relief of symptoms associated with perennial allergic rhinitis (1.1 )  The treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria (1.2) 1.2 Chronic Idiopathic Urticaria Levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older.", "_input_hash": -1607978552, "_task_hash": 1910516857, "_is_binary": false, "tokens": [{"text": "Levocetirizine", "start": 0, "end": 14, "id": 0, "ws": true}, {"text": "dihydrochloride", "start": 15, "end": 30, "id": 1, "ws": true}, {"text": "tablets", "start": 31, "end": 38, "id": 2, "ws": true}, {"text": "are", "start": 39, "end": 42, "id": 3, "ws": true}, {"text": "a", "start": 43, "end": 44, "id": 4, "ws": true}, {"text": "histamine", "start": 45, "end": 54, "id": 5, "ws": true}, {"text": "H1", "start": 55, "end": 57, "id": 6, "ws": false}, {"text": "-", "start": 57, "end": 58, "id": 7, "ws": false}, {"text": "receptor", "start": 58, "end": 66, "id": 8, "ws": true}, {"text": "antagonist", "start": 67, "end": 77, "id": 9, "ws": true}, {"text": "indicated", "start": 78, "end": 87, "id": 10, "ws": true}, {"text": "for", "start": 88, "end": 91, "id": 11, "ws": false}, {"text": ":", "start": 91, "end": 92, "id": 12, "ws": true}, {"text": " ", "start": 93, "end": 94, "id": 13, "ws": false}, {"text": "The", "start": 94, "end": 97, "id": 14, "ws": true}, {"text": "relief", "start": 98, "end": 104, "id": 15, "ws": true}, {"text": "of", "start": 105, "end": 107, "id": 16, "ws": true}, {"text": "symptoms", "start": 108, "end": 116, "id": 17, "ws": true}, {"text": "associated", "start": 117, "end": 127, "id": 18, "ws": true}, {"text": "with", "start": 128, "end": 132, "id": 19, "ws": true}, {"text": "perennial", "start": 133, "end": 142, "id": 20, "ws": true}, {"text": "allergic", "start": 143, "end": 151, "id": 21, "ws": true}, {"text": "rhinitis", "start": 152, "end": 160, "id": 22, "ws": true}, {"text": "(", "start": 161, "end": 162, "id": 23, "ws": false}, {"text": "1.1", "start": 162, "end": 165, "id": 24, "ws": true}, {"text": ")", "start": 166, "end": 167, "id": 25, "ws": true}, {"text": " ", "start": 168, "end": 169, "id": 26, "ws": false}, {"text": "The", "start": 169, "end": 172, "id": 27, "ws": true}, {"text": "treatment", "start": 173, "end": 182, "id": 28, "ws": true}, {"text": "of", "start": 183, "end": 185, "id": 29, "ws": true}, {"text": "the", "start": 186, "end": 189, "id": 30, "ws": true}, {"text": "uncomplicated", "start": 190, "end": 203, "id": 31, "ws": true}, {"text": "skin", "start": 204, "end": 208, "id": 32, "ws": true}, {"text": "manifestations", "start": 209, "end": 223, "id": 33, "ws": true}, {"text": "of", "start": 224, "end": 226, "id": 34, "ws": true}, {"text": "chronic", "start": 227, "end": 234, "id": 35, "ws": true}, {"text": "idiopathic", "start": 235, "end": 245, "id": 36, "ws": true}, {"text": "urticaria", "start": 246, "end": 255, "id": 37, "ws": true}, {"text": "(", "start": 256, "end": 257, "id": 38, "ws": false}, {"text": "1.2", "start": 257, "end": 260, "id": 39, "ws": false}, {"text": ")", "start": 260, "end": 261, "id": 40, "ws": true}, {"text": "1.2", "start": 262, "end": 265, "id": 41, "ws": true}, {"text": "Chronic", "start": 266, "end": 273, "id": 42, "ws": true}, {"text": "Idiopathic", "start": 274, "end": 284, "id": 43, "ws": true}, {"text": "Urticaria", "start": 285, "end": 294, "id": 44, "ws": true}, {"text": "Levocetirizine", "start": 295, "end": 309, "id": 45, "ws": true}, {"text": "dihydrochloride", "start": 310, "end": 325, "id": 46, "ws": true}, {"text": "tablets", "start": 326, "end": 333, "id": 47, "ws": true}, {"text": "are", "start": 334, "end": 337, "id": 48, "ws": true}, {"text": "indicated", "start": 338, "end": 347, "id": 49, "ws": true}, {"text": "for", "start": 348, "end": 351, "id": 50, "ws": true}, {"text": "the", "start": 352, "end": 355, "id": 51, "ws": true}, {"text": "treatment", "start": 356, "end": 365, "id": 52, "ws": true}, {"text": "of", "start": 366, "end": 368, "id": 53, "ws": true}, {"text": "the", "start": 369, "end": 372, "id": 54, "ws": true}, {"text": "uncomplicated", "start": 373, "end": 386, "id": 55, "ws": true}, {"text": "skin", "start": 387, "end": 391, "id": 56, "ws": true}, {"text": "manifestations", "start": 392, "end": 406, "id": 57, "ws": true}, {"text": "of", "start": 407, "end": 409, "id": 58, "ws": true}, {"text": "chronic", "start": 410, "end": 417, "id": 59, "ws": true}, {"text": "idiopathic", "start": 418, "end": 428, "id": 60, "ws": true}, {"text": "urticaria", "start": 429, "end": 438, "id": 61, "ws": true}, {"text": "in", "start": 439, "end": 441, "id": 62, "ws": true}, {"text": "adults", "start": 442, "end": 448, "id": 63, "ws": true}, {"text": "and", "start": 449, "end": 452, "id": 64, "ws": true}, {"text": "children", "start": 453, "end": 461, "id": 65, "ws": true}, {"text": "6", "start": 462, "end": 463, "id": 66, "ws": true}, {"text": "years", "start": 464, "end": 469, "id": 67, "ws": true}, {"text": "of", "start": 470, "end": 472, "id": 68, "ws": true}, {"text": "age", "start": 473, "end": 476, "id": 69, "ws": true}, {"text": "and", "start": 477, "end": 480, "id": 70, "ws": true}, {"text": "older", "start": 481, "end": 486, "id": 71, "ws": false}, {"text": ".", "start": 486, "end": 487, "id": 72, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 14, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 15, "end": 30, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 31, "end": 38, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 45, "end": 77, "token_start": 5, "token_end": 9, "label": "MECHANISM"}, {"start": 98, "end": 104, "token_start": 15, "token_end": 15, "label": "ACTION"}, {"start": 108, "end": 116, "token_start": 17, "token_end": 17, "label": "INDICATION"}, {"start": 133, "end": 160, "token_start": 20, "token_end": 22, "label": "BASECONDITION"}, {"start": 173, "end": 182, "token_start": 28, "token_end": 28, "label": "ACTION"}, {"start": 190, "end": 223, "token_start": 31, "token_end": 33, "label": "INDICATION"}, {"start": 227, "end": 255, "token_start": 35, "token_end": 37, "label": "BASECONDITION"}, {"start": 295, "end": 309, "token_start": 45, "token_end": 45, "label": "DRUG"}, {"start": 310, "end": 325, "token_start": 46, "token_end": 46, "label": "SALT"}, {"start": 326, "end": 333, "token_start": 47, "token_end": 47, "label": "FORMULATION"}, {"start": 356, "end": 365, "token_start": 52, "token_end": 52, "label": "ACTION"}, {"start": 373, "end": 386, "token_start": 55, "token_end": 55, "label": "SEVERITY"}, {"start": 387, "end": 406, "token_start": 56, "token_end": 57, "label": "INDICATION"}, {"start": 410, "end": 438, "token_start": 59, "token_end": 61, "label": "BASECONDITION"}, {"start": 442, "end": 448, "token_start": 63, "token_end": 63, "label": "TARGET_GROUP"}, {"start": 453, "end": 486, "token_start": 65, "token_end": 71, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694525336, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimers type. Memantine hydrochloride tablets are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimers type. (1)", "_input_hash": -2146414332, "_task_hash": -672412985, "_is_binary": false, "tokens": [{"text": "Memantine", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 10, "end": 23, "id": 1, "ws": true}, {"text": "tablets", "start": 24, "end": 31, "id": 2, "ws": true}, {"text": "are", "start": 32, "end": 35, "id": 3, "ws": true}, {"text": "indicated", "start": 36, "end": 45, "id": 4, "ws": true}, {"text": "for", "start": 46, "end": 49, "id": 5, "ws": true}, {"text": "the", "start": 50, "end": 53, "id": 6, "ws": true}, {"text": "treatment", "start": 54, "end": 63, "id": 7, "ws": true}, {"text": "of", "start": 64, "end": 66, "id": 8, "ws": true}, {"text": "moderate", "start": 67, "end": 75, "id": 9, "ws": true}, {"text": "to", "start": 76, "end": 78, "id": 10, "ws": true}, {"text": "severe", "start": 79, "end": 85, "id": 11, "ws": true}, {"text": "dementia", "start": 86, "end": 94, "id": 12, "ws": true}, {"text": "of", "start": 95, "end": 97, "id": 13, "ws": true}, {"text": "the", "start": 98, "end": 101, "id": 14, "ws": true}, {"text": "Alzheimers", "start": 102, "end": 112, "id": 15, "ws": true}, {"text": "type", "start": 113, "end": 117, "id": 16, "ws": false}, {"text": ".", "start": 117, "end": 118, "id": 17, "ws": true}, {"text": "Memantine", "start": 119, "end": 128, "id": 18, "ws": true}, {"text": "hydrochloride", "start": 129, "end": 142, "id": 19, "ws": true}, {"text": "tablets", "start": 143, "end": 150, "id": 20, "ws": true}, {"text": "are", "start": 151, "end": 154, "id": 21, "ws": true}, {"text": "an", "start": 155, "end": 157, "id": 22, "ws": true}, {"text": "N", "start": 158, "end": 159, "id": 23, "ws": false}, {"text": "-", "start": 159, "end": 160, "id": 24, "ws": false}, {"text": "methyl", "start": 160, "end": 166, "id": 25, "ws": false}, {"text": "-", "start": 166, "end": 167, "id": 26, "ws": false}, {"text": "D", "start": 167, "end": 168, "id": 27, "ws": false}, {"text": "-", "start": 168, "end": 169, "id": 28, "ws": false}, {"text": "aspartate", "start": 169, "end": 178, "id": 29, "ws": true}, {"text": "(", "start": 179, "end": 180, "id": 30, "ws": false}, {"text": "NMDA", "start": 180, "end": 184, "id": 31, "ws": false}, {"text": ")", "start": 184, "end": 185, "id": 32, "ws": true}, {"text": "receptor", "start": 186, "end": 194, "id": 33, "ws": true}, {"text": "antagonist", "start": 195, "end": 205, "id": 34, "ws": true}, {"text": "indicated", "start": 206, "end": 215, "id": 35, "ws": true}, {"text": "for", "start": 216, "end": 219, "id": 36, "ws": true}, {"text": "the", "start": 220, "end": 223, "id": 37, "ws": true}, {"text": "treatment", "start": 224, "end": 233, "id": 38, "ws": true}, {"text": "of", "start": 234, "end": 236, "id": 39, "ws": true}, {"text": "moderate", "start": 237, "end": 245, "id": 40, "ws": true}, {"text": "to", "start": 246, "end": 248, "id": 41, "ws": true}, {"text": "severe", "start": 249, "end": 255, "id": 42, "ws": true}, {"text": "dementia", "start": 256, "end": 264, "id": 43, "ws": true}, {"text": "of", "start": 265, "end": 267, "id": 44, "ws": true}, {"text": "the", "start": 268, "end": 271, "id": 45, "ws": true}, {"text": "Alzheimers", "start": 272, "end": 282, "id": 46, "ws": true}, {"text": "type", "start": 283, "end": 287, "id": 47, "ws": false}, {"text": ".", "start": 287, "end": 288, "id": 48, "ws": true}, {"text": "(", "start": 289, "end": 290, "id": 49, "ws": false}, {"text": "1", "start": 290, "end": 291, "id": 50, "ws": false}, {"text": ")", "start": 291, "end": 292, "id": 51, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 31, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 54, "end": 63, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 67, "end": 85, "token_start": 9, "token_end": 11, "label": "SEVERITY"}, {"start": 86, "end": 94, "token_start": 12, "token_end": 12, "label": "INDICATION"}, {"start": 102, "end": 117, "token_start": 15, "token_end": 16, "label": "BASECONDITION"}, {"start": 119, "end": 128, "token_start": 18, "token_end": 18, "label": "DRUG"}, {"start": 129, "end": 142, "token_start": 19, "token_end": 19, "label": "SALT"}, {"start": 143, "end": 150, "token_start": 20, "token_end": 20, "label": "FORMULATION"}, {"start": 158, "end": 205, "token_start": 23, "token_end": 34, "label": "MECHANISM"}, {"start": 224, "end": 233, "token_start": 38, "token_end": 38, "label": "ACTION"}, {"start": 237, "end": 255, "token_start": 40, "token_end": 42, "label": "SEVERITY"}, {"start": 256, "end": 264, "token_start": 43, "token_end": 43, "label": "INDICATION"}, {"start": 272, "end": 287, "token_start": 46, "token_end": 47, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694528417, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Vivacaine (bupivacaine hydrochloride and epinephrine injection, USP) is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. Vivacaine (bupivacaine hydrochloride and epinephrine injection, USP) is not recommended for children.", "_input_hash": 1652534899, "_task_hash": -2126690986, "_is_binary": false, "tokens": [{"text": "Vivacaine", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "(", "start": 10, "end": 11, "id": 1, "ws": false}, {"text": "bupivacaine", "start": 11, "end": 22, "id": 2, "ws": true}, {"text": "hydrochloride", "start": 23, "end": 36, "id": 3, "ws": true}, {"text": "and", "start": 37, "end": 40, "id": 4, "ws": true}, {"text": "epinephrine", "start": 41, "end": 52, "id": 5, "ws": true}, {"text": "injection", "start": 53, "end": 62, "id": 6, "ws": false}, {"text": ",", "start": 62, "end": 63, "id": 7, "ws": true}, {"text": "USP", "start": 64, "end": 67, "id": 8, "ws": false}, {"text": ")", "start": 67, "end": 68, "id": 9, "ws": true}, {"text": "is", "start": 69, "end": 71, "id": 10, "ws": true}, {"text": "indicated", "start": 72, "end": 81, "id": 11, "ws": true}, {"text": "for", "start": 82, "end": 85, "id": 12, "ws": true}, {"text": "the", "start": 86, "end": 89, "id": 13, "ws": true}, {"text": "production", "start": 90, "end": 100, "id": 14, "ws": true}, {"text": "of", "start": 101, "end": 103, "id": 15, "ws": true}, {"text": "local", "start": 104, "end": 109, "id": 16, "ws": true}, {"text": "anesthesia", "start": 110, "end": 120, "id": 17, "ws": true}, {"text": "for", "start": 121, "end": 124, "id": 18, "ws": true}, {"text": "dental", "start": 125, "end": 131, "id": 19, "ws": true}, {"text": "procedures", "start": 132, "end": 142, "id": 20, "ws": true}, {"text": "by", "start": 143, "end": 145, "id": 21, "ws": true}, {"text": "infiltration", "start": 146, "end": 158, "id": 22, "ws": true}, {"text": "injection", "start": 159, "end": 168, "id": 23, "ws": true}, {"text": "or", "start": 169, "end": 171, "id": 24, "ws": true}, {"text": "nerve", "start": 172, "end": 177, "id": 25, "ws": true}, {"text": "block", "start": 178, "end": 183, "id": 26, "ws": true}, {"text": "in", "start": 184, "end": 186, "id": 27, "ws": true}, {"text": "adults", "start": 187, "end": 193, "id": 28, "ws": false}, {"text": ".", "start": 193, "end": 194, "id": 29, "ws": true}, {"text": "Vivacaine", "start": 195, "end": 204, "id": 30, "ws": true}, {"text": "(", "start": 205, "end": 206, "id": 31, "ws": false}, {"text": "bupivacaine", "start": 206, "end": 217, "id": 32, "ws": true}, {"text": "hydrochloride", "start": 218, "end": 231, "id": 33, "ws": true}, {"text": "and", "start": 232, "end": 235, "id": 34, "ws": true}, {"text": "epinephrine", "start": 236, "end": 247, "id": 35, "ws": true}, {"text": "injection", "start": 248, "end": 257, "id": 36, "ws": false}, {"text": ",", "start": 257, "end": 258, "id": 37, "ws": true}, {"text": "USP", "start": 259, "end": 262, "id": 38, "ws": false}, {"text": ")", "start": 262, "end": 263, "id": 39, "ws": true}, {"text": "is", "start": 264, "end": 266, "id": 40, "ws": true}, {"text": "not", "start": 267, "end": 270, "id": 41, "ws": true}, {"text": "recommended", "start": 271, "end": 282, "id": 42, "ws": true}, {"text": "for", "start": 283, "end": 286, "id": 43, "ws": true}, {"text": "children", "start": 287, "end": 295, "id": 44, "ws": false}, {"text": ".", "start": 295, "end": 296, "id": 45, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 22, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 23, "end": 36, "token_start": 3, "token_end": 3, "label": "SALT"}, {"start": 41, "end": 52, "token_start": 5, "token_end": 5, "label": "DRUG"}, {"start": 53, "end": 62, "token_start": 6, "token_end": 6, "label": "ROUTE"}, {"start": 90, "end": 120, "token_start": 14, "token_end": 17, "label": "EFFECT"}, {"start": 125, "end": 142, "token_start": 19, "token_end": 20, "label": "MEDICAL_CTX"}, {"start": 146, "end": 168, "token_start": 22, "token_end": 23, "label": "MECHANISM"}, {"start": 172, "end": 183, "token_start": 25, "token_end": 26, "label": "MECHANISM"}, {"start": 187, "end": 193, "token_start": 28, "token_end": 28, "label": "TARGET_GROUP"}, {"start": 195, "end": 295, "token_start": 30, "token_end": 44, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694526939, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "MIRAPEX ER tablets are indicated for the treatment of Parkinson's disease. MIRAPEX ER is a non-ergot dopamine agonist indicated for the treatment of Parkinson's disease (PD) (1)", "_input_hash": 772009561, "_task_hash": 137227464, "_is_binary": false, "tokens": [{"text": "MIRAPEX", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "ER", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "tablets", "start": 11, "end": 18, "id": 2, "ws": true}, {"text": "are", "start": 19, "end": 22, "id": 3, "ws": true}, {"text": "indicated", "start": 23, "end": 32, "id": 4, "ws": true}, {"text": "for", "start": 33, "end": 36, "id": 5, "ws": true}, {"text": "the", "start": 37, "end": 40, "id": 6, "ws": true}, {"text": "treatment", "start": 41, "end": 50, "id": 7, "ws": true}, {"text": "of", "start": 51, "end": 53, "id": 8, "ws": true}, {"text": "Parkinson", "start": 54, "end": 63, "id": 9, "ws": false}, {"text": "'s", "start": 63, "end": 65, "id": 10, "ws": true}, {"text": "disease", "start": 66, "end": 73, "id": 11, "ws": false}, {"text": ".", "start": 73, "end": 74, "id": 12, "ws": true}, {"text": "MIRAPEX", "start": 75, "end": 82, "id": 13, "ws": true}, {"text": "ER", "start": 83, "end": 85, "id": 14, "ws": true}, {"text": "is", "start": 86, "end": 88, "id": 15, "ws": true}, {"text": "a", "start": 89, "end": 90, "id": 16, "ws": true}, {"text": "non", "start": 91, "end": 94, "id": 17, "ws": false}, {"text": "-", "start": 94, "end": 95, "id": 18, "ws": false}, {"text": "ergot", "start": 95, "end": 100, "id": 19, "ws": true}, {"text": "dopamine", "start": 101, "end": 109, "id": 20, "ws": true}, {"text": "agonist", "start": 110, "end": 117, "id": 21, "ws": true}, {"text": "indicated", "start": 118, "end": 127, "id": 22, "ws": true}, {"text": "for", "start": 128, "end": 131, "id": 23, "ws": true}, {"text": "the", "start": 132, "end": 135, "id": 24, "ws": true}, {"text": "treatment", "start": 136, "end": 145, "id": 25, "ws": true}, {"text": "of", "start": 146, "end": 148, "id": 26, "ws": true}, {"text": "Parkinson", "start": 149, "end": 158, "id": 27, "ws": false}, {"text": "'s", "start": 158, "end": 160, "id": 28, "ws": true}, {"text": "disease", "start": 161, "end": 168, "id": 29, "ws": true}, {"text": "(", "start": 169, "end": 170, "id": 30, "ws": false}, {"text": "PD", "start": 170, "end": 172, "id": 31, "ws": false}, {"text": ")", "start": 172, "end": 173, "id": 32, "ws": true}, {"text": "(", "start": 174, "end": 175, "id": 33, "ws": false}, {"text": "1", "start": 175, "end": 176, "id": 34, "ws": false}, {"text": ")", "start": 176, "end": 177, "id": 35, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 18, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 41, "end": 50, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 54, "end": 73, "token_start": 9, "token_end": 11, "label": "INDICATION"}, {"start": 75, "end": 82, "token_start": 13, "token_end": 13, "label": "DRUG"}, {"start": 91, "end": 117, "token_start": 17, "token_end": 21, "label": "MECHANISM"}, {"start": 136, "end": 145, "token_start": 25, "token_end": 25, "label": "ACTION"}, {"start": 149, "end": 168, "token_start": 27, "token_end": 29, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526319, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Haloperidol Decanoate Injection is indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy.", "_input_hash": 561980756, "_task_hash": 2044901225, "_is_binary": false, "tokens": [{"text": "Haloperidol", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "Decanoate", "start": 12, "end": 21, "id": 1, "ws": true}, {"text": "Injection", "start": 22, "end": 31, "id": 2, "ws": true}, {"text": "is", "start": 32, "end": 34, "id": 3, "ws": true}, {"text": "indicated", "start": 35, "end": 44, "id": 4, "ws": true}, {"text": "for", "start": 45, "end": 48, "id": 5, "ws": true}, {"text": "the", "start": 49, "end": 52, "id": 6, "ws": true}, {"text": "treatment", "start": 53, "end": 62, "id": 7, "ws": true}, {"text": "of", "start": 63, "end": 65, "id": 8, "ws": true}, {"text": "patients", "start": 66, "end": 74, "id": 9, "ws": true}, {"text": "with", "start": 75, "end": 79, "id": 10, "ws": true}, {"text": "schizophrenia", "start": 80, "end": 93, "id": 11, "ws": true}, {"text": "who", "start": 94, "end": 97, "id": 12, "ws": true}, {"text": "require", "start": 98, "end": 105, "id": 13, "ws": true}, {"text": "prolonged", "start": 106, "end": 115, "id": 14, "ws": true}, {"text": "parenteral", "start": 116, "end": 126, "id": 15, "ws": true}, {"text": "antipsychotic", "start": 127, "end": 140, "id": 16, "ws": true}, {"text": "therapy", "start": 141, "end": 148, "id": 17, "ws": false}, {"text": ".", "start": 148, "end": 149, "id": 18, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 21, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 22, "end": 31, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 53, "end": 62, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 80, "end": 93, "token_start": 11, "token_end": 11, "label": "BASECONDITION"}, {"start": 98, "end": 148, "token_start": 13, "token_end": 17, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694175594, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Oxcarbazepine tablets USP are indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and as monotherapy in the treatment of partial seizures in children aged 4 years and above with epilepsy, and as adjunctive therapy in children aged 2 years and above with partial seizures.", "_input_hash": 1859304030, "_task_hash": 1408617422, "_is_binary": false, "tokens": [{"text": "Oxcarbazepine", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "tablets", "start": 14, "end": 21, "id": 1, "ws": true}, {"text": "USP", "start": 22, "end": 25, "id": 2, "ws": true}, {"text": "are", "start": 26, "end": 29, "id": 3, "ws": true}, {"text": "indicated", "start": 30, "end": 39, "id": 4, "ws": true}, {"text": "for", "start": 40, "end": 43, "id": 5, "ws": true}, {"text": "use", "start": 44, "end": 47, "id": 6, "ws": true}, {"text": "as", "start": 48, "end": 50, "id": 7, "ws": true}, {"text": "monotherapy", "start": 51, "end": 62, "id": 8, "ws": true}, {"text": "or", "start": 63, "end": 65, "id": 9, "ws": true}, {"text": "adjunctive", "start": 66, "end": 76, "id": 10, "ws": true}, {"text": "therapy", "start": 77, "end": 84, "id": 11, "ws": true}, {"text": "in", "start": 85, "end": 87, "id": 12, "ws": true}, {"text": "the", "start": 88, "end": 91, "id": 13, "ws": true}, {"text": "treatment", "start": 92, "end": 101, "id": 14, "ws": true}, {"text": "of", "start": 102, "end": 104, "id": 15, "ws": true}, {"text": "partial", "start": 105, "end": 112, "id": 16, "ws": true}, {"text": "seizures", "start": 113, "end": 121, "id": 17, "ws": true}, {"text": "in", "start": 122, "end": 124, "id": 18, "ws": true}, {"text": "adults", "start": 125, "end": 131, "id": 19, "ws": true}, {"text": "and", "start": 132, "end": 135, "id": 20, "ws": true}, {"text": "as", "start": 136, "end": 138, "id": 21, "ws": true}, {"text": "monotherapy", "start": 139, "end": 150, "id": 22, "ws": true}, {"text": "in", "start": 151, "end": 153, "id": 23, "ws": true}, {"text": "the", "start": 154, "end": 157, "id": 24, "ws": true}, {"text": "treatment", "start": 158, "end": 167, "id": 25, "ws": true}, {"text": "of", "start": 168, "end": 170, "id": 26, "ws": true}, {"text": "partial", "start": 171, "end": 178, "id": 27, "ws": true}, {"text": "seizures", "start": 179, "end": 187, "id": 28, "ws": true}, {"text": "in", "start": 188, "end": 190, "id": 29, "ws": true}, {"text": "children", "start": 191, "end": 199, "id": 30, "ws": true}, {"text": "aged", "start": 200, "end": 204, "id": 31, "ws": true}, {"text": "4", "start": 205, "end": 206, "id": 32, "ws": true}, {"text": "years", "start": 207, "end": 212, "id": 33, "ws": true}, {"text": "and", "start": 213, "end": 216, "id": 34, "ws": true}, {"text": "above", "start": 217, "end": 222, "id": 35, "ws": true}, {"text": "with", "start": 223, "end": 227, "id": 36, "ws": true}, {"text": "epilepsy", "start": 228, "end": 236, "id": 37, "ws": false}, {"text": ",", "start": 236, "end": 237, "id": 38, "ws": true}, {"text": "and", "start": 238, "end": 241, "id": 39, "ws": true}, {"text": "as", "start": 242, "end": 244, "id": 40, "ws": true}, {"text": "adjunctive", "start": 245, "end": 255, "id": 41, "ws": true}, {"text": "therapy", "start": 256, "end": 263, "id": 42, "ws": true}, {"text": "in", "start": 264, "end": 266, "id": 43, "ws": true}, {"text": "children", "start": 267, "end": 275, "id": 44, "ws": true}, {"text": "aged", "start": 276, "end": 280, "id": 45, "ws": true}, {"text": "2", "start": 281, "end": 282, "id": 46, "ws": true}, {"text": "years", "start": 283, "end": 288, "id": 47, "ws": true}, {"text": "and", "start": 289, "end": 292, "id": 48, "ws": true}, {"text": "above", "start": 293, "end": 298, "id": 49, "ws": true}, {"text": "with", "start": 299, "end": 303, "id": 50, "ws": true}, {"text": "partial", "start": 304, "end": 311, "id": 51, "ws": true}, {"text": "seizures", "start": 312, "end": 320, "id": 52, "ws": false}, {"text": ".", "start": 320, "end": 321, "id": 53, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 21, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 92, "end": 101, "token_start": 14, "token_end": 14, "label": "ACTION"}, {"start": 105, "end": 121, "token_start": 16, "token_end": 17, "label": "INDICATION"}, {"start": 125, "end": 131, "token_start": 19, "token_end": 19, "label": "TARGET_GROUP"}, {"start": 158, "end": 167, "token_start": 25, "token_end": 25, "label": "ACTION"}, {"start": 171, "end": 187, "token_start": 27, "token_end": 28, "label": "INDICATION"}, {"start": 191, "end": 212, "token_start": 30, "token_end": 33, "label": "TARGET_GROUP"}, {"start": 228, "end": 236, "token_start": 37, "token_end": 37, "label": "BASECONDITION"}, {"start": 245, "end": 263, "token_start": 41, "token_end": 42, "label": "INDICATION"}, {"start": 267, "end": 298, "token_start": 44, "token_end": 49, "label": "TARGET_GROUP"}, {"start": 304, "end": 320, "token_start": 51, "token_end": 52, "label": "CO_MORBIDITY"}], "answer": "accept", "_timestamp": 1694525490, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "LYLLANA is indicated for: LYLLANA  is an estrogen indicated for: Treatment of moderate to severe vasomotor symptoms due to menopause (1.1) Prevention of postmenopausal osteoporosis (1.2) Limitations of Use When prescribing solely for the treatment of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis. 1.1 Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause 1.2 Prevention of Postmenopausal Osteoporosis Limitation of Use When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.", "_input_hash": -729157465, "_task_hash": -1081522554, "_is_binary": false, "tokens": [{"text": "LYLLANA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": false}, {"text": ":", "start": 24, "end": 25, "id": 4, "ws": true}, {"text": "LYLLANA", "start": 26, "end": 33, "id": 5, "ws": true}, {"text": " ", "start": 34, "end": 35, "id": 6, "ws": false}, {"text": "is", "start": 35, "end": 37, "id": 7, "ws": true}, {"text": "an", "start": 38, "end": 40, "id": 8, "ws": true}, {"text": "estrogen", "start": 41, "end": 49, "id": 9, "ws": true}, {"text": "indicated", "start": 50, "end": 59, "id": 10, "ws": true}, {"text": "for", "start": 60, "end": 63, "id": 11, "ws": false}, {"text": ":", "start": 63, "end": 64, "id": 12, "ws": true}, {"text": "Treatment", "start": 65, "end": 74, "id": 13, "ws": true}, {"text": "of", "start": 75, "end": 77, "id": 14, "ws": true}, {"text": "moderate", "start": 78, "end": 86, "id": 15, "ws": true}, {"text": "to", "start": 87, "end": 89, "id": 16, "ws": true}, {"text": "severe", "start": 90, "end": 96, "id": 17, "ws": true}, {"text": "vasomotor", "start": 97, "end": 106, "id": 18, "ws": true}, {"text": "symptoms", "start": 107, "end": 115, "id": 19, "ws": true}, {"text": "due", "start": 116, "end": 119, "id": 20, "ws": true}, {"text": "to", "start": 120, "end": 122, "id": 21, "ws": true}, {"text": "menopause", "start": 123, "end": 132, "id": 22, "ws": true}, {"text": "(", "start": 133, "end": 134, "id": 23, "ws": false}, {"text": "1.1", "start": 134, "end": 137, "id": 24, "ws": false}, {"text": ")", "start": 137, "end": 138, "id": 25, "ws": true}, {"text": "Prevention", "start": 139, "end": 149, "id": 26, "ws": true}, {"text": "of", "start": 150, "end": 152, "id": 27, "ws": true}, {"text": "postmenopausal", "start": 153, "end": 167, "id": 28, "ws": true}, {"text": "osteoporosis", "start": 168, "end": 180, "id": 29, "ws": true}, {"text": "(", "start": 181, "end": 182, "id": 30, "ws": false}, {"text": "1.2", "start": 182, "end": 185, "id": 31, "ws": false}, {"text": ")", "start": 185, "end": 186, "id": 32, "ws": true}, {"text": "Limitations", "start": 187, "end": 198, "id": 33, "ws": true}, {"text": "of", "start": 199, "end": 201, "id": 34, "ws": true}, {"text": "Use", "start": 202, "end": 205, "id": 35, "ws": true}, {"text": "When", "start": 206, "end": 210, "id": 36, "ws": true}, {"text": "prescribing", "start": 211, "end": 222, "id": 37, "ws": true}, {"text": "solely", "start": 223, "end": 229, "id": 38, "ws": true}, {"text": "for", "start": 230, "end": 233, "id": 39, "ws": true}, {"text": "the", "start": 234, "end": 237, "id": 40, "ws": true}, {"text": "treatment", "start": 238, "end": 247, "id": 41, "ws": true}, {"text": "of", "start": 248, "end": 250, "id": 42, "ws": true}, {"text": "postmenopausal", "start": 251, "end": 265, "id": 43, "ws": true}, {"text": "osteoporosis", "start": 266, "end": 278, "id": 44, "ws": false}, {"text": ",", "start": 278, "end": 279, "id": 45, "ws": true}, {"text": "first", "start": 280, "end": 285, "id": 46, "ws": true}, {"text": "consider", "start": 286, "end": 294, "id": 47, "ws": true}, {"text": "the", "start": 295, "end": 298, "id": 48, "ws": true}, {"text": "use", "start": 299, "end": 302, "id": 49, "ws": true}, {"text": "of", "start": 303, "end": 305, "id": 50, "ws": true}, {"text": "non", "start": 306, "end": 309, "id": 51, "ws": false}, {"text": "-", "start": 309, "end": 310, "id": 52, "ws": false}, {"text": "estrogen", "start": 310, "end": 318, "id": 53, "ws": true}, {"text": "medications", "start": 319, "end": 330, "id": 54, "ws": false}, {"text": ".", "start": 330, "end": 331, "id": 55, "ws": true}, {"text": "Consider", "start": 332, "end": 340, "id": 56, "ws": true}, {"text": "estrogen", "start": 341, "end": 349, "id": 57, "ws": true}, {"text": "therapy", "start": 350, "end": 357, "id": 58, "ws": true}, {"text": "only", "start": 358, "end": 362, "id": 59, "ws": true}, {"text": "for", "start": 363, "end": 366, "id": 60, "ws": true}, {"text": "women", "start": 367, "end": 372, "id": 61, "ws": true}, {"text": "at", "start": 373, "end": 375, "id": 62, "ws": true}, {"text": "significant", "start": 376, "end": 387, "id": 63, "ws": true}, {"text": "risk", "start": 388, "end": 392, "id": 64, "ws": true}, {"text": "of", "start": 393, "end": 395, "id": 65, "ws": true}, {"text": "osteoporosis", "start": 396, "end": 408, "id": 66, "ws": false}, {"text": ".", "start": 408, "end": 409, "id": 67, "ws": true}, {"text": "1.1", "start": 410, "end": 413, "id": 68, "ws": true}, {"text": "Treatment", "start": 414, "end": 423, "id": 69, "ws": true}, {"text": "of", "start": 424, "end": 426, "id": 70, "ws": true}, {"text": "Moderate", "start": 427, "end": 435, "id": 71, "ws": true}, {"text": "to", "start": 436, "end": 438, "id": 72, "ws": true}, {"text": "Severe", "start": 439, "end": 445, "id": 73, "ws": true}, {"text": "Vasomotor", "start": 446, "end": 455, "id": 74, "ws": true}, {"text": "Symptoms", "start": 456, "end": 464, "id": 75, "ws": true}, {"text": "Due", "start": 465, "end": 468, "id": 76, "ws": true}, {"text": "to", "start": 469, "end": 471, "id": 77, "ws": true}, {"text": "Menopause", "start": 472, "end": 481, "id": 78, "ws": true}, {"text": "1.2", "start": 482, "end": 485, "id": 79, "ws": true}, {"text": "Prevention", "start": 486, "end": 496, "id": 80, "ws": true}, {"text": "of", "start": 497, "end": 499, "id": 81, "ws": true}, {"text": "Postmenopausal", "start": 500, "end": 514, "id": 82, "ws": true}, {"text": "Osteoporosis", "start": 515, "end": 527, "id": 83, "ws": true}, {"text": "Limitation", "start": 528, "end": 538, "id": 84, "ws": true}, {"text": "of", "start": 539, "end": 541, "id": 85, "ws": true}, {"text": "Use", "start": 542, "end": 545, "id": 86, "ws": true}, {"text": "When", "start": 546, "end": 550, "id": 87, "ws": true}, {"text": "prescribing", "start": 551, "end": 562, "id": 88, "ws": true}, {"text": "solely", "start": 563, "end": 569, "id": 89, "ws": true}, {"text": "for", "start": 570, "end": 573, "id": 90, "ws": true}, {"text": "the", "start": 574, "end": 577, "id": 91, "ws": true}, {"text": "prevention", "start": 578, "end": 588, "id": 92, "ws": true}, {"text": "of", "start": 589, "end": 591, "id": 93, "ws": true}, {"text": "postmenopausal", "start": 592, "end": 606, "id": 94, "ws": true}, {"text": "osteoporosis", "start": 607, "end": 619, "id": 95, "ws": false}, {"text": ",", "start": 619, "end": 620, "id": 96, "ws": true}, {"text": "first", "start": 621, "end": 626, "id": 97, "ws": true}, {"text": "consider", "start": 627, "end": 635, "id": 98, "ws": true}, {"text": "the", "start": 636, "end": 639, "id": 99, "ws": true}, {"text": "use", "start": 640, "end": 643, "id": 100, "ws": true}, {"text": "of", "start": 644, "end": 646, "id": 101, "ws": true}, {"text": "non", "start": 647, "end": 650, "id": 102, "ws": false}, {"text": "-", "start": 650, "end": 651, "id": 103, "ws": false}, {"text": "estrogen", "start": 651, "end": 659, "id": 104, "ws": true}, {"text": "medications", "start": 660, "end": 671, "id": 105, "ws": false}, {"text": ".", "start": 671, "end": 672, "id": 106, "ws": true}, {"text": "Consider", "start": 673, "end": 681, "id": 107, "ws": true}, {"text": "estrogen", "start": 682, "end": 690, "id": 108, "ws": true}, {"text": "therapy", "start": 691, "end": 698, "id": 109, "ws": true}, {"text": "only", "start": 699, "end": 703, "id": 110, "ws": true}, {"text": "for", "start": 704, "end": 707, "id": 111, "ws": true}, {"text": "women", "start": 708, "end": 713, "id": 112, "ws": true}, {"text": "at", "start": 714, "end": 716, "id": 113, "ws": true}, {"text": "significant", "start": 717, "end": 728, "id": 114, "ws": true}, {"text": "risk", "start": 729, "end": 733, "id": 115, "ws": true}, {"text": "of", "start": 734, "end": 736, "id": 116, "ws": true}, {"text": "osteoporosis", "start": 737, "end": 749, "id": 117, "ws": false}, {"text": ".", "start": 749, "end": 750, "id": 118, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 26, "end": 33, "token_start": 5, "token_end": 5, "label": "DRUG"}, {"start": 41, "end": 49, "token_start": 9, "token_end": 9, "label": "MECHANISM"}, {"start": 65, "end": 74, "token_start": 13, "token_end": 13, "label": "ACTION"}, {"start": 78, "end": 96, "token_start": 15, "token_end": 17, "label": "SEVERITY"}, {"start": 97, "end": 115, "token_start": 18, "token_end": 19, "label": "INDICATION"}, {"start": 123, "end": 132, "token_start": 22, "token_end": 22, "label": "BASECONDITION"}, {"start": 139, "end": 149, "token_start": 26, "token_end": 26, "label": "ACTION"}, {"start": 153, "end": 180, "token_start": 28, "token_end": 29, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694528692, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Mometasone furoate ointment, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age or older. Mometasone furoate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age. (1)", "_input_hash": 903455608, "_task_hash": -1699739491, "_is_binary": false, "tokens": [{"text": "Mometasone", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "furoate", "start": 11, "end": 18, "id": 1, "ws": true}, {"text": "ointment", "start": 19, "end": 27, "id": 2, "ws": false}, {"text": ",", "start": 27, "end": 28, "id": 3, "ws": true}, {"text": "0.1", "start": 29, "end": 32, "id": 4, "ws": false}, {"text": "%", "start": 32, "end": 33, "id": 5, "ws": true}, {"text": "is", "start": 34, "end": 36, "id": 6, "ws": true}, {"text": "a", "start": 37, "end": 38, "id": 7, "ws": true}, {"text": "corticosteroid", "start": 39, "end": 53, "id": 8, "ws": true}, {"text": "indicated", "start": 54, "end": 63, "id": 9, "ws": true}, {"text": "for", "start": 64, "end": 67, "id": 10, "ws": true}, {"text": "the", "start": 68, "end": 71, "id": 11, "ws": true}, {"text": "relief", "start": 72, "end": 78, "id": 12, "ws": true}, {"text": "of", "start": 79, "end": 81, "id": 13, "ws": true}, {"text": "the", "start": 82, "end": 85, "id": 14, "ws": true}, {"text": "inflammatory", "start": 86, "end": 98, "id": 15, "ws": true}, {"text": "and", "start": 99, "end": 102, "id": 16, "ws": true}, {"text": "pruritic", "start": 103, "end": 111, "id": 17, "ws": true}, {"text": "manifestations", "start": 112, "end": 126, "id": 18, "ws": true}, {"text": "of", "start": 127, "end": 129, "id": 19, "ws": true}, {"text": "corticosteroid", "start": 130, "end": 144, "id": 20, "ws": false}, {"text": "-", "start": 144, "end": 145, "id": 21, "ws": false}, {"text": "responsive", "start": 145, "end": 155, "id": 22, "ws": true}, {"text": "dermatoses", "start": 156, "end": 166, "id": 23, "ws": true}, {"text": "in", "start": 167, "end": 169, "id": 24, "ws": true}, {"text": "patients", "start": 170, "end": 178, "id": 25, "ws": true}, {"text": "2", "start": 179, "end": 180, "id": 26, "ws": true}, {"text": "years", "start": 181, "end": 186, "id": 27, "ws": true}, {"text": "of", "start": 187, "end": 189, "id": 28, "ws": true}, {"text": "age", "start": 190, "end": 193, "id": 29, "ws": true}, {"text": "or", "start": 194, "end": 196, "id": 30, "ws": true}, {"text": "older", "start": 197, "end": 202, "id": 31, "ws": false}, {"text": ".", "start": 202, "end": 203, "id": 32, "ws": true}, {"text": "Mometasone", "start": 204, "end": 214, "id": 33, "ws": true}, {"text": "furoate", "start": 215, "end": 222, "id": 34, "ws": true}, {"text": "ointment", "start": 223, "end": 231, "id": 35, "ws": true}, {"text": "is", "start": 232, "end": 234, "id": 36, "ws": true}, {"text": "a", "start": 235, "end": 236, "id": 37, "ws": true}, {"text": "corticosteroid", "start": 237, "end": 251, "id": 38, "ws": true}, {"text": "indicated", "start": 252, "end": 261, "id": 39, "ws": true}, {"text": "for", "start": 262, "end": 265, "id": 40, "ws": true}, {"text": "the", "start": 266, "end": 269, "id": 41, "ws": true}, {"text": "relief", "start": 270, "end": 276, "id": 42, "ws": true}, {"text": "of", "start": 277, "end": 279, "id": 43, "ws": true}, {"text": "the", "start": 280, "end": 283, "id": 44, "ws": true}, {"text": "inflammatory", "start": 284, "end": 296, "id": 45, "ws": true}, {"text": "and", "start": 297, "end": 300, "id": 46, "ws": true}, {"text": "pruritic", "start": 301, "end": 309, "id": 47, "ws": true}, {"text": "manifestations", "start": 310, "end": 324, "id": 48, "ws": true}, {"text": "of", "start": 325, "end": 327, "id": 49, "ws": true}, {"text": "corticosteroid", "start": 328, "end": 342, "id": 50, "ws": false}, {"text": "-", "start": 342, "end": 343, "id": 51, "ws": false}, {"text": "responsive", "start": 343, "end": 353, "id": 52, "ws": true}, {"text": "dermatoses", "start": 354, "end": 364, "id": 53, "ws": true}, {"text": "in", "start": 365, "end": 367, "id": 54, "ws": true}, {"text": "patients", "start": 368, "end": 376, "id": 55, "ws": true}, {"text": "2", "start": 377, "end": 378, "id": 56, "ws": true}, {"text": "years", "start": 379, "end": 384, "id": 57, "ws": true}, {"text": "of", "start": 385, "end": 387, "id": 58, "ws": true}, {"text": "age", "start": 388, "end": 391, "id": 59, "ws": false}, {"text": ".", "start": 391, "end": 392, "id": 60, "ws": true}, {"text": "(", "start": 393, "end": 394, "id": 61, "ws": false}, {"text": "1", "start": 394, "end": 395, "id": 62, "ws": false}, {"text": ")", "start": 395, "end": 396, "id": 63, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 18, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 19, "end": 27, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 39, "end": 53, "token_start": 8, "token_end": 8, "label": "MECHANISM"}, {"start": 72, "end": 78, "token_start": 12, "token_end": 12, "label": "ACTION"}, {"start": 86, "end": 126, "token_start": 15, "token_end": 18, "label": "INDICATION"}, {"start": 130, "end": 166, "token_start": 20, "token_end": 23, "label": "BASECONDITION"}, {"start": 170, "end": 202, "token_start": 25, "token_end": 31, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694176986, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "IOPIDINE 1% Ophthalmic Solution is indicated to control or prevent post-surgical elevations in IOP that occur in patients after argon laser trabeculoplasty, argon laser iridotomy or Nd:YAG posterior capsulotomy.", "_input_hash": -490650295, "_task_hash": 2093188417, "_is_binary": false, "tokens": [{"text": "IOPIDINE", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "1", "start": 9, "end": 10, "id": 1, "ws": false}, {"text": "%", "start": 10, "end": 11, "id": 2, "ws": true}, {"text": "Ophthalmic", "start": 12, "end": 22, "id": 3, "ws": true}, {"text": "Solution", "start": 23, "end": 31, "id": 4, "ws": true}, {"text": "is", "start": 32, "end": 34, "id": 5, "ws": true}, {"text": "indicated", "start": 35, "end": 44, "id": 6, "ws": true}, {"text": "to", "start": 45, "end": 47, "id": 7, "ws": true}, {"text": "control", "start": 48, "end": 55, "id": 8, "ws": true}, {"text": "or", "start": 56, "end": 58, "id": 9, "ws": true}, {"text": "prevent", "start": 59, "end": 66, "id": 10, "ws": true}, {"text": "post", "start": 67, "end": 71, "id": 11, "ws": false}, {"text": "-", "start": 71, "end": 72, "id": 12, "ws": false}, {"text": "surgical", "start": 72, "end": 80, "id": 13, "ws": true}, {"text": "elevations", "start": 81, "end": 91, "id": 14, "ws": true}, {"text": "in", "start": 92, "end": 94, "id": 15, "ws": true}, {"text": "IOP", "start": 95, "end": 98, "id": 16, "ws": true}, {"text": "that", "start": 99, "end": 103, "id": 17, "ws": true}, {"text": "occur", "start": 104, "end": 109, "id": 18, "ws": true}, {"text": "in", "start": 110, "end": 112, "id": 19, "ws": true}, {"text": "patients", "start": 113, "end": 121, "id": 20, "ws": true}, {"text": "after", "start": 122, "end": 127, "id": 21, "ws": true}, {"text": "argon", "start": 128, "end": 133, "id": 22, "ws": true}, {"text": "laser", "start": 134, "end": 139, "id": 23, "ws": true}, {"text": "trabeculoplasty", "start": 140, "end": 155, "id": 24, "ws": false}, {"text": ",", "start": 155, "end": 156, "id": 25, "ws": true}, {"text": "argon", "start": 157, "end": 162, "id": 26, "ws": true}, {"text": "laser", "start": 163, "end": 168, "id": 27, "ws": true}, {"text": "iridotomy", "start": 169, "end": 178, "id": 28, "ws": true}, {"text": "or", "start": 179, "end": 181, "id": 29, "ws": true}, {"text": "Nd", "start": 182, "end": 184, "id": 30, "ws": false}, {"text": ":", "start": 184, "end": 185, "id": 31, "ws": false}, {"text": "YAG", "start": 185, "end": 188, "id": 32, "ws": true}, {"text": "posterior", "start": 189, "end": 198, "id": 33, "ws": true}, {"text": "capsulotomy", "start": 199, "end": 210, "id": 34, "ws": false}, {"text": ".", "start": 210, "end": 211, "id": 35, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 22, "token_start": 3, "token_end": 3, "label": "ROUTE"}, {"start": 23, "end": 31, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 48, "end": 55, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 59, "end": 66, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 67, "end": 98, "token_start": 11, "token_end": 16, "label": "INDICATION"}, {"start": 113, "end": 210, "token_start": 20, "token_end": 34, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694525981, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Isoproterenol Hydrochloride Injection, USP is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. For serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation) (See CONTRAS). For use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, is available (See CONTRAS). For bronchospasm occurring during anesthesia. As an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure, and cardiogenic shock (See WARNINGS).", "_input_hash": 526410143, "_task_hash": 1365841171, "_is_binary": false, "tokens": [{"text": "Isoproterenol", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "Hydrochloride", "start": 14, "end": 27, "id": 1, "ws": true}, {"text": "Injection", "start": 28, "end": 37, "id": 2, "ws": false}, {"text": ",", "start": 37, "end": 38, "id": 3, "ws": true}, {"text": "USP", "start": 39, "end": 42, "id": 4, "ws": true}, {"text": "is", "start": 43, "end": 45, "id": 5, "ws": true}, {"text": "indicated", "start": 46, "end": 55, "id": 6, "ws": false}, {"text": ":", "start": 55, "end": 56, "id": 7, "ws": true}, {"text": "For", "start": 57, "end": 60, "id": 8, "ws": true}, {"text": "mild", "start": 61, "end": 65, "id": 9, "ws": true}, {"text": "or", "start": 66, "end": 68, "id": 10, "ws": true}, {"text": "transient", "start": 69, "end": 78, "id": 11, "ws": true}, {"text": "episodes", "start": 79, "end": 87, "id": 12, "ws": true}, {"text": "of", "start": 88, "end": 90, "id": 13, "ws": true}, {"text": "heart", "start": 91, "end": 96, "id": 14, "ws": true}, {"text": "block", "start": 97, "end": 102, "id": 15, "ws": true}, {"text": "that", "start": 103, "end": 107, "id": 16, "ws": true}, {"text": "do", "start": 108, "end": 110, "id": 17, "ws": true}, {"text": "not", "start": 111, "end": 114, "id": 18, "ws": true}, {"text": "require", "start": 115, "end": 122, "id": 19, "ws": true}, {"text": "electric", "start": 123, "end": 131, "id": 20, "ws": true}, {"text": "shock", "start": 132, "end": 137, "id": 21, "ws": true}, {"text": "or", "start": 138, "end": 140, "id": 22, "ws": true}, {"text": "pacemaker", "start": 141, "end": 150, "id": 23, "ws": true}, {"text": "therapy", "start": 151, "end": 158, "id": 24, "ws": false}, {"text": ".", "start": 158, "end": 159, "id": 25, "ws": true}, {"text": "For", "start": 160, "end": 163, "id": 26, "ws": true}, {"text": "serious", "start": 164, "end": 171, "id": 27, "ws": true}, {"text": "episodes", "start": 172, "end": 180, "id": 28, "ws": true}, {"text": "of", "start": 181, "end": 183, "id": 29, "ws": true}, {"text": "heart", "start": 184, "end": 189, "id": 30, "ws": true}, {"text": "block", "start": 190, "end": 195, "id": 31, "ws": true}, {"text": "and", "start": 196, "end": 199, "id": 32, "ws": true}, {"text": "Adams", "start": 200, "end": 205, "id": 33, "ws": false}, {"text": "-", "start": 205, "end": 206, "id": 34, "ws": false}, {"text": "Stokes", "start": 206, "end": 212, "id": 35, "ws": true}, {"text": "attacks", "start": 213, "end": 220, "id": 36, "ws": true}, {"text": "(", "start": 221, "end": 222, "id": 37, "ws": false}, {"text": "except", "start": 222, "end": 228, "id": 38, "ws": true}, {"text": "when", "start": 229, "end": 233, "id": 39, "ws": true}, {"text": "caused", "start": 234, "end": 240, "id": 40, "ws": true}, {"text": "by", "start": 241, "end": 243, "id": 41, "ws": true}, {"text": "ventricular", "start": 244, "end": 255, "id": 42, "ws": true}, {"text": "tachycardia", "start": 256, "end": 267, "id": 43, "ws": true}, {"text": "or", "start": 268, "end": 270, "id": 44, "ws": true}, {"text": "fibrillation", "start": 271, "end": 283, "id": 45, "ws": false}, {"text": ")", "start": 283, "end": 284, "id": 46, "ws": true}, {"text": "(", "start": 285, "end": 286, "id": 47, "ws": false}, {"text": "See", "start": 286, "end": 289, "id": 48, "ws": true}, {"text": "CONTRAS", "start": 290, "end": 297, "id": 49, "ws": false}, {"text": ")", "start": 297, "end": 298, "id": 50, "ws": false}, {"text": ".", "start": 298, "end": 299, "id": 51, "ws": true}, {"text": "For", "start": 300, "end": 303, "id": 52, "ws": true}, {"text": "use", "start": 304, "end": 307, "id": 53, "ws": true}, {"text": "in", "start": 308, "end": 310, "id": 54, "ws": true}, {"text": "cardiac", "start": 311, "end": 318, "id": 55, "ws": true}, {"text": "arrest", "start": 319, "end": 325, "id": 56, "ws": true}, {"text": "until", "start": 326, "end": 331, "id": 57, "ws": true}, {"text": "electric", "start": 332, "end": 340, "id": 58, "ws": true}, {"text": "shock", "start": 341, "end": 346, "id": 59, "ws": true}, {"text": "or", "start": 347, "end": 349, "id": 60, "ws": true}, {"text": "pacemaker", "start": 350, "end": 359, "id": 61, "ws": true}, {"text": "therapy", "start": 360, "end": 367, "id": 62, "ws": false}, {"text": ",", "start": 367, "end": 368, "id": 63, "ws": true}, {"text": "the", "start": 369, "end": 372, "id": 64, "ws": true}, {"text": "treatments", "start": 373, "end": 383, "id": 65, "ws": true}, {"text": "of", "start": 384, "end": 386, "id": 66, "ws": true}, {"text": "choice", "start": 387, "end": 393, "id": 67, "ws": false}, {"text": ",", "start": 393, "end": 394, "id": 68, "ws": true}, {"text": "is", "start": 395, "end": 397, "id": 69, "ws": true}, {"text": "available", "start": 398, "end": 407, "id": 70, "ws": true}, {"text": "(", "start": 408, "end": 409, "id": 71, "ws": false}, {"text": "See", "start": 409, "end": 412, "id": 72, "ws": true}, {"text": "CONTRAS", "start": 413, "end": 420, "id": 73, "ws": false}, {"text": ")", "start": 420, "end": 421, "id": 74, "ws": false}, {"text": ".", "start": 421, "end": 422, "id": 75, "ws": true}, {"text": "For", "start": 423, "end": 426, "id": 76, "ws": true}, {"text": "bronchospasm", "start": 427, "end": 439, "id": 77, "ws": true}, {"text": "occurring", "start": 440, "end": 449, "id": 78, "ws": true}, {"text": "during", "start": 450, "end": 456, "id": 79, "ws": true}, {"text": "anesthesia", "start": 457, "end": 467, "id": 80, "ws": false}, {"text": ".", "start": 467, "end": 468, "id": 81, "ws": true}, {"text": "As", "start": 469, "end": 471, "id": 82, "ws": true}, {"text": "an", "start": 472, "end": 474, "id": 83, "ws": true}, {"text": "adjunct", "start": 475, "end": 482, "id": 84, "ws": true}, {"text": "to", "start": 483, "end": 485, "id": 85, "ws": true}, {"text": "fluid", "start": 486, "end": 491, "id": 86, "ws": true}, {"text": "and", "start": 492, "end": 495, "id": 87, "ws": true}, {"text": "electrolyte", "start": 496, "end": 507, "id": 88, "ws": true}, {"text": "replacement", "start": 508, "end": 519, "id": 89, "ws": true}, {"text": "therapy", "start": 520, "end": 527, "id": 90, "ws": true}, {"text": "and", "start": 528, "end": 531, "id": 91, "ws": true}, {"text": "the", "start": 532, "end": 535, "id": 92, "ws": true}, {"text": "use", "start": 536, "end": 539, "id": 93, "ws": true}, {"text": "of", "start": 540, "end": 542, "id": 94, "ws": true}, {"text": "other", "start": 543, "end": 548, "id": 95, "ws": true}, {"text": "drugs", "start": 549, "end": 554, "id": 96, "ws": true}, {"text": "and", "start": 555, "end": 558, "id": 97, "ws": true}, {"text": "procedures", "start": 559, "end": 569, "id": 98, "ws": true}, {"text": "in", "start": 570, "end": 572, "id": 99, "ws": true}, {"text": "the", "start": 573, "end": 576, "id": 100, "ws": true}, {"text": "treatment", "start": 577, "end": 586, "id": 101, "ws": true}, {"text": "of", "start": 587, "end": 589, "id": 102, "ws": true}, {"text": "hypovolemic", "start": 590, "end": 601, "id": 103, "ws": true}, {"text": "and", "start": 602, "end": 605, "id": 104, "ws": true}, {"text": "septic", "start": 606, "end": 612, "id": 105, "ws": true}, {"text": "shock", "start": 613, "end": 618, "id": 106, "ws": false}, {"text": ",", "start": 618, "end": 619, "id": 107, "ws": true}, {"text": "low", "start": 620, "end": 623, "id": 108, "ws": true}, {"text": "cardiac", "start": 624, "end": 631, "id": 109, "ws": true}, {"text": "output", "start": 632, "end": 638, "id": 110, "ws": true}, {"text": "(", "start": 639, "end": 640, "id": 111, "ws": false}, {"text": "hypoperfusion", "start": 640, "end": 653, "id": 112, "ws": false}, {"text": ")", "start": 653, "end": 654, "id": 113, "ws": true}, {"text": "states", "start": 655, "end": 661, "id": 114, "ws": false}, {"text": ",", "start": 661, "end": 662, "id": 115, "ws": true}, {"text": "congestive", "start": 663, "end": 673, "id": 116, "ws": true}, {"text": "heart", "start": 674, "end": 679, "id": 117, "ws": true}, {"text": "failure", "start": 680, "end": 687, "id": 118, "ws": false}, {"text": ",", "start": 687, "end": 688, "id": 119, "ws": true}, {"text": "and", "start": 689, "end": 692, "id": 120, "ws": true}, {"text": "cardiogenic", "start": 693, "end": 704, "id": 121, "ws": true}, {"text": "shock", "start": 705, "end": 710, "id": 122, "ws": true}, {"text": "(", "start": 711, "end": 712, "id": 123, "ws": false}, {"text": "See", "start": 712, "end": 715, "id": 124, "ws": true}, {"text": "WARNINGS", "start": 716, "end": 724, "id": 125, "ws": false}, {"text": ")", "start": 724, "end": 725, "id": 126, "ws": false}, {"text": ".", "start": 725, "end": 726, "id": 127, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 27, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 28, "end": 37, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 61, "end": 78, "token_start": 9, "token_end": 11, "label": "SEVERITY"}, {"start": 91, "end": 102, "token_start": 14, "token_end": 15, "label": "INDICATION"}, {"start": 103, "end": 158, "token_start": 16, "token_end": 24, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694527032, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Citanest Forte is indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques. Only accepted procedures for these techniques as described in standard textbooks are recommended.", "_input_hash": -550663736, "_task_hash": -1085702292, "_is_binary": false, "tokens": [{"text": "Citanest", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "Forte", "start": 9, "end": 14, "id": 1, "ws": true}, {"text": "is", "start": 15, "end": 17, "id": 2, "ws": true}, {"text": "indicated", "start": 18, "end": 27, "id": 3, "ws": true}, {"text": "for", "start": 28, "end": 31, "id": 4, "ws": true}, {"text": "the", "start": 32, "end": 35, "id": 5, "ws": true}, {"text": "production", "start": 36, "end": 46, "id": 6, "ws": true}, {"text": "of", "start": 47, "end": 49, "id": 7, "ws": true}, {"text": "local", "start": 50, "end": 55, "id": 8, "ws": true}, {"text": "anesthesia", "start": 56, "end": 66, "id": 9, "ws": true}, {"text": "in", "start": 67, "end": 69, "id": 10, "ws": true}, {"text": "dentistry", "start": 70, "end": 79, "id": 11, "ws": true}, {"text": "by", "start": 80, "end": 82, "id": 12, "ws": true}, {"text": "nerve", "start": 83, "end": 88, "id": 13, "ws": true}, {"text": "block", "start": 89, "end": 94, "id": 14, "ws": true}, {"text": "or", "start": 95, "end": 97, "id": 15, "ws": true}, {"text": "infiltration", "start": 98, "end": 110, "id": 16, "ws": true}, {"text": "techniques", "start": 111, "end": 121, "id": 17, "ws": false}, {"text": ".", "start": 121, "end": 122, "id": 18, "ws": true}, {"text": "Only", "start": 123, "end": 127, "id": 19, "ws": true}, {"text": "accepted", "start": 128, "end": 136, "id": 20, "ws": true}, {"text": "procedures", "start": 137, "end": 147, "id": 21, "ws": true}, {"text": "for", "start": 148, "end": 151, "id": 22, "ws": true}, {"text": "these", "start": 152, "end": 157, "id": 23, "ws": true}, {"text": "techniques", "start": 158, "end": 168, "id": 24, "ws": true}, {"text": "as", "start": 169, "end": 171, "id": 25, "ws": true}, {"text": "described", "start": 172, "end": 181, "id": 26, "ws": true}, {"text": "in", "start": 182, "end": 184, "id": 27, "ws": true}, {"text": "standard", "start": 185, "end": 193, "id": 28, "ws": true}, {"text": "textbooks", "start": 194, "end": 203, "id": 29, "ws": true}, {"text": "are", "start": 204, "end": 207, "id": 30, "ws": true}, {"text": "recommended", "start": 208, "end": 219, "id": 31, "ws": false}, {"text": ".", "start": 219, "end": 220, "id": 32, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 36, "end": 46, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 56, "end": 66, "token_start": 9, "token_end": 9, "label": "EFFECT"}], "answer": "accept", "_timestamp": 1694175910, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Neo-PolycinTM Ophthalmic Ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis, and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.", "_input_hash": -992574558, "_task_hash": -750965657, "_is_binary": false, "tokens": [{"text": "Neo", "start": 0, "end": 3, "id": 0, "ws": false}, {"text": "-", "start": 3, "end": 4, "id": 1, "ws": false}, {"text": "PolycinTM", "start": 4, "end": 13, "id": 2, "ws": true}, {"text": "Ophthalmic", "start": 14, "end": 24, "id": 3, "ws": true}, {"text": "Ointment", "start": 25, "end": 33, "id": 4, "ws": true}, {"text": "is", "start": 34, "end": 36, "id": 5, "ws": true}, {"text": "indicated", "start": 37, "end": 46, "id": 6, "ws": true}, {"text": "for", "start": 47, "end": 50, "id": 7, "ws": true}, {"text": "the", "start": 51, "end": 54, "id": 8, "ws": true}, {"text": "topical", "start": 55, "end": 62, "id": 9, "ws": true}, {"text": "treatment", "start": 63, "end": 72, "id": 10, "ws": true}, {"text": "of", "start": 73, "end": 75, "id": 11, "ws": true}, {"text": "superficial", "start": 76, "end": 87, "id": 12, "ws": true}, {"text": "infections", "start": 88, "end": 98, "id": 13, "ws": true}, {"text": "of", "start": 99, "end": 101, "id": 14, "ws": true}, {"text": "the", "start": 102, "end": 105, "id": 15, "ws": true}, {"text": "external", "start": 106, "end": 114, "id": 16, "ws": true}, {"text": "eye", "start": 115, "end": 118, "id": 17, "ws": true}, {"text": "and", "start": 119, "end": 122, "id": 18, "ws": true}, {"text": "its", "start": 123, "end": 126, "id": 19, "ws": true}, {"text": "adnexa", "start": 127, "end": 133, "id": 20, "ws": true}, {"text": "caused", "start": 134, "end": 140, "id": 21, "ws": true}, {"text": "by", "start": 141, "end": 143, "id": 22, "ws": true}, {"text": "susceptible", "start": 144, "end": 155, "id": 23, "ws": true}, {"text": "bacteria", "start": 156, "end": 164, "id": 24, "ws": false}, {"text": ".", "start": 164, "end": 165, "id": 25, "ws": true}, {"text": "Such", "start": 166, "end": 170, "id": 26, "ws": true}, {"text": "infections", "start": 171, "end": 181, "id": 27, "ws": true}, {"text": "encompass", "start": 182, "end": 191, "id": 28, "ws": true}, {"text": "conjunctivitis", "start": 192, "end": 206, "id": 29, "ws": false}, {"text": ",", "start": 206, "end": 207, "id": 30, "ws": true}, {"text": "keratitis", "start": 208, "end": 217, "id": 31, "ws": false}, {"text": ",", "start": 217, "end": 218, "id": 32, "ws": true}, {"text": "and", "start": 219, "end": 222, "id": 33, "ws": true}, {"text": "keratoconjunctivitis", "start": 223, "end": 243, "id": 34, "ws": false}, {"text": ",", "start": 243, "end": 244, "id": 35, "ws": true}, {"text": "blepharitis", "start": 245, "end": 256, "id": 36, "ws": true}, {"text": "and", "start": 257, "end": 260, "id": 37, "ws": true}, {"text": "blepharoconjunctivitis", "start": 261, "end": 283, "id": 38, "ws": false}, {"text": ".", "start": 283, "end": 284, "id": 39, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 2, "label": "DRUG"}, {"start": 14, "end": 24, "token_start": 3, "token_end": 3, "label": "ROUTE"}, {"start": 25, "end": 33, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 63, "end": 72, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 76, "end": 98, "token_start": 12, "token_end": 13, "label": "ACTION"}, {"start": 106, "end": 118, "token_start": 16, "token_end": 17, "label": "ANATOMY"}, {"start": 127, "end": 133, "token_start": 20, "token_end": 20, "label": "ANATOMY"}, {"start": 144, "end": 164, "token_start": 23, "token_end": 24, "label": "CAUSED_BY"}, {"start": 192, "end": 206, "token_start": 29, "token_end": 29, "label": "INDICATION"}, {"start": 208, "end": 217, "token_start": 31, "token_end": 31, "label": "INDICATION"}, {"start": 223, "end": 243, "token_start": 34, "token_end": 34, "label": "INDICATION"}, {"start": 245, "end": 256, "token_start": 36, "token_end": 36, "label": "INDICATION"}, {"start": 261, "end": 283, "token_start": 38, "token_end": 38, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694175946, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14)]. Guanfacine extended-release tablets are a central alpha2A-adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications (1, 14).", "_input_hash": -1336535262, "_task_hash": -1041163624, "_is_binary": false, "tokens": [{"text": "Guanfacine", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "extended", "start": 11, "end": 19, "id": 1, "ws": false}, {"text": "-", "start": 19, "end": 20, "id": 2, "ws": false}, {"text": "release", "start": 20, "end": 27, "id": 3, "ws": true}, {"text": "tablets", "start": 28, "end": 35, "id": 4, "ws": true}, {"text": "are", "start": 36, "end": 39, "id": 5, "ws": true}, {"text": "indicated", "start": 40, "end": 49, "id": 6, "ws": true}, {"text": "for", "start": 50, "end": 53, "id": 7, "ws": true}, {"text": "the", "start": 54, "end": 57, "id": 8, "ws": true}, {"text": "treatment", "start": 58, "end": 67, "id": 9, "ws": true}, {"text": "of", "start": 68, "end": 70, "id": 10, "ws": true}, {"text": "Attention", "start": 71, "end": 80, "id": 11, "ws": true}, {"text": "Deficit", "start": 81, "end": 88, "id": 12, "ws": true}, {"text": "Hyperactivity", "start": 89, "end": 102, "id": 13, "ws": true}, {"text": "Disorder", "start": 103, "end": 111, "id": 14, "ws": true}, {"text": "(", "start": 112, "end": 113, "id": 15, "ws": false}, {"text": "ADHD", "start": 113, "end": 117, "id": 16, "ws": false}, {"text": ")", "start": 117, "end": 118, "id": 17, "ws": true}, {"text": "as", "start": 119, "end": 121, "id": 18, "ws": true}, {"text": "monotherapy", "start": 122, "end": 133, "id": 19, "ws": true}, {"text": "and", "start": 134, "end": 137, "id": 20, "ws": true}, {"text": "as", "start": 138, "end": 140, "id": 21, "ws": true}, {"text": "adjunctive", "start": 141, "end": 151, "id": 22, "ws": true}, {"text": "therapy", "start": 152, "end": 159, "id": 23, "ws": true}, {"text": "to", "start": 160, "end": 162, "id": 24, "ws": true}, {"text": "stimulant", "start": 163, "end": 172, "id": 25, "ws": true}, {"text": "medications", "start": 173, "end": 184, "id": 26, "ws": true}, {"text": "[", "start": 185, "end": 186, "id": 27, "ws": false}, {"text": "see", "start": 186, "end": 189, "id": 28, "ws": true}, {"text": "Clinical", "start": 190, "end": 198, "id": 29, "ws": true}, {"text": "Studies", "start": 199, "end": 206, "id": 30, "ws": true}, {"text": "(", "start": 207, "end": 208, "id": 31, "ws": false}, {"text": "14", "start": 208, "end": 210, "id": 32, "ws": false}, {"text": ")", "start": 210, "end": 211, "id": 33, "ws": false}, {"text": "]", "start": 211, "end": 212, "id": 34, "ws": false}, {"text": ".", "start": 212, "end": 213, "id": 35, "ws": true}, {"text": "Guanfacine", "start": 214, "end": 224, "id": 36, "ws": true}, {"text": "extended", "start": 225, "end": 233, "id": 37, "ws": false}, {"text": "-", "start": 233, "end": 234, "id": 38, "ws": false}, {"text": "release", "start": 234, "end": 241, "id": 39, "ws": true}, {"text": "tablets", "start": 242, "end": 249, "id": 40, "ws": true}, {"text": "are", "start": 250, "end": 253, "id": 41, "ws": true}, {"text": "a", "start": 254, "end": 255, "id": 42, "ws": true}, {"text": "central", "start": 256, "end": 263, "id": 43, "ws": true}, {"text": "alpha2A", "start": 264, "end": 271, "id": 44, "ws": false}, {"text": "-", "start": 271, "end": 272, "id": 45, "ws": false}, {"text": "adrenergic", "start": 272, "end": 282, "id": 46, "ws": true}, {"text": "receptor", "start": 283, "end": 291, "id": 47, "ws": true}, {"text": "agonist", "start": 292, "end": 299, "id": 48, "ws": true}, {"text": "indicated", "start": 300, "end": 309, "id": 49, "ws": true}, {"text": "for", "start": 310, "end": 313, "id": 50, "ws": true}, {"text": "the", "start": 314, "end": 317, "id": 51, "ws": true}, {"text": "treatment", "start": 318, "end": 327, "id": 52, "ws": true}, {"text": "of", "start": 328, "end": 330, "id": 53, "ws": true}, {"text": "Attention", "start": 331, "end": 340, "id": 54, "ws": true}, {"text": "Deficit", "start": 341, "end": 348, "id": 55, "ws": true}, {"text": "Hyperactivity", "start": 349, "end": 362, "id": 56, "ws": true}, {"text": "Disorder", "start": 363, "end": 371, "id": 57, "ws": true}, {"text": "(", "start": 372, "end": 373, "id": 58, "ws": false}, {"text": "ADHD", "start": 373, "end": 377, "id": 59, "ws": false}, {"text": ")", "start": 377, "end": 378, "id": 60, "ws": true}, {"text": "as", "start": 379, "end": 381, "id": 61, "ws": true}, {"text": "monotherapy", "start": 382, "end": 393, "id": 62, "ws": true}, {"text": "and", "start": 394, "end": 397, "id": 63, "ws": true}, {"text": "as", "start": 398, "end": 400, "id": 64, "ws": true}, {"text": "adjunctive", "start": 401, "end": 411, "id": 65, "ws": true}, {"text": "therapy", "start": 412, "end": 419, "id": 66, "ws": true}, {"text": "to", "start": 420, "end": 422, "id": 67, "ws": true}, {"text": "stimulant", "start": 423, "end": 432, "id": 68, "ws": true}, {"text": "medications", "start": 433, "end": 444, "id": 69, "ws": true}, {"text": "(", "start": 445, "end": 446, "id": 70, "ws": false}, {"text": "1", "start": 446, "end": 447, "id": 71, "ws": false}, {"text": ",", "start": 447, "end": 448, "id": 72, "ws": true}, {"text": "14", "start": 449, "end": 451, "id": 73, "ws": false}, {"text": ")", "start": 451, "end": 452, "id": 74, "ws": false}, {"text": ".", "start": 452, "end": 453, "id": 75, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 27, "token_start": 1, "token_end": 3, "label": "FORMULATION"}, {"start": 58, "end": 67, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 71, "end": 111, "token_start": 11, "token_end": 14, "label": "INDICATION"}, {"start": 214, "end": 224, "token_start": 36, "token_end": 36, "label": "DRUG"}, {"start": 225, "end": 249, "token_start": 37, "token_end": 40, "label": "FORMULATION"}, {"start": 256, "end": 299, "token_start": 43, "token_end": 48, "label": "MECHANISM"}, {"start": 318, "end": 327, "token_start": 52, "token_end": 52, "label": "ACTION"}, {"start": 331, "end": 371, "token_start": 54, "token_end": 57, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694528227, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "FOSRENOL is a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). Management of elevated serum phosphorus levels in patients with ESRD usually includes all of the following: reduction in dietary intake of phosphate, removal of phosphate by dialysis, and reduction of intestinal phosphate absorption with phosphate binders. FOSRENOL is a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). (1)", "_input_hash": -754949548, "_task_hash": -1269869370, "_is_binary": false, "tokens": [{"text": "FOSRENOL", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "a", "start": 12, "end": 13, "id": 2, "ws": true}, {"text": "phosphate", "start": 14, "end": 23, "id": 3, "ws": true}, {"text": "binder", "start": 24, "end": 30, "id": 4, "ws": true}, {"text": "indicated", "start": 31, "end": 40, "id": 5, "ws": true}, {"text": "to", "start": 41, "end": 43, "id": 6, "ws": true}, {"text": "reduce", "start": 44, "end": 50, "id": 7, "ws": true}, {"text": "serum", "start": 51, "end": 56, "id": 8, "ws": true}, {"text": "phosphate", "start": 57, "end": 66, "id": 9, "ws": true}, {"text": "in", "start": 67, "end": 69, "id": 10, "ws": true}, {"text": "patients", "start": 70, "end": 78, "id": 11, "ws": true}, {"text": "with", "start": 79, "end": 83, "id": 12, "ws": true}, {"text": "end", "start": 84, "end": 87, "id": 13, "ws": false}, {"text": "-", "start": 87, "end": 88, "id": 14, "ws": false}, {"text": "stage", "start": 88, "end": 93, "id": 15, "ws": true}, {"text": "renal", "start": 94, "end": 99, "id": 16, "ws": true}, {"text": "disease", "start": 100, "end": 107, "id": 17, "ws": true}, {"text": "(", "start": 108, "end": 109, "id": 18, "ws": false}, {"text": "ESRD", "start": 109, "end": 113, "id": 19, "ws": false}, {"text": ")", "start": 113, "end": 114, "id": 20, "ws": false}, {"text": ".", "start": 114, "end": 115, "id": 21, "ws": true}, {"text": "Management", "start": 116, "end": 126, "id": 22, "ws": true}, {"text": "of", "start": 127, "end": 129, "id": 23, "ws": true}, {"text": "elevated", "start": 130, "end": 138, "id": 24, "ws": true}, {"text": "serum", "start": 139, "end": 144, "id": 25, "ws": true}, {"text": "phosphorus", "start": 145, "end": 155, "id": 26, "ws": true}, {"text": "levels", "start": 156, "end": 162, "id": 27, "ws": true}, {"text": "in", "start": 163, "end": 165, "id": 28, "ws": true}, {"text": "patients", "start": 166, "end": 174, "id": 29, "ws": true}, {"text": "with", "start": 175, "end": 179, "id": 30, "ws": true}, {"text": "ESRD", "start": 180, "end": 184, "id": 31, "ws": true}, {"text": "usually", "start": 185, "end": 192, "id": 32, "ws": true}, {"text": "includes", "start": 193, "end": 201, "id": 33, "ws": true}, {"text": "all", "start": 202, "end": 205, "id": 34, "ws": true}, {"text": "of", "start": 206, "end": 208, "id": 35, "ws": true}, {"text": "the", "start": 209, "end": 212, "id": 36, "ws": true}, {"text": "following", "start": 213, "end": 222, "id": 37, "ws": false}, {"text": ":", "start": 222, "end": 223, "id": 38, "ws": true}, {"text": "reduction", "start": 224, "end": 233, "id": 39, "ws": true}, {"text": "in", "start": 234, "end": 236, "id": 40, "ws": true}, {"text": "dietary", "start": 237, "end": 244, "id": 41, "ws": true}, {"text": "intake", "start": 245, "end": 251, "id": 42, "ws": true}, {"text": "of", "start": 252, "end": 254, "id": 43, "ws": true}, {"text": "phosphate", "start": 255, "end": 264, "id": 44, "ws": false}, {"text": ",", "start": 264, "end": 265, "id": 45, "ws": true}, {"text": "removal", "start": 266, "end": 273, "id": 46, "ws": true}, {"text": "of", "start": 274, "end": 276, "id": 47, "ws": true}, {"text": "phosphate", "start": 277, "end": 286, "id": 48, "ws": true}, {"text": "by", "start": 287, "end": 289, "id": 49, "ws": true}, {"text": "dialysis", "start": 290, "end": 298, "id": 50, "ws": false}, {"text": ",", "start": 298, "end": 299, "id": 51, "ws": true}, {"text": "and", "start": 300, "end": 303, "id": 52, "ws": true}, {"text": "reduction", "start": 304, "end": 313, "id": 53, "ws": true}, {"text": "of", "start": 314, "end": 316, "id": 54, "ws": true}, {"text": "intestinal", "start": 317, "end": 327, "id": 55, "ws": true}, {"text": "phosphate", "start": 328, "end": 337, "id": 56, "ws": true}, {"text": "absorption", "start": 338, "end": 348, "id": 57, "ws": true}, {"text": "with", "start": 349, "end": 353, "id": 58, "ws": true}, {"text": "phosphate", "start": 354, "end": 363, "id": 59, "ws": true}, {"text": "binders", "start": 364, "end": 371, "id": 60, "ws": false}, {"text": ".", "start": 371, "end": 372, "id": 61, "ws": true}, {"text": "FOSRENOL", "start": 373, "end": 381, "id": 62, "ws": true}, {"text": "is", "start": 382, "end": 384, "id": 63, "ws": true}, {"text": "a", "start": 385, "end": 386, "id": 64, "ws": true}, {"text": "phosphate", "start": 387, "end": 396, "id": 65, "ws": true}, {"text": "binder", "start": 397, "end": 403, "id": 66, "ws": true}, {"text": "indicated", "start": 404, "end": 413, "id": 67, "ws": true}, {"text": "to", "start": 414, "end": 416, "id": 68, "ws": true}, {"text": "reduce", "start": 417, "end": 423, "id": 69, "ws": true}, {"text": "serum", "start": 424, "end": 429, "id": 70, "ws": true}, {"text": "phosphate", "start": 430, "end": 439, "id": 71, "ws": true}, {"text": "in", "start": 440, "end": 442, "id": 72, "ws": true}, {"text": "patients", "start": 443, "end": 451, "id": 73, "ws": true}, {"text": "with", "start": 452, "end": 456, "id": 74, "ws": true}, {"text": "end", "start": 457, "end": 460, "id": 75, "ws": false}, {"text": "-", "start": 460, "end": 461, "id": 76, "ws": false}, {"text": "stage", "start": 461, "end": 466, "id": 77, "ws": true}, {"text": "renal", "start": 467, "end": 472, "id": 78, "ws": true}, {"text": "disease", "start": 473, "end": 480, "id": 79, "ws": true}, {"text": "(", "start": 481, "end": 482, "id": 80, "ws": false}, {"text": "ESRD", "start": 482, "end": 486, "id": 81, "ws": false}, {"text": ")", "start": 486, "end": 487, "id": 82, "ws": false}, {"text": ".", "start": 487, "end": 488, "id": 83, "ws": true}, {"text": "(", "start": 489, "end": 490, "id": 84, "ws": false}, {"text": "1", "start": 490, "end": 491, "id": 85, "ws": false}, {"text": ")", "start": 491, "end": 492, "id": 86, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 30, "token_start": 3, "token_end": 4, "label": "MECHANISM"}, {"start": 44, "end": 66, "token_start": 7, "token_end": 9, "label": "EFFECT"}, {"start": 84, "end": 107, "token_start": 13, "token_end": 17, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694177404, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Floxuridine for Injection, USP is effective in the palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. Patients with known disease extending beyond an area capable of infusion via a single artery should, except in unusual circumstances, be considered for systemic therapy with other chemotherapeutic agents.", "_input_hash": -1388470459, "_task_hash": 1453000024, "_is_binary": false, "tokens": [{"text": "Floxuridine", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "for", "start": 12, "end": 15, "id": 1, "ws": true}, {"text": "Injection", "start": 16, "end": 25, "id": 2, "ws": false}, {"text": ",", "start": 25, "end": 26, "id": 3, "ws": true}, {"text": "USP", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "is", "start": 31, "end": 33, "id": 5, "ws": true}, {"text": "effective", "start": 34, "end": 43, "id": 6, "ws": true}, {"text": "in", "start": 44, "end": 46, "id": 7, "ws": true}, {"text": "the", "start": 47, "end": 50, "id": 8, "ws": true}, {"text": "palliative", "start": 51, "end": 61, "id": 9, "ws": true}, {"text": "management", "start": 62, "end": 72, "id": 10, "ws": true}, {"text": "of", "start": 73, "end": 75, "id": 11, "ws": true}, {"text": "gastrointestinal", "start": 76, "end": 92, "id": 12, "ws": true}, {"text": "adenocarcinoma", "start": 93, "end": 107, "id": 13, "ws": true}, {"text": "metastatic", "start": 108, "end": 118, "id": 14, "ws": true}, {"text": "to", "start": 119, "end": 121, "id": 15, "ws": true}, {"text": "the", "start": 122, "end": 125, "id": 16, "ws": true}, {"text": "liver", "start": 126, "end": 131, "id": 17, "ws": false}, {"text": ",", "start": 131, "end": 132, "id": 18, "ws": true}, {"text": "when", "start": 133, "end": 137, "id": 19, "ws": true}, {"text": "given", "start": 138, "end": 143, "id": 20, "ws": true}, {"text": "by", "start": 144, "end": 146, "id": 21, "ws": true}, {"text": "continuous", "start": 147, "end": 157, "id": 22, "ws": true}, {"text": "regional", "start": 158, "end": 166, "id": 23, "ws": true}, {"text": "intra", "start": 167, "end": 172, "id": 24, "ws": false}, {"text": "-", "start": 172, "end": 173, "id": 25, "ws": false}, {"text": "arterial", "start": 173, "end": 181, "id": 26, "ws": true}, {"text": "infusion", "start": 182, "end": 190, "id": 27, "ws": true}, {"text": "in", "start": 191, "end": 193, "id": 28, "ws": true}, {"text": "carefully", "start": 194, "end": 203, "id": 29, "ws": true}, {"text": "selected", "start": 204, "end": 212, "id": 30, "ws": true}, {"text": "patients", "start": 213, "end": 221, "id": 31, "ws": true}, {"text": "who", "start": 222, "end": 225, "id": 32, "ws": true}, {"text": "are", "start": 226, "end": 229, "id": 33, "ws": true}, {"text": "considered", "start": 230, "end": 240, "id": 34, "ws": true}, {"text": "incurable", "start": 241, "end": 250, "id": 35, "ws": true}, {"text": "by", "start": 251, "end": 253, "id": 36, "ws": true}, {"text": "surgery", "start": 254, "end": 261, "id": 37, "ws": true}, {"text": "or", "start": 262, "end": 264, "id": 38, "ws": true}, {"text": "other", "start": 265, "end": 270, "id": 39, "ws": true}, {"text": "means", "start": 271, "end": 276, "id": 40, "ws": false}, {"text": ".", "start": 276, "end": 277, "id": 41, "ws": true}, {"text": "Patients", "start": 278, "end": 286, "id": 42, "ws": true}, {"text": "with", "start": 287, "end": 291, "id": 43, "ws": true}, {"text": "known", "start": 292, "end": 297, "id": 44, "ws": true}, {"text": "disease", "start": 298, "end": 305, "id": 45, "ws": true}, {"text": "extending", "start": 306, "end": 315, "id": 46, "ws": true}, {"text": "beyond", "start": 316, "end": 322, "id": 47, "ws": true}, {"text": "an", "start": 323, "end": 325, "id": 48, "ws": true}, {"text": "area", "start": 326, "end": 330, "id": 49, "ws": true}, {"text": "capable", "start": 331, "end": 338, "id": 50, "ws": true}, {"text": "of", "start": 339, "end": 341, "id": 51, "ws": true}, {"text": "infusion", "start": 342, "end": 350, "id": 52, "ws": true}, {"text": "via", "start": 351, "end": 354, "id": 53, "ws": true}, {"text": "a", "start": 355, "end": 356, "id": 54, "ws": true}, {"text": "single", "start": 357, "end": 363, "id": 55, "ws": true}, {"text": "artery", "start": 364, "end": 370, "id": 56, "ws": true}, {"text": "should", "start": 371, "end": 377, "id": 57, "ws": false}, {"text": ",", "start": 377, "end": 378, "id": 58, "ws": true}, {"text": "except", "start": 379, "end": 385, "id": 59, "ws": true}, {"text": "in", "start": 386, "end": 388, "id": 60, "ws": true}, {"text": "unusual", "start": 389, "end": 396, "id": 61, "ws": true}, {"text": "circumstances", "start": 397, "end": 410, "id": 62, "ws": false}, {"text": ",", "start": 410, "end": 411, "id": 63, "ws": true}, {"text": "be", "start": 412, "end": 414, "id": 64, "ws": true}, {"text": "considered", "start": 415, "end": 425, "id": 65, "ws": true}, {"text": "for", "start": 426, "end": 429, "id": 66, "ws": true}, {"text": "systemic", "start": 430, "end": 438, "id": 67, "ws": true}, {"text": "therapy", "start": 439, "end": 446, "id": 68, "ws": true}, {"text": "with", "start": 447, "end": 451, "id": 69, "ws": true}, {"text": "other", "start": 452, "end": 457, "id": 70, "ws": true}, {"text": "chemotherapeutic", "start": 458, "end": 474, "id": 71, "ws": true}, {"text": "agents", "start": 475, "end": 481, "id": 72, "ws": false}, {"text": ".", "start": 481, "end": 482, "id": 73, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 16, "end": 25, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 51, "end": 72, "token_start": 9, "token_end": 10, "label": "ACTION"}, {"start": 76, "end": 118, "token_start": 12, "token_end": 14, "label": "INDICATION"}, {"start": 126, "end": 131, "token_start": 17, "token_end": 17, "label": "ANATOMY"}], "answer": "accept", "_timestamp": 1694177134, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Ifosfamide Injection is indicated for use in combination with certain other approved antineoplastic agentsfor third-line chemotherapy of germ cell testicular cancer. It should be used in combination with mesna for prophylaxis of hemorrhagic cystitis. Ifosfamide Injection is an alkylating drug indicated for use in combination with certain other approved antineoplastic agents for third-line chemotherapy of germ cell testicular cancer. It should be used in combination with mesna for prophylaxis of hemorrhagic cystitis. (1)", "_input_hash": -878580590, "_task_hash": 1560474718, "_is_binary": false, "tokens": [{"text": "Ifosfamide", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "Injection", "start": 11, "end": 20, "id": 1, "ws": true}, {"text": "is", "start": 21, "end": 23, "id": 2, "ws": true}, {"text": "indicated", "start": 24, "end": 33, "id": 3, "ws": true}, {"text": "for", "start": 34, "end": 37, "id": 4, "ws": true}, {"text": "use", "start": 38, "end": 41, "id": 5, "ws": true}, {"text": "in", "start": 42, "end": 44, "id": 6, "ws": true}, {"text": "combination", "start": 45, "end": 56, "id": 7, "ws": true}, {"text": "with", "start": 57, "end": 61, "id": 8, "ws": true}, {"text": "certain", "start": 62, "end": 69, "id": 9, "ws": true}, {"text": "other", "start": 70, "end": 75, "id": 10, "ws": true}, {"text": "approved", "start": 76, "end": 84, "id": 11, "ws": true}, {"text": "antineoplastic", "start": 85, "end": 99, "id": 12, "ws": true}, {"text": "agentsfor", "start": 100, "end": 109, "id": 13, "ws": true}, {"text": "third", "start": 110, "end": 115, "id": 14, "ws": false}, {"text": "-", "start": 115, "end": 116, "id": 15, "ws": false}, {"text": "line", "start": 116, "end": 120, "id": 16, "ws": true}, {"text": "chemotherapy", "start": 121, "end": 133, "id": 17, "ws": true}, {"text": "of", "start": 134, "end": 136, "id": 18, "ws": true}, {"text": "germ", "start": 137, "end": 141, "id": 19, "ws": true}, {"text": "cell", "start": 142, "end": 146, "id": 20, "ws": true}, {"text": "testicular", "start": 147, "end": 157, "id": 21, "ws": true}, {"text": "cancer", "start": 158, "end": 164, "id": 22, "ws": false}, {"text": ".", "start": 164, "end": 165, "id": 23, "ws": true}, {"text": "It", "start": 166, "end": 168, "id": 24, "ws": true}, {"text": "should", "start": 169, "end": 175, "id": 25, "ws": true}, {"text": "be", "start": 176, "end": 178, "id": 26, "ws": true}, {"text": "used", "start": 179, "end": 183, "id": 27, "ws": true}, {"text": "in", "start": 184, "end": 186, "id": 28, "ws": true}, {"text": "combination", "start": 187, "end": 198, "id": 29, "ws": true}, {"text": "with", "start": 199, "end": 203, "id": 30, "ws": true}, {"text": "mesna", "start": 204, "end": 209, "id": 31, "ws": true}, {"text": "for", "start": 210, "end": 213, "id": 32, "ws": true}, {"text": "prophylaxis", "start": 214, "end": 225, "id": 33, "ws": true}, {"text": "of", "start": 226, "end": 228, "id": 34, "ws": true}, {"text": "hemorrhagic", "start": 229, "end": 240, "id": 35, "ws": true}, {"text": "cystitis", "start": 241, "end": 249, "id": 36, "ws": false}, {"text": ".", "start": 249, "end": 250, "id": 37, "ws": true}, {"text": "Ifosfamide", "start": 251, "end": 261, "id": 38, "ws": true}, {"text": "Injection", "start": 262, "end": 271, "id": 39, "ws": true}, {"text": "is", "start": 272, "end": 274, "id": 40, "ws": true}, {"text": "an", "start": 275, "end": 277, "id": 41, "ws": true}, {"text": "alkylating", "start": 278, "end": 288, "id": 42, "ws": true}, {"text": "drug", "start": 289, "end": 293, "id": 43, "ws": true}, {"text": "indicated", "start": 294, "end": 303, "id": 44, "ws": true}, {"text": "for", "start": 304, "end": 307, "id": 45, "ws": true}, {"text": "use", "start": 308, "end": 311, "id": 46, "ws": true}, {"text": "in", "start": 312, "end": 314, "id": 47, "ws": true}, {"text": "combination", "start": 315, "end": 326, "id": 48, "ws": true}, {"text": "with", "start": 327, "end": 331, "id": 49, "ws": true}, {"text": "certain", "start": 332, "end": 339, "id": 50, "ws": true}, {"text": "other", "start": 340, "end": 345, "id": 51, "ws": true}, {"text": "approved", "start": 346, "end": 354, "id": 52, "ws": true}, {"text": "antineoplastic", "start": 355, "end": 369, "id": 53, "ws": true}, {"text": "agents", "start": 370, "end": 376, "id": 54, "ws": true}, {"text": "for", "start": 377, "end": 380, "id": 55, "ws": true}, {"text": "third", "start": 381, "end": 386, "id": 56, "ws": false}, {"text": "-", "start": 386, "end": 387, "id": 57, "ws": false}, {"text": "line", "start": 387, "end": 391, "id": 58, "ws": true}, {"text": "chemotherapy", "start": 392, "end": 404, "id": 59, "ws": true}, {"text": "of", "start": 405, "end": 407, "id": 60, "ws": true}, {"text": "germ", "start": 408, "end": 412, "id": 61, "ws": true}, {"text": "cell", "start": 413, "end": 417, "id": 62, "ws": true}, {"text": "testicular", "start": 418, "end": 428, "id": 63, "ws": true}, {"text": "cancer", "start": 429, "end": 435, "id": 64, "ws": false}, {"text": ".", "start": 435, "end": 436, "id": 65, "ws": true}, {"text": "It", "start": 437, "end": 439, "id": 66, "ws": true}, {"text": "should", "start": 440, "end": 446, "id": 67, "ws": true}, {"text": "be", "start": 447, "end": 449, "id": 68, "ws": true}, {"text": "used", "start": 450, "end": 454, "id": 69, "ws": true}, {"text": "in", "start": 455, "end": 457, "id": 70, "ws": true}, {"text": "combination", "start": 458, "end": 469, "id": 71, "ws": true}, {"text": "with", "start": 470, "end": 474, "id": 72, "ws": true}, {"text": "mesna", "start": 475, "end": 480, "id": 73, "ws": true}, {"text": "for", "start": 481, "end": 484, "id": 74, "ws": true}, {"text": "prophylaxis", "start": 485, "end": 496, "id": 75, "ws": true}, {"text": "of", "start": 497, "end": 499, "id": 76, "ws": true}, {"text": "hemorrhagic", "start": 500, "end": 511, "id": 77, "ws": true}, {"text": "cystitis", "start": 512, "end": 520, "id": 78, "ws": false}, {"text": ".", "start": 520, "end": 521, "id": 79, "ws": true}, {"text": "(", "start": 522, "end": 523, "id": 80, "ws": false}, {"text": "1", "start": 523, "end": 524, "id": 81, "ws": false}, {"text": ")", "start": 524, "end": 525, "id": 82, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 20, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 42, "end": 109, "token_start": 6, "token_end": 13, "label": "CO_PRESCRIPTION"}, {"start": 137, "end": 164, "token_start": 19, "token_end": 22, "label": "BASECONDITION"}, {"start": 251, "end": 261, "token_start": 38, "token_end": 38, "label": "DRUG"}, {"start": 262, "end": 271, "token_start": 39, "token_end": 39, "label": "ROUTE"}, {"start": 278, "end": 293, "token_start": 42, "token_end": 43, "label": "MECHANISM"}, {"start": 304, "end": 376, "token_start": 45, "token_end": 54, "label": "CO_PRESCRIPTION"}, {"start": 408, "end": 435, "token_start": 61, "token_end": 64, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694528296, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "XANAX is indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD), with or without agoraphobia in adults. XANAX is a benzodiazepine indicated for the: Acute treatment of generalized anxiety disorder in adults. (1) Treatment of panic disorder with or without agoraphobia in adults. (1)", "_input_hash": -84361967, "_task_hash": -529722705, "_is_binary": false, "tokens": [{"text": "XANAX", "start": 0, "end": 5, "id": 0, "ws": true}, {"text": "is", "start": 6, "end": 8, "id": 1, "ws": true}, {"text": "indicated", "start": 9, "end": 18, "id": 2, "ws": true}, {"text": "for", "start": 19, "end": 22, "id": 3, "ws": true}, {"text": "the", "start": 23, "end": 26, "id": 4, "ws": false}, {"text": ":", "start": 26, "end": 27, "id": 5, "ws": true}, {"text": "acute", "start": 28, "end": 33, "id": 6, "ws": true}, {"text": "treatment", "start": 34, "end": 43, "id": 7, "ws": true}, {"text": "of", "start": 44, "end": 46, "id": 8, "ws": true}, {"text": "generalized", "start": 47, "end": 58, "id": 9, "ws": true}, {"text": "anxiety", "start": 59, "end": 66, "id": 10, "ws": true}, {"text": "disorder", "start": 67, "end": 75, "id": 11, "ws": true}, {"text": "(", "start": 76, "end": 77, "id": 12, "ws": false}, {"text": "GAD", "start": 77, "end": 80, "id": 13, "ws": false}, {"text": ")", "start": 80, "end": 81, "id": 14, "ws": true}, {"text": "in", "start": 82, "end": 84, "id": 15, "ws": true}, {"text": "adults", "start": 85, "end": 91, "id": 16, "ws": false}, {"text": ".", "start": 91, "end": 92, "id": 17, "ws": true}, {"text": "treatment", "start": 93, "end": 102, "id": 18, "ws": true}, {"text": "of", "start": 103, "end": 105, "id": 19, "ws": true}, {"text": "panic", "start": 106, "end": 111, "id": 20, "ws": true}, {"text": "disorder", "start": 112, "end": 120, "id": 21, "ws": true}, {"text": "(", "start": 121, "end": 122, "id": 22, "ws": false}, {"text": "PD", "start": 122, "end": 124, "id": 23, "ws": false}, {"text": ")", "start": 124, "end": 125, "id": 24, "ws": false}, {"text": ",", "start": 125, "end": 126, "id": 25, "ws": true}, {"text": "with", "start": 127, "end": 131, "id": 26, "ws": true}, {"text": "or", "start": 132, "end": 134, "id": 27, "ws": true}, {"text": "without", "start": 135, "end": 142, "id": 28, "ws": true}, {"text": "agoraphobia", "start": 143, "end": 154, "id": 29, "ws": true}, {"text": "in", "start": 155, "end": 157, "id": 30, "ws": true}, {"text": "adults", "start": 158, "end": 164, "id": 31, "ws": false}, {"text": ".", "start": 164, "end": 165, "id": 32, "ws": true}, {"text": "XANAX", "start": 166, "end": 171, "id": 33, "ws": true}, {"text": "is", "start": 172, "end": 174, "id": 34, "ws": true}, {"text": "a", "start": 175, "end": 176, "id": 35, "ws": true}, {"text": "benzodiazepine", "start": 177, "end": 191, "id": 36, "ws": true}, {"text": "indicated", "start": 192, "end": 201, "id": 37, "ws": true}, {"text": "for", "start": 202, "end": 205, "id": 38, "ws": true}, {"text": "the", "start": 206, "end": 209, "id": 39, "ws": false}, {"text": ":", "start": 209, "end": 210, "id": 40, "ws": true}, {"text": "Acute", "start": 211, "end": 216, "id": 41, "ws": true}, {"text": "treatment", "start": 217, "end": 226, "id": 42, "ws": true}, {"text": "of", "start": 227, "end": 229, "id": 43, "ws": true}, {"text": "generalized", "start": 230, "end": 241, "id": 44, "ws": true}, {"text": "anxiety", "start": 242, "end": 249, "id": 45, "ws": true}, {"text": "disorder", "start": 250, "end": 258, "id": 46, "ws": true}, {"text": "in", "start": 259, "end": 261, "id": 47, "ws": true}, {"text": "adults", "start": 262, "end": 268, "id": 48, "ws": false}, {"text": ".", "start": 268, "end": 269, "id": 49, "ws": true}, {"text": "(", "start": 270, "end": 271, "id": 50, "ws": false}, {"text": "1", "start": 271, "end": 272, "id": 51, "ws": false}, {"text": ")", "start": 272, "end": 273, "id": 52, "ws": true}, {"text": "Treatment", "start": 274, "end": 283, "id": 53, "ws": true}, {"text": "of", "start": 284, "end": 286, "id": 54, "ws": true}, {"text": "panic", "start": 287, "end": 292, "id": 55, "ws": true}, {"text": "disorder", "start": 293, "end": 301, "id": 56, "ws": true}, {"text": "with", "start": 302, "end": 306, "id": 57, "ws": true}, {"text": "or", "start": 307, "end": 309, "id": 58, "ws": true}, {"text": "without", "start": 310, "end": 317, "id": 59, "ws": true}, {"text": "agoraphobia", "start": 318, "end": 329, "id": 60, "ws": true}, {"text": "in", "start": 330, "end": 332, "id": 61, "ws": true}, {"text": "adults", "start": 333, "end": 339, "id": 62, "ws": false}, {"text": ".", "start": 339, "end": 340, "id": 63, "ws": true}, {"text": "(", "start": 341, "end": 342, "id": 64, "ws": false}, {"text": "1", "start": 342, "end": 343, "id": 65, "ws": false}, {"text": ")", "start": 343, "end": 344, "id": 66, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 5, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 28, "end": 46, "token_start": 6, "token_end": 8, "label": "ACTION"}, {"start": 47, "end": 80, "token_start": 9, "token_end": 13, "label": "INDICATION"}, {"start": 85, "end": 91, "token_start": 16, "token_end": 16, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694175572, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Duraclon is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see Clinical Trials ). The safety of this drug product has only been established in a highly selected group of cancer patients, and only after an adequate trial of opioid analgesia. Other use is of unproven safety and is not recommended. In a rare patient, the potential benefits may outweigh the known risks (see WARNINGS ).", "_input_hash": -1829668049, "_task_hash": 541706484, "_is_binary": false, "tokens": [{"text": "Duraclon", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "in", "start": 22, "end": 24, "id": 3, "ws": true}, {"text": "combination", "start": 25, "end": 36, "id": 4, "ws": true}, {"text": "with", "start": 37, "end": 41, "id": 5, "ws": true}, {"text": "opiates", "start": 42, "end": 49, "id": 6, "ws": true}, {"text": "for", "start": 50, "end": 53, "id": 7, "ws": true}, {"text": "the", "start": 54, "end": 57, "id": 8, "ws": true}, {"text": "treatment", "start": 58, "end": 67, "id": 9, "ws": true}, {"text": "of", "start": 68, "end": 70, "id": 10, "ws": true}, {"text": "severe", "start": 71, "end": 77, "id": 11, "ws": true}, {"text": "pain", "start": 78, "end": 82, "id": 12, "ws": true}, {"text": "in", "start": 83, "end": 85, "id": 13, "ws": true}, {"text": "cancer", "start": 86, "end": 92, "id": 14, "ws": true}, {"text": "patients", "start": 93, "end": 101, "id": 15, "ws": true}, {"text": "that", "start": 102, "end": 106, "id": 16, "ws": true}, {"text": "is", "start": 107, "end": 109, "id": 17, "ws": true}, {"text": "not", "start": 110, "end": 113, "id": 18, "ws": true}, {"text": "adequately", "start": 114, "end": 124, "id": 19, "ws": true}, {"text": "relieved", "start": 125, "end": 133, "id": 20, "ws": true}, {"text": "by", "start": 134, "end": 136, "id": 21, "ws": true}, {"text": "opioid", "start": 137, "end": 143, "id": 22, "ws": true}, {"text": "analgesics", "start": 144, "end": 154, "id": 23, "ws": true}, {"text": "alone", "start": 155, "end": 160, "id": 24, "ws": false}, {"text": ".", "start": 160, "end": 161, "id": 25, "ws": true}, {"text": "Epidural", "start": 162, "end": 170, "id": 26, "ws": true}, {"text": "clonidine", "start": 171, "end": 180, "id": 27, "ws": true}, {"text": "is", "start": 181, "end": 183, "id": 28, "ws": true}, {"text": "more", "start": 184, "end": 188, "id": 29, "ws": true}, {"text": "likely", "start": 189, "end": 195, "id": 30, "ws": true}, {"text": "to", "start": 196, "end": 198, "id": 31, "ws": true}, {"text": "be", "start": 199, "end": 201, "id": 32, "ws": true}, {"text": "effective", "start": 202, "end": 211, "id": 33, "ws": true}, {"text": "in", "start": 212, "end": 214, "id": 34, "ws": true}, {"text": "patients", "start": 215, "end": 223, "id": 35, "ws": true}, {"text": "with", "start": 224, "end": 228, "id": 36, "ws": true}, {"text": "neuropathic", "start": 229, "end": 240, "id": 37, "ws": true}, {"text": "pain", "start": 241, "end": 245, "id": 38, "ws": true}, {"text": "than", "start": 246, "end": 250, "id": 39, "ws": true}, {"text": "somatic", "start": 251, "end": 258, "id": 40, "ws": true}, {"text": "or", "start": 259, "end": 261, "id": 41, "ws": true}, {"text": "visceral", "start": 262, "end": 270, "id": 42, "ws": true}, {"text": "pain", "start": 271, "end": 275, "id": 43, "ws": true}, {"text": "(", "start": 276, "end": 277, "id": 44, "ws": false}, {"text": "see", "start": 277, "end": 280, "id": 45, "ws": true}, {"text": "Clinical", "start": 281, "end": 289, "id": 46, "ws": true}, {"text": "Trials", "start": 290, "end": 296, "id": 47, "ws": true}, {"text": ")", "start": 297, "end": 298, "id": 48, "ws": false}, {"text": ".", "start": 298, "end": 299, "id": 49, "ws": true}, {"text": "The", "start": 300, "end": 303, "id": 50, "ws": true}, {"text": "safety", "start": 304, "end": 310, "id": 51, "ws": true}, {"text": "of", "start": 311, "end": 313, "id": 52, "ws": true}, {"text": "this", "start": 314, "end": 318, "id": 53, "ws": true}, {"text": "drug", "start": 319, "end": 323, "id": 54, "ws": true}, {"text": "product", "start": 324, "end": 331, "id": 55, "ws": true}, {"text": "has", "start": 332, "end": 335, "id": 56, "ws": true}, {"text": "only", "start": 336, "end": 340, "id": 57, "ws": true}, {"text": "been", "start": 341, "end": 345, "id": 58, "ws": true}, {"text": "established", "start": 346, "end": 357, "id": 59, "ws": true}, {"text": "in", "start": 358, "end": 360, "id": 60, "ws": true}, {"text": "a", "start": 361, "end": 362, "id": 61, "ws": true}, {"text": "highly", "start": 363, "end": 369, "id": 62, "ws": true}, {"text": "selected", "start": 370, "end": 378, "id": 63, "ws": true}, {"text": "group", "start": 379, "end": 384, "id": 64, "ws": true}, {"text": "of", "start": 385, "end": 387, "id": 65, "ws": true}, {"text": "cancer", "start": 388, "end": 394, "id": 66, "ws": true}, {"text": "patients", "start": 395, "end": 403, "id": 67, "ws": false}, {"text": ",", "start": 403, "end": 404, "id": 68, "ws": true}, {"text": "and", "start": 405, "end": 408, "id": 69, "ws": true}, {"text": "only", "start": 409, "end": 413, "id": 70, "ws": true}, {"text": "after", "start": 414, "end": 419, "id": 71, "ws": true}, {"text": "an", "start": 420, "end": 422, "id": 72, "ws": true}, {"text": "adequate", "start": 423, "end": 431, "id": 73, "ws": true}, {"text": "trial", "start": 432, "end": 437, "id": 74, "ws": true}, {"text": "of", "start": 438, "end": 440, "id": 75, "ws": true}, {"text": "opioid", "start": 441, "end": 447, "id": 76, "ws": true}, {"text": "analgesia", "start": 448, "end": 457, "id": 77, "ws": false}, {"text": ".", "start": 457, "end": 458, "id": 78, "ws": true}, {"text": "Other", "start": 459, "end": 464, "id": 79, "ws": true}, {"text": "use", "start": 465, "end": 468, "id": 80, "ws": true}, {"text": "is", "start": 469, "end": 471, "id": 81, "ws": true}, {"text": "of", "start": 472, "end": 474, "id": 82, "ws": true}, {"text": "unproven", "start": 475, "end": 483, "id": 83, "ws": true}, {"text": "safety", "start": 484, "end": 490, "id": 84, "ws": true}, {"text": "and", "start": 491, "end": 494, "id": 85, "ws": true}, {"text": "is", "start": 495, "end": 497, "id": 86, "ws": true}, {"text": "not", "start": 498, "end": 501, "id": 87, "ws": true}, {"text": "recommended", "start": 502, "end": 513, "id": 88, "ws": false}, {"text": ".", "start": 513, "end": 514, "id": 89, "ws": true}, {"text": "In", "start": 515, "end": 517, "id": 90, "ws": true}, {"text": "a", "start": 518, "end": 519, "id": 91, "ws": true}, {"text": "rare", "start": 520, "end": 524, "id": 92, "ws": true}, {"text": "patient", "start": 525, "end": 532, "id": 93, "ws": false}, {"text": ",", "start": 532, "end": 533, "id": 94, "ws": true}, {"text": "the", "start": 534, "end": 537, "id": 95, "ws": true}, {"text": "potential", "start": 538, "end": 547, "id": 96, "ws": true}, {"text": "benefits", "start": 548, "end": 556, "id": 97, "ws": true}, {"text": "may", "start": 557, "end": 560, "id": 98, "ws": true}, {"text": "outweigh", "start": 561, "end": 569, "id": 99, "ws": true}, {"text": "the", "start": 570, "end": 573, "id": 100, "ws": true}, {"text": "known", "start": 574, "end": 579, "id": 101, "ws": true}, {"text": "risks", "start": 580, "end": 585, "id": 102, "ws": true}, {"text": "(", "start": 586, "end": 587, "id": 103, "ws": false}, {"text": "see", "start": 587, "end": 590, "id": 104, "ws": true}, {"text": "WARNINGS", "start": 591, "end": 599, "id": 105, "ws": true}, {"text": ")", "start": 600, "end": 601, "id": 106, "ws": false}, {"text": ".", "start": 601, "end": 602, "id": 107, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 42, "end": 49, "token_start": 6, "token_end": 6, "label": "CO_PRESCRIPTION"}, {"start": 58, "end": 67, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 71, "end": 77, "token_start": 11, "token_end": 11, "label": "SEVERITY"}, {"start": 78, "end": 82, "token_start": 12, "token_end": 12, "label": "INDICATION"}, {"start": 86, "end": 92, "token_start": 14, "token_end": 14, "label": "BASECONDITION"}, {"start": 110, "end": 160, "token_start": 18, "token_end": 24, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694176089, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Timolol Maleate Sterile Ophthalmic Gel Forming Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.", "_input_hash": 1696912716, "_task_hash": -584669254, "_is_binary": false, "tokens": [{"text": "Timolol", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "Maleate", "start": 8, "end": 15, "id": 1, "ws": true}, {"text": "Sterile", "start": 16, "end": 23, "id": 2, "ws": true}, {"text": "Ophthalmic", "start": 24, "end": 34, "id": 3, "ws": true}, {"text": "Gel", "start": 35, "end": 38, "id": 4, "ws": true}, {"text": "Forming", "start": 39, "end": 46, "id": 5, "ws": true}, {"text": "Solution", "start": 47, "end": 55, "id": 6, "ws": true}, {"text": "is", "start": 56, "end": 58, "id": 7, "ws": true}, {"text": "indicated", "start": 59, "end": 68, "id": 8, "ws": true}, {"text": "in", "start": 69, "end": 71, "id": 9, "ws": true}, {"text": "the", "start": 72, "end": 75, "id": 10, "ws": true}, {"text": "treatment", "start": 76, "end": 85, "id": 11, "ws": true}, {"text": "of", "start": 86, "end": 88, "id": 12, "ws": true}, {"text": "elevated", "start": 89, "end": 97, "id": 13, "ws": true}, {"text": "intraocular", "start": 98, "end": 109, "id": 14, "ws": true}, {"text": "pressure", "start": 110, "end": 118, "id": 15, "ws": true}, {"text": "in", "start": 119, "end": 121, "id": 16, "ws": true}, {"text": "patients", "start": 122, "end": 130, "id": 17, "ws": true}, {"text": "with", "start": 131, "end": 135, "id": 18, "ws": true}, {"text": "ocular", "start": 136, "end": 142, "id": 19, "ws": true}, {"text": "hypertension", "start": 143, "end": 155, "id": 20, "ws": true}, {"text": "or", "start": 156, "end": 158, "id": 21, "ws": true}, {"text": "open", "start": 159, "end": 163, "id": 22, "ws": false}, {"text": "-", "start": 163, "end": 164, "id": 23, "ws": false}, {"text": "angle", "start": 164, "end": 169, "id": 24, "ws": true}, {"text": "glaucoma", "start": 170, "end": 178, "id": 25, "ws": false}, {"text": ".", "start": 178, "end": 179, "id": 26, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 15, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 16, "end": 55, "token_start": 2, "token_end": 6, "label": "FORMULATION"}, {"start": 76, "end": 85, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 89, "end": 118, "token_start": 13, "token_end": 15, "label": "INDICATION"}, {"start": 136, "end": 155, "token_start": 19, "token_end": 20, "label": "BASECONDITION"}, {"start": 159, "end": 178, "token_start": 22, "token_end": 25, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176778, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Mesalamine delayed-release tablets is an aminosalicylate indicated for the treatment of moderately active ulcerative colitis in adults. (1) Limitation of Use: Safety and effectiveness of Mesalamine delayed-release tablets beyond 6 weeks have not been established (1) Mesalamine delayed-release tablets is indicated for the treatment of moderately active ulcerative colitis in adults. Limitations of Use: Safety and effectiveness of Mesalamine delayed-release tablets beyond 6 weeks have not been established.", "_input_hash": -605802100, "_task_hash": -1950353324, "_is_binary": false, "tokens": [{"text": "Mesalamine", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "delayed", "start": 11, "end": 18, "id": 1, "ws": false}, {"text": "-", "start": 18, "end": 19, "id": 2, "ws": false}, {"text": "release", "start": 19, "end": 26, "id": 3, "ws": true}, {"text": "tablets", "start": 27, "end": 34, "id": 4, "ws": true}, {"text": "is", "start": 35, "end": 37, "id": 5, "ws": true}, {"text": "an", "start": 38, "end": 40, "id": 6, "ws": true}, {"text": "aminosalicylate", "start": 41, "end": 56, "id": 7, "ws": true}, {"text": "indicated", "start": 57, "end": 66, "id": 8, "ws": true}, {"text": "for", "start": 67, "end": 70, "id": 9, "ws": true}, {"text": "the", "start": 71, "end": 74, "id": 10, "ws": true}, {"text": "treatment", "start": 75, "end": 84, "id": 11, "ws": true}, {"text": "of", "start": 85, "end": 87, "id": 12, "ws": true}, {"text": "moderately", "start": 88, "end": 98, "id": 13, "ws": true}, {"text": "active", "start": 99, "end": 105, "id": 14, "ws": true}, {"text": "ulcerative", "start": 106, "end": 116, "id": 15, "ws": true}, {"text": "colitis", "start": 117, "end": 124, "id": 16, "ws": true}, {"text": "in", "start": 125, "end": 127, "id": 17, "ws": true}, {"text": "adults", "start": 128, "end": 134, "id": 18, "ws": false}, {"text": ".", "start": 134, "end": 135, "id": 19, "ws": true}, {"text": "(", "start": 136, "end": 137, "id": 20, "ws": false}, {"text": "1", "start": 137, "end": 138, "id": 21, "ws": false}, {"text": ")", "start": 138, "end": 139, "id": 22, "ws": true}, {"text": "Limitation", "start": 140, "end": 150, "id": 23, "ws": true}, {"text": "of", "start": 151, "end": 153, "id": 24, "ws": true}, {"text": "Use", "start": 154, "end": 157, "id": 25, "ws": false}, {"text": ":", "start": 157, "end": 158, "id": 26, "ws": true}, {"text": "Safety", "start": 159, "end": 165, "id": 27, "ws": true}, {"text": "and", "start": 166, "end": 169, "id": 28, "ws": true}, {"text": "effectiveness", "start": 170, "end": 183, "id": 29, "ws": true}, {"text": "of", "start": 184, "end": 186, "id": 30, "ws": true}, {"text": "Mesalamine", "start": 187, "end": 197, "id": 31, "ws": true}, {"text": "delayed", "start": 198, "end": 205, "id": 32, "ws": false}, {"text": "-", "start": 205, "end": 206, "id": 33, "ws": false}, {"text": "release", "start": 206, "end": 213, "id": 34, "ws": true}, {"text": "tablets", "start": 214, "end": 221, "id": 35, "ws": true}, {"text": "beyond", "start": 222, "end": 228, "id": 36, "ws": true}, {"text": "6", "start": 229, "end": 230, "id": 37, "ws": true}, {"text": "weeks", "start": 231, "end": 236, "id": 38, "ws": true}, {"text": "have", "start": 237, "end": 241, "id": 39, "ws": true}, {"text": "not", "start": 242, "end": 245, "id": 40, "ws": true}, {"text": "been", "start": 246, "end": 250, "id": 41, "ws": true}, {"text": "established", "start": 251, "end": 262, "id": 42, "ws": true}, {"text": "(", "start": 263, "end": 264, "id": 43, "ws": false}, {"text": "1", "start": 264, "end": 265, "id": 44, "ws": false}, {"text": ")", "start": 265, "end": 266, "id": 45, "ws": true}, {"text": "Mesalamine", "start": 267, "end": 277, "id": 46, "ws": true}, {"text": "delayed", "start": 278, "end": 285, "id": 47, "ws": false}, {"text": "-", "start": 285, "end": 286, "id": 48, "ws": false}, {"text": "release", "start": 286, "end": 293, "id": 49, "ws": true}, {"text": "tablets", "start": 294, "end": 301, "id": 50, "ws": true}, {"text": "is", "start": 302, "end": 304, "id": 51, "ws": true}, {"text": "indicated", "start": 305, "end": 314, "id": 52, "ws": true}, {"text": "for", "start": 315, "end": 318, "id": 53, "ws": true}, {"text": "the", "start": 319, "end": 322, "id": 54, "ws": true}, {"text": "treatment", "start": 323, "end": 332, "id": 55, "ws": true}, {"text": "of", "start": 333, "end": 335, "id": 56, "ws": true}, {"text": "moderately", "start": 336, "end": 346, "id": 57, "ws": true}, {"text": "active", "start": 347, "end": 353, "id": 58, "ws": true}, {"text": "ulcerative", "start": 354, "end": 364, "id": 59, "ws": true}, {"text": "colitis", "start": 365, "end": 372, "id": 60, "ws": true}, {"text": "in", "start": 373, "end": 375, "id": 61, "ws": true}, {"text": "adults", "start": 376, "end": 382, "id": 62, "ws": false}, {"text": ".", "start": 382, "end": 383, "id": 63, "ws": true}, {"text": "Limitations", "start": 384, "end": 395, "id": 64, "ws": true}, {"text": "of", "start": 396, "end": 398, "id": 65, "ws": true}, {"text": "Use", "start": 399, "end": 402, "id": 66, "ws": false}, {"text": ":", "start": 402, "end": 403, "id": 67, "ws": true}, {"text": "Safety", "start": 404, "end": 410, "id": 68, "ws": true}, {"text": "and", "start": 411, "end": 414, "id": 69, "ws": true}, {"text": "effectiveness", "start": 415, "end": 428, "id": 70, "ws": true}, {"text": "of", "start": 429, "end": 431, "id": 71, "ws": true}, {"text": "Mesalamine", "start": 432, "end": 442, "id": 72, "ws": true}, {"text": "delayed", "start": 443, "end": 450, "id": 73, "ws": false}, {"text": "-", "start": 450, "end": 451, "id": 74, "ws": false}, {"text": "release", "start": 451, "end": 458, "id": 75, "ws": true}, {"text": "tablets", "start": 459, "end": 466, "id": 76, "ws": true}, {"text": "beyond", "start": 467, "end": 473, "id": 77, "ws": true}, {"text": "6", "start": 474, "end": 475, "id": 78, "ws": true}, {"text": "weeks", "start": 476, "end": 481, "id": 79, "ws": true}, {"text": "have", "start": 482, "end": 486, "id": 80, "ws": true}, {"text": "not", "start": 487, "end": 490, "id": 81, "ws": true}, {"text": "been", "start": 491, "end": 495, "id": 82, "ws": true}, {"text": "established", "start": 496, "end": 507, "id": 83, "ws": false}, {"text": ".", "start": 507, "end": 508, "id": 84, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 34, "token_start": 1, "token_end": 4, "label": "FORMULATION"}, {"start": 41, "end": 56, "token_start": 7, "token_end": 7, "label": "MECHANISM"}, {"start": 75, "end": 87, "token_start": 11, "token_end": 12, "label": "MECHANISM"}, {"start": 88, "end": 105, "token_start": 13, "token_end": 14, "label": "SEVERITY"}, {"start": 106, "end": 124, "token_start": 15, "token_end": 16, "label": "INDICATION"}, {"start": 128, "end": 134, "token_start": 18, "token_end": 18, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694174974, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "SEROSTIM (somatropin) is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight, and improve physical endurance. Concomitant antiretroviral therapy is necessary. SEROSTIM is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight, and improve physical endurance (1)", "_input_hash": 151249673, "_task_hash": 768532806, "_is_binary": false, "tokens": [{"text": "SEROSTIM", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "(", "start": 9, "end": 10, "id": 1, "ws": false}, {"text": "somatropin", "start": 10, "end": 20, "id": 2, "ws": false}, {"text": ")", "start": 20, "end": 21, "id": 3, "ws": true}, {"text": "is", "start": 22, "end": 24, "id": 4, "ws": true}, {"text": "indicated", "start": 25, "end": 34, "id": 5, "ws": true}, {"text": "for", "start": 35, "end": 38, "id": 6, "ws": true}, {"text": "the", "start": 39, "end": 42, "id": 7, "ws": true}, {"text": "treatment", "start": 43, "end": 52, "id": 8, "ws": true}, {"text": "of", "start": 53, "end": 55, "id": 9, "ws": true}, {"text": "HIV", "start": 56, "end": 59, "id": 10, "ws": true}, {"text": "patients", "start": 60, "end": 68, "id": 11, "ws": true}, {"text": "with", "start": 69, "end": 73, "id": 12, "ws": true}, {"text": "wasting", "start": 74, "end": 81, "id": 13, "ws": true}, {"text": "or", "start": 82, "end": 84, "id": 14, "ws": true}, {"text": "cachexia", "start": 85, "end": 93, "id": 15, "ws": true}, {"text": "to", "start": 94, "end": 96, "id": 16, "ws": true}, {"text": "increase", "start": 97, "end": 105, "id": 17, "ws": true}, {"text": "lean", "start": 106, "end": 110, "id": 18, "ws": true}, {"text": "body", "start": 111, "end": 115, "id": 19, "ws": true}, {"text": "mass", "start": 116, "end": 120, "id": 20, "ws": true}, {"text": "and", "start": 121, "end": 124, "id": 21, "ws": true}, {"text": "body", "start": 125, "end": 129, "id": 22, "ws": true}, {"text": "weight", "start": 130, "end": 136, "id": 23, "ws": false}, {"text": ",", "start": 136, "end": 137, "id": 24, "ws": true}, {"text": "and", "start": 138, "end": 141, "id": 25, "ws": true}, {"text": "improve", "start": 142, "end": 149, "id": 26, "ws": true}, {"text": "physical", "start": 150, "end": 158, "id": 27, "ws": true}, {"text": "endurance", "start": 159, "end": 168, "id": 28, "ws": false}, {"text": ".", "start": 168, "end": 169, "id": 29, "ws": true}, {"text": "Concomitant", "start": 170, "end": 181, "id": 30, "ws": true}, {"text": "antiretroviral", "start": 182, "end": 196, "id": 31, "ws": true}, {"text": "therapy", "start": 197, "end": 204, "id": 32, "ws": true}, {"text": "is", "start": 205, "end": 207, "id": 33, "ws": true}, {"text": "necessary", "start": 208, "end": 217, "id": 34, "ws": false}, {"text": ".", "start": 217, "end": 218, "id": 35, "ws": true}, {"text": "SEROSTIM", "start": 219, "end": 227, "id": 36, "ws": true}, {"text": "is", "start": 228, "end": 230, "id": 37, "ws": true}, {"text": "indicated", "start": 231, "end": 240, "id": 38, "ws": true}, {"text": "for", "start": 241, "end": 244, "id": 39, "ws": true}, {"text": "the", "start": 245, "end": 248, "id": 40, "ws": true}, {"text": "treatment", "start": 249, "end": 258, "id": 41, "ws": true}, {"text": "of", "start": 259, "end": 261, "id": 42, "ws": true}, {"text": "HIV", "start": 262, "end": 265, "id": 43, "ws": true}, {"text": "patients", "start": 266, "end": 274, "id": 44, "ws": true}, {"text": "with", "start": 275, "end": 279, "id": 45, "ws": true}, {"text": "wasting", "start": 280, "end": 287, "id": 46, "ws": true}, {"text": "or", "start": 288, "end": 290, "id": 47, "ws": true}, {"text": "cachexia", "start": 291, "end": 299, "id": 48, "ws": true}, {"text": "to", "start": 300, "end": 302, "id": 49, "ws": true}, {"text": "increase", "start": 303, "end": 311, "id": 50, "ws": true}, {"text": "lean", "start": 312, "end": 316, "id": 51, "ws": true}, {"text": "body", "start": 317, "end": 321, "id": 52, "ws": true}, {"text": "mass", "start": 322, "end": 326, "id": 53, "ws": true}, {"text": "and", "start": 327, "end": 330, "id": 54, "ws": true}, {"text": "body", "start": 331, "end": 335, "id": 55, "ws": true}, {"text": "weight", "start": 336, "end": 342, "id": 56, "ws": false}, {"text": ",", "start": 342, "end": 343, "id": 57, "ws": true}, {"text": "and", "start": 344, "end": 347, "id": 58, "ws": true}, {"text": "improve", "start": 348, "end": 355, "id": 59, "ws": true}, {"text": "physical", "start": 356, "end": 364, "id": 60, "ws": true}, {"text": "endurance", "start": 365, "end": 374, "id": 61, "ws": true}, {"text": "(", "start": 375, "end": 376, "id": 62, "ws": false}, {"text": "1", "start": 376, "end": 377, "id": 63, "ws": false}, {"text": ")", "start": 377, "end": 378, "id": 64, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 20, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 43, "end": 52, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 56, "end": 68, "token_start": 10, "token_end": 11, "label": "TARGET_GROUP"}, {"start": 74, "end": 81, "token_start": 13, "token_end": 13, "label": "CO_MORBIDITY"}, {"start": 85, "end": 93, "token_start": 15, "token_end": 15, "label": "CO_MORBIDITY"}, {"start": 97, "end": 136, "token_start": 17, "token_end": 23, "label": "EFFECT"}, {"start": 142, "end": 168, "token_start": 26, "token_end": 28, "label": "EFFECT"}], "answer": "accept", "_timestamp": 1694176733, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "LOREEV XR is indicated for the treatment of anxiety disorders in adults who are receiving stable, evenly divided, three times daily dosing with lorazepam tablets. LOREEV XR is a benzodiazepine indicated for the treatment of anxiety disorders in adults who are receiving stable, evenly divided, three times daily dosing with lorazepam tablets (1)", "_input_hash": 102063944, "_task_hash": 1599045680, "_is_binary": false, "tokens": [{"text": "LOREEV", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "XR", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 2, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 3, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 4, "ws": true}, {"text": "the", "start": 27, "end": 30, "id": 5, "ws": true}, {"text": "treatment", "start": 31, "end": 40, "id": 6, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 7, "ws": true}, {"text": "anxiety", "start": 44, "end": 51, "id": 8, "ws": true}, {"text": "disorders", "start": 52, "end": 61, "id": 9, "ws": true}, {"text": "in", "start": 62, "end": 64, "id": 10, "ws": true}, {"text": "adults", "start": 65, "end": 71, "id": 11, "ws": true}, {"text": "who", "start": 72, "end": 75, "id": 12, "ws": true}, {"text": "are", "start": 76, "end": 79, "id": 13, "ws": true}, {"text": "receiving", "start": 80, "end": 89, "id": 14, "ws": true}, {"text": "stable", "start": 90, "end": 96, "id": 15, "ws": false}, {"text": ",", "start": 96, "end": 97, "id": 16, "ws": true}, {"text": "evenly", "start": 98, "end": 104, "id": 17, "ws": true}, {"text": "divided", "start": 105, "end": 112, "id": 18, "ws": false}, {"text": ",", "start": 112, "end": 113, "id": 19, "ws": true}, {"text": "three", "start": 114, "end": 119, "id": 20, "ws": true}, {"text": "times", "start": 120, "end": 125, "id": 21, "ws": true}, {"text": "daily", "start": 126, "end": 131, "id": 22, "ws": true}, {"text": "dosing", "start": 132, "end": 138, "id": 23, "ws": true}, {"text": "with", "start": 139, "end": 143, "id": 24, "ws": true}, {"text": "lorazepam", "start": 144, "end": 153, "id": 25, "ws": true}, {"text": "tablets", "start": 154, "end": 161, "id": 26, "ws": false}, {"text": ".", "start": 161, "end": 162, "id": 27, "ws": true}, {"text": "LOREEV", "start": 163, "end": 169, "id": 28, "ws": true}, {"text": "XR", "start": 170, "end": 172, "id": 29, "ws": true}, {"text": "is", "start": 173, "end": 175, "id": 30, "ws": true}, {"text": "a", "start": 176, "end": 177, "id": 31, "ws": true}, {"text": "benzodiazepine", "start": 178, "end": 192, "id": 32, "ws": true}, {"text": "indicated", "start": 193, "end": 202, "id": 33, "ws": true}, {"text": "for", "start": 203, "end": 206, "id": 34, "ws": true}, {"text": "the", "start": 207, "end": 210, "id": 35, "ws": true}, {"text": "treatment", "start": 211, "end": 220, "id": 36, "ws": true}, {"text": "of", "start": 221, "end": 223, "id": 37, "ws": true}, {"text": "anxiety", "start": 224, "end": 231, "id": 38, "ws": true}, {"text": "disorders", "start": 232, "end": 241, "id": 39, "ws": true}, {"text": "in", "start": 242, "end": 244, "id": 40, "ws": true}, {"text": "adults", "start": 245, "end": 251, "id": 41, "ws": true}, {"text": "who", "start": 252, "end": 255, "id": 42, "ws": true}, {"text": "are", "start": 256, "end": 259, "id": 43, "ws": true}, {"text": "receiving", "start": 260, "end": 269, "id": 44, "ws": true}, {"text": "stable", "start": 270, "end": 276, "id": 45, "ws": false}, {"text": ",", "start": 276, "end": 277, "id": 46, "ws": true}, {"text": "evenly", "start": 278, "end": 284, "id": 47, "ws": true}, {"text": "divided", "start": 285, "end": 292, "id": 48, "ws": false}, {"text": ",", "start": 292, "end": 293, "id": 49, "ws": true}, {"text": "three", "start": 294, "end": 299, "id": 50, "ws": true}, {"text": "times", "start": 300, "end": 305, "id": 51, "ws": true}, {"text": "daily", "start": 306, "end": 311, "id": 52, "ws": true}, {"text": "dosing", "start": 312, "end": 318, "id": 53, "ws": true}, {"text": "with", "start": 319, "end": 323, "id": 54, "ws": true}, {"text": "lorazepam", "start": 324, "end": 333, "id": 55, "ws": true}, {"text": "tablets", "start": 334, "end": 341, "id": 56, "ws": true}, {"text": "(", "start": 342, "end": 343, "id": 57, "ws": false}, {"text": "1", "start": 343, "end": 344, "id": 58, "ws": false}, {"text": ")", "start": 344, "end": 345, "id": 59, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 43, "token_start": 6, "token_end": 7, "label": "ACTION"}, {"start": 44, "end": 61, "token_start": 8, "token_end": 9, "label": "INDICATION"}, {"start": 65, "end": 71, "token_start": 11, "token_end": 11, "label": "TARGET_GROUP"}, {"start": 144, "end": 153, "token_start": 25, "token_end": 25, "label": "CO_PRESCRIPTION"}, {"start": 163, "end": 169, "token_start": 28, "token_end": 28, "label": "DRUG"}, {"start": 178, "end": 192, "token_start": 32, "token_end": 32, "label": "MECHANISM"}, {"start": 211, "end": 223, "token_start": 36, "token_end": 37, "label": "ACTION"}, {"start": 224, "end": 241, "token_start": 38, "token_end": 39, "label": "INDICATION"}, {"start": 245, "end": 251, "token_start": 41, "token_end": 41, "label": "TARGET_GROUP"}, {"start": 324, "end": 333, "token_start": 55, "token_end": 55, "label": "CO_PRESCRIPTION"}], "answer": "accept", "_timestamp": 1694174882, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "HALOG OINTMENT (Halcinonide Ointment, USP) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.", "_input_hash": 1914046623, "_task_hash": 420297411, "_is_binary": false, "tokens": [{"text": "HALOG", "start": 0, "end": 5, "id": 0, "ws": true}, {"text": "OINTMENT", "start": 6, "end": 14, "id": 1, "ws": true}, {"text": "(", "start": 15, "end": 16, "id": 2, "ws": false}, {"text": "Halcinonide", "start": 16, "end": 27, "id": 3, "ws": true}, {"text": "Ointment", "start": 28, "end": 36, "id": 4, "ws": false}, {"text": ",", "start": 36, "end": 37, "id": 5, "ws": true}, {"text": "USP", "start": 38, "end": 41, "id": 6, "ws": false}, {"text": ")", "start": 41, "end": 42, "id": 7, "ws": true}, {"text": "0.1", "start": 43, "end": 46, "id": 8, "ws": false}, {"text": "%", "start": 46, "end": 47, "id": 9, "ws": true}, {"text": "is", "start": 48, "end": 50, "id": 10, "ws": true}, {"text": "indicated", "start": 51, "end": 60, "id": 11, "ws": true}, {"text": "for", "start": 61, "end": 64, "id": 12, "ws": true}, {"text": "the", "start": 65, "end": 68, "id": 13, "ws": true}, {"text": "relief", "start": 69, "end": 75, "id": 14, "ws": true}, {"text": "of", "start": 76, "end": 78, "id": 15, "ws": true}, {"text": "the", "start": 79, "end": 82, "id": 16, "ws": true}, {"text": "inflammatory", "start": 83, "end": 95, "id": 17, "ws": true}, {"text": "and", "start": 96, "end": 99, "id": 18, "ws": true}, {"text": "pruritic", "start": 100, "end": 108, "id": 19, "ws": true}, {"text": "manifestations", "start": 109, "end": 123, "id": 20, "ws": true}, {"text": "of", "start": 124, "end": 126, "id": 21, "ws": true}, {"text": "corticosteroid", "start": 127, "end": 141, "id": 22, "ws": true}, {"text": "responsive", "start": 142, "end": 152, "id": 23, "ws": true}, {"text": "dermatoses", "start": 153, "end": 163, "id": 24, "ws": false}, {"text": ".", "start": 163, "end": 164, "id": 25, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 5, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 6, "end": 14, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 16, "end": 27, "token_start": 3, "token_end": 3, "label": "DRUG"}, {"start": 28, "end": 36, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 69, "end": 75, "token_start": 14, "token_end": 14, "label": "ACTION"}, {"start": 83, "end": 123, "token_start": 17, "token_end": 20, "label": "INDICATION"}, {"start": 127, "end": 163, "token_start": 22, "token_end": 24, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694177453, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Calcitrene (calcipotriene) ointment, 0.005%, is indicated for the treatment of plaque psoriasis in adults. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.", "_input_hash": 1085190749, "_task_hash": -2089759911, "_is_binary": false, "tokens": [{"text": "Calcitrene", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "(", "start": 11, "end": 12, "id": 1, "ws": false}, {"text": "calcipotriene", "start": 12, "end": 25, "id": 2, "ws": false}, {"text": ")", "start": 25, "end": 26, "id": 3, "ws": true}, {"text": "ointment", "start": 27, "end": 35, "id": 4, "ws": false}, {"text": ",", "start": 35, "end": 36, "id": 5, "ws": true}, {"text": "0.005", "start": 37, "end": 42, "id": 6, "ws": false}, {"text": "%", "start": 42, "end": 43, "id": 7, "ws": false}, {"text": ",", "start": 43, "end": 44, "id": 8, "ws": true}, {"text": "is", "start": 45, "end": 47, "id": 9, "ws": true}, {"text": "indicated", "start": 48, "end": 57, "id": 10, "ws": true}, {"text": "for", "start": 58, "end": 61, "id": 11, "ws": true}, {"text": "the", "start": 62, "end": 65, "id": 12, "ws": true}, {"text": "treatment", "start": 66, "end": 75, "id": 13, "ws": true}, {"text": "of", "start": 76, "end": 78, "id": 14, "ws": true}, {"text": "plaque", "start": 79, "end": 85, "id": 15, "ws": true}, {"text": "psoriasis", "start": 86, "end": 95, "id": 16, "ws": true}, {"text": "in", "start": 96, "end": 98, "id": 17, "ws": true}, {"text": "adults", "start": 99, "end": 105, "id": 18, "ws": false}, {"text": ".", "start": 105, "end": 106, "id": 19, "ws": true}, {"text": "The", "start": 107, "end": 110, "id": 20, "ws": true}, {"text": "safety", "start": 111, "end": 117, "id": 21, "ws": true}, {"text": "and", "start": 118, "end": 121, "id": 22, "ws": true}, {"text": "effectiveness", "start": 122, "end": 135, "id": 23, "ws": true}, {"text": "of", "start": 136, "end": 138, "id": 24, "ws": true}, {"text": "topical", "start": 139, "end": 146, "id": 25, "ws": true}, {"text": "calcipotriene", "start": 147, "end": 160, "id": 26, "ws": true}, {"text": "in", "start": 161, "end": 163, "id": 27, "ws": true}, {"text": "dermatoses", "start": 164, "end": 174, "id": 28, "ws": true}, {"text": "other", "start": 175, "end": 180, "id": 29, "ws": true}, {"text": "than", "start": 181, "end": 185, "id": 30, "ws": true}, {"text": "psoriasis", "start": 186, "end": 195, "id": 31, "ws": true}, {"text": "have", "start": 196, "end": 200, "id": 32, "ws": true}, {"text": "not", "start": 201, "end": 204, "id": 33, "ws": true}, {"text": "been", "start": 205, "end": 209, "id": 34, "ws": true}, {"text": "established", "start": 210, "end": 221, "id": 35, "ws": false}, {"text": ".", "start": 221, "end": 222, "id": 36, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 25, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 27, "end": 35, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 66, "end": 75, "token_start": 13, "token_end": 13, "label": "ACTION"}, {"start": 79, "end": 95, "token_start": 15, "token_end": 16, "label": "INDICATION"}, {"start": 99, "end": 105, "token_start": 18, "token_end": 18, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694526549, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1)], heart [see Clinical Studies (14.2)] or liver transplants [see Clinical Studies (14.3)] , in combination with other immunosuppressants. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. ( 1)", "_input_hash": 818838828, "_task_hash": 244054048, "_is_binary": false, "tokens": [{"text": "Mycophenolate", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "mofetil", "start": 14, "end": 21, "id": 1, "ws": true}, {"text": "(", "start": 22, "end": 23, "id": 2, "ws": false}, {"text": "MMF", "start": 23, "end": 26, "id": 3, "ws": false}, {"text": ")", "start": 26, "end": 27, "id": 4, "ws": true}, {"text": "is", "start": 28, "end": 30, "id": 5, "ws": true}, {"text": "indicated", "start": 31, "end": 40, "id": 6, "ws": true}, {"text": "for", "start": 41, "end": 44, "id": 7, "ws": true}, {"text": "the", "start": 45, "end": 48, "id": 8, "ws": true}, {"text": "prophylaxis", "start": 49, "end": 60, "id": 9, "ws": true}, {"text": "of", "start": 61, "end": 63, "id": 10, "ws": true}, {"text": "organ", "start": 64, "end": 69, "id": 11, "ws": true}, {"text": "rejection", "start": 70, "end": 79, "id": 12, "ws": false}, {"text": ",", "start": 79, "end": 80, "id": 13, "ws": true}, {"text": "in", "start": 81, "end": 83, "id": 14, "ws": true}, {"text": "adult", "start": 84, "end": 89, "id": 15, "ws": true}, {"text": "and", "start": 90, "end": 93, "id": 16, "ws": true}, {"text": "pediatric", "start": 94, "end": 103, "id": 17, "ws": true}, {"text": "recipients", "start": 104, "end": 114, "id": 18, "ws": true}, {"text": "3", "start": 115, "end": 116, "id": 19, "ws": true}, {"text": "months", "start": 117, "end": 123, "id": 20, "ws": true}, {"text": "of", "start": 124, "end": 126, "id": 21, "ws": true}, {"text": "age", "start": 127, "end": 130, "id": 22, "ws": true}, {"text": "and", "start": 131, "end": 134, "id": 23, "ws": true}, {"text": "older", "start": 135, "end": 140, "id": 24, "ws": true}, {"text": "of", "start": 141, "end": 143, "id": 25, "ws": true}, {"text": "allogeneic", "start": 144, "end": 154, "id": 26, "ws": true}, {"text": "kidney", "start": 155, "end": 161, "id": 27, "ws": true}, {"text": "[", "start": 162, "end": 163, "id": 28, "ws": false}, {"text": "see", "start": 163, "end": 166, "id": 29, "ws": true}, {"text": "Clinical", "start": 167, "end": 175, "id": 30, "ws": true}, {"text": "Studies", "start": 176, "end": 183, "id": 31, "ws": true}, {"text": "(", "start": 184, "end": 185, "id": 32, "ws": false}, {"text": "14.1", "start": 185, "end": 189, "id": 33, "ws": false}, {"text": ")", "start": 189, "end": 190, "id": 34, "ws": false}, {"text": "]", "start": 190, "end": 191, "id": 35, "ws": false}, {"text": ",", "start": 191, "end": 192, "id": 36, "ws": true}, {"text": "heart", "start": 193, "end": 198, "id": 37, "ws": true}, {"text": "[", "start": 199, "end": 200, "id": 38, "ws": false}, {"text": "see", "start": 200, "end": 203, "id": 39, "ws": true}, {"text": "Clinical", "start": 204, "end": 212, "id": 40, "ws": true}, {"text": "Studies", "start": 213, "end": 220, "id": 41, "ws": true}, {"text": "(", "start": 221, "end": 222, "id": 42, "ws": false}, {"text": "14.2", "start": 222, "end": 226, "id": 43, "ws": false}, {"text": ")", "start": 226, "end": 227, "id": 44, "ws": false}, {"text": "]", "start": 227, "end": 228, "id": 45, "ws": true}, {"text": "or", "start": 229, "end": 231, "id": 46, "ws": true}, {"text": "liver", "start": 232, "end": 237, "id": 47, "ws": true}, {"text": "transplants", "start": 238, "end": 249, "id": 48, "ws": true}, {"text": "[", "start": 250, "end": 251, "id": 49, "ws": false}, {"text": "see", "start": 251, "end": 254, "id": 50, "ws": true}, {"text": "Clinical", "start": 255, "end": 263, "id": 51, "ws": true}, {"text": "Studies", "start": 264, "end": 271, "id": 52, "ws": true}, {"text": "(", "start": 272, "end": 273, "id": 53, "ws": false}, {"text": "14.3", "start": 273, "end": 277, "id": 54, "ws": false}, {"text": ")", "start": 277, "end": 278, "id": 55, "ws": false}, {"text": "]", "start": 278, "end": 279, "id": 56, "ws": true}, {"text": ",", "start": 280, "end": 281, "id": 57, "ws": true}, {"text": "in", "start": 282, "end": 284, "id": 58, "ws": true}, {"text": "combination", "start": 285, "end": 296, "id": 59, "ws": true}, {"text": "with", "start": 297, "end": 301, "id": 60, "ws": true}, {"text": "other", "start": 302, "end": 307, "id": 61, "ws": true}, {"text": "immunosuppressants", "start": 308, "end": 326, "id": 62, "ws": false}, {"text": ".", "start": 326, "end": 327, "id": 63, "ws": true}, {"text": "Mycophenolate", "start": 328, "end": 341, "id": 64, "ws": true}, {"text": "mofetil", "start": 342, "end": 349, "id": 65, "ws": true}, {"text": "is", "start": 350, "end": 352, "id": 66, "ws": true}, {"text": "an", "start": 353, "end": 355, "id": 67, "ws": true}, {"text": "antimetabolite", "start": 356, "end": 370, "id": 68, "ws": true}, {"text": "immunosuppressant", "start": 371, "end": 388, "id": 69, "ws": true}, {"text": "indicated", "start": 389, "end": 398, "id": 70, "ws": true}, {"text": "for", "start": 399, "end": 402, "id": 71, "ws": true}, {"text": "the", "start": 403, "end": 406, "id": 72, "ws": true}, {"text": "prophylaxis", "start": 407, "end": 418, "id": 73, "ws": true}, {"text": "of", "start": 419, "end": 421, "id": 74, "ws": true}, {"text": "organ", "start": 422, "end": 427, "id": 75, "ws": true}, {"text": "rejection", "start": 428, "end": 437, "id": 76, "ws": true}, {"text": "in", "start": 438, "end": 440, "id": 77, "ws": true}, {"text": "adult", "start": 441, "end": 446, "id": 78, "ws": true}, {"text": "and", "start": 447, "end": 450, "id": 79, "ws": true}, {"text": "pediatric", "start": 451, "end": 460, "id": 80, "ws": true}, {"text": "recipients", "start": 461, "end": 471, "id": 81, "ws": true}, {"text": "3", "start": 472, "end": 473, "id": 82, "ws": true}, {"text": "months", "start": 474, "end": 480, "id": 83, "ws": true}, {"text": "of", "start": 481, "end": 483, "id": 84, "ws": true}, {"text": "age", "start": 484, "end": 487, "id": 85, "ws": true}, {"text": "and", "start": 488, "end": 491, "id": 86, "ws": true}, {"text": "older", "start": 492, "end": 497, "id": 87, "ws": true}, {"text": "of", "start": 498, "end": 500, "id": 88, "ws": true}, {"text": "allogeneic", "start": 501, "end": 511, "id": 89, "ws": true}, {"text": "kidney", "start": 512, "end": 518, "id": 90, "ws": false}, {"text": ",", "start": 518, "end": 519, "id": 91, "ws": true}, {"text": "heart", "start": 520, "end": 525, "id": 92, "ws": true}, {"text": "or", "start": 526, "end": 528, "id": 93, "ws": true}, {"text": "liver", "start": 529, "end": 534, "id": 94, "ws": true}, {"text": "transplants", "start": 535, "end": 546, "id": 95, "ws": false}, {"text": ",", "start": 546, "end": 547, "id": 96, "ws": true}, {"text": "in", "start": 548, "end": 550, "id": 97, "ws": true}, {"text": "combination", "start": 551, "end": 562, "id": 98, "ws": true}, {"text": "with", "start": 563, "end": 567, "id": 99, "ws": true}, {"text": "other", "start": 568, "end": 573, "id": 100, "ws": true}, {"text": "immunosuppressants", "start": 574, "end": 592, "id": 101, "ws": false}, {"text": ".", "start": 592, "end": 593, "id": 102, "ws": true}, {"text": "(", "start": 594, "end": 595, "id": 103, "ws": true}, {"text": "1", "start": 596, "end": 597, "id": 104, "ws": false}, {"text": ")", "start": 597, "end": 598, "id": 105, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 21, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 49, "end": 60, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 64, "end": 79, "token_start": 11, "token_end": 12, "label": "INDICATION"}, {"start": 84, "end": 89, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 94, "end": 140, "token_start": 17, "token_end": 24, "label": "TARGET_GROUP"}, {"start": 144, "end": 161, "token_start": 26, "token_end": 27, "label": "BASECONDITION"}, {"start": 282, "end": 326, "token_start": 58, "token_end": 62, "label": "CO_PRESCRIPTION"}, {"start": 328, "end": 341, "token_start": 64, "token_end": 64, "label": "DRUG"}, {"start": 342, "end": 349, "token_start": 65, "token_end": 65, "label": "SALT"}, {"start": 356, "end": 388, "token_start": 68, "token_end": 69, "label": "MECHANISM"}, {"start": 407, "end": 418, "token_start": 73, "token_end": 73, "label": "ACTION"}, {"start": 422, "end": 437, "token_start": 75, "token_end": 76, "label": "INDICATION"}, {"start": 441, "end": 497, "token_start": 78, "token_end": 87, "label": "TARGET_GROUP"}, {"start": 501, "end": 518, "token_start": 89, "token_end": 90, "label": "BASECONDITION"}, {"start": 520, "end": 546, "token_start": 92, "token_end": 95, "label": "BASECONDITION"}, {"start": 548, "end": 592, "token_start": 97, "token_end": 101, "label": "CO_PRESCRIPTION"}], "answer": "accept", "_timestamp": 1694528382, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Megace  ES (megestrol acetate) oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).", "_input_hash": 572778724, "_task_hash": 2122029677, "_is_binary": false, "tokens": [{"text": "Megace", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": " ", "start": 7, "end": 8, "id": 1, "ws": false}, {"text": "ES", "start": 8, "end": 10, "id": 2, "ws": true}, {"text": "(", "start": 11, "end": 12, "id": 3, "ws": false}, {"text": "megestrol", "start": 12, "end": 21, "id": 4, "ws": true}, {"text": "acetate", "start": 22, "end": 29, "id": 5, "ws": false}, {"text": ")", "start": 29, "end": 30, "id": 6, "ws": true}, {"text": "oral", "start": 31, "end": 35, "id": 7, "ws": true}, {"text": "suspension", "start": 36, "end": 46, "id": 8, "ws": true}, {"text": "is", "start": 47, "end": 49, "id": 9, "ws": true}, {"text": "indicated", "start": 50, "end": 59, "id": 10, "ws": true}, {"text": "for", "start": 60, "end": 63, "id": 11, "ws": true}, {"text": "the", "start": 64, "end": 67, "id": 12, "ws": true}, {"text": "treatment", "start": 68, "end": 77, "id": 13, "ws": true}, {"text": "of", "start": 78, "end": 80, "id": 14, "ws": true}, {"text": "anorexia", "start": 81, "end": 89, "id": 15, "ws": false}, {"text": ",", "start": 89, "end": 90, "id": 16, "ws": true}, {"text": "cachexia", "start": 91, "end": 99, "id": 17, "ws": false}, {"text": ",", "start": 99, "end": 100, "id": 18, "ws": true}, {"text": "or", "start": 101, "end": 103, "id": 19, "ws": true}, {"text": "an", "start": 104, "end": 106, "id": 20, "ws": true}, {"text": "unexplained", "start": 107, "end": 118, "id": 21, "ws": false}, {"text": ",", "start": 118, "end": 119, "id": 22, "ws": true}, {"text": "significant", "start": 120, "end": 131, "id": 23, "ws": true}, {"text": "weight", "start": 132, "end": 138, "id": 24, "ws": true}, {"text": "loss", "start": 139, "end": 143, "id": 25, "ws": true}, {"text": "in", "start": 144, "end": 146, "id": 26, "ws": true}, {"text": "patients", "start": 147, "end": 155, "id": 27, "ws": true}, {"text": "with", "start": 156, "end": 160, "id": 28, "ws": true}, {"text": "a", "start": 161, "end": 162, "id": 29, "ws": true}, {"text": "diagnosis", "start": 163, "end": 172, "id": 30, "ws": true}, {"text": "of", "start": 173, "end": 175, "id": 31, "ws": true}, {"text": "acquired", "start": 176, "end": 184, "id": 32, "ws": true}, {"text": "immunodeficiency", "start": 185, "end": 201, "id": 33, "ws": true}, {"text": "syndrome", "start": 202, "end": 210, "id": 34, "ws": true}, {"text": "(", "start": 211, "end": 212, "id": 35, "ws": false}, {"text": "AIDS", "start": 212, "end": 216, "id": 36, "ws": false}, {"text": ")", "start": 216, "end": 217, "id": 37, "ws": false}, {"text": ".", "start": 217, "end": 218, "id": 38, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 31, "end": 35, "token_start": 7, "token_end": 7, "label": "ROUTE"}, {"start": 36, "end": 46, "token_start": 8, "token_end": 8, "label": "FORMULATION"}, {"start": 68, "end": 77, "token_start": 13, "token_end": 13, "label": "ACTION"}, {"start": 81, "end": 89, "token_start": 15, "token_end": 15, "label": "INDICATION"}, {"start": 91, "end": 99, "token_start": 17, "token_end": 17, "label": "INDICATION"}, {"start": 107, "end": 143, "token_start": 21, "token_end": 25, "label": "INDICATION"}, {"start": 176, "end": 216, "token_start": 32, "token_end": 36, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176272, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "DILT-XR [Diltiazem Hydrochloride Extended-Release Capsules, USP (Once-a-day dosage)] are indicated for the treatment of hypertension. Diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics. DILT-XR [Diltiazem Hydrochloride Extended-Release Capsules, USP (Once-a-day dosage)] are indicated for the management of chronic stable angina.", "_input_hash": 486906198, "_task_hash": -1965895933, "_is_binary": false, "tokens": [{"text": "DILT", "start": 0, "end": 4, "id": 0, "ws": false}, {"text": "-", "start": 4, "end": 5, "id": 1, "ws": false}, {"text": "XR", "start": 5, "end": 7, "id": 2, "ws": true}, {"text": "[", "start": 8, "end": 9, "id": 3, "ws": false}, {"text": "Diltiazem", "start": 9, "end": 18, "id": 4, "ws": true}, {"text": "Hydrochloride", "start": 19, "end": 32, "id": 5, "ws": true}, {"text": "Extended", "start": 33, "end": 41, "id": 6, "ws": false}, {"text": "-", "start": 41, "end": 42, "id": 7, "ws": false}, {"text": "Release", "start": 42, "end": 49, "id": 8, "ws": true}, {"text": "Capsules", "start": 50, "end": 58, "id": 9, "ws": false}, {"text": ",", "start": 58, "end": 59, "id": 10, "ws": true}, {"text": "USP", "start": 60, "end": 63, "id": 11, "ws": true}, {"text": "(", "start": 64, "end": 65, "id": 12, "ws": false}, {"text": "Once", "start": 65, "end": 69, "id": 13, "ws": false}, {"text": "-", "start": 69, "end": 70, "id": 14, "ws": false}, {"text": "a", "start": 70, "end": 71, "id": 15, "ws": false}, {"text": "-", "start": 71, "end": 72, "id": 16, "ws": false}, {"text": "day", "start": 72, "end": 75, "id": 17, "ws": true}, {"text": "dosage", "start": 76, "end": 82, "id": 18, "ws": false}, {"text": ")", "start": 82, "end": 83, "id": 19, "ws": false}, {"text": "]", "start": 83, "end": 84, "id": 20, "ws": true}, {"text": "are", "start": 85, "end": 88, "id": 21, "ws": true}, {"text": "indicated", "start": 89, "end": 98, "id": 22, "ws": true}, {"text": "for", "start": 99, "end": 102, "id": 23, "ws": true}, {"text": "the", "start": 103, "end": 106, "id": 24, "ws": true}, {"text": "treatment", "start": 107, "end": 116, "id": 25, "ws": true}, {"text": "of", "start": 117, "end": 119, "id": 26, "ws": true}, {"text": "hypertension", "start": 120, "end": 132, "id": 27, "ws": false}, {"text": ".", "start": 132, "end": 133, "id": 28, "ws": true}, {"text": "Diltiazem", "start": 134, "end": 143, "id": 29, "ws": true}, {"text": "hydrochloride", "start": 144, "end": 157, "id": 30, "ws": true}, {"text": "may", "start": 158, "end": 161, "id": 31, "ws": true}, {"text": "be", "start": 162, "end": 164, "id": 32, "ws": true}, {"text": "used", "start": 165, "end": 169, "id": 33, "ws": true}, {"text": "alone", "start": 170, "end": 175, "id": 34, "ws": true}, {"text": "or", "start": 176, "end": 178, "id": 35, "ws": true}, {"text": "in", "start": 179, "end": 181, "id": 36, "ws": true}, {"text": "combination", "start": 182, "end": 193, "id": 37, "ws": true}, {"text": "with", "start": 194, "end": 198, "id": 38, "ws": true}, {"text": "other", "start": 199, "end": 204, "id": 39, "ws": true}, {"text": "antihypertensive", "start": 205, "end": 221, "id": 40, "ws": true}, {"text": "medications", "start": 222, "end": 233, "id": 41, "ws": false}, {"text": ",", "start": 233, "end": 234, "id": 42, "ws": true}, {"text": "such", "start": 235, "end": 239, "id": 43, "ws": true}, {"text": "as", "start": 240, "end": 242, "id": 44, "ws": true}, {"text": "diuretics", "start": 243, "end": 252, "id": 45, "ws": false}, {"text": ".", "start": 252, "end": 253, "id": 46, "ws": true}, {"text": "DILT", "start": 254, "end": 258, "id": 47, "ws": false}, {"text": "-", "start": 258, "end": 259, "id": 48, "ws": false}, {"text": "XR", "start": 259, "end": 261, "id": 49, "ws": true}, {"text": "[", "start": 262, "end": 263, "id": 50, "ws": false}, {"text": "Diltiazem", "start": 263, "end": 272, "id": 51, "ws": true}, {"text": "Hydrochloride", "start": 273, "end": 286, "id": 52, "ws": true}, {"text": "Extended", "start": 287, "end": 295, "id": 53, "ws": false}, {"text": "-", "start": 295, "end": 296, "id": 54, "ws": false}, {"text": "Release", "start": 296, "end": 303, "id": 55, "ws": true}, {"text": "Capsules", "start": 304, "end": 312, "id": 56, "ws": false}, {"text": ",", "start": 312, "end": 313, "id": 57, "ws": true}, {"text": "USP", "start": 314, "end": 317, "id": 58, "ws": true}, {"text": "(", "start": 318, "end": 319, "id": 59, "ws": false}, {"text": "Once", "start": 319, "end": 323, "id": 60, "ws": false}, {"text": "-", "start": 323, "end": 324, "id": 61, "ws": false}, {"text": "a", "start": 324, "end": 325, "id": 62, "ws": false}, {"text": "-", "start": 325, "end": 326, "id": 63, "ws": false}, {"text": "day", "start": 326, "end": 329, "id": 64, "ws": true}, {"text": "dosage", "start": 330, "end": 336, "id": 65, "ws": false}, {"text": ")", "start": 336, "end": 337, "id": 66, "ws": false}, {"text": "]", "start": 337, "end": 338, "id": 67, "ws": true}, {"text": "are", "start": 339, "end": 342, "id": 68, "ws": true}, {"text": "indicated", "start": 343, "end": 352, "id": 69, "ws": true}, {"text": "for", "start": 353, "end": 356, "id": 70, "ws": true}, {"text": "the", "start": 357, "end": 360, "id": 71, "ws": true}, {"text": "management", "start": 361, "end": 371, "id": 72, "ws": true}, {"text": "of", "start": 372, "end": 374, "id": 73, "ws": true}, {"text": "chronic", "start": 375, "end": 382, "id": 74, "ws": true}, {"text": "stable", "start": 383, "end": 389, "id": 75, "ws": true}, {"text": "angina", "start": 390, "end": 396, "id": 76, "ws": false}, {"text": ".", "start": 396, "end": 397, "id": 77, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 2, "label": "DRUG"}, {"start": 9, "end": 18, "token_start": 4, "token_end": 4, "label": "DRUG"}, {"start": 19, "end": 32, "token_start": 5, "token_end": 5, "label": "SALT"}, {"start": 33, "end": 58, "token_start": 6, "token_end": 9, "label": "FORMULATION"}, {"start": 107, "end": 116, "token_start": 25, "token_end": 25, "label": "ACTION"}, {"start": 120, "end": 132, "token_start": 27, "token_end": 27, "label": "INDICATION"}, {"start": 263, "end": 272, "token_start": 51, "token_end": 51, "label": "DRUG"}, {"start": 273, "end": 286, "token_start": 52, "token_end": 52, "label": "SALT"}, {"start": 287, "end": 312, "token_start": 53, "token_end": 56, "label": "FORMULATION"}, {"start": 361, "end": 371, "token_start": 72, "token_end": 72, "label": "ACTION"}, {"start": 375, "end": 396, "token_start": 74, "token_end": 76, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694175422, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Diltiazem hydrochloride extended-release capsules, USP is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Diltiazem hydrochloride extended-release capsules, USP is indicated for the management of chronic stable angina and angina due to coronary artery spasm.", "_input_hash": 821572180, "_task_hash": 560113673, "_is_binary": false, "tokens": [{"text": "Diltiazem", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 10, "end": 23, "id": 1, "ws": true}, {"text": "extended", "start": 24, "end": 32, "id": 2, "ws": false}, {"text": "-", "start": 32, "end": 33, "id": 3, "ws": false}, {"text": "release", "start": 33, "end": 40, "id": 4, "ws": true}, {"text": "capsules", "start": 41, "end": 49, "id": 5, "ws": false}, {"text": ",", "start": 49, "end": 50, "id": 6, "ws": true}, {"text": "USP", "start": 51, "end": 54, "id": 7, "ws": true}, {"text": "is", "start": 55, "end": 57, "id": 8, "ws": true}, {"text": "indicated", "start": 58, "end": 67, "id": 9, "ws": true}, {"text": "for", "start": 68, "end": 71, "id": 10, "ws": true}, {"text": "the", "start": 72, "end": 75, "id": 11, "ws": true}, {"text": "treatment", "start": 76, "end": 85, "id": 12, "ws": true}, {"text": "of", "start": 86, "end": 88, "id": 13, "ws": true}, {"text": "hypertension", "start": 89, "end": 101, "id": 14, "ws": false}, {"text": ".", "start": 101, "end": 102, "id": 15, "ws": true}, {"text": "It", "start": 103, "end": 105, "id": 16, "ws": true}, {"text": "may", "start": 106, "end": 109, "id": 17, "ws": true}, {"text": "be", "start": 110, "end": 112, "id": 18, "ws": true}, {"text": "used", "start": 113, "end": 117, "id": 19, "ws": true}, {"text": "alone", "start": 118, "end": 123, "id": 20, "ws": true}, {"text": "or", "start": 124, "end": 126, "id": 21, "ws": true}, {"text": "in", "start": 127, "end": 129, "id": 22, "ws": true}, {"text": "combination", "start": 130, "end": 141, "id": 23, "ws": true}, {"text": "with", "start": 142, "end": 146, "id": 24, "ws": true}, {"text": "other", "start": 147, "end": 152, "id": 25, "ws": true}, {"text": "antihypertensive", "start": 153, "end": 169, "id": 26, "ws": true}, {"text": "medications", "start": 170, "end": 181, "id": 27, "ws": false}, {"text": ".", "start": 181, "end": 182, "id": 28, "ws": true}, {"text": "Diltiazem", "start": 183, "end": 192, "id": 29, "ws": true}, {"text": "hydrochloride", "start": 193, "end": 206, "id": 30, "ws": true}, {"text": "extended", "start": 207, "end": 215, "id": 31, "ws": false}, {"text": "-", "start": 215, "end": 216, "id": 32, "ws": false}, {"text": "release", "start": 216, "end": 223, "id": 33, "ws": true}, {"text": "capsules", "start": 224, "end": 232, "id": 34, "ws": false}, {"text": ",", "start": 232, "end": 233, "id": 35, "ws": true}, {"text": "USP", "start": 234, "end": 237, "id": 36, "ws": true}, {"text": "is", "start": 238, "end": 240, "id": 37, "ws": true}, {"text": "indicated", "start": 241, "end": 250, "id": 38, "ws": true}, {"text": "for", "start": 251, "end": 254, "id": 39, "ws": true}, {"text": "the", "start": 255, "end": 258, "id": 40, "ws": true}, {"text": "management", "start": 259, "end": 269, "id": 41, "ws": true}, {"text": "of", "start": 270, "end": 272, "id": 42, "ws": true}, {"text": "chronic", "start": 273, "end": 280, "id": 43, "ws": true}, {"text": "stable", "start": 281, "end": 287, "id": 44, "ws": true}, {"text": "angina", "start": 288, "end": 294, "id": 45, "ws": true}, {"text": "and", "start": 295, "end": 298, "id": 46, "ws": true}, {"text": "angina", "start": 299, "end": 305, "id": 47, "ws": true}, {"text": "due", "start": 306, "end": 309, "id": 48, "ws": true}, {"text": "to", "start": 310, "end": 312, "id": 49, "ws": true}, {"text": "coronary", "start": 313, "end": 321, "id": 50, "ws": true}, {"text": "artery", "start": 322, "end": 328, "id": 51, "ws": true}, {"text": "spasm", "start": 329, "end": 334, "id": 52, "ws": false}, {"text": ".", "start": 334, "end": 335, "id": 53, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 49, "token_start": 2, "token_end": 5, "label": "FORMULATION"}, {"start": 76, "end": 85, "token_start": 12, "token_end": 12, "label": "ACTION"}, {"start": 89, "end": 101, "token_start": 14, "token_end": 14, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694176442, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Etoposide capsules are indicated in the management of the following neoplasms: Small Cell Lung Cancer Etoposide capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.", "_input_hash": -1095769346, "_task_hash": -1288047242, "_is_binary": false, "tokens": [{"text": "Etoposide", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "capsules", "start": 10, "end": 18, "id": 1, "ws": true}, {"text": "are", "start": 19, "end": 22, "id": 2, "ws": true}, {"text": "indicated", "start": 23, "end": 32, "id": 3, "ws": true}, {"text": "in", "start": 33, "end": 35, "id": 4, "ws": true}, {"text": "the", "start": 36, "end": 39, "id": 5, "ws": true}, {"text": "management", "start": 40, "end": 50, "id": 6, "ws": true}, {"text": "of", "start": 51, "end": 53, "id": 7, "ws": true}, {"text": "the", "start": 54, "end": 57, "id": 8, "ws": true}, {"text": "following", "start": 58, "end": 67, "id": 9, "ws": true}, {"text": "neoplasms", "start": 68, "end": 77, "id": 10, "ws": false}, {"text": ":", "start": 77, "end": 78, "id": 11, "ws": true}, {"text": "Small", "start": 79, "end": 84, "id": 12, "ws": true}, {"text": "Cell", "start": 85, "end": 89, "id": 13, "ws": true}, {"text": "Lung", "start": 90, "end": 94, "id": 14, "ws": true}, {"text": "Cancer", "start": 95, "end": 101, "id": 15, "ws": true}, {"text": "Etoposide", "start": 102, "end": 111, "id": 16, "ws": true}, {"text": "capsules", "start": 112, "end": 120, "id": 17, "ws": true}, {"text": "in", "start": 121, "end": 123, "id": 18, "ws": true}, {"text": "combination", "start": 124, "end": 135, "id": 19, "ws": true}, {"text": "with", "start": 136, "end": 140, "id": 20, "ws": true}, {"text": "other", "start": 141, "end": 146, "id": 21, "ws": true}, {"text": "approved", "start": 147, "end": 155, "id": 22, "ws": true}, {"text": "chemotherapeutic", "start": 156, "end": 172, "id": 23, "ws": true}, {"text": "agents", "start": 173, "end": 179, "id": 24, "ws": true}, {"text": "as", "start": 180, "end": 182, "id": 25, "ws": true}, {"text": "first", "start": 183, "end": 188, "id": 26, "ws": true}, {"text": "line", "start": 189, "end": 193, "id": 27, "ws": true}, {"text": "treatment", "start": 194, "end": 203, "id": 28, "ws": true}, {"text": "in", "start": 204, "end": 206, "id": 29, "ws": true}, {"text": "patients", "start": 207, "end": 215, "id": 30, "ws": true}, {"text": "with", "start": 216, "end": 220, "id": 31, "ws": true}, {"text": "small", "start": 221, "end": 226, "id": 32, "ws": true}, {"text": "cell", "start": 227, "end": 231, "id": 33, "ws": true}, {"text": "lung", "start": 232, "end": 236, "id": 34, "ws": true}, {"text": "cancer", "start": 237, "end": 243, "id": 35, "ws": false}, {"text": ".", "start": 243, "end": 244, "id": 36, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 18, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 40, "end": 50, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 79, "end": 111, "token_start": 12, "token_end": 16, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694525572, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ZELAPAR is indicated as an adjunct in the management of patients with Parkinsons disease being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. There is no evidence from controlled studies that ZELAPAR has any beneficial effect in the absence of concurrent levodopa therapy [see Clinical Studies (14 ) ]. ZELAPAR, a monoamine oxidase type B (MAO-B) inhibitor, is indicated as an adjunct in the management of patients with Parkinsons disease being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy (1)", "_input_hash": 371118663, "_task_hash": 2026595592, "_is_binary": false, "tokens": [{"text": "ZELAPAR", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "as", "start": 21, "end": 23, "id": 3, "ws": true}, {"text": "an", "start": 24, "end": 26, "id": 4, "ws": true}, {"text": "adjunct", "start": 27, "end": 34, "id": 5, "ws": true}, {"text": "in", "start": 35, "end": 37, "id": 6, "ws": true}, {"text": "the", "start": 38, "end": 41, "id": 7, "ws": true}, {"text": "management", "start": 42, "end": 52, "id": 8, "ws": true}, {"text": "of", "start": 53, "end": 55, "id": 9, "ws": true}, {"text": "patients", "start": 56, "end": 64, "id": 10, "ws": true}, {"text": "with", "start": 65, "end": 69, "id": 11, "ws": true}, {"text": "Parkinsons", "start": 70, "end": 80, "id": 12, "ws": true}, {"text": "disease", "start": 81, "end": 88, "id": 13, "ws": true}, {"text": "being", "start": 89, "end": 94, "id": 14, "ws": true}, {"text": "treated", "start": 95, "end": 102, "id": 15, "ws": true}, {"text": "with", "start": 103, "end": 107, "id": 16, "ws": true}, {"text": "levodopa", "start": 108, "end": 116, "id": 17, "ws": false}, {"text": "/", "start": 116, "end": 117, "id": 18, "ws": false}, {"text": "carbidopa", "start": 117, "end": 126, "id": 19, "ws": true}, {"text": "who", "start": 127, "end": 130, "id": 20, "ws": true}, {"text": "exhibit", "start": 131, "end": 138, "id": 21, "ws": true}, {"text": "deterioration", "start": 139, "end": 152, "id": 22, "ws": true}, {"text": "in", "start": 153, "end": 155, "id": 23, "ws": true}, {"text": "the", "start": 156, "end": 159, "id": 24, "ws": true}, {"text": "quality", "start": 160, "end": 167, "id": 25, "ws": true}, {"text": "of", "start": 168, "end": 170, "id": 26, "ws": true}, {"text": "their", "start": 171, "end": 176, "id": 27, "ws": true}, {"text": "response", "start": 177, "end": 185, "id": 28, "ws": true}, {"text": "to", "start": 186, "end": 188, "id": 29, "ws": true}, {"text": "this", "start": 189, "end": 193, "id": 30, "ws": true}, {"text": "therapy", "start": 194, "end": 201, "id": 31, "ws": false}, {"text": ".", "start": 201, "end": 202, "id": 32, "ws": true}, {"text": "There", "start": 203, "end": 208, "id": 33, "ws": true}, {"text": "is", "start": 209, "end": 211, "id": 34, "ws": true}, {"text": "no", "start": 212, "end": 214, "id": 35, "ws": true}, {"text": "evidence", "start": 215, "end": 223, "id": 36, "ws": true}, {"text": "from", "start": 224, "end": 228, "id": 37, "ws": true}, {"text": "controlled", "start": 229, "end": 239, "id": 38, "ws": true}, {"text": "studies", "start": 240, "end": 247, "id": 39, "ws": true}, {"text": "that", "start": 248, "end": 252, "id": 40, "ws": true}, {"text": "ZELAPAR", "start": 253, "end": 260, "id": 41, "ws": true}, {"text": "has", "start": 261, "end": 264, "id": 42, "ws": true}, {"text": "any", "start": 265, "end": 268, "id": 43, "ws": true}, {"text": "beneficial", "start": 269, "end": 279, "id": 44, "ws": true}, {"text": "effect", "start": 280, "end": 286, "id": 45, "ws": true}, {"text": "in", "start": 287, "end": 289, "id": 46, "ws": true}, {"text": "the", "start": 290, "end": 293, "id": 47, "ws": true}, {"text": "absence", "start": 294, "end": 301, "id": 48, "ws": true}, {"text": "of", "start": 302, "end": 304, "id": 49, "ws": true}, {"text": "concurrent", "start": 305, "end": 315, "id": 50, "ws": true}, {"text": "levodopa", "start": 316, "end": 324, "id": 51, "ws": true}, {"text": "therapy", "start": 325, "end": 332, "id": 52, "ws": true}, {"text": "[", "start": 333, "end": 334, "id": 53, "ws": false}, {"text": "see", "start": 334, "end": 337, "id": 54, "ws": true}, {"text": "Clinical", "start": 338, "end": 346, "id": 55, "ws": true}, {"text": "Studies", "start": 347, "end": 354, "id": 56, "ws": true}, {"text": "(", "start": 355, "end": 356, "id": 57, "ws": false}, {"text": "14", "start": 356, "end": 358, "id": 58, "ws": true}, {"text": ")", "start": 359, "end": 360, "id": 59, "ws": true}, {"text": "]", "start": 361, "end": 362, "id": 60, "ws": false}, {"text": ".", "start": 362, "end": 363, "id": 61, "ws": true}, {"text": "ZELAPAR", "start": 364, "end": 371, "id": 62, "ws": false}, {"text": ",", "start": 371, "end": 372, "id": 63, "ws": true}, {"text": "a", "start": 373, "end": 374, "id": 64, "ws": true}, {"text": "monoamine", "start": 375, "end": 384, "id": 65, "ws": true}, {"text": "oxidase", "start": 385, "end": 392, "id": 66, "ws": true}, {"text": "type", "start": 393, "end": 397, "id": 67, "ws": true}, {"text": "B", "start": 398, "end": 399, "id": 68, "ws": true}, {"text": "(", "start": 400, "end": 401, "id": 69, "ws": false}, {"text": "MAO", "start": 401, "end": 404, "id": 70, "ws": false}, {"text": "-", "start": 404, "end": 405, "id": 71, "ws": false}, {"text": "B", "start": 405, "end": 406, "id": 72, "ws": false}, {"text": ")", "start": 406, "end": 407, "id": 73, "ws": true}, {"text": "inhibitor", "start": 408, "end": 417, "id": 74, "ws": false}, {"text": ",", "start": 417, "end": 418, "id": 75, "ws": true}, {"text": "is", "start": 419, "end": 421, "id": 76, "ws": true}, {"text": "indicated", "start": 422, "end": 431, "id": 77, "ws": true}, {"text": "as", "start": 432, "end": 434, "id": 78, "ws": true}, {"text": "an", "start": 435, "end": 437, "id": 79, "ws": true}, {"text": "adjunct", "start": 438, "end": 445, "id": 80, "ws": true}, {"text": "in", "start": 446, "end": 448, "id": 81, "ws": true}, {"text": "the", "start": 449, "end": 452, "id": 82, "ws": true}, {"text": "management", "start": 453, "end": 463, "id": 83, "ws": true}, {"text": "of", "start": 464, "end": 466, "id": 84, "ws": true}, {"text": "patients", "start": 467, "end": 475, "id": 85, "ws": true}, {"text": "with", "start": 476, "end": 480, "id": 86, "ws": true}, {"text": "Parkinsons", "start": 481, "end": 491, "id": 87, "ws": true}, {"text": "disease", "start": 492, "end": 499, "id": 88, "ws": true}, {"text": "being", "start": 500, "end": 505, "id": 89, "ws": true}, {"text": "treated", "start": 506, "end": 513, "id": 90, "ws": true}, {"text": "with", "start": 514, "end": 518, "id": 91, "ws": true}, {"text": "levodopa", "start": 519, "end": 527, "id": 92, "ws": false}, {"text": "/", "start": 527, "end": 528, "id": 93, "ws": false}, {"text": "carbidopa", "start": 528, "end": 537, "id": 94, "ws": true}, {"text": "who", "start": 538, "end": 541, "id": 95, "ws": true}, {"text": "exhibit", "start": 542, "end": 549, "id": 96, "ws": true}, {"text": "deterioration", "start": 550, "end": 563, "id": 97, "ws": true}, {"text": "in", "start": 564, "end": 566, "id": 98, "ws": true}, {"text": "the", "start": 567, "end": 570, "id": 99, "ws": true}, {"text": "quality", "start": 571, "end": 578, "id": 100, "ws": true}, {"text": "of", "start": 579, "end": 581, "id": 101, "ws": true}, {"text": "their", "start": 582, "end": 587, "id": 102, "ws": true}, {"text": "response", "start": 588, "end": 596, "id": 103, "ws": true}, {"text": "to", "start": 597, "end": 599, "id": 104, "ws": true}, {"text": "this", "start": 600, "end": 604, "id": 105, "ws": true}, {"text": "therapy", "start": 605, "end": 612, "id": 106, "ws": true}, {"text": "(", "start": 613, "end": 614, "id": 107, "ws": false}, {"text": "1", "start": 614, "end": 615, "id": 108, "ws": false}, {"text": ")", "start": 615, "end": 616, "id": 109, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 42, "end": 55, "token_start": 8, "token_end": 9, "label": "ACTION"}, {"start": 70, "end": 88, "token_start": 12, "token_end": 13, "label": "BASECONDITION"}, {"start": 108, "end": 126, "token_start": 17, "token_end": 19, "label": "CO_PRESCRIPTION"}, {"start": 139, "end": 201, "token_start": 22, "token_end": 31, "label": "SYMPTOM"}, {"start": 364, "end": 371, "token_start": 62, "token_end": 62, "label": "DRUG"}, {"start": 375, "end": 417, "token_start": 65, "token_end": 74, "label": "MECHANISM"}, {"start": 453, "end": 475, "token_start": 83, "token_end": 85, "label": "ACTION"}, {"start": 481, "end": 499, "token_start": 87, "token_end": 88, "label": "INDICATION"}, {"start": 519, "end": 537, "token_start": 92, "token_end": 94, "label": "CO_PRESCRIPTION"}, {"start": 550, "end": 612, "token_start": 97, "token_end": 106, "label": "SYMPTOM"}], "answer": "accept", "_timestamp": 1694174034, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "ZONISADE is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years and older. ZONISADE is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years of age and older (1).", "_input_hash": 1116276400, "_task_hash": 965873347, "_is_binary": false, "tokens": [{"text": "ZONISADE", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "as", "start": 22, "end": 24, "id": 3, "ws": true}, {"text": "adjunctive", "start": 25, "end": 35, "id": 4, "ws": true}, {"text": "therapy", "start": 36, "end": 43, "id": 5, "ws": true}, {"text": "for", "start": 44, "end": 47, "id": 6, "ws": true}, {"text": "the", "start": 48, "end": 51, "id": 7, "ws": true}, {"text": "treatment", "start": 52, "end": 61, "id": 8, "ws": true}, {"text": "of", "start": 62, "end": 64, "id": 9, "ws": true}, {"text": "partial", "start": 65, "end": 72, "id": 10, "ws": false}, {"text": "-", "start": 72, "end": 73, "id": 11, "ws": false}, {"text": "onset", "start": 73, "end": 78, "id": 12, "ws": true}, {"text": "seizures", "start": 79, "end": 87, "id": 13, "ws": true}, {"text": "in", "start": 88, "end": 90, "id": 14, "ws": true}, {"text": "adults", "start": 91, "end": 97, "id": 15, "ws": true}, {"text": "and", "start": 98, "end": 101, "id": 16, "ws": true}, {"text": "pediatric", "start": 102, "end": 111, "id": 17, "ws": true}, {"text": "patients", "start": 112, "end": 120, "id": 18, "ws": true}, {"text": "16", "start": 121, "end": 123, "id": 19, "ws": true}, {"text": "years", "start": 124, "end": 129, "id": 20, "ws": true}, {"text": "and", "start": 130, "end": 133, "id": 21, "ws": true}, {"text": "older", "start": 134, "end": 139, "id": 22, "ws": false}, {"text": ".", "start": 139, "end": 140, "id": 23, "ws": true}, {"text": "ZONISADE", "start": 141, "end": 149, "id": 24, "ws": true}, {"text": "is", "start": 150, "end": 152, "id": 25, "ws": true}, {"text": "indicated", "start": 153, "end": 162, "id": 26, "ws": true}, {"text": "as", "start": 163, "end": 165, "id": 27, "ws": true}, {"text": "adjunctive", "start": 166, "end": 176, "id": 28, "ws": true}, {"text": "therapy", "start": 177, "end": 184, "id": 29, "ws": true}, {"text": "for", "start": 185, "end": 188, "id": 30, "ws": true}, {"text": "the", "start": 189, "end": 192, "id": 31, "ws": true}, {"text": "treatment", "start": 193, "end": 202, "id": 32, "ws": true}, {"text": "of", "start": 203, "end": 205, "id": 33, "ws": true}, {"text": "partial", "start": 206, "end": 213, "id": 34, "ws": false}, {"text": "-", "start": 213, "end": 214, "id": 35, "ws": false}, {"text": "onset", "start": 214, "end": 219, "id": 36, "ws": true}, {"text": "seizures", "start": 220, "end": 228, "id": 37, "ws": true}, {"text": "in", "start": 229, "end": 231, "id": 38, "ws": true}, {"text": "adults", "start": 232, "end": 238, "id": 39, "ws": true}, {"text": "and", "start": 239, "end": 242, "id": 40, "ws": true}, {"text": "pediatric", "start": 243, "end": 252, "id": 41, "ws": true}, {"text": "patients", "start": 253, "end": 261, "id": 42, "ws": true}, {"text": "16", "start": 262, "end": 264, "id": 43, "ws": true}, {"text": "years", "start": 265, "end": 270, "id": 44, "ws": true}, {"text": "of", "start": 271, "end": 273, "id": 45, "ws": true}, {"text": "age", "start": 274, "end": 277, "id": 46, "ws": true}, {"text": "and", "start": 278, "end": 281, "id": 47, "ws": true}, {"text": "older", "start": 282, "end": 287, "id": 48, "ws": true}, {"text": "(", "start": 288, "end": 289, "id": 49, "ws": false}, {"text": "1", "start": 289, "end": 290, "id": 50, "ws": false}, {"text": ")", "start": 290, "end": 291, "id": 51, "ws": false}, {"text": ".", "start": 291, "end": 292, "id": 52, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 25, "end": 43, "token_start": 4, "token_end": 5, "label": "ACTION"}, {"start": 52, "end": 61, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 65, "end": 87, "token_start": 10, "token_end": 13, "label": "INDICATION"}, {"start": 91, "end": 97, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 102, "end": 139, "token_start": 17, "token_end": 22, "label": "TARGET_GROUP"}, {"start": 141, "end": 149, "token_start": 24, "token_end": 24, "label": "DRUG"}, {"start": 166, "end": 184, "token_start": 28, "token_end": 29, "label": "ACTION"}, {"start": 206, "end": 228, "token_start": 34, "token_end": 37, "label": "INDICATION"}, {"start": 232, "end": 238, "token_start": 39, "token_end": 39, "label": "TARGET_GROUP"}, {"start": 243, "end": 287, "token_start": 41, "token_end": 48, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694527193, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "RIOMET is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. RIOMET is a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. (1)", "_input_hash": 643597757, "_task_hash": 1863576281, "_is_binary": false, "tokens": [{"text": "RIOMET", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "as", "start": 20, "end": 22, "id": 3, "ws": true}, {"text": "an", "start": 23, "end": 25, "id": 4, "ws": true}, {"text": "adjunct", "start": 26, "end": 33, "id": 5, "ws": true}, {"text": "to", "start": 34, "end": 36, "id": 6, "ws": true}, {"text": "diet", "start": 37, "end": 41, "id": 7, "ws": true}, {"text": "and", "start": 42, "end": 45, "id": 8, "ws": true}, {"text": "exercise", "start": 46, "end": 54, "id": 9, "ws": true}, {"text": "to", "start": 55, "end": 57, "id": 10, "ws": true}, {"text": "improve", "start": 58, "end": 65, "id": 11, "ws": true}, {"text": "glycemic", "start": 66, "end": 74, "id": 12, "ws": true}, {"text": "control", "start": 75, "end": 82, "id": 13, "ws": true}, {"text": "in", "start": 83, "end": 85, "id": 14, "ws": true}, {"text": "adults", "start": 86, "end": 92, "id": 15, "ws": true}, {"text": "and", "start": 93, "end": 96, "id": 16, "ws": true}, {"text": "pediatric", "start": 97, "end": 106, "id": 17, "ws": true}, {"text": "patients", "start": 107, "end": 115, "id": 18, "ws": true}, {"text": "10", "start": 116, "end": 118, "id": 19, "ws": true}, {"text": "years", "start": 119, "end": 124, "id": 20, "ws": true}, {"text": "of", "start": 125, "end": 127, "id": 21, "ws": true}, {"text": "age", "start": 128, "end": 131, "id": 22, "ws": true}, {"text": "and", "start": 132, "end": 135, "id": 23, "ws": true}, {"text": "older", "start": 136, "end": 141, "id": 24, "ws": true}, {"text": "with", "start": 142, "end": 146, "id": 25, "ws": true}, {"text": "type", "start": 147, "end": 151, "id": 26, "ws": true}, {"text": "2", "start": 152, "end": 153, "id": 27, "ws": true}, {"text": "diabetes", "start": 154, "end": 162, "id": 28, "ws": true}, {"text": "mellitus", "start": 163, "end": 171, "id": 29, "ws": false}, {"text": ".", "start": 171, "end": 172, "id": 30, "ws": true}, {"text": "RIOMET", "start": 173, "end": 179, "id": 31, "ws": true}, {"text": "is", "start": 180, "end": 182, "id": 32, "ws": true}, {"text": "a", "start": 183, "end": 184, "id": 33, "ws": true}, {"text": "biguanide", "start": 185, "end": 194, "id": 34, "ws": true}, {"text": "indicated", "start": 195, "end": 204, "id": 35, "ws": true}, {"text": "as", "start": 205, "end": 207, "id": 36, "ws": true}, {"text": "an", "start": 208, "end": 210, "id": 37, "ws": true}, {"text": "adjunct", "start": 211, "end": 218, "id": 38, "ws": true}, {"text": "to", "start": 219, "end": 221, "id": 39, "ws": true}, {"text": "diet", "start": 222, "end": 226, "id": 40, "ws": true}, {"text": "and", "start": 227, "end": 230, "id": 41, "ws": true}, {"text": "exercise", "start": 231, "end": 239, "id": 42, "ws": true}, {"text": "to", "start": 240, "end": 242, "id": 43, "ws": true}, {"text": "improve", "start": 243, "end": 250, "id": 44, "ws": true}, {"text": "glycemic", "start": 251, "end": 259, "id": 45, "ws": true}, {"text": "control", "start": 260, "end": 267, "id": 46, "ws": true}, {"text": "in", "start": 268, "end": 270, "id": 47, "ws": true}, {"text": "adults", "start": 271, "end": 277, "id": 48, "ws": true}, {"text": "and", "start": 278, "end": 281, "id": 49, "ws": true}, {"text": "pediatric", "start": 282, "end": 291, "id": 50, "ws": true}, {"text": "patients", "start": 292, "end": 300, "id": 51, "ws": true}, {"text": "10", "start": 301, "end": 303, "id": 52, "ws": true}, {"text": "years", "start": 304, "end": 309, "id": 53, "ws": true}, {"text": "of", "start": 310, "end": 312, "id": 54, "ws": true}, {"text": "age", "start": 313, "end": 316, "id": 55, "ws": true}, {"text": "and", "start": 317, "end": 320, "id": 56, "ws": true}, {"text": "older", "start": 321, "end": 326, "id": 57, "ws": true}, {"text": "with", "start": 327, "end": 331, "id": 58, "ws": true}, {"text": "type", "start": 332, "end": 336, "id": 59, "ws": true}, {"text": "2", "start": 337, "end": 338, "id": 60, "ws": true}, {"text": "diabetes", "start": 339, "end": 347, "id": 61, "ws": true}, {"text": "mellitus", "start": 348, "end": 356, "id": 62, "ws": false}, {"text": ".", "start": 356, "end": 357, "id": 63, "ws": true}, {"text": "(", "start": 358, "end": 359, "id": 64, "ws": false}, {"text": "1", "start": 359, "end": 360, "id": 65, "ws": false}, {"text": ")", "start": 360, "end": 361, "id": 66, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 26, "end": 33, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 58, "end": 82, "token_start": 11, "token_end": 13, "label": "EFFECT"}, {"start": 86, "end": 92, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 97, "end": 141, "token_start": 17, "token_end": 24, "label": "TARGET_GROUP"}, {"start": 147, "end": 171, "token_start": 26, "token_end": 29, "label": "BASECONDITION"}, {"start": 173, "end": 179, "token_start": 31, "token_end": 31, "label": "DRUG"}, {"start": 195, "end": 204, "token_start": 35, "token_end": 35, "label": "MECHANISM"}, {"start": 211, "end": 218, "token_start": 38, "token_end": 38, "label": "ACTION"}, {"start": 243, "end": 267, "token_start": 44, "token_end": 46, "label": "EFFECT"}, {"start": 271, "end": 277, "token_start": 48, "token_end": 48, "label": "TARGET_GROUP"}, {"start": 282, "end": 326, "token_start": 50, "token_end": 57, "label": "TARGET_GROUP"}, {"start": 332, "end": 356, "token_start": 59, "token_end": 62, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526190, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "PRANDIN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.", "_input_hash": -931716443, "_task_hash": 49724451, "_is_binary": false, "tokens": [{"text": "PRANDIN", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "as", "start": 21, "end": 23, "id": 3, "ws": true}, {"text": "an", "start": 24, "end": 26, "id": 4, "ws": true}, {"text": "adjunct", "start": 27, "end": 34, "id": 5, "ws": true}, {"text": "to", "start": 35, "end": 37, "id": 6, "ws": true}, {"text": "diet", "start": 38, "end": 42, "id": 7, "ws": true}, {"text": "and", "start": 43, "end": 46, "id": 8, "ws": true}, {"text": "exercise", "start": 47, "end": 55, "id": 9, "ws": true}, {"text": "to", "start": 56, "end": 58, "id": 10, "ws": true}, {"text": "improve", "start": 59, "end": 66, "id": 11, "ws": true}, {"text": "glycemic", "start": 67, "end": 75, "id": 12, "ws": true}, {"text": "control", "start": 76, "end": 83, "id": 13, "ws": true}, {"text": "in", "start": 84, "end": 86, "id": 14, "ws": true}, {"text": "adults", "start": 87, "end": 93, "id": 15, "ws": true}, {"text": "with", "start": 94, "end": 98, "id": 16, "ws": true}, {"text": "type", "start": 99, "end": 103, "id": 17, "ws": true}, {"text": "2", "start": 104, "end": 105, "id": 18, "ws": true}, {"text": "diabetes", "start": 106, "end": 114, "id": 19, "ws": true}, {"text": "mellitus", "start": 115, "end": 123, "id": 20, "ws": false}, {"text": ".", "start": 123, "end": 124, "id": 21, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 24, "end": 37, "token_start": 4, "token_end": 6, "label": "ACTION"}, {"start": 59, "end": 83, "token_start": 11, "token_end": 13, "label": "EFFECT"}, {"start": 87, "end": 93, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 99, "end": 123, "token_start": 17, "token_end": 20, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694174805, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Cromolyn Sodium Ophthalmic Solution USP, 4% is indicated in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.", "_input_hash": 1415360390, "_task_hash": 1417777543, "_is_binary": false, "tokens": [{"text": "Cromolyn", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "Sodium", "start": 9, "end": 15, "id": 1, "ws": true}, {"text": "Ophthalmic", "start": 16, "end": 26, "id": 2, "ws": true}, {"text": "Solution", "start": 27, "end": 35, "id": 3, "ws": true}, {"text": "USP", "start": 36, "end": 39, "id": 4, "ws": false}, {"text": ",", "start": 39, "end": 40, "id": 5, "ws": true}, {"text": "4", "start": 41, "end": 42, "id": 6, "ws": false}, {"text": "%", "start": 42, "end": 43, "id": 7, "ws": true}, {"text": "is", "start": 44, "end": 46, "id": 8, "ws": true}, {"text": "indicated", "start": 47, "end": 56, "id": 9, "ws": true}, {"text": "in", "start": 57, "end": 59, "id": 10, "ws": true}, {"text": "the", "start": 60, "end": 63, "id": 11, "ws": true}, {"text": "treatment", "start": 64, "end": 73, "id": 12, "ws": true}, {"text": "of", "start": 74, "end": 76, "id": 13, "ws": true}, {"text": "vernal", "start": 77, "end": 83, "id": 14, "ws": true}, {"text": "keratoconjunctivitis", "start": 84, "end": 104, "id": 15, "ws": false}, {"text": ",", "start": 104, "end": 105, "id": 16, "ws": true}, {"text": "vernal", "start": 106, "end": 112, "id": 17, "ws": true}, {"text": "conjunctivitis", "start": 113, "end": 127, "id": 18, "ws": false}, {"text": ",", "start": 127, "end": 128, "id": 19, "ws": true}, {"text": "and", "start": 129, "end": 132, "id": 20, "ws": true}, {"text": "vernal", "start": 133, "end": 139, "id": 21, "ws": true}, {"text": "keratitis", "start": 140, "end": 149, "id": 22, "ws": false}, {"text": ".", "start": 149, "end": 150, "id": 23, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 15, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 16, "end": 26, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 27, "end": 35, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 64, "end": 73, "token_start": 12, "token_end": 12, "label": "ACTION"}, {"start": 77, "end": 104, "token_start": 14, "token_end": 15, "label": "INDICATION"}, {"start": 106, "end": 127, "token_start": 17, "token_end": 18, "label": "INDICATION"}, {"start": 133, "end": 149, "token_start": 21, "token_end": 22, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694177416, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "FLECTOR  is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions in adults and pediatric patients 6 years and older. FLECTOR is a nonsteroidal anti-inflammatory drug (NSAID) and is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions in adults and pediatric patients 6 years and older. ( 1)", "_input_hash": 941928205, "_task_hash": 1179009250, "_is_binary": false, "tokens": [{"text": "FLECTOR", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": " ", "start": 8, "end": 9, "id": 1, "ws": false}, {"text": "is", "start": 9, "end": 11, "id": 2, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 3, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 4, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 5, "ws": true}, {"text": "topical", "start": 30, "end": 37, "id": 6, "ws": true}, {"text": "treatment", "start": 38, "end": 47, "id": 7, "ws": true}, {"text": "of", "start": 48, "end": 50, "id": 8, "ws": true}, {"text": "acute", "start": 51, "end": 56, "id": 9, "ws": true}, {"text": "pain", "start": 57, "end": 61, "id": 10, "ws": true}, {"text": "due", "start": 62, "end": 65, "id": 11, "ws": true}, {"text": "to", "start": 66, "end": 68, "id": 12, "ws": true}, {"text": "minor", "start": 69, "end": 74, "id": 13, "ws": true}, {"text": "strains", "start": 75, "end": 82, "id": 14, "ws": false}, {"text": ",", "start": 82, "end": 83, "id": 15, "ws": true}, {"text": "sprains", "start": 84, "end": 91, "id": 16, "ws": false}, {"text": ",", "start": 91, "end": 92, "id": 17, "ws": true}, {"text": "and", "start": 93, "end": 96, "id": 18, "ws": true}, {"text": "contusions", "start": 97, "end": 107, "id": 19, "ws": true}, {"text": "in", "start": 108, "end": 110, "id": 20, "ws": true}, {"text": "adults", "start": 111, "end": 117, "id": 21, "ws": true}, {"text": "and", "start": 118, "end": 121, "id": 22, "ws": true}, {"text": "pediatric", "start": 122, "end": 131, "id": 23, "ws": true}, {"text": "patients", "start": 132, "end": 140, "id": 24, "ws": true}, {"text": "6", "start": 141, "end": 142, "id": 25, "ws": true}, {"text": "years", "start": 143, "end": 148, "id": 26, "ws": true}, {"text": "and", "start": 149, "end": 152, "id": 27, "ws": true}, {"text": "older", "start": 153, "end": 158, "id": 28, "ws": false}, {"text": ".", "start": 158, "end": 159, "id": 29, "ws": true}, {"text": "FLECTOR", "start": 160, "end": 167, "id": 30, "ws": true}, {"text": "is", "start": 168, "end": 170, "id": 31, "ws": true}, {"text": "a", "start": 171, "end": 172, "id": 32, "ws": true}, {"text": "nonsteroidal", "start": 173, "end": 185, "id": 33, "ws": true}, {"text": "anti", "start": 186, "end": 190, "id": 34, "ws": false}, {"text": "-", "start": 190, "end": 191, "id": 35, "ws": false}, {"text": "inflammatory", "start": 191, "end": 203, "id": 36, "ws": true}, {"text": "drug", "start": 204, "end": 208, "id": 37, "ws": true}, {"text": "(", "start": 209, "end": 210, "id": 38, "ws": false}, {"text": "NSAID", "start": 210, "end": 215, "id": 39, "ws": false}, {"text": ")", "start": 215, "end": 216, "id": 40, "ws": true}, {"text": "and", "start": 217, "end": 220, "id": 41, "ws": true}, {"text": "is", "start": 221, "end": 223, "id": 42, "ws": true}, {"text": "indicated", "start": 224, "end": 233, "id": 43, "ws": true}, {"text": "for", "start": 234, "end": 237, "id": 44, "ws": true}, {"text": "the", "start": 238, "end": 241, "id": 45, "ws": true}, {"text": "topical", "start": 242, "end": 249, "id": 46, "ws": true}, {"text": "treatment", "start": 250, "end": 259, "id": 47, "ws": true}, {"text": "of", "start": 260, "end": 262, "id": 48, "ws": true}, {"text": "acute", "start": 263, "end": 268, "id": 49, "ws": true}, {"text": "pain", "start": 269, "end": 273, "id": 50, "ws": true}, {"text": "due", "start": 274, "end": 277, "id": 51, "ws": true}, {"text": "to", "start": 278, "end": 280, "id": 52, "ws": true}, {"text": "minor", "start": 281, "end": 286, "id": 53, "ws": true}, {"text": "strains", "start": 287, "end": 294, "id": 54, "ws": false}, {"text": ",", "start": 294, "end": 295, "id": 55, "ws": true}, {"text": "sprains", "start": 296, "end": 303, "id": 56, "ws": false}, {"text": ",", "start": 303, "end": 304, "id": 57, "ws": true}, {"text": "and", "start": 305, "end": 308, "id": 58, "ws": true}, {"text": "contusions", "start": 309, "end": 319, "id": 59, "ws": true}, {"text": "in", "start": 320, "end": 322, "id": 60, "ws": true}, {"text": "adults", "start": 323, "end": 329, "id": 61, "ws": true}, {"text": "and", "start": 330, "end": 333, "id": 62, "ws": true}, {"text": "pediatric", "start": 334, "end": 343, "id": 63, "ws": true}, {"text": "patients", "start": 344, "end": 352, "id": 64, "ws": true}, {"text": "6", "start": 353, "end": 354, "id": 65, "ws": true}, {"text": "years", "start": 355, "end": 360, "id": 66, "ws": true}, {"text": "and", "start": 361, "end": 364, "id": 67, "ws": true}, {"text": "older", "start": 365, "end": 370, "id": 68, "ws": false}, {"text": ".", "start": 370, "end": 371, "id": 69, "ws": true}, {"text": "(", "start": 372, "end": 373, "id": 70, "ws": true}, {"text": "1", "start": 374, "end": 375, "id": 71, "ws": false}, {"text": ")", "start": 375, "end": 376, "id": 72, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 50, "token_start": 6, "token_end": 8, "label": "ACTION"}, {"start": 51, "end": 61, "token_start": 9, "token_end": 10, "label": "INDICATION"}, {"start": 69, "end": 82, "token_start": 13, "token_end": 14, "label": "BASECONDITION"}, {"start": 84, "end": 91, "token_start": 16, "token_end": 16, "label": "BASECONDITION"}, {"start": 97, "end": 107, "token_start": 19, "token_end": 19, "label": "BASECONDITION"}, {"start": 111, "end": 117, "token_start": 21, "token_end": 21, "label": "BASECONDITION"}, {"start": 122, "end": 158, "token_start": 23, "token_end": 28, "label": "BASECONDITION"}, {"start": 160, "end": 167, "token_start": 30, "token_end": 30, "label": "DRUG"}, {"start": 173, "end": 216, "token_start": 33, "token_end": 40, "label": "MECHANISM"}, {"start": 242, "end": 262, "token_start": 46, "token_end": 48, "label": "ACTION"}, {"start": 263, "end": 273, "token_start": 49, "token_end": 50, "label": "INDICATION"}, {"start": 281, "end": 294, "token_start": 53, "token_end": 54, "label": "BASECONDITION"}, {"start": 296, "end": 303, "token_start": 56, "token_end": 56, "label": "BASECONDITION"}, {"start": 309, "end": 319, "token_start": 59, "token_end": 59, "label": "BASECONDITION"}, {"start": 323, "end": 329, "token_start": 61, "token_end": 61, "label": "BASECONDITION"}, {"start": 334, "end": 370, "token_start": 63, "token_end": 68, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694174844, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "CINQAIR is indicated for the add-on maintenance treatment of patients with severe asthma aged 18 years and older with an eosinophilic phenotype [see Clinical Studies (14)]. Limitation of Use: CINQAIR is not indicated for treatment of other eosinophilic conditions. CINQAIR is not indicated for the relief of acute bronchospasm or status asthmaticus [see Warnings and Precautions (5.2)]. CINQAIR is an interleukin-5 antagonist monoclonal antibody (IgG4 kappa) indicated for add-on maintenance treatment of patients with severe asthma aged 18 years and older, and with an eosinophilic phenotype (1). Limitations of Use: CINQAIR is not indicated for: treatment of other eosinophilic conditions (1) relief of acute bronchospasm or status asthmaticus (1)", "_input_hash": 1132943116, "_task_hash": -2053495461, "_is_binary": false, "tokens": [{"text": "CINQAIR", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "add", "start": 29, "end": 32, "id": 5, "ws": false}, {"text": "-", "start": 32, "end": 33, "id": 6, "ws": false}, {"text": "on", "start": 33, "end": 35, "id": 7, "ws": true}, {"text": "maintenance", "start": 36, "end": 47, "id": 8, "ws": true}, {"text": "treatment", "start": 48, "end": 57, "id": 9, "ws": true}, {"text": "of", "start": 58, "end": 60, "id": 10, "ws": true}, {"text": "patients", "start": 61, "end": 69, "id": 11, "ws": true}, {"text": "with", "start": 70, "end": 74, "id": 12, "ws": true}, {"text": "severe", "start": 75, "end": 81, "id": 13, "ws": true}, {"text": "asthma", "start": 82, "end": 88, "id": 14, "ws": true}, {"text": "aged", "start": 89, "end": 93, "id": 15, "ws": true}, {"text": "18", "start": 94, "end": 96, "id": 16, "ws": true}, {"text": "years", "start": 97, "end": 102, "id": 17, "ws": true}, {"text": "and", "start": 103, "end": 106, "id": 18, "ws": true}, {"text": "older", "start": 107, "end": 112, "id": 19, "ws": true}, {"text": "with", "start": 113, "end": 117, "id": 20, "ws": true}, {"text": "an", "start": 118, "end": 120, "id": 21, "ws": true}, {"text": "eosinophilic", "start": 121, "end": 133, "id": 22, "ws": true}, {"text": "phenotype", "start": 134, "end": 143, "id": 23, "ws": true}, {"text": "[", "start": 144, "end": 145, "id": 24, "ws": false}, {"text": "see", "start": 145, "end": 148, "id": 25, "ws": true}, {"text": "Clinical", "start": 149, "end": 157, "id": 26, "ws": true}, {"text": "Studies", "start": 158, "end": 165, "id": 27, "ws": true}, {"text": "(", "start": 166, "end": 167, "id": 28, "ws": false}, {"text": "14", "start": 167, "end": 169, "id": 29, "ws": false}, {"text": ")", "start": 169, "end": 170, "id": 30, "ws": false}, {"text": "]", "start": 170, "end": 171, "id": 31, "ws": false}, {"text": ".", "start": 171, "end": 172, "id": 32, "ws": true}, {"text": "Limitation", "start": 173, "end": 183, "id": 33, "ws": true}, {"text": "of", "start": 184, "end": 186, "id": 34, "ws": true}, {"text": "Use", "start": 187, "end": 190, "id": 35, "ws": false}, {"text": ":", "start": 190, "end": 191, "id": 36, "ws": true}, {"text": "CINQAIR", "start": 192, "end": 199, "id": 37, "ws": true}, {"text": "is", "start": 200, "end": 202, "id": 38, "ws": true}, {"text": "not", "start": 203, "end": 206, "id": 39, "ws": true}, {"text": "indicated", "start": 207, "end": 216, "id": 40, "ws": true}, {"text": "for", "start": 217, "end": 220, "id": 41, "ws": true}, {"text": "treatment", "start": 221, "end": 230, "id": 42, "ws": true}, {"text": "of", "start": 231, "end": 233, "id": 43, "ws": true}, {"text": "other", "start": 234, "end": 239, "id": 44, "ws": true}, {"text": "eosinophilic", "start": 240, "end": 252, "id": 45, "ws": true}, {"text": "conditions", "start": 253, "end": 263, "id": 46, "ws": false}, {"text": ".", "start": 263, "end": 264, "id": 47, "ws": true}, {"text": "CINQAIR", "start": 265, "end": 272, "id": 48, "ws": true}, {"text": "is", "start": 273, "end": 275, "id": 49, "ws": true}, {"text": "not", "start": 276, "end": 279, "id": 50, "ws": true}, {"text": "indicated", "start": 280, "end": 289, "id": 51, "ws": true}, {"text": "for", "start": 290, "end": 293, "id": 52, "ws": true}, {"text": "the", "start": 294, "end": 297, "id": 53, "ws": true}, {"text": "relief", "start": 298, "end": 304, "id": 54, "ws": true}, {"text": "of", "start": 305, "end": 307, "id": 55, "ws": true}, {"text": "acute", "start": 308, "end": 313, "id": 56, "ws": true}, {"text": "bronchospasm", "start": 314, "end": 326, "id": 57, "ws": true}, {"text": "or", "start": 327, "end": 329, "id": 58, "ws": true}, {"text": "status", "start": 330, "end": 336, "id": 59, "ws": true}, {"text": "asthmaticus", "start": 337, "end": 348, "id": 60, "ws": true}, {"text": "[", "start": 349, "end": 350, "id": 61, "ws": false}, {"text": "see", "start": 350, "end": 353, "id": 62, "ws": true}, {"text": "Warnings", "start": 354, "end": 362, "id": 63, "ws": true}, {"text": "and", "start": 363, "end": 366, "id": 64, "ws": true}, {"text": "Precautions", "start": 367, "end": 378, "id": 65, "ws": true}, {"text": "(", "start": 379, "end": 380, "id": 66, "ws": false}, {"text": "5.2", "start": 380, "end": 383, "id": 67, "ws": false}, {"text": ")", "start": 383, "end": 384, "id": 68, "ws": false}, {"text": "]", "start": 384, "end": 385, "id": 69, "ws": false}, {"text": ".", "start": 385, "end": 386, "id": 70, "ws": true}, {"text": "CINQAIR", "start": 387, "end": 394, "id": 71, "ws": true}, {"text": "is", "start": 395, "end": 397, "id": 72, "ws": true}, {"text": "an", "start": 398, "end": 400, "id": 73, "ws": true}, {"text": "interleukin-5", "start": 401, "end": 414, "id": 74, "ws": true}, {"text": "antagonist", "start": 415, "end": 425, "id": 75, "ws": true}, {"text": "monoclonal", "start": 426, "end": 436, "id": 76, "ws": true}, {"text": "antibody", "start": 437, "end": 445, "id": 77, "ws": true}, {"text": "(", "start": 446, "end": 447, "id": 78, "ws": false}, {"text": "IgG4", "start": 447, "end": 451, "id": 79, "ws": true}, {"text": "kappa", "start": 452, "end": 457, "id": 80, "ws": false}, {"text": ")", "start": 457, "end": 458, "id": 81, "ws": true}, {"text": "indicated", "start": 459, "end": 468, "id": 82, "ws": true}, {"text": "for", "start": 469, "end": 472, "id": 83, "ws": true}, {"text": "add", "start": 473, "end": 476, "id": 84, "ws": false}, {"text": "-", "start": 476, "end": 477, "id": 85, "ws": false}, {"text": "on", "start": 477, "end": 479, "id": 86, "ws": true}, {"text": "maintenance", "start": 480, "end": 491, "id": 87, "ws": true}, {"text": "treatment", "start": 492, "end": 501, "id": 88, "ws": true}, {"text": "of", "start": 502, "end": 504, "id": 89, "ws": true}, {"text": "patients", "start": 505, "end": 513, "id": 90, "ws": true}, {"text": "with", "start": 514, "end": 518, "id": 91, "ws": true}, {"text": "severe", "start": 519, "end": 525, "id": 92, "ws": true}, {"text": "asthma", "start": 526, "end": 532, "id": 93, "ws": true}, {"text": "aged", "start": 533, "end": 537, "id": 94, "ws": true}, {"text": "18", "start": 538, "end": 540, "id": 95, "ws": true}, {"text": "years", "start": 541, "end": 546, "id": 96, "ws": true}, {"text": "and", "start": 547, "end": 550, "id": 97, "ws": true}, {"text": "older", "start": 551, "end": 556, "id": 98, "ws": false}, {"text": ",", "start": 556, "end": 557, "id": 99, "ws": true}, {"text": "and", "start": 558, "end": 561, "id": 100, "ws": true}, {"text": "with", "start": 562, "end": 566, "id": 101, "ws": true}, {"text": "an", "start": 567, "end": 569, "id": 102, "ws": true}, {"text": "eosinophilic", "start": 570, "end": 582, "id": 103, "ws": true}, {"text": "phenotype", "start": 583, "end": 592, "id": 104, "ws": true}, {"text": "(", "start": 593, "end": 594, "id": 105, "ws": false}, {"text": "1", "start": 594, "end": 595, "id": 106, "ws": false}, {"text": ")", "start": 595, "end": 596, "id": 107, "ws": false}, {"text": ".", "start": 596, "end": 597, "id": 108, "ws": true}, {"text": "Limitations", "start": 598, "end": 609, "id": 109, "ws": true}, {"text": "of", "start": 610, "end": 612, "id": 110, "ws": true}, {"text": "Use", "start": 613, "end": 616, "id": 111, "ws": false}, {"text": ":", "start": 616, "end": 617, "id": 112, "ws": true}, {"text": "CINQAIR", "start": 618, "end": 625, "id": 113, "ws": true}, {"text": "is", "start": 626, "end": 628, "id": 114, "ws": true}, {"text": "not", "start": 629, "end": 632, "id": 115, "ws": true}, {"text": "indicated", "start": 633, "end": 642, "id": 116, "ws": true}, {"text": "for", "start": 643, "end": 646, "id": 117, "ws": false}, {"text": ":", "start": 646, "end": 647, "id": 118, "ws": true}, {"text": "treatment", "start": 648, "end": 657, "id": 119, "ws": true}, {"text": "of", "start": 658, "end": 660, "id": 120, "ws": true}, {"text": "other", "start": 661, "end": 666, "id": 121, "ws": true}, {"text": "eosinophilic", "start": 667, "end": 679, "id": 122, "ws": true}, {"text": "conditions", "start": 680, "end": 690, "id": 123, "ws": true}, {"text": "(", "start": 691, "end": 692, "id": 124, "ws": false}, {"text": "1", "start": 692, "end": 693, "id": 125, "ws": false}, {"text": ")", "start": 693, "end": 694, "id": 126, "ws": true}, {"text": "relief", "start": 695, "end": 701, "id": 127, "ws": true}, {"text": "of", "start": 702, "end": 704, "id": 128, "ws": true}, {"text": "acute", "start": 705, "end": 710, "id": 129, "ws": true}, {"text": "bronchospasm", "start": 711, "end": 723, "id": 130, "ws": true}, {"text": "or", "start": 724, "end": 726, "id": 131, "ws": true}, {"text": "status", "start": 727, "end": 733, "id": 132, "ws": true}, {"text": "asthmaticus", "start": 734, "end": 745, "id": 133, "ws": true}, {"text": "(", "start": 746, "end": 747, "id": 134, "ws": false}, {"text": "1", "start": 747, "end": 748, "id": 135, "ws": false}, {"text": ")", "start": 748, "end": 749, "id": 136, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 36, "end": 57, "token_start": 8, "token_end": 9, "label": "ACTION"}, {"start": 75, "end": 81, "token_start": 13, "token_end": 13, "label": "SEVERITY"}, {"start": 82, "end": 88, "token_start": 14, "token_end": 14, "label": "INDICATION"}, {"start": 89, "end": 112, "token_start": 15, "token_end": 19, "label": "TARGET_GROUP"}, {"start": 121, "end": 143, "token_start": 22, "token_end": 23, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526964, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.", "_input_hash": -2112397338, "_task_hash": -595408257, "_is_binary": false, "tokens": [{"text": "Intravenous", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "solutions", "start": 12, "end": 21, "id": 1, "ws": true}, {"text": "containing", "start": 22, "end": 32, "id": 2, "ws": true}, {"text": "sodium", "start": 33, "end": 39, "id": 3, "ws": true}, {"text": "chloride", "start": 40, "end": 48, "id": 4, "ws": true}, {"text": "are", "start": 49, "end": 52, "id": 5, "ws": true}, {"text": "indicated", "start": 53, "end": 62, "id": 6, "ws": true}, {"text": "for", "start": 63, "end": 66, "id": 7, "ws": true}, {"text": "parenteral", "start": 67, "end": 77, "id": 8, "ws": true}, {"text": "replenishment", "start": 78, "end": 91, "id": 9, "ws": true}, {"text": "of", "start": 92, "end": 94, "id": 10, "ws": true}, {"text": "fluid", "start": 95, "end": 100, "id": 11, "ws": true}, {"text": "and", "start": 101, "end": 104, "id": 12, "ws": true}, {"text": "sodium", "start": 105, "end": 111, "id": 13, "ws": true}, {"text": "chloride", "start": 112, "end": 120, "id": 14, "ws": true}, {"text": "as", "start": 121, "end": 123, "id": 15, "ws": true}, {"text": "required", "start": 124, "end": 132, "id": 16, "ws": true}, {"text": "by", "start": 133, "end": 135, "id": 17, "ws": true}, {"text": "the", "start": 136, "end": 139, "id": 18, "ws": true}, {"text": "clinical", "start": 140, "end": 148, "id": 19, "ws": true}, {"text": "condition", "start": 149, "end": 158, "id": 20, "ws": true}, {"text": "of", "start": 159, "end": 161, "id": 21, "ws": true}, {"text": "the", "start": 162, "end": 165, "id": 22, "ws": true}, {"text": "patient", "start": 166, "end": 173, "id": 23, "ws": false}, {"text": ".", "start": 173, "end": 174, "id": 24, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "ROUTE"}, {"start": 12, "end": 21, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 33, "end": 48, "token_start": 3, "token_end": 4, "label": "DRUG"}, {"start": 67, "end": 120, "token_start": 8, "token_end": 14, "label": "EFFECT"}], "answer": "accept", "_timestamp": 1694525268, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients.", "_input_hash": 1363722734, "_task_hash": -597880316, "_is_binary": false, "tokens": [{"text": "Mepivacaine", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "is", "start": 12, "end": 14, "id": 1, "ws": true}, {"text": "indicated", "start": 15, "end": 24, "id": 2, "ws": true}, {"text": "for", "start": 25, "end": 28, "id": 3, "ws": true}, {"text": "production", "start": 29, "end": 39, "id": 4, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 5, "ws": true}, {"text": "local", "start": 43, "end": 48, "id": 6, "ws": true}, {"text": "anesthesia", "start": 49, "end": 59, "id": 7, "ws": true}, {"text": "for", "start": 60, "end": 63, "id": 8, "ws": true}, {"text": "dental", "start": 64, "end": 70, "id": 9, "ws": true}, {"text": "procedures", "start": 71, "end": 81, "id": 10, "ws": true}, {"text": "by", "start": 82, "end": 84, "id": 11, "ws": true}, {"text": "infiltration", "start": 85, "end": 97, "id": 12, "ws": true}, {"text": "or", "start": 98, "end": 100, "id": 13, "ws": true}, {"text": "nerve", "start": 101, "end": 106, "id": 14, "ws": true}, {"text": "block", "start": 107, "end": 112, "id": 15, "ws": true}, {"text": "in", "start": 113, "end": 115, "id": 16, "ws": true}, {"text": "adults", "start": 116, "end": 122, "id": 17, "ws": true}, {"text": "and", "start": 123, "end": 126, "id": 18, "ws": true}, {"text": "pediatric", "start": 127, "end": 136, "id": 19, "ws": true}, {"text": "patients", "start": 137, "end": 145, "id": 20, "ws": false}, {"text": ".", "start": 145, "end": 146, "id": 21, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 39, "token_start": 4, "token_end": 4, "label": "ACTION"}, {"start": 43, "end": 59, "token_start": 6, "token_end": 7, "label": "EFFECT"}, {"start": 64, "end": 81, "token_start": 9, "token_end": 10, "label": "MEDICAL_CTX"}, {"start": 85, "end": 112, "token_start": 12, "token_end": 15, "label": "MECHANISM"}, {"start": 116, "end": 122, "token_start": 17, "token_end": 17, "label": "TARGET_GROUP"}, {"start": 127, "end": 145, "token_start": 19, "token_end": 20, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694525801, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Nalmefene hydrochloride injection is indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids. Nalmefene hydrochloride injection is indicated in the management of known or suspected opioid overdose.", "_input_hash": 1115061435, "_task_hash": -1773605440, "_is_binary": false, "tokens": [{"text": "Nalmefene", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 10, "end": 23, "id": 1, "ws": true}, {"text": "injection", "start": 24, "end": 33, "id": 2, "ws": true}, {"text": "is", "start": 34, "end": 36, "id": 3, "ws": true}, {"text": "indicated", "start": 37, "end": 46, "id": 4, "ws": true}, {"text": "for", "start": 47, "end": 50, "id": 5, "ws": true}, {"text": "the", "start": 51, "end": 54, "id": 6, "ws": true}, {"text": "complete", "start": 55, "end": 63, "id": 7, "ws": true}, {"text": "or", "start": 64, "end": 66, "id": 8, "ws": true}, {"text": "partial", "start": 67, "end": 74, "id": 9, "ws": true}, {"text": "reversal", "start": 75, "end": 83, "id": 10, "ws": true}, {"text": "of", "start": 84, "end": 86, "id": 11, "ws": true}, {"text": "opioid", "start": 87, "end": 93, "id": 12, "ws": true}, {"text": "drug", "start": 94, "end": 98, "id": 13, "ws": true}, {"text": "effects", "start": 99, "end": 106, "id": 14, "ws": false}, {"text": ",", "start": 106, "end": 107, "id": 15, "ws": true}, {"text": "including", "start": 108, "end": 117, "id": 16, "ws": true}, {"text": "respiratory", "start": 118, "end": 129, "id": 17, "ws": true}, {"text": "depression", "start": 130, "end": 140, "id": 18, "ws": false}, {"text": ",", "start": 140, "end": 141, "id": 19, "ws": true}, {"text": "induced", "start": 142, "end": 149, "id": 20, "ws": true}, {"text": "by", "start": 150, "end": 152, "id": 21, "ws": true}, {"text": "either", "start": 153, "end": 159, "id": 22, "ws": true}, {"text": "natural", "start": 160, "end": 167, "id": 23, "ws": true}, {"text": "or", "start": 168, "end": 170, "id": 24, "ws": true}, {"text": "synthetic", "start": 171, "end": 180, "id": 25, "ws": true}, {"text": "opioids", "start": 181, "end": 188, "id": 26, "ws": false}, {"text": ".", "start": 188, "end": 189, "id": 27, "ws": true}, {"text": "Nalmefene", "start": 190, "end": 199, "id": 28, "ws": true}, {"text": "hydrochloride", "start": 200, "end": 213, "id": 29, "ws": true}, {"text": "injection", "start": 214, "end": 223, "id": 30, "ws": true}, {"text": "is", "start": 224, "end": 226, "id": 31, "ws": true}, {"text": "indicated", "start": 227, "end": 236, "id": 32, "ws": true}, {"text": "in", "start": 237, "end": 239, "id": 33, "ws": true}, {"text": "the", "start": 240, "end": 243, "id": 34, "ws": true}, {"text": "management", "start": 244, "end": 254, "id": 35, "ws": true}, {"text": "of", "start": 255, "end": 257, "id": 36, "ws": true}, {"text": "known", "start": 258, "end": 263, "id": 37, "ws": true}, {"text": "or", "start": 264, "end": 266, "id": 38, "ws": true}, {"text": "suspected", "start": 267, "end": 276, "id": 39, "ws": true}, {"text": "opioid", "start": 277, "end": 283, "id": 40, "ws": true}, {"text": "overdose", "start": 284, "end": 292, "id": 41, "ws": false}, {"text": ".", "start": 292, "end": 293, "id": 42, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 10, "end": 23, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 24, "end": 33, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 75, "end": 86, "token_start": 10, "token_end": 11, "label": "ACTION"}, {"start": 87, "end": 106, "token_start": 12, "token_end": 14, "label": "INDICATION"}, {"start": 118, "end": 140, "token_start": 17, "token_end": 18, "label": "INDICATION"}, {"start": 142, "end": 188, "token_start": 20, "token_end": 26, "label": "CAUSED_BY"}, {"start": 190, "end": 199, "token_start": 28, "token_end": 28, "label": "DRUG"}, {"start": 200, "end": 213, "token_start": 29, "token_end": 29, "label": "SALT"}, {"start": 214, "end": 223, "token_start": 30, "token_end": 30, "label": "ROUTE"}, {"start": 244, "end": 257, "token_start": 35, "token_end": 36, "label": "ACTION"}, {"start": 277, "end": 292, "token_start": 40, "token_end": 41, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694174161, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Hypertension Acebutolol hydrochloride capsules, USP are indicated for the management of hypertension in adults. It may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. Ventricular Arrhythmias Acebutolol hydrochloride capsules, USP are indicated in the management of ventricular premature beats; it reduces the total number of premature beats, as well as the number of paired and multiform ventricular ectopic beats, and R-on-T beats.", "_input_hash": -1233102880, "_task_hash": 882404839, "_is_binary": false, "tokens": [{"text": "Hypertension", "start": 0, "end": 12, "id": 0, "ws": true}, {"text": "Acebutolol", "start": 13, "end": 23, "id": 1, "ws": true}, {"text": "hydrochloride", "start": 24, "end": 37, "id": 2, "ws": true}, {"text": "capsules", "start": 38, "end": 46, "id": 3, "ws": false}, {"text": ",", "start": 46, "end": 47, "id": 4, "ws": true}, {"text": "USP", "start": 48, "end": 51, "id": 5, "ws": true}, {"text": "are", "start": 52, "end": 55, "id": 6, "ws": true}, {"text": "indicated", "start": 56, "end": 65, "id": 7, "ws": true}, {"text": "for", "start": 66, "end": 69, "id": 8, "ws": true}, {"text": "the", "start": 70, "end": 73, "id": 9, "ws": true}, {"text": "management", "start": 74, "end": 84, "id": 10, "ws": true}, {"text": "of", "start": 85, "end": 87, "id": 11, "ws": true}, {"text": "hypertension", "start": 88, "end": 100, "id": 12, "ws": true}, {"text": "in", "start": 101, "end": 103, "id": 13, "ws": true}, {"text": "adults", "start": 104, "end": 110, "id": 14, "ws": false}, {"text": ".", "start": 110, "end": 111, "id": 15, "ws": true}, {"text": "It", "start": 112, "end": 114, "id": 16, "ws": true}, {"text": "may", "start": 115, "end": 118, "id": 17, "ws": true}, {"text": "be", "start": 119, "end": 121, "id": 18, "ws": true}, {"text": "used", "start": 122, "end": 126, "id": 19, "ws": true}, {"text": "alone", "start": 127, "end": 132, "id": 20, "ws": true}, {"text": "or", "start": 133, "end": 135, "id": 21, "ws": true}, {"text": "in", "start": 136, "end": 138, "id": 22, "ws": true}, {"text": "combination", "start": 139, "end": 150, "id": 23, "ws": true}, {"text": "with", "start": 151, "end": 155, "id": 24, "ws": true}, {"text": "other", "start": 156, "end": 161, "id": 25, "ws": true}, {"text": "antihypertensive", "start": 162, "end": 178, "id": 26, "ws": true}, {"text": "agents", "start": 179, "end": 185, "id": 27, "ws": false}, {"text": ",", "start": 185, "end": 186, "id": 28, "ws": true}, {"text": "especially", "start": 187, "end": 197, "id": 29, "ws": true}, {"text": "thiazide", "start": 198, "end": 206, "id": 30, "ws": false}, {"text": "-", "start": 206, "end": 207, "id": 31, "ws": false}, {"text": "type", "start": 207, "end": 211, "id": 32, "ws": true}, {"text": "diuretics", "start": 212, "end": 221, "id": 33, "ws": false}, {"text": ".", "start": 221, "end": 222, "id": 34, "ws": true}, {"text": "Ventricular", "start": 223, "end": 234, "id": 35, "ws": true}, {"text": "Arrhythmias", "start": 235, "end": 246, "id": 36, "ws": true}, {"text": "Acebutolol", "start": 247, "end": 257, "id": 37, "ws": true}, {"text": "hydrochloride", "start": 258, "end": 271, "id": 38, "ws": true}, {"text": "capsules", "start": 272, "end": 280, "id": 39, "ws": false}, {"text": ",", "start": 280, "end": 281, "id": 40, "ws": true}, {"text": "USP", "start": 282, "end": 285, "id": 41, "ws": true}, {"text": "are", "start": 286, "end": 289, "id": 42, "ws": true}, {"text": "indicated", "start": 290, "end": 299, "id": 43, "ws": true}, {"text": "in", "start": 300, "end": 302, "id": 44, "ws": true}, {"text": "the", "start": 303, "end": 306, "id": 45, "ws": true}, {"text": "management", "start": 307, "end": 317, "id": 46, "ws": true}, {"text": "of", "start": 318, "end": 320, "id": 47, "ws": true}, {"text": "ventricular", "start": 321, "end": 332, "id": 48, "ws": true}, {"text": "premature", "start": 333, "end": 342, "id": 49, "ws": true}, {"text": "beats", "start": 343, "end": 348, "id": 50, "ws": false}, {"text": ";", "start": 348, "end": 349, "id": 51, "ws": true}, {"text": "it", "start": 350, "end": 352, "id": 52, "ws": true}, {"text": "reduces", "start": 353, "end": 360, "id": 53, "ws": true}, {"text": "the", "start": 361, "end": 364, "id": 54, "ws": true}, {"text": "total", "start": 365, "end": 370, "id": 55, "ws": true}, {"text": "number", "start": 371, "end": 377, "id": 56, "ws": true}, {"text": "of", "start": 378, "end": 380, "id": 57, "ws": true}, {"text": "premature", "start": 381, "end": 390, "id": 58, "ws": true}, {"text": "beats", "start": 391, "end": 396, "id": 59, "ws": false}, {"text": ",", "start": 396, "end": 397, "id": 60, "ws": true}, {"text": "as", "start": 398, "end": 400, "id": 61, "ws": true}, {"text": "well", "start": 401, "end": 405, "id": 62, "ws": true}, {"text": "as", "start": 406, "end": 408, "id": 63, "ws": true}, {"text": "the", "start": 409, "end": 412, "id": 64, "ws": true}, {"text": "number", "start": 413, "end": 419, "id": 65, "ws": true}, {"text": "of", "start": 420, "end": 422, "id": 66, "ws": true}, {"text": "paired", "start": 423, "end": 429, "id": 67, "ws": true}, {"text": "and", "start": 430, "end": 433, "id": 68, "ws": true}, {"text": "multiform", "start": 434, "end": 443, "id": 69, "ws": true}, {"text": "ventricular", "start": 444, "end": 455, "id": 70, "ws": true}, {"text": "ectopic", "start": 456, "end": 463, "id": 71, "ws": true}, {"text": "beats", "start": 464, "end": 469, "id": 72, "ws": false}, {"text": ",", "start": 469, "end": 470, "id": 73, "ws": true}, {"text": "and", "start": 471, "end": 474, "id": 74, "ws": true}, {"text": "R", "start": 475, "end": 476, "id": 75, "ws": false}, {"text": "-", "start": 476, "end": 477, "id": 76, "ws": false}, {"text": "on", "start": 477, "end": 479, "id": 77, "ws": false}, {"text": "-", "start": 479, "end": 480, "id": 78, "ws": false}, {"text": "T", "start": 480, "end": 481, "id": 79, "ws": true}, {"text": "beats", "start": 482, "end": 487, "id": 80, "ws": false}, {"text": ".", "start": 487, "end": 488, "id": 81, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 13, "end": 23, "token_start": 1, "token_end": 1, "label": "DRUG"}, {"start": 24, "end": 37, "token_start": 2, "token_end": 2, "label": "SALT"}, {"start": 38, "end": 46, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 74, "end": 84, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 88, "end": 100, "token_start": 12, "token_end": 12, "label": "INDICATION"}, {"start": 104, "end": 110, "token_start": 14, "token_end": 14, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694177356, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "VARITHENA (polidocanol injectable foam) is indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein (GSV) system above and below the knee. VARITHENA improves the symptoms of superficial venous incompetence and the appearance of visible varicosities. VARITHENA (polidocanol injectable foam) is a sclerosing agent indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein (GSV) system above and below the knee. VARITHENA improves the symptoms of superficial venous incompetence and the appearance of visible varicosities. (1).", "_input_hash": -211526310, "_task_hash": -1740453966, "_is_binary": false, "tokens": [{"text": "VARITHENA", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "(", "start": 10, "end": 11, "id": 1, "ws": false}, {"text": "polidocanol", "start": 11, "end": 22, "id": 2, "ws": true}, {"text": "injectable", "start": 23, "end": 33, "id": 3, "ws": true}, {"text": "foam", "start": 34, "end": 38, "id": 4, "ws": false}, {"text": ")", "start": 38, "end": 39, "id": 5, "ws": true}, {"text": "is", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "indicated", "start": 43, "end": 52, "id": 7, "ws": true}, {"text": "for", "start": 53, "end": 56, "id": 8, "ws": true}, {"text": "the", "start": 57, "end": 60, "id": 9, "ws": true}, {"text": "treatment", "start": 61, "end": 70, "id": 10, "ws": true}, {"text": "of", "start": 71, "end": 73, "id": 11, "ws": true}, {"text": "incompetent", "start": 74, "end": 85, "id": 12, "ws": true}, {"text": "great", "start": 86, "end": 91, "id": 13, "ws": true}, {"text": "saphenous", "start": 92, "end": 101, "id": 14, "ws": true}, {"text": "veins", "start": 102, "end": 107, "id": 15, "ws": false}, {"text": ",", "start": 107, "end": 108, "id": 16, "ws": true}, {"text": "accessory", "start": 109, "end": 118, "id": 17, "ws": true}, {"text": "saphenous", "start": 119, "end": 128, "id": 18, "ws": true}, {"text": "veins", "start": 129, "end": 134, "id": 19, "ws": false}, {"text": ",", "start": 134, "end": 135, "id": 20, "ws": true}, {"text": "and", "start": 136, "end": 139, "id": 21, "ws": true}, {"text": "visible", "start": 140, "end": 147, "id": 22, "ws": true}, {"text": "varicosities", "start": 148, "end": 160, "id": 23, "ws": true}, {"text": "of", "start": 161, "end": 163, "id": 24, "ws": true}, {"text": "the", "start": 164, "end": 167, "id": 25, "ws": true}, {"text": "great", "start": 168, "end": 173, "id": 26, "ws": true}, {"text": "saphenous", "start": 174, "end": 183, "id": 27, "ws": true}, {"text": "vein", "start": 184, "end": 188, "id": 28, "ws": true}, {"text": "(", "start": 189, "end": 190, "id": 29, "ws": false}, {"text": "GSV", "start": 190, "end": 193, "id": 30, "ws": false}, {"text": ")", "start": 193, "end": 194, "id": 31, "ws": true}, {"text": "system", "start": 195, "end": 201, "id": 32, "ws": true}, {"text": "above", "start": 202, "end": 207, "id": 33, "ws": true}, {"text": "and", "start": 208, "end": 211, "id": 34, "ws": true}, {"text": "below", "start": 212, "end": 217, "id": 35, "ws": true}, {"text": "the", "start": 218, "end": 221, "id": 36, "ws": true}, {"text": "knee", "start": 222, "end": 226, "id": 37, "ws": false}, {"text": ".", "start": 226, "end": 227, "id": 38, "ws": true}, {"text": "VARITHENA", "start": 228, "end": 237, "id": 39, "ws": true}, {"text": "improves", "start": 238, "end": 246, "id": 40, "ws": true}, {"text": "the", "start": 247, "end": 250, "id": 41, "ws": true}, {"text": "symptoms", "start": 251, "end": 259, "id": 42, "ws": true}, {"text": "of", "start": 260, "end": 262, "id": 43, "ws": true}, {"text": "superficial", "start": 263, "end": 274, "id": 44, "ws": true}, {"text": "venous", "start": 275, "end": 281, "id": 45, "ws": true}, {"text": "incompetence", "start": 282, "end": 294, "id": 46, "ws": true}, {"text": "and", "start": 295, "end": 298, "id": 47, "ws": true}, {"text": "the", "start": 299, "end": 302, "id": 48, "ws": true}, {"text": "appearance", "start": 303, "end": 313, "id": 49, "ws": true}, {"text": "of", "start": 314, "end": 316, "id": 50, "ws": true}, {"text": "visible", "start": 317, "end": 324, "id": 51, "ws": true}, {"text": "varicosities", "start": 325, "end": 337, "id": 52, "ws": false}, {"text": ".", "start": 337, "end": 338, "id": 53, "ws": true}, {"text": "VARITHENA", "start": 339, "end": 348, "id": 54, "ws": true}, {"text": "(", "start": 349, "end": 350, "id": 55, "ws": false}, {"text": "polidocanol", "start": 350, "end": 361, "id": 56, "ws": true}, {"text": "injectable", "start": 362, "end": 372, "id": 57, "ws": true}, {"text": "foam", "start": 373, "end": 377, "id": 58, "ws": false}, {"text": ")", "start": 377, "end": 378, "id": 59, "ws": true}, {"text": "is", "start": 379, "end": 381, "id": 60, "ws": true}, {"text": "a", "start": 382, "end": 383, "id": 61, "ws": true}, {"text": "sclerosing", "start": 384, "end": 394, "id": 62, "ws": true}, {"text": "agent", "start": 395, "end": 400, "id": 63, "ws": true}, {"text": "indicated", "start": 401, "end": 410, "id": 64, "ws": true}, {"text": "for", "start": 411, "end": 414, "id": 65, "ws": true}, {"text": "the", "start": 415, "end": 418, "id": 66, "ws": true}, {"text": "treatment", "start": 419, "end": 428, "id": 67, "ws": true}, {"text": "of", "start": 429, "end": 431, "id": 68, "ws": true}, {"text": "incompetent", "start": 432, "end": 443, "id": 69, "ws": true}, {"text": "great", "start": 444, "end": 449, "id": 70, "ws": true}, {"text": "saphenous", "start": 450, "end": 459, "id": 71, "ws": true}, {"text": "veins", "start": 460, "end": 465, "id": 72, "ws": false}, {"text": ",", "start": 465, "end": 466, "id": 73, "ws": true}, {"text": "accessory", "start": 467, "end": 476, "id": 74, "ws": true}, {"text": "saphenous", "start": 477, "end": 486, "id": 75, "ws": true}, {"text": "veins", "start": 487, "end": 492, "id": 76, "ws": false}, {"text": ",", "start": 492, "end": 493, "id": 77, "ws": true}, {"text": "and", "start": 494, "end": 497, "id": 78, "ws": true}, {"text": "visible", "start": 498, "end": 505, "id": 79, "ws": true}, {"text": "varicosities", "start": 506, "end": 518, "id": 80, "ws": true}, {"text": "of", "start": 519, "end": 521, "id": 81, "ws": true}, {"text": "the", "start": 522, "end": 525, "id": 82, "ws": true}, {"text": "great", "start": 526, "end": 531, "id": 83, "ws": true}, {"text": "saphenous", "start": 532, "end": 541, "id": 84, "ws": true}, {"text": "vein", "start": 542, "end": 546, "id": 85, "ws": true}, {"text": "(", "start": 547, "end": 548, "id": 86, "ws": false}, {"text": "GSV", "start": 548, "end": 551, "id": 87, "ws": false}, {"text": ")", "start": 551, "end": 552, "id": 88, "ws": true}, {"text": "system", "start": 553, "end": 559, "id": 89, "ws": true}, {"text": "above", "start": 560, "end": 565, "id": 90, "ws": true}, {"text": "and", "start": 566, "end": 569, "id": 91, "ws": true}, {"text": "below", "start": 570, "end": 575, "id": 92, "ws": true}, {"text": "the", "start": 576, "end": 579, "id": 93, "ws": true}, {"text": "knee", "start": 580, "end": 584, "id": 94, "ws": false}, {"text": ".", "start": 584, "end": 585, "id": 95, "ws": true}, {"text": "VARITHENA", "start": 586, "end": 595, "id": 96, "ws": true}, {"text": "improves", "start": 596, "end": 604, "id": 97, "ws": true}, {"text": "the", "start": 605, "end": 608, "id": 98, "ws": true}, {"text": "symptoms", "start": 609, "end": 617, "id": 99, "ws": true}, {"text": "of", "start": 618, "end": 620, "id": 100, "ws": true}, {"text": "superficial", "start": 621, "end": 632, "id": 101, "ws": true}, {"text": "venous", "start": 633, "end": 639, "id": 102, "ws": true}, {"text": "incompetence", "start": 640, "end": 652, "id": 103, "ws": true}, {"text": "and", "start": 653, "end": 656, "id": 104, "ws": true}, {"text": "the", "start": 657, "end": 660, "id": 105, "ws": true}, {"text": "appearance", "start": 661, "end": 671, "id": 106, "ws": true}, {"text": "of", "start": 672, "end": 674, "id": 107, "ws": true}, {"text": "visible", "start": 675, "end": 682, "id": 108, "ws": true}, {"text": "varicosities", "start": 683, "end": 695, "id": 109, "ws": false}, {"text": ".", "start": 695, "end": 696, "id": 110, "ws": true}, {"text": "(", "start": 697, "end": 698, "id": 111, "ws": false}, {"text": "1", "start": 698, "end": 699, "id": 112, "ws": false}, {"text": ")", "start": 699, "end": 700, "id": 113, "ws": false}, {"text": ".", "start": 700, "end": 701, "id": 114, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 22, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 23, "end": 33, "token_start": 3, "token_end": 3, "label": "ROUTE"}, {"start": 34, "end": 38, "token_start": 4, "token_end": 4, "label": "FORMULATION"}, {"start": 61, "end": 70, "token_start": 10, "token_end": 10, "label": "ACTION"}, {"start": 74, "end": 107, "token_start": 12, "token_end": 15, "label": "INDICATION"}, {"start": 109, "end": 134, "token_start": 17, "token_end": 19, "label": "INDICATION"}, {"start": 140, "end": 188, "token_start": 22, "token_end": 28, "label": "INDICATION"}, {"start": 222, "end": 226, "token_start": 37, "token_end": 37, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527526, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "NEXPLANON is indicated for use by women to prevent pregnancy. NEXPLANON is a progestin indicated for use by women to prevent pregnancy. (1)", "_input_hash": -787664614, "_task_hash": -510464826, "_is_binary": false, "tokens": [{"text": "NEXPLANON", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 1, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 2, "ws": true}, {"text": "for", "start": 23, "end": 26, "id": 3, "ws": true}, {"text": "use", "start": 27, "end": 30, "id": 4, "ws": true}, {"text": "by", "start": 31, "end": 33, "id": 5, "ws": true}, {"text": "women", "start": 34, "end": 39, "id": 6, "ws": true}, {"text": "to", "start": 40, "end": 42, "id": 7, "ws": true}, {"text": "prevent", "start": 43, "end": 50, "id": 8, "ws": true}, {"text": "pregnancy", "start": 51, "end": 60, "id": 9, "ws": false}, {"text": ".", "start": 60, "end": 61, "id": 10, "ws": true}, {"text": "NEXPLANON", "start": 62, "end": 71, "id": 11, "ws": true}, {"text": "is", "start": 72, "end": 74, "id": 12, "ws": true}, {"text": "a", "start": 75, "end": 76, "id": 13, "ws": true}, {"text": "progestin", "start": 77, "end": 86, "id": 14, "ws": true}, {"text": "indicated", "start": 87, "end": 96, "id": 15, "ws": true}, {"text": "for", "start": 97, "end": 100, "id": 16, "ws": true}, {"text": "use", "start": 101, "end": 104, "id": 17, "ws": true}, {"text": "by", "start": 105, "end": 107, "id": 18, "ws": true}, {"text": "women", "start": 108, "end": 113, "id": 19, "ws": true}, {"text": "to", "start": 114, "end": 116, "id": 20, "ws": true}, {"text": "prevent", "start": 117, "end": 124, "id": 21, "ws": true}, {"text": "pregnancy", "start": 125, "end": 134, "id": 22, "ws": false}, {"text": ".", "start": 134, "end": 135, "id": 23, "ws": true}, {"text": "(", "start": 136, "end": 137, "id": 24, "ws": false}, {"text": "1", "start": 137, "end": 138, "id": 25, "ws": false}, {"text": ")", "start": 138, "end": 139, "id": 26, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 27, "end": 30, "token_start": 4, "token_end": 4, "label": "ACTION"}, {"start": 34, "end": 39, "token_start": 6, "token_end": 6, "label": "TARGET_GROUP"}, {"start": 43, "end": 50, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 51, "end": 60, "token_start": 9, "token_end": 9, "label": "INDICATION"}, {"start": 62, "end": 71, "token_start": 11, "token_end": 11, "label": "DRUG"}, {"start": 77, "end": 86, "token_start": 14, "token_end": 14, "label": "MECHANISM"}, {"start": 101, "end": 104, "token_start": 17, "token_end": 17, "label": "ACTION"}, {"start": 108, "end": 113, "token_start": 19, "token_end": 19, "label": "TARGET_GROUP"}, {"start": 117, "end": 124, "token_start": 21, "token_end": 21, "label": "ACTION"}, {"start": 125, "end": 134, "token_start": 22, "token_end": 22, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527651, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "REYVOW is indicated for the acute treatment of migraine with or without aura in adults. REYVOW is a serotonin (5-HT) 1F receptor agonist indicated for the acute treatment of migraine with or without aura in adults. (1) Limitations of Use REYVOW is not indicated for the preventive treatment of migraine. (1) Limitations of Use REYVOW is not indicated for the preventive treatment of migraine.", "_input_hash": 963635482, "_task_hash": 74789984, "_is_binary": false, "tokens": [{"text": "REYVOW", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "for", "start": 20, "end": 23, "id": 3, "ws": true}, {"text": "the", "start": 24, "end": 27, "id": 4, "ws": true}, {"text": "acute", "start": 28, "end": 33, "id": 5, "ws": true}, {"text": "treatment", "start": 34, "end": 43, "id": 6, "ws": true}, {"text": "of", "start": 44, "end": 46, "id": 7, "ws": true}, {"text": "migraine", "start": 47, "end": 55, "id": 8, "ws": true}, {"text": "with", "start": 56, "end": 60, "id": 9, "ws": true}, {"text": "or", "start": 61, "end": 63, "id": 10, "ws": true}, {"text": "without", "start": 64, "end": 71, "id": 11, "ws": true}, {"text": "aura", "start": 72, "end": 76, "id": 12, "ws": true}, {"text": "in", "start": 77, "end": 79, "id": 13, "ws": true}, {"text": "adults", "start": 80, "end": 86, "id": 14, "ws": false}, {"text": ".", "start": 86, "end": 87, "id": 15, "ws": true}, {"text": "REYVOW", "start": 88, "end": 94, "id": 16, "ws": true}, {"text": "is", "start": 95, "end": 97, "id": 17, "ws": true}, {"text": "a", "start": 98, "end": 99, "id": 18, "ws": true}, {"text": "serotonin", "start": 100, "end": 109, "id": 19, "ws": true}, {"text": "(", "start": 110, "end": 111, "id": 20, "ws": false}, {"text": "5", "start": 111, "end": 112, "id": 21, "ws": false}, {"text": "-", "start": 112, "end": 113, "id": 22, "ws": false}, {"text": "HT", "start": 113, "end": 115, "id": 23, "ws": false}, {"text": ")", "start": 115, "end": 116, "id": 24, "ws": true}, {"text": "1F", "start": 117, "end": 119, "id": 25, "ws": true}, {"text": "receptor", "start": 120, "end": 128, "id": 26, "ws": true}, {"text": "agonist", "start": 129, "end": 136, "id": 27, "ws": true}, {"text": "indicated", "start": 137, "end": 146, "id": 28, "ws": true}, {"text": "for", "start": 147, "end": 150, "id": 29, "ws": true}, {"text": "the", "start": 151, "end": 154, "id": 30, "ws": true}, {"text": "acute", "start": 155, "end": 160, "id": 31, "ws": true}, {"text": "treatment", "start": 161, "end": 170, "id": 32, "ws": true}, {"text": "of", "start": 171, "end": 173, "id": 33, "ws": true}, {"text": "migraine", "start": 174, "end": 182, "id": 34, "ws": true}, {"text": "with", "start": 183, "end": 187, "id": 35, "ws": true}, {"text": "or", "start": 188, "end": 190, "id": 36, "ws": true}, {"text": "without", "start": 191, "end": 198, "id": 37, "ws": true}, {"text": "aura", "start": 199, "end": 203, "id": 38, "ws": true}, {"text": "in", "start": 204, "end": 206, "id": 39, "ws": true}, {"text": "adults", "start": 207, "end": 213, "id": 40, "ws": false}, {"text": ".", "start": 213, "end": 214, "id": 41, "ws": true}, {"text": "(", "start": 215, "end": 216, "id": 42, "ws": false}, {"text": "1", "start": 216, "end": 217, "id": 43, "ws": false}, {"text": ")", "start": 217, "end": 218, "id": 44, "ws": true}, {"text": "Limitations", "start": 219, "end": 230, "id": 45, "ws": true}, {"text": "of", "start": 231, "end": 233, "id": 46, "ws": true}, {"text": "Use", "start": 234, "end": 237, "id": 47, "ws": true}, {"text": "REYVOW", "start": 238, "end": 244, "id": 48, "ws": true}, {"text": "is", "start": 245, "end": 247, "id": 49, "ws": true}, {"text": "not", "start": 248, "end": 251, "id": 50, "ws": true}, {"text": "indicated", "start": 252, "end": 261, "id": 51, "ws": true}, {"text": "for", "start": 262, "end": 265, "id": 52, "ws": true}, {"text": "the", "start": 266, "end": 269, "id": 53, "ws": true}, {"text": "preventive", "start": 270, "end": 280, "id": 54, "ws": true}, {"text": "treatment", "start": 281, "end": 290, "id": 55, "ws": true}, {"text": "of", "start": 291, "end": 293, "id": 56, "ws": true}, {"text": "migraine", "start": 294, "end": 302, "id": 57, "ws": false}, {"text": ".", "start": 302, "end": 303, "id": 58, "ws": true}, {"text": "(", "start": 304, "end": 305, "id": 59, "ws": false}, {"text": "1", "start": 305, "end": 306, "id": 60, "ws": false}, {"text": ")", "start": 306, "end": 307, "id": 61, "ws": true}, {"text": "Limitations", "start": 308, "end": 319, "id": 62, "ws": true}, {"text": "of", "start": 320, "end": 322, "id": 63, "ws": true}, {"text": "Use", "start": 323, "end": 326, "id": 64, "ws": true}, {"text": "REYVOW", "start": 327, "end": 333, "id": 65, "ws": true}, {"text": "is", "start": 334, "end": 336, "id": 66, "ws": true}, {"text": "not", "start": 337, "end": 340, "id": 67, "ws": true}, {"text": "indicated", "start": 341, "end": 350, "id": 68, "ws": true}, {"text": "for", "start": 351, "end": 354, "id": 69, "ws": true}, {"text": "the", "start": 355, "end": 358, "id": 70, "ws": true}, {"text": "preventive", "start": 359, "end": 369, "id": 71, "ws": true}, {"text": "treatment", "start": 370, "end": 379, "id": 72, "ws": true}, {"text": "of", "start": 380, "end": 382, "id": 73, "ws": true}, {"text": "migraine", "start": 383, "end": 391, "id": 74, "ws": false}, {"text": ".", "start": 391, "end": 392, "id": 75, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 34, "end": 43, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 47, "end": 55, "token_start": 8, "token_end": 8, "label": "INDICATION"}, {"start": 80, "end": 86, "token_start": 14, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 88, "end": 94, "token_start": 16, "token_end": 16, "label": "DRUG"}, {"start": 100, "end": 136, "token_start": 19, "token_end": 27, "label": "MECHANISM"}, {"start": 161, "end": 170, "token_start": 32, "token_end": 32, "label": "ACTION"}, {"start": 174, "end": 182, "token_start": 34, "token_end": 34, "label": "INDICATION"}, {"start": 207, "end": 213, "token_start": 40, "token_end": 40, "label": "TARGET_GROUP"}, {"start": 238, "end": 302, "token_start": 48, "token_end": 57, "label": "CONTRAINDICATION"}, {"start": 327, "end": 391, "token_start": 65, "token_end": 74, "label": "CONTRAINDICATION"}], "answer": "accept", "_timestamp": 1694175684, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Oxycodone and aspirin tablets are indicated for the management of moderate to moderately severe pain.", "_input_hash": 1322635632, "_task_hash": 1029793407, "_is_binary": false, "tokens": [{"text": "Oxycodone", "start": 0, "end": 9, "id": 0, "ws": true}, {"text": "and", "start": 10, "end": 13, "id": 1, "ws": true}, {"text": "aspirin", "start": 14, "end": 21, "id": 2, "ws": true}, {"text": "tablets", "start": 22, "end": 29, "id": 3, "ws": true}, {"text": "are", "start": 30, "end": 33, "id": 4, "ws": true}, {"text": "indicated", "start": 34, "end": 43, "id": 5, "ws": true}, {"text": "for", "start": 44, "end": 47, "id": 6, "ws": true}, {"text": "the", "start": 48, "end": 51, "id": 7, "ws": true}, {"text": "management", "start": 52, "end": 62, "id": 8, "ws": true}, {"text": "of", "start": 63, "end": 65, "id": 9, "ws": true}, {"text": "moderate", "start": 66, "end": 74, "id": 10, "ws": true}, {"text": "to", "start": 75, "end": 77, "id": 11, "ws": true}, {"text": "moderately", "start": 78, "end": 88, "id": 12, "ws": true}, {"text": "severe", "start": 89, "end": 95, "id": 13, "ws": true}, {"text": "pain", "start": 96, "end": 100, "id": 14, "ws": false}, {"text": ".", "start": 100, "end": 101, "id": 15, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 9, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 21, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 22, "end": 29, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 52, "end": 62, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 66, "end": 95, "token_start": 10, "token_end": 13, "label": "SEVERITY"}, {"start": 96, "end": 100, "token_start": 14, "token_end": 14, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527222, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
